Compound ID,Uniprot ID,Compound Name,Standard inchi key,Max Phase,Target Pref Name,Gene Names,Target Class,Wild type or mutant,Mutation information,PubMed ID,End Point Standard Type,End Point Standard Relation,End Point Standard Value,End Point Standard Units,Endpoint Mode of Action,Assay Format,Assay Type,Assay Sub Type,Inhibitor Type,Detection Technology,Compound concentration value,Compound concentration value units,Substrate type,Substrate Type Standard Relation,Substrate Type Standard Value,Substrate Type Standard Units,Assay cell line,Assay Description,Activity Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation Comments,Assay ID,DTC Tid,DTC Activity ID,DTC Molregno,Record ID,DTC Document ID
CHEMBL10,P23975,SB-203580,CDMGBJANTYXAIV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482013,DTCC00132413,2089752,46191
CHEMBL10,P23975,SB-203580,CDMGBJANTYXAIV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482014,DTCC00132413,2089752,46191
CHEMBL1006,P23975,AMIFOSTINE,JKOQGQFVAUAYPM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290025,DTCC00224760,898282,46191
CHEMBL1006,P23975,AMIFOSTINE,JKOQGQFVAUAYPM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290026,DTCC00224760,898282,46191
CHEMBL1009,P23975,LEVODOPA,WTDRDQBEARUVNC-LURJTMIESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423055,DTCC00224903,1351112,46191
CHEMBL1009,P23975,LEVODOPA,WTDRDQBEARUVNC-LURJTMIESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423056,DTCC00224903,1351112,46191
CHEMBL101,P23975,PHENYLBUTAZONE,VYMDGNCVAMGZFE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7397989,DTCC00142582,217583,46191
CHEMBL101,P23975,PHENYLBUTAZONE,VYMDGNCVAMGZFE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7397990,DTCC00142582,217583,46191
CHEMBL101055,P23975,,XLJMMCKWKGQCNY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,208,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657197,DTCC00265752,876952,30478
CHEMBL101055,P23975,,XLJMMCKWKGQCNY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,316,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657168,DTCC00265752,876952,30478
CHEMBL101168,P23975,1-AMINOBENZOTRIAZOLE,JCXKHYLLVKZPKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301368,DTCC01742000,2057641,46191
CHEMBL101168,P23975,1-AMINOBENZOTRIAZOLE,JCXKHYLLVKZPKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301369,DTCC01742000,2057641,46191
CHEMBL101250,P23975,,QDNMERQLRWGGDY-AXRJEEMOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10698458,IC50,=,296,NM,,cell_based,,,,,,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,2000,10,3,"Tamiz AP, Smith MP, Kozikowski AP",,142803,DTCT0023180,1149336,DTCC00270669,906843,4077
CHEMBL1016,P23975,CANDESARTAN,HTQMVQVXFRQIKW-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3065.2,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269089,DTCC00228418,413969,46191
CHEMBL1016,P23975,CANDESARTAN,HTQMVQVXFRQIKW-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3039.8,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269090,DTCC00228418,413969,46191
CHEMBL101740,P23975,CIDOXEPIN,ODQWQRRAPPTVAG-BOPFTXTBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,29.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14758919,DTCC00106776,2111389,68566
CHEMBL101740,P23975,CIDOXEPIN,ODQWQRRAPPTVAG-BOPFTXTBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,29.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14759568,DTCC00106776,2111389,68566
CHEMBL101899,P23975,,ZUFCXVFSSJFSOT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,121,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657195,DTCC00265751,455880,30478
CHEMBL101899,P23975,,ZUFCXVFSSJFSOT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,149,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657166,DTCC00265751,455880,30478
CHEMBL101905,P23975,,BMNNHOAPHMYHIH-NUWOQIAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10698458,IC50,=,2.2,NM,,cell_based,,,,,,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,2000,10,3,"Tamiz AP, Smith MP, Kozikowski AP",,142803,DTCT0023180,1150450,DTCC00269662,1668755,4077
CHEMBL1020,P23975,TOLMETIN,UPSPUYADGBWSHF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7470544,DTCC00229841,477924,46191
CHEMBL1020,P23975,TOLMETIN,UPSPUYADGBWSHF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7470545,DTCC00229841,477924,46191
CHEMBL102018,P23975,,NWRMTPHQJUHLJH-NOZYUVCASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10698458,IC50,=,110,NM,,cell_based,,,,,,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,2000,10,3,"Tamiz AP, Smith MP, Kozikowski AP",,142803,DTCT0023180,1170412,DTCC00270720,226144,4077
CHEMBL1024,P23975,IFOSFAMIDE,HOMGKSMUEGBAAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304445,DTCC00230672,703982,46191
CHEMBL1024,P23975,IFOSFAMIDE,HOMGKSMUEGBAAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304446,DTCC00230672,703982,46191
CHEMBL103,P23975,PROGESTERONE,RJKFOVLPORLFTN-LEKSSAKUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372725,DTCC00142899,1092348,46191
CHEMBL103,P23975,PROGESTERONE,RJKFOVLPORLFTN-LEKSSAKUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372726,DTCC00142899,1092348,46191
CHEMBL10316,P23975,IDAZOXAN,HPMRFMKYPGXPEP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,961334,DTCC00137754,369489,13807
CHEMBL103504,P23975,,DZQDCXYKGIEDDJ-XBBDAYDNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10698458,IC50,=,18,NM,,cell_based,,,,,,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,2000,10,3,"Tamiz AP, Smith MP, Kozikowski AP",,142803,DTCT0023180,1144412,DTCC00270703,1035590,4077
CHEMBL103701,P23975,,GZWGAKOZADNOEU-NPHMYQBISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10698458,IC50,=,109,NM,,cell_based,,,,,,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,2000,10,3,"Tamiz AP, Smith MP, Kozikowski AP",,142803,DTCT0023180,1152710,DTCC00270675,64705,4077
CHEMBL103936,P23975,,SKSUKRWKVAZHJI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,46700,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149707,DTCC00269421,1378089,23432
CHEMBL103936,P23975,,SKSUKRWKVAZHJI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150040,DTCC00269421,1378089,23432
CHEMBL104,P23975,CLOTRIMAZOLE,VNFPBHJOKIVQEB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,7936,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7356553,DTCC00143452,1960074,46191
CHEMBL104,P23975,CLOTRIMAZOLE,VNFPBHJOKIVQEB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,7870,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7356554,DTCC00143452,1960074,46191
CHEMBL1042,P23975,CHOLECALCIFEROL,QYSXJUFSXHHAJI-YRZJJWOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351771,DTCC00235252,1992802,46191
CHEMBL1042,P23975,CHOLECALCIFEROL,QYSXJUFSXHHAJI-YRZJJWOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351772,DTCC00235252,1992802,46191
CHEMBL1046,P23975,AMINOCAPROIC ACID,SLXKOJJOQWFEFD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298145,DTCC00237384,574618,46191
CHEMBL1046,P23975,AMINOCAPROIC ACID,SLXKOJJOQWFEFD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298146,DTCC00237384,574618,46191
CHEMBL104673,P23975,,JJAUMTXFZLAGOI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10956218,KI,=,1205,NM,,,,,,,,,,,,,,In vitro binding affinity on cloned Norepinephrine transporter,,"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.",J. Med. Chem.,2000,43,16,"Wilson AA, Ginovart N, Schmidt M, Meyer JH, Threlkeld PG, Houle S",,142937,DTCT0023180,565161,DTCC00274975,853566,15844
CHEMBL104700,P23975,,SCDKHPSUXHBJDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478144,DTCC00272114,931177,48255
CHEMBL105,P23975,MITOMYCIN,NWIBSHFKIJFRCO-WUDYKRTCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7430527,DTCC00143504,542580,46191
CHEMBL105,P23975,MITOMYCIN,NWIBSHFKIJFRCO-WUDYKRTCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7430528,DTCC00143504,542580,46191
CHEMBL1054,P23975,TRICHLORMETHIAZIDE,LMJSLTNSBFUCMU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448164,DTCC00242621,2025646,46191
CHEMBL1054,P23975,TRICHLORMETHIAZIDE,LMJSLTNSBFUCMU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448165,DTCC00242621,2025646,46191
CHEMBL1055,P23975,CHLORTHALIDONE,JIVPVXMEBJLZRO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7343209,DTCC00242796,1798406,46191
CHEMBL1055,P23975,CHLORTHALIDONE,JIVPVXMEBJLZRO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7343210,DTCC00242796,1798406,46191
CHEMBL106,P23975,FLUCONAZOLE,RFHAOTPXVQNOHP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335309,DTCC00143630,51470,46191
CHEMBL106,P23975,FLUCONAZOLE,RFHAOTPXVQNOHP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335310,DTCC00143630,51470,46191
CHEMBL1062,P23975,HYDROXYPROGESTERONE,DBPWSSGDRRHUNT-CEGNMAFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312902,DTCC00245885,1092342,46191
CHEMBL1062,P23975,HYDROXYPROGESTERONE,DBPWSSGDRRHUNT-CEGNMAFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312903,DTCC00245885,1092342,46191
CHEMBL1064,P23975,SIMVASTATIN,RYMZZMVNJRMUDD-HGQWONQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7480086,DTCC00246331,217585,46191
CHEMBL1064,P23975,SIMVASTATIN,RYMZZMVNJRMUDD-HGQWONQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7480087,DTCC00246331,217585,46191
CHEMBL1065,P23975,METHYSERGIDE,KPJZHOPZRAFDTN-ZRGWGRIASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7438873,DTCC00246366,1124452,46191
CHEMBL1065,P23975,METHYSERGIDE,KPJZHOPZRAFDTN-ZRGWGRIASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7438874,DTCC00246366,1124452,46191
CHEMBL1068,P23975,OXCARBAZEPINE,CTRLABGOLIVAIY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7388875,DTCC00246694,1285880,46191
CHEMBL1068,P23975,OXCARBAZEPINE,CTRLABGOLIVAIY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7388876,DTCC00246694,1285880,46191
CHEMBL1069,P23975,VALSARTAN,ACWBQPMHZXGDFX-QFIPXVFZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444796,DTCC00246716,1992811,46191
CHEMBL1069,P23975,VALSARTAN,ACWBQPMHZXGDFX-QFIPXVFZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444797,DTCC00246716,1992811,46191
CHEMBL106939,P23975,,UVWLEPXXYOYDGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10956218,KI,=,1350,NM,,,,,,,,,,,,,,In vitro binding affinity on cloned Norepinephrine transporter,,"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.",J. Med. Chem.,2000,43,16,"Wilson AA, Ginovart N, Schmidt M, Meyer JH, Threlkeld PG, Houle S",,142937,DTCT0023180,556756,DTCC00275056,594703,15844
CHEMBL106939,P23975,,UVWLEPXXYOYDGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15456270,KI,>,1000,NM,,cell_based,,,,,,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,2004,47,21,"Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP",,303519,DTCT0023180,1793402,DTCC00275056,584493,19119
CHEMBL106939,P23975,,UVWLEPXXYOYDGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,5127,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822314,DTCC00275056,584567,19630
CHEMBL107,P23975,COLCHICINE,IAKHMKGGTNLKSZ-INIZCTEOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7346004,DTCC00144185,153441,46191
CHEMBL107,P23975,COLCHICINE,IAKHMKGGTNLKSZ-INIZCTEOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7346005,DTCC00144185,153441,46191
CHEMBL1070,P23975,NABUMETONE,BLXXJMDCKKHMKV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1868,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7424453,DTCC00246857,1992808,46191
CHEMBL1070,P23975,NABUMETONE,BLXXJMDCKKHMKV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1853,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7424454,DTCC00246857,1992808,46191
CHEMBL107077,P23975,,HYOCZQPMJUZYKD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10956218,KI,=,1992,NM,,,,,,,,,,,,,,In vitro binding affinity on cloned Norepinephrine transporter,,"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.",J. Med. Chem.,2000,43,16,"Wilson AA, Ginovart N, Schmidt M, Meyer JH, Threlkeld PG, Houle S",,142937,DTCT0023180,566101,DTCC00275255,1079699,15844
CHEMBL1071,P23975,OXAPROZIN,OFPXSFXSNFPTHF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7384520,DTCC00246868,1092346,46191
CHEMBL1071,P23975,OXAPROZIN,OFPXSFXSNFPTHF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7384521,DTCC00246868,1092346,46191
CHEMBL1073,P23975,GLIPIZIDE,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325245,DTCC00246919,1285876,46191
CHEMBL1073,P23975,GLIPIZIDE,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325246,DTCC00246919,1285876,46191
CHEMBL1075627,P23975,,ODLHCKMRHURGDZ-MIBBOOFZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263143,DTCC00628124,921687,37806
CHEMBL1076211,P23975,TOLPERISONE,FSKFPVLPFLJRQB-UHFFFAOYSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7479279,DTCC00627461,315671,46191
CHEMBL1076211,P23975,TOLPERISONE,FSKFPVLPFLJRQB-UHFFFAOYSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7479280,DTCC00627461,315671,46191
CHEMBL1076360,P23975,,RZMZSLGBWMSARY-ZWRUYHAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in COS7 cells assessed as inhibition of [3H]norepinephrine uptake at 1 uM,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620286,DTCT0023180,3263158,DTCC00628101,112521,37806
CHEMBL1076360,P23975,,RZMZSLGBWMSARY-ZWRUYHAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,IC50,=,181.97,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263156,DTCC00628101,112521,37806
CHEMBL1076360,P23975,,RZMZSLGBWMSARY-ZWRUYHAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,LOGEC50,=,-6.74,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in COS7 cells assessed as inhibition of [3H]norepinephrine uptake,,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620287,DTCT0023180,3263157,DTCC00628101,112521,37806
CHEMBL1076366,P23975,,WXWLWERTZPQZCF-HRIPAEOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263110,DTCC00628107,663290,37806
CHEMBL1076367,P23975,,RRVNDCQJFDMBLZ-ZIZRRBHYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263112,DTCC00628108,437660,37806
CHEMBL1076368,P23975,,BUUOITHKMQYTQY-ZWRUYHAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263111,DTCC00628109,1116264,37806
CHEMBL1076369,P23975,,PBRMKXYKEKJWTD-CISKXPIPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263109,DTCC00628110,566393,37806
CHEMBL1076370,P23975,,RZCFFRMJSWPPMC-WBFXVXKESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263134,DTCC00628116,405595,37806
CHEMBL1076371,P23975,,PPGSXHUOGGBHHP-YNBFDDPPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263133,DTCC00628117,1083724,37806
CHEMBL1076372,P23975,,JMMANJJHPYIIKO-WBFXVXKESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263132,DTCC00628118,1439566,37806
CHEMBL1076373,P23975,,INIVRKBZJAJTGE-UUPYPVMGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263131,DTCC00628119,1471978,37806
CHEMBL1076374,P23975,,LFFZPLJZCPCTRA-WIRYOQIKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263144,DTCC00628123,1211800,37806
CHEMBL1076375,P23975,,ASGUPSYAPIGYKQ-ATAGQQDESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263142,DTCC00628125,469396,37806
CHEMBL1076376,P23975,,RDWNVUCLDHTWPI-MLSOLMIFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263139,DTCC00628126,1789833,37806
CHEMBL1076377,P23975,,BOKVAQSTZQNOIA-UVWWSMGFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263113,DTCC00628111,112522,37806
CHEMBL1076378,P23975,,HPLIJTVQBQSTDD-ZWRUYHAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263116,DTCC00628112,502049,37806
CHEMBL1076379,P23975,,OVMNIKGRTOYPDR-JATJWMBJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263115,DTCC00628113,534164,37806
CHEMBL1076380,P23975,,BWNPTZCMCUMGFU-IAMOBIESSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263114,DTCC00628114,857613,37806
CHEMBL1076381,P23975,,PRJXZTZPPOXOHQ-BLPBYGFISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263128,DTCC00628115,695583,37806
CHEMBL1076382,P23975,,DPMFIKUKSRSTHR-STYDTVTQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263130,DTCC00628120,1789830,37806
CHEMBL1076383,P23975,,RAVKGPRQAKJYQC-CISKXPIPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263129,DTCC00628121,437661,37806
CHEMBL1076384,P23975,,JQMZORXHAOQOMZ-HVHKLXTMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263140,DTCC00628122,1568571,37806
CHEMBL1076385,P23975,,RZMZSLGBWMSARY-VBIRFCDQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263150,DTCC00621432,502051,37806
CHEMBL1076386,P23975,,RZMZSLGBWMSARY-CAKWXZNXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263149,DTCC00625073,1568572,37806
CHEMBL1076387,P23975,,RZMZSLGBWMSARY-HBHWHIAESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263151,DTCC00625599,1407714,37806
CHEMBL1076388,P23975,,RZMZSLGBWMSARY-GFFHZWSNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263148,DTCC00628127,1148669,37806
CHEMBL1076389,P23975,,XCAPQYWGCHEMFA-JXJOGBRVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263141,DTCC00628128,1407713,37806
CHEMBL1076390,P23975,,RZMZSLGBWMSARY-NILNYKIASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263145,DTCC00628129,1727139,37806
CHEMBL1076391,P23975,,RZMZSLGBWMSARY-NJPHSXLDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263147,DTCC00626492,307367,37806
CHEMBL1076392,P23975,,LYZSYRVZMDTIKX-QLYQYUPWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263146,DTCC00628130,2081495,37806
CHEMBL1076393,P23975,,DJWCABWSEAXBCU-BOTYWPRBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263152,DTCC00628131,1375281,37806
CHEMBL1076394,P23975,,ZSLRJBTZLBKDHH-AEXJFDPHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263122,DTCC00628139,1697754,37806
CHEMBL1076395,P23975,,AHRCLHZVCLENJC-KMFDXPJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263121,DTCC00628140,1727140,37806
CHEMBL1076396,P23975,,FTMPAENPBHVAOJ-QLOTUHGJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263120,DTCC00628141,986367,37806
CHEMBL1076397,P23975,,SZRIYBBJSDFTBY-LJJGSBRBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263119,DTCC00628142,1439567,37806
CHEMBL1076398,P23975,,HGJXQBURQUDARU-YNBFDDPPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263126,DTCC00628135,1536659,37806
CHEMBL1076399,P23975,,CIKMPDFZQJOHQC-QLOTUHGJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263125,DTCC00628136,953960,37806
CHEMBL1076400,P23975,,JMXYLTXGYKFHEY-AFYXJIINSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263124,DTCC00628137,1822315,37806
CHEMBL1076401,P23975,,ZVAYAKGYURRAPZ-AEXJFDPHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263123,DTCC00628138,1051089,37806
CHEMBL1076402,P23975,,QESSYWKKODTFHV-DNUYABSHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263153,DTCC00628132,1018612,37806
CHEMBL1076403,P23975,,IVKLSMVTZWVITC-GLNHKFLLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263154,DTCC00628133,340007,37806
CHEMBL1076404,P23975,,UOTRVSJUPBLQSJ-ZWRUYHAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263127,DTCC00628134,824707,37806
CHEMBL1076405,P23975,,PSGQFYHSPPQQPO-HFKIQIMQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263118,DTCC00628143,1951518,37806
CHEMBL1076406,P23975,,RZMZSLGBWMSARY-OECJZXFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263049,DTCC00628144,792152,37806
CHEMBL1076407,P23975,,YDKFYCWSHGTMTO-SQKGNGEWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,Not Active,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620285,DTCT0023180,3263117,DTCC00628145,1727141,37806
CHEMBL1076586,P23975,,APHXKHUFVKITGC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232512,DTCC00628883,1395765,37887
CHEMBL1077,P23975,BROMFENAC,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7261602,DTCC00247634,930077,46191
CHEMBL1077,P23975,BROMFENAC,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7261603,DTCC00247634,930077,46191
CHEMBL1077202,P23975,,HDTINEVDGKNACJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,910,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224267,DTCC00631135,1330734,38126
CHEMBL1077209,P23975,,OYUQXAOEDHJVKK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,88,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224276,DTCC00631210,1168041,38126
CHEMBL1077638,P23975,,CCXVQWDBHGEOJC-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,103,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265123,DTCC00633241,1083776,37586
CHEMBL1077647,P23975,,UAOCSOBBQYATOV-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,198,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265119,DTCC00633174,663340,37586
CHEMBL1078073,P23975,,UWLXWGKTAMTBSF-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,139,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265127,DTCC00633245,598664,37586
CHEMBL1078074,P23975,,JEEXCFPOFSQJAA-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265128,DTCC00633246,792204,37586
CHEMBL1078076,P23975,,GZJJRCVIVJXCPO-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,263,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265129,DTCC00633287,1633481,37586
CHEMBL1078162,P23975,,VJADHLVJCCCGKY-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,29,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265124,DTCC00633242,2081552,37586
CHEMBL1078163,P23975,,NFOLOYSQMPQIMO-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,69,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265125,DTCC00633243,1310194,37586
CHEMBL1078164,P23975,,KKHPGFXTXRPZGB-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,67,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265126,DTCC00633244,1375343,37586
CHEMBL1078169,P23975,,WUTRVCAUFFQVGX-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,65,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265130,DTCC00633288,405640,37586
CHEMBL1078170,P23975,,PIKCALBGLDBAKK-LLVKDONJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,169,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265131,DTCC00633289,1951559,37586
CHEMBL1078312,P23975,,JSYQQBKBYKJHAO-VIFPVBQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,217,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265108,DTCC00124864,1665790,37586
CHEMBL1078741,P23975,,IECZTWNGAWLQAQ-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,43,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265120,DTCC00633175,792203,37586
CHEMBL1078742,P23975,,ZMEHJZMEBDWMRH-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,50,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265121,DTCC00633176,80382,37586
CHEMBL1078743,P23975,,CMNJEKBHBKVRME-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,135,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265122,DTCC00633177,1342749,37586
CHEMBL1079079,P23975,,WGIPGQAPFNVWIX-XXFZXMJFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19767206,INHIBITION,<,50,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM by scintillation counting,,Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.,Bioorg. Med. Chem. Lett.,2009,19,21,"Donohue SR, Varnäs K, Jia Z, Gulyás B, Pike VW, Halldin C",,619820,DTCT0023180,3267827,DTCC00632772,857661,37697
CHEMBL1079263,P23975,,AUYQRPCINYAISL-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265116,DTCC00633171,1375342,37586
CHEMBL1079264,P23975,,IAPNVLHDPZOUSQ-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265117,DTCC00633172,1918713,37586
CHEMBL1079265,P23975,,IDJLHSSQHKZAPT-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,37,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265118,DTCC00633173,1407752,37586
CHEMBL1079973,P23975,,ZLUFXVJXYLAVEN-AWDFDDCISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20138515,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 1 uM,Active,Synthesis and in vitro evaluation of (18)F-labelled S-fluoroalkyl diarylguanidines: Novel high-affinity NMDA receptor antagonists for imaging with PET.,Bioorg. Med. Chem. Lett.,2010,20,5,"Robins EG, Zhao Y, Khan I, Wilson A, Luthra SK, Rstad E",,616388,DTCT0023180,3239431,DTCC00628690,812837,38076
CHEMBL1079973,P23975,,ZLUFXVJXYLAVEN-AWDFDDCISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20138515,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 10 nM,Not Active,Synthesis and in vitro evaluation of (18)F-labelled S-fluoroalkyl diarylguanidines: Novel high-affinity NMDA receptor antagonists for imaging with PET.,Bioorg. Med. Chem. Lett.,2010,20,5,"Robins EG, Zhao Y, Khan I, Wilson A, Luthra SK, Rstad E",,616396,DTCT0023180,3239452,DTCC00628690,812837,38076
CHEMBL108,P23975,CARBAMAZEPINE,FFGPTBGBLSHEPO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7262068,DTCC00144764,249939,46191
CHEMBL108,P23975,CARBAMAZEPINE,FFGPTBGBLSHEPO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7262069,DTCC00144764,249939,46191
CHEMBL1080069,P23975,,GAOZHRLCFIUCBN-JTQLQIEISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,36,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265109,DTCC00634087,1148723,37586
CHEMBL1080155,P23975,,UPQNBHKMICCAIA-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232515,DTCC00628951,360780,37887
CHEMBL1080389,P23975,,MESZSUFNQDICOD-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232520,DTCC00629139,845782,37887
CHEMBL1080556,P23975,,ZMAZHOAGBMLOSO-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232521,DTCC00629140,1972518,37887
CHEMBL1080735,P23975,,CZUGKEKGXKWONC-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232522,DTCC00629141,1557015,37887
CHEMBL1080755,P23975,,MIJPHKXHAZCAQK-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232525,DTCC00629203,1428131,37887
CHEMBL1080787,P23975,PF-184298,PIKCALBGLDBAKK-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,21,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265110,DTCC00030741,502108,37586
CHEMBL1080787,P23975,PF-184298,PIKCALBGLDBAKK-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,21,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348373,DTCC00030741,502239,39093
CHEMBL1080788,P23975,,IUTSKNRONKMGOS-QMMMGPOBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,95,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265111,DTCC00634088,921742,37586
CHEMBL1080789,P23975,,GZAWVIWERRSMCS-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,24,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265112,DTCC00124867,1854443,37586
CHEMBL1080790,P23975,,GSMFLJBANXQXTM-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,13,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265113,DTCC00124868,1665791,37586
CHEMBL1080907,P23975,,LADSERODBYZUAW-FQEVSTJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232523,DTCC00629142,619263,37887
CHEMBL1080926,P23975,,KFUNLUIORXHBPH-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232526,DTCC00629204,68682,37887
CHEMBL1080968,P23975,,MPGDFMOXIHFZSL-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265114,DTCC00124869,1789884,37586
CHEMBL1080969,P23975,,PMZYRKGBQBCWOA-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,37,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265115,DTCC00124870,241663,37586
CHEMBL1081212,P23975,,WGTCBXOFOSMWEQ-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232519,DTCC00629053,1746137,37887
CHEMBL1081254,P23975,,ZALZZXXESRJJEH-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232524,DTCC00629202,1524928,37887
CHEMBL1081648,P23975,,YNLYAYGRKYOTBJ-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232513,DTCC00628885,133282,37887
CHEMBL1081649,P23975,,YNLYAYGRKYOTBJ-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232514,DTCC00628886,1298076,37887
CHEMBL1082,P23975,AMOXICILLIN,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7284697,DTCC00250356,51444,46191
CHEMBL1082,P23975,AMOXICILLIN,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7284698,DTCC00250356,51444,46191
CHEMBL1082209,P23975,,MYYHPWVXRPLYMD-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232516,DTCC00629050,1428125,37887
CHEMBL1082210,P23975,,LGKIWGDJKNJYMG-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232517,DTCC00629051,1717622,37887
CHEMBL1082211,P23975,,GGUUYQBMWBFCFQ-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615847,DTCT0023180,3232518,DTCC00629052,68680,37887
CHEMBL1082292,P23975,,HSMMZWQHSZFBQK-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,155,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342513,DTCC00646351,1245006,39069
CHEMBL1082292,P23975,,HSMMZWQHSZFBQK-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,294,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342534,DTCC00646351,1245006,39069
CHEMBL1082458,P23975,,PHSDSMUCNUCJGQ-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,1,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3341764,DTCC00646290,824910,39069
CHEMBL1082458,P23975,,PHSDSMUCNUCJGQ-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3341769,DTCC00646290,824910,39069
CHEMBL1082458,P23975,,PHSDSMUCNUCJGQ-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093894,DTCC00646290,832216,45987
CHEMBL1082458,P23975,,PHSDSMUCNUCJGQ-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093908,DTCC00646290,832216,45987
CHEMBL1082459,P23975,,HZFCYBLDOJMSFO-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,48,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342516,DTCC00646291,1536867,39069
CHEMBL1082459,P23975,,HZFCYBLDOJMSFO-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,61,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342520,DTCC00646291,1536867,39069
CHEMBL1082534,P23975,,KOMVBLAWAGFCNI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,1030,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224261,DTCC00631060,426188,38126
CHEMBL1082611,P23975,,RDRQTGHODUVHMX-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,36,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342567,DTCC00646473,1822503,39069
CHEMBL1082611,P23975,,RDRQTGHODUVHMX-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,43,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342517,DTCC00646473,1822503,39069
CHEMBL1082723,P23975,NITD609,CKLPLPZSUQEDRT-WPCRTTGESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20813948,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant norepinephrine transporter,,"Spiroindolones, a potent compound class for the treatment of malaria.",Science,2010,329,5996,"Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, González-Páez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT",,658576,DTCT0023180,3467853,DTCC00031143,1686650,40818
CHEMBL1083083,P23975,,PHSDSMUCNUCJGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342558,DTCC00646150,986558,39069
CHEMBL1083083,P23975,,PHSDSMUCNUCJGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,10,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342508,DTCC00646150,986558,39069
CHEMBL1083118,P23975,,UJEHPOIYQOLYRD-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3341771,DTCC00646469,1342903,39069
CHEMBL1083118,P23975,,UJEHPOIYQOLYRD-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3341761,DTCC00646469,1342903,39069
CHEMBL1083210,P23975,,PITDIXLZXHYFAC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,120,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224274,DTCC00631208,910850,38126
CHEMBL1083211,P23975,,JLHRDEJKVFNGBV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224275,DTCC00631209,490397,38126
CHEMBL1083392,P23975,,BXRBQSOCONPANY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342559,DTCC00646151,502243,39069
CHEMBL1083392,P23975,,BXRBQSOCONPANY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,5.1,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3341762,DTCC00646151,502243,39069
CHEMBL1083393,P23975,,OIFBYCGNUDQJBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3341765,DTCC00646152,1310322,39069
CHEMBL1083405,P23975,,HSRUEFWMMBYMIL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348378,DTCC00646094,469578,39093
CHEMBL1083408,P23975,,OIFBYCGNUDQJBL-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342505,DTCC00646287,1854565,39069
CHEMBL1083408,P23975,,OIFBYCGNUDQJBL-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,9,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342562,DTCC00646287,1854565,39069
CHEMBL1083409,P23975,,OIFBYCGNUDQJBL-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3341766,DTCC00646288,1211989,39069
CHEMBL1083409,P23975,,OIFBYCGNUDQJBL-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3341775,DTCC00646288,1211989,39069
CHEMBL1083410,P23975,,PHSDSMUCNUCJGQ-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3341776,DTCC00646289,889956,39069
CHEMBL1083410,P23975,,PHSDSMUCNUCJGQ-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3341772,DTCC00646289,889956,39069
CHEMBL1083410,P23975,,PHSDSMUCNUCJGQ-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093906,DTCC00646289,897446,45987
CHEMBL1083410,P23975,,PHSDSMUCNUCJGQ-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,9,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093893,DTCC00646289,897446,45987
CHEMBL1083425,P23975,,IAMMWWXBTYJBCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,40,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348393,DTCC00646238,566609,39093
CHEMBL1083426,P23975,1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),WARUECLCXNMKJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,17,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348402,DTCC00646239,1918860,39093
CHEMBL1083426,P23975,1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),WARUECLCXNMKJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,46,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348394,DTCC00646239,1918856,39093
CHEMBL1083426,P23975,1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),WARUECLCXNMKJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,116,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348401,DTCC00646239,1918859,39093
CHEMBL1083427,P23975,,LRKGVRWKYSKWQW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348395,DTCC00646240,1633624,39093
CHEMBL1083428,P23975,,KCQQWPYAESYXHU-GFCCVEGCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342510,DTCC00646470,209460,39069
CHEMBL1083428,P23975,,KCQQWPYAESYXHU-GFCCVEGCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,9,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342506,DTCC00646470,209460,39069
CHEMBL1083429,P23975,,KCQQWPYAESYXHU-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3341767,DTCC00646471,1697959,39069
CHEMBL1083429,P23975,,KCQQWPYAESYXHU-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3341768,DTCC00646471,1697959,39069
CHEMBL1083430,P23975,,RDRQTGHODUVHMX-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,277,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342536,DTCC00646472,1116478,39069
CHEMBL1083430,P23975,,RDRQTGHODUVHMX-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,394,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342532,DTCC00646472,1116478,39069
CHEMBL1083705,P23975,,NSVJPFSJIISEIG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348379,DTCC00646095,1918852,39093
CHEMBL1083706,P23975,,AQGRUVIDIWOMIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,25,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348380,DTCC00646096,986557,39093
CHEMBL1083707,P23975,,JLTIELDULXFJCW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,340,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348381,DTCC00646097,1633623,39093
CHEMBL1083708,P23975,1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX),VCVDPONUNCPTCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348382,DTCC00646099,792357,39093
CHEMBL1083708,P23975,1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX),VCVDPONUNCPTCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348399,DTCC00646099,792360,39093
CHEMBL1083708,P23975,1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX),VCVDPONUNCPTCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,180,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348400,DTCC00646099,792361,39093
CHEMBL1083741,P23975,,AMRZCARGTNPWTE-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,441,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342570,DTCC00646045,760280,39069
CHEMBL1083741,P23975,,AMRZCARGTNPWTE-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,602,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342543,DTCC00646045,760280,39069
CHEMBL1084015,P23975,,VGSAURUBNJSRDU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,196,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342533,DTCC00646214,1886824,39069
CHEMBL1084016,P23975,,ZLLRZVQIIORCDV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,2255,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342555,DTCC00646215,340221,39069
CHEMBL1084033,P23975,1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),SQSFWPVYWBTHEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348404,DTCC00646305,889959,39093
CHEMBL1084033,P23975,1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),SQSFWPVYWBTHEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,51,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348396,DTCC00646305,889957,39093
CHEMBL1084033,P23975,1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),SQSFWPVYWBTHEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348403,DTCC00646305,889958,39093
CHEMBL1084042,P23975,,OIHGHECQZMOUEI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342557,DTCC00646046,80515,39069
CHEMBL1084042,P23975,,OIHGHECQZMOUEI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,7,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342507,DTCC00646046,80515,39069
CHEMBL1084291,P23975,,AZFGCYKKRIPXTL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,9,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342509,DTCC00646216,760283,39069
CHEMBL1084292,P23975,,LUSQFJUMCWATFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,853,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342545,DTCC00646217,857814,39069
CHEMBL1084309,P23975,,FCEXIPULXFOGIW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,46,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348391,DTCC00646236,241796,39093
CHEMBL1084311,P23975,,JWVNRZQALLUPMN-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,100,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342528,DTCC00646415,792362,39069
CHEMBL1084311,P23975,,JWVNRZQALLUPMN-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,109,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342514,DTCC00646415,792362,39069
CHEMBL1084312,P23975,,JWVNRZQALLUPMN-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,18,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342515,DTCC00646416,1536870,39069
CHEMBL1084312,P23975,,JWVNRZQALLUPMN-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,19,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342564,DTCC00646416,1536870,39069
CHEMBL1084313,P23975,,UJEHPOIYQOLYRD-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,10,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342504,DTCC00646417,372797,39069
CHEMBL1084313,P23975,,UJEHPOIYQOLYRD-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,34,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342566,DTCC00646417,372797,39069
CHEMBL1084577,P23975,,BGJYOLBNUMRPNE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348392,DTCC00646237,1984411,39093
CHEMBL1084828,P23975,,VUEFLJKLCMGDEG-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,244,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342530,DTCC00646413,274635,39069
CHEMBL1084828,P23975,,VUEFLJKLCMGDEG-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,328,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342524,DTCC00646413,274635,39069
CHEMBL1084829,P23975,,VUEFLJKLCMGDEG-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,51,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342568,DTCC00646414,274636,39069
CHEMBL1084829,P23975,,VUEFLJKLCMGDEG-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,146,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342522,DTCC00646414,274636,39069
CHEMBL1084933,P23975,,OWEYOMCWVMSOQF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,38,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224272,DTCC00631206,1589343,38126
CHEMBL1084934,P23975,,GESKFXJTJLLILS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,1400,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224273,DTCC00631207,845809,38126
CHEMBL1084971,P23975,,SBKGLFTUHHUCII-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,58,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348375,DTCC00645991,1790026,39093
CHEMBL1085066,P23975,,HSMMZWQHSZFBQK-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,22,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342565,DTCC00646352,1277535,39069
CHEMBL1085066,P23975,,HSMMZWQHSZFBQK-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,64,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342518,DTCC00646352,1277535,39069
CHEMBL1085197,P23975,,SPHAUOPMTCENAZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,55,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224278,DTCC00631282,1778102,38126
CHEMBL1085198,P23975,,KINFMOXIYLIVMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,52,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224280,DTCC00631283,974485,38126
CHEMBL1085233,P23975,,AMRZCARGTNPWTE-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,57,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342569,DTCC00646044,1918851,39069
CHEMBL1085233,P23975,,AMRZCARGTNPWTE-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,305,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342537,DTCC00646044,1918851,39069
CHEMBL1085321,P23975,,WHMNJJQFCNBWSW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348389,DTCC00646173,1148848,39093
CHEMBL1085322,P23975,,PKVDODLSCSUTRW-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,80,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342519,DTCC00646353,274633,39069
CHEMBL1085322,P23975,,PKVDODLSCSUTRW-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,143,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342525,DTCC00646353,274633,39069
CHEMBL1085323,P23975,,PKVDODLSCSUTRW-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,19,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342563,DTCC00646354,2081676,39069
CHEMBL1085323,P23975,,PKVDODLSCSUTRW-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,25,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342511,DTCC00646354,2081676,39069
CHEMBL1085338,P23975,,MFTRIVHFDLRKDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,1,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3341763,DTCC00646042,1790028,39069
CHEMBL1085338,P23975,,MFTRIVHFDLRKDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,2.7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3341774,DTCC00646042,1790028,39069
CHEMBL1085339,P23975,,AVTQGGVDIQOXSO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342560,DTCC00646043,1018798,39069
CHEMBL1085339,P23975,,AVTQGGVDIQOXSO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,72,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342526,DTCC00646043,1018798,39069
CHEMBL108545,P23975,METHYL SALICYLATE,OSWPMRLSEDHDFF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7419551,DTCC00280235,1705877,46191
CHEMBL108545,P23975,METHYL SALICYLATE,OSWPMRLSEDHDFF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7419552,DTCC00280235,1705877,46191
CHEMBL1085567,P23975,,FGLZNYXYSDQEEU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348390,DTCC00646174,1504502,39093
CHEMBL1085830,P23975,,QWFUAOOOLIDWBY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,94,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342523,DTCC00646148,145198,39069
CHEMBL1085830,P23975,,QWFUAOOOLIDWBY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,238,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342540,DTCC00646148,145198,39069
CHEMBL1085831,P23975,,YFXILLLEWBTOSN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,1.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3341770,DTCC00646149,2017415,39069
CHEMBL1085831,P23975,,YFXILLLEWBTOSN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,4.5,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3341773,DTCC00646149,2017415,39069
CHEMBL1085904,P23975,,ZFGMAUXPSXKTKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,790,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224262,DTCC00631061,1298104,38126
CHEMBL1085905,P23975,,FPJZMICPDWNXEV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,490,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224263,DTCC00631062,393579,38126
CHEMBL1085906,P23975,,VXBYAINQGAYGQT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,140,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224264,DTCC00631063,748522,38126
CHEMBL1085907,P23975,,FZUUUZNHPYGRAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,3550,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224266,DTCC00631064,1810525,38126
CHEMBL1085959,P23975,,CLUGYQSXBJPTPD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,97,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348387,DTCC00646098,241794,39093
CHEMBL1086035,P23975,,HZFCYBLDOJMSFO-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,8,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342561,DTCC00646350,1504505,39069
CHEMBL1086035,P23975,,HZFCYBLDOJMSFO-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,28,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342512,DTCC00646350,1504505,39069
CHEMBL1086220,P23975,,KEQORMMUOMSYLY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,IC50,=,481,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342539,DTCC00646218,1918855,39069
CHEMBL1086273,P23975,,RANMCMHHAKTCAZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,84,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348384,DTCC00646170,1018801,39093
CHEMBL1086274,P23975,,FWSGTPZWDAUURJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,27,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348385,DTCC00646171,1601305,39093
CHEMBL1086275,P23975,,FNRNKAMBXVROAU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,58,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348386,DTCC00646172,1504501,39093
CHEMBL1086398,P23975,,UBBWGPMMVOSPDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,130,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224259,DTCC00630991,360810,38126
CHEMBL1086399,P23975,,QIQQZHLHCWKLNI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,630,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224260,DTCC00630992,522725,38126
CHEMBL1087,P23975,MEPIVACAINE,INWLQCZOYSRPNW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7432183,DTCC00254348,1416035,46191
CHEMBL1087,P23975,MEPIVACAINE,INWLQCZOYSRPNW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7432184,DTCC00254348,1416035,46191
CHEMBL1087921,P23975,,NJGYZOMKDMARER-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,970,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224268,DTCC00631136,295592,38126
CHEMBL1087922,P23975,,AOJOZQNALFJCNW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,1500,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224269,DTCC00631137,1842885,38126
CHEMBL1087923,P23975,,IWHDPHKISOJDMA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,200,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224270,DTCC00631138,1589341,38126
CHEMBL1087924,P23975,,KUHFOMDKXOTLGD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,29,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224271,DTCC00631139,974482,38126
CHEMBL1089,P23975,PHENELZINE,RMUCZJUITONUFY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14735027,DTCC00254379,2105469,68566
CHEMBL1089,P23975,PHENELZINE,RMUCZJUITONUFY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372157,DTCC00254379,1188072,46191
CHEMBL1089,P23975,PHENELZINE,RMUCZJUITONUFY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372158,DTCC00254379,1188072,46191
CHEMBL108947,P23975,DOTHIEPIN,PHTUQLWOUWZIMZ-BOPFTXTBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,46,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14758761,DTCC00278250,2111356,68566
CHEMBL109,P23975,VALPROIC ACID,NIJJYAXOARWZEE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7443217,DTCC00144879,413980,46191
CHEMBL109,P23975,VALPROIC ACID,NIJJYAXOARWZEE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7443218,DTCC00144879,413980,46191
CHEMBL1094208,P23975,"1-(2,3-DICHLOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",SGKVPHOMCZNDPT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631451,DTCT0023180,3338839,DTCC00642251,1232809,38666
CHEMBL1094209,P23975,,HOMRLSWXGFQYGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631451,DTCT0023180,3338835,DTCC00642252,1746259,38666
CHEMBL1094231,P23975,"1-(3-CHLORO-4-FLUOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",DAXGWLCLIPNRDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631451,DTCT0023180,3338836,DTCC00642205,133424,38666
CHEMBL1094514,P23975,,FQPJRGDRIOAJCS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631451,DTCT0023180,3338838,DTCC00642303,683992,38666
CHEMBL109517,P23975,,NWCPOGFPLUASJD-PEVDHWGLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,=,34,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142776,DTCT0023180,1586482,DTCC00284131,1175858,5814
CHEMBL109517,P23975,,NWCPOGFPLUASJD-PEVDHWGLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,149,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1586479,DTCC00284131,1175858,5814
CHEMBL1095274,P23975,,LFLUHLCPXQWQKW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19939513,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter at 10 uM by radioligand displacement assay,Active,"8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2010,45,2,"Ivachtchenko AV, Mitkin OD, Tkachenko SE, Okun IM, Kysil VM",,627785,DTCT0023180,3303538,DTCC00638646,1051183,38522
CHEMBL1095367,P23975,,JVDABEHLVBLHMY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,170,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224282,DTCC00631284,522726,38126
CHEMBL1095523,P23975,,DMULXMAWQFEZSA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,225,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324060,DTCC00641492,1244943,38843
CHEMBL1095523,P23975,,DMULXMAWQFEZSA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,94000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324031,DTCC00641492,1244943,38843
CHEMBL1095524,P23975,,TVEJRNDJZBJGNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,720,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324061,DTCC00641493,1472138,38843
CHEMBL1095524,P23975,,TVEJRNDJZBJGNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,55000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324030,DTCC00641493,1472138,38843
CHEMBL1095525,P23975,,SRKHUCZOFIQCSE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,100,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324062,DTCC00641494,1472139,38843
CHEMBL1095525,P23975,,SRKHUCZOFIQCSE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,86000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324029,DTCC00641494,1472139,38843
CHEMBL1095699,P23975,AZASERINE,MZZGOOYMKKIOOX-VKHMYHEASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7259459,DTCC00644151,1960073,46191
CHEMBL1095699,P23975,AZASERINE,MZZGOOYMKKIOOX-VKHMYHEASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7259460,DTCC00644151,1960073,46191
CHEMBL109571,P23975,,NWCPOGFPLUASJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,=,45,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142776,DTCT0023180,1594172,DTCC00284130,368767,5814
CHEMBL109571,P23975,,NWCPOGFPLUASJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,111,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1594169,DTCC00284130,368767,5814
CHEMBL1095850,P23975,,KHYNNQYNYMSTIB-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,57,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324068,DTCC00641565,469523,38843
CHEMBL1095850,P23975,,KHYNNQYNYMSTIB-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,91000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324023,DTCC00641565,469523,38843
CHEMBL1096001,P23975,,CLLQMGVKRYVVFS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,93,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224285,DTCC00631348,1460173,38126
CHEMBL1096467,P23975,,DXRCWRDHBIVBIS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631451,DTCT0023180,3338837,DTCC00642302,1746261,38666
CHEMBL1096495,P23975,,GRUIIAQNNWQJPW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,56,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324050,DTCC00641425,1116416,38843
CHEMBL1097146,P23975,,IWXNUOQJTVYMHH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Not Determined,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324065,DTCC00641562,1051220,38843
CHEMBL1097146,P23975,,IWXNUOQJTVYMHH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,54000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324026,DTCC00641562,1051220,38843
CHEMBL1097147,P23975,,QVVYUPDVPHVIPQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Not Determined,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324066,DTCC00641563,631301,38843
CHEMBL1097147,P23975,,QVVYUPDVPHVIPQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,50800,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324025,DTCC00641563,631301,38843
CHEMBL1097148,P23975,,KHYNNQYNYMSTIB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,95,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324067,DTCC00641564,695706,38843
CHEMBL1097148,P23975,,KHYNNQYNYMSTIB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,88000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324024,DTCC00641564,695706,38843
CHEMBL1097469,P23975,,DRAQRLXEPIYYIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,255,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324063,DTCC00641560,1018746,38843
CHEMBL1097469,P23975,,DRAQRLXEPIYYIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,82000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324028,DTCC00641560,1018746,38843
CHEMBL1097470,P23975,,IFCHBQFBWRMERT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,550,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324064,DTCC00641561,1342847,38843
CHEMBL1097470,P23975,,IFCHBQFBWRMERT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,73000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324027,DTCC00641561,1342847,38843
CHEMBL1097660,P23975,,MGCWVDDXPPKNQT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Not Determined,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324059,DTCC00641491,1536809,38843
CHEMBL1097660,P23975,,MGCWVDDXPPKNQT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,19000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324032,DTCC00641491,1536809,38843
CHEMBL1098855,P23975,,VUNYCPOWVGTRIS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Not Determined,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324057,DTCC00641489,986514,38843
CHEMBL1098855,P23975,,VUNYCPOWVGTRIS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,21000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324034,DTCC00641489,986514,38843
CHEMBL1099134,P23975,,UIOCALWWKYWNPJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Not Determined,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324058,DTCC00641490,1918808,38843
CHEMBL1099134,P23975,,UIOCALWWKYWNPJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,32000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324033,DTCC00641490,1918808,38843
CHEMBL1099178,P23975,,KHYNNQYNYMSTIB-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,18000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324069,DTCC00641627,80473,38843
CHEMBL1099178,P23975,,KHYNNQYNYMSTIB-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,0,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324022,DTCC00641627,80473,38843
CHEMBL1099179,P23975,,GRUIIAQNNWQJPW-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324070,DTCC00641628,1984362,38843
CHEMBL1099179,P23975,,GRUIIAQNNWQJPW-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INH,=,92000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324021,DTCC00641628,1984362,38843
CHEMBL1099212,P23975,,BHCVJMVHWIDLDP-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,576,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324071,DTCC00641629,1244945,38843
CHEMBL1099212,P23975,,BHCVJMVHWIDLDP-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Not Determined,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632593,DTCT0023180,3324020,DTCC00641629,1244945,38843
CHEMBL1099284,P23975,,LEEDRVGVQYVFHX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19939513,ACTIVITY,=,15,%,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter at 1 uM by radioligand displacement assay,,"8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2010,45,2,"Ivachtchenko AV, Mitkin OD, Tkachenko SE, Okun IM, Kysil VM",,627774,DTCT0023180,3303527,DTCC00639104,1727244,38522
CHEMBL1099373,P23975,,KPUDPAXPYHVNAD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,25,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224287,DTCC00631349,1330735,38126
CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,20,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755650,DTCC00132703,2110616,68466
CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,142,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755649,DTCC00132703,2110616,68466
CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,37,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755651,DTCC00132703,2110742,68566
CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10411589,KI,=,118,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755648,DTCC00132703,2110619,69057
CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845,KI,=,98,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755652,DTCC00132703,2110743,68736
CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15081025,KI,=,16,NM,,,,,,,,,,,,,,Binding affinity towards Norepinephrine transporter using [3H]nisoxitine as radioligand,,"Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).",Bioorg. Med. Chem. Lett.,2004,14,9,"Peddi S, Roth BL, Glennon RA, Westkaemper RB",,143139,DTCT0023180,840658,DTCC00132703,3614,6858
CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138,IC50,=,74,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007,51,11,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923,DTCT0023180,2718430,DTCC00132703,9998,34126
CHEMBL1103,P23975,FURAZOLIDONE,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318477,DTCC00257236,1512809,46191
CHEMBL1103,P23975,FURAZOLIDONE,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318478,DTCC00257236,1512809,46191
CHEMBL1105,P23975,6-METHOXY-2-NAPHTHYLACETIC ACID,PHJFLPMVEFKEPL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301786,DTCC00257334,1830683,46191
CHEMBL1105,P23975,6-METHOXY-2-NAPHTHYLACETIC ACID,PHJFLPMVEFKEPL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301787,DTCC00257334,1830683,46191
CHEMBL110691,P23975,CHLORMADINONE ACETATE,QMBJSIBWORFWQT-DFXBJWIESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7353723,DTCC00283843,217574,46191
CHEMBL110691,P23975,CHLORMADINONE ACETATE,QMBJSIBWORFWQT-DFXBJWIESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7353724,DTCC00283843,217574,46191
CHEMBL1108,P23975,DROPERIDOL,RMEDXOLNCUSCGS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7332295,DTCC00258432,542573,46191
CHEMBL1108,P23975,DROPERIDOL,RMEDXOLNCUSCGS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7332296,DTCC00258432,542573,46191
CHEMBL1109,P23975,SULFAPHENAZOLE,QWCJHSGMANYXCW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469718,DTCC00258904,1544901,46191
CHEMBL1109,P23975,SULFAPHENAZOLE,QWCJHSGMANYXCW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469719,DTCC00258904,1544901,46191
CHEMBL1110,P23975,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287265,DTCC00258915,1318437,46191
CHEMBL1110,P23975,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287266,DTCC00258915,1318437,46191
CHEMBL111128,P23975,,PORDAYLSLHLTRQ-FYOYPEGLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,=,28,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142776,DTCT0023180,1594179,DTCC00284061,1144732,5814
CHEMBL111128,P23975,,PORDAYLSLHLTRQ-FYOYPEGLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,99,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1594176,DTCC00284061,1144732,5814
CHEMBL1112,P23975,ARIPIPRAZOLE,CEUORZQYGODEFX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12784105,KI,=,2090,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14756448,DTCC00106550,2110875,69826
CHEMBL1113,P23975,AMOXAPINE,QWGDMFLQWFTERH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,16,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733926,DTCC00260398,2105076,68566
CHEMBL1113,P23975,AMOXAPINE,QWGDMFLQWFTERH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,13,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281774,DTCC00260398,1059327,46191
CHEMBL1113,P23975,AMOXAPINE,QWGDMFLQWFTERH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,13,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281775,DTCC00260398,1059327,46191
CHEMBL111639,P23975,FLUOROCARAZOLOL,QHLGXPUIUKSADT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11512051,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736651,DTCC00281815,2106040,69642
CHEMBL1117,P23975,IDARUBICIN,XDXDZDZNSLXDNA-TZNDIEGXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325685,DTCC00263156,153444,46191
CHEMBL1117,P23975,IDARUBICIN,XDXDZDZNSLXDNA-TZNDIEGXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325686,DTCC00263156,153444,46191
CHEMBL1118,P23975,DESVENLAFAXINE,KYYIDSXMWOZKMP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,2753,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739349,DTCC00265702,2107017,68466
CHEMBL1118,P23975,DESVENLAFAXINE,KYYIDSXMWOZKMP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,3152,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739348,DTCC00265702,2107017,68466
CHEMBL1118,P23975,DESVENLAFAXINE,KYYIDSXMWOZKMP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16675639,KI,=,531.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739346,DTCC00265702,2107016,69000
CHEMBL1118,P23975,DESVENLAFAXINE,KYYIDSXMWOZKMP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16675639,KI,=,558.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739345,DTCC00265702,2107016,69000
CHEMBL1118,P23975,DESVENLAFAXINE,KYYIDSXMWOZKMP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16675639,KI,=,3385.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739347,DTCC00265702,2107016,69000
CHEMBL1118,P23975,DESVENLAFAXINE,KYYIDSXMWOZKMP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454708,DTCC00265702,1009569,54354
CHEMBL1118,P23975,DESVENLAFAXINE,KYYIDSXMWOZKMP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,>,650,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454787,DTCC00265702,1009569,54354
CHEMBL111861,P23975,CORTISONE,LPYXTAPPNYMYOP-XDBTXSBWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7358914,DTCC00283836,671786,46191
CHEMBL111861,P23975,CORTISONE,LPYXTAPPNYMYOP-XDBTXSBWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7358915,DTCC00283836,671786,46191
CHEMBL112,P23975,ACETAMINOPHEN,RZVAJINKPMORJF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7299032,DTCC00145865,1544892,46191
CHEMBL112,P23975,ACETAMINOPHEN,RZVAJINKPMORJF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7299033,DTCC00145865,1544892,46191
CHEMBL1123,P23975,DICYCLOMINE,CURUTKGFNZGFSE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7348805,DTCC00269590,1798408,46191
CHEMBL1123,P23975,DICYCLOMINE,CURUTKGFNZGFSE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7348806,DTCC00269590,1798408,46191
CHEMBL1124,P23975,DEALKYLATED DIETHYLPROPION,PUAQLLVFLMYYJJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,12.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741484,DTCC00269903,2107730,69025
CHEMBL113,P23975,CAFFEINE,RYYVLZVUVIJVGH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7263394,DTCC00145890,51450,46191
CHEMBL113,P23975,CAFFEINE,RYYVLZVUVIJVGH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7263395,DTCC00145890,51450,46191
CHEMBL1130,P23975,DOXIFLURIDINE,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340658,DTCC00272346,1124449,46191
CHEMBL1130,P23975,DOXIFLURIDINE,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340659,DTCC00272346,1124449,46191
CHEMBL113136,P23975,,XAYGSYISSLIYTN-CXMPNGEBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,=,44,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142776,DTCT0023180,1582749,DTCC00284678,982502,5814
CHEMBL113136,P23975,,XAYGSYISSLIYTN-CXMPNGEBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,51,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1582746,DTCC00284678,982502,5814
CHEMBL114,P23975,SAQUINAVIR,QWAXKHKRTORLEM-UGJKXSETSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473326,DTCC00146405,703985,46191
CHEMBL114,P23975,SAQUINAVIR,QWAXKHKRTORLEM-UGJKXSETSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473327,DTCC00146405,703985,46191
CHEMBL1140,P23975,NIACINAMIDE,DFPAKSUCGFBDDF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7390465,DTCC00277524,800582,46191
CHEMBL1140,P23975,NIACINAMIDE,DFPAKSUCGFBDDF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7390466,DTCC00277524,800582,46191
CHEMBL114275,P23975,,WDZSPNFWRVITEJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9986702,KI,=,234,NM,,cell_based,,,,,,,,,,,,In vitro binding affinity against monoamine transporter NET (norepinephrine transporter) in LLC-PK1 cell membranes.,,"A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.",J. Med. Chem.,1999,42,3,"Oya S, Kung MP, Acton PD, Mu M, Hou C, Kung HF",,142940,DTCT0023180,1700497,DTCC00287304,659609,15555
CHEMBL114275,P23975,,WDZSPNFWRVITEJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15456270,KI,=,234,NM,,cell_based,,,,,,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,2004,47,21,"Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP",,303519,DTCT0023180,1792710,DTCC00287304,649547,19119
CHEMBL1144,P23975,PRAVASTATIN,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376765,DTCC00280505,413976,46191
CHEMBL1144,P23975,PRAVASTATIN,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376766,DTCC00280505,413976,46191
CHEMBL1148,P23975,TORSEMIDE,NGBFQHCMQULJNZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7487791,DTCC00281790,1830692,46191
CHEMBL1148,P23975,TORSEMIDE,NGBFQHCMQULJNZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7487792,DTCC00281790,1830692,46191
CHEMBL1149,P23975,LEVOCARNITINE,PHIQHXFUZVPYII-ZCFIWIBFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418780,DTCC00283052,51485,46191
CHEMBL1149,P23975,LEVOCARNITINE,PHIQHXFUZVPYII-ZCFIWIBFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418781,DTCC00283052,51485,46191
CHEMBL11493,P23975,,HZEVDVGPBUFIAW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,KI,=,1330,NM,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143140,DTCT0023180,1046553,DTCC00140506,842358,14474
CHEMBL115,P23975,INDINAVIR,CBVCZFGXHXORBI-PXQQMZJSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7424503,DTCC00146406,51478,46191
CHEMBL115,P23975,INDINAVIR,CBVCZFGXHXORBI-PXQQMZJSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7424504,DTCC00146406,51478,46191
CHEMBL115280,P23975,,SKVXOYIMICHFPV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11585444,IC50,=,2810,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine transporter,,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,2001,44,21,"Poulain R, Horvath D, Bonnet B, Eckhoff C, Chapelain B, Bodinier MC, Déprez B",,142801,DTCT0023180,1380565,DTCC00288032,1774431,16444
CHEMBL115444,P23975,,HLZHNRNWOPIWCL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11585444,IC50,=,3020,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine transporter,,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,2001,44,21,"Poulain R, Horvath D, Bonnet B, Eckhoff C, Chapelain B, Bodinier MC, Déprez B",,142801,DTCT0023180,1404243,DTCC00288647,194012,16444
CHEMBL115769,P23975,RWJ-68354,ADQZGIYHFQQPRB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1070,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464480,DTCC01742367,2057653,46191
CHEMBL115769,P23975,RWJ-68354,ADQZGIYHFQQPRB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1061,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464481,DTCC01742367,2057653,46191
CHEMBL1159650,P23975,CLOBETASOL PROPIONATE,CBGUOGMQLZIXBE-XGQKBEPLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7350057,DTCC00648029,703979,46191
CHEMBL1159650,P23975,CLOBETASOL PROPIONATE,CBGUOGMQLZIXBE-XGQKBEPLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7350058,DTCC00648029,703979,46191
CHEMBL116,P23975,AMPRENAVIR,YMARZQAQMVYCKC-OEMFJLHTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295582,DTCC00146541,833155,46191
CHEMBL116,P23975,AMPRENAVIR,YMARZQAQMVYCKC-OEMFJLHTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295583,DTCC00146541,833155,46191
CHEMBL1162,P23975,NORETHINDRONE,VIKNJXKGJWUCNN-XGXHKTLJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7382037,DTCC00288264,510305,46191
CHEMBL1162,P23975,NORETHINDRONE,VIKNJXKGJWUCNN-XGXHKTLJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7382038,DTCC00288264,510305,46191
CHEMBL1162965,P23975,,DEMWBYUAYXJYOC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853342,DTCC00650351,1936965,19894
CHEMBL116463,P23975,,GALCSZPFCCZIBC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11585444,IC50,=,1140,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine transporter,,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,2001,44,21,"Poulain R, Horvath D, Bonnet B, Eckhoff C, Chapelain B, Bodinier MC, Déprez B",,142801,DTCT0023180,1367723,DTCC00289654,162133,16444
CHEMBL1167,P23975,SPECTINOMYCIN,UNFWWIHTNXNPBV-WXKVUWSESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7480231,DTCC00289197,249944,46191
CHEMBL1167,P23975,SPECTINOMYCIN,UNFWWIHTNXNPBV-WXKVUWSESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7480232,DTCC00289197,249944,46191
CHEMBL1168,P23975,RAMIPRIL,HDACQVRGBOVJII-JBDAPHQKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481530,DTCC00289284,1765979,46191
CHEMBL1168,P23975,RAMIPRIL,HDACQVRGBOVJII-JBDAPHQKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481531,DTCC00289284,1765979,46191
CHEMBL1169,P23975,AMINOSALICYLIC ACID,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287480,DTCC00290367,671785,46191
CHEMBL1169,P23975,AMINOSALICYLIC ACID,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287481,DTCC00290367,671785,46191
CHEMBL1169388,P23975,(S)-FLUOXETINE,RTHCYVBBDHJXIQ-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,410,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739204,DTCC00031584,2106961,68918
CHEMBL1169388,P23975,(S)-FLUOXETINE,RTHCYVBBDHJXIQ-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,686,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739203,DTCC00031584,2106961,68918
CHEMBL1169524,P23975,,XZQBKIYIWLHZIO-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303631,DTCC00125684,666563,25699
CHEMBL1169622,P23975,,CREVKPZAPMYUJW-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,3162.28,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395814,DTCC00656185,2081766,39684
CHEMBL1169733,P23975,,NPBFISOTLZPTLN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,199.53,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387682,DTCC00653804,502302,39409
CHEMBL1169912,P23975,,SKRQWFVNZMYZQL-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,31.62,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387679,DTCC00653807,1051324,39409
CHEMBL1169916,P23975,,UOSHXPJHXMVWLW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,251.19,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387672,DTCC00653838,2049593,39409
CHEMBL1170017,P23975,,WBGRUPCVVLWKNH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,501.19,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387688,DTCC00653769,1148880,39409
CHEMBL1170209,P23975,,VBDVAWKLCDBKGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,50.12,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387687,DTCC00653770,1018864,39409
CHEMBL1170210,P23975,,QWWBXRLAEPLMHV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,12.59,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387686,DTCC00653771,405834,39409
CHEMBL1170211,P23975,,BTDSNKFEFWKZPW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,6.31,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387685,DTCC00653772,1245059,39409
CHEMBL1170212,P23975,,YXKXFXIRENCHSD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,251.19,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387684,DTCC00653773,1601364,39409
CHEMBL1170213,P23975,,JFCGNEFWNWVNQD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,316.23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387673,DTCC00653837,209513,39409
CHEMBL1170233,P23975,,LNWGBLPMTUFHJM-HUUCEWRRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,794.33,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395391,DTCC00655598,1568860,39684
CHEMBL1170373,P23975,,OOXRIQOVBUMMQG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,79.43,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387681,DTCC00653805,2017469,39409
CHEMBL1170374,P23975,,SKRQWFVNZMYZQL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,39.81,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387680,DTCC00653806,728103,39409
CHEMBL1170396,P23975,,ZJJWZZFPUVRGQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,316.23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387671,DTCC00653839,80565,39409
CHEMBL1170397,P23975,,ZJJWZZFPUVRGQQ-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387670,DTCC00653840,80566,39409
CHEMBL1170441,P23975,,PLVMDZQEFNUCOF-SMDDNHRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,1680,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392356,DTCC00656484,1396044,39669
CHEMBL1170585,P23975,,AMKBEJSLPSMHMK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,501.19,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387692,DTCC00653735,1536906,39409
CHEMBL1170793,P23975,,RVOPEWUULYWWBF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,15.85,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387691,DTCC00653736,80564,39409
CHEMBL1170794,P23975,,UKQYNWZANZHZLT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,50.12,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387690,DTCC00653737,1951748,39409
CHEMBL1170795,P23975,,QSIIURGKHNVJBN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,>,5011.87,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387689,DTCC00653738,857859,39409
CHEMBL1171007,P23975,,ZJJWZZFPUVRGQQ-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,316.23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387669,DTCC00653866,824958,39409
CHEMBL1171260,P23975,,KHVUFWSEOLNUFN-IINYFYTJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,415,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392337,DTCC00655830,1104807,39669
CHEMBL1171260,P23975,,KHVUFWSEOLNUFN-IINYFYTJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21319801,IC50,=,170,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,2011,54,5,"Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ",,741840,DTCT0023180,5920197,DTCC00655830,1123343,44216
CHEMBL1171391,P23975,,KOPIUBJLSUXFHC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,7.94,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387694,DTCC00653733,1472243,39409
CHEMBL1171392,P23975,,UGNWXJYZJYLNRT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,398.11,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387693,DTCC00653734,710832,39409
CHEMBL1171424,P23975,,SKNMQBHFOCWPIZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,1584.89,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387675,DTCC00653835,1633686,39409
CHEMBL1171425,P23975,,XRHNNEJZJBTDKD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,316.23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387674,DTCC00653836,1854608,39409
CHEMBL1171434,P23975,,XVOYSCVBGLVSOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14737613,DTCC00655109,2106368,69159
CHEMBL1171975,P23975,,BLEJWKMRQPRJHY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,25.12,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387683,DTCC00653774,307567,39409
CHEMBL1172,P23975,DESLORATADINE,JAUOIFJMECXRGI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1116,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357225,DTCC00291020,1674143,46191
CHEMBL1172,P23975,DESLORATADINE,JAUOIFJMECXRGI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1107,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357226,DTCC00291020,1674143,46191
CHEMBL1172381,P23975,,CJOKQBSVKKHHCD-COPLHBTASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,1995.26,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395824,DTCC00656135,1984476,39684
CHEMBL1172524,P23975,,SKRQWFVNZMYZQL-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,158.49,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387678,DTCC00653808,1439820,39409
CHEMBL1172525,P23975,,HESFIOJTTFAYOC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,79.43,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387677,DTCC00653809,1665965,39409
CHEMBL1172526,P23975,,CJIGYBHHAXYYSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,19.95,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387676,DTCC00653810,372850,39409
CHEMBL1172744,P23975,1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX),KTJHVHZJTXJNIH-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,10,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395796,DTCC00655682,1342972,39684
CHEMBL1172744,P23975,1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX),KTJHVHZJTXJNIH-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,12.59,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395802,DTCC00655682,1342968,39684
CHEMBL1172744,P23975,1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX),KTJHVHZJTXJNIH-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,39.81,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395799,DTCC00655682,1342971,39684
CHEMBL1172760,P23975,,UOWSMEUBNCLAHO-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,5011.87,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395388,DTCC00655938,209537,39684
CHEMBL1172850,P23975,"RAC-1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-2-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",WGLPIGWBBSYDNT-KBPBESRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,100,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395857,DTCC00656253,890018,39684
CHEMBL1172850,P23975,"RAC-1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-2-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",WGLPIGWBBSYDNT-KBPBESRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,199.53,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395863,DTCC00656253,890016,39684
CHEMBL1172850,P23975,"RAC-1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-2-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",WGLPIGWBBSYDNT-KBPBESRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,1000,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395860,DTCC00656253,890017,39684
CHEMBL1172902,P23975,"3-(3,4-DICHLORO-PHENYL)-6-AZA-TRICYCLO[4.2.1.0*1,3*]NONANE (STRUCTURAL MIX)",URWDPKNAGFZFDK-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,63.1,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395385,DTCC00655867,2081770,39684
CHEMBL1172902,P23975,"3-(3,4-DICHLORO-PHENYL)-6-AZA-TRICYCLO[4.2.1.0*1,3*]NONANE (STRUCTURAL MIX)",URWDPKNAGFZFDK-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,794.33,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395382,DTCC00655867,2081764,39684
CHEMBL1172919,P23975,,DGWDYSSUZQAJAQ-MISXGVKJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,63.1,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395854,DTCC00656254,145268,39684
CHEMBL1172928,P23975,RADAFAXINE,RCOBKSKAZMVBHT-TVQRCGJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,9900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392346,DTCC00656449,13712,39669
CHEMBL1172928,P23975,RADAFAXINE,RCOBKSKAZMVBHT-TVQRCGJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21319801,IC50,=,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,2011,54,5,"Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ",,741840,DTCT0023180,5920193,DTCC00656449,49600,44216
CHEMBL1172929,P23975,,RCOBKSKAZMVBHT-RNCFNFMXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,241,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392347,DTCC00656450,1557256,39669
CHEMBL1172929,P23975,,RCOBKSKAZMVBHT-RNCFNFMXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21319801,IC50,=,1200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,2011,54,5,"Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ",,741840,DTCT0023180,5920194,DTCC00656450,1575806,44216
CHEMBL1173085,P23975,,XPEGTFDNPKUQMC-RRFJBIMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,1258.93,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395750,DTCC00655595,437947,39684
CHEMBL1173086,P23975,,XPEGTFDNPKUQMC-RBSFLKMASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,1584.89,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395747,DTCC00655596,598889,39684
CHEMBL1173087,P23975,"6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)",AOUKQWFJPNRGAH-FGJGXXMFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,1,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395744,DTCC00655597,112789,39684
CHEMBL1173087,P23975,"6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)",AOUKQWFJPNRGAH-FGJGXXMFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,3.98,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395741,DTCC00655597,112790,39684
CHEMBL1173274,P23975,,NGHJSSNVKXEBAB-GXFFZTMASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,550,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392348,DTCC00656475,1428371,39669
CHEMBL1173275,P23975,,NNTJAYKRPQPBCZ-TVQRCGJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,740,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392349,DTCC00656476,974722,39669
CHEMBL1173275,P23975,,NNTJAYKRPQPBCZ-TVQRCGJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21319801,IC50,=,32,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,2011,54,5,"Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ",,741840,DTCT0023180,5920195,DTCC00656476,993412,44216
CHEMBL1173276,P23975,,DHXSMGUKIICGAC-TVQRCGJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,920,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392350,DTCC00656477,1622193,39669
CHEMBL1173276,P23975,,DHXSMGUKIICGAC-TVQRCGJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21319801,IC50,=,150,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,2011,54,5,"Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ",,741840,DTCT0023180,5920196,DTCC00656477,1640697,44216
CHEMBL1173277,P23975,,RLZACOPBIXSOEX-SMDDNHRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,1130,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392351,DTCC00656478,328449,39669
CHEMBL1173279,P23975,,ZHBAFJPTWCEURK-IINYFYTJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,3000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392352,DTCC00656480,1104806,39669
CHEMBL1173280,P23975,,MTLOYHNBLPYTSE-TVQRCGJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,1210,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392353,DTCC00656481,1330974,39669
CHEMBL1173341,P23975,1-PHENYL-3-AZABICYCLO[4.1.0]HEPTANE (STRUCTURAL MIX),IWEJGKHITDGZSV-CABZTGNLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,63.1,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395870,DTCC00656182,921945,39684
CHEMBL1173341,P23975,1-PHENYL-3-AZABICYCLO[4.1.0]HEPTANE (STRUCTURAL MIX),IWEJGKHITDGZSV-CABZTGNLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,158.49,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395873,DTCC00656182,921944,39684
CHEMBL1173341,P23975,1-PHENYL-3-AZABICYCLO[4.1.0]HEPTANE (STRUCTURAL MIX),IWEJGKHITDGZSV-CABZTGNLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,398.11,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395866,DTCC00656182,921946,39684
CHEMBL1173342,P23975,,CJOKQBSVKKHHCD-MISXGVKJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,316.23,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395821,DTCC00656183,502326,39684
CHEMBL1173353,P23975,,SXEGCINDYXTNFI-TVQRCGJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,3800,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392354,DTCC00656482,393836,39669
CHEMBL1173354,P23975,,MFHSHFDIBPWOJA-TVQRCGJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,830,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392355,DTCC00656483,1200585,39669
CHEMBL1173355,P23975,,QAPDCFXYLMIQOK-IINYFYTJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392357,DTCC00656485,652070,39669
CHEMBL1173412,P23975,,RTLOWGFIODTOMO-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,199.53,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395817,DTCC00656184,954222,39684
CHEMBL1173413,P23975,,SAIAWHLAJVOTCR-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,316.23,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395811,DTCC00656186,890019,39684
CHEMBL1173414,P23975,,LSPLQALBHLTUIH-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,199.53,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395808,DTCC00656187,1918924,39684
CHEMBL1173415,P23975,,KXJGGCUESGCVLH-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,125.89,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395805,DTCC00656188,890020,39684
CHEMBL1173416,P23975,,UVVKDTGZBLYAEF-COLVAYQJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,50.12,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395759,DTCC00656189,241869,39684
CHEMBL1173427,P23975,,LHPUYZQFWLLHPT-ISVAXAHUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,740,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392359,DTCC00656489,101169,39669
CHEMBL1173428,P23975,,GRQDILLJMSLURW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,114,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392344,DTCC00656490,813085,39669
CHEMBL1173429,P23975,,FOKYJAFKMXEAJL-ISVAXAHUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,151,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392343,DTCC00656491,942589,39669
CHEMBL1173430,P23975,,DLXDOKNGJXKCNQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,2440,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392342,DTCC00656492,1168259,39669
CHEMBL1173519,P23975,,RNWPCCAJXHTPIS-BFHYXJOUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,100,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395756,DTCC00655503,1757828,39684
CHEMBL1173520,P23975,,RNWPCCAJXHTPIS-MGPQQGTHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,50.12,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395753,DTCC00655504,1310416,39684
CHEMBL1173530,P23975,"RAC-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTAN-6-YL)METHANOL (STRUCTURAL MIX)",RVRYTWVPEPGNKI-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,100,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395836,DTCC00655740,695860,39684
CHEMBL1173530,P23975,"RAC-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTAN-6-YL)METHANOL (STRUCTURAL MIX)",RVRYTWVPEPGNKI-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,158.49,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395842,DTCC00655740,695858,39684
CHEMBL1173530,P23975,"RAC-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTAN-6-YL)METHANOL (STRUCTURAL MIX)",RVRYTWVPEPGNKI-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,398.11,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395839,DTCC00655740,695859,39684
CHEMBL1173532,P23975,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",ICXJGCSEMJXNQF-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]noradrenalin reuptake at human NET expressed in pig LLCPK cells after 1 hr,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642195,DTCT0023180,3395888,DTCC00655741,1568857,39684
CHEMBL1173532,P23975,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",ICXJGCSEMJXNQF-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,7.94,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395830,DTCC00655741,1568857,39684
CHEMBL1173532,P23975,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",ICXJGCSEMJXNQF-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,12.02,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by SPA,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642198,DTCT0023180,3395346,DTCC00655741,1568857,39684
CHEMBL1173532,P23975,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",ICXJGCSEMJXNQF-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,12.59,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395833,DTCC00655741,1568856,39684
CHEMBL1173532,P23975,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",ICXJGCSEMJXNQF-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,125.89,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395827,DTCC00655741,1568858,39684
CHEMBL1173532,P23975,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",ICXJGCSEMJXNQF-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,7.94,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065308,DTCC00655741,1558053,45533
CHEMBL1173533,P23975,"6-(3,4-DICHLOROPHENYL)-1-[(ETHYLOXY)METHYL]-3-AZABICYCLO[4.1.0]-HEPTANE (ENANTIOMERIC MIX)",PWRNDGOMCQHVRL-HUUCEWRRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,7.94,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395787,DTCC00655742,986640,39684
CHEMBL1173533,P23975,"6-(3,4-DICHLOROPHENYL)-1-[(ETHYLOXY)METHYL]-3-AZABICYCLO[4.1.0]-HEPTANE (ENANTIOMERIC MIX)",PWRNDGOMCQHVRL-HUUCEWRRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,10,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395793,DTCC00655742,986638,39684
CHEMBL1173533,P23975,"6-(3,4-DICHLOROPHENYL)-1-[(ETHYLOXY)METHYL]-3-AZABICYCLO[4.1.0]-HEPTANE (ENANTIOMERIC MIX)",PWRNDGOMCQHVRL-HUUCEWRRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,100,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395790,DTCC00655742,986639,39684
CHEMBL1173594,P23975,,TYRLWIIURFREJC-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,79.43,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395784,DTCC00655743,437945,39684
CHEMBL1173595,P23975,"1-((CYCLOPROPYLMETHOXY)METHYL)-6-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",ZPPOFTVMEMXBDU-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,19.95,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395778,DTCC00655744,1822583,39684
CHEMBL1173595,P23975,"1-((CYCLOPROPYLMETHOXY)METHYL)-6-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",ZPPOFTVMEMXBDU-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,50.12,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395781,DTCC00655744,1822580,39684
CHEMBL1173595,P23975,"1-((CYCLOPROPYLMETHOXY)METHYL)-6-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",ZPPOFTVMEMXBDU-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,125.89,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395775,DTCC00655744,1822584,39684
CHEMBL1173597,P23975,,ZWMHSADWUIOURG-ZFWWWQNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,31,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392338,DTCC00655829,974724,39669
CHEMBL1173597,P23975,,ZWMHSADWUIOURG-ZFWWWQNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21319801,IC50,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,2011,54,5,"Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ",,741840,DTCT0023180,5920201,DTCC00655829,993413,44216
CHEMBL1173598,P23975,,XVUDIIQDUSBBTF-IINYFYTJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,527,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392336,DTCC00655831,1746341,39669
CHEMBL1173599,P23975,,FAQPJNPOZWJWED-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392335,DTCC00655832,1428374,39669
CHEMBL1173600,P23975,,WROCJHDKYNTMKL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,7950,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392334,DTCC00655833,748761,39669
CHEMBL1173607,P23975,,FOZZHOLQHJQMRY-SWLSCSKDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,3.98,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395876,DTCC00655924,1727393,39684
CHEMBL1173607,P23975,,FOZZHOLQHJQMRY-SWLSCSKDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,3.98,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065306,DTCC00655924,1718655,45533
CHEMBL1173701,P23975,,CWQJTYANMLPKAM-IFXJQAMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,10300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392358,DTCC00656511,393837,39669
CHEMBL1173751,P23975,,OWTIWTHXBDWNDV-HUUCEWRRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,7.94,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395772,DTCC00656136,437946,39684
CHEMBL1173752,P23975,,RFTBXAYWUQYHOQ-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,794.33,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395768,DTCC00656137,1310415,39684
CHEMBL1173753,P23975,,QUJMNYWULZSJDX-HZPDHXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,501.19,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395765,DTCC00656138,1854645,39684
CHEMBL1173754,P23975,,RYHCLMRIRKKHKV-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,15.85,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395762,DTCC00656139,2081768,39684
CHEMBL1173770,P23975,,FZKVHQCDVIXSMY-QMHKHESXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,411,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392341,DTCC00656519,101170,39669
CHEMBL1173771,P23975,,YFWBKVXUOIZZMD-QMHKHESXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,1570,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392340,DTCC00656520,911100,39669
CHEMBL1173772,P23975,,LYDZRRKPDGFEON-JSGCOSHPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,43.4,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392339,DTCC00656521,780722,39669
CHEMBL1173772,P23975,,LYDZRRKPDGFEON-JSGCOSHPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21319801,IC50,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,2011,54,5,"Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ",,741840,DTCT0023180,5920200,DTCC00656521,799426,44216
CHEMBL117405,P23975,S(-)-PINDOLOL,JZQKKSLKJUAGIC-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287715,DTCC01742455,1992798,46191
CHEMBL117405,P23975,S(-)-PINDOLOL,JZQKKSLKJUAGIC-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287716,DTCC01742455,1992798,46191
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11750180,KI,=,7.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732462,DTCC00292361,2104685,69314
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,7.5,NM,,,,,,,,,,,,,,Ability to inhibit the reuptake of NE at human norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142609,DTCT0023180,1074791,DTCC00292361,950654,6048
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,=,7450,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142807,DTCT0023180,1084954,DTCC00292361,938819,6492
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16220969,KI,=,16,NM,,,,,,,,,,,,,,Inhibition constant against norepinephrine transporter,,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,2005,48,21,"Morphy R, Rankovic Z",,320757,DTCT0023180,1861967,DTCC00292361,940158,19940
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965625,DTCC00292361,951833,21201
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964063,DTCC00292361,940373,21124
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224521,DTCC00292361,956951,24303
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,8.9,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303668,DTCC00292361,957165,25699
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,45,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367361,DTCC00292361,957227,26231
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,4,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686035,DTCC00292361,952963,31294
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,8.9,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2599982,DTCC00292361,953188,32649
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725274,DTCC00292361,941509,34196
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876599,DTCC00292361,953218,34589
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,7.94,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916820,DTCC00292361,942015,34271
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,45,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265106,DTCC00292361,954022,37586
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324047,DTCC00292361,954101,38843
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,45,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348372,DTCC00292361,954144,39093
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,5.97,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461598,DTCC00292361,944433,52000
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,1.58,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800438,DTCC00292361,944911,53876
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,515,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880518,DTCC00292361,946226,60843
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,29,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454711,DTCC00292361,2096107,54354
CHEMBL1175,P23975,DULOXETINE,ZEUITGRIYCTCEM-KRWDZBQOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,6.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454789,DTCC00292361,2096107,54354
CHEMBL11768,P23975,,BYLRMZMKZKCWAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,INHIBITION,=,60,%,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143138,DTCT0023180,1029168,DTCC00140464,422853,14474
CHEMBL1177,P23975,PEMOLINE,NRNCYVBFPDDJNE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7391204,DTCC00292515,1576126,46191
CHEMBL1177,P23975,PEMOLINE,NRNCYVBFPDDJNE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7391205,DTCC00292515,1576126,46191
CHEMBL11776,P23975,,ZBKITZYQNFJNIF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,KI,>,8000,NM,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET).,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143141,DTCT0023180,1038940,DTCC00140695,745196,14474
CHEMBL118,P23975,CELECOXIB,RZEKVGVHFLEQIL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,7308,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7353616,DTCC01738574,51454,46191
CHEMBL118,P23975,CELECOXIB,RZEKVGVHFLEQIL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,7247,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7353617,DTCC01738574,51454,46191
CHEMBL1189234,P23975,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11474386,DTCC00667938,1780157,51935
CHEMBL1189234,P23975,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12600279,DTCC00667938,1780916,55935
CHEMBL1191,P23975,SULFAMETHIZOLE,VACCAVUAMIDAGB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456596,DTCC00301538,1577010,46191
CHEMBL1191,P23975,SULFAMETHIZOLE,VACCAVUAMIDAGB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456597,DTCC00301538,1577010,46191
CHEMBL119385,P23975,VX-745,VEPKQEUBKLEPRA-UHFFFAOYSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,20404,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446767,DTCC00293200,1092352,46191
CHEMBL119385,P23975,VX-745,VEPKQEUBKLEPRA-UHFFFAOYSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,20236,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446768,DTCC00293200,1092352,46191
CHEMBL1194,P23975,PRILOCAINE,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402683,DTCC00305352,898295,46191
CHEMBL1194,P23975,PRILOCAINE,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402684,DTCC00305352,898295,46191
CHEMBL119443,P23975,ERGONOVINE,WVVSZNPYNCNODU-XTQGRXLLSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7326101,DTCC00295305,1798410,46191
CHEMBL119443,P23975,ERGONOVINE,WVVSZNPYNCNODU-XTQGRXLLSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7326102,DTCC00295305,1798410,46191
CHEMBL1196,P23975,PROPARACAINE,KCLANYCVBBTKTO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7392183,DTCC00305570,1927021,46191
CHEMBL1196,P23975,PROPARACAINE,KCLANYCVBBTKTO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7392184,DTCC00305570,1927021,46191
CHEMBL1196025,P23975,,TXPPKWZEHFNZOE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24187998,KI,=,128900,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-dopamine from human NET expressed in African green monkey COS7 cells after 10 mins,,"Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists.",J. Med. Chem.,2013,56,23,"Crestey F, Jensen AA, Borch M, Andreasen JT, Andersen J, Balle T, Kristensen JL",,1335319,DTCT0023180,13627477,DTCC00674539,2029412,57973
CHEMBL119605,P23975,,MHWRJCBZOCBFBD-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,=,920000,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142807,DTCT0023180,1061311,DTCC00292353,1489149,6492
CHEMBL1198,P23975,PRAMOXINE,DQKXQSGTHWVTAD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372503,DTCC00305773,1674146,46191
CHEMBL1198,P23975,PRAMOXINE,DQKXQSGTHWVTAD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372504,DTCC00305773,1674146,46191
CHEMBL12,P23975,DIAZEPAM,AAOVKJBEBIDNHE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7361592,DTCC00132806,51463,46191
CHEMBL12,P23975,DIAZEPAM,AAOVKJBEBIDNHE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7361593,DTCC00132806,51463,46191
CHEMBL1200322,P23975,ESCITALOPRAM OXALATE,KTGRHKOEFSJQNS-BDQAORGHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20597489,KI,,,,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,Not Determined,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,2010,53,15,"Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM",,646995,DTCT0023180,3432101,DTCC00678321,1363729,40077
CHEMBL1200391,P23975,TROMETHAMINE,LENZDBCJOHFCAS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450153,DTCC00678381,1092351,46191
CHEMBL1200391,P23975,TROMETHAMINE,LENZDBCJOHFCAS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450154,DTCC00678381,1092351,46191
CHEMBL1200396,P23975,BUPIVACAINE HYDROCHLORIDE,SIEYLFHKZGLBNX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7280429,DTCC00678386,1155677,46191
CHEMBL1200396,P23975,BUPIVACAINE HYDROCHLORIDE,SIEYLFHKZGLBNX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7280430,DTCC00678386,1155677,46191
CHEMBL1200406,P23975,DIMENHYDRINATE,NFLLKCVHYJRNRH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2037,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7364061,DTCC00678394,736259,46191
CHEMBL1200406,P23975,DIMENHYDRINATE,NFLLKCVHYJRNRH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2020,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7364062,DTCC00678394,736259,46191
CHEMBL1200431,P23975,GADOPENTETATE DIMEGLUMINE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331323,DTCC00678414,1544899,46191
CHEMBL1200431,P23975,GADOPENTETATE DIMEGLUMINE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331324,DTCC00678414,1544899,46191
CHEMBL1200528,P23975,CHROMIC CHLORIDE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7369165,DTCC00678493,1447878,46191
CHEMBL1200528,P23975,CHROMIC CHLORIDE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7369166,DTCC00678493,1447878,46191
CHEMBL1200545,P23975,DIFLORASONE DIACETATE,BOBLHFUVNSFZPJ-JOYXJVLSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366008,DTCC00678506,1734055,46191
CHEMBL1200545,P23975,DIFLORASONE DIACETATE,BOBLHFUVNSFZPJ-JOYXJVLSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366009,DTCC00678506,1734055,46191
CHEMBL1200558,P23975,BACITRACIN,CLKOFPXJLQSYAH-ABRJDSQDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7279658,DTCC00678469,1734054,46191
CHEMBL1200558,P23975,BACITRACIN,CLKOFPXJLQSYAH-ABRJDSQDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7279659,DTCC00678469,1734054,46191
CHEMBL1200559,P23975,LACTIC ACID,JVTAAEKCZFNVCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435619,DTCC00678516,1124450,46191
CHEMBL1200559,P23975,LACTIC ACID,JVTAAEKCZFNVCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435620,DTCC00678516,1124450,46191
CHEMBL1200585,P23975,OXYMETHOLONE,ICMWWNHDUZJFDW-DHODBPELSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7378069,DTCC00678533,1577006,46191
CHEMBL1200585,P23975,OXYMETHOLONE,ICMWWNHDUZJFDW-DHODBPELSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7378070,DTCC00678533,1577006,46191
CHEMBL1200600,P23975,FLUOROMETHOLONE,FAOZLTXFLGPHNG-KNAQIMQKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7314166,DTCC00678548,1027053,46191
CHEMBL1200600,P23975,FLUOROMETHOLONE,FAOZLTXFLGPHNG-KNAQIMQKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7314167,DTCC00678548,1027053,46191
CHEMBL1200604,P23975,TROPICAMIDE,BGDKAVGWHJFAGW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7452009,DTCC00678551,1416038,46191
CHEMBL1200604,P23975,TROPICAMIDE,BGDKAVGWHJFAGW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7452010,DTCC00678551,1416038,46191
CHEMBL1200623,P23975,ETHYLESTRENOL,AOXRBFRFYPMWLR-XGXHKTLJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2098,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7315801,DTCC00678568,1544897,46191
CHEMBL1200623,P23975,ETHYLESTRENOL,AOXRBFRFYPMWLR-XGXHKTLJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2080,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7315802,DTCC00678568,1544897,46191
CHEMBL1200624,P23975,ETHYNODIOL DIACETATE,ONKUMRGIYFNPJW-KIEAKMPYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7320032,DTCC00678569,88628,46191
CHEMBL1200624,P23975,ETHYNODIOL DIACETATE,ONKUMRGIYFNPJW-KIEAKMPYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7320033,DTCC00678569,88628,46191
CHEMBL1200629,P23975,VECURONIUM BROMIDE,VEPSYABRBFXYIB-PWXDFCLTSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448533,DTCC00678574,703989,46191
CHEMBL1200629,P23975,VECURONIUM BROMIDE,VEPSYABRBFXYIB-PWXDFCLTSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448534,DTCC00678574,703989,46191
CHEMBL1200633,P23975,IVERMECTIN,SPBDXSGPUHCETR-JFUDTMANSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3947.5,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414140,DTCC00678578,606970,46191
CHEMBL1200633,P23975,IVERMECTIN,SPBDXSGPUHCETR-JFUDTMANSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3914.9,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414141,DTCC00678578,606970,46191
CHEMBL1200656,P23975,NATAMYCIN,NCXMLFZGDNKEPB-FFPOYIOWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380854,DTCC00678594,1351116,46191
CHEMBL1200656,P23975,NATAMYCIN,NCXMLFZGDNKEPB-FFPOYIOWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380855,DTCC00678594,1351116,46191
CHEMBL1200679,P23975,ZINC CHLORIDE,JIAARYAFYJHUJI-UHFFFAOYSA-L,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,7008.3,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7449678,DTCC00678612,315674,46191
CHEMBL1200679,P23975,ZINC CHLORIDE,JIAARYAFYJHUJI-UHFFFAOYSA-L,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,6950.4,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7449679,DTCC00678612,315674,46191
CHEMBL1200693,P23975,MANGANESE CHLORIDE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431975,DTCC00678623,671789,46191
CHEMBL1200693,P23975,MANGANESE CHLORIDE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431976,DTCC00678623,671789,46191
CHEMBL1200709,P23975,CROTAMITON,DNTGGZPQPQTDQF-XBXARRHUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7341856,DTCC00678636,1188066,46191
CHEMBL1200709,P23975,CROTAMITON,DNTGGZPQPQTDQF-XBXARRHUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7341857,DTCC00678636,1188066,46191
CHEMBL1200748,P23975,CARBIDOPA,QTAOMKOIBXZKND-PPHPATTJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477568,DTCC00678662,606973,46191
CHEMBL1200748,P23975,CARBIDOPA,QTAOMKOIBXZKND-PPHPATTJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477569,DTCC00678662,606973,46191
CHEMBL1200845,P23975,HALCINONIDE,MUQNGPZZQDCDFT-JNQJZLCISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7329807,DTCC00678745,1765972,46191
CHEMBL1200845,P23975,HALCINONIDE,MUQNGPZZQDCDFT-JNQJZLCISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7329808,DTCC00678745,1765972,46191
CHEMBL1200862,P23975,METYROSINE,NHTGHBARYWONDQ-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7430496,DTCC00678758,88631,46191
CHEMBL1200862,P23975,METYROSINE,NHTGHBARYWONDQ-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7430497,DTCC00678758,88631,46191
CHEMBL1200993,P23975,GALLAMINE TRIETHIODIDE,REEUVFCVXKWOFE-UHFFFAOYSA-K,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305757,DTCC00678870,381013,46191
CHEMBL1200993,P23975,GALLAMINE TRIETHIODIDE,REEUVFCVXKWOFE-UHFFFAOYSA-K,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305758,DTCC00678870,381013,46191
CHEMBL1201010,P23975,FLUDROCORTISONE ACETATE,SYWHXTATXSMDSB-GSLJADNHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7314072,DTCC00678884,381011,46191
CHEMBL1201010,P23975,FLUDROCORTISONE ACETATE,SYWHXTATXSMDSB-GSLJADNHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7314073,DTCC00678884,381011,46191
CHEMBL1201012,P23975,FLURANDRENOLIDE,POPFMWWJOGLOIF-XWCQMRHXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331185,DTCC00678886,381012,46191
CHEMBL1201012,P23975,FLURANDRENOLIDE,POPFMWWJOGLOIF-XWCQMRHXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331186,DTCC00678886,381012,46191
CHEMBL1201024,P23975,METHSCOPOLAMINE BROMIDE,CXYRUNPLKGGUJF-XKTSLVMZSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410899,DTCC00678896,1059334,46191
CHEMBL1201024,P23975,METHSCOPOLAMINE BROMIDE,CXYRUNPLKGGUJF-XKTSLVMZSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410900,DTCC00678896,1059334,46191
CHEMBL1201066,P23975,VENLAFAXINE HYDROCHLORIDE,QYRYFNHXARDNFZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,2553,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531911,DTCC00678930,301239,63581
CHEMBL1201066,P23975,VENLAFAXINE HYDROCHLORIDE,QYRYFNHXARDNFZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,2550,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122191,DTCC00678930,289849,66412
CHEMBL1201082,P23975,FLUOXETINE HYDROCHLORIDE,GIYXAJPCNFJEHY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,IC50,=,4410,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863447,DTCT0023180,11410188,DTCC00678941,770252,51438
CHEMBL1201082,P23975,FLUOXETINE HYDROCHLORIDE,GIYXAJPCNFJEHY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,4.7,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410242,DTCC00678941,770252,51438
CHEMBL1201117,P23975,METHOCARBAMOL,GNXFOGHNGIVQEH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7432268,DTCC00678968,800581,46191
CHEMBL1201117,P23975,METHOCARBAMOL,GNXFOGHNGIVQEH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7432269,DTCC00678968,800581,46191
CHEMBL1201139,P23975,MEGESTROL ACETATE,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410696,DTCC00678986,639582,46191
CHEMBL1201139,P23975,MEGESTROL ACETATE,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410697,DTCC00678986,639582,46191
CHEMBL1201146,P23975,NORETHINDRONE ACETATE,IMONTRJLAWHYGT-ZCPXKWAGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386382,DTCC00678989,703984,46191
CHEMBL1201146,P23975,NORETHINDRONE ACETATE,IMONTRJLAWHYGT-ZCPXKWAGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386383,DTCC00678989,703984,46191
CHEMBL1201151,P23975,MESTRANOL,IMSSROKUHAOUJS-MJCUULBUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1382,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410811,DTCC00678994,542579,46191
CHEMBL1201151,P23975,MESTRANOL,IMSSROKUHAOUJS-MJCUULBUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1371,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410812,DTCC00678994,542579,46191
CHEMBL1201193,P23975,LEVOBUPIVACAINE,LEBVLXFERQHONN-INIZCTEOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414462,DTCC00679027,282998,46191
CHEMBL1201193,P23975,LEVOBUPIVACAINE,LEBVLXFERQHONN-INIZCTEOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414463,DTCC00679027,282998,46191
CHEMBL1201195,P23975,CEFMETAZOLE,SNBUBQHDYVFSQF-HIFRSBDPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7345047,DTCC00679029,833158,46191
CHEMBL1201195,P23975,CEFMETAZOLE,SNBUBQHDYVFSQF-HIFRSBDPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7345048,DTCC00679029,833158,46191
CHEMBL1201203,P23975,BENZTROPINE,GIJXKZJWITVLHI-PMOLBWCYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1391,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7275555,DTCC00679037,1609543,46191
CHEMBL1201203,P23975,BENZTROPINE,GIJXKZJWITVLHI-PMOLBWCYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1379,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7275556,DTCC00679037,1609543,46191
CHEMBL1201207,P23975,BETAMETHASONE PHOSPHORIC ACID,VQODGRNSFPNSQE-DVTGEIKXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7278597,DTCC00679040,444634,46191
CHEMBL1201207,P23975,BETAMETHASONE PHOSPHORIC ACID,VQODGRNSFPNSQE-DVTGEIKXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7278598,DTCC00679040,444634,46191
CHEMBL1201216,P23975,DAPIPRAZOLE,RFWZESUMWJKKRN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340022,DTCC00679045,1544895,46191
CHEMBL1201216,P23975,DAPIPRAZOLE,RFWZESUMWJKKRN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340023,DTCC00679045,1544895,46191
CHEMBL1201220,P23975,DIATRIZOIC ACID,YVPYQUNUQOZFHG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357309,DTCC00679049,444639,46191
CHEMBL1201220,P23975,DIATRIZOIC ACID,YVPYQUNUQOZFHG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357310,DTCC00679049,444639,46191
CHEMBL1201237,P23975,LEVOBUNOLOL,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410138,DTCC00679063,736261,46191
CHEMBL1201237,P23975,LEVOBUNOLOL,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410139,DTCC00679063,736261,46191
CHEMBL1201346,P23975,BALSALAZID,IPOKCKJONYRRHP-FMQUCBEESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7262548,DTCC00679132,1512805,46191
CHEMBL1201346,P23975,BALSALAZID,IPOKCKJONYRRHP-FMQUCBEESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7262549,DTCC00679132,1512805,46191
CHEMBL1201353,P23975,DEXCHLORPHENIRAMINE,SOYKEARSMXGVTM-HNNXBMFYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,4966,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370259,DTCC00679137,185552,46191
CHEMBL1201353,P23975,DEXCHLORPHENIRAMINE,SOYKEARSMXGVTM-HNNXBMFYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4925,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370260,DTCC00679137,185552,46191
CHEMBL1201356,P23975,METHYLERGONOVINE,UNBRKDKAWYKMIV-QWQRMKEZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428115,DTCC00679140,1124451,46191
CHEMBL1201356,P23975,METHYLERGONOVINE,UNBRKDKAWYKMIV-QWQRMKEZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428116,DTCC00679140,1124451,46191
CHEMBL1201469,P23975,GRAMICIDIN,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325389,DTCC00679278,217579,46191
CHEMBL1201469,P23975,GRAMICIDIN,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325390,DTCC00679278,217579,46191
CHEMBL1201631,P23975,INSULIN HUMAN,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7433066,DTCC00679306,1798411,46191
CHEMBL1201631,P23975,INSULIN HUMAN,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7433067,DTCC00679306,1798411,46191
CHEMBL1202031,P23975,,AVZJOJWZRMWFIR-OZIFAFRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,1400,NM,,,,,,,,,,,,,,Binding affinity against human cloned norepinephrine transporter using 40-80 pM [125I]RTI.,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,197580,DTCT0023180,1150696,DTCC00679605,1586182,16052
CHEMBL1202031,P23975,,AVZJOJWZRMWFIR-OZIFAFRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,3200,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1150697,DTCC00679605,1586182,16052
CHEMBL1204009,P23975,,IFWPZKFWNGLFCD-UFTMZEDQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821575,IC50,=,0.037,NM,,,,,,,,,,,,,,Inhibition of NET,,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,21,"Marquis RW, Lago AM, Callahan JF, Rahman A, Dong X, Stroup GB, Hoffman S, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Roethke T, Smith BR, Ward KW, Bhatnagar P",,591455,DTCT0023180,3056359,DTCC00125752,1939058,35717
CHEMBL1204410,P23975,,TWOLHZITFDHKDN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,12,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224277,DTCC00681902,295594,38126
CHEMBL1204411,P23975,,DOQYJYPXUDTPLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224279,DTCC00681903,1874950,38126
CHEMBL1204412,P23975,,AQZJYBPKTZMMER-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224281,DTCC00681904,1778103,38126
CHEMBL1204413,P23975,,GSXGGZMCFSEFOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,26,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224284,DTCC00681905,1939359,38126
CHEMBL1204414,P23975,,AFRJOWOPSIECIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,11,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224286,DTCC00681906,619288,38126
CHEMBL1204415,P23975,,UCFNHHVPDLJJEJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,27,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224288,DTCC00681907,490399,38126
CHEMBL1208572,P23975,SALINOMYCIN,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464605,DTCC00685596,1641853,46191
CHEMBL1208572,P23975,SALINOMYCIN,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464606,DTCC00685596,1641853,46191
CHEMBL12089,P23975,BERBERINE CHLORIDE,VKJGBAJNNALVAV-UHFFFAOYSA-M,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7258472,DTCC00140102,1416025,46191
CHEMBL12089,P23975,BERBERINE CHLORIDE,VKJGBAJNNALVAV-UHFFFAOYSA-M,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7258473,DTCC00140102,1416025,46191
CHEMBL121,P23975,ROSIGLITAZONE,YASAKCUCGLMORW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481767,DTCC00148715,51506,46191
CHEMBL121,P23975,ROSIGLITAZONE,YASAKCUCGLMORW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481768,DTCC00148715,51506,46191
CHEMBL121027,P23975,,NVIYCTHUJATAOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,279,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,962713,DTCC00298143,1753940,15367
CHEMBL121027,P23975,,NVIYCTHUJATAOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,370,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,962708,DTCC00298143,1753940,15367
CHEMBL12131,P23975,CLOSANTEL,JMPFSEBWVLAJKM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7352248,DTCC00140760,1674142,46191
CHEMBL12131,P23975,CLOSANTEL,JMPFSEBWVLAJKM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7352249,DTCC00140760,1674142,46191
CHEMBL1214005,P23975,,SGCXLJVGGMOGGK-PMWAWBRWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20597489,KI,=,2607,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,2010,53,15,"Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM",,646995,DTCT0023180,3432094,DTCC00688643,1557311,40077
CHEMBL1214006,P23975,,LMVDJMCDHZLBFE-PMWAWBRWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20597489,KI,=,142,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,2010,53,15,"Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM",,646995,DTCT0023180,3432095,DTCC00688644,295860,40077
CHEMBL1214007,P23975,,FXIKVFNIIRHKBX-PMWAWBRWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20597489,KI,=,87,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,2010,53,15,"Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM",,646995,DTCT0023180,3432096,DTCC00688645,1331020,40077
CHEMBL1214059,P23975,,YANGDSFZAMQEBP-PMWAWBRWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20597489,KI,=,145,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,2010,53,15,"Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM",,646995,DTCT0023180,3432097,DTCC00688699,1746391,40077
CHEMBL1214060,P23975,,XZWRXMFAFBSAJC-OWANBTPYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20597489,KI,=,265,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,2010,53,15,"Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM",,646995,DTCT0023180,3432098,DTCC00688700,1007219,40077
CHEMBL1214060,P23975,,XZWRXMFAFBSAJC-OWANBTPYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of NET,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700839,DTCT0023180,5036550,DTCC00688700,1007506,42620
CHEMBL1214185,P23975,ROXITHROMYCIN,RXZBMPWDPOLZGW-XMRMVWPWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460059,DTCC00688811,2057652,46191
CHEMBL1214185,P23975,ROXITHROMYCIN,RXZBMPWDPOLZGW-XMRMVWPWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460060,DTCC00688811,2057652,46191
CHEMBL121460,P23975,,LDCWRCFCYHTIGC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,2600,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,966743,DTCC00298076,530543,15367
CHEMBL121460,P23975,,LDCWRCFCYHTIGC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,261,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,966738,DTCC00298076,530543,15367
CHEMBL1215761,P23975,,KDRRURQANSXWJL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23168018,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine uptake at human NET expressed in COS7 cells after 5 mins by beta-counting,Not Determined,A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.,Bioorg. Med. Chem. Lett.,2013,23,1,"Zhang P, Jørgensen TN, Loland CJ, Newman AH",,943964,DTCT0023180,11814242,DTCC00690313,1748608,53759
CHEMBL121611,P23975,,AFTYGKFAHDIZJA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,116,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,939371,DTCC00298072,498450,15367
CHEMBL121611,P23975,,AFTYGKFAHDIZJA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,82,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,939366,DTCC00298072,498450,15367
CHEMBL1219,P23975,RABEPRAZOLE,YREYEVIYCVEVJK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472856,DTCC00316485,574625,46191
CHEMBL1219,P23975,RABEPRAZOLE,YREYEVIYCVEVJK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472857,DTCC00316485,574625,46191
CHEMBL122,P23975,ROFECOXIB,RZJQGNCSTQAWON-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477448,DTCC00150159,1830689,46191
CHEMBL122,P23975,ROFECOXIB,RZJQGNCSTQAWON-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477449,DTCC00150159,1830689,46191
CHEMBL1220,P23975,TINIDAZOLE,HJLSLZFTEKNLFI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7483439,DTCC00316820,1318449,46191
CHEMBL1220,P23975,TINIDAZOLE,HJLSLZFTEKNLFI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7483440,DTCC00316820,1318449,46191
CHEMBL1221,P23975,SULCONAZOLE,AFNXATANNDIXLG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2027,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460809,DTCC00317729,1830690,46191
CHEMBL1221,P23975,SULCONAZOLE,AFNXATANNDIXLG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2010,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460810,DTCC00317729,1830690,46191
CHEMBL1221512,P23975,L-744832,PGOKBMWPBDRDGN-IBXSQZDTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414224,DTCC00031822,1927016,46191
CHEMBL1221512,P23975,L-744832,PGOKBMWPBDRDGN-IBXSQZDTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414225,DTCC00031822,1927016,46191
CHEMBL12227,P23975,,CYUGXTVDOUZASH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,KI,=,3520,NM,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143140,DTCT0023180,1025385,DTCC00140623,1871674,14474
CHEMBL1224024,P23975,,HWJCHTVVHUINLQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,12.59,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448121,DTCC00692755,566796,40418
CHEMBL1224024,P23975,,HWJCHTVVHUINLQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,19.95,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448116,DTCC00692755,566797,40418
CHEMBL1224025,P23975,,HWJCHTVVHUINLQ-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,158.49,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448126,DTCC00692756,177416,40418
CHEMBL1224034,P23975,,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20692833,INHIBITION,=,34.1,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET at 10 uM,,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,2010,20,18,"Kwon YJ, Saubern S, Macdonald JM, Huang XP, Setola V, Roth BL",,652469,DTCT0023180,3449434,DTCC00692765,716520,40427
CHEMBL1224034,P23975,,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20692833,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET,,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,2010,20,18,"Kwon YJ, Saubern S, Macdonald JM, Huang XP, Setola V, Roth BL",,652474,DTCT0023180,3449439,DTCC00692765,716520,40427
CHEMBL1224089,P23975,,WVZMHYCNWMCWBJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,7.94,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448131,DTCC00692821,1116630,40418
CHEMBL1224090,P23975,,KSKOKUBPUSATCC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,2.51,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448136,DTCC00692822,1084124,40418
CHEMBL1224091,P23975,,HFJPQKBQGCFBQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,2.51,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448141,DTCC00692823,438031,40418
CHEMBL1224092,P23975,,FTQBIVFBXYAAQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,12.59,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448146,DTCC00692824,695952,40418
CHEMBL1224093,P23975,,HXVMFBSINMZKRO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,7.94,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448151,DTCC00692825,1277709,40418
CHEMBL1224094,P23975,,WMONHIUXMOXBDS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,7.94,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448156,DTCC00692826,1472360,40418
CHEMBL1224095,P23975,,MDLYPVGOCJZPGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,158.49,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448161,DTCC00692827,1537015,40418
CHEMBL1224160,P23975,,LPLLJFFJYKVRLO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,7.94,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448164,DTCC00692893,1084127,40418
CHEMBL1224161,P23975,,JHBXYVBNWXENQD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,25.12,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448167,DTCC00692894,1439948,40418
CHEMBL1224162,P23975,,LGCPITGZBZPIIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,100,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448170,DTCC00692895,1245192,40418
CHEMBL1224163,P23975,,GZMVATBMIADACI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,251.19,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448173,DTCC00692896,2049691,40418
CHEMBL1224164,P23975,,PMWJXJVDUJHXHT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,3.16,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448106,DTCC00692897,1633798,40418
CHEMBL1224165,P23975,,WTCFDFPSNBMAOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,2,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448111,DTCC00126071,405951,40418
CHEMBL1224224,P23975,,WHNHYVQHXLVZHR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,IC50,=,264,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118,DTCT0023180,3446664,DTCC00692955,2017595,40497
CHEMBL1224224,P23975,,WHNHYVQHXLVZHR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,30,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446729,DTCC00692955,2017595,40497
CHEMBL1224225,P23975,,IYTKIEQZFQYQAC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,12,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446732,DTCC00692956,1116632,40497
CHEMBL1224226,P23975,,XLHBGLMPNFVKBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446669,DTCC00692957,372958,40497
CHEMBL1224227,P23975,,DKLPATDCBOSBMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,IC50,=,13.3,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118,DTCT0023180,3446726,DTCC00692958,598977,40497
CHEMBL1224227,P23975,,DKLPATDCBOSBMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,84,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446735,DTCC00692958,598977,40497
CHEMBL1224237,P23975,,MUCOWQIQUFKAFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,2.51,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447374,DTCC00692968,1212173,40418
CHEMBL1224238,P23975,,GBLULAKVGYVWTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,2.51,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447379,DTCC00692969,1822682,40418
CHEMBL1224239,P23975,,FEFGXICFKQBCRL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,3.16,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448096,DTCC00692970,1504706,40418
CHEMBL1224240,P23975,,PJIMUTYPWDGKIC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,0.631,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448101,DTCC00126072,1343072,40418
CHEMBL1224241,P23975,,AIGSBZFJFSQVPD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,7.94,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447349,DTCC00126073,1984565,40418
CHEMBL1224298,P23975,,VSRNUBMEUKSAAJ-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,37,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446777,DTCC00693019,1951883,40497
CHEMBL1224300,P23975,,NSQVIEVBUSYQLK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,25,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446738,DTCC00693021,631529,40497
CHEMBL1224301,P23975,,MGURNBDIUXGJTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,39,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446741,DTCC00693022,1439951,40497
CHEMBL1224303,P23975,,PVTZQLSVJXEDHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,IC50,=,234,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118,DTCT0023180,3446714,DTCC00693024,39744,40497
CHEMBL1224303,P23975,,PVTZQLSVJXEDHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,37,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446744,DTCC00693024,39744,40497
CHEMBL1224316,P23975,,SVDKSLGSXDLGEV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447354,DTCC00126080,1919024,40418
CHEMBL1224317,P23975,,APFRQKRCPYHTLD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,5.01,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447359,DTCC00126081,274838,40418
CHEMBL1224318,P23975,,DJFCVWKVRXLZFF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,50.12,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447364,DTCC00126082,1727487,40418
CHEMBL1224319,P23975,,JXIHZLYRWFFHPQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,6.31,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447369,DTCC00126083,1277711,40418
CHEMBL1224320,P23975,,KIMRUTAJTDBFHO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,0.501,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447314,DTCC00126084,1310526,40418
CHEMBL1224320,P23975,,KIMRUTAJTDBFHO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,0.794,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447309,DTCC00126084,1310531,40418
CHEMBL1224321,P23975,,MJCKYDPFUPMINT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,1.26,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447318,DTCC00126085,1568941,40418
CHEMBL1224321,P23975,,MJCKYDPFUPMINT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,1.26,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447323,DTCC00126085,1568942,40418
CHEMBL1224381,P23975,,XENSJUHNMOKFGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,IC50,=,69,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118,DTCT0023180,3446717,DTCC00693086,1537017,40497
CHEMBL1224381,P23975,,XENSJUHNMOKFGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,56,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446747,DTCC00693086,1537017,40497
CHEMBL1224382,P23975,,ZLRRLSAVNUFCQT-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,IC50,=,19.8,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118,DTCT0023180,3446720,DTCC00693087,695956,40497
CHEMBL1224382,P23975,,ZLRRLSAVNUFCQT-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,84,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446750,DTCC00693087,695956,40497
CHEMBL1224383,P23975,,UOGHZTJKVOOTDF-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,IC50,=,14.7,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118,DTCT0023180,3446723,DTCC00693088,1310529,40497
CHEMBL1224383,P23975,,UOGHZTJKVOOTDF-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,76,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446753,DTCC00693088,1310529,40497
CHEMBL1224384,P23975,,SLSGGVPSCGVWNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,39,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446756,DTCC00693089,1919025,40497
CHEMBL1224385,P23975,,PCXZFUGPNRGVAN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,70,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446759,DTCC00693090,405953,40497
CHEMBL1224399,P23975,,MZGJPVOTOHUEGK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,3.98,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447328,DTCC00126088,566798,40418
CHEMBL1224400,P23975,,IYHIZUCENFBTJG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,3.16,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447339,DTCC00126089,1084133,40418
CHEMBL1224400,P23975,,IYHIZUCENFBTJG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,6.31,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447333,DTCC00126089,1084132,40418
CHEMBL1224401,P23975,,BINJCVHVYJSTMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447344,DTCC00126090,857995,40418
CHEMBL1224402,P23975,,NVHLQOKZIFFNOX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,2.51,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447279,DTCC00126091,534536,40418
CHEMBL1224402,P23975,,NVHLQOKZIFFNOX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,6.31,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447274,DTCC00126091,534535,40418
CHEMBL1224467,P23975,,QANXQNKYGWZPJQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,84,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446762,DTCC00126101,890122,40497
CHEMBL1224468,P23975,,JORAUIMOUGISHQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,20,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446765,DTCC00126102,566799,40497
CHEMBL1224469,P23975,,UNCNBGAOAXFUFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,55,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446768,DTCC00693147,1084134,40497
CHEMBL1224470,P23975,,ALCQDLGGOYWNLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,32,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446771,DTCC00693148,1408072,40497
CHEMBL1224471,P23975,,VSRNUBMEUKSAAJ-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,INHIBITION,=,79,%,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654115,DTCT0023180,3446774,DTCC00693149,1343075,40497
CHEMBL1224490,P23975,,BLKNUASSHDJVDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,1.26,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447289,DTCC00693161,80690,40418
CHEMBL1224490,P23975,,BLKNUASSHDJVDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,2.51,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447284,DTCC00693161,80689,40418
CHEMBL1224491,P23975,,PKEWUQPHEKJOIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,19.95,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447294,DTCC00693162,307680,40418
CHEMBL1224492,P23975,,INEHYFAMZQPYDY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447304,DTCC00693163,39750,40418
CHEMBL1224492,P23975,,INEHYFAMZQPYDY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,2.51,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447299,DTCC00693163,39749,40418
CHEMBL122452,P23975,,FFZXXMKWEGRDRF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,210,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,958776,DTCC00297903,562756,15367
CHEMBL122452,P23975,,FFZXXMKWEGRDRF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,194,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,958771,DTCC00297903,562756,15367
CHEMBL1224562,P23975,,LWIZTBGDAFNFMW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,19.95,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447256,DTCC00693208,857997,40418
CHEMBL1224563,P23975,,ZOOYCXCRVKSAIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,7.94,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447265,DTCC00693209,792542,40418
CHEMBL1224563,P23975,,ZOOYCXCRVKSAIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447260,DTCC00693209,792541,40418
CHEMBL1224563,P23975,,ZOOYCXCRVKSAIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,19.95,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3447270,DTCC00693209,792543,40418
CHEMBL122859,P23975,,UKJAARKQBNAPHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,>,10,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,941768,DTCC00297904,1694130,15367
CHEMBL122859,P23975,,UKJAARKQBNAPHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,7050,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,941763,DTCC00297904,1694130,15367
CHEMBL1230333,P23975,,VYTXLSQVYGNWLV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7297481,DTCC00693927,2089742,46191
CHEMBL1230333,P23975,,VYTXLSQVYGNWLV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7297482,DTCC00693927,2089742,46191
CHEMBL1230813,P23975,ALFADEX,HFHDHCJBZVLPGP-RWMJIURBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7289933,DTCC00693991,1155676,46191
CHEMBL1230813,P23975,ALFADEX,HFHDHCJBZVLPGP-RWMJIURBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7289934,DTCC00693991,1155676,46191
CHEMBL1231,P23975,OXYBUTYNIN,XIQVNETUBQGFHX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2595.1,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7401768,DTCC00321776,542581,46191
CHEMBL1231,P23975,OXYBUTYNIN,XIQVNETUBQGFHX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2573.7,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7401769,DTCC00321776,542581,46191
CHEMBL1231107,P23975,CYROMAZINE,LVQDKIWDGQRHTE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7341933,DTCC00694021,1027050,46191
CHEMBL1231107,P23975,CYROMAZINE,LVQDKIWDGQRHTE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7341934,DTCC00694021,1027050,46191
CHEMBL1231530,P23975,BETAMIPRON,CWXYHOHYCJXYFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7258578,DTCC00694066,1830684,46191
CHEMBL1231530,P23975,BETAMIPRON,CWXYHOHYCJXYFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7258579,DTCC00694066,1830684,46191
CHEMBL123252,P23975,,WGJCAKQLYZFCSH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,143,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,943047,DTCC00298147,691912,15367
CHEMBL123252,P23975,,WGJCAKQLYZFCSH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,943042,DTCC00298147,691912,15367
CHEMBL123292,P23975,CYCLOHEXIMIDE,YPHMISFOHDHNIV-FSZOTQKASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7354704,DTCC00297204,477915,46191
CHEMBL123292,P23975,CYCLOHEXIMIDE,YPHMISFOHDHNIV-FSZOTQKASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7354705,DTCC00297204,477915,46191
CHEMBL1233878,P23975,KURASOIN A,PJJNUMKZYDTVRG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23880542,INHIBITION,,,,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter by ligand displacement assay,Not Active,Neuroactive diol and acyloin metabolites from cone snail-associated bacteria.,Bioorg. Med. Chem. Lett.,2013,23,17,"Lin Z, Marett L, Hughen RW, Flores M, Forteza I, Ammon MA, Concepcion GP, Espino S, Olivera BM, Rosenberg G, Haygood MG, Light AR, Schmidt EW",,976616,DTCT0023180,12540442,DTCC00694326,1676945,55488
CHEMBL1233879,P23975,KURASOIN B,AWNMAACWZSNOOV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23880542,KI,=,2757,NM,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter by ligand displacement assay,,Neuroactive diol and acyloin metabolites from cone snail-associated bacteria.,Bioorg. Med. Chem. Lett.,2013,23,17,"Lin Z, Marett L, Hughen RW, Flores M, Forteza I, Ammon MA, Concepcion GP, Espino S, Olivera BM, Rosenberg G, Haygood MG, Light AR, Schmidt EW",,976616,DTCT0023180,12540441,DTCC00694327,156392,55488
CHEMBL1235242,P23975,,XWHHYOYVRVGJJY-QMMMGPOBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282389,DTCC00694481,413967,46191
CHEMBL1235242,P23975,,XWHHYOYVRVGJJY-QMMMGPOBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282390,DTCC00694481,413967,46191
CHEMBL1236282,P23975,THIAMPHENICOL,OTVAEFIXJLOWRX-NXEZZACHSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472401,DTCC00694596,1894975,46191
CHEMBL1236282,P23975,THIAMPHENICOL,OTVAEFIXJLOWRX-NXEZZACHSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472402,DTCC00694596,1894975,46191
CHEMBL1237,P23975,LISINOPRIL,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414595,DTCC00323141,88630,46191
CHEMBL1237,P23975,LISINOPRIL,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414596,DTCC00323141,88630,46191
CHEMBL1237044,P23975,TRAMADOL,TVYLLZQTGLZFBW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16257206,IC50,=,790,NM,,,,,,,,,,,,,,Inhibition of reuptake of Norepinephrine,,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,2006,16,3,"Shao L, Abolin C, Hewitt MC, Koch P, Varney M",,333146,DTCT0023180,1892062,DTCC00694678,370245,20316
CHEMBL1237044,P23975,TRAMADOL,TVYLLZQTGLZFBW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,3861,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307421,DTCC00694678,375676,25295
CHEMBL1237044,P23975,TRAMADOL,TVYLLZQTGLZFBW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464136,DTCC00694678,381017,46191
CHEMBL1237044,P23975,TRAMADOL,TVYLLZQTGLZFBW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464137,DTCC00694678,381017,46191
CHEMBL1237064,P23975,"RAC-1-(3,4-DICHLO ROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",OIRCMLIIRQJBKA-CABZTGNLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,100,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395845,DTCC00694685,469672,39684
CHEMBL1237064,P23975,"RAC-1-(3,4-DICHLO ROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",OIRCMLIIRQJBKA-CABZTGNLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,251.19,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395848,DTCC00694685,469671,39684
CHEMBL1237064,P23975,"RAC-1-(3,4-DICHLO ROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",OIRCMLIIRQJBKA-CABZTGNLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,251.19,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395851,DTCC00694685,469670,39684
CHEMBL1237174,P23975,HYDRAZINE,OAKJQQAXSVQMHS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7329868,DTCC00126200,639581,46191
CHEMBL1237174,P23975,HYDRAZINE,OAKJQQAXSVQMHS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7329869,DTCC00126200,639581,46191
CHEMBL12375,P23975,,YDSZXMRCXLHXST-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,KI,=,2080,NM,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143140,DTCT0023180,1055213,DTCC00140495,1714656,14474
CHEMBL123830,P23975,,AWHFBFFVXKIBQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,299,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,966752,DTCC00298179,1500633,15367
CHEMBL123830,P23975,,AWHFBFFVXKIBQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,844,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,966747,DTCC00298179,1500633,15367
CHEMBL1241348,P23975,FALDAPREVIR,LLGDPTDZOVKFDU-XUHJSTDZSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20823284,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,2010,54,11,"White PW, Llinàs-Brunet M, Amad M, Bethell RC, Bolger G, Cordingley MG, Duan J, Garneau M, Lagacé L, Thibeault D, Kukolj G",,724378,DTCT0023180,5127096,DTCC00126282,118904,43507
CHEMBL124222,P23975,,KSRAFZQYEJWAQE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,>,10,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,967848,DTCC00298096,1818640,15367
CHEMBL124222,P23975,,KSRAFZQYEJWAQE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,5850,NM,,cell_based,,,,,,,,,,,,Compound was tested for its affinity by the inhibition of [125I]RTI-55 binding at norepinephrine transporter (NET) transfected in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142936,DTCT0023180,967843,DTCC00298096,1818640,15367
CHEMBL1242923,P23975,,FLGSUSWMWSZVMP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20684563,KI,>=,1000,NM,,,,,,,,,,,,,,Binding affinity to human NE transporter by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659601,DTCT0023180,3460938,DTCC00697046,1200707,40772
CHEMBL1242950,P23975,AC-42,ANTKBACNWQHQJE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20684563,KI,>=,1000,NM,,,,,,,,,,,,,,Binding affinity to human NE transporter by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659601,DTCT0023180,3460939,DTCC00032233,1972874,40772
CHEMBL1243,P23975,SULFABENZAMIDE,PBCZLFBEBARBBI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465217,DTCC00325694,217587,46191
CHEMBL1243,P23975,SULFABENZAMIDE,PBCZLFBEBARBBI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465218,DTCC00325694,217587,46191
CHEMBL1255834,P23975,BW-723C86,ALFGDCNSEBJYSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3625.7,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7274616,DTCC00032296,1124446,46191
CHEMBL1255834,P23975,BW-723C86,ALFGDCNSEBJYSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3595.7,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7274617,DTCC00032296,1124446,46191
CHEMBL1255837,P23975,DIHYDROERGOCRISTINE MESYLATE,SPXACGZWWVIDGR-SPZWACKZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351152,DTCC00699500,1447881,46191
CHEMBL1255837,P23975,DIHYDROERGOCRISTINE MESYLATE,SPXACGZWWVIDGR-SPZWACKZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351153,DTCC00699500,1447881,46191
CHEMBL1255901,P23975,HUPERZINE A,ZRJBHWIHUMBLCN-HZRLMBICSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321264,DTCC00699536,930079,46191
CHEMBL1255901,P23975,HUPERZINE A,ZRJBHWIHUMBLCN-HZRLMBICSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321265,DTCC00699536,930079,46191
CHEMBL1256017,P23975,ARCAINE SULFATE,RWTGFMPOODRXIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7263669,DTCC00699626,994589,46191
CHEMBL1256017,P23975,ARCAINE SULFATE,RWTGFMPOODRXIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7263670,DTCC00699626,994589,46191
CHEMBL1257555,P23975,,KYYMUHCVQBBYFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20833036,ACTIVITY,=,88,%,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter at 10 uM by radioligand displacement assay,,Thienopyrimidines as ß3-adrenoceptor agonists: hit-to-lead optimization.,Bioorg. Med. Chem. Lett.,2010,20,20,"Tasler S, Baumgartner R, Ammendola A, Schachtner J, Wieber T, Blisse M, Rath S, Zaja M, Klahn P, Quotschalla U, Ney P",,665482,DTCT0023180,3534729,DTCC00700749,631639,41184
CHEMBL1257975,P23975,,RUQIIZGSRSUFTC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20801651,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of NET,Active,Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,19,"Bridges TM, Kennedy JP, Hopkins CR, Conn PJ, Lindsley CW",,664698,DTCT0023180,3531433,DTCC00701164,1952005,41125
CHEMBL1258223,P23975,,WKWADEWWLCVVLF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20812727,KI,=,3226,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010,53,19,"Xu R, Hong J, Morse CL, Pike VW",,664967,DTCT0023180,3532980,DTCC00701398,1168405,41144
CHEMBL1258452,P23975,,DZZIAERGLDKTBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20812727,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010,53,19,"Xu R, Hong J, Morse CL, Pike VW",,664967,DTCT0023180,3533024,DTCC00701623,716604,41144
CHEMBL1258614,P23975,,IUEKKZWRWOFGRT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664309,DTCT0023180,3527801,DTCC00701782,911256,41064
CHEMBL1258671,P23975,,WLHFUBIRAHRPHA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20812727,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010,53,19,"Xu R, Hong J, Morse CL, Pike VW",,664967,DTCT0023180,3533068,DTCC00701836,911257,41144
CHEMBL1258722,P23975,,FZPKLZHGBRKKCP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664309,DTCT0023180,3527766,DTCC00701888,2038361,41064
CHEMBL1258723,P23975,,LHSWZGXDIPQNGE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664309,DTCT0023180,3527871,DTCC00701889,14439,41064
CHEMBL1258843,P23975,,VHENJOBTWCOIPN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664309,DTCT0023180,3527904,DTCC00702004,1265966,41064
CHEMBL1261,P23975,CITRIC ACID,KRKNYBCHXYNGOX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7356286,DTCC00331493,1609544,46191
CHEMBL1261,P23975,CITRIC ACID,KRKNYBCHXYNGOX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7356287,DTCC00331493,1609544,46191
CHEMBL1262,P23975,OXICONAZOLE,QRJJEGAJXVEBNE-HKOYGPOVSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1910.3,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7397449,DTCC00332757,1059336,46191
CHEMBL1262,P23975,OXICONAZOLE,QRJJEGAJXVEBNE-HKOYGPOVSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1894.5,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7397450,DTCC00332757,1059336,46191
CHEMBL126224,P23975,IPRINDOLE,PLIGPBGDXASWPX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,1262,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14744428,DTCC00306308,2108720,68566
CHEMBL127,P23975,MEROPENEM,DMJNNHOOLUXYBV-PQTSNVLCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7436415,DTCC00154030,51487,46191
CHEMBL127,P23975,MEROPENEM,DMJNNHOOLUXYBV-PQTSNVLCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7436416,DTCC00154030,51487,46191
CHEMBL127516,P23975,BUTAMBEN,IUWVALYLNVXWKX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7268987,DTCC00306410,381006,46191
CHEMBL127516,P23975,BUTAMBEN,IUWVALYLNVXWKX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7268988,DTCC00306410,381006,46191
CHEMBL1275709,P23975,,CMJSIPQFDNXSOL-QWHCGFSZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20949929,IC50,=,0.22,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,J. Med. Chem.,2010,53,21,"King HD, Meng Z, Deskus JA, Sloan CP, Gao Q, Beno BR, Kozlowski ES, Lapaglia MA, Mattson GK, Molski TF, Taber MT, Lodge NJ, Mattson RJ, Macor JE",,685484,DTCT0023180,3584607,DTCC00126640,566925,41914
CHEMBL1275791,P23975,,LRSVJJWABVMKRA-PWSUYJOCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20949929,IC50,=,0.63,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,J. Med. Chem.,2010,53,21,"King HD, Meng Z, Deskus JA, Sloan CP, Gao Q, Beno BR, Kozlowski ES, Lapaglia MA, Mattson GK, Molski TF, Taber MT, Lodge NJ, Mattson RJ, Macor JE",,685484,DTCT0023180,3584608,DTCC00705594,275031,41914
CHEMBL1276308,P23975,MIFEPRISTONE,VKHAHZOOUSRJNA-GCNJZUOMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7417680,DTCC00706050,120974,46191
CHEMBL1276308,P23975,MIFEPRISTONE,VKHAHZOOUSRJNA-GCNJZUOMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7417681,DTCC00706050,120974,46191
CHEMBL1278088,P23975,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20931963,IC50,>,1000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684929,DTCT0023180,3586989,DTCC00707742,716661,41871
CHEMBL128,P23975,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7478550,DTCC00154636,671796,46191
CHEMBL128,P23975,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7478551,DTCC00154636,671796,46191
CHEMBL1282,P23975,IMIQUIMOD,DOUYETYNHWVLEO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7315177,DTCC00339893,1927015,46191
CHEMBL1282,P23975,IMIQUIMOD,DOUYETYNHWVLEO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7315178,DTCC00339893,1927015,46191
CHEMBL12856,P23975,INAMRINONE,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298444,DTCC00141434,1447876,46191
CHEMBL12856,P23975,INAMRINONE,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298445,DTCC00141434,1447876,46191
CHEMBL128593,P23975,,ZFZUYTCCHMWWTD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11082457,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14743697,DTCC00311393,2108473,69438
CHEMBL1289,P23975,HALOPROGIN,CTETYYAZBPJBHE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2770,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304208,DTCC00108442,1512810,46191
CHEMBL1289,P23975,HALOPROGIN,CTETYYAZBPJBHE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2747,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304209,DTCC00108442,1512810,46191
CHEMBL129,P23975,ZIDOVUDINE,HBOMLICNUCNMMY-XLPZGREQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7445945,DTCC00154782,51517,46191
CHEMBL129,P23975,ZIDOVUDINE,HBOMLICNUCNMMY-XLPZGREQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7445946,DTCC00154782,51517,46191
CHEMBL12948,P23975,SEMUSTINE,FVLVBPDQNARYJU-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464718,DTCC00141274,1318442,46191
CHEMBL12948,P23975,SEMUSTINE,FVLVBPDQNARYJU-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464719,DTCC00141274,1318442,46191
CHEMBL1297,P23975,FENOPROFEN,RDJGLLICXDHJDY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305316,DTCC00343797,1830685,46191
CHEMBL1297,P23975,FENOPROFEN,RDJGLLICXDHJDY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305317,DTCC00343797,1830685,46191
CHEMBL13,P23975,METOPROLOL,IUBSYMUCCVWXPE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7417632,DTCC00132868,1798412,46191
CHEMBL13,P23975,METOPROLOL,IUBSYMUCCVWXPE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7417633,DTCC00132868,1798412,46191
CHEMBL130,P23975,CHLORAMPHENICOL,WIIZWVCIJKGZOK-RKDXNWHRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7345144,DTCC00154805,51455,46191
CHEMBL130,P23975,CHLORAMPHENICOL,WIIZWVCIJKGZOK-RKDXNWHRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7345145,DTCC00154805,51455,46191
CHEMBL130477,P23975,,ZGLAJTSGABGHND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,4.9,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,847681,DTCC00313545,1662163,16914
CHEMBL130477,P23975,,ZGLAJTSGABGHND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,18,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,847678,DTCC00313545,1662163,16914
CHEMBL130477,P23975,,ZGLAJTSGABGHND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213054,KI,=,18.2,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Ahmad UF, Koletar J, Kelly L, Brand L, Kopajtic TA",,62322,DTCT0023180,887145,DTCC00313545,1662169,16915
CHEMBL1306,P23975,TERCONAZOLE,BLSQLHNBWJLIBQ-OZXSUGGESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,25391,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472316,DTCC00347547,1830691,46191
CHEMBL1306,P23975,TERCONAZOLE,BLSQLHNBWJLIBQ-OZXSUGGESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,25182,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472317,DTCC00347547,1830691,46191
CHEMBL130668,P23975,,NFNRNOMETYDQMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,1.9,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,822727,DTCC00314032,1754106,16914
CHEMBL130668,P23975,,NFNRNOMETYDQMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,380,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,822724,DTCC00314032,1754106,16914
CHEMBL1308,P23975,FOMEPIZOLE,RIKMMFOAQPJVMX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7285343,DTCC00348807,1862712,46191
CHEMBL1308,P23975,FOMEPIZOLE,RIKMMFOAQPJVMX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7285344,DTCC00348807,1862712,46191
CHEMBL131,P23975,PREDNISOLONE,OIGNJSKKLXVSLS-VWUMJDOOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389776,DTCC00154827,1734061,46191
CHEMBL131,P23975,PREDNISOLONE,OIGNJSKKLXVSLS-VWUMJDOOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389777,DTCC00154827,1734061,46191
CHEMBL1319362,P23975,HOMATROPINE HYDROBROMIDE,DWSGTFTVBLXELC-RDYJJYPNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7317034,DTCC00729363,1027054,46191
CHEMBL1319362,P23975,HOMATROPINE HYDROBROMIDE,DWSGTFTVBLXELC-RDYJJYPNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7317035,DTCC00729363,1027054,46191
CHEMBL132082,P23975,,LCWPWPFSABPKJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,1.46,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,852744,DTCC00314109,853994,16914
CHEMBL132082,P23975,,LCWPWPFSABPKJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,23,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,852741,DTCC00314109,853994,16914
CHEMBL13209,P23975,NITRAZEPAM,KJONHKAYOJNZEC-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394861,DTCC00141996,477919,46191
CHEMBL13209,P23975,NITRAZEPAM,KJONHKAYOJNZEC-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394862,DTCC00141996,477919,46191
CHEMBL1321,P23975,PROCARBAZINE,CPTBDICYNRMXFX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398494,DTCC00352822,671792,46191
CHEMBL1321,P23975,PROCARBAZINE,CPTBDICYNRMXFX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398495,DTCC00352822,671792,46191
CHEMBL1321154,P23975,ROXARSONE,XMVJITFPVVRMHC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455732,DTCC00731018,542582,46191
CHEMBL1321154,P23975,ROXARSONE,XMVJITFPVVRMHC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455733,DTCC00731018,542582,46191
CHEMBL1323615,P23975,,HFXCUJLZEIBVQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3943,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late-stage radioligand binding dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): PDSP screen Ki. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1792, AID1796, AID1823, AID2532, AID2538, AID2539, AID2541, AID2545, AID2556, AID2664, AID2752, AID2773, AID434992, AID434993, AID434997, AID435002, AID435009, AID435013, AID463255, AID488778, AID504381, AID504410] Panel member name: Biogenic amine transporter NET",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737553,DTCT0023180,5403299,DTCC00733300,992395,33038
CHEMBL132614,P23975,,QZZUDVMQVVGVGN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142608,DTCT0023180,827324,DTCC00314362,724378,5984
CHEMBL132676,P23975,,RKCUTIXVCFBEGE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213054,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Ahmad UF, Koletar J, Kelly L, Brand L, Kopajtic TA",,142614,DTCT0023180,883545,DTCC00313377,238152,16915
CHEMBL132683,P23975,,KFDFKTMFADMFFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,IC50,=,122,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142799,DTCT0023180,843431,DTCC00314333,917988,5984
CHEMBL132683,P23975,,KFDFKTMFADMFFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,IC50,=,173,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142799,DTCT0023180,817154,DTCC00314333,917989,5984
CHEMBL132683,P23975,,KFDFKTMFADMFFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,KI,=,2960,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142608,DTCT0023180,843430,DTCC00314333,917988,5984
CHEMBL132683,P23975,,KFDFKTMFADMFFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,KI,=,3060,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142608,DTCT0023180,817153,DTCC00314333,917989,5984
CHEMBL132954,P23975,,YPRKQXGDPALXAP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,1.73,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,853957,DTCC00314005,659903,16914
CHEMBL132954,P23975,,YPRKQXGDPALXAP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,23.1,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,853954,DTCC00314005,659903,16914
CHEMBL132955,P23975,,JOBHARMVZDXCRY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,10,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,847698,DTCC00314006,434142,16914
CHEMBL132955,P23975,,JOBHARMVZDXCRY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,40,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,847695,DTCC00314006,434142,16914
CHEMBL133043,P23975,,BPGNWJZOLVBWNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,4.1,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,830740,DTCC00314014,1723816,16914
CHEMBL133043,P23975,,BPGNWJZOLVBWNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,84,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,830737,DTCC00314014,1723816,16914
CHEMBL133070,P23975,,CFMJSXBSNWAVPU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142608,DTCT0023180,820799,DTCC00314202,1273903,5984
CHEMBL133070,P23975,,CFMJSXBSNWAVPU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142608,DTCT0023180,849751,DTCC00314202,1273904,5984
CHEMBL1333512,P23975,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE",UTGQNNCQYDRXCH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,786,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7420185,DTCC00742601,1155682,46191
CHEMBL1333512,P23975,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE",UTGQNNCQYDRXCH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,780,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7420186,DTCC00742601,1155682,46191
CHEMBL13341,P23975,NIMETAZEPAM,GWUSZQUVEVMBPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381915,DTCC00141962,606971,46191
CHEMBL13341,P23975,NIMETAZEPAM,GWUSZQUVEVMBPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381917,DTCC00141962,606971,46191
CHEMBL133455,P23975,,VVHJUSGIUWQPIT-VIFPVBQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954071,KI,>,10000,NM,,,,,,,,,,,,,,Inhibitory constant against norepinephrine transporter receptor using [3H]radioligand,,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,2003,46,19,"May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA",,144998,DTCT0023180,1106914,DTCC00315452,2045939,17506
CHEMBL133646,P23975,,GYTGCOARTYXPAX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213054,KI,=,33.4,NM,,,,,,,,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Ahmad UF, Koletar J, Kelly L, Brand L, Kopajtic TA",,142614,DTCT0023180,870571,DTCC00313536,205683,16915
CHEMBL13378,P23975,"(R,S)-AMPA",UUDAMDVQRQNNHZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7284918,DTCC00141891,1220272,46191
CHEMBL13378,P23975,"(R,S)-AMPA",UUDAMDVQRQNNHZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7284919,DTCC00141891,1220272,46191
CHEMBL133868,P23975,,VVHJUSGIUWQPIT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954071,KI,>,30000,NM,,,,,,,,,,,,,,Inhibitory constant against norepinephrine transporter receptor using [3H]radioligand,,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,2003,46,19,"May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA",,144998,DTCT0023180,1109521,DTCC00315451,173712,17506
CHEMBL133902,P23975,,AYCFVKGYERYDRT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,2.8,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,831906,DTCC00313640,369127,16914
CHEMBL133902,P23975,,AYCFVKGYERYDRT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,100,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,831903,DTCC00313640,369127,16914
CHEMBL134,P23975,CLONIDINE,GJSURZIOUXUGAL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,965095,DTCC00155022,32101,13807
CHEMBL134,P23975,CLONIDINE,GJSURZIOUXUGAL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11082457,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14740497,DTCC00155022,2104792,69438
CHEMBL134,P23975,CLONIDINE,GJSURZIOUXUGAL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7339404,DTCC00155022,51459,46191
CHEMBL134,P23975,CLONIDINE,GJSURZIOUXUGAL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7339020,DTCC00155022,51459,46191
CHEMBL134342,P23975,LIPOIC ACID,AGBQKNBQESQNJD-SSDOTTSWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485343,DTCC00318217,1220281,46191
CHEMBL134342,P23975,LIPOIC ACID,AGBQKNBQESQNJD-SSDOTTSWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485344,DTCC00318217,1220281,46191
CHEMBL1349,P23975,VALACYCLOVIR,HDOVUKNUBWVHOX-QMMMGPOBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7452113,DTCC00378678,930089,46191
CHEMBL1349,P23975,VALACYCLOVIR,HDOVUKNUBWVHOX-QMMMGPOBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7452114,DTCC00378678,930089,46191
CHEMBL135,P23975,ESTRADIOL,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264316,DTCC00155036,51448,46191
CHEMBL135,P23975,ESTRADIOL,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264317,DTCC00155036,51448,46191
CHEMBL1351,P23975,CARBOPLATIN,OLESAACUTLOWQZ-UHFFFAOYSA-L,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7353511,DTCC00380917,1480344,46191
CHEMBL1351,P23975,CARBOPLATIN,OLESAACUTLOWQZ-UHFFFAOYSA-L,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7353512,DTCC00380917,1480344,46191
CHEMBL135982,P23975,,CQSPEDPZNBMSKV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,INHIBITION,=,29.4,%,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143138,DTCT0023180,1038945,DTCC00319529,5534,14474
CHEMBL136478,P23975,SODIUM NITROPRUSSIDE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7458358,DTCC00320064,1155687,46191
CHEMBL136478,P23975,SODIUM NITROPRUSSIDE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7458359,DTCC00320064,1155687,46191
CHEMBL1365675,P23975,AMITRAZ,QXAITBQSYVNQDR-ZIOPAAQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7294068,DTCC00772476,1027047,46191
CHEMBL1365675,P23975,AMITRAZ,QXAITBQSYVNQDR-ZIOPAAQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7294069,DTCC00772476,1027047,46191
CHEMBL1366,P23975,AURANOFIN,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7273561,DTCC00388917,833156,46191
CHEMBL1366,P23975,AURANOFIN,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7273562,DTCC00388917,833156,46191
CHEMBL137,P23975,METRONIDAZOLE,VAOCPAMSLUNLGC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7421914,DTCC00155250,51489,46191
CHEMBL137,P23975,METRONIDAZOLE,VAOCPAMSLUNLGC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7421915,DTCC00155250,51489,46191
CHEMBL1370,P23975,BUDESONIDE,VOVIALXJUBGFJZ-KWVAZRHASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7274497,DTCC00392952,898284,46191
CHEMBL1370,P23975,BUDESONIDE,VOVIALXJUBGFJZ-KWVAZRHASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7274498,DTCC00392952,898284,46191
CHEMBL137020,P23975,,IBKOZXQELVZJBY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213078,IC50,=,260,NM,,,,,,,,,,,,,,Compound was tested for the inhibition of norepinephrine (NE) reuptake,,Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,2002,45,19,"Prisinzano T, Greiner E, Johnson EM, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,142775,DTCT0023180,900087,DTCC00319677,1980945,16938
CHEMBL137020,P23975,,IBKOZXQELVZJBY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213078,RATIO,=,22,,,,,,,,,,,,,,,Ratio of IC50 value against Norepinephrine transporter (NE) to that of Dopamine transporter (DA),,Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,2002,45,19,"Prisinzano T, Greiner E, Johnson EM, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,142781,DTCT0023180,900090,DTCC00319677,1980945,16938
CHEMBL1370561,P23975,AMINOPHYLLINE,FQPFAHBPWDRTLU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281588,DTCC00777070,1383772,46191
CHEMBL1370561,P23975,AMINOPHYLLINE,FQPFAHBPWDRTLU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281589,DTCC00777070,1383772,46191
CHEMBL1371,P23975,CHLORZOXAZONE,TZFWDZFKRBELIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347499,DTCC00394427,1992801,46191
CHEMBL1371,P23975,CHLORZOXAZONE,TZFWDZFKRBELIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347500,DTCC00394427,1992801,46191
CHEMBL1371125,P23975,BENZO[E]PYRENE,TXVHTIQJNYSSKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264236,DTCC00777599,2025635,46191
CHEMBL1371125,P23975,BENZO[E]PYRENE,TXVHTIQJNYSSKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264237,DTCC00777599,2025635,46191
CHEMBL1371770,P23975,PIRIBEDIL,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11356907,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14744443,DTCC00778211,2108727,69742
CHEMBL1371937,P23975,PANTHENOL,SNPLKNRPJHDVJA-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7395377,DTCC00778371,1059337,46191
CHEMBL1371937,P23975,PANTHENOL,SNPLKNRPJHDVJA-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7395378,DTCC00778371,1059337,46191
CHEMBL1372,P23975,OXIGLUTATIONE,YPZRWBKMTBYPTK-BJDJZHNGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7329567,DTCC00395874,898290,46191
CHEMBL1372,P23975,OXIGLUTATIONE,YPZRWBKMTBYPTK-BJDJZHNGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7329568,DTCC00395874,898290,46191
CHEMBL1373,P23975,MODAFINIL,YFGHCGITMMYXAQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7411433,DTCC00396162,1512812,46191
CHEMBL1373,P23975,MODAFINIL,YFGHCGITMMYXAQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7411434,DTCC00396162,1512812,46191
CHEMBL137769,P23975,,KXVANVFVPHMDSA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,INHIBITION,=,8.5,%,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143138,DTCT0023180,1028050,DTCC00319606,745197,14474
CHEMBL137936,P23975,,WGXGFDYUAPSJDQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,INHIBITION,=,55,%,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,145003,DTCT0023180,1079305,DTCC00322995,1208486,6048
CHEMBL138031,P23975,,DCTIZVFKPUZNEA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,55,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1060496,DTCC00322709,1274006,6048
CHEMBL1381098,P23975,1-NAPHTHYLISOTHIOCYANATE,JBDOSUUXMYMWQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7285004,DTCC00786869,866013,46191
CHEMBL1381098,P23975,1-NAPHTHYLISOTHIOCYANATE,JBDOSUUXMYMWQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7285005,DTCC00786869,866013,46191
CHEMBL138195,P23975,,JCYQFYGFKORSIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,INHIBITION,=,25.5,%,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,145003,DTCT0023180,1093105,DTCC00323865,1015300,6048
CHEMBL1382,P23975,TOLTERODINE,OOGJQPCLVADCPB-HXUWFJFHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21863888,ACTIVITY,=,15,%,,,,,,,,,,,,,,Binding affinity at human NET receptor at 10 uM,,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771739,DTCT0023180,6112814,DTCC00400338,443793,46044
CHEMBL138343,P23975,,OKTHWSZPNZAXGL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,INHIBITION,=,23,%,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,145003,DTCT0023180,1065343,DTCC00323460,1723945,6048
CHEMBL138354,P23975,,MZEULCTZLPBZKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,INHIBITION,=,39,%,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,145003,DTCT0023180,1080665,DTCC00322955,1694411,6048
CHEMBL1384,P23975,KANAMYCIN,SBUJHOSQTJFQJX-NOAMYHISSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418456,DTCC00402979,51482,46191
CHEMBL1384,P23975,KANAMYCIN,SBUJHOSQTJFQJX-NOAMYHISSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418457,DTCC00402979,51482,46191
CHEMBL1385840,P23975,ERGOCORNINE,UJYGDMFEEDNVBF-OGGGUQDZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321827,DTCC00791188,444641,46191
CHEMBL1385840,P23975,ERGOCORNINE,UJYGDMFEEDNVBF-OGGGUQDZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321828,DTCC00791188,444641,46191
CHEMBL1386,P23975,TRANSPLATIN,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448057,DTCC00405544,315673,46191
CHEMBL1386,P23975,TRANSPLATIN,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448058,DTCC00405544,315673,46191
CHEMBL1388,P23975,MONOBENZONE,VYQNWZOUAUKGHI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3886,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415782,DTCC00405603,833163,46191
CHEMBL1388,P23975,MONOBENZONE,VYQNWZOUAUKGHI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3854,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415783,DTCC00405603,833163,46191
CHEMBL138958,P23975,,GYIQQYDOLSGVHC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,145003,DTCT0023180,1074782,DTCC00321455,2046034,6048
CHEMBL139,P23975,DICLOFENAC,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340249,DTCC00156996,1220275,46191
CHEMBL139,P23975,DICLOFENAC,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340250,DTCC00156996,1220275,46191
CHEMBL139106,P23975,,OZRCVSKLTROWSZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,INHIBITION,=,56,%,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,145003,DTCT0023180,1079307,DTCC00322666,1241275,6048
CHEMBL139168,P23975,,TVGWXQAGBGCBIQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,160,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1059185,DTCC00323437,1915437,6048
CHEMBL139245,P23975,,IDWDPGNSPWMIDM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,78,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1074784,DTCC00323140,1883233,6048
CHEMBL139277,P23975,,CGAIDLFOIWNVLO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,40,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1061793,DTCC00322667,1694412,6048
CHEMBL1393,P23975,SPIRONOLACTONE,LXMSZDCAJNLERA-ZHYRCANASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7488711,DTCC00405635,1512816,46191
CHEMBL1393,P23975,SPIRONOLACTONE,LXMSZDCAJNLERA-ZHYRCANASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7488712,DTCC00405635,1512816,46191
CHEMBL1395,P23975,METHYLTESTOSTERONE,GCKMFJBGXUYNAG-HLXURNFRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7294535,DTCC00405823,1798403,46191
CHEMBL1395,P23975,METHYLTESTOSTERONE,GCKMFJBGXUYNAG-HLXURNFRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7294536,DTCC00405823,1798403,46191
CHEMBL139513,P23975,,BGNPKSJMUHXEOF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,145003,DTCT0023180,1073522,DTCC00323459,1947992,6048
CHEMBL139835,P23975,CYPROTERONE ACETATE,UWFYSQMTEOIJJG-FDTZYFLXSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337602,DTCC00327558,153442,46191
CHEMBL139835,P23975,CYPROTERONE ACETATE,UWFYSQMTEOIJJG-FDTZYFLXSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337603,DTCC00327558,153442,46191
CHEMBL1399,P23975,ANASTROZOLE,YBBLVLTVTVSKRW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281873,DTCC00413581,1992800,46191
CHEMBL1399,P23975,ANASTROZOLE,YBBLVLTVTVSKRW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281874,DTCC00413581,1992800,46191
CHEMBL14,P23975,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7280650,DTCC00132960,1862714,46191
CHEMBL14,P23975,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7280651,DTCC00132960,1862714,46191
CHEMBL1400,P23975,O-DESMETHYL TRAMADOL,UWJUQVWARXYRCG-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16257206,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of reuptake of Norepinephrine,,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,2006,16,3,"Shao L, Abolin C, Hewitt MC, Koch P, Varney M",,333146,DTCT0023180,1892076,DTCC00414467,337640,20316
CHEMBL1400,P23975,O-DESMETHYL TRAMADOL,UWJUQVWARXYRCG-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307494,DTCC00414467,343123,25295
CHEMBL1400945,P23975,PREGNENOLONE CARBONITRILE ,VSBHRRMYCDQLJF-ZDNYCOCVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398351,DTCC00805254,1220279,46191
CHEMBL1400945,P23975,PREGNENOLONE CARBONITRILE ,VSBHRRMYCDQLJF-ZDNYCOCVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398352,DTCC00805254,1220279,46191
CHEMBL1403281,P23975,ERGOCRYPTINE,YDOTUXAWKBPQJW-NSLWYYNWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7292486,DTCC00807428,381005,46191
CHEMBL1403281,P23975,ERGOCRYPTINE,YDOTUXAWKBPQJW-NSLWYYNWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7292487,DTCC00807428,381005,46191
CHEMBL1405,P23975,ESTRONE,DNXHEGUUPJUMQT-CBZIJGRNSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7315687,DTCC00418600,606969,46191
CHEMBL1405,P23975,ESTRONE,DNXHEGUUPJUMQT-CBZIJGRNSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7315688,DTCC00418600,606969,46191
CHEMBL14053,P23975,TRICHLOROACETIC ACID,YNJBWRMUSHSURL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450025,DTCC00143400,444644,46191
CHEMBL14053,P23975,TRICHLOROACETIC ACID,YNJBWRMUSHSURL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450026,DTCC00143400,444644,46191
CHEMBL14060,P23975,PHENOL,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385084,DTCC00143418,413974,46191
CHEMBL14060,P23975,PHENOL,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385085,DTCC00143418,413974,46191
CHEMBL141,P23975,LAMIVUDINE,JTEGQNOMFQHVDC-NKWVEPMBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7439873,DTCC00160169,51484,46191
CHEMBL141,P23975,LAMIVUDINE,JTEGQNOMFQHVDC-NKWVEPMBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7439874,DTCC00160169,51484,46191
CHEMBL141114,P23975,,BBPHSCYBCPQBRH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,36,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1081879,DTCC00322692,595271,6048
CHEMBL1411979,P23975,METHAPYRILENE,HNJJXZKZRAWDPF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1391,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423693,DTCC00815629,153445,46191
CHEMBL1411979,P23975,METHAPYRILENE,HNJJXZKZRAWDPF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1380,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423694,DTCC00815629,153445,46191
CHEMBL1413,P23975,CICLOPIROX,SCKYRAXSEDYPSA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7339053,DTCC00427786,1416026,46191
CHEMBL1413,P23975,CICLOPIROX,SCKYRAXSEDYPSA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7339054,DTCC00427786,1416026,46191
CHEMBL141343,P23975,U-78517F,KPZQRBACZSLMPH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446531,DTCC01743360,671797,46191
CHEMBL141343,P23975,U-78517F,KPZQRBACZSLMPH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446532,DTCC01743360,671797,46191
CHEMBL14144,P23975,,AAEKULYONKUBOZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,242.29,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144969,DTCT0023180,936944,DTCC00144033,564570,17996
CHEMBL141681,P23975,,IUSCPVMMEKQANO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1067690,DTCC00322613,1047714,6048
CHEMBL141741,P23975,,ABARJWHHNCOEQT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1089270,DTCC00322693,1500918,6048
CHEMBL1419,P23975,SIBUTRAMINE,UNAANXDKBXWMLN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,5665,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7471364,DTCC00432414,1765981,46191
CHEMBL1419,P23975,SIBUTRAMINE,UNAANXDKBXWMLN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5619,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7471365,DTCC00432414,1765981,46191
CHEMBL14192,P23975,BENZYLIMIDAZOLE,KKKDZZRICRFGSD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282063,DTCC00143373,381004,46191
CHEMBL14192,P23975,BENZYLIMIDAZOLE,KKKDZZRICRFGSD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282064,DTCC00143373,381004,46191
CHEMBL141974,P23975,,NRBVOOUZUSJEKA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,70,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1062886,DTCC00322770,465835,6048
CHEMBL142028,P23975,,GMHDOCXPDYDKOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,21,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1074786,DTCC00323467,1947990,6048
CHEMBL1425,P23975,MERCAPTOPURINE,GLVAUDGFNGKCSF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298917,DTCC00110799,51440,46191
CHEMBL1425,P23975,MERCAPTOPURINE,GLVAUDGFNGKCSF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298918,DTCC00110799,51440,46191
CHEMBL14257,P23975,,AEYFRZGFXCIRPL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,5.6,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144970,DTCT0023180,968059,DTCC00144110,2079674,17996
CHEMBL1428,P23975,NIMODIPINE,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386265,DTCC00437760,930083,46191
CHEMBL1428,P23975,NIMODIPINE,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386266,DTCC00437760,930083,46191
CHEMBL1430,P23975,PENICILLAMINE,VVNCNSJFMMFHPL-VKHMYHEASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399828,DTCC00441311,898294,46191
CHEMBL1430,P23975,PENICILLAMINE,VVNCNSJFMMFHPL-VKHMYHEASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399829,DTCC00441311,898294,46191
CHEMBL14305,P23975,,QRRDJSMVPRYYBA-KTKRTIGZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,111,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144970,DTCT0023180,943315,DTCC00143994,500322,17996
CHEMBL1431,P23975,METFORMIN,XZWYZXLIPXDOLR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7419430,DTCC00441526,1318443,46191
CHEMBL1431,P23975,METFORMIN,XZWYZXLIPXDOLR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7419431,DTCC00441526,1318443,46191
CHEMBL1433,P23975,DOXYCYCLINE,JBIWCJUYHHGXTC-AKNGSSGZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7328027,DTCC00443319,381009,46191
CHEMBL1433,P23975,DOXYCYCLINE,JBIWCJUYHHGXTC-AKNGSSGZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7328028,DTCC00443319,381009,46191
CHEMBL1437,P23975,NOREPINEPHRINE,SFLSHLFXELFNJZ-QMMMGPOBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19962901,ACTIVITY,>,10000,%,,,,,,,,,,,,,,Inhibition of NET PDSP analysis,,"Synthesis, pharmacological studies and molecular modeling of some tetracyclic 1,3-diazepinium chlorides.",Bioorg. Med. Chem.,2010,18,2,"Grant JA, Bonnick T, Gossell-Williams M, Clayton T, Cook JM, Jackson YA",,607606,DTCT0023180,3220453,DTCC00444460,942277,37303
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12620070,RATIO,=,0.15,,,,,,,,,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),,Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,2003,46,6,"Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB",,144999,DTCT0023180,561450,DTCC00144053,2014372,17720
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,1.1,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144969,DTCT0023180,941995,DTCC00144053,2015391,17996
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965624,DTCC00144053,2014973,21201
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964062,DTCC00144053,2003035,21124
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322660,DTCC00144053,2003829,19394
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367392,DTCC00144053,2020380,26231
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,3,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686038,DTCC00144053,2016122,31294
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789618,DTCC00144053,2003970,31613
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725273,DTCC00144053,2004233,34196
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,3.2,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901928,DTCC00144053,2016556,35305
CHEMBL14370,P23975,REBOXETINE,CBQGYUDMJHNJBX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,3.2,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217236,DTCC00144053,2017187,37100
CHEMBL143707,P23975,,OTCJLGGVKHCDCO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,663.8,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822329,DTCC00329053,358370,19630
CHEMBL14376,P23975,ILOPERIDONE,XMXHEBAFVSFQEX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11750183,KI,=,1479,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732031,DTCC00143788,2104585,69484
CHEMBL1440,P23975,TETRACYCLINE,OFVLGDICTFRJMM-WESIUVDSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7454933,DTCC00445351,51511,46191
CHEMBL1440,P23975,TETRACYCLINE,OFVLGDICTFRJMM-WESIUVDSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7454934,DTCC00445351,51511,46191
CHEMBL1444,P23975,LETROZOLE,HPJKCIUCZWXJDR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431508,DTCC00445802,1285878,46191
CHEMBL1444,P23975,LETROZOLE,HPJKCIUCZWXJDR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431509,DTCC00445802,1285878,46191
CHEMBL1447,P23975,LINCOMYCIN,OJMMVQQUTAEWLP-KIDUDLJLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7440138,DTCC00448831,1059331,46191
CHEMBL1447,P23975,LINCOMYCIN,OJMMVQQUTAEWLP-KIDUDLJLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7440139,DTCC00448831,1059331,46191
CHEMBL1451,P23975,TRIAMCINOLONE,GFNANZIMVAIWHM-OBYCQNJPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441253,DTCC00451754,1512818,46191
CHEMBL1451,P23975,TRIAMCINOLONE,GFNANZIMVAIWHM-OBYCQNJPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441254,DTCC00451754,1512818,46191
CHEMBL14531,P23975,,PETAHELMBJGYJY-HJWRWDBZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,2.5,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144970,DTCT0023180,976674,DTCC00144130,1949684,17996
CHEMBL1454,P23975,LEVAMISOLE,HLFSDGLLUJUHTE-SNVBAGLBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7440008,DTCC00454681,1927017,46191
CHEMBL1454,P23975,LEVAMISOLE,HLFSDGLLUJUHTE-SNVBAGLBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7440009,DTCC00454681,1927017,46191
CHEMBL1454946,P23975,FLUBENDAZOLE,CPEUVMUXAHMANV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331020,DTCC00855742,51469,46191
CHEMBL1454946,P23975,FLUBENDAZOLE,CPEUVMUXAHMANV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331021,DTCC00855742,51469,46191
CHEMBL1455,P23975,ALTRETAMINE,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281463,DTCC00455954,800569,46191
CHEMBL1455,P23975,ALTRETAMINE,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281464,DTCC00455954,800569,46191
CHEMBL1455766,P23975,,JEJWQCTZDAJWOX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24690494,KI,<,1000,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin),,Antagonists of the kappa opioid receptor.,Bioorg. Med. Chem. Lett.,2014,24,9,"Urbano M, Guerrero M, Rosen H, Roberts E",,1352904,DTCT0023180,13690247,DTCC00856520,1677898,58670
CHEMBL1456,P23975,MYCOPHENOLATE MOFETIL,RTGDFNSFWBGLEC-SYZQJQIISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7432883,DTCC00456082,477918,46191
CHEMBL1456,P23975,MYCOPHENOLATE MOFETIL,RTGDFNSFWBGLEC-SYZQJQIISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7432884,DTCC00456082,477918,46191
CHEMBL145810,P23975,,NNNDXILSDZTFTR-LPHOPBHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,540,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1162868,DTCC00334007,1003971,16052
CHEMBL145810,P23975,,NNNDXILSDZTFTR-LPHOPBHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,2000,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1162867,DTCC00334007,1003971,16052
CHEMBL1458880,P23975,CADMIUM DICHLORIDE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7280532,DTCC00859394,800572,46191
CHEMBL1458880,P23975,CADMIUM DICHLORIDE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7280533,DTCC00859394,800572,46191
CHEMBL145940,P23975,,IAXQDXIYZZJWKO-YJBOKZPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,1100,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1140374,DTCC00334562,551676,16052
CHEMBL145940,P23975,,IAXQDXIYZZJWKO-YJBOKZPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,1800,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1140375,DTCC00334562,551676,16052
CHEMBL145994,P23975,,FVVRXOHRSYEMTM-SIKLNZKXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,460,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1145881,DTCC00334266,5906,16052
CHEMBL145994,P23975,,FVVRXOHRSYEMTM-SIKLNZKXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,2600,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1145882,DTCC00334266,5906,16052
CHEMBL1460,P23975,DIDANOSINE,BXZVVICBKDXVGW-NKWVEPMBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7353088,DTCC00459811,348398,46191
CHEMBL1460,P23975,DIDANOSINE,BXZVVICBKDXVGW-NKWVEPMBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7353089,DTCC00459811,348398,46191
CHEMBL146042,P23975,,FSUVEHUIVCMLNZ-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,55,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1164241,DTCC00334009,1360315,16052
CHEMBL146042,P23975,,FSUVEHUIVCMLNZ-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,130,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1164242,DTCC00334009,1360315,16052
CHEMBL14613,P23975,,IBOZZWGMZPMXBO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,7.5,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144969,DTCT0023180,966863,DTCC00144034,726131,17996
CHEMBL1463,P23975,FLUCYTOSINE,XRECTZIEBJDKEO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305457,DTCC00462514,1674145,46191
CHEMBL1463,P23975,FLUCYTOSINE,XRECTZIEBJDKEO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305458,DTCC00462514,1674145,46191
CHEMBL146332,P23975,,SVFXPTLYMIXFRX-BBRMVZONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,130,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1143567,DTCC00334240,1003972,16052
CHEMBL146332,P23975,,SVFXPTLYMIXFRX-BBRMVZONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,600,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1143566,DTCC00334240,1003972,16052
CHEMBL1464,P23975,WARFARIN,PJVWKTKQMONHTI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448639,DTCC00462727,2089753,46191
CHEMBL1464,P23975,WARFARIN,PJVWKTKQMONHTI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448640,DTCC00462727,2089753,46191
CHEMBL1466,P23975,DICUMAROL,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7344538,DTCC00462777,1480345,46191
CHEMBL1466,P23975,DICUMAROL,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7344539,DTCC00462777,1480345,46191
CHEMBL146615,P23975,,FSUVEHUIVCMLNZ-YJBOKZPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,540,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1152954,DTCC00334385,487349,16052
CHEMBL146615,P23975,,FSUVEHUIVCMLNZ-YJBOKZPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,630,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1152956,DTCC00334385,487349,16052
CHEMBL1467,P23975,ALLOPURINOL,OFCNXPDARWKPPY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282714,DTCC00463996,51443,46191
CHEMBL1467,P23975,ALLOPURINOL,OFCNXPDARWKPPY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282715,DTCC00463996,51443,46191
CHEMBL147040,P23975,,DDKXNVHSNBNSEK-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,150,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1142539,DTCC00334596,907647,16052
CHEMBL147040,P23975,,DDKXNVHSNBNSEK-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,250,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1142538,DTCC00334596,907647,16052
CHEMBL1475,P23975,TRIOXSALEN,FMHHVULEAZTJMA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446413,DTCC00470391,153447,46191
CHEMBL1475,P23975,TRIOXSALEN,FMHHVULEAZTJMA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446414,DTCC00470391,153447,46191
CHEMBL147544,P23975,,FVVRXOHRSYEMTM-UGKGYDQZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,4800,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1151826,DTCC00334537,777455,16052
CHEMBL147544,P23975,,FVVRXOHRSYEMTM-UGKGYDQZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1151827,DTCC00334537,777455,16052
CHEMBL1476898,P23975,CADMIUM ACETATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277543,DTCC00876074,51449,46191
CHEMBL1476898,P23975,CADMIUM ACETATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277544,DTCC00876074,51449,46191
CHEMBL1477,P23975,CERIVASTATIN,SEERZIQQUAZTOL-ANMDKAQQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362252,DTCC00471235,736257,46191
CHEMBL1477,P23975,CERIVASTATIN,SEERZIQQUAZTOL-ANMDKAQQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362253,DTCC00471235,736257,46191
CHEMBL1479,P23975,DANAZOL,POZRVZJJTULAOH-LHZXLZLDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,5698,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367851,DTCC00472761,1512807,46191
CHEMBL1479,P23975,DANAZOL,POZRVZJJTULAOH-LHZXLZLDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5651,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367852,DTCC00472761,1512807,46191
CHEMBL147950,P23975,,UNCBFTIAWJTNTF-YOEHRIQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,86,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1159201,DTCC00334018,1164840,16052
CHEMBL147950,P23975,,UNCBFTIAWJTNTF-YOEHRIQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,150,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1159200,DTCC00334018,1164840,16052
CHEMBL147983,P23975,,FIGPOABEAKIBCL-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,28,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1137924,DTCC00334597,1294979,16052
CHEMBL147983,P23975,,FIGPOABEAKIBCL-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,48,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1137923,DTCC00334597,1294979,16052
CHEMBL1480,P23975,FELODIPINE,RZTAMFZIAATZDJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7324425,DTCC00472762,1894965,46191
CHEMBL1480,P23975,FELODIPINE,RZTAMFZIAATZDJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7324426,DTCC00472762,1894965,46191
CHEMBL1480987,P23975,CYCLANDELATE,WZHCOOQXZCIUNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7346142,DTCC00879865,444638,46191
CHEMBL1480987,P23975,CYCLANDELATE,WZHCOOQXZCIUNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7346143,DTCC00879865,444638,46191
CHEMBL1481,P23975,GLIMEPIRIDE,WIGIZIANZCJQQY-RUCARUNLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7320965,DTCC00472763,1641848,46191
CHEMBL1481,P23975,GLIMEPIRIDE,WIGIZIANZCJQQY-RUCARUNLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7320966,DTCC00472763,1641848,46191
CHEMBL148104,P23975,,RUFGGNDBOBTWQC-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,440,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1154113,DTCC00333989,2066654,16052
CHEMBL148104,P23975,,RUFGGNDBOBTWQC-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,1000,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1154114,DTCC00333989,2066654,16052
CHEMBL1483,P23975,ALBENDAZOLE,HXHWSAZORRCQMX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7296335,DTCC00474063,315661,46191
CHEMBL1483,P23975,ALBENDAZOLE,HXHWSAZORRCQMX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7296336,DTCC00474063,315661,46191
CHEMBL148489,P23975,N-(3-PYRIDYLMETHYL)PYRROLIDINE,YFCWBKBNFCDPDF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478858,DTCC00339052,2026783,48255
CHEMBL1487,P23975,ATORVASTATIN,XUKUURHRXDUEBC-KAYWLYCHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7265185,DTCC00483650,1480343,46191
CHEMBL1487,P23975,ATORVASTATIN,XUKUURHRXDUEBC-KAYWLYCHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7265186,DTCC00483650,1480343,46191
CHEMBL1489,P23975,AZACITIDINE,NMUSYJAQQFHJEW-KVTDHHQDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7276516,DTCC00484776,1416024,46191
CHEMBL1489,P23975,AZACITIDINE,NMUSYJAQQFHJEW-KVTDHHQDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7276517,DTCC00484776,1416024,46191
CHEMBL1489254,P23975,TRIACETIN,URAYPUMNDPQOKB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453500,DTCC00887628,249945,46191
CHEMBL1489254,P23975,TRIACETIN,URAYPUMNDPQOKB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453501,DTCC00887628,249945,46191
CHEMBL1490,P23975,TRIHEXYPHENIDYL,HWHLPVGTWGOCJO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441382,DTCC00112203,703988,46191
CHEMBL1490,P23975,TRIHEXYPHENIDYL,HWHLPVGTWGOCJO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441383,DTCC00112203,703988,46191
CHEMBL1491,P23975,AMLODIPINE,HTIQEAQVCYTUBX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7299559,DTCC00112206,217573,46191
CHEMBL1491,P23975,AMLODIPINE,HTIQEAQVCYTUBX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7299560,DTCC00112206,217573,46191
CHEMBL14924,P23975,,NVNZDUXXKQYTHC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,161,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144970,DTCT0023180,972010,DTCC00144046,822830,17996
CHEMBL149246,P23975,3-BENZHYDRYL-PYRIDINE,HGVLJGHVYCBNBB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12565962,KI,=,7320,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),,Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,3,"Enyedy IJ, Sakamuri S, Zaman WA, Johnson KM, Wang S",,142780,DTCT0023180,670719,DTCC01743629,1489704,6092
CHEMBL1493,P23975,FLAVOXATE,SPIUTQOUKAMGCX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322415,DTCC00112214,1960075,46191
CHEMBL1493,P23975,FLAVOXATE,SPIUTQOUKAMGCX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322416,DTCC00112214,1960075,46191
CHEMBL149878,P23975,,XVELJKVGYZEBLI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12565962,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),,Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,3,"Enyedy IJ, Sakamuri S, Zaman WA, Johnson KM, Wang S",,142780,DTCT0023180,688436,DTCC00337220,939340,6092
CHEMBL150045,P23975,4-BENZHYDRYL-PYRIDINE,ZWLWOTHDIGRTNE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12565962,KI,=,3460,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),,Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,3,"Enyedy IJ, Sakamuri S, Zaman WA, Johnson KM, Wang S",,142780,DTCT0023180,670715,DTCC01743624,713107,6092
CHEMBL1501,P23975,FLUOCINONIDE,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305555,DTCC00485637,1253323,46191
CHEMBL1501,P23975,FLUOCINONIDE,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305556,DTCC00485637,1253323,46191
CHEMBL1502,P23975,PANTOPRAZOLE,IQPSEEYGBUAQFF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399706,DTCC00485677,1027057,46191
CHEMBL1502,P23975,PANTOPRAZOLE,IQPSEEYGBUAQFF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399707,DTCC00485677,1027057,46191
CHEMBL1503,P23975,OMEPRAZOLE,SUBDBMMJDZJVOS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7397332,DTCC00485679,1609551,46191
CHEMBL1503,P23975,OMEPRAZOLE,SUBDBMMJDZJVOS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7397333,DTCC00485679,1609551,46191
CHEMBL1504,P23975,TRIAMCINOLONE ACETONIDE,YNDXUCZADRHECN-JNQJZLCISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7442862,DTCC00485699,833165,46191
CHEMBL1504,P23975,TRIAMCINOLONE ACETONIDE,YNDXUCZADRHECN-JNQJZLCISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7442863,DTCC00485699,833165,46191
CHEMBL1508,P23975,ESCITALOPRAM,WSEQXVZVJXJVFP-FQEVSTJZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24944746,INHIBITION,,,,,cell_based,,,,,,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Not Active,Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,2014,5,6,"Kumar V, Rahbek-Clemmensen T, Billesbølle CB, Jorgensen TN, Gether U, Newman AH",,1365902,DTCT0023180,13778963,DTCC00486768,1367028,59573
CHEMBL150932,P23975,,KPDJDJHGSVDTMY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,120,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876640,DTCC00341916,37631,34589
CHEMBL1512,P23975,FLUNISOLIDE,XSFJVAJPIHIPKU-XWCQMRHXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7326815,DTCC00486813,703980,46191
CHEMBL1512,P23975,FLUNISOLIDE,XSFJVAJPIHIPKU-XWCQMRHXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7326816,DTCC00486813,703980,46191
CHEMBL1513,P23975,IRBESARTAN,YOSHYTLCDANDAN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7416062,DTCC00486818,1609548,46191
CHEMBL1513,P23975,IRBESARTAN,YOSHYTLCDANDAN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7416063,DTCC00486818,1609548,46191
CHEMBL1515,P23975,METHIMAZOLE,PMRYVIKBURPHAH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427980,DTCC00486838,153446,46191
CHEMBL1515,P23975,METHIMAZOLE,PMRYVIKBURPHAH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427981,DTCC00486838,153446,46191
CHEMBL1515611,P23975,BROMISOVALUM,CMCCHHWTTBEZNM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267434,DTCC00912063,1220274,46191
CHEMBL1515611,P23975,BROMISOVALUM,CMCCHHWTTBEZNM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267435,DTCC00912063,1220274,46191
CHEMBL1516176,P23975,,PDNJLMZEGXHSCU-VKHMYHEASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14742313,DTCC00912618,2108018,69159
CHEMBL1517,P23975,OXYTETRACYCLINE,IWVCMVBTMGNXQD-PXOLEDIWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386776,DTCC00486898,413973,46191
CHEMBL1517,P23975,OXYTETRACYCLINE,IWVCMVBTMGNXQD-PXOLEDIWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386777,DTCC00486898,413973,46191
CHEMBL1518,P23975,PROPYLTHIOURACIL,KNAHARQHSZJURB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7375015,DTCC00486945,348404,46191
CHEMBL1518,P23975,PROPYLTHIOURACIL,KNAHARQHSZJURB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7375016,DTCC00486945,348404,46191
CHEMBL1521,P23975,ZALEPLON,HUNXMJYCHXQEGX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7442648,DTCC00487037,994596,46191
CHEMBL1521,P23975,ZALEPLON,HUNXMJYCHXQEGX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7442649,DTCC00487037,994596,46191
CHEMBL152362,P23975,,CGFBQVYTBDDHBS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,951996,DTCC00344953,1630298,13807
CHEMBL15245,P23975,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,976333,DTCC00144859,77188,13807
CHEMBL15245,P23975,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7452362,DTCC00144859,88638,46191
CHEMBL15245,P23975,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7452363,DTCC00144859,88638,46191
CHEMBL152748,P23975,,GJPNFSRZAKZIAJ-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,6900,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,942907,DTCC00344868,724808,13807
CHEMBL1527608,P23975,DOXOFYLLINE,HWXIGFIVGWUZAO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7319463,DTCC00923329,88626,46191
CHEMBL1527608,P23975,DOXOFYLLINE,HWXIGFIVGWUZAO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7319464,DTCC00923329,88626,46191
CHEMBL152842,P23975,,DZLHSFJMKLMKMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,945439,DTCC00344955,983196,13807
CHEMBL153062,P23975,4-NONYLPHENOL,IGFHQQFPSIBGKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1254,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7288140,DTCC00341324,1609541,46191
CHEMBL153062,P23975,4-NONYLPHENOL,IGFHQQFPSIBGKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1244,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7288141,DTCC00341324,1609541,46191
CHEMBL153479,P23975,AMBROXOL,JBDGDEWWOUBZPM-XYPYZODXSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287353,DTCC00342236,2057643,46191
CHEMBL153479,P23975,AMBROXOL,JBDGDEWWOUBZPM-XYPYZODXSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287354,DTCC00342236,2057643,46191
CHEMBL1535,P23975,HYDROXYCHLOROQUINE,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308579,DTCC00494467,1416033,46191
CHEMBL1535,P23975,HYDROXYCHLOROQUINE,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308580,DTCC00494467,1416033,46191
CHEMBL1536,P23975,ERGOCALCIFEROL,MECHNRXZTMCUDQ-RKHKHRCZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7317595,DTCC00494790,348400,46191
CHEMBL1536,P23975,ERGOCALCIFEROL,MECHNRXZTMCUDQ-RKHKHRCZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7317596,DTCC00494790,348400,46191
CHEMBL1537,P23975,AZLOCILLIN,JTWOMNBEOCYFNV-NFFDBFGFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7273706,DTCC00495073,1059328,46191
CHEMBL1537,P23975,AZLOCILLIN,JTWOMNBEOCYFNV-NFFDBFGFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7273707,DTCC00495073,1059328,46191
CHEMBL153847,P23975,,LACNYBMZWJBWCU-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,953427,DTCC00345653,109442,13807
CHEMBL1539,P23975,SULFADOXINE,PJSFRIWCGOHTNF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7478309,DTCC00495107,1512817,46191
CHEMBL1539,P23975,SULFADOXINE,PJSFRIWCGOHTNF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7478310,DTCC00495107,1512817,46191
CHEMBL154,P23975,NAPROXEN,CMWTZPSULFXXJA-VIFPVBQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7390348,DTCC00174165,1992809,46191
CHEMBL154,P23975,NAPROXEN,CMWTZPSULFXXJA-VIFPVBQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7390349,DTCC00174165,1992809,46191
CHEMBL1540,P23975,PENCICLOVIR,JNTOCHDNEULJHD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7395499,DTCC00495142,1577007,46191
CHEMBL1540,P23975,PENCICLOVIR,JNTOCHDNEULJHD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7395500,DTCC00495142,1577007,46191
CHEMBL154111,P23975,SALSALATE,WVYADZUPLLSGPU-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468953,DTCC00343795,1894974,46191
CHEMBL154111,P23975,SALSALATE,WVYADZUPLLSGPU-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468954,DTCC00343795,1894974,46191
CHEMBL1542,P23975,AZATHIOPRINE,LMEKQMALGUDUQG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7265312,DTCC00495633,962447,46191
CHEMBL1542,P23975,AZATHIOPRINE,LMEKQMALGUDUQG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7265313,DTCC00495633,962447,46191
CHEMBL154228,P23975,,KHGNFQVPPCBUSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,945450,DTCC00345667,1662559,13807
CHEMBL154257,P23975,,DFZMRCICMFOMSN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,3300,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,952010,DTCC00345637,1208738,13807
CHEMBL154297,P23975,,SPGFFOXASUPGGC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,3600,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,970376,DTCC00344800,1080503,13807
CHEMBL154319,P23975,,LWXMYCZRAJRIND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,955985,DTCC00345214,1694712,13807
CHEMBL1544,P23975,LIOTHYRONINE,AUYYCJSJGJYCDS-LBPRGKRZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7294628,DTCC00497321,1480341,46191
CHEMBL1544,P23975,LIOTHYRONINE,AUYYCJSJGJYCDS-LBPRGKRZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7294629,DTCC00497321,1480341,46191
CHEMBL154488,P23975,,YFXZWVUZIPQSKX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,939144,DTCC00345361,402339,13807
CHEMBL154541,P23975,,RBKZPZVPVZNIMS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,250,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,950592,DTCC00344823,238545,13807
CHEMBL154735,P23975,,XPRQYNYHTBQVGX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,2600,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,936478,DTCC00345030,563267,13807
CHEMBL15476,P23975,,MXYUKLILVYORSK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15121762,KI,=,1870,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741214,DTCC00144956,2107516,69662
CHEMBL154945,P23975,,JCEBKNUYKMFQGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,959923,DTCC00345208,1372115,13807
CHEMBL155109,P23975,,OSRPQIAWURAKDF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,430,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,936486,DTCC00345045,1208737,13807
CHEMBL15511,P23975,ENROFLOXACIN,SPFYMRJSYKOXGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7330308,DTCC00145113,1577005,46191
CHEMBL15511,P23975,ENROFLOXACIN,SPFYMRJSYKOXGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7330309,DTCC00145113,1577005,46191
CHEMBL155211,P23975,,SYFFAEMYTWTOCA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,570,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,968961,DTCC00345116,1981241,13807
CHEMBL155359,P23975,,AMAFHSJSCNHJAA-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,17000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,958634,DTCC00345572,1883475,13807
CHEMBL1554,P23975,DACTINOMYCIN,RJURFGZVJUQBHK-IIXSONLDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7363442,DTCC00113195,2089745,46191
CHEMBL1554,P23975,DACTINOMYCIN,RJURFGZVJUQBHK-IIXSONLDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7363443,DTCC00113195,2089745,46191
CHEMBL155460,P23975,,HQWVGYBVUZNQFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,965090,DTCC00345228,434513,13807
CHEMBL155603,P23975,,OCTRGLRMRCYOEE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,962518,DTCC00345140,1241538,13807
CHEMBL1560,P23975,CAPTOPRIL,FAKRSMQSSFJEIM-RQJHMYQMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277657,DTCC00507377,1092341,46191
CHEMBL1560,P23975,CAPTOPRIL,FAKRSMQSSFJEIM-RQJHMYQMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277658,DTCC00507377,1092341,46191
CHEMBL156455,P23975,"1,1-DICHLOROETHENE",LGXVIGDEPROXKC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7286603,DTCC00349580,866014,46191
CHEMBL156455,P23975,"1,1-DICHLOROETHENE",LGXVIGDEPROXKC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7286604,DTCC00349580,866014,46191
CHEMBL1566,P23975,ACARBOSE,XUFXOAAUWZOOIT-SXARVLRPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7288226,DTCC00510603,994587,46191
CHEMBL1566,P23975,ACARBOSE,XUFXOAAUWZOOIT-SXARVLRPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7288227,DTCC00510603,994587,46191
CHEMBL1566249,P23975,AMPIROXICAM,LSNWBKACGXCGAJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7292891,DTCC00959245,800570,46191
CHEMBL1566249,P23975,AMPIROXICAM,LSNWBKACGXCGAJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7292892,DTCC00959245,800570,46191
CHEMBL1566956,P23975,TROXIPIDE,YSIITVVESCNIPR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7443105,DTCC00959918,283002,46191
CHEMBL1566956,P23975,TROXIPIDE,YSIITVVESCNIPR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7443106,DTCC00959918,283002,46191
CHEMBL1567463,P23975,CHOLINE ALFOSCERATE,SUHOQUVVVLNYQR-MRVPVSSYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7360431,DTCC00960399,315662,46191
CHEMBL1567463,P23975,CHOLINE ALFOSCERATE,SUHOQUVVVLNYQR-MRVPVSSYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7360432,DTCC00960399,315662,46191
CHEMBL1568,P23975,FLUDARABINE,HBUBKKRHXORPQB-FJFJXFQQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7309762,DTCC00513782,1894966,46191
CHEMBL1568,P23975,FLUDARABINE,HBUBKKRHXORPQB-FJFJXFQQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7309763,DTCC00513782,1894966,46191
CHEMBL157138,P23975,LISURIDE,BKRGVLQUQGGVSM-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418911,DTCC00350629,1447884,46191
CHEMBL157138,P23975,LISURIDE,BKRGVLQUQGGVSM-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418912,DTCC00350629,1447884,46191
CHEMBL1572,P23975,NETILMICIN,CIDUJQMULVCIBT-MQDUPKMGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7377436,DTCC00514638,1734059,46191
CHEMBL1572,P23975,NETILMICIN,CIDUJQMULVCIBT-MQDUPKMGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7377437,DTCC00514638,1734059,46191
CHEMBL157455,P23975,,USKJECUROJSHQU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105015,DTCC00346356,372342,36341
CHEMBL157455,P23975,,USKJECUROJSHQU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105061,DTCC00346356,372342,36341
CHEMBL157548,P23975,DANOFLOXACIN,QMLVECGLEOSESV-RYUDHWBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370154,DTCC00348763,1798407,46191
CHEMBL157548,P23975,DANOFLOXACIN,QMLVECGLEOSESV-RYUDHWBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370155,DTCC00348763,1798407,46191
CHEMBL15770,P23975,SULINDAC,MLKXDPUZXIRXEP-MFOYZWKCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456736,DTCC00145905,930088,46191
CHEMBL15770,P23975,SULINDAC,MLKXDPUZXIRXEP-MFOYZWKCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456737,DTCC00145905,930088,46191
CHEMBL157902,P23975,,QVETYJWSBDNUGB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,941600,DTCC00345227,1436464,13807
CHEMBL157971,P23975,,BOUBQAHEWYSCCH-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,966528,DTCC00345570,304251,13807
CHEMBL158,P23975,AZTREONAM,WZPBZJONDBGPKJ-VEHQQRBSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7276662,DTCC00182933,510296,46191
CHEMBL158,P23975,AZTREONAM,WZPBZJONDBGPKJ-VEHQQRBSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7276663,DTCC00182933,510296,46191
CHEMBL1586,P23975,BECLOMETHASONE,NBMKJKDGKREAPL-DVTGEIKXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7270898,DTCC00514882,1188063,46191
CHEMBL1586,P23975,BECLOMETHASONE,NBMKJKDGKREAPL-DVTGEIKXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7270899,DTCC00514882,1188063,46191
CHEMBL159,P23975,VINBLASTINE,JXLYSJRDGCGARV-CFWMRBGOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453977,DTCC00190732,1577012,46191
CHEMBL159,P23975,VINBLASTINE,JXLYSJRDGCGARV-CFWMRBGOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453978,DTCC00190732,1577012,46191
CHEMBL1592,P23975,QUINAPRIL,JSDRRTOADPPCHY-HSQYWUDLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373090,DTCC00515121,1705879,46191
CHEMBL1592,P23975,QUINAPRIL,JSDRRTOADPPCHY-HSQYWUDLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373091,DTCC00515121,1705879,46191
CHEMBL1598608,P23975,AZASETRON,WUKZPHOXUVCQOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7262405,DTCC00989336,1734053,46191
CHEMBL1598608,P23975,AZASETRON,WUKZPHOXUVCQOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7262406,DTCC00989336,1734053,46191
CHEMBL16,P23975,PHENYTOIN,CXOFVDLJLONNDW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372264,DTCC00132980,51500,46191
CHEMBL16,P23975,PHENYTOIN,CXOFVDLJLONNDW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372265,DTCC00132980,51500,46191
CHEMBL160,P23975,CYCLOSPORINE,PMATZTZNYRCHOR-CGLBZJNRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7363339,DTCC00191777,51461,46191
CHEMBL160,P23975,CYCLOSPORINE,PMATZTZNYRCHOR-CGLBZJNRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7363340,DTCC00191777,51461,46191
CHEMBL1601669,P23975,ALFACALCIDOL,OFHCOWSQAMBJIW-AVJTYSNKSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1009,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7302023,DTCC00992187,217572,46191
CHEMBL1601669,P23975,ALFACALCIDOL,OFHCOWSQAMBJIW-AVJTYSNKSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1000,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7302024,DTCC00992187,217572,46191
CHEMBL16068,P23975,BROMOBENZENE,QARVLSVVCXYDNA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7270086,DTCC00145980,2057646,46191
CHEMBL16068,P23975,BROMOBENZENE,QARVLSVVCXYDNA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7270087,DTCC00145980,2057646,46191
CHEMBL16073,P23975,PHENACETIN,CPJSUEIXXCENMM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402210,DTCC00145899,120977,46191
CHEMBL16073,P23975,PHENACETIN,CPJSUEIXXCENMM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402211,DTCC00145899,120977,46191
CHEMBL1612004,P23975,,VMPITZXILSNTON-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380081,DTCC01001920,736263,46191
CHEMBL1612004,P23975,,VMPITZXILSNTON-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380082,DTCC01001920,736263,46191
CHEMBL1614641,P23975,FLUNOXAPROFEN,ARPYQKTVRGFPIS-VIFPVBQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331121,DTCC01003541,510300,46191
CHEMBL1614641,P23975,FLUNOXAPROFEN,ARPYQKTVRGFPIS-VIFPVBQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331122,DTCC01003541,510300,46191
CHEMBL1614664,P23975,PSEUDOHYPERICIN,YXBUQQDFTYOHQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14759178,DTCC01003548,2107269,69275
CHEMBL1614664,P23975,PSEUDOHYPERICIN,YXBUQQDFTYOHQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14759827,DTCC01003548,2107269,69275
CHEMBL1618305,P23975,NALOXONAZINE,AJPSBXJNFJCCBI-YOHUGVJRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407352,DTCC01006289,120976,46191
CHEMBL1618305,P23975,NALOXONAZINE,AJPSBXJNFJCCBI-YOHUGVJRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407353,DTCC01006289,120976,46191
CHEMBL1619,P23975,CLADRIBINE,PTOAARAWEBMLNO-KVQBGUIXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7364933,DTCC00525900,217575,46191
CHEMBL1619,P23975,CLADRIBINE,PTOAARAWEBMLNO-KVQBGUIXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7364934,DTCC00525900,217575,46191
CHEMBL1626,P23975,CLEMASTINE,YNNUSGIPVFPVBX-NHCUHLMSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3086,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7339221,DTCC00527946,639576,46191
CHEMBL1626,P23975,CLEMASTINE,YNNUSGIPVFPVBX-NHCUHLMSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3060,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7339222,DTCC00527946,639576,46191
CHEMBL1627,P23975,,ZMOPTLXEYOVARP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18783208,ACTIVITY,<,50,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET at 10 uM,,Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function.,J. Med. Chem.,2008,51,19,"Lazarova N, Zoghbi SS, Hong J, Seneca N, Tuan E, Gladding RL, Liow JS, Taku A, Innis RB, Pike VW",,539335,DTCT0023180,2565791,DTCC00528903,2048118,31935
CHEMBL1628227,P23975,DOXEPIN,ODQWQRRAPPTVAG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,29,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347099,DTCC01015577,898288,46191
CHEMBL1628227,P23975,DOXEPIN,ODQWQRRAPPTVAG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,29,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347100,DTCC01015577,898288,46191
CHEMBL1628648,P23975,[3H]NISOXETINE,ITJNARMNRKSWTA-RLXJOQACSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17428804,BMAX,=,129.5,PMOL,,cell_based,,,,,,,,,,,,Activity at human wild type NET expressed in african green monkey COS1 cells assessed per mg protein,,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,2007,282,24,"Paczkowski FA, Sharpe IA, Dutertre S, Lewis RJ",,505497,DTCT0023180,2401707,DTCC01015641,1309241,29252
CHEMBL1628648,P23975,[3H]NISOXETINE,ITJNARMNRKSWTA-RLXJOQACSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17428804,KD,=,5.1,NM,,cell_based,,,,,,,,,,,,Binding affinity to human wild type NET expressed in african green monkey COS1 cells,,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,2007,282,24,"Paczkowski FA, Sharpe IA, Dutertre S, Lewis RJ",,505498,DTCT0023180,2401695,DTCC01015641,1309241,29252
CHEMBL1629810,P23975,2-HYDROXYPROPYL-BETA-CYCLODEXTRIN,BIIFEDMBGOQTDO-USCPGHQQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1270,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7300132,DTCC00033243,510295,46191
CHEMBL1629810,P23975,2-HYDROXYPROPYL-BETA-CYCLODEXTRIN,BIIFEDMBGOQTDO-USCPGHQQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1260,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7300133,DTCC00033243,510295,46191
CHEMBL163,P23975,RITONAVIR,NCDNCNXCDXHOMX-XGKFQTDJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468698,DTCC00204116,51505,46191
CHEMBL163,P23975,RITONAVIR,NCDNCNXCDXHOMX-XGKFQTDJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468699,DTCC00204116,51505,46191
CHEMBL1630578,P23975,TIRILIZAD,RBKASMJPSJDQKY-RBFSKHHSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7487668,DTCC01016434,1798419,46191
CHEMBL1630578,P23975,TIRILIZAD,RBKASMJPSJDQKY-RBFSKHHSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7487669,DTCC01016434,1798419,46191
CHEMBL1630579,P23975,MYRTECAINE,BZRYYBWNOUALTQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407221,DTCC01016435,1416036,46191
CHEMBL1630579,P23975,MYRTECAINE,BZRYYBWNOUALTQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407222,DTCC01016435,1416036,46191
CHEMBL1641622,P23975,,RAQYAPJFZWPJNL-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,1849,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043157,DTCC01020197,1574857,42669
CHEMBL1642890,P23975,,INFXKGQBKNZHOQ-JSGCOSHPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,124,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038932,DTCC01019614,1671966,42566
CHEMBL1642891,P23975,,INFXKGQBKNZHOQ-TZMCWYRMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,731,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038933,DTCC01019615,701854,42566
CHEMBL1642892,P23975,,INFXKGQBKNZHOQ-OCCSQVGLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,855,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038934,DTCC01019616,701855,42566
CHEMBL1642893,P23975,,INFXKGQBKNZHOQ-GXTWGEPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,174,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038935,DTCC01019617,1316296,42566
CHEMBL1642894,P23975,,KDERKEZKMQCRPQ-ZFWWWQNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,27,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038936,DTCC01019618,346252,42566
CHEMBL1642895,P23975,,KDERKEZKMQCRPQ-UKRRQHHQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,117,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038938,DTCC01019619,1924874,42566
CHEMBL1642896,P23975,,KDERKEZKMQCRPQ-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,45,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038939,DTCC01019620,183362,42566
CHEMBL1642897,P23975,,KDERKEZKMQCRPQ-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,73,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038940,DTCC01019621,86482,42566
CHEMBL1642897,P23975,,KDERKEZKMQCRPQ-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,73,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043147,DTCC01019621,86486,42669
CHEMBL1642898,P23975,,DVCQRBZBVYAGNZ-HOCLYGCPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,167,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038941,DTCC01019622,669615,42566
CHEMBL1642899,P23975,,DVCQRBZBVYAGNZ-GDBMZVCRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,174,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038942,DTCC01019623,411865,42566
CHEMBL164290,P23975,N-NITROSODIETHYLAMINE,WBNQDOYYEUMPFS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7411534,DTCC00108812,703983,46191
CHEMBL164290,P23975,N-NITROSODIETHYLAMINE,WBNQDOYYEUMPFS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7411535,DTCC00108812,703983,46191
CHEMBL1642900,P23975,,DVCQRBZBVYAGNZ-ZBFHGGJFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,164,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038943,DTCC01019624,2087643,42566
CHEMBL1642901,P23975,,DVCQRBZBVYAGNZ-GOEBONIOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,98,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038944,DTCC01019625,1542747,42566
CHEMBL1642902,P23975,,AUOZLNRXVPELRP-ABAIWWIYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,28,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038945,DTCC01019626,1057294,42566
CHEMBL1642903,P23975,,AUOZLNRXVPELRP-XHDPSFHLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,257,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038946,DTCC01019627,1024836,42566
CHEMBL1642904,P23975,,AUOZLNRXVPELRP-NHYWBVRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,92,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038947,DTCC01019628,378839,42566
CHEMBL1642905,P23975,,AUOZLNRXVPELRP-IAQYHMDHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,371,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038948,DTCC01019629,1607338,42566
CHEMBL1642906,P23975,,NDCNHLIWHOBKGK-LRDDRELGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,72,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038949,DTCC01019630,830952,42566
CHEMBL1642907,P23975,,NDCNHLIWHOBKGK-MLGOLLRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,126,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038950,DTCC01019631,1990669,42566
CHEMBL1642908,P23975,,NDCNHLIWHOBKGK-WBMJQRKESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,210,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038951,DTCC00127403,863875,42566
CHEMBL1642909,P23975,,NDCNHLIWHOBKGK-BLLLJJGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,372,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038952,DTCC01019632,215476,42566
CHEMBL1642910,P23975,,WUSGTAILSJGBRD-DYVFJYSZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,565,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038953,DTCC01019633,1671967,42566
CHEMBL1642911,P23975,,WUSGTAILSJGBRD-GUYCJALGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,309,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038954,DTCC01019634,1316297,42566
CHEMBL1642912,P23975,,SNDGNPRZZZPUAX-WBMJQRKESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,26,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038955,DTCC01019635,313568,42566
CHEMBL1642913,P23975,,SNDGNPRZZZPUAX-BLLLJJGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,158,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038956,DTCC01019636,540439,42566
CHEMBL1642914,P23975,,YTBOYUYWXPLZQM-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,766,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038957,DTCC01019637,280852,42566
CHEMBL1642915,P23975,,YTBOYUYWXPLZQM-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,112,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038958,DTCC01019638,1828562,42566
CHEMBL1642916,P23975,,YTBOYUYWXPLZQM-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,1642,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038959,DTCC01019639,215477,42566
CHEMBL1642917,P23975,,YTBOYUYWXPLZQM-DLBZAZTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,7262,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038960,DTCC01019640,1024838,42566
CHEMBL1643,P23975,RIBAVIRIN,IWUCXVSUMQZMFG-AFCXAGJDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468574,DTCC00540588,217584,46191
CHEMBL1643,P23975,RIBAVIRIN,IWUCXVSUMQZMFG-AFCXAGJDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468575,DTCC00540588,217584,46191
CHEMBL1643509,P23975,,OBKCQTGBMZHBFE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,926,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043148,DTCC01020188,411874,42669
CHEMBL1643510,P23975,,UEPBVWIBDNMJPA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,7141,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043149,DTCC01020189,766379,42669
CHEMBL1643511,P23975,,RYIJMRFACOYPNH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,934,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043150,DTCC01020190,572580,42669
CHEMBL1643512,P23975,,OBKCQTGBMZHBFE-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,138,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043151,DTCC01020191,1607345,42669
CHEMBL1643513,P23975,,RYIJMRFACOYPNH-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,601,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043152,DTCC01020192,1218120,42669
CHEMBL1643514,P23975,,UEPBVWIBDNMJPA-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,1184,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043153,DTCC01020193,313571,42669
CHEMBL1643515,P23975,,RAQYAPJFZWPJNL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,2597,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043154,DTCC01020194,1153476,42669
CHEMBL1643516,P23975,,RRPWTJMHWMGFPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,1857,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043155,DTCC01020195,280859,42669
CHEMBL1643517,P23975,,VNSMQTHLCZBNAH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,1005,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043156,DTCC01020196,1185890,42669
CHEMBL1643518,P23975,,VNSMQTHLCZBNAH-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,1246,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043158,DTCC01020198,442555,42669
CHEMBL1643519,P23975,,RRPWTJMHWMGFPI-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21095126,IC50,=,3091,NM,,,,,,,,,,,,,,Inhibition of human recombinant norepinephrine transporter,,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,1,"Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,699574,DTCT0023180,5043159,DTCC01020199,1381616,42669
CHEMBL1643896,P23975,RTI-229,HPQILAIJSLHQQC-MLHJIOFPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989,IC50,=,1728,NM,,,,,,,,,,,,,,Inhibition of NET,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700839,DTCT0023180,5036553,DTCC00033377,1843394,42620
CHEMBL1643897,P23975,,YYCOWMQMXNLRHZ-GOOGKZTPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989,KI,>,1000,NM,,,,,,,,,,,,,,Inhibition of NET,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700839,DTCT0023180,5036541,DTCC01020574,1811063,42620
CHEMBL1643899,P23975,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989,KI,=,5883,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700847,DTCT0023180,5036589,DTCC01020576,166198,42620
CHEMBL1643899,P23975,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,=,5883,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12601185,DTCC01020576,168448,55935
CHEMBL1643900,P23975,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989,KI,=,3623,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700847,DTCT0023180,5036585,DTCC01020577,942929,42620
CHEMBL1643900,P23975,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,=,3623,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12601189,DTCC01020577,945255,55935
CHEMBL1643901,P23975,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700847,DTCT0023180,5036568,DTCC01020578,1460729,42620
CHEMBL1643901,P23975,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601148,DTCC01020578,1463030,55935
CHEMBL1643902,P23975,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700847,DTCT0023180,5036570,DTCC01020579,619871,42620
CHEMBL1643902,P23975,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601144,DTCC01020579,622243,55935
CHEMBL1644470,P23975,,OTYQXOHDRTWMJY-MUJYYYPQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,26,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049104,DTCC01021125,1233281,42542
CHEMBL1644471,P23975,,HQWOOKZKFBMBCD-PTEHBNRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,54,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049105,DTCC01021126,1137391,42542
CHEMBL1644472,P23975,,SYNKGZURWSKSDC-DABQJJPHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,86,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049106,DTCC01021127,975027,42542
CHEMBL1644473,P23975,,NUQHQIXAXZDZPW-PTEHBNRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,347,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049107,DTCC01021128,1525538,42542
CHEMBL1644474,P23975,,CEJARUPLPSANRD-PTEHBNRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,19,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049108,DTCC01021129,1460734,42542
CHEMBL1644475,P23975,,MJWXDPDEDHUUJV-JGPRNRPPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,188,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049109,DTCC01021130,1907797,42542
CHEMBL1644476,P23975,,PICCBNDESXQSTL-PTEHBNRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,13,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049110,DTCC01021131,296146,42542
CHEMBL1644477,P23975,,LXIOTZOSBNBEKN-PTEHBNRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,12,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049111,DTCC01021132,1396402,42542
CHEMBL1644478,P23975,,XWDJHMXLIXWQGQ-PTEHBNRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,67,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049112,DTCC01021133,1811069,42542
CHEMBL1644479,P23975,,PHOVKMVBVOKTKB-DABQJJPHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,92,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049113,DTCC01021134,1396403,42542
CHEMBL1644480,P23975,,WQUWMFJMVPTZHQ-DDFAGTSDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,91,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049114,DTCC01021135,457725,42542
CHEMBL1644481,P23975,,CIJDXZHBTVURGN-PTEHBNRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,128,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049115,DTCC01021136,1778694,42542
CHEMBL1644482,P23975,,IQNGYWRUWKYNSE-GNXNZQSNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,222,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049116,DTCC01021137,2038525,42542
CHEMBL1644483,P23975,,OGKOSOTXSHSDIP-DABQJJPHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,126,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049117,DTCC01021138,684436,42542
CHEMBL1644600,P23975,,NAZAMXVJDAUZNQ-IZZQQSIFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,891,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049118,DTCC01021249,587513,42542
CHEMBL1644601,P23975,,OKLKBYAVPPRKEG-IZZQQSIFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,132,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049119,DTCC01021250,1811071,42542
CHEMBL1644602,P23975,,GYNVBZHVGBAXPA-IZZQQSIFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,30,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049120,DTCC01021251,846352,42542
CHEMBL1644603,P23975,,NPRIIPJXYKFSOJ-IZZQQSIFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,85,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049122,DTCC01021252,1266141,42542
CHEMBL1644604,P23975,,QRRQVHBNSBQIBJ-OPVJXMOQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,148,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049123,DTCC01021253,878791,42542
CHEMBL1644605,P23975,,NRKLSKYRBUUDLU-BJWYYQGGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,90,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049124,DTCC01021254,1105099,42542
CHEMBL1644606,P23975,,RGCRPWWXLBCYBL-OPVJXMOQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,60,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049125,DTCC01021255,523252,42542
CHEMBL1644607,P23975,,GSHCBUDNKQJONH-OPVJXMOQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,31,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049126,DTCC01021256,1072350,42542
CHEMBL1644608,P23975,,JGPRTHDFGZBWFN-IZZQQSIFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,5,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049127,DTCC01021257,457727,42542
CHEMBL1644609,P23975,,SCEZKNSHVTVFNV-MUJYYYPQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,9,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049128,DTCC01021258,2070319,42542
CHEMBL1644610,P23975,,QOSPLNXOHCYGSB-BJWYYQGGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21112782,IC50,=,13,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700294,DTCT0023180,5049129,DTCC01021259,975030,42542
CHEMBL1645596,P23975,3-(2-PHENOXYPHENOXY)AZETIDINE,MKIMQSUJTXVNED-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,1640,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048971,DTCC00033425,1493216,42462
CHEMBL1645597,P23975,,WWTGDTLFSFRIFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,528,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048878,DTCC01022149,1396419,42462
CHEMBL1645598,P23975,,VBNJXEPLSRKHGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,507,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048972,DTCC01022150,1973113,42462
CHEMBL1645599,P23975,,HJCOGULOEUQZGT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,198,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048973,DTCC01022151,911442,42462
CHEMBL1645600,P23975,,CUHDMEXRHJPGHR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,EC50,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human cloned NET expressed in HEK293 cells by FLIPR assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698920,DTCT0023180,5049814,DTCC01022152,296160,42462
CHEMBL1645600,P23975,,CUHDMEXRHJPGHR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,138,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048974,DTCC01022152,296160,42462
CHEMBL1645601,P23975,,QHOAGSGZOCDBGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,EC50,=,239,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human cloned NET expressed in HEK293 cells by FLIPR assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698920,DTCT0023180,5049813,DTCC01022153,587521,42462
CHEMBL1645601,P23975,,QHOAGSGZOCDBGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,116,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048975,DTCC01022153,587521,42462
CHEMBL1645602,P23975,,JVFNBOUZKYZEJE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,482,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048976,DTCC01022154,1939924,42462
CHEMBL1645603,P23975,,VWOHPBLHZAONKH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,164,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048977,DTCC01022155,652422,42462
CHEMBL1645604,P23975,,VHKIHYNCEPOAKX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,433,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048978,DTCC01022156,426725,42462
CHEMBL1645605,P23975,,WYYIFGYFQYWQOA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,374,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048979,DTCC01022157,1686838,42462
CHEMBL1645606,P23975,,YZDRSNBYBMAHDD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,1000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048980,DTCC01022158,166211,42462
CHEMBL1645607,P23975,,XFIFFAHPFWAWSS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,489,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048981,DTCC01022159,1622547,42462
CHEMBL1645608,P23975,,LGPYPLZSWZJHBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,218,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048982,DTCC01022160,1589904,42462
CHEMBL1645609,P23975,,YIGLINOPTZCHQC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,323,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048983,DTCC01022161,262929,42462
CHEMBL1645610,P23975,,YYTDEVINWTYBOD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,1950,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048984,DTCC01022162,262930,42462
CHEMBL1645611,P23975,,VWOHRXMXNABMIC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,1350,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048985,DTCC01022163,1654775,42462
CHEMBL1645612,P23975,,FWSGCKKLRWEEEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,1020,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048986,DTCC01022164,1973114,42462
CHEMBL1645613,P23975,,UNWRSVCWVWOSPV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,192,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048987,DTCC01022165,878802,42462
CHEMBL1645614,P23975,,KUTIVIKNDVNVAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,328,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048988,DTCC01022166,262931,42462
CHEMBL1645615,P23975,,PDVOMSJUMYNNBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,EC50,=,97,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human cloned NET expressed in HEK293 cells by FLIPR assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698920,DTCT0023180,5049819,DTCC01022167,1137409,42462
CHEMBL1645615,P23975,,PDVOMSJUMYNNBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,226,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048989,DTCC01022167,1137409,42462
CHEMBL1645616,P23975,,PDVOMSJUMYNNBT-JTQLQIEISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,1010,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048990,DTCC01022168,942945,42462
CHEMBL1645617,P23975,,PDVOMSJUMYNNBT-SNVBAGLBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,110,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048991,DTCC01022169,262932,42462
CHEMBL1645618,P23975,,NYOUEYCHUPCVGU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,1140,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048992,DTCC01022170,1200909,42462
CHEMBL1645619,P23975,,KCIORJWXNLIEPL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,73,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048993,DTCC01022171,1907809,42462
CHEMBL1649,P23975,DEMETHYL-CITALOPRAM,PTJADDMMFYXMMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,1820,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14740387,DTCC00541501,2107376,68566
CHEMBL1649,P23975,DEMETHYL-CITALOPRAM,PTJADDMMFYXMMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,0.77,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556616,DTCC00541501,1231842,28813
CHEMBL165,P23975,RESVERATROL,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2312,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464217,DTCC00217176,930085,46191
CHEMBL165,P23975,RESVERATROL,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2293,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464218,DTCC00217176,930085,46191
CHEMBL1650,P23975,CORTISONE ACETATE,ITRJWOMZKQRYTA-RFZYENFJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7363218,DTCC00542150,1705875,46191
CHEMBL1650,P23975,CORTISONE ACETATE,ITRJWOMZKQRYTA-RFZYENFJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7363219,DTCC00542150,1705875,46191
CHEMBL1650844,P23975,,MEBYDATXPNEUSM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20875743,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 1 uM relative to control,,"Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships.",Bioorg. Med. Chem.,2010,18,21,"Hayashi S, Nakata E, Morita A, Mizuno K, Yamamura K, Kato A, Ohashi K",,714711,DTCT0023180,5075417,DTCC01023170,1137420,43117
CHEMBL1651208,P23975,,DWTYHCYVKJONSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23009245,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human NET at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012,55,22,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876170,DTCT0023180,11437727,DTCC01023515,317585,51586
CHEMBL1651219,P23975,,ZQBPXBADOJMCRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23009245,INHIBITION,=,-17,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human NET at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012,55,22,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876170,DTCT0023180,11437678,DTCC01023526,1675972,51586
CHEMBL1651906,P23975,STREPTOZOTOCIN,ZSJLQEPLLKMAKR-YDEIVXIUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7478190,DTCC01024120,1318448,46191
CHEMBL1651906,P23975,STREPTOZOTOCIN,ZSJLQEPLLKMAKR-YDEIVXIUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7478191,DTCC01024120,1318448,46191
CHEMBL165790,P23975,IPRIFLAVONE,SFBODOKJTYAUCM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2512.5,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407392,DTCC00358921,542578,46191
CHEMBL165790,P23975,IPRIFLAVONE,SFBODOKJTYAUCM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2491.7,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407393,DTCC00358921,542578,46191
CHEMBL1660,P23975,RIFAPENTINE,WDZCUPBHRAEYDL-GZAUEHORSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481657,DTCC00550275,930086,46191
CHEMBL1660,P23975,RIFAPENTINE,WDZCUPBHRAEYDL-GZAUEHORSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481658,DTCC00550275,930086,46191
CHEMBL1668584,P23975,,YPVOSIDECMYMTD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21333408,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter at 10 uM by radioligand binding assay,Not Active,"2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2011,46,4,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Mitkin OD, Tkachenko SE, Kysil VM, Okun I",,740381,DTCT0023180,5907297,DTCC01025412,943137,44130
CHEMBL1669669,P23975,RO-5212773,KLFVWQCQUXXLOU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21237643,INHIBITION,=,44,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).,Bioorg. Med. Chem. Lett.,2011,21,4,"Stalder H, Hoener MC, Norcross RD",,716528,DTCT0023180,5105760,DTCC00033580,1557659,43309
CHEMBL1670,P23975,MITOTANE,JWBOIMRXGHLCPP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,819,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7434780,DTCC00555980,2057649,46191
CHEMBL1670,P23975,MITOTANE,JWBOIMRXGHLCPP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,812,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7434781,DTCC00555980,2057649,46191
CHEMBL1672288,P23975,,LVXAMCKZCLWWTF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21207959,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to NET,,Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.,J. Med. Chem.,2011,54,3,"Siméon FG, Wendahl MT, Pike VW",,718176,DTCT0023180,5116597,DTCC01026954,798550,43561
CHEMBL1679,P23975,LEUCOVORIN,VVIAGPKUTFNRDU-ABLWVSNPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435755,DTCC00560549,1188068,46191
CHEMBL1679,P23975,LEUCOVORIN,VVIAGPKUTFNRDU-ABLWVSNPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435756,DTCC00560549,1188068,46191
CHEMBL167911,P23975,DICHLORVOS,OEBRKCOSUFCWJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370378,DTCC00362299,1544896,46191
CHEMBL167911,P23975,DICHLORVOS,OEBRKCOSUFCWJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370379,DTCC00362299,1544896,46191
CHEMBL1681810,P23975,,QIYANFXIRPCCFR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,529,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147745,DTCC01029879,896323,43651
CHEMBL1683870,P23975,,NDMODESSMWGHBK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,85,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147700,DTCC01029854,2023585,43651
CHEMBL1683870,P23975,,NDMODESSMWGHBK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,85,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147959,DTCC01029854,2005859,43660
CHEMBL1683871,P23975,"(1-(3,4-DICHLOROPHENYL)CYCLOHEXYL)METHANAMINE",JTOBXLVKTKGLSL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,273,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147734,DTCC00033688,247923,43651
CHEMBL1683872,P23975,,LJALDWYVBOLBGW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147652,DTCC01029855,1732062,43651
CHEMBL1683873,P23975,,VAXCWNURWRJNKL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,36,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147681,DTCC01029856,215581,43651
CHEMBL1683874,P23975,,MSRLFKAAHSYYJT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147624,DTCC01029857,48339,43651
CHEMBL1683875,P23975,,ZZRHLICOWQQNJL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147634,DTCC01029858,604939,43651
CHEMBL1683876,P23975,,ZXAIYPYVRUXIRT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147629,DTCC01029859,247924,43651
CHEMBL1683877,P23975,,YWOVEHIRDVATGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,232,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147727,DTCC01029860,1796309,43651
CHEMBL1683878,P23975,,QQKNLGCYRCQFQP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,114,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147705,DTCC01029861,572683,43651
CHEMBL1683879,P23975,,YOVGBLUPSNTJCU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,790,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147754,DTCC01029862,928052,43651
CHEMBL1683880,P23975,,FSYUMFOIUHBSHI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147682,DTCC01029863,1218227,43651
CHEMBL1683881,P23975,"(1-(3,4-DICHLOROPHENYL)CYCLOHEPTYL)METHANAMINE",NMFAKPRDDDKVBP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,2783,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147769,DTCC00033689,1218228,43651
CHEMBL1683882,P23975,,CLQNHTVQVGGNMJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,63,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147693,DTCC01029864,151369,43651
CHEMBL1683883,P23975,,MKEIWZZHDFWQBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147663,DTCC01029865,1251333,43651
CHEMBL1683884,P23975,,UFFRBOMGNQGCAY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,51,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147686,DTCC01029866,1283851,43651
CHEMBL1683885,P23975,,HOXBFDRIDWJAEN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,326,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147741,DTCC01029867,475932,43651
CHEMBL1683886,P23975,,WWUXHADAODEZLF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,9990,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147780,DTCC01029868,1957996,43651
CHEMBL1683887,P23975,,WGNABQIMYMHUQC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,269,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147733,DTCC01029869,1316416,43651
CHEMBL1683888,P23975,,FFPZKPBDKMJMOH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147670,DTCC01029870,2055641,43651
CHEMBL1683889,P23975,,FGMVBSZPVPCFKQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147636,DTCC01029871,1990787,43651
CHEMBL1683890,P23975,,FLAQOJMPRHHQFA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,137,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147712,DTCC01029872,2055642,43651
CHEMBL1683891,P23975,,PUCWXLYHLYMUCG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,61,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147692,DTCC01029873,151370,43651
CHEMBL1683892,P23975,,XRXPUZOKWCSSLL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,2188,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147766,DTCC01029874,1957997,43651
CHEMBL1683893,P23975,,YEMZPAKBIRTBDG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,146,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147714,DTCC01029875,798582,43651
CHEMBL1683894,P23975,,FVPYKEUHDWGTTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,206,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147721,DTCC01029876,1218229,43651
CHEMBL1683895,P23975,,XQUUVZDIAMCEHA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,346,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147742,DTCC01029877,2087772,43651
CHEMBL1683896,P23975,,SYDXJSKTVHXBGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147672,DTCC01029878,1732063,43651
CHEMBL1683897,P23975,,XWHBDOLRNWCIGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,5761,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147772,DTCC01029880,346396,43651
CHEMBL1683898,P23975,,WQBHQWJJWWMKPS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,3177,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147770,DTCC01029881,701978,43651
CHEMBL1683899,P23975,,UTQLEVQLADDVHS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147656,DTCC01029882,572684,43651
CHEMBL1683900,P23975,,SAARGPSTPXUSIL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,232,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147728,DTCC01029883,1732064,43651
CHEMBL1683901,P23975,,TVDNUGUVGACHFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,295,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147737,DTCC01029884,378986,43651
CHEMBL1683901,P23975,,TVDNUGUVGACHFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,295,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147960,DTCC01029884,361513,43660
CHEMBL1683902,P23975,,SWBCLQGKCJMOJJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147630,DTCC01029885,766472,43651
CHEMBL1683903,P23975,,DTPYYGUOEBJVJL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,8733,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147776,DTCC01029886,766473,43651
CHEMBL1683904,P23975,,FVJRSFJCTCDWPN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,9217,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147777,DTCC01029887,1251334,43651
CHEMBL1683905,P23975,,QVLGCILLMAUJBI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310609,IC50,=,9987,NM,,,,,,,,,,,,,,Inhibition of human recombinant Norepinephrine transporter,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726927,DTCT0023180,5147779,DTCC01029888,151371,43651
CHEMBL1684042,P23975,,XAXLSVQFDZVYNG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,170,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148730,DTCC01030021,1298767,43660
CHEMBL1684042,P23975,,XAXLSVQFDZVYNG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,320,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147961,DTCC01030021,1298766,43660
CHEMBL1684042,P23975,,XAXLSVQFDZVYNG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,1000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148731,DTCC01030021,1298768,43660
CHEMBL1684043,P23975,,JKRXUDRMEIXFBV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,120,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147962,DTCC01030022,16148,43660
CHEMBL1684044,P23975,,CDXVXAPUCWBZKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,890,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147963,DTCC01030023,491093,43660
CHEMBL1684045,P23975,,ZJNJPYFFMXVAGY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,37,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147964,DTCC01030024,296248,43660
CHEMBL1684045,P23975,,ZJNJPYFFMXVAGY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,57,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148733,DTCC01030024,296252,43660
CHEMBL1684045,P23975,,ZJNJPYFFMXVAGY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,440,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148732,DTCC01030024,296251,43660
CHEMBL1684046,P23975,,POKCWLLPLOIIOW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,960,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147965,DTCC01030025,1233406,43660
CHEMBL1684047,P23975,,OBWKCACUZGJXHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147966,DTCC01030026,296249,43660
CHEMBL1684047,P23975,,OBWKCACUZGJXHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148734,DTCC01030026,296253,43660
CHEMBL1684047,P23975,,OBWKCACUZGJXHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,570,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148735,DTCC01030026,296254,43660
CHEMBL1684047,P23975,,OBWKCACUZGJXHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26935940,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of recombinant human norepinephrine transporter assessed as reduction in [3H]-NA reuptake,,Emerging targets and new small molecule therapies in Parkinson's disease treatment.,Bioorg. Med. Chem.,2016,24,7,"Zhang H, Tong R, Bai L, Shi J, Ouyang L.",,1558447,DTCT0023180,105203,DTCC01030026,302046,66318
CHEMBL1684048,P23975,,PKNHHRUELROULR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147967,DTCC01030027,813534,43660
CHEMBL1684049,P23975,,UKMRWNNKRBSVIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,4000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147968,DTCC01030028,781138,43660
CHEMBL1684050,P23975,,GXDMUUDAPHURSU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,330,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147969,DTCC01030029,878908,43660
CHEMBL1684050,P23975,,GXDMUUDAPHURSU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,530,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148736,DTCC01030029,878909,43660
CHEMBL1684050,P23975,,GXDMUUDAPHURSU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,780,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148737,DTCC01030029,878910,43660
CHEMBL1684051,P23975,,VRVDHYBVMARMIQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,3200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147970,DTCC01030030,1266267,43660
CHEMBL1684052,P23975,,HULJRWTYZFVYPA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,5000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5147971,DTCC01030031,101611,43660
CHEMBL1684053,P23975,,OLMZNNJAFQDNIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148727,DTCC01030032,296250,43660
CHEMBL1684054,P23975,,CELRKOSFIVSEBS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,4000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148728,DTCC01030033,1557711,43660
CHEMBL1684055,P23975,,DIOWQSMFSBKMCS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,21,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148740,DTCC01030034,846450,43660
CHEMBL1684055,P23975,,DIOWQSMFSBKMCS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,61,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148729,DTCC01030034,846449,43660
CHEMBL1684055,P23975,,DIOWQSMFSBKMCS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,470,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148741,DTCC01030034,846451,43660
CHEMBL1684056,P23975,,WISXSHNMYCUZHH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,23,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148738,DTCC01030035,2005860,43660
CHEMBL1684056,P23975,,WISXSHNMYCUZHH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,180,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148739,DTCC01030035,2005861,43660
CHEMBL1687,P23975,TUBOCURARINE CHLORIDE,MHXYWXHKLBMJKL-QBYKQQEBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7354806,DTCC00570867,1253320,46191
CHEMBL1687,P23975,TUBOCURARINE CHLORIDE,MHXYWXHKLBMJKL-QBYKQQEBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7354807,DTCC00570867,1253320,46191
CHEMBL1696,P23975,DESIPRAMINE HYDROCHLORIDE,XAEWZDYWZHIUCT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20597489,KI,=,0.8,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,2010,53,15,"Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM",,646995,DTCT0023180,3432102,DTCC00574419,1072082,40077
CHEMBL1697694,P23975,AFLATOXIN,OQIQSTLJSLGHID-WNWIJWBNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290899,DTCC00127800,1092339,46191
CHEMBL1697694,P23975,AFLATOXIN,OQIQSTLJSLGHID-WNWIJWBNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290900,DTCC00127800,1092339,46191
CHEMBL1702607,P23975,,ADVPTQAUNPRNPO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733105,DTCC01037443,2104825,69159
CHEMBL1712923,P23975,IRSOGLADINE MALEATE,PJLVTVAIERNDEQ-BTJKTKAUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7424626,DTCC01047420,1894969,46191
CHEMBL1712923,P23975,IRSOGLADINE MALEATE,PJLVTVAIERNDEQ-BTJKTKAUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7424627,DTCC01047420,1894969,46191
CHEMBL17157,P23975,TERFENADINE,GUGOEEXESWIERI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1928,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7476653,DTCC00148306,510307,46191
CHEMBL17157,P23975,TERFENADINE,GUGOEEXESWIERI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1912,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7476654,DTCC00148306,510307,46191
CHEMBL172090,P23975,,RJVRDLDDCGQDGE-GTRCSXEUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15012999,INHIBITION,=,15,%,,,,,,,,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,2004,14,4,"Shu M, Loebach JL, Parker KA, Mills SG, Chapman KT, Shen DM, Malkowitz L, Springer MS, Gould SL, DeMartino JA, Siciliano SJ, Salvo JD, Lyons K, Pivnichny JV, Kwei GY, Carella A, Carver G, Holmes K, Schleif WA, Danzeisen R, Hazuda D, Kessler J, Lineberger J, Miller MD, Emini EA",,142805,DTCT0023180,1453007,DTCC00372758,98235,6665
CHEMBL1722,P23975,METHYLPHENIDATE HYDROCHLORIDE,JUMYIBMBTDDLNG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,=,51,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306535,DTCT0023180,1824000,DTCC00581471,1630904,19663
CHEMBL1722,P23975,METHYLPHENIDATE HYDROCHLORIDE,JUMYIBMBTDDLNG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,=,788,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306359,DTCT0023180,1824001,DTCC00581471,1630904,19663
CHEMBL1726,P23975,NISOLDIPINE,VKQFCGNPDRICFG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7390577,DTCC00583129,1830687,46191
CHEMBL1726,P23975,NISOLDIPINE,VKQFCGNPDRICFG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7390578,DTCC00583129,1830687,46191
CHEMBL1727,P23975,CEPHALEXIN,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357951,DTCC00584128,444636,46191
CHEMBL1727,P23975,CEPHALEXIN,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357952,DTCC00584128,444636,46191
CHEMBL172806,P23975,,RCAXDUZVJIMXJF-UFZHQWOOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15012999,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,2004,14,4,"Shu M, Loebach JL, Parker KA, Mills SG, Chapman KT, Shen DM, Malkowitz L, Springer MS, Gould SL, DeMartino JA, Siciliano SJ, Salvo JD, Lyons K, Pivnichny JV, Kwei GY, Carella A, Carver G, Holmes K, Schleif WA, Danzeisen R, Hazuda D, Kessler J, Lineberger J, Miller MD, Emini EA",,142805,DTCT0023180,1454139,DTCC00373558,713500,6665
CHEMBL1729,P23975,CISAPRIDE,DCSUBABJRXZOMT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7343447,DTCC00585645,315663,46191
CHEMBL1729,P23975,CISAPRIDE,DCSUBABJRXZOMT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7343448,DTCC00585645,315663,46191
CHEMBL1729417,P23975,,PMTIWRPLQBVEMR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24690494,KI,<,1000,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin),,Antagonists of the kappa opioid receptor.,Bioorg. Med. Chem. Lett.,2014,24,9,"Urbano M, Guerrero M, Rosen H, Roberts E",,1352904,DTCT0023180,13690248,DTCC01063399,253806,58670
CHEMBL1730,P23975,CEFOTAXIME,GPRBEKHLDVQUJE-QSWIMTSFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7349324,DTCC00585909,51453,46191
CHEMBL1730,P23975,CEFOTAXIME,GPRBEKHLDVQUJE-QSWIMTSFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7349325,DTCC00585909,51453,46191
CHEMBL1732,P23975,DIHYDROERGOTAMINE,LUZRJRNZXALNLM-JGRZULCMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7355437,DTCC00586321,381008,46191
CHEMBL1732,P23975,DIHYDROERGOTAMINE,LUZRJRNZXALNLM-JGRZULCMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7355438,DTCC00586321,381008,46191
CHEMBL173427,P23975,,GZWPHROGQGOESZ-PHHAAFCNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12620070,KI,=,32,NM,,cell_based,,,,,,,,,,,,In vitro competitive binding versus [3H]- nisoxatine in murine kidney cells transfected with cDNA for human norepinephrine transporter (NET),,Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,2003,46,6,"Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB",,144973,DTCT0023180,575462,DTCC00371243,1501481,17720
CHEMBL173427,P23975,,GZWPHROGQGOESZ-PHHAAFCNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12620070,RATIO,=,19.6,,,,,,,,,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),,Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,2003,46,6,"Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB",,144999,DTCT0023180,575464,DTCC00371243,1501481,17720
CHEMBL173861,P23975,,JOQQHMGSIKNGAF-NXDIHJKXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989,KI,=,44,NM,,,,,,,,,,,,,,Inhibition of NET,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700839,DTCT0023180,5036557,DTCC00371609,1746678,42620
CHEMBL1738699,P23975,,YVPGZQLRPAGKLA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219,DTCT0023180,5976447,DTCC01070772,735160,44781
CHEMBL174,P23975,AMPICILLIN,AVKUERGKIZMTKX-NJBDSQKTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290173,DTCC00385816,51446,46191
CHEMBL174,P23975,AMPICILLIN,AVKUERGKIZMTKX-NJBDSQKTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290174,DTCC00385816,51446,46191
CHEMBL1740,P23975,RACEPINEPHRINE,UCTWMZQNUQWSLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10411589,KI,=,3680,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731176,DTCC00594206,2104339,69057
CHEMBL174088,P23975,,GZWPHROGQGOESZ-SYEBVZJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12620070,KI,=,24,NM,,cell_based,,,,,,,,,,,,In vitro competitive binding versus [3H]- nisoxatine in murine kidney cells transfected with cDNA for human norepinephrine transporter (NET),,Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,2003,46,6,"Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB",,144972,DTCT0023180,549450,DTCC00370872,531414,17720
CHEMBL174088,P23975,,GZWPHROGQGOESZ-SYEBVZJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12620070,RATIO,=,474,,,,,,,,,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),,Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,2003,46,6,"Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB",,144999,DTCT0023180,549452,DTCC00370872,531414,17720
CHEMBL1741,P23975,CLARITHROMYCIN,AGOYDEPGAOXOCK-KCBOHYOISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7369344,DTCC00596664,1641846,46191
CHEMBL1741,P23975,CLARITHROMYCIN,AGOYDEPGAOXOCK-KCBOHYOISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7369345,DTCC00596664,1641846,46191
CHEMBL174304,P23975,,QTGSINBFNYAXSI-HYRLGQOJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15012999,INHIBITION,=,21,%,,,,,,,,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,2004,14,4,"Shu M, Loebach JL, Parker KA, Mills SG, Chapman KT, Shen DM, Malkowitz L, Springer MS, Gould SL, DeMartino JA, Siciliano SJ, Salvo JD, Lyons K, Pivnichny JV, Kwei GY, Carella A, Carver G, Holmes K, Schleif WA, Danzeisen R, Hazuda D, Kessler J, Lineberger J, Miller MD, Emini EA",,142805,DTCT0023180,1467360,DTCC00370553,1425578,6665
CHEMBL1743259,P23975,ETOPERIDONE,IZBNNCFOBMGTQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736247,DTCC01074180,2105925,68566
CHEMBL1744173,P23975,,GJZWWIMXGJBWFD-HAEFCHRDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,2400,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1165657,DTCC01074760,616110,16052
CHEMBL1744173,P23975,,GJZWWIMXGJBWFD-HAEFCHRDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,4400,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1165658,DTCC01074760,616110,16052
CHEMBL1744190,P23975,,COGUASSENRQBTI-KMIIZFTKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1173005,DTCC01074777,1871839,16052
CHEMBL1744190,P23975,,COGUASSENRQBTI-KMIIZFTKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1173006,DTCC01074777,1871839,16052
CHEMBL1744448,P23975,BLEOMYCIN A2,LOLFAJUUOFBGSF-KYIYJVAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7275744,DTCC00127875,898283,46191
CHEMBL1744448,P23975,BLEOMYCIN A2,LOLFAJUUOFBGSF-KYIYJVAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7275745,DTCC00127875,898283,46191
CHEMBL1747,P23975,TOBRAMYCIN,NLVFBUXFDBBNBW-PBSUHMDJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7457419,DTCC00603485,1734066,46191
CHEMBL1747,P23975,TOBRAMYCIN,NLVFBUXFDBBNBW-PBSUHMDJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7457420,DTCC00603485,1734066,46191
CHEMBL175,P23975,DEXIBUPROFEN,HEFNNWSXXWATRW-JTQLQIEISA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7344398,DTCC00396784,1862715,46191
CHEMBL175,P23975,DEXIBUPROFEN,HEFNNWSXXWATRW-JTQLQIEISA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7344399,DTCC00396784,1862715,46191
CHEMBL1751,P23975,DIGOXIN,LTMHDMANZUZIPE-PUGKRICDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7348871,DTCC00607566,51464,46191
CHEMBL1751,P23975,DIGOXIN,LTMHDMANZUZIPE-PUGKRICDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7348872,DTCC00607566,51464,46191
CHEMBL1752,P23975,DYPHYLLINE,KSCFJBIXMNOVSH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7336568,DTCC00607571,2089746,46191
CHEMBL1752,P23975,DYPHYLLINE,KSCFJBIXMNOVSH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7336569,DTCC00607571,2089746,46191
CHEMBL1753,P23975,CLINDAMYCIN,KDLRVYVGXIQJDK-AWPVFWJPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7345792,DTCC00607595,898286,46191
CHEMBL1753,P23975,CLINDAMYCIN,KDLRVYVGXIQJDK-AWPVFWJPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7345793,DTCC00607595,898286,46191
CHEMBL1754,P23975,DOXAPRAM,XFDJYSQDBULQSI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370810,DTCC00607599,1027051,46191
CHEMBL1754,P23975,DOXAPRAM,XFDJYSQDBULQSI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370811,DTCC00607599,1027051,46191
CHEMBL1760,P23975,TERBUTALINE,XWTYSIMOBUGWOL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7467952,DTCC00609006,542583,46191
CHEMBL1760,P23975,TERBUTALINE,XWTYSIMOBUGWOL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7467953,DTCC00609006,542583,46191
CHEMBL1762,P23975,TOCAINIDE,BUJAGSGYPOAWEI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7461794,DTCC00609197,1544903,46191
CHEMBL1762,P23975,TOCAINIDE,BUJAGSGYPOAWEI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7461795,DTCC00609197,1544903,46191
CHEMBL1762470,P23975,,PGBKVMPEZANYQB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,,,,,,,,,,,,,,,,,Inhibition of NET,Not Active,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908706,DTCC01077413,1940116,44050
CHEMBL1762471,P23975,,UJFDPLITEKQPEB-WMQZXYHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,=,0,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908707,DTCC01077414,1493417,44050
CHEMBL1762472,P23975,,XFORHSSANNSJHD-PKLMIRHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908708,DTCC01077415,813601,44050
CHEMBL1762473,P23975,,PPQGTHAGWWVLEX-XFULWGLBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908709,DTCC01077416,134043,44050
CHEMBL1762474,P23975,,HDHLQBIWVMHJAZ-WMQZXYHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,=,17000,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908710,DTCC01077417,1331515,44050
CHEMBL1762475,P23975,,XKEZEUVEUQSKDY-PKLMIRHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,=,28000,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908711,DTCC01077418,1525736,44050
CHEMBL1762476,P23975,,FCJZJQBLFVEPPT-UNTBIKODSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,=,12000,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908712,DTCC01077419,296340,44050
CHEMBL1762477,P23975,,PHTBVQOXRLNFDB-RWKFXIDCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,,,,,,,,,,,,,,,,,Inhibition of NET,Not Active,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908713,DTCC01077420,134044,44050
CHEMBL1762478,P23975,,ISUTYHCEBNDJBQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,=,7100,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908714,DTCC01077421,394358,44050
CHEMBL1762479,P23975,,PAHRBTYOMQPLOY-XFULWGLBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,=,16000,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908715,DTCC01077422,1940117,44050
CHEMBL1762480,P23975,,GXBAVPWCNHSDRH-WMQZXYHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,=,7400,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908716,DTCC01077423,1072554,44050
CHEMBL1762481,P23975,,UTNAGBHMGVWHTR-SBSPUUFOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of NET,,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908717,DTCC01077424,1266368,44050
CHEMBL1765599,P23975,,VNRFZHXTMQEXQW-XHDPSFHLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21319801,IC50,=,24,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,2011,54,5,"Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ",,741840,DTCT0023180,5920198,DTCC01078151,379820,44216
CHEMBL1765600,P23975,,XNZHLLAIQAZMMY-BLLLJJGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21319801,IC50,=,13,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,2011,54,5,"Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ",,741840,DTCT0023180,5920199,DTCC01078152,1284721,44216
CHEMBL1765683,P23975,,ZVRXOXFSMYJETP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21428406,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011,54,8,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743847,DTCT0023180,5918995,DTCC01078226,652599,44302
CHEMBL1765684,P23975,,VCKIDQVWSDVZCZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21428406,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011,54,8,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743847,DTCT0023180,5918996,DTCC01078227,975211,44302
CHEMBL1766,P23975,DESOXIMETASONE,VWVSBHGCDBMOOT-IIEHVVJPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7361488,DTCC00610116,348397,46191
CHEMBL1766,P23975,DESOXIMETASONE,VWVSBHGCDBMOOT-IIEHVVJPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7361489,DTCC00610116,348397,46191
CHEMBL177,P23975,AMIKACIN,LKCWBDHBTVXHDL-RMDFUYIESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7292583,DTCC00409875,1253318,46191
CHEMBL177,P23975,AMIKACIN,LKCWBDHBTVXHDL-RMDFUYIESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7292584,DTCC00409875,1253318,46191
CHEMBL1771,P23975,CLOPIDOGREL,GKTWGGQPFAXNFI-HNNXBMFYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7343702,DTCC00616891,639577,46191
CHEMBL1771,P23975,CLOPIDOGREL,GKTWGGQPFAXNFI-HNNXBMFYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7343703,DTCC00616891,639577,46191
CHEMBL177756,P23975,FLUORESCEIN,YKGGGCXBWXHKIZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7309857,DTCC00376005,1894967,46191
CHEMBL177756,P23975,FLUORESCEIN,YKGGGCXBWXHKIZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7309858,DTCC00376005,1894967,46191
CHEMBL1779058,P23975,,HJKLOGARPBXZTP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11474313,DTCC01084658,232067,51935
CHEMBL1779059,P23975,,QCBXRMVDVAHCPR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11474290,DTCC01084659,1365536,51935
CHEMBL1779060,P23975,,ZOAKYUHDXICZSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11474265,DTCC01084660,1719581,51935
CHEMBL178,P23975,DAUNORUBICIN,STQGQHZAVUOBTE-VGBVRHCVSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7344312,DTCC00413150,477916,46191
CHEMBL178,P23975,DAUNORUBICIN,STQGQHZAVUOBTE-VGBVRHCVSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7344313,DTCC00413150,477916,46191
CHEMBL1783889,P23975,,DSNALXIKDKGHLJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human NET at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496655,DTCT0023180,14434955,DTCC01087435,1615288,62611
CHEMBL1784671,P23975,,NVCJMYLJSSPEKR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219,DTCT0023180,5976448,DTCC01088207,184448,44781
CHEMBL1784673,P23975,,CPOQTXKWWFQYCF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219,DTCT0023180,5976449,DTCC01088209,314586,44781
CHEMBL1784685,P23975,,APARPRRWRUIPGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219,DTCT0023180,5976450,DTCC01088221,1764905,44781
CHEMBL1784694,P23975,,USRJTKDRTOTPRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219,DTCT0023180,5976451,DTCC01088230,347293,44781
CHEMBL1788140,P23975,,YABYABUWFUDQKN-GUUGRXDUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,34,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1159187,DTCC01088626,390277,16052
CHEMBL1788140,P23975,,YABYABUWFUDQKN-GUUGRXDUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,95,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1159185,DTCC01088626,390277,16052
CHEMBL1790041,P23975,RANITIDINE,VMXUWOKSQNHOCA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485758,DTCC01089619,2025642,46191
CHEMBL1790041,P23975,RANITIDINE,VMXUWOKSQNHOCA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485759,DTCC01089619,2025642,46191
CHEMBL1790051,P23975,WIN-35065-2,LTKIILYBJZQLLW-QNIIYNMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,920,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955095,DTCC00034247,1295987,20957
CHEMBL1790051,P23975,WIN-35065-2,LTKIILYBJZQLLW-QNIIYNMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,550,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955094,DTCC00034247,1295987,20957
CHEMBL1790051,P23975,WIN-35065-2,LTKIILYBJZQLLW-QNIIYNMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,556,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655385,DTCC00034247,1296888,30473
CHEMBL179166,P23975,SODIUM ORTHOVANAD,IHIXIJGXTJIKRB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7462730,DTCC00382287,217586,46191
CHEMBL179166,P23975,SODIUM ORTHOVANAD,IHIXIJGXTJIKRB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7462731,DTCC00382287,217586,46191
CHEMBL179249,P23975,,YLQFFYJKBKUKLF-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19067522,KI,=,0.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,2009,52,1,"Zeng F, Mun J, Jarkas N, Stehouwer JS, Voll RJ, Tamagnan GD, Howell L, Votaw JR, Kilts CD, Nemeroff CB, Goodman MM",,560274,DTCT0023180,2450473,DTCC00383406,811902,31766
CHEMBL1794855,P23975,,RPZYOWNZYQHSLJ-SPIKMXEPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15203136,ACTIVITY,,,,,,,,,,,,,,,,,Binding towards norepinephrine transporter; NA= Not active,Not Active,"(+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents.",Bioorg. Med. Chem. Lett.,2004,14,14,"Dukat M, Taroua M, Dahdouh A, Siripurapu U, Damaj MI, Martin BR, Glennon RA",,143136,DTCT0023180,1179901,DTCC01091119,1176028,6518
CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11454918,KI,=,15.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736025,DTCC00383453,2105849,69315
CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845,KI,=,11,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736026,DTCC00383453,2105848,68736
CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447044,DTCC00383453,1362808,30886
CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19067522,KI,=,1.04,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,2009,52,1,"Zeng F, Mun J, Jarkas N, Stehouwer JS, Voll RJ, Tamagnan GD, Howell L, Votaw JR, Kilts CD, Nemeroff CB, Goodman MM",,560274,DTCT0023180,2450472,DTCC00383453,1362421,31766
CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,3.1,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901947,DTCC00383453,1374683,35305
CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,0.3,NM,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake at NET,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603447,DTCT0023180,3155569,DTCC00383453,669727,36729
CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800437,DTCC00383453,1366045,53876
CHEMBL180630,P23975,,LRAFIWLBFGAPRJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853306,DTCC00383031,1393564,19894
CHEMBL180630,P23975,,LRAFIWLBFGAPRJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20034793,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,Not Determined,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,2010,20,3,"Marcin LR, Mattson RJ, Gao Q, Wu D, Molski TF, Mattson GK, Lodge NJ",,610435,DTCT0023180,3195437,DTCC00383031,1407648,37394
CHEMBL180672,P23975,SB-262470,PZUJQWHTIRWCID-HXUWFJFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821575,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of NET,,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,21,"Marquis RW, Lago AM, Callahan JF, Rahman A, Dong X, Stroup GB, Hoffman S, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Roethke T, Smith BR, Ward KW, Bhatnagar P",,591455,DTCT0023180,3056367,DTCC00000727,456905,35717
CHEMBL1807053,P23975,,PSUFQBRCUSJTDO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21618986,INHIBITION,>,16,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 4 uM,,Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.,J. Med. Chem.,2011,54,12,"Hodgetts KJ, Ge P, Yoon T, De Lombaert S, Brodbeck R, Gulianello M, Kieltyka A, Horvath RF, Kehne JH, Krause JE, Maynard GD, Hoffman D, Lee Y, Fung L, Doller D",,757661,DTCT0023180,6037414,DTCC00128477,1908226,45246
CHEMBL1808424,P23975,,PQQHOBXFKJXQAU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21724392,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,15,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759483,DTCT0023180,6029650,DTCC01098485,216595,45305
CHEMBL1808425,P23975,,IISCUUOMDCMADJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21724392,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,15,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759483,DTCT0023180,6029661,DTCC01098486,735258,45305
CHEMBL1808426,P23975,,BSUNLXLBVQPAFJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21724392,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,15,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759483,DTCT0023180,6029673,DTCC01098487,1187041,45305
CHEMBL1808432,P23975,,FEJYXUSNDZMQOV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21724392,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,15,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759483,DTCT0023180,6029684,DTCC01098493,735260,45305
CHEMBL1808433,P23975,,JEZVWAQXXDFILV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21724392,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,15,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759483,DTCT0023180,6029695,DTCC01098494,1091327,45305
CHEMBL1808437,P23975,,BZMIEAZWZMSACC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21724392,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,15,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759483,DTCT0023180,6029706,DTCC01098498,1991784,45305
CHEMBL181,P23975,DIAZOXIDE,GDLBFKVLRPITMI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7365945,DTCC00110806,800574,46191
CHEMBL181,P23975,DIAZOXIDE,GDLBFKVLRPITMI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7365946,DTCC00110806,800574,46191
CHEMBL181188,P23975,,VWKLNUPRXXIKKE-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17983754,KI,=,0.76,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,2008,16,2,"Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,466322,DTCT0023180,2290055,DTCC00383399,310508,25467
CHEMBL1812545,P23975,,JDBSZVDIUIRSDG-DAFODLJHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21726069,INHIBITION,<,10,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NE transporter at 10 uM relative to control,,"Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.",J. Med. Chem.,2011,54,15,"Dolusic E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R",,762045,DTCT0023180,6053739,DTCC01099864,1959018,45491
CHEMBL1812739,P23975,,YKXMGNSTADTLNN-MLHJIOFPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,52,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049259,DTCC01100056,1875917,45377
CHEMBL1812740,P23975,,LBLVIDUIWXYVNG-AITUJVMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,122,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049258,DTCC01100057,231074,45377
CHEMBL1812741,P23975,,JZWBQZKHNDUSFQ-XFKSJGNHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049257,DTCC01100058,684897,45377
CHEMBL1812742,P23975,,MUVQRHMVRFZUGP-IKJKNFHUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,310,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049256,DTCC01100059,1105589,45377
CHEMBL1812743,P23975,,MZBDCJWEXVZTQQ-AYEZKCMBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049255,DTCC01100060,1461216,45377
CHEMBL1812744,P23975,,ZONWPEAFLDQJPL-KKXYHZGYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049254,DTCC01100061,846808,45377
CHEMBL1812745,P23975,,VMITZEMDDZVHBZ-XNISGKROSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,1.1,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049253,DTCC01100062,1493704,45377
CHEMBL1812746,P23975,,YBVYVIFNGYOFSX-MXYBEHONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,0.9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049252,DTCC01100063,1623017,45377
CHEMBL1812747,P23975,,ZSEXNBSYJGXEIW-MGTHKWJCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,6.3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049251,DTCC01100064,1137892,45377
CHEMBL1812748,P23975,,QGJBJCQWBZDANK-WGWURMLHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,14,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049250,DTCC01100065,1331810,45377
CHEMBL1812749,P23975,,VMITZEMDDZVHBZ-UGQVUOCMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,6.5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049249,DTCC01100066,1266674,45377
CHEMBL1812750,P23975,,QDZIBQWKRRRXAL-VIRABCJISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,0.5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049248,DTCC01100067,620374,45377
CHEMBL1813306,P23975,,FCMFWPCHZOKPLR-NHYWBVRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,912.01,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040578,DTCC01100576,1396922,45500
CHEMBL1813307,P23975,,KOMUTRYSVZSJSV-LSDHHAIUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,562.34,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040577,DTCC01100577,1940433,45500
CHEMBL1813308,P23975,,KEIRMFURGIUOGY-SWLSCSKDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,2344.23,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040579,DTCC01100578,101987,45500
CHEMBL1813309,P23975,,NBIXVIPZQQXWBM-GOEBONIOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,2454.71,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040580,DTCC01100579,231082,45500
CHEMBL1813310,P23975,,GVWVNROHWPGGAQ-GOEBONIOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,14125.38,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040581,DTCC01100580,329262,45500
CHEMBL1813311,P23975,,ANLYZSJGJNCZJB-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,5888.44,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040582,DTCC01100581,652849,45500
CHEMBL1813312,P23975,,JUHGVUXNNZSORA-LPHOPBHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,416.87,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040583,DTCC01100582,1105599,45500
CHEMBL1813312,P23975,,JUHGVUXNNZSORA-LPHOPBHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,>,10000,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040589,DTCC01100582,1105600,45500
CHEMBL1813313,P23975,,BIDMNSYJUSJTRE-RBUKOAKNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,537.03,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040584,DTCC01100583,781533,45500
CHEMBL1813313,P23975,,BIDMNSYJUSJTRE-RBUKOAKNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,724.44,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040591,DTCC01100583,781534,45500
CHEMBL1813314,P23975,,FEYNATNTSNGKKO-DOMZBBRYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,56.23,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040585,DTCC01100584,652850,45500
CHEMBL1813315,P23975,,FEYNATNTSNGKKO-SWLSCSKDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,141.25,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040586,DTCC01100585,813918,45500
CHEMBL1813316,P23975,,KVTPLEPXMVVCIZ-CJNGLKHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,26.92,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040587,DTCC01100586,813919,45500
CHEMBL1813317,P23975,,KVTPLEPXMVVCIZ-XJKSGUPXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,38.02,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040588,DTCC01100587,361893,45500
CHEMBL1813318,P23975,,JUHGVUXNNZSORA-VQIMIIECSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,204.17,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040590,DTCC01100588,1429150,45500
CHEMBL1813470,P23975,,BIDMNSYJUSJTRE-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,537.03,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040592,DTCC01100734,813923,45500
CHEMBL1813471,P23975,,UIBIRCANCAKLIN-SMDDNHRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,112.2,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040619,DTCC01100735,101990,45500
CHEMBL1813471,P23975,,UIBIRCANCAKLIN-SMDDNHRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,177.83,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040621,DTCC01100735,101991,45500
CHEMBL1813472,P23975,,UIBIRCANCAKLIN-RISCZKNCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,204.17,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040620,DTCC01100736,17151,45500
CHEMBL1813473,P23975,,UIBIRCANCAKLIN-BXUZGUMPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,2137.96,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040623,DTCC01100737,1461228,45500
CHEMBL1813473,P23975,,UIBIRCANCAKLIN-BXUZGUMPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,6025.6,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040622,DTCC01100737,1461227,45500
CHEMBL1813474,P23975,,ZOSQXAHBYHMVCA-GXFFZTMASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,208.93,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040624,DTCC01100738,1266681,45500
CHEMBL1813475,P23975,,ZOSQXAHBYHMVCA-MFKMUULPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,107.15,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040625,DTCC01100739,1779212,45500
CHEMBL1813476,P23975,,KZCROLYCBADBTI-DLBZAZTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,14.13,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040626,DTCC01100740,198584,45500
CHEMBL1813477,P23975,,KZCROLYCBADBTI-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,60.26,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040627,DTCC01100741,749580,45500
CHEMBL1813478,P23975,,RCJIOMDJRBCHJE-SMDDNHRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,23.99,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040648,DTCC01100742,1526027,45500
CHEMBL1813478,P23975,,RCJIOMDJRBCHJE-SMDDNHRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,95.5,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040654,DTCC01100742,1526028,45500
CHEMBL1813479,P23975,,ITPUGBSWGNTRDI-SMDDNHRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,6456.54,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040649,DTCC01100743,1364489,45500
CHEMBL1813480,P23975,,OQMBCBJEQWFPSN-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,>,10000,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040650,DTCC01100744,1007965,45500
CHEMBL1813481,P23975,,ZUYOKFFWVNAACC-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,>,10000,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040651,DTCC01100745,1072837,45500
CHEMBL1813482,P23975,,KXQVOLBRJCPHMW-HZMBPMFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,4265.8,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040652,DTCC01100746,555858,45500
CHEMBL1813483,P23975,,QSOVYEIFTQKDEW-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,208.93,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040656,DTCC01100747,749582,45500
CHEMBL1813483,P23975,,QSOVYEIFTQKDEW-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,467.74,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040653,DTCC01100747,749581,45500
CHEMBL1813484,P23975,,RCJIOMDJRBCHJE-RISCZKNCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,22.39,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040655,DTCC01100748,1940436,45500
CHEMBL1813485,P23975,,QSOVYEIFTQKDEW-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,190.55,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040657,DTCC01100749,587981,45500
CHEMBL1813486,P23975,,CHWUQEOFMAPDHN-BBRMVZONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,4466.84,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040669,DTCC01100750,427207,45500
CHEMBL1813487,P23975,,CHWUQEOFMAPDHN-CZUORRHYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,3801.89,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040672,DTCC01100751,1718637,45500
CHEMBL1813488,P23975,,MEAWOAPXKTVYPU-WFASDCNBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,5370.32,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040675,DTCC01100752,1687294,45500
CHEMBL1813489,P23975,,MEAWOAPXKTVYPU-IUODEOHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,2951.21,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6040679,DTCC01100753,1526029,45500
CHEMBL1818218,P23975,PF-4840154,PPANZCQXFYBGHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21741838,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of noradrenaline transporter at 2.8 uM,,"Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.",Bioorg. Med. Chem. Lett.,2011,21,16,"Ryckmans T, Aubdool AA, Bodkin JV, Cox P, Brain SD, Dupont T, Fairman E, Hashizume Y, Ishii N, Kato T, Kitching L, Newman J, Omoto K, Rawson D, Strover J",,763639,DTCT0023180,6065504,DTCC00034645,1687311,45601
CHEMBL1818441,P23975,,GRCVTMNCDBAKJY-GFOWMXPYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,50.12,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065958,DTCC01102611,1137918,45533
CHEMBL1818442,P23975,AMITIFADINE HYDROCHLORIDE,KAGBHVBIOJBGBD-NINOIYOQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,63.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065304,DTCC01102612,1137919,45533
CHEMBL1818442,P23975,AMITIFADINE HYDROCHLORIDE,KAGBHVBIOJBGBD-NINOIYOQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,IC50,=,71,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275,DTCT0023180,10527341,DTCC01102612,1138569,48646
CHEMBL1818443,P23975,,HHRJGTNXMGSJLB-HZPDHXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,6.31,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065309,DTCC01102613,620410,45533
CHEMBL1818444,P23975,,KUJKCGJIUCGPED-HZPDHXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,0.398,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065310,DTCC01102614,1169080,45533
CHEMBL1818445,P23975,,KUJKCGJIUCGPED-AAFJCEBUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,0.398,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065311,DTCC01102615,69740,45533
CHEMBL1818445,P23975,,KUJKCGJIUCGPED-AAFJCEBUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,31.62,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065312,DTCC01102615,69739,45533
CHEMBL1818446,P23975,,AMIXKESLNNOGEZ-HZPDHXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,39.81,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065313,DTCC01102616,427237,45533
CHEMBL1818447,P23975,,OVVOKUDGMQGUQG-HUUCEWRRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,31.62,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065314,DTCC01102617,2070790,45533
CHEMBL1818448,P23975,,KMNJYBBPXRFSBY-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,0.631,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065315,DTCC01102618,134399,45533
CHEMBL1818449,P23975,,XAKHVFLBNVAXLY-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,31.62,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065316,DTCC01102619,1747197,45533
CHEMBL1818450,P23975,,GTRIRKWLHVGYGS-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,25.12,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065317,DTCC01102620,1233828,45533
CHEMBL1818451,P23975,,VUEZBOYAXGKAME-ZYMOGRSISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,3.16,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065319,DTCC01102621,394665,45533
CHEMBL1818451,P23975,,VUEZBOYAXGKAME-ZYMOGRSISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,1000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065318,DTCC01102621,394664,45533
CHEMBL1818452,P23975,,FTQFUQZSKDXZNW-ZYMOGRSISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,1.58,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065321,DTCC01102622,1233830,45533
CHEMBL1818452,P23975,,FTQFUQZSKDXZNW-ZYMOGRSISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,316.23,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065320,DTCC01102622,1233829,45533
CHEMBL1818453,P23975,,ZKPUOIMTKQGENL-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,79.43,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065322,DTCC01102623,1266701,45533
CHEMBL1818454,P23975,,FYXXTOJUMHTXEW-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,1.58,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065323,DTCC01102624,943442,45533
CHEMBL1818455,P23975,,FYXXTOJUMHTXEW-QRWMCTBCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065325,DTCC01102625,813945,45533
CHEMBL1818455,P23975,,FYXXTOJUMHTXEW-QRWMCTBCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,501.19,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065324,DTCC01102625,813944,45533
CHEMBL1818456,P23975,,LWFZPUPJSMFIKP-HZPDHXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,10,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065326,DTCC01102626,1623043,45533
CHEMBL1818457,P23975,,VQZCUVHOYIJXAO-HZPDHXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,158.49,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065327,DTCC01102627,555878,45533
CHEMBL1818458,P23975,,VQEHAMZDBNCIFO-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,31.62,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065328,DTCC01102628,2039000,45533
CHEMBL1818459,P23975,,YBZZUBMYXLOQMZ-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,25.12,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065329,DTCC01102629,1908286,45533
CHEMBL1818460,P23975,,QYAZFPSPLQVWMZ-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,25.12,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065330,DTCC01102630,1364520,45533
CHEMBL1818461,P23975,,YEAGKKNHGFQLKI-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,10,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065331,DTCC01102631,1266702,45533
CHEMBL1818462,P23975,,JQQXRQMPNKINQO-WOJBJXKFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,50.12,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065332,DTCC01102632,491487,45533
CHEMBL1818463,P23975,,AJFRCYMRJNJFPE-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,10,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065333,DTCC01102633,166684,45533
CHEMBL1818464,P23975,,GUIDCAHCXPHFSP-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,39.81,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065334,DTCC01102634,1072858,45533
CHEMBL1818465,P23975,,HBZMBTZPNQEKHQ-QRWMCTBCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,31.62,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065335,DTCC01102635,1718656,45533
CHEMBL1818466,P23975,,SOSAAAUSVCKKRE-QRWMCTBCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,39.81,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065948,DTCC01102636,134400,45533
CHEMBL1818467,P23975,,AFOUVNVDHQZVBK-RTBURBONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,19.95,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065949,DTCC01102637,1623044,45533
CHEMBL1818468,P23975,,KWIJNWQXQHEXSP-RTBURBONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,19.95,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065950,DTCC01102638,911933,45533
CHEMBL1818469,P23975,,YPIFSSZDJKDNEK-HUUCEWRRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,100,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065951,DTCC01102639,1940461,45533
CHEMBL1818542,P23975,,WDNOUFVJCUYSDQ-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,39.81,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065952,DTCC01102707,17206,45533
CHEMBL1818543,P23975,,WDNOUFVJCUYSDQ-ZYMOGRSISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,25.12,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065953,DTCC01102708,1461249,45533
CHEMBL1818543,P23975,,WDNOUFVJCUYSDQ-ZYMOGRSISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,1584.89,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065954,DTCC01102708,1461250,45533
CHEMBL1818544,P23975,,IYUTUTQAPBTSKQ-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,398.11,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065955,DTCC01102709,1526058,45533
CHEMBL1818545,P23975,,PHRHUWNKARHRNO-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,398.11,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065956,DTCC01102710,1266703,45533
CHEMBL1818546,P23975,,AJRLLMMPWPRYOM-BPGUCPLFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,63.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065957,DTCC01102711,1201353,45533
CHEMBL1818547,P23975,,HRCVSENKVJEEJB-GFOWMXPYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,50.12,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065959,DTCC01102712,1396951,45533
CHEMBL182,P23975,GANCICLOVIR,IRSCQMHQWWYFCW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7314370,DTCC00437788,639580,46191
CHEMBL182,P23975,GANCICLOVIR,IRSCQMHQWWYFCW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7314371,DTCC00437788,639580,46191
CHEMBL1824777,P23975,,ZHHLHBNBIKLLJG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21788137,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET transporter at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767217,DTCT0023180,6091822,DTCC01106515,961498,45468
CHEMBL1824778,P23975,,LPAMOYXJLQSGRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21788137,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET transporter by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767228,DTCT0023180,6074480,DTCC01106516,1058448,45468
CHEMBL1824784,P23975,,HXOMGUPFBWZKBK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21788137,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET transporter by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767228,DTCT0023180,6074481,DTCC01106522,638709,45468
CHEMBL1824785,P23975,,ZILQWXOKQUVSTI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21788137,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET transporter by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767228,DTCT0023180,6074482,DTCC01106523,1640941,45468
CHEMBL1828653,P23975,,MZTLLFJYLUUPPP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093958,DTCC01109121,1091444,45987
CHEMBL1828653,P23975,,MZTLLFJYLUUPPP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,22,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093954,DTCC01109121,1091444,45987
CHEMBL1829335,P23975,IRDABISANT,XUKROCVZGZNGSI-CQSZACIVSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21634396,IC50,=,17500,NM,,,,,,,,,,,,,,Inhibition of recombinant human norepinephrine transporter,,"Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.",J. Med. Chem.,2011,54,13,"Hudkins RL, Raddatz R, Tao M, Mathiasen JR, Aimone LD, Becknell NC, Prouty CP, Knutsen LJ, Yazdanian M, Moachon G, Ator MA, Mallamo JP, Marino MJ, Bacon ER, Williams M",,761643,DTCT0023180,6055967,DTCC01107613,1558037,45444
CHEMBL1829335,P23975,IRDABISANT,XUKROCVZGZNGSI-CQSZACIVSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21634396,KI,=,10000,NM,,,,,,,,,,,,,,Inhibition of norepinephrine transporter ,,"Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.",J. Med. Chem.,2011,54,13,"Hudkins RL, Raddatz R, Tao M, Mathiasen JR, Aimone LD, Becknell NC, Prouty CP, Knutsen LJ, Yazdanian M, Moachon G, Ator MA, Mallamo JP, Marino MJ, Bacon ER, Williams M",,761553,DTCT0023180,6055963,DTCC01107613,1558037,45444
CHEMBL1829477,P23975,,YVXDOSIKSIZMGR-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21782432,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity.",Bioorg. Med. Chem. Lett.,2011,21,18,"Hudkins RL, Aimone LD, Bailey TR, Bendesky RJ, Dandu RR, Dunn D, Gruner JA, Josef KA, Lin YG, Lyons J, Marcy VR, Mathiasen JR, Sundar BG, Tao M, Zulli AL, Raddatz R, Bacon ER",,768664,DTCT0023180,6102856,DTCC01107755,1558132,45869
CHEMBL1829485,P23975,,VHKZHZYOGPESQF-JKSUJKDBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21782432,INHIBITION,=,19,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity.",Bioorg. Med. Chem. Lett.,2011,21,18,"Hudkins RL, Aimone LD, Bailey TR, Bendesky RJ, Dandu RR, Dunn D, Gruner JA, Josef KA, Lin YG, Lyons J, Marcy VR, Mathiasen JR, Sundar BG, Tao M, Zulli AL, Raddatz R, Bacon ER",,768664,DTCT0023180,6102857,DTCC01107763,394710,45869
CHEMBL1830875,P23975,,LFTRJEGVGRCFEP-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,103,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093892,DTCC01109107,573751,45987
CHEMBL1830875,P23975,,LFTRJEGVGRCFEP-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,151,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093907,DTCC01109107,573751,45987
CHEMBL1830876,P23975,,LFTRJEGVGRCFEP-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,13,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093891,DTCC01109108,1219339,45987
CHEMBL1830876,P23975,,LFTRJEGVGRCFEP-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,27,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093904,DTCC01109108,1219339,45987
CHEMBL1830877,P23975,,QVFGNQQNMCPCBY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093890,DTCC01109109,1608620,45987
CHEMBL1830877,P23975,,QVFGNQQNMCPCBY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,18,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093903,DTCC01109109,1608620,45987
CHEMBL1830878,P23975,,QVFGNQQNMCPCBY-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,9,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093889,DTCC01109110,606046,45987
CHEMBL1830878,P23975,,QVFGNQQNMCPCBY-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,13,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093902,DTCC01109110,606046,45987
CHEMBL1830879,P23975,,QVFGNQQNMCPCBY-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093888,DTCC01109111,1285021,45987
CHEMBL1830879,P23975,,QVFGNQQNMCPCBY-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,11,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093901,DTCC01109111,1285021,45987
CHEMBL1830880,P23975,,HTXNJLFLQDPRHG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,74,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093887,DTCC01109112,380121,45987
CHEMBL1830880,P23975,,HTXNJLFLQDPRHG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,147,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093900,DTCC01109112,380121,45987
CHEMBL1830881,P23975,,HTXNJLFLQDPRHG-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,207,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093899,DTCC01109113,1861758,45987
CHEMBL1830881,P23975,,HTXNJLFLQDPRHG-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,Not Determined,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093886,DTCC01109113,1861758,45987
CHEMBL1830882,P23975,,HTXNJLFLQDPRHG-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,199,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093898,DTCC01109114,1382859,45987
CHEMBL1830882,P23975,,HTXNJLFLQDPRHG-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,Not Determined,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093885,DTCC01109114,1382859,45987
CHEMBL1830883,P23975,,HRZCVADZOIJDCK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,2304,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093884,DTCC01109115,184629,45987
CHEMBL1830883,P23975,,HRZCVADZOIJDCK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,4310,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093897,DTCC01109115,184629,45987
CHEMBL1830884,P23975,,HXPJUTFPDVBIKT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093883,DTCC01109116,1219340,45987
CHEMBL1830884,P23975,,HXPJUTFPDVBIKT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,54,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093896,DTCC01109116,1219340,45987
CHEMBL1830885,P23975,WYE-114152,UIKJCHWTULEUKX-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093928,DTCC00034789,1894061,45987
CHEMBL1830885,P23975,WYE-114152,UIKJCHWTULEUKX-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,15,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093923,DTCC00034789,1894061,45987
CHEMBL1830886,P23975,,XPDPSRJQWMZUMS-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,89,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093924,DTCC01109117,767556,45987
CHEMBL1830886,P23975,,XPDPSRJQWMZUMS-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,99,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093929,DTCC01109117,767556,45987
CHEMBL1830887,P23975,,KKELNYPZMKZDOL-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,283,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093930,DTCC01109118,1058473,45987
CHEMBL1830887,P23975,,KKELNYPZMKZDOL-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,611,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093925,DTCC01109118,1058473,45987
CHEMBL1830888,P23975,,GRFGQBNGPFNYCF-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,143,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093932,DTCC01109119,1861759,45987
CHEMBL1830888,P23975,,GRFGQBNGPFNYCF-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,199,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093926,DTCC01109119,1861759,45987
CHEMBL1830889,P23975,,IODCZMRTDNJNCT-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,80,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093933,DTCC01109120,347487,45987
CHEMBL1830889,P23975,,IODCZMRTDNJNCT-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,91,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093927,DTCC01109120,347487,45987
CHEMBL1830890,P23975,,VOAKSCZKUWRXKS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,8,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093959,DTCC01109122,541693,45987
CHEMBL1830890,P23975,,VOAKSCZKUWRXKS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,14,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093955,DTCC01109122,541693,45987
CHEMBL1830891,P23975,,DKFCBQMDHKALKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,120,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093956,DTCC01109123,1894062,45987
CHEMBL1830891,P23975,,DKFCBQMDHKALKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,209,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093960,DTCC01109123,1894062,45987
CHEMBL1830892,P23975,,HMXOXSKENXHTKZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,7,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093957,DTCC01109124,120069,45987
CHEMBL1830892,P23975,,HMXOXSKENXHTKZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,13,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093961,DTCC01109124,120069,45987
CHEMBL1831166,P23975,,SAUWBVJOXSKPQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21899931,KI,=,1350,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Synthesis and pharmacological evaluation of indole-based sigma receptor ligands.,Eur. J. Med. Chem.,2011,46,10,"Mésangeau C, Amata E, Alsharif W, Seminerio MJ, Robson MJ, Matsumoto RR, Poupaert JH, McCurdy CR",,769365,DTCT0023180,6108053,DTCC01109384,897450,45976
CHEMBL1834184,P23975,,YNFDIGJKJPNFFD-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21873051,INHIBITION,=,9,%,,,,,,,,,,,,,,Binding affinity to human NET at 10 uM by radioligand binding assay,,"Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.",Bioorg. Med. Chem. Lett.,2011,21,19,"Kley JT, Mack J, Hamilton B, Scheuerer S, Redemann N",,771381,DTCT0023180,6119812,DTCC01109702,1526121,46053
CHEMBL183470,P23975,,UMYMNRFUWNCPOG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15456270,KI,=,20,NM,,cell_based,,,,,,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,2004,47,21,"Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP",,303519,DTCT0023180,1792713,DTCC00393031,1619496,19119
CHEMBL1835609,P23975,,UBQRACCCHXXOJB-ZOWNYOTGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21905669,INHIBITION,=,14.2,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM by radioligand displacement assay,,Discovery of Isoxazole Analogues of Sazetidine-A as Selective a4ß2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression.,J. Med. Chem.,2011,54,20,"Liu J, Yu LF, Eaton JB, Caldarone B, Cavino K, Ruiz C, Terry M, Fedolak A, Wang D, Ghavami A, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,772132,DTCT0023180,6125244,DTCC01111063,1285033,46123
CHEMBL1835782,P23975,,CWDYYODRDVPEOW-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21906941,INHIBITION,=,60,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 10 uM,,"Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2011,21,20,"Tao M, Raddatz R, Aimone LD, Hudkins RL",,772507,DTCT0023180,6126481,DTCC01111234,1008054,46126
CHEMBL1836644,P23975,,DVDGHCLLWLHYLG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21863888,KI,=,6.8,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET receptor,,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771726,DTCT0023180,6112793,DTCC01112009,1479486,46044
CHEMBL1836645,P23975,,IUTQZHKFJYKMRH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21863888,KI,,,,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET receptor,Not Determined,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771726,DTCT0023180,6112792,DTCC01112010,1544021,46044
CHEMBL1836646,P23975,,ITXRGZRPRZJEGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21863888,KI,=,2900,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET receptor,,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771726,DTCT0023180,6112794,DTCC01112011,1058505,46044
CHEMBL184,P23975,ACYCLOVIR,MKUXAQIIEYXACX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7288344,DTCC00438001,51442,46191
CHEMBL184,P23975,ACYCLOVIR,MKUXAQIIEYXACX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7288345,DTCC00438001,51442,46191
CHEMBL184238,P23975,URB597,ROFVXGGUISEHAM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16352709,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14740664,DTCC00000860,2107472,69711
CHEMBL184618,P23975,NEOMYCIN,PGBHMTALBVVCIT-VCIWKGPPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7403280,DTCC00392052,1894971,46191
CHEMBL184618,P23975,NEOMYCIN,PGBHMTALBVVCIT-VCIWKGPPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7403281,DTCC00392052,1894971,46191
CHEMBL185,P23975,FLUOROURACIL,GHASVSINZRGABV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318413,DTCC00440753,51471,46191
CHEMBL185,P23975,FLUOROURACIL,GHASVSINZRGABV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318414,DTCC00440753,51471,46191
CHEMBL186056,P23975,,BRZFVBLWHJLYPD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15456270,KI,=,17,NM,,cell_based,,,,,,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,2004,47,21,"Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP",,303519,DTCT0023180,1793399,DTCC00393193,358289,19119
CHEMBL186962,P23975,,FXPKVPDERQMXMV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15456270,KI,=,286,NM,,cell_based,,,,,,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,2004,47,21,"Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP",,303519,DTCT0023180,1793095,DTCC00393344,454646,19119
CHEMBL18701,P23975,RO-201724,PDMUULPVBYQBBK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473064,DTCC00149559,1674149,46191
CHEMBL18701,P23975,RO-201724,PDMUULPVBYQBBK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473065,DTCC00149559,1674149,46191
CHEMBL187093,P23975,,KCKIWWYHRZPHRB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15380202,INHIBITION,=,68,%,,,,,,,,,,,,,,Inhibitory activity against Norepinephrine transporter at 10 uM,,4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists.,Bioorg. Med. Chem. Lett.,2004,14,20,"Receveur JM, Bjurling E, Ulven T, Little PB, Nørregaard PK, Högberg T",,307690,DTCT0023180,1772670,DTCC00389652,1263074,18270
CHEMBL1873703,P23975,DIELDRIN,DFBKLUNHFCTMDC-PICURKEMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357427,DTCC01123582,800575,46191
CHEMBL1873703,P23975,DIELDRIN,DFBKLUNHFCTMDC-PICURKEMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357428,DTCC01123582,800575,46191
CHEMBL187935,P23975,,OFFZXSBVSKRSFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,194,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809539,DTCC00395927,1501748,19300
CHEMBL18797,P23975,SULINDAC SULFIDE,LFWHFZJPXXOYNR-MFOYZWKCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7461073,DTCC00150119,994595,46191
CHEMBL18797,P23975,SULINDAC SULFIDE,LFWHFZJPXXOYNR-MFOYZWKCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7461074,DTCC00150119,994595,46191
CHEMBL1885748,P23975,,JQSJAVBMIMDUFO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23642479,INHIBITION,=,59,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM relative to control,,Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.,Bioorg. Med. Chem. Lett.,2013,23,12,"Coombs TC, Tanega C, Shen M, Wang JL, Auld DS, Gerritz SW, Schoenen FJ, Thomas CJ, Aubé J",,965549,DTCT0023180,12471419,DTCC01135294,545285,54833
CHEMBL188921,P23975,BUFLOMEDIL,OWYLAEYXIQKAOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277431,DTCC00395665,1188065,46191
CHEMBL188921,P23975,BUFLOMEDIL,OWYLAEYXIQKAOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277432,DTCC00395665,1188065,46191
CHEMBL188964,P23975,,LOONKLFFRKQSJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,946.2,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822332,DTCC00395928,972094,19630
CHEMBL188964,P23975,,LOONKLFFRKQSJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,>,5000,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809542,DTCC00395928,983787,19300
CHEMBL189,P23975,MILRINONE,PZRHRDRVRGEVNW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7421945,DTCC00450749,930081,46191
CHEMBL189,P23975,MILRINONE,PZRHRDRVRGEVNW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7421946,DTCC00450749,930081,46191
CHEMBL189171,P23975,ACEMETACIN,FSQKKOOTNAMONP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7296215,DTCC00393990,800567,46191
CHEMBL189171,P23975,ACEMETACIN,FSQKKOOTNAMONP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7296216,DTCC00393990,800567,46191
CHEMBL189367,P23975,,MUWHGPWUJGZMPM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,370,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809428,DTCC00396084,1469433,19300
CHEMBL189375,P23975,,XIVFNOGFYONSDE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,445.36,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809557,DTCC00395770,1630872,19300
CHEMBL18972,P23975,GLEMANSERIN,AXNGJCOYCMDPQG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15999145,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741921,DTCC00150824,2107870,69464
CHEMBL190,P23975,THEOPHYLLINE,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7463666,DTCC00451755,413979,46191
CHEMBL190,P23975,THEOPHYLLINE,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7463667,DTCC00451755,413979,46191
CHEMBL19019,P23975,NALTREXONE,DQCKKXVULJGBQN-XFWGSAIBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418158,DTCC00149948,88632,46191
CHEMBL19019,P23975,NALTREXONE,DQCKKXVULJGBQN-XFWGSAIBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418159,DTCC00149948,88632,46191
CHEMBL1902627,P23975,CLORPRENALINE,SSMSBSWKLKKXGG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347975,DTCC01151693,866018,46191
CHEMBL1902627,P23975,CLORPRENALINE,SSMSBSWKLKKXGG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347976,DTCC01151693,866018,46191
CHEMBL1902981,P23975,EPERISONE,SQUNAWUMZGQQJD-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304751,DTCC01152035,348399,46191
CHEMBL1902981,P23975,EPERISONE,SQUNAWUMZGQQJD-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304752,DTCC01152035,348399,46191
CHEMBL190573,P23975,,VGKDLMBJGBXTGI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14573386,KI,=,715,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741433,DTCC00399704,2107716,69056
CHEMBL190700,P23975,,USOGSVQPPWDNQD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,4.95,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809420,DTCC00395799,110001,19300
CHEMBL190703,P23975,,ROARIPXQVCVHPS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,269,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809424,DTCC00395800,142407,19300
CHEMBL1908355,P23975,TENIDAP,LXIKEPCNDFVJKC-QXMHVHEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7487141,DTCC01156858,1285881,46191
CHEMBL1908355,P23975,TENIDAP,LXIKEPCNDFVJKC-QXMHVHEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7487142,DTCC01156858,1285881,46191
CHEMBL190860,P23975,,ODXYYPIOITXURW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,141.7,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822323,DTCC00398944,746095,19630
CHEMBL1909048,P23975,,RBCUCXILXJXLTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290249,DTCC00128929,444633,46191
CHEMBL1909048,P23975,,RBCUCXILXJXLTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290250,DTCC00128929,444633,46191
CHEMBL1909049,P23975,,FSIWGHXVLYRBFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295693,DTCC00128930,930074,46191
CHEMBL1909049,P23975,,FSIWGHXVLYRBFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295694,DTCC00128930,930074,46191
CHEMBL1909050,P23975,,DLDAZIVPAOLETE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298505,DTCC01157054,413966,46191
CHEMBL1909050,P23975,,DLDAZIVPAOLETE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298506,DTCC01157054,413966,46191
CHEMBL1909051,P23975,,LUHHARLTABWBTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7300237,DTCC01157055,1480342,46191
CHEMBL1909051,P23975,,LUHHARLTABWBTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7300238,DTCC01157055,1480342,46191
CHEMBL1909054,P23975,CARBOXYMETHYLCELLULOSE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357864,DTCC01157056,768475,46191
CHEMBL1909054,P23975,CARBOXYMETHYLCELLULOSE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7357865,DTCC01157056,768475,46191
CHEMBL1909055,P23975,COBALTOUS CHLORIDE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367473,DTCC01157057,1992803,46191
CHEMBL1909055,P23975,COBALTOUS CHLORIDE,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367474,DTCC01157057,1992803,46191
CHEMBL1909056,P23975,COBALT(II) ACETYLACETONATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337383,DTCC01157058,736258,46191
CHEMBL1909056,P23975,COBALT(II) ACETYLACETONATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337384,DTCC01157058,736258,46191
CHEMBL1909057,P23975,COPPER(II) OXIDE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7354582,DTCC01157059,1318440,46191
CHEMBL1909057,P23975,COPPER(II) OXIDE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7354583,DTCC01157059,1318440,46191
CHEMBL1909062,P23975,LEAD (II) ACETATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418651,DTCC01157060,1609549,46191
CHEMBL1909062,P23975,LEAD (II) ACETATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418652,DTCC01157060,1609549,46191
CHEMBL1909063,P23975,LEAD(IV) ACETATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7422925,DTCC01157061,1765974,46191
CHEMBL1909063,P23975,LEAD(IV) ACETATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7422926,DTCC01157061,1765974,46191
CHEMBL1909064,P23975,LIPOPOLYSACCHARIDE E. COLI O55:B5,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410273,DTCC01157062,898291,46191
CHEMBL1909064,P23975,LIPOPOLYSACCHARIDE E. COLI O55:B5,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410274,DTCC01157062,898291,46191
CHEMBL1909065,P23975,LYSERGOL,RWVUEZAROXKXRT-VQLSFVLHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423399,DTCC01157063,510303,46191
CHEMBL1909065,P23975,LYSERGOL,RWVUEZAROXKXRT-VQLSFVLHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423400,DTCC01157063,510303,46191
CHEMBL1909067,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410573,DTCC01157064,1734058,46191
CHEMBL1909067,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410574,DTCC01157064,1734058,46191
CHEMBL1909068,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414893,DTCC01157065,1059333,46191
CHEMBL1909068,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414894,DTCC01157065,1059333,46191
CHEMBL1909069,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7419233,DTCC01157066,1253326,46191
CHEMBL1909069,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7419234,DTCC01157066,1253326,46191
CHEMBL1909070,P23975,NAFENOPIN,XJGBDJOMWKAZJS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7433020,DTCC01157067,866020,46191
CHEMBL1909070,P23975,NAFENOPIN,XJGBDJOMWKAZJS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7433021,DTCC01157067,866020,46191
CHEMBL1909071,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7405902,DTCC01157068,1765978,46191
CHEMBL1909071,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7405903,DTCC01157068,1765978,46191
CHEMBL1909072,P23975,PIPAMAZINE,OSJJYEUEJRVVOD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,450,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393815,DTCC01157069,1927019,46191
CHEMBL1909072,P23975,PIPAMAZINE,OSJJYEUEJRVVOD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,446,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393816,DTCC01157069,1927019,46191
CHEMBL1909073,P23975,PIPERILATE ETHOBROMIDE,VPUGSHLBERYQGC-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402426,DTCC01157070,348403,46191
CHEMBL1909073,P23975,PIPERILATE ETHOBROMIDE,VPUGSHLBERYQGC-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402427,DTCC01157070,348403,46191
CHEMBL1909074,P23975,POLYVINYLPYRROLIDONE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398227,DTCC01157071,1059338,46191
CHEMBL1909074,P23975,POLYVINYLPYRROLIDONE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398228,DTCC01157071,1059338,46191
CHEMBL1909075,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7379533,DTCC01157072,606972,46191
CHEMBL1909075,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7379534,DTCC01157072,606972,46191
CHEMBL1909076,P23975,,RSTSYGXUDMJEFP-SECBINFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473183,DTCC01157073,1894973,46191
CHEMBL1909076,P23975,,RSTSYGXUDMJEFP-SECBINFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473184,DTCC01157073,1894973,46191
CHEMBL1909078,P23975,SODIUM ARSENITE,PTLRDCMBXHILCL-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7488573,DTCC01157074,1351117,46191
CHEMBL1909078,P23975,SODIUM ARSENITE,PTLRDCMBXHILCL-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7488574,DTCC01157074,1351117,46191
CHEMBL1909079,P23975,STANNOUS FLUORIDE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456339,DTCC01157075,671794,46191
CHEMBL1909079,P23975,STANNOUS FLUORIDE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456340,DTCC01157075,671794,46191
CHEMBL1909080,P23975,STRONTIUM CHLORIDE HEXAHYDRATE,AMGRXJSJSONEEG-UHFFFAOYSA-L,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482507,DTCC01157076,1124455,46191
CHEMBL1909080,P23975,STRONTIUM CHLORIDE HEXAHYDRATE,AMGRXJSJSONEEG-UHFFFAOYSA-L,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482508,DTCC01157076,1124455,46191
CHEMBL1909083,P23975,ZIRCONIUM(IV) CHLORIDE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7451534,DTCC01157077,120980,46191
CHEMBL1909083,P23975,ZIRCONIUM(IV) CHLORIDE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7451535,DTCC01157077,120980,46191
CHEMBL190937,P23975,,IAGCXXVAWFKIDP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,787.4,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822326,DTCC00396111,293170,19630
CHEMBL190937,P23975,,IAGCXXVAWFKIDP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,303,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809432,DTCC00396111,304834,19300
CHEMBL190937,P23975,,IAGCXXVAWFKIDP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18085744,KI,=,303,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET t expressed in HEK293 cells,,"Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.",J. Med. Chem.,2008,51,2,"Jarkas N, Voll RJ, Williams L, Votaw JR, Owens M, Goodman MM",,460402,DTCT0023180,2268672,DTCC00396111,294051,24992
CHEMBL191,P23975,LOSARTAN,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7408195,DTCC00475883,1705876,46191
CHEMBL191,P23975,LOSARTAN,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7408196,DTCC00475883,1705876,46191
CHEMBL1914692,P23975,,LEESYDIUWLXOSV-DXCLHELWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21458259,KI,=,3855,NM,,cell_based,,,,,,,,,,,LLC-PK1,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,2011,21,10,"Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF",,785532,DTCT0023180,7517116,DTCC01159553,362142,46346
CHEMBL1914693,P23975,,DAXFTWVNVGRVQC-AFNJWWOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21458259,KI,=,16211,NM,,cell_based,,,,,,,,,,,LLC-PK1,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,2011,21,10,"Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF",,785532,DTCT0023180,7517115,DTCC01159554,2071000,46346
CHEMBL1914694,P23975,,DGHITSOFNGOFOI-AFNJWWOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21458259,KI,=,12090,NM,,cell_based,,,,,,,,,,,LLC-PK1,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,2011,21,10,"Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF",,785532,DTCT0023180,7517114,DTCC01159555,17616,46346
CHEMBL1914695,P23975,,SKIKZARVXIZUJL-DXCLHELWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21458259,KI,=,16877,NM,,cell_based,,,,,,,,,,,LLC-PK1,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,2011,21,10,"Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF",,785532,DTCT0023180,7517113,DTCC01159556,1747389,46346
CHEMBL1914696,P23975,,RZDYKEZBUSRGJW-UMQBVGHOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21458259,KI,=,29.1,NM,,cell_based,,,,,,,,,,,LLC-PK1,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,2011,21,10,"Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF",,785532,DTCT0023180,7517112,DTCC01159557,1590640,46346
CHEMBL1914697,P23975,,CSQWTWVZSNGFRN-IAFLDTSXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21458259,KI,=,49.1,NM,,cell_based,,,,,,,,,,,LLC-PK1,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,2011,21,10,"Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF",,785532,DTCT0023180,7517111,DTCC01159558,1332061,46346
CHEMBL1914698,P23975,,DZCYWZREDUKUMT-IAFLDTSXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21458259,KI,=,27.7,NM,,cell_based,,,,,,,,,,,LLC-PK1,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,2011,21,10,"Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF",,785532,DTCT0023180,7517110,DTCC01159559,394864,46346
CHEMBL1914699,P23975,,QWGVIOYTQRTWPO-UMQBVGHOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21458259,KI,=,66.2,NM,,cell_based,,,,,,,,,,,LLC-PK1,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,2011,21,10,"Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF",,785532,DTCT0023180,7517109,DTCC01159560,847044,46346
CHEMBL192,P23975,SILDENAFIL,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7475728,DTCC00477686,639584,46191
CHEMBL192,P23975,SILDENAFIL,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7475729,DTCC00477686,639584,46191
CHEMBL19215,P23975,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20451398,ACTIVITY,=,1132,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human cloned NET,,Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.,Bioorg. Med. Chem.,2010,18,22,"Hooker JM, Kim SW, Reibel AT, Alexoff D, Xu Y, Shea C",,681154,DTCT0023180,3578670,DTCC00150357,296043,41784
CHEMBL19215,P23975,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,366,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415123,DTCC00150357,315666,46191
CHEMBL19215,P23975,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,363,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415124,DTCC00150357,315666,46191
CHEMBL19224,P23975,PAPAVERINE,XQYZDYMELSJDRZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7404052,DTCC00150178,1351115,46191
CHEMBL19224,P23975,PAPAVERINE,XQYZDYMELSJDRZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7404053,DTCC00150178,1351115,46191
CHEMBL1923307,P23975,,PCZMXCGDABFVFX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22078214,INHIBITION,>,80,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 10 uM,,Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2.,Bioorg. Med. Chem. Lett.,2011,21,24,"Brumfield S, Matasi JJ, Tulshian D, Czarniecki M, Greenlee W, Garlisi C, Qiu H, Devito K, Chen SC, Sun Y, Bertorelli R, Ansell J, Geiss W, Le VD, Martin GS, Vellekoop SA, Haber J, Allard ML",,790235,DTCT0023180,7548192,DTCC01164107,800661,46652
CHEMBL19236,P23975,MOXONIDINE,WPNJAUFVNXKLIM-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428610,DTCC00150160,1894970,46191
CHEMBL19236,P23975,MOXONIDINE,WPNJAUFVNXKLIM-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428611,DTCC00150160,1894970,46191
CHEMBL192528,P23975,,OGVZXKWRLUGGKA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,3910,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822455,DTCC00399036,66281,19630
CHEMBL192619,P23975,,BXZSHOGOEKAIFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,7552,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822452,DTCC00399007,1328342,19630
CHEMBL192824,P23975,,KTFFRYZZEFRULN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,7036,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822320,DTCC00399208,1619565,19630
CHEMBL19299,P23975,LOXOPROFEN,YMBXTVYHTMGZDW-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414809,DTCC00151156,1960076,46191
CHEMBL19299,P23975,LOXOPROFEN,YMBXTVYHTMGZDW-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414810,DTCC00151156,1960076,46191
CHEMBL193,P23975,NIFEDIPINE,HYIMSNHJOBLJNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399050,DTCC00485676,51493,46191
CHEMBL193,P23975,NIFEDIPINE,HYIMSNHJOBLJNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399051,DTCC00485676,51493,46191
CHEMBL193482,P23975,ESTRIOL,PROQIPRRNZUXQM-ZXXIGWHRSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7311415,DTCC00405591,348401,46191
CHEMBL193482,P23975,ESTRIOL,PROQIPRRNZUXQM-ZXXIGWHRSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7311416,DTCC00405591,348401,46191
CHEMBL1939222,P23975,,HTSQRRQNKJNSLH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22191331,INHIBITION,=,-10,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM by radioligand displacement assay,,ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis.,J. Med. Chem.,2012,55,1,"Chen T, Benmohamed R, Kim J, Smith K, Amante D, Morimoto RI, Kirsch DR, Ferrante RJ, Silverman RB",,858363,DTCT0023180,11390338,DTCC01170899,931965,51183
CHEMBL1940402,P23975,,ZTBBOIYRZHAFIN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422,KI,=,1225,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255,DTCT0023180,13943040,DTCC01172005,1581044,61087
CHEMBL1940403,P23975,,FGTGRXMIFIZGBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422,KI,=,2249,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255,DTCT0023180,13943042,DTCC01172006,385012,61087
CHEMBL1940404,P23975,,JPTSMZMSIACDAD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422,KI,=,3959,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255,DTCT0023180,13943041,DTCC01172007,59465,61087
CHEMBL194205,P23975,,JMCFSRJDUZTPRD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,44,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858069,DTCC00407285,163458,19679
CHEMBL194310,P23975,,VROMWSWPRNOJJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,38,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858026,DTCC00407153,1361148,19679
CHEMBL194310,P23975,,VROMWSWPRNOJJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,54,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858031,DTCC00407153,1361149,19679
CHEMBL1945251,P23975,,FOGCUXYHCCUINS-UNSMHXHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24262882,KI,=,20,NM,,,,,,,,,,,,,,Displacement of [3H]Imipramin from human NET after 2 hrs by liquid scintillation counting analysis,,"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,2013,21,24,"Rami-Mark C, Bornatowicz B, Fink C, Otter P, Ungersboeck J, Vraka C, Haeusler D, Nics L, Spreitzer H, Hacker M, Mitterhauser M, Wadsak W",,1285656,DTCT0023180,12992724,DTCC01173195,1463182,56861
CHEMBL194574,P23975,,SVXFDINGBNILGI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,79,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858062,DTCC00407132,1587020,19679
CHEMBL1947087,P23975,,XOBBOJHELMBHFC-JVEPLPTMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22300887,KI,=,426,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET receptor expressed in HEK293 cells,,QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).,Bioorg. Med. Chem.,2012,20,4,"Mavel S, Mincheva Z, Méheux N, Carcenac Y, Guilloteau D, Abarbri M, Emond P",,801861,DTCT0023180,7620650,DTCC01174969,1655604,47277
CHEMBL1947088,P23975,,RYXJNKOIIVLWKR-ANDHVUINSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22300887,KI,=,188,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET receptor expressed in HEK293 cells,,QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).,Bioorg. Med. Chem.,2012,20,4,"Mavel S, Mincheva Z, Méheux N, Carcenac Y, Guilloteau D, Abarbri M, Emond P",,801861,DTCT0023180,7620651,DTCC01174970,491857,47277
CHEMBL194781,P23975,,BEKVIGOVWYQMOT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,5,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858164,DTCC00407233,1198206,19679
CHEMBL194907,P23975,,XWULIDJGQOXILD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,92,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858079,DTCC00407291,358453,19679
CHEMBL194909,P23975,,DDBXZYDSZVDTAS-ZJUUUORDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853339,DTCC00406345,1905006,19894
CHEMBL194910,P23975,,DEMWBYUAYXJYOC-RYUDHWBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853363,DTCC00406346,1102306,19894
CHEMBL194960,P23975,,JDYWZWHJMGYGFK-SKDRFNHKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853331,DTCC00406337,843398,19894
CHEMBL1949930,P23975,,IKXSPLZKOZXPFB-RQBPZYBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22226656,IC50,=,4400,NM,,,,,,,,,,,,,,Inhibition of NA transporter,,"Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test.",Bioorg. Med. Chem. Lett.,2012,22,3,"Tripathy R, McHugh RJ, Bacon ER, Salvino JM, Morton GC, Aimone LD, Huang Z, Mathiasen JR, DiCamillo A, Huffman MJ, McKenna BA, Kopec K, Lu LD, Qian J, Angeles TS, Connors T, Spais C, Holskin B, Duzic E, Schaffhauser H, Rossé GC",,804675,DTCT0023180,7639586,DTCC01175384,653195,47384
CHEMBL1949930,P23975,,IKXSPLZKOZXPFB-RQBPZYBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22226656,INHIBITION,>,50,%,,,,,,,,,,,,,,Inhibition of NA transporter at 10 uM,,"Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test.",Bioorg. Med. Chem. Lett.,2012,22,3,"Tripathy R, McHugh RJ, Bacon ER, Salvino JM, Morton GC, Aimone LD, Huang Z, Mathiasen JR, DiCamillo A, Huffman MJ, McKenna BA, Kopec K, Lu LD, Qian J, Angeles TS, Connors T, Spais C, Holskin B, Duzic E, Schaffhauser H, Rossé GC",,804669,DTCT0023180,7639580,DTCC01175384,653195,47384
CHEMBL1950351,P23975,,UCMNIYFDRVBMFV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22284817,ACTIVITY,<,50,%,,,,,,,,,,,,,,Activity at human NET receptor at 10 uM,,¿-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration.,Bioorg. Med. Chem. Lett.,2012,22,4,"Cheng YX, Pourashraf M, Luo X, Srivastava S, Walpole C, Salois D, St-Onge S, Payza K, Lessard E, Yu XH, Tomaszewski MJ",,804094,DTCT0023180,7637703,DTCC01175791,1397355,47435
CHEMBL195437,P23975,4-OCTYLPHENOL,NTDQQZYCCIDJRK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,61647,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290674,DTCC00405592,1285870,46191
CHEMBL195437,P23975,4-OCTYLPHENOL,NTDQQZYCCIDJRK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,61138,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290675,DTCC00405592,1285870,46191
CHEMBL195585,P23975,,TZHJRGABGIEARJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,4332,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822461,DTCC00399289,778174,19630
CHEMBL1956107,P23975,,HGVUTNMCDMGTOE-WOVMCDHWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22175766,IC50,=,4400,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells after 120 mins,,"Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.",J. Med. Chem.,2012,55,2,"Annedi SC, Ramnauth J, Maddaford SP, Renton P, Rakhit S, Mladenova G, Dove P, Silverman S, Andrews JS, Felice MD, Porreca F",,806517,DTCT0023180,7652553,DTCC01177827,781958,47509
CHEMBL1956107,P23975,,HGVUTNMCDMGTOE-WOVMCDHWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22175766,INHIBITION,=,86,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins,,"Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.",J. Med. Chem.,2012,55,2,"Annedi SC, Ramnauth J, Maddaford SP, Renton P, Rakhit S, Mladenova G, Dove P, Silverman S, Andrews JS, Felice MD, Porreca F",,806516,DTCT0023180,7652552,DTCC01177827,781958,47509
CHEMBL1956115,P23975,,GDYIQUFNICPYHF-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22175825,IC50,=,340,NM,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter,,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,2012,55,2,"Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, Barham RA, Che Y, Chen JM, Collantes EM, Chung SW, Desbonnet C, Doty J, Doroski M, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, Marra A, McElroy E, Melnick M, Menard CA, Montgomery JI, Mullins L, Noe MC, O'Donnell J, Penzien J, Plummer MS, Price LM, Shanmugasundaram V, Thoma C, Uccello DP, Warmus JS, Wishka DG",,806656,DTCT0023180,7652753,DTCC01177834,866270,47510
CHEMBL1956115,P23975,,GDYIQUFNICPYHF-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22175825,INHIBITION,>,50,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,2012,55,2,"Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, Barham RA, Che Y, Chen JM, Collantes EM, Chung SW, Desbonnet C, Doty J, Doroski M, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, Marra A, McElroy E, Melnick M, Menard CA, Montgomery JI, Mullins L, Noe MC, O'Donnell J, Penzien J, Plummer MS, Price LM, Shanmugasundaram V, Thoma C, Uccello DP, Warmus JS, Wishka DG",,806655,DTCT0023180,7652752,DTCC01177834,866270,47510
CHEMBL1956115,P23975,,GDYIQUFNICPYHF-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22175825,KI,=,250,NM,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter,,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,2012,55,2,"Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, Barham RA, Che Y, Chen JM, Collantes EM, Chung SW, Desbonnet C, Doty J, Doroski M, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, Marra A, McElroy E, Melnick M, Menard CA, Montgomery JI, Mullins L, Noe MC, O'Donnell J, Penzien J, Plummer MS, Price LM, Shanmugasundaram V, Thoma C, Uccello DP, Warmus JS, Wishka DG",,806656,DTCT0023180,7652754,DTCC01177834,866270,47510
CHEMBL195774,P23975,,DEMWBYUAYXJYOC-NWDGAFQWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853351,DTCC00406354,227740,19894
CHEMBL196,P23975,ASCORBATE,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7272028,DTCC00506386,282996,46191
CHEMBL196,P23975,ASCORBATE,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7272029,DTCC00506386,282996,46191
CHEMBL196110,P23975,,ZTNSUUWAQMMYEF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,8,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858160,DTCC00407232,1808231,19679
CHEMBL196258,P23975,,PYUBHJHQYILWFE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16250647,INHIBITION,<,10,%,,,,,,,,,,,,,,Percent inhibition against Norepinephrine transporter at 1 uM nonselective,,"2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.",J. Med. Chem.,2005,48,22,"Minetti P, Tinti MO, Carminati P, Castorina M, Di Cesare MA, Di Serio S, Gallo G, Ghirardi O, Giorgi F, Giorgi L, Piersanti G, Bartoccini F, Tarzia G",,321779,DTCT0023180,1855388,DTCC00406824,1016173,19966
CHEMBL196365,P23975,,KIDMMWCQWSLXGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,8,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858036,DTCC00407114,520388,19679
CHEMBL196365,P23975,,KIDMMWCQWSLXGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858052,DTCC00407114,520391,19679
CHEMBL196365,P23975,,KIDMMWCQWSLXGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,190,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858041,DTCC00407114,520389,19679
CHEMBL196368,P23975,,FQUMMDVLHAIHNA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858057,DTCC00407131,1295807,19679
CHEMBL196468,P23975,,DEMWBYUAYXJYOC-NEPJUHHUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853312,DTCC00406353,810539,19894
CHEMBL196468,P23975,,DEMWBYUAYXJYOC-NEPJUHHUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,KI,=,4600,NM,,,,,,,,,,,,,,In vitro binding affinity towards human norepinephrine transporter,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,320832,DTCT0023180,1853348,DTCC00406353,810540,19894
CHEMBL196468,P23975,,DEMWBYUAYXJYOC-NEPJUHHUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560923,IC50,=,9200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]nisoxetine from human NET expressed in HEK293 cells,,Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,15,"Denhart DJ, Deskus JA, Ditta JL, Gao Q, Dalton King H, Kozlowski ES, Meng Z, LaPaglia MA, Mattson GK, Molski TF, Taber MT, Lodge NJ, Mattson RJ, Macor JE",,578029,DTCT0023180,2898661,DTCC00406353,823963,34817
CHEMBL196468,P23975,,DEMWBYUAYXJYOC-NEPJUHHUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20034793,IC50,=,9200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,2010,20,3,"Marcin LR, Mattson RJ, Gao Q, Wu D, Molski TF, Mattson GK, Lodge NJ",,610435,DTCT0023180,3195438,DTCC00406353,824639,37394
CHEMBL196513,P23975,,QZFLFWOTDWFGFO-ONGXEEELSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853345,DTCC00406347,66367,19894
CHEMBL196513,P23975,,QZFLFWOTDWFGFO-ONGXEEELSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853366,DTCC00406347,66368,19894
CHEMBL196751,P23975,,IHBSSBISPQPZFN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858147,DTCC00407335,908514,19679
CHEMBL196760,P23975,,WYURUVQXJTWRLS-QEJKBDCMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16302792,KI,=,194,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,2005,48,24,"Cha JH, Zou MF, Adkins EM, Rasmussen SG, Loland CJ, Schoenenberger B, Gether U, Newman AH",,326506,DTCT0023180,1868417,DTCC00408971,435279,20039
CHEMBL196760,P23975,,WYURUVQXJTWRLS-QEJKBDCMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24944746,KI,=,91,NM,,cell_based,,,,,,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",,Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,2014,5,6,"Kumar V, Rahbek-Clemmensen T, Billesbølle CB, Jorgensen TN, Gether U, Newman AH",,1365900,DTCT0023180,13778957,DTCC00408971,429587,59573
CHEMBL1970071,P23975,,NDKGACIWVAOUQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24135724,INHIBITION,>=,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter (unknown origin) at 30 uM,,"Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist.",Bioorg. Med. Chem. Lett.,2013,23,23,"Guerrero M, Poddutoori R, Urbano M, Peng X, Spicer TP, Chase PS, Hodder PS, Schaeffer MT, Brown S, Rosen H, Roberts E",,1276206,DTCT0023180,12937062,DTCC01187017,124076,56388
CHEMBL197315,P23975,,QZFLFWOTDWFGFO-GXSJLCMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853357,DTCC00406361,98610,19894
CHEMBL197354,P23975,,XOQCOACREKNTCH-YPMHNXCESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853315,DTCC00406445,1872650,19894
CHEMBL197643,P23975,,JZXQQBOUEFCSBP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,21,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858084,DTCC00407297,2002825,19679
CHEMBL197669,P23975,ST1535,CYYQMAWUIRPCNW-UHFFFAOYSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16250647,INHIBITION,<,10,%,,,,,,,,,,,,,,Percent inhibition against Norepinephrine transporter at 1 uM nonselective,,"2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.",J. Med. Chem.,2005,48,22,"Minetti P, Tinti MO, Carminati P, Castorina M, Di Cesare MA, Di Serio S, Gallo G, Ghirardi O, Giorgi F, Giorgi L, Piersanti G, Bartoccini F, Tarzia G",,321779,DTCT0023180,1855343,DTCC00406821,1048667,19966
CHEMBL197913,P23975,,OECITYWBFXTMBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,23000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874493,DTCC00410563,391207,20064
CHEMBL197960,P23975,,WXJZYVUSQHOXID-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858137,DTCC00407329,1457909,19679
CHEMBL197966,P23975,,WFSQIXHBUDPSMK-YPMHNXCESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853318,DTCC00406328,1230385,19894
CHEMBL198011,P23975,,OMMZYEKKLHJLJY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,77,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858121,DTCC00407321,1037096,19679
CHEMBL198018,P23975,,BKQSBMKFNNGLCD-NEPJUHHUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,KI,,,,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter; nt is not tested,Not Determined,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,320847,DTCT0023180,1853321,DTCC00406329,1715566,19894
CHEMBL198019,P23975,,QZFLFWOTDWFGFO-KOLCDFICSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853325,DTCC00406330,423920,19894
CHEMBL198019,P23975,,QZFLFWOTDWFGFO-KOLCDFICSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853354,DTCC00406330,423921,19894
CHEMBL198033,P23975,,DFPNKBKLTJXKDT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858089,DTCC00407298,1134439,19679
CHEMBL198038,P23975,,RPAXLFKEFIYMPQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,150,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858094,DTCC00407303,1102316,19679
CHEMBL198176,P23975,,FKPQTOXELNJTMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858104,DTCC00407310,972183,19679
CHEMBL198177,P23975,,CSIVTULLSFNYFC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,ACTIVITY,=,18,%,,,,,,,,,,,,,,Percentage displacement of [3H]nisoxetine radioligand from norepinephrine transporter at concentration of 1000 nM,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,321703,DTCT0023180,1858114,DTCC00407311,1425920,19679
CHEMBL198177,P23975,,CSIVTULLSFNYFC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,>,200,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858109,DTCC00407311,1425920,19679
CHEMBL198215,P23975,,JTBUWXHKRDNJAX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858176,DTCC00407247,2067445,19679
CHEMBL198275,P23975,,YQMJGYZSSOOMCO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,62,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858115,DTCC00407316,746184,19679
CHEMBL198463,P23975,,IXHFUNSVBJAYHP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16219465,ACTIVITY,,,,,,,,,,,,,,,,,Inhibitory activity against NET upto 10 uM,Not Active,Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs.,Bioorg. Med. Chem. Lett.,2005,15,24,"Kling A, Lange UE, Mack H, Bakker MH, Drescher KU, Hornberger W, Hutchins CW, Möller A, Müller R, Schmidt M, Unger L, Wicke K, Schellhaas K, Steiner G",,326587,DTCT0023180,1875132,DTCC00410127,271990,20052
CHEMBL198655,P23975,,CJVNIBWRWXJTAF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,ACTIVITY,=,53,%,,,,,,,,,,,,,,Percentage displacement of [3H]nisoxetine radioligand from norepinephrine transporter at concentration of 1000 nM,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,321703,DTCT0023180,1858051,DTCC00407115,520390,19679
CHEMBL198655,P23975,,CJVNIBWRWXJTAF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,>,200,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858046,DTCC00407115,520390,19679
CHEMBL198706,P23975,,HWOCKNMBFVXGDK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,165,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858126,DTCC00407322,454820,19679
CHEMBL198842,P23975,,OOXDSSIGOMBXFF-WKIMUTGTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16302792,KI,=,308,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,2005,48,24,"Cha JH, Zou MF, Adkins EM, Rasmussen SG, Loland CJ, Schoenenberger B, Gether U, Newman AH",,326506,DTCT0023180,1868424,DTCC00109910,1177243,20039
CHEMBL198960,P23975,,LQONCZWYZLNINV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,7,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858142,DTCC00407334,293270,19679
CHEMBL199053,P23975,,KOGVQIODXLTVAN-OLZOCXBDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853377,DTCC00406375,163449,19894
CHEMBL199054,P23975,,FBYZEHXPWUZCPM-KGLIPLIRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853380,DTCC00406376,1808215,19894
CHEMBL199093,P23975,,GWNCELRRXGHFMX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,47,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858180,DTCC00407248,1425921,19679
CHEMBL199116,P23975,,YPBIYYFCLCGRRL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858152,DTCC00407227,1134440,19679
CHEMBL199598,P23975,,QXKRLFHQZJJIMH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,62600,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874500,DTCC00410598,227774,20064
CHEMBL199824,P23975,,GKTQBPYMIGXPKG-JVVVGQRLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16392798,KI,=,6980,NM,,,,,,,,,,,,,,Binding affinity to NET,,"Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.",J. Med. Chem.,2006,49,1,"Kumar JS, Majo VJ, Hsiung SC, Millak MS, Liu KP, Tamir H, Prabhakaran J, Simpson NR, Van Heertum RL, Mann JJ, Parsey RV",,329917,DTCT0023180,1880822,DTCC00411727,1981952,20222
CHEMBL2,P23975,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385444,DTCC00132268,1155685,46191
CHEMBL2,P23975,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385445,DTCC00132268,1155685,46191
CHEMBL20,P23975,ACETAZOLAMIDE,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301901,DTCC00133144,51441,46191
CHEMBL20,P23975,ACETAZOLAMIDE,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301902,DTCC00133144,51441,46191
CHEMBL200473,P23975,,CNTBONUVPQEEGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,66300,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874499,DTCC00410607,1905052,20064
CHEMBL200906,P23975,,OQMLSKSSPKAKJQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16275071,ACTIVITY,=,12,%,,,,,,,,,,,,,,Activity against norepinephrine uptake at 10 uM,,A new chemical tool for exploring the physiological function of the PDE2 isozyme.,Bioorg. Med. Chem. Lett.,2006,16,2,"Chambers RJ, Abrams K, Garceau NY, Kamath AV, Manley CM, Lilley SC, Otte DA, Scott DO, Sheils AL, Tess DA, Vellekoop AS, Zhang Y, Lam KT",,327556,DTCT0023180,1878556,DTCC00411800,1393610,20142
CHEMBL201223,P23975,,OAASRUWEEIXAQF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,82700,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874496,DTCC00410512,649734,20064
CHEMBL2012728,P23975,,LTQWNQOQFFXHAJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22342142,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of norepinephrine channel at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012,22,6,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811316,DTCT0023180,10427268,DTCC01227134,427664,47711
CHEMBL2012737,P23975,,NFEVAAXMHCVVQF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22342142,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of norepinephrine channel at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012,22,6,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811316,DTCT0023180,10427269,DTCC01227143,620872,47711
CHEMBL201531,P23975,,TVYLLZQTGLZFBW-TUYUVJPESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16257206,IC50,=,3600,NM,,,,,,,,,,,,,,Inhibition of reuptake of Norepinephrine,,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,2006,16,3,"Shao L, Abolin C, Hewitt MC, Koch P, Varney M",,333146,DTCT0023180,1892075,DTCC00414438,1566299,20316
CHEMBL201556,P23975,,UWJUQVWARXYRCG-BMJHUOGNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16257206,IC50,=,6700,NM,,,,,,,,,,,,,,Inhibition of reuptake of Norepinephrine,,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,2006,16,3,"Shao L, Abolin C, Hewitt MC, Koch P, Varney M",,333146,DTCT0023180,1892073,DTCC00414453,142621,20316
CHEMBL201666,P23975,,RUCXEVOCSDADAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,22.8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895019,DTCC00110141,1884125,20391
CHEMBL201666,P23975,,RUCXEVOCSDADAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,1140,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894989,DTCC00110141,1884125,20391
CHEMBL201960,P23975,PYROVALERONE,SWUVZKWCOBGPTH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,28.3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1894828,DTCC00415070,1598838,20391
CHEMBL201960,P23975,PYROVALERONE,SWUVZKWCOBGPTH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,195,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894827,DTCC00415070,1598838,20391
CHEMBL201976,P23975,,ULUHBYVKNOUSDX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,93,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895011,DTCC00414760,564005,20391
CHEMBL201976,P23975,,ULUHBYVKNOUSDX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,95,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894979,DTCC00414760,564005,20391
CHEMBL201977,P23975,,MEMCHWOZQTXCNY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894973,DTCC00414761,1081316,20391
CHEMBL201978,P23975,,DZULEPZTNHLZTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,18.5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895009,DTCC00414762,822257,20391
CHEMBL201978,P23975,,DZULEPZTNHLZTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,262,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894972,DTCC00414762,822257,20391
CHEMBL202055,P23975,,NJZIWQLWRVISOP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894965,DTCC00414840,206859,20391
CHEMBL2021577,P23975,,YUSAYELUMYRKMP-CIUDSAMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,199.53,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213776,DTCC01230348,1179480,37197
CHEMBL2021580,P23975,,CIVPMJLKYXGWQT-KKUMJFAQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,IC50,=,0.398,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]noradrenalin reuptake at human NET expressed in LLCPK cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613762,DTCT0023180,3213869,DTCC01230351,1471872,37197
CHEMBL2021580,P23975,,CIVPMJLKYXGWQT-KKUMJFAQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213751,DTCC01230351,1471872,37197
CHEMBL2021580,P23975,,CIVPMJLKYXGWQT-KKUMJFAQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,3.16,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213752,DTCC01230351,1471871,37197
CHEMBL2021581,P23975,,CIVPMJLKYXGWQT-KFWWJZLASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213750,DTCC01230352,1277246,37197
CHEMBL2021582,P23975,,PQMJWYCYCSXLGZ-JYAVWHMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,12.59,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213742,DTCC01230353,986260,37197
CHEMBL2021583,P23975,,PQMJWYCYCSXLGZ-JJLQDPRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,25118.86,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213741,DTCC01230354,1244680,37197
CHEMBL202348,P23975,,SIFVHGKZPNIKBO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,24.9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895006,DTCC00414834,1501978,20391
CHEMBL202348,P23975,,SIFVHGKZPNIKBO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,509,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894969,DTCC00414834,1501978,20391
CHEMBL2024087,P23975,,FQIJPHXWIONJLF-JKOKRWQUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22171543,INHIBITION,=,-10.6,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012,55,2,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815956,DTCT0023180,10457870,DTCC01232472,1365032,48063
CHEMBL2024089,P23975,,HGSHFGWWOPXUPH-WHOFXGATSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22171543,INHIBITION,=,69.6,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012,55,2,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815956,DTCT0023180,10457871,DTCC01232474,102538,48063
CHEMBL202409,P23975,,GMWFVXBLHOYMAG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895008,DTCC00414826,337653,20391
CHEMBL202409,P23975,,GMWFVXBLHOYMAG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,259,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894971,DTCC00414826,337653,20391
CHEMBL2024094,P23975,,NMIIKXFGCKOYRV-WHOFXGATSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22171543,INHIBITION,=,-0.2,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012,55,2,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815956,DTCT0023180,10457872,DTCC01232479,1008460,48063
CHEMBL202410,P23975,,JREHJCKVQXOMFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,88,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895007,DTCC00414827,789852,20391
CHEMBL202410,P23975,,JREHJCKVQXOMFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,1400,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894970,DTCC00414827,789852,20391
CHEMBL202420,P23975,,RAHKQMUBMIJUFG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,83,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895027,DTCC00415035,435343,20391
CHEMBL202420,P23975,,RAHKQMUBMIJUFG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,386,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894997,DTCC00415035,435343,20391
CHEMBL202479,P23975,,QXBWECFEEZMKTN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,46.5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895026,DTCC00415036,1695446,20391
CHEMBL202479,P23975,,QXBWECFEEZMKTN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,310,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894996,DTCC00415036,1695446,20391
CHEMBL202518,P23975,,AQQRGNNYEPRIIF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894994,DTCC00415058,33485,20391
CHEMBL202565,P23975,,CZICWAXMIHSKKP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894974,DTCC00415047,499749,20391
CHEMBL202644,P23975,,HGUDCSBIBQSBGQ-BQAIUKQQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,160,NM,,,,,,,,,,,,,,Inhibition of [3H]NE uptake,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335149,DTCT0023180,1902574,DTCC00416862,239335,20396
CHEMBL202644,P23975,,HGUDCSBIBQSBGQ-BQAIUKQQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,380,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902466,DTCC00416862,239335,20396
CHEMBL202755,P23975,,NSIMWGJISYLRDI-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,Not Determined,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,341075,DTCC00417439,1937078,20502
CHEMBL202810,P23975,,MLTWEZLEOAHOAA-SMWAQBJTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,450,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906262,DTCC00417441,358544,20502
CHEMBL202811,P23975,,BJJMXMMHXNEXRL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901153,DTCC00416709,1872761,20463
CHEMBL202846,P23975,,KKTUFJIEHNEGDF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,7.6,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895012,DTCC00415508,1016267,20391
CHEMBL202846,P23975,,KKTUFJIEHNEGDF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,219,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894981,DTCC00415508,1016267,20391
CHEMBL202860,P23975,,XBIRPUDVQBQYMW-XXIQNXCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,79,NM,,,,,,,,,,,,,,Inhibition of [3H]NE uptake,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335149,DTCT0023180,1902577,DTCC00416620,1209464,20396
CHEMBL202860,P23975,,XBIRPUDVQBQYMW-XXIQNXCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,460,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902471,DTCC00416620,1209464,20396
CHEMBL2029052,P23975,,GRIXJAFEBWYBJE-ANUWOGMRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,=,5454000,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142807,DTCT0023180,1071982,DTCC01233807,1714356,6492
CHEMBL2029053,P23975,,OBIZFSZXDHWUJZ-ANUWOGMRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,>,10000000,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142807,DTCT0023180,1080091,DTCC01233808,1003439,6492
CHEMBL2029054,P23975,,MERKGGYYOYLGCB-ROPJLGIWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,>,10000000,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142807,DTCT0023180,1057637,DTCC01233809,4973,6492
CHEMBL2029055,P23975,,YAGXEFDTWYZUEO-PHHSGPBWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,>,10000000,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142807,DTCT0023180,1074416,DTCC01233810,389787,6492
CHEMBL202907,P23975,,FUNFIWMUTFWLPO-GTNSWQLSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,2100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906281,DTCC00417379,1037220,20502
CHEMBL202910,P23975,,PRPQDTYJTKSLKO-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,20300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906283,DTCC00417339,195464,20502
CHEMBL202913,P23975,,LBFUCVLJJXYYQF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901152,DTCC00416710,972273,20463
CHEMBL202939,P23975,,CCCKABNBMAAFTD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894976,DTCC00415097,984004,20391
CHEMBL2029821,P23975,,IPTWXMISVLTMAV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22364337,ACTIVITY,>,50,%,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter at 10 uM,,"Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor.",J. Med. Chem.,2012,55,5,"Cid JM, Duvey G, Tresadern G, Nhem V, Furnari R, Cluzeau P, Vega JA, de Lucas AI, Matesanz E, Alonso JM, Linares ML, Andrés JI, Poli SM, Lutjens R, Himogai H, Rocher JP, Macdonald GJ, Oehlrich D, Lavreysen H, Ahnaou A, Drinkenburg W, Mackie C, Trabanco AA",,820190,DTCT0023180,10469918,DTCC01234334,737308,48171
CHEMBL203013,P23975,,LJRLAJVWAFFRLV-IAQYHMDHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16361098,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity to NA transporter,,"Synthesis and biological evaluation of novel hexahydro-pyrido[3',2':4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT(2C) receptor agonists.",Bioorg. Med. Chem. Lett.,2006,16,5,"Richter HG, Adams DR, Benardeau A, Bickerdike MJ, Bentley JM, Blench TJ, Cliffe IA, Dourish C, Hebeisen P, Kennett GA, Knight AR, Malcolm CS, Mattei P, Misra A, Mizrahi J, Monck NJ, Plancher JM, Roever S, Roffey JR, Taylor S, Vickers SP",,340111,DTCT0023180,1907786,DTCC00418228,1587128,20508
CHEMBL2030622,P23975,,ITUMTGGIBOPIJQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478008,DTCC01235111,1610661,48255
CHEMBL2030623,P23975,,HJOLMLNXMCFYQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478050,DTCC01235112,382111,48255
CHEMBL2030624,P23975,,MFKYGKXYJBKSQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478097,DTCC01235113,218663,48255
CHEMBL2030625,P23975,,JVHYCBRRZUMPEJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478187,DTCC01235114,53054,48255
CHEMBL2030626,P23975,,TWUZJTIHFYRNSV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478235,DTCC01235115,1735130,48255
CHEMBL2030627,P23975,,JJTSIVODPMDGBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478277,DTCC01235116,1417143,48255
CHEMBL2030628,P23975,,URNOPSHFIGOPOJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478626,DTCC01235117,1221331,48255
CHEMBL2030629,P23975,,SRRZEMVAQOSBLB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478673,DTCC01235118,963513,48255
CHEMBL2030630,P23975,,LCBQDWKMNGEPLD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478699,DTCC01235119,1961153,48255
CHEMBL2030631,P23975,N-BENZYLPYRROLIDINE,CWEGCQIIDCZZED-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478746,DTCC00041635,1993939,48255
CHEMBL2030632,P23975,N-(3-FLUOROBENZYL)PYRROLIDINE,PRKCBGIXZFUCEF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478783,DTCC00041636,1417144,48255
CHEMBL2030633,P23975,"N-(3,4-DIMETHOXYBENZYL)PYRROLIDINE",MIZXZRHARATZMK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10478830,DTCC00041637,801620,48255
CHEMBL2030634,P23975,N-(CYCLOHEXYLMETHYL)PYRROLIDINE,ADGIWWYGVBZYMC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10479218,DTCC00041638,769521,48255
CHEMBL2030635,P23975,N-(2-PHENYLETHYL)PYRROLIDINE,KLUCWWVQVUXBSE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10479265,DTCC00041639,995674,48255
CHEMBL2030636,P23975,,PXBKRGXXBYALIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10479312,DTCC00129963,1156787,48255
CHEMBL2030637,P23975,,VBKWQJLSFFFYLC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10479395,DTCC00129964,834331,48255
CHEMBL2031737,P23975,,GPZMWOXSIRVXQW-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22313227,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant NET,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012,55,5,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818831,DTCT0023180,10474293,DTCC01236182,1106160,48153
CHEMBL2032049,P23975,,WAOZNBXSEVIAGX-MBOZVWFJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22542010,KI,>,2000,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter,,Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition.,Bioorg. Med. Chem. Lett.,2012,22,11,"Mihalic JT, Fan P, Chen X, Chen X, Fu Y, Motani A, Liang L, Lindstrom M, Tang L, Chen JL, Jaen J, Dai K, Li L",,818589,DTCT0023180,10469513,DTCC01236483,284103,48184
CHEMBL203236,P23975,,UYRXAUJWAVZHMT-LIRRHRJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,2700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906295,DTCC00416926,1587127,20502
CHEMBL203266,P23975,TRIMETAZIDINE,UHWVSEOVJBQKBE-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7442985,DTCC00417182,381018,46191
CHEMBL203266,P23975,TRIMETAZIDINE,UHWVSEOVJBQKBE-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7442986,DTCC00417182,381018,46191
CHEMBL203331,P23975,,HGBGXSPIBLZGHS-SJKOYZFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,310,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906298,DTCC00417449,1134542,20502
CHEMBL203403,P23975,,VVIVTDYOMWHKAE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,19.7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895016,DTCC00415093,33486,20391
CHEMBL203403,P23975,,VVIVTDYOMWHKAE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,425,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894985,DTCC00415093,33486,20391
CHEMBL203453,P23975,,RISBSIZJBWBMEB-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,4200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906287,DTCC00417227,454939,20502
CHEMBL203488,P23975,,OYYFMZJTKZIRQM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,21,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895013,DTCC00415501,142626,20391
CHEMBL203488,P23975,,OYYFMZJTKZIRQM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,37.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894982,DTCC00415501,142626,20391
CHEMBL2034995,P23975,,KWGNEMHDJWLIGQ-SWQINVOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,2200,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484598,DTCC01238057,801649,48312
CHEMBL203562,P23975,,FDCLNKXJEZCPEW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,12.4,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895023,DTCC00415329,1981988,20391
CHEMBL203562,P23975,,FDCLNKXJEZCPEW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,150,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894993,DTCC00415329,1981988,20391
CHEMBL203563,P23975,,XCHIECWEKDGHNL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,86.7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895022,DTCC00415330,1146222,20391
CHEMBL203563,P23975,,XCHIECWEKDGHNL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,1290,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894992,DTCC00415330,1146222,20391
CHEMBL2036264,P23975,,NFVFEGNKXDEQPE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,550,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484592,DTCC01238053,284120,48312
CHEMBL2036264,P23975,,NFVFEGNKXDEQPE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,960,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484594,DTCC01238053,284122,48312
CHEMBL2036264,P23975,,NFVFEGNKXDEQPE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,1100,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484593,DTCC01238053,284121,48312
CHEMBL2036265,P23975,,JVVOHDBHFSMSNA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,1300,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484595,DTCC01238054,899412,48312
CHEMBL2036266,P23975,,UTTUELHWYPRNHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,280,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484596,DTCC01238055,445712,48312
CHEMBL2036267,P23975,,KWGNEMHDJWLIGQ-JPWYFDBFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,160,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484597,DTCC01238056,1799495,48312
CHEMBL2036268,P23975,,PIAOYGXDXCCGEO-KAECKJJSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,400,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484599,DTCC01238058,1863806,48312
CHEMBL2036269,P23975,,PIAOYGXDXCCGEO-SKKCDYJJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,2000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484600,DTCC01238059,834359,48312
CHEMBL2036270,P23975,,IKMZLQWBQYJRNA-KBGJBQQCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,380,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484601,DTCC01238060,1993969,48312
CHEMBL2036271,P23975,,IKMZLQWBQYJRNA-ZGTDKVADSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,2800,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484602,DTCC01238061,834360,48312
CHEMBL2036272,P23975,,DZWCPJPFRNJGMB-DFQHDRSWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,2400,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484603,DTCC01238062,1961173,48312
CHEMBL2036273,P23975,,DZWCPJPFRNJGMB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,1000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484604,DTCC01238063,218701,48312
CHEMBL2036273,P23975,,DZWCPJPFRNJGMB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,5200,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484605,DTCC01238063,218702,48312
CHEMBL2036274,P23975,,DZWCPJPFRNJGMB-IODNYQNNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,880,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484606,DTCC01238064,1961175,48312
CHEMBL2036275,P23975,,MRZYSDFMLQKBFH-LIOBNPLQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,1700,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484607,DTCC01238065,705051,48312
CHEMBL2036276,P23975,,MRZYSDFMLQKBFH-YYLIZZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,760,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484608,DTCC01238066,963536,48312
CHEMBL203640,P23975,,BQLSUBYYRRZHRK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,171,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895029,DTCC00415080,1405348,20391
CHEMBL203640,P23975,,BQLSUBYYRRZHRK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,830,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894998,DTCC00415080,1405348,20391
CHEMBL203674,P23975,,AKYOXKZSLULYCY-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,920,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906268,DTCC00417100,2035775,20502
CHEMBL203741,P23975,,CROGUKBPHFMYKB-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,3200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906273,DTCC00417017,1554939,20502
CHEMBL2037528,P23975,,USGLWFZAXHASGB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22520153,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET by liquid scintillation assay,,Benzothiazoles as probes for the 5HT(1A) receptor and the serotonin transporter (SERT): A search for new dual-acting agents as potential antidepressants.,Eur. J. Med. Chem.,2012,53,,"Zhu XY, Etukala JR, Eyunni SV, Setola V, Roth BL, Ablordeppey SY",,820698,DTCT0023180,10499031,DTCC01239247,2090829,48339
CHEMBL2037531,P23975,,CHGXPKZHRZIZSQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22520153,KI,=,49,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET by liquid scintillation assay,,Benzothiazoles as probes for the 5HT(1A) receptor and the serotonin transporter (SERT): A search for new dual-acting agents as potential antidepressants.,Eur. J. Med. Chem.,2012,53,,"Zhu XY, Etukala JR, Eyunni SV, Setola V, Roth BL, Ablordeppey SY",,820698,DTCT0023180,10499032,DTCC01239250,1706934,48339
CHEMBL203776,P23975,,OUQMYOZRLIWPPV-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,1250,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906296,DTCC00417525,681699,20502
CHEMBL203821,P23975,,BXVHYBOSHLZFER-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901129,DTCC00416310,260100,20463
CHEMBL204005,P23975,,JAPHVUWBEYMUCG-ZBEGNZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,880,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906279,DTCC00417433,1263384,20502
CHEMBL204060,P23975,,LBZCFIOVPDHQQT-LNLSOMNWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,>,5600,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902465,DTCC00416869,564006,20396
CHEMBL204199,P23975,,DSAPXKWYVMTXKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901128,DTCC00416351,260101,20463
CHEMBL204254,P23975,,HHSYAWUBPBEDMP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,9.4,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895015,DTCC00415347,1307725,20391
CHEMBL204254,P23975,,HHSYAWUBPBEDMP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,216,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894984,DTCC00415347,1307725,20391
CHEMBL204285,P23975,,LXNRWPBVYRKZDQ-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,2100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906289,DTCC00417085,1970355,20502
CHEMBL204288,P23975,,OVEGFFRUJIZDSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,800,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895003,DTCC00415181,1916399,20391
CHEMBL204288,P23975,,OVEGFFRUJIZDSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,2350,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894966,DTCC00415181,1916399,20391
CHEMBL204323,P23975,,HGBGXSPIBLZGHS-YVEFUNNKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,310,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906260,DTCC00417448,1198329,20502
CHEMBL204449,P23975,,LRQBXHMVEXEFBO-GFCCVEGCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16263279,ACTIVITY,=,14,%,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter at 10 uM,,A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function.,Bioorg. Med. Chem. Lett.,2006,16,3,"Chambers RJ, Abrams K, Castleberry TA, Cheng JB, Fisher DA, Kamath AV, Marfat A, Nettleton DO, Pillar JD, Salter ED, Sheils AL, Shirley JT, Turner CR, Umland JP, Lam KT",,334434,DTCT0023180,1897133,DTCC00415662,908590,20371
CHEMBL204490,P23975,,OIZUHURZTLEFGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894987,DTCC00415087,1242362,20391
CHEMBL204530,P23975,,LMAWVKHKZVLUQO-LNLSOMNWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,143,NM,,,,,,,,,,,,,,Inhibition of [3H]NE uptake,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335149,DTCT0023180,1902533,DTCC00416355,2079104,20396
CHEMBL204530,P23975,,LMAWVKHKZVLUQO-LNLSOMNWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,1221,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902473,DTCC00416355,2079104,20396
CHEMBL204538,P23975,,FCINLQHPPAWABH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,19.3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895017,DTCC00415088,370255,20391
CHEMBL204538,P23975,,FCINLQHPPAWABH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,69.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894986,DTCC00415088,370255,20391
CHEMBL204574,P23975,,WGCRPMFFZVDRHS-BJKOFHAPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,3.7,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917178,DTCC00420460,1069687,20590
CHEMBL204586,P23975,,XPPDUQXXSFOWGY-JCOPYZAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,485,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902474,DTCC00416348,2047030,20396
CHEMBL204591,P23975,,ZXSCHWNAHIGTOP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901155,DTCC00416568,1522782,20463
CHEMBL2046455,P23975,,QVIAHGYFYZASCH-GAJHUEQPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,34,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527324,DTCC01242751,1365138,48646
CHEMBL204702,P23975,,UWLGSNCXKLOAAD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901158,DTCC00416369,1619752,20463
CHEMBL2047561,P23975,,NBIWTPBSAFCSRX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,IC50,=,327,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275,DTCT0023180,10527340,DTCC00130266,167263,48646
CHEMBL2047562,P23975,,SSEWYSOPUMSOTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,61,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527339,DTCC00130267,653435,48646
CHEMBL2047563,P23975,,GCQYUVJKJNRUBX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,50,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527338,DTCC00130268,492082,48646
CHEMBL2047564,P23975,,JGZNMAIDTSSPBU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,83,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527337,DTCC00130269,782168,48646
CHEMBL2047565,P23975,,JWEVRDWOVZZPKU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,82,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527336,DTCC00130270,231674,48646
CHEMBL2047566,P23975,,KNEXRPBWIYIHRH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,63,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527335,DTCC00130271,1201940,48646
CHEMBL2047567,P23975,,CLPXEXYSIPWDMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,74,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527334,DTCC00130272,1623630,48646
CHEMBL2047568,P23975,,CTGKEWQPUSZCPT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,78,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527333,DTCC00130273,1234431,48646
CHEMBL2047569,P23975,,PQGQRUUEBWORMY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,62,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527332,DTCC00130274,199225,48646
CHEMBL2047570,P23975,,QXCOEFGWAUGVTR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,IC50,=,385,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275,DTCT0023180,10527331,DTCC00130275,1429720,48646
CHEMBL2047571,P23975,,JYIMWQCCVNSNJW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,IC50,=,420,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275,DTCT0023180,10527330,DTCC01242745,1332453,48646
CHEMBL2047572,P23975,,ATXUZVSWVVGJPF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,IC50,=,800,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275,DTCT0023180,10527329,DTCC01242746,70294,48646
CHEMBL2047573,P23975,,JZHYJRPFUZJBQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,IC50,=,265,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275,DTCT0023180,10527328,DTCC01242747,1138570,48646
CHEMBL2047574,P23975,,NQXSFBZVBLPNCG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,IC50,=,178,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275,DTCT0023180,10527327,DTCC01242748,524316,48646
CHEMBL2047575,P23975,,IDGXKCMPBMPCQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,88,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527326,DTCC01242749,1812164,48646
CHEMBL2047576,P23975,,QVIAHGYFYZASCH-UZUQRXQVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,78,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527325,DTCC01242750,458848,48646
CHEMBL2047577,P23975,,BONBIWJAPUUALK-IQGLISFBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,63,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527323,DTCC01242752,1234432,48646
CHEMBL2047578,P23975,,BONBIWJAPUUALK-AVRWGWEMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,55,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527322,DTCC01242753,362489,48646
CHEMBL2047579,P23975,,BLVOPMLJPLEJNF-QVKFZJNVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,36,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527321,DTCC01242754,199226,48646
CHEMBL2047580,P23975,,BLVOPMLJPLEJNF-YCRPNKLZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,IC50,=,531,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275,DTCT0023180,10527320,DTCC01242755,1008570,48646
CHEMBL2047581,P23975,,XQLBAPHRSPLANO-VGOFRKELSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,62,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527319,DTCC01242756,427789,48646
CHEMBL2047582,P23975,,XQLBAPHRSPLANO-HTAPYJJXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,55,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527318,DTCC01242757,1687873,48646
CHEMBL2047583,P23975,,SQNUVGLAMLMYCU-IIBYNOLFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,83,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527317,DTCC01242758,2006938,48646
CHEMBL2047584,P23975,,SQNUVGLAMLMYCU-HRAATJIYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762,INHIBITION,=,57,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827276,DTCT0023180,10527316,DTCC01242759,814568,48646
CHEMBL204759,P23975,,DTNUPBSOODGRKW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,11.7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895014,DTCC00415341,1631065,20391
CHEMBL204759,P23975,,DTNUPBSOODGRKW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,136,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894983,DTCC00415341,1631065,20391
CHEMBL204814,P23975,,XQOCAAJLFFVLEP-QDSLRZTOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,402,NM,,,,,,,,,,,,,,Inhibition of [3H]NE uptake,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335149,DTCT0023180,1902576,DTCC00416540,887369,20396
CHEMBL204814,P23975,,XQOCAAJLFFVLEP-QDSLRZTOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,941,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902469,DTCC00416540,887369,20396
CHEMBL205005,P23975,,GEBDYHRDARRAJZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,43,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902459,DTCC00416489,142628,20396
CHEMBL205025,P23975,,JNVMCWLQXGNYMA-JCOPYZAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,440,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902462,DTCC00416443,1048765,20396
CHEMBL205028,P23975,,HYMIOQDNASQILW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,2520,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895004,DTCC00415174,1884174,20391
CHEMBL205028,P23975,,HYMIOQDNASQILW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,4200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894967,DTCC00415174,1884174,20391
CHEMBL205082,P23975,,YDIIDRWHPFMLGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,56,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895030,DTCC00415079,1307724,20391
CHEMBL205082,P23975,,YDIIDRWHPFMLGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,199,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894999,DTCC00415079,1307724,20391
CHEMBL205313,P23975,,NBVSCHGTCFRUCS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901156,DTCC00416482,1587117,20463
CHEMBL205505,P23975,,GWNPJZXWVMSYBY-LIRRHRJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,11500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906284,DTCC00417333,972286,20502
CHEMBL205596,P23975,CHOLIC ACID,BHQCQFFYRZLCQQ-OELDTZBJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7356111,DTCC00419527,1027049,46191
CHEMBL205596,P23975,CHOLIC ACID,BHQCQFFYRZLCQQ-OELDTZBJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7356112,DTCC00419527,1027049,46191
CHEMBL205837,P23975,,MQFDETILCHDOAZ-ZBEGNZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,1150,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906278,DTCC00417354,1198328,20502
CHEMBL205866,P23975,,SUXMSNIBAHOLFO-RBUKOAKNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,INHIBITION,=,25.2,%,,,,,,,,,,,,,,Binding affinity to NET at 100 nM,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344146,DTCT0023180,1917213,DTCC00419221,1905134,20590
CHEMBL206007,P23975,,GPHQCFPKKILZDC-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,54.4,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917179,DTCC00420452,1587147,20590
CHEMBL206128,P23975,,KGRXCESVCIYMSX-OVWBULDYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,359,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902457,DTCC00416760,1949079,20396
CHEMBL206152,P23975,,BBGHTDMYOQEIGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,13.3,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927973,DTCC00422502,1695514,20707
CHEMBL206153,P23975,,PQGGSLAVULAHLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,13.3,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927972,DTCC00422503,984081,20707
CHEMBL206211,P23975,,JSMCJJAIEPJIIJ-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,2100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906263,DTCC00417364,908621,20502
CHEMBL206404,P23975,,TUDVVMCZTNBXMS-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,1500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906277,DTCC00417355,7528,20502
CHEMBL206521,P23975,,IXXMPCPWTWLRBY-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,11.9,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917182,DTCC00420071,1295937,20590
CHEMBL206580,P23975,,OJTUQCJDORIBOX-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,300,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1928006,DTCC00422773,984080,20707
CHEMBL206598,P23975,,CTGMREDPJFWWBJ-LIRRHRJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,960,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906265,DTCC00417108,1361251,20502
CHEMBL206599,P23975,,MFRFEHWQLFFQLQ-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,5000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906285,DTCC00417332,1263387,20502
CHEMBL206608,P23975,,BSUHUYQWXIGAFH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901154,DTCC00416708,810631,20463
CHEMBL206649,P23975,,PXASTWDWEDJFAW-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,680,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906292,DTCC00417117,552591,20502
CHEMBL206697,P23975,,WPEZYNICVOURFR-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,980,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906291,DTCC00417118,1004859,20502
CHEMBL2068237,P23975,CISPLATIN,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347704,DTCC01249018,51458,46191
CHEMBL2068237,P23975,CISPLATIN,,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347705,DTCC01249018,51458,46191
CHEMBL207023,P23975,,CFFAIDBFDNPCHJ-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,5.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927920,DTCC00422778,467017,20707
CHEMBL207067,P23975,,MRYGKPHUQVMAJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,6.5,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927978,DTCC00422862,1146301,20707
CHEMBL207214,P23975,,PGIUKOCTZQBZIO-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,6.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927979,DTCC00422853,1852182,20707
CHEMBL207374,P23975,,UZGZHONLKDCUMO-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,4.8,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927989,DTCC00422470,1016319,20707
CHEMBL207407,P23975,,GOZTZBHGDRHFET-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,42,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1928005,DTCC00422815,1340437,20707
CHEMBL207480,P23975,,OQNFDJJNTQSMQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,3.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927977,DTCC00422786,1534412,20707
CHEMBL207634,P23975,,ZDCUVFAPACGOSD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,6.2,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927970,DTCC00422849,1016320,20707
CHEMBL207635,P23975,,NUNBGFOIBBDTEC-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,95.9,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927969,DTCC00422850,305089,20707
CHEMBL207712,P23975,,VGJFVJKZCAUGKE-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,148,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917184,DTCC00420069,1426051,20590
CHEMBL207713,P23975,,UMMWKVQAQBVCAO-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,30,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917183,DTCC00420070,681712,20590
CHEMBL207719,P23975,,PKVYOVHKHCWTDE-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,78,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927997,DTCC00422434,628892,20707
CHEMBL207755,P23975,,LSDAXRLUBRBZQK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,5.4,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927976,DTCC00422488,951751,20707
CHEMBL207804,P23975,,ZCPBUGPJVONOEH-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,INHIBITION,=,-67,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET at 1 uM,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355137,DTCT0023180,1927877,DTCC00422839,661068,20707
CHEMBL207807,P23975,,VMRYJLGXIPJJKQ-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,20,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927990,DTCC00422823,628893,20707
CHEMBL207810,P23975,,CIIUAPSLDQFRMB-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,42.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927987,DTCC00422480,435400,20707
CHEMBL207837,P23975,,LDELVNUHOAVIQP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,91,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927967,DTCC00422755,1663421,20707
CHEMBL207854,P23975,,WFIWNBXHHPXBTA-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,3.6,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927981,DTCC00422840,951750,20707
CHEMBL207860,P23975,,FXACQNXCWARQOA-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,2,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927985,DTCC00422485,1534411,20707
CHEMBL207867,P23975,,KJSYAMNHDJSTMY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,135,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461624,DTCC00419927,1073917,52000
CHEMBL207886,P23975,,RYUCCDFXIDUVPN-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,15,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927999,DTCC00422478,435398,20707
CHEMBL207894,P23975,,NYDRNGXEWTVMOM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,51,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927909,DTCC00422869,693334,20707
CHEMBL207914,P23975,,NQWIZKWCQGEVLT-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,7.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927994,DTCC00422836,239392,20707
CHEMBL207915,P23975,,GSQLCOBXOUVYQV-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,145,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927993,DTCC00422837,33584,20707
CHEMBL2079586,P23975,WIN-35428,QUSLQENMLDRCTO-TUVASFSCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9804682,IC50,=,834,NM,,,,,,,,,,,,,,The compound was tested in vitro for binding affinity for the norepinephrine transporter (NET) using competitive binding assay.,,TROTEC-1: a new high-affinity ligand for labeling of the dopamine transporter.,J. Med. Chem.,1998,41,23,"Hoepping A, Reisgys M, Brust P, Seifert S, Spies H, Alberto R, Johannsen B",,142804,DTCT0023180,1508053,DTCC00042466,1489487,14928
CHEMBL2079586,P23975,WIN-35428,QUSLQENMLDRCTO-TUVASFSCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,835,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043086,DTCC00042466,1502271,22167
CHEMBL2079586,P23975,WIN-35428,QUSLQENMLDRCTO-TUVASFSCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,503,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043087,DTCC00042466,1502271,22167
CHEMBL2079586,P23975,WIN-35428,QUSLQENMLDRCTO-TUVASFSCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20597489,KI,,,,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,Not Determined,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,2010,53,15,"Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM",,646995,DTCT0023180,3432099,DTCC00042466,1492919,40077
CHEMBL2079586,P23975,WIN-35428,QUSLQENMLDRCTO-TUVASFSCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21458259,KI,=,635,NM,,cell_based,,,,,,,,,,,LLC-PK1,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,2011,21,10,"Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF",,785532,DTCT0023180,7517117,DTCC00042466,1493952,46346
CHEMBL2079587,P23975,STANOZOLOL,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465096,DTCC01253362,930087,46191
CHEMBL2079587,P23975,STANOZOLOL,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465097,DTCC01253362,930087,46191
CHEMBL208067,P23975,,WXXAHIZLARZXBW-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,3.3,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1928002,DTCC00422387,1146300,20707
CHEMBL208069,P23975,,NXRRKZLGAMZHCY-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,61,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927892,DTCC00422847,1209528,20707
CHEMBL208070,P23975,,DHYMNQOPOAQKFE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,9.7,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927974,DTCC00422497,1437316,20707
CHEMBL208121,P23975,,PMVYNXPSCGXPRM-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,6.5,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927922,DTCC00422848,467016,20707
CHEMBL208178,P23975,,BDXVEVIJMYWTJE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,6.8,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927911,DTCC00422596,1755308,20707
CHEMBL208191,P23975,,TYAWVYXKOKCMIW-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,4.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927915,DTCC00422420,206906,20707
CHEMBL208232,P23975,,BJSTYDNATGHOTI-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,2.2,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927982,DTCC00422833,435401,20707
CHEMBL208251,P23975,,MFXWGMNUZKYAND-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,1.4,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927996,DTCC00422708,337731,20707
CHEMBL208252,P23975,,UYKZMZQXFWTAIG-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,3.4,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927992,DTCC00422844,951749,20707
CHEMBL208420,P23975,,NCBUFRZNBFLCMW-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,2.7,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927917,DTCC00422571,499832,20707
CHEMBL208444,P23975,,SDXZUZKWTPTGAT-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,43,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927998,DTCC00422427,467018,20707
CHEMBL208533,P23975,,XOXGVFCUPFEFPL-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,420,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927984,DTCC00422486,1081392,20707
CHEMBL208535,P23975,,ODVLOSXWFXUKAY-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,5.5,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927983,DTCC00422493,596365,20707
CHEMBL2087421,P23975,,TYDKAHFZLFMNQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22369198,INHIBITION,=,2,%,,cell_based,,,,,,,,,,,,Inhibition of human NE transporter at 5 uM by cell based assay,,From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.,J. Med. Chem.,2012,55,6,"Barth M, Bondoux M, Luccarini JM, Peyrou V, Dodey P, Pruneau D, Massardier C, Paquet JL",,841761,DTCT0023180,10599218,DTCC01254414,1578316,50456
CHEMBL20883,P23975,TEGAFUR,WFWLQNSHRPWKFK-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472188,DTCC00152531,1027060,46191
CHEMBL20883,P23975,TEGAFUR,WFWLQNSHRPWKFK-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472189,DTCC00152531,1027060,46191
CHEMBL208993,P23975,,SJKATDZDYZMMAP-VQTJNVASSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,5.2,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917181,DTCC00420079,1619773,20590
CHEMBL209094,P23975,,OEPVPUNMOOHWKG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,4.2,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927968,DTCC00422863,1598904,20707
CHEMBL2093958,P23975,,ZNSNAOXTBUHNKX-IODNYQNNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,=,290,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306535,DTCT0023180,1824007,DTCC01256673,1884066,19663
CHEMBL2093958,P23975,,ZNSNAOXTBUHNKX-IODNYQNNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,=,3700,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306359,DTCT0023180,1824008,DTCC01256673,1884066,19663
CHEMBL2093958,P23975,,ZNSNAOXTBUHNKX-IODNYQNNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306359,DTCT0023180,1824110,DTCC01256673,1884067,19663
CHEMBL2093958,P23975,,ZNSNAOXTBUHNKX-IODNYQNNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306535,DTCT0023180,1824109,DTCC01256673,1884067,19663
CHEMBL2096856,P23975,,OMBOXYLBBHNWHL-HXSCFSKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043065,DTCC01257005,370550,22167
CHEMBL2096857,P23975,,QUSLQENMLDRCTO-HXSCFSKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,7200,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043063,DTCC01257006,757984,22167
CHEMBL2096857,P23975,,QUSLQENMLDRCTO-HXSCFSKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,4340,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043064,DTCC01257006,757984,22167
CHEMBL2096858,P23975,,ZEOHVQFWFVMPGM-HXSCFSKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,444,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043061,DTCC01257007,596587,22167
CHEMBL2096858,P23975,,ZEOHVQFWFVMPGM-HXSCFSKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,222,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043062,DTCC01257007,596587,22167
CHEMBL2096859,P23975,,HNVGNUVAMRLMSG-HXSCFSKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,272,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043059,DTCC01257008,34019,22167
CHEMBL2096859,P23975,,HNVGNUVAMRLMSG-HXSCFSKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,136,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043060,DTCC01257008,34019,22167
CHEMBL2096860,P23975,,SIIICDNNMDMWCI-HXSCFSKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,760,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043057,DTCC01257009,239579,22167
CHEMBL2096860,P23975,,SIIICDNNMDMWCI-HXSCFSKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,458,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043058,DTCC01257009,239579,22167
CHEMBL2096861,P23975,,MMKZDDDDODERSJ-GYTBAZASSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,2230,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043054,DTCC01257010,2015113,22167
CHEMBL2096861,P23975,,MMKZDDDDODERSJ-GYTBAZASSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,1120,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043055,DTCC01257010,2015113,22167
CHEMBL2096874,P23975,,URXGPOFPBIBVGT-ZUPWUQBJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,1040,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050423,DTCC01257022,1069948,22251
CHEMBL2096874,P23975,,URXGPOFPBIBVGT-ZUPWUQBJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,626,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050424,DTCC01257022,1069948,22251
CHEMBL2096875,P23975,,YJWQTICONBXOHT-KWJLTHHISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,4850,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050418,DTCC01257023,424308,22251
CHEMBL2096875,P23975,,YJWQTICONBXOHT-KWJLTHHISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,2920,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050419,DTCC01257023,424308,22251
CHEMBL2096876,P23975,,PSPJUVHWZINCFD-KWJLTHHISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,4700,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050414,DTCC01257024,1328808,22251
CHEMBL2096876,P23975,,PSPJUVHWZINCFD-KWJLTHHISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,2800,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050415,DTCC01257024,1328808,22251
CHEMBL2096877,P23975,,DTGXSBMWMFLEGI-JRRMTSHWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,780,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050412,DTCC01257025,1873052,22251
CHEMBL2096877,P23975,,DTGXSBMWMFLEGI-JRRMTSHWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,390,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050413,DTCC01257025,1873052,22251
CHEMBL2096878,P23975,,ZCJYSKHDYKCJTO-CFBBYLOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,,,,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,Not Determined,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,341521,DTCC01257026,1361532,22251
CHEMBL209707,P23975,,QKYQOSPSZVKFEL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1963899,DTCC00429975,1174544,21124
CHEMBL209821,P23975,NALUZOTAN,SPWZXWDPAWDKQE-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16722631,KI,>,2000,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter by radioligand binding assay,,"An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.",J. Med. Chem.,2006,49,11,"Becker OM, Dhanoa DS, Marantz Y, Chen D, Shacham S, Cheruku S, Heifetz A, Mohanty P, Fichman M, Sharadendu A, Nudelman R, Kauffman M, Noiman S",,357806,DTCT0023180,1929815,DTCC00423188,1372972,20825
CHEMBL209969,P23975,,MGQYROXWDORYIL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965621,DTCC00429679,790002,21201
CHEMBL21,P23975,SULFANILAMIDE,FDDDEECHVMSUSB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465366,DTCC00133176,88635,46191
CHEMBL21,P23975,SULFANILAMIDE,FDDDEECHVMSUSB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465367,DTCC00133176,88635,46191
CHEMBL210026,P23975,,VPNYIGJUQBPBMU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,14,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965651,DTCC00429751,1695590,21201
CHEMBL210027,P23975,,MQGLAASXHMCXDS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,31,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965613,DTCC00429752,1340515,21201
CHEMBL210028,P23975,,XPYLNZBNFQMTKZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,90,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965614,DTCC00429753,887515,21201
CHEMBL210116,P23975,,KURNFMGUSYWHLC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,340,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964051,DTCC00429785,2035882,21124
CHEMBL210126,P23975,,USQDYFAONFKQLW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,72,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965615,DTCC00429754,1884385,21201
CHEMBL2103747,P23975,ACONITINE,XFSBVAOIAHNAPC-FKHWODAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7285548,DTCC00130938,671783,46191
CHEMBL2103747,P23975,ACONITINE,XFSBVAOIAHNAPC-FKHWODAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7285549,DTCC00130938,671783,46191
CHEMBL2103774,P23975,TIBOLONE,WZDGZWOAQTVYBX-XOINTXKNSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468105,DTCC01257131,1416037,46191
CHEMBL2103774,P23975,TIBOLONE,WZDGZWOAQTVYBX-XOINTXKNSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468106,DTCC01257131,1416037,46191
CHEMBL210514,P23975,,IGTBNUVMBDYPQG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16722655,KI,=,5090,NM,,,,,,,,,,,,,,Binding affinity to human NE transporter,,"Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.",J. Med. Chem.,2006,49,11,"Li H, Anderes KL, Kraynov EA, Luthin DR, Do QQ, Hong Y, Tompkins E, Sun ET, Rajapakse R, Pathak VP, Christie LC, Feng J, Vazir H, Castillo R, Gregory ML, Castro M, Nared-Hood K, Paderes G, Anderson MB",,361253,DTCT0023180,1934366,DTCC00424511,822340,20877
CHEMBL2105617,P23975,AJMALINE,CJDRUOGAGYHKKD-FUIWMBJSSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7293599,DTCC01258909,2089743,46191
CHEMBL2105617,P23975,AJMALINE,CJDRUOGAGYHKKD-FUIWMBJSSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7293600,DTCC01258909,2089743,46191
CHEMBL210578,P23975,,CXQUOFVDYCOSEZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422,KI,,,,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Not Determined,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255,DTCT0023180,13943043,DTCC00423474,578712,61087
CHEMBL2105807,P23975,MADURAMICIN,WQGJEAMPBSZCIF-HKSLRPGUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427681,DTCC01259078,898292,46191
CHEMBL2105807,P23975,MADURAMICIN,WQGJEAMPBSZCIF-HKSLRPGUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427682,DTCC01259078,898292,46191
CHEMBL2106399,P23975,KITASAMYCIN,IEMDOFXTVAPVLX-YWQHLDGFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7409902,DTCC01259639,800579,46191
CHEMBL2106399,P23975,KITASAMYCIN,IEMDOFXTVAPVLX-YWQHLDGFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7409903,DTCC01259639,800579,46191
CHEMBL2107687,P23975,VALETHAMATE BROMIDE,CEJGGHKJHDHLAZ-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441613,DTCC01260864,1512819,46191
CHEMBL2107687,P23975,VALETHAMATE BROMIDE,CEJGGHKJHDHLAZ-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441614,DTCC01260864,1512819,46191
CHEMBL2107797,P23975,NORGESTREL,WWYNJERNGUHSAO-CULCCENASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394981,DTCC01260973,1894972,46191
CHEMBL2107797,P23975,NORGESTREL,WWYNJERNGUHSAO-CULCCENASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394982,DTCC01260973,1894972,46191
CHEMBL2110816,P23975,BUTRIPTYLINE,ALELTFCQZDXAMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,5100,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741096,DTCC01263483,2107621,68566
CHEMBL2111067,P23975,OXAPROTILINE,ZRGONKKAENTXKT-ZBOSIHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,4.9,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14750295,DTCC01263721,2109885,68566
CHEMBL2112075,P23975,,ZEBNDUQLNGYBNL-VEIFNGETSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19492813,IC50,=,200,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter,,Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,13,"Marquis RW, Lago AM, Callahan JF, Trout RE, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Yang Z, Roethke T, Smith BR, Ward KW, Lee J, Keenan RM, Bhatnagar P",,520036,DTCT0023180,2835755,DTCC01264439,79364,33744
CHEMBL2112594,P23975,,LZTYLQCFLVOYDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,205,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,958864,DTCC01264926,1208167,15367
CHEMBL2112594,P23975,,LZTYLQCFLVOYDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,545,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,958859,DTCC01264926,1208167,15367
CHEMBL2112595,P23975,,CEQQBJFDYJRGJS-FOCLMDBBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,>,10,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,976453,DTCC01264927,1403975,15367
CHEMBL2112595,P23975,,CEQQBJFDYJRGJS-FOCLMDBBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,1760,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,976448,DTCC01264927,1403975,15367
CHEMBL2113054,P23975,,NXQVAVZAULOMGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,191,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809554,DTCC00130987,1146040,19300
CHEMBL2113055,P23975,,DGOLMTSTXLHVKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,37.52,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809551,DTCC00130988,1437036,19300
CHEMBL2113217,P23975,,RRFLDGUEDAERPR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,350,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895005,DTCC01265516,239334,20391
CHEMBL2113217,P23975,,RRFLDGUEDAERPR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,4100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894968,DTCC01265516,239334,20391
CHEMBL2113279,P23975,,AUJWWBGAFLMMKB-SMTRIPRVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,>,6900,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115144,DTCC01265577,2079509,23035
CHEMBL2113279,P23975,,AUJWWBGAFLMMKB-SMTRIPRVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,1390,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115090,DTCC01265577,2079509,23035
CHEMBL211372,P23975,,ZVUBOJJCNXGQFS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,2800,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955024,DTCC00428038,131080,20957
CHEMBL211372,P23975,,ZVUBOJJCNXGQFS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,1400,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955020,DTCC00428038,131080,20957
CHEMBL211396,P23975,,MTTQVAJJGOFFBH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954988,DTCC00428085,358608,20957
CHEMBL211412,P23975,,MVELXQAMQGKSIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,130,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964055,DTCC00429841,1619860,21124
CHEMBL211494,P23975,,BNTIEMZWVNNNAF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955081,DTCC00428455,810724,20957
CHEMBL211501,P23975,ANTIMYCIN A,UIFFUZWRFRDZJC-SBOOETFBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7280799,DTCC00428375,930076,46191
CHEMBL211501,P23975,ANTIMYCIN A,UIFFUZWRFRDZJC-SBOOETFBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7280800,DTCC00428375,930076,46191
CHEMBL211527,P23975,,FABMPYBEKUUBIW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964045,DTCC00429839,1619859,21124
CHEMBL212328,P23975,,DBPGONCPPLDYIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954934,DTCC00428272,1458098,20957
CHEMBL212452,P23975,,KVHKGSIWONIENO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16784855,KI,=,2.94,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,2006,16,17,"Zeng F, Jarkas N, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,395400,DTCT0023180,1974027,DTCC00432235,1872901,21323
CHEMBL212763,P23975,,CTAHXNUPBZTDFO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,130,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965608,DTCC00429794,78105,21201
CHEMBL212877,P23975,,ZASFISMVWZDDES-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,76,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1963901,DTCC00430001,972397,21124
CHEMBL212878,P23975,,VWOWSEBOGHLBFX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964040,DTCC00430003,1775992,21124
CHEMBL213030,P23975,,FLCMZOWXDMNREV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,45,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964050,DTCC00429928,843630,21124
CHEMBL213035,P23975,,FCHUPCOGZXEFDS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,73,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965620,DTCC00429797,1016412,21201
CHEMBL213229,P23975,,FVLUAITUNFZGCJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,15,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964049,DTCC00429927,1587233,21124
CHEMBL213287,P23975,,SDLVJPBOBLQFEW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965610,DTCC00429825,1598973,21201
CHEMBL213287,P23975,,SDLVJPBOBLQFEW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964091,DTCC00429825,1587232,21124
CHEMBL213496,P23975,,VPVFIULLMFQQSH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,21,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964054,DTCC00429819,391382,21124
CHEMBL213632,P23975,,QJMPSMDQYHMYSR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,270,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965622,DTCC00429704,725704,21201
CHEMBL213754,P23975,,PSIGDYKJTYBHDY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,31,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965618,DTCC00110526,1275155,21201
CHEMBL213754,P23975,,PSIGDYKJTYBHDY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,31,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348377,DTCC00110526,1277527,39093
CHEMBL213785,P23975,,ULVITMXAXCXEQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,94,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964059,DTCC00429722,195568,21124
CHEMBL214003,P23975,,YTAOQYQJPVKYAI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,8.8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1963902,DTCC00430020,843626,21124
CHEMBL214004,P23975,,QVONDVLKKQSPCH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964043,DTCC00430021,1102521,21124
CHEMBL214021,P23975,,FVFURMJFTAJXRH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17234405,INHIBITION,=,48,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter receptor at 10uM,,"An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Iyengar RR, Lynch JK, Mulhern MM, Judd AS, Freeman JC, Gao J, Souers AJ, Zhao G, Wodka D, Doug Falls H, Brodjian S, Dayton BD, Reilly RM, Swanson S, Su Z, Martin RL, Leitza ST, Houseman KA, Diaz G, Collins CA, Sham HL, Kym PR",,421688,DTCT0023180,1995225,DTCC00434919,919397,21561
CHEMBL214056,P23975,,NXRPSLBPUSCIJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964044,DTCC00430022,972396,21124
CHEMBL214121,P23975,,XURYNEATXQVNNR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,25,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964057,DTCC00429720,746388,21124
CHEMBL214159,P23975,,NJCGBANIMWAYHY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964060,DTCC00429744,552687,21124
CHEMBL214209,P23975,,IRVGZJHWMUWHKA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,40,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955071,DTCC00428478,843598,20957
CHEMBL214209,P23975,,IRVGZJHWMUWHKA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,20,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955070,DTCC00428478,843598,20957
CHEMBL214237,P23975,,NIBIYLDNVMUKNB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,39,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965604,DTCC00110521,1967088,21201
CHEMBL214240,P23975,,LTKQGPSHVUGDKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,54,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965605,DTCC00110522,174941,21201
CHEMBL214259,P23975,,QYPSCQLKEMPYGY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,82,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964047,DTCC00429871,1037301,21124
CHEMBL214268,P23975,PHA-543613,IPKZCLGGYKRDES-ZDUSSCGKSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16821801,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human NE transporter at 1 uM,,"Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.",J. Med. Chem.,2006,49,14,"Wishka DG, Walker DP, Yates KM, Reitz SC, Jia S, Myers JK, Olson KL, Jacobsen EJ, Wolfe ML, Groppi VE, Hanchar AJ, Thornburgh BA, Cortes-Burgos LA, Wong EH, Staton BA, Raub TJ, Higdon NR, Wall TM, Hurst RS, Walters RR, Hoffmann WE, Hajos M, Franklin S, Carey G, Gold LH, Cook KK, Sands SB, Zhao SX, Soglia JR, Kalgutkar AS, Arneric SP, Rogers BN",,369033,DTCT0023180,1951636,DTCC00427596,1134622,20998
CHEMBL214273,P23975,,PGYQPHBCJVVZFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965609,DTCC00429795,855317,21201
CHEMBL214335,P23975,,PFTJCYRHNKTTTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965616,DTCC00110524,1916549,21201
CHEMBL214335,P23975,,PFTJCYRHNKTTTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348398,DTCC00110524,1918858,39093
CHEMBL214335,P23975,,PFTJCYRHNKTTTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348376,DTCC00110524,1918850,39093
CHEMBL214335,P23975,,PFTJCYRHNKTTTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,83,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348397,DTCC00110524,1918857,39093
CHEMBL214395,P23975,,QXDADQKWVQYGSQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964058,DTCC00429721,1165919,21124
CHEMBL2144958,P23975,,QNRODODTMXCRKU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22172704,INHIBITION,=,67,%,,,,,,,,,,,,,,Inhibition of human NET at 10 uM by radioligand displacement assay,,Discovery of a new molecular probe ML228: an activator of the hypoxia inducible factor (HIF) pathway.,Bioorg. Med. Chem. Lett.,2012,22,1,"Theriault JR, Felts AS, Bates BS, Perez JR, Palmer M, Gilbert SR, Dawson ES, Engers JL, Lindsley CW, Emmitte KA",,851769,DTCT0023180,11366643,DTCC01281341,1429932,50980
CHEMBL2152070,P23975,AM-1638,CHEANNSDVJOIBS-MHZLTWQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,INHIBITION,>,70,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM relative to control,,,ACS Med. Chem. Lett.,2013,4,6,,,960921,DTCT0023180,12452532,DTCC00045095,1656820,54625
CHEMBL215236,P23975,,MOULTCTZAHHVRO-WQLSENKSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16784855,KI,=,13.03,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,2006,16,17,"Zeng F, Jarkas N, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,395400,DTCT0023180,1974022,DTCC00432349,455079,21323
CHEMBL215376,P23975,,SIIICDNNMDMWCI-YJNKXOJESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24262882,KI,=,32.77,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin),,"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,2013,21,24,"Rami-Mark C, Bornatowicz B, Fink C, Otter P, Ungersboeck J, Vraka C, Haeusler D, Nics L, Spreitzer H, Hacker M, Mitterhauser M, Wadsak W",,1285652,DTCT0023180,12992716,DTCC00433606,298671,56861
CHEMBL2158704,P23975,,MYJQZBNYMUUXQI-HXUWFJFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22386241,INHIBITION,,,,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter at 10 uM,Not Active,Synthesis and pharmacological evaluation of carbamic acid 1-phenyl-3-(4-phenyl-piperazine-1-yl)-propyl ester derivatives as new analgesic agents.,Bioorg. Med. Chem. Lett.,2012,22,7,"Chae E, Yi H, Choi Y, Cho H, Lee K, Moon H",,856032,DTCT0023180,11373076,DTCC01287405,1812372,51025
CHEMBL215988,P23975,,MXCAKGCIGZRYGJ-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,855,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149712,DTCC00433578,1636198,23432
CHEMBL216015,P23975,,QRBFMQFAEQGJIW-ZROIWOOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16784855,KI,=,25.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,2006,16,17,"Zeng F, Jarkas N, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,395400,DTCT0023180,1974024,DTCC00432347,1393786,21323
CHEMBL2164371,P23975,,ICGMZCVSHDKQTE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22770500,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 10 uM by radioligand binding assay,Not Active,"3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.",J. Med. Chem.,2012,55,15,"Macsari I, Besidski Y, Csjernyik G, Nilsson LI, Sandberg L, Yngve U, Ahlin K, Bueters T, Eriksson AB, Lund PE, Venyike E, Oerther S, Hygge Blakeman K, Luo L, Arvidsson PI",,860729,DTCT0023180,11403830,DTCC01289836,641467,51252
CHEMBL2164389,P23975,,BECROBIDPQYXRW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22770500,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 10 uM by radioligand binding assay,Not Active,"3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.",J. Med. Chem.,2012,55,15,"Macsari I, Besidski Y, Csjernyik G, Nilsson LI, Sandberg L, Yngve U, Ahlin K, Bueters T, Eriksson AB, Lund PE, Venyike E, Oerther S, Hygge Blakeman K, Luo L, Arvidsson PI",,860729,DTCT0023180,11403831,DTCC01289855,1222079,51252
CHEMBL2165063,P23975,,VQECILSOQQFMKP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25155913,INHIBITION,=,61,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 30 uM,,Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa.,Bioorg. Med. Chem.,2014,22,19,"Reck F, Ehmann DE, Dougherty TJ, Newman JV, Hopkins S, Stone G, Agrawal N, Ciaccio P, McNulty J, Barthlow H, O'Donnell J, Goteti K, Breen J, Comita-Prevoir J, Cornebise M, Cronin M, Eyermann CJ, Geng B, Carr GR, Pandarinathan L, Tang X, Cottone A, Zhao L, Bezdenejnih-Snyder N",,1454242,DTCT0023180,13949311,DTCC01290469,849555,59769
CHEMBL2165447,P23975,,KZONDTNPVHWVKU-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,EFFICACY,=,97.2,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,880443,DTCT0023180,11471914,DTCC01290805,912917,51811
CHEMBL2165447,P23975,,KZONDTNPVHWVKU-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,191,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,880413,DTCT0023180,11471911,DTCC01290805,912917,51811
CHEMBL216736,P23975,,AHEMMEONOCHONP-DBUDALRPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17154506,KI,=,102.2,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,2006,49,23,"Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Owens MJ, Votaw JR, Goodman MM",,409351,DTCT0023180,1988931,DTCC00435243,78136,21461
CHEMBL216773,P23975,,NYBAGOILAMMUMR-NCHKHCDFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16302792,KI,=,627,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,2005,48,24,"Cha JH, Zou MF, Adkins EM, Rasmussen SG, Loland CJ, Schoenenberger B, Gether U, Newman AH",,326506,DTCT0023180,1868421,DTCC00408860,563951,20039
CHEMBL2169900,P23975,AZETIDIN-3-YL(PHENYL)METHANOL HCL,ABCUTHOEKRCYIS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,0.2,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410239,DTCC00045336,964193,51438
CHEMBL217053,P23975,,DMFOOUGJUFPBOG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17154491,INHIBITION,<,30,%,,,,,,,,,,,,,,Inhibition of human NE transporter at 10 uM,,Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.,J. Med. Chem.,2006,49,23,"Ulven T, Receveur JM, Grimstrup M, Rist Ø, Frimurer TM, Gerlach LO, Mathiesen JM, Kostenis E, Uller L, Högberg T",,408492,DTCT0023180,1989066,DTCC00434849,1949253,21450
CHEMBL2171209,P23975,,NYTOPNHZBPMVJZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,3.5,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410238,DTCC01292522,2091575,51438
CHEMBL2171210,P23975,3-(METHOXY(PHENYL)METHYL)AZETIDINE HCL,PBCQYBZENRQFON-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,1.5,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410237,DTCC00045337,446436,51438
CHEMBL2171211,P23975,3-(ETHOXY(PHENYL)METHYL)AZETIDINE HCL,QADQXQPJDYRHHG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,4.5,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410236,DTCC00045338,964196,51438
CHEMBL2171212,P23975,3-((4-CHLOROPHENYL)(METHOXY)METHYL)AZETIDINE HCL,VQJDDPXSICHYDO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,7.7,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410235,DTCC00045339,1255196,51438
CHEMBL2171213,P23975,3-((4-CHLOROPHENYL)(ETHOXY)METHYL)AZETIDINE HCL,GRGFMFALKDYCBN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410234,DTCC00045340,1482200,51438
CHEMBL2171214,P23975,"3-((3,4-DICHLOROPHENYL)(METHOXY)METHYL)AZETIDINE HCL",ULHAPYHRFNPZCO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,47,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410233,DTCC00045341,1800193,51438
CHEMBL2171408,P23975,"3-((3,4-DICHLOROPHENYL)(ETHOXY)METHYL)AZETIDINE HCL",FAVINESADHRZRB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,49,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410232,DTCC00045343,415801,51438
CHEMBL2171409,P23975,3-(PHENOXY(PHENYL)METHYL)AZETIDINE HCL,QNUHQFJRHPIXTE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,18,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410231,DTCC00045344,673617,51438
CHEMBL2171410,P23975,3-((4-CHLOROPHENYL)(PHENOXY)METHYL)AZETIDINE HCL,XDHXBWIHBPXIJQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,68,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410230,DTCC00045345,155369,51438
CHEMBL2171411,P23975,"3-((3,4-DICHLOROPHENYL)(PHENOXY)METHYL)AZETIDINE HCL",PGJNAAAPLQPFLU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,89,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410229,DTCC00045346,1896805,51438
CHEMBL2171412,P23975,3-((BENZYLOXY)(PHENYL)METHYL)AZETIDINE HCL,WTTOEXNCJGXGDZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,9.4,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410228,DTCC00045347,1028920,51438
CHEMBL2171413,P23975,3-((BENZYLOXY)(4-CHLOROPHENYL)METHYL)AZETIDINE HCL,VCDSAMDGVWEPBI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,16,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410227,DTCC00045348,1546693,51438
CHEMBL2171414,P23975,"3-((BENZYLOXY)(3,4-DICHLOROPHENYL)METHYL)AZETIDINE HCL",FNYDYQPDDZMXFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,30,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410226,DTCC00045349,1611436,51438
CHEMBL2171415,P23975,"3-((3,4-DICHLOROPHENYL)(PROPOXY)METHYL)AZETIDINE HCL",CLYPRUFOUBOJEJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,IC50,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863447,DTCT0023180,11410185,DTCC00045350,155370,51438
CHEMBL2171415,P23975,"3-((3,4-DICHLOROPHENYL)(PROPOXY)METHYL)AZETIDINE HCL",CLYPRUFOUBOJEJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,87,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410225,DTCC00045350,155370,51438
CHEMBL2171416,P23975,,JWNKMCJAUXMBAD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,IC50,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863447,DTCT0023180,11410184,DTCC00131355,1287750,51438
CHEMBL2171416,P23975,,JWNKMCJAUXMBAD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,87,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410224,DTCC00131355,1287750,51438
CHEMBL2171417,P23975,,XZKCSWMXTDEREX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,IC50,=,3.1,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863447,DTCT0023180,11410183,DTCC00131356,576440,51438
CHEMBL2171417,P23975,,XZKCSWMXTDEREX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,90,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410223,DTCC00131356,576440,51438
CHEMBL2171418,P23975,,XKYAZKCRLILWNB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,IC50,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863447,DTCT0023180,11410182,DTCC00131357,1578875,51438
CHEMBL2171418,P23975,,XKYAZKCRLILWNB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,79,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410222,DTCC00131357,1578875,51438
CHEMBL2171419,P23975,,YFIDHTXSPXGKFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,IC50,=,21,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863447,DTCT0023180,11410181,DTCC00131358,544386,51438
CHEMBL2171419,P23975,,YFIDHTXSPXGKFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,76,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410221,DTCC00131358,544386,51438
CHEMBL2171420,P23975,,FBCBBHPWZDGQBH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,81,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410220,DTCC00131359,1255206,51438
CHEMBL2172192,P23975,,CHVVPMVMKPMDFR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22664127,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to NET at 1 uM by radioligand displacement assay,Not Active,"Antagonists of 5-HT(6) receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.",Bioorg. Med. Chem. Lett.,2012,22,13,"Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Vorobiev AA, Okun I",,863374,DTCT0023180,11411327,DTCC01293389,576450,51365
CHEMBL21731,P23975,MAPROTILINE,QSLMDECMDJKHMQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,11.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733949,DTCC00155108,2105088,68566
CHEMBL21731,P23975,MAPROTILINE,QSLMDECMDJKHMQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,12,NM,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake at NET,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603447,DTCT0023180,3155573,DTCC00155108,1050949,36729
CHEMBL21731,P23975,MAPROTILINE,QSLMDECMDJKHMQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,30,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406293,DTCC00155108,1059332,46191
CHEMBL21731,P23975,MAPROTILINE,QSLMDECMDJKHMQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,30,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406294,DTCC00155108,1059332,46191
CHEMBL2179217,P23975,,ZPUAIXYROPYWKA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23006002,KI,=,2006,NM,,,,,,,,,,,,,,Binding affinity to NOR transporter,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012,55,21,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875716,DTCT0023180,11435582,DTCC01295975,641546,51583
CHEMBL2179222,P23975,,XRDVQWJPAZZLKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23006002,KI,=,2129,NM,,,,,,,,,,,,,,Binding affinity to NOR transporter,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012,55,21,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875716,DTCT0023180,11435581,DTCC01295978,1028954,51583
CHEMBL217928,P23975,,AKEDNWBVXPATHJ-LVXARBLLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,,,,,,,,,,,,,,,,,Inhibition of NET,Not Determined,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,341382,DTCC00439809,1048984,21742
CHEMBL217975,P23975,,ZBCBLJHLBKPDBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,330,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006055,DTCC00438180,435557,21696
CHEMBL217975,P23975,,ZBCBLJHLBKPDBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,1400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006269,DTCC00438180,435558,21696
CHEMBL217975,P23975,,ZBCBLJHLBKPDBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,3800,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006046,DTCC00438180,435557,21696
CHEMBL217975,P23975,,ZBCBLJHLBKPDBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,12000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006261,DTCC00438180,435558,21696
CHEMBL217987,P23975,,RKHFLVYZXJYWKW-RDPSFJRHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,95,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010366,DTCC00439855,1146451,21742
CHEMBL218082,P23975,,HNVGNUVAMRLMSG-JYVUQVBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,37.4,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043082,DTCC00434727,175059,22167
CHEMBL218082,P23975,,HNVGNUVAMRLMSG-JYVUQVBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,23,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043083,DTCC00434727,175059,22167
CHEMBL218174,P23975,,SLSRYMJCMOWUIE-RDPSFJRHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,257,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010365,DTCC00439856,337870,21742
CHEMBL2181924,P23975,,DNGYIBDXSUNKMV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22853801,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter at 100 nM,,New positron emission tomography (PET) radioligand for imaging s-1 receptors in living subjects.,J. Med. Chem.,2012,55,19,"James ML, Shen B, Zavaleta CL, Nielsen CH, Mesangeau C, Vuppala PK, Chan C, Avery BA, Fishback JA, Matsumoto RR, Gambhir SS, McCurdy CR, Chin FT",,873473,DTCT0023180,11455705,DTCC01298562,1832556,51519
CHEMBL218193,P23975,,OYPZJIHQZRPSNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,7100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006054,DTCC00438181,1631285,21696
CHEMBL218193,P23975,,OYPZJIHQZRPSNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,>,8700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006268,DTCC00438181,1631286,21696
CHEMBL218193,P23975,,OYPZJIHQZRPSNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,2500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006045,DTCC00438181,1631285,21696
CHEMBL218193,P23975,,OYPZJIHQZRPSNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,3200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006260,DTCC00438181,1631286,21696
CHEMBL218262,P23975,,UHVITKONHRHSFJ-FIPFOOKPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,876,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010359,DTCC00439874,1114117,21742
CHEMBL218568,P23975,,KHIUUVSTTUGPRZ-CUNXSJBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,1390,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010358,DTCC00439788,693492,21742
CHEMBL218581,P23975,,CVHOPXZORYBSMH-UNMCSNQZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,39,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010368,DTCC00439849,207059,21742
CHEMBL218847,P23975,,OICPVJMMZDEJMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,50,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005905,DTCC00438216,78169,21696
CHEMBL218847,P23975,,OICPVJMMZDEJMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006131,DTCC00438216,78171,21696
CHEMBL218847,P23975,,OICPVJMMZDEJMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005896,DTCC00438216,78169,21696
CHEMBL218847,P23975,,OICPVJMMZDEJMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,1400,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006122,DTCC00438216,78171,21696
CHEMBL218848,P23975,,SSUIQPFKMQJHGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,51,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005904,DTCC00438217,1852330,21696
CHEMBL218848,P23975,,SSUIQPFKMQJHGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,810,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005895,DTCC00438217,1852330,21696
CHEMBL218848,P23975,,SSUIQPFKMQJHGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,>,10000000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006136,DTCC00438217,1852331,21696
CHEMBL218849,P23975,,ZYPXTTXHMBCKFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005903,DTCC00438218,2015035,21696
CHEMBL218849,P23975,,ZYPXTTXHMBCKFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,180,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006130,DTCC00438218,2015036,21696
CHEMBL218849,P23975,,ZYPXTTXHMBCKFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,230,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005894,DTCC00438218,2015035,21696
CHEMBL218849,P23975,,ZYPXTTXHMBCKFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,1600,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006121,DTCC00438218,2015036,21696
CHEMBL218894,P23975,,HWQHDSKQNMHWMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,410,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006056,DTCC00438227,2047238,21696
CHEMBL218894,P23975,,HWQHDSKQNMHWMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,1600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006270,DTCC00438227,2047241,21696
CHEMBL218894,P23975,,HWQHDSKQNMHWMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,3100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006047,DTCC00438227,2047238,21696
CHEMBL218894,P23975,,HWQHDSKQNMHWMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,16000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006262,DTCC00438227,2047241,21696
CHEMBL218997,P23975,,FFTNCZSASXDDKK-FPOVZHCZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,37,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010304,DTCC00439827,499973,21742
CHEMBL218997,P23975,,FFTNCZSASXDDKK-FPOVZHCZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,46,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010369,DTCC00439827,499974,21742
CHEMBL218999,P23975,,MXBQNIQYUCTYND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006058,DTCC00438225,2047237,21696
CHEMBL218999,P23975,,MXBQNIQYUCTYND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006272,DTCC00438225,2047240,21696
CHEMBL218999,P23975,,MXBQNIQYUCTYND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,25,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006049,DTCC00438225,2047237,21696
CHEMBL218999,P23975,,MXBQNIQYUCTYND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,120,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006264,DTCC00438225,2047240,21696
CHEMBL219048,P23975,,WYKUNXLKNJTHND-UGKGYDQZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,233,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010367,DTCC00439850,1469898,21742
CHEMBL219116,P23975,,DJLLHNLJLSEKHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005908,DTCC00438189,629042,21696
CHEMBL219116,P23975,,DJLLHNLJLSEKHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,1400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006134,DTCC00438189,629043,21696
CHEMBL219116,P23975,,DJLLHNLJLSEKHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,110,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005899,DTCC00438189,629042,21696
CHEMBL219116,P23975,,DJLLHNLJLSEKHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,>,6100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006125,DTCC00438189,629043,21696
CHEMBL219146,P23975,VINDESINE,HHJUWIANJFBDHT-KOTLKJBCSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7443338,DTCC00110817,833166,46191
CHEMBL219146,P23975,VINDESINE,HHJUWIANJFBDHT-KOTLKJBCSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7443339,DTCC00110817,833166,46191
CHEMBL219224,P23975,,BMRJUXFHOOHDBF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,35,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005907,DTCC00438190,207053,21696
CHEMBL219224,P23975,,BMRJUXFHOOHDBF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,3200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006133,DTCC00438190,207054,21696
CHEMBL219224,P23975,,BMRJUXFHOOHDBF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,360,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005898,DTCC00438190,207053,21696
CHEMBL219224,P23975,,BMRJUXFHOOHDBF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,>,6300,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006124,DTCC00438190,207054,21696
CHEMBL219281,P23975,,QUVNADBNAUIISW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,610,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006176,DTCC00438199,887591,21696
CHEMBL219281,P23975,,QUVNADBNAUIISW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,680,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005982,DTCC00438199,887589,21696
CHEMBL219281,P23975,,QUVNADBNAUIISW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,1800,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005972,DTCC00438199,887589,21696
CHEMBL219281,P23975,,QUVNADBNAUIISW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,2400,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006184,DTCC00438199,887591,21696
CHEMBL219334,P23975,,ISSWMAXVWUPHQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,330,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005980,DTCC00438207,337865,21696
CHEMBL219334,P23975,,ISSWMAXVWUPHQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,3800,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006174,DTCC00438207,337866,21696
CHEMBL219334,P23975,,ISSWMAXVWUPHQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,970,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005970,DTCC00438207,337865,21696
CHEMBL219334,P23975,,ISSWMAXVWUPHQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,4300,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006182,DTCC00438207,337866,21696
CHEMBL219335,P23975,,BRQZSYKMAXVFLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,14,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005978,DTCC00438209,1566494,21696
CHEMBL219335,P23975,,BRQZSYKMAXVFLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,73,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006172,DTCC00438209,1566495,21696
CHEMBL219335,P23975,,BRQZSYKMAXVFLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005968,DTCC00438209,1566494,21696
CHEMBL219335,P23975,,BRQZSYKMAXVFLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,340,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006180,DTCC00438209,1566495,21696
CHEMBL219540,P23975,,IYNBYQDXVFMDGE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,220,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006053,DTCC00438182,467178,21696
CHEMBL219540,P23975,,IYNBYQDXVFMDGE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,2700,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006044,DTCC00438182,467178,21696
CHEMBL219649,P23975,,USGRALLMTYXJMV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,8.1,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006060,DTCC00438235,855377,21696
CHEMBL219649,P23975,,USGRALLMTYXJMV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,47,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006274,DTCC00438235,855379,21696
CHEMBL219649,P23975,,USGRALLMTYXJMV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,3.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006051,DTCC00438235,855377,21696
CHEMBL219649,P23975,,USGRALLMTYXJMV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006266,DTCC00438235,855379,21696
CHEMBL219653,P23975,,IHBJHYKTBCSULK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,310,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005985,DTCC00438171,370472,21696
CHEMBL219653,P23975,,IHBJHYKTBCSULK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,730,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006179,DTCC00438171,370473,21696
CHEMBL219653,P23975,,IHBJHYKTBCSULK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,1700,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005975,DTCC00438171,370472,21696
CHEMBL219653,P23975,,IHBJHYKTBCSULK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,2600,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006187,DTCC00438171,370473,21696
CHEMBL219703,P23975,,PAZWPXLTYQROKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,49,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005901,DTCC00438245,1725208,21696
CHEMBL219703,P23975,,PAZWPXLTYQROKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,860,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006128,DTCC00438245,1725209,21696
CHEMBL219703,P23975,,PAZWPXLTYQROKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,160,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005892,DTCC00438245,1725208,21696
CHEMBL219703,P23975,,PAZWPXLTYQROKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,1500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006119,DTCC00438245,1725209,21696
CHEMBL219707,P23975,,ZTZXXNVAKZPHBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,940,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005984,DTCC00438172,855376,21696
CHEMBL219707,P23975,,ZTZXXNVAKZPHBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,1700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006178,DTCC00438172,855378,21696
CHEMBL219707,P23975,,ZTZXXNVAKZPHBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,4200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005974,DTCC00438172,855376,21696
CHEMBL219707,P23975,,ZTZXXNVAKZPHBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,4300,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006186,DTCC00438172,855378,21696
CHEMBL219916,P23975,DOMPERIDONE,FGXWKSZFVQUSTL-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2614,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366406,DTCC00437363,898287,46191
CHEMBL219916,P23975,DOMPERIDONE,FGXWKSZFVQUSTL-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2593,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366407,DTCC00437363,898287,46191
CHEMBL220195,P23975,,JUKMAYKVHWKRKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006061,DTCC00438234,887590,21696
CHEMBL220195,P23975,,JUKMAYKVHWKRKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,190,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006275,DTCC00438234,887592,21696
CHEMBL220195,P23975,,JUKMAYKVHWKRKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,14,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006052,DTCC00438234,887590,21696
CHEMBL220195,P23975,,JUKMAYKVHWKRKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,4200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006267,DTCC00438234,887592,21696
CHEMBL220247,P23975,,UWHKVOABKKOHHU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,120,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005902,DTCC00438244,822476,21696
CHEMBL220247,P23975,,UWHKVOABKKOHHU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,750,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006129,DTCC00438244,822477,21696
CHEMBL220247,P23975,,UWHKVOABKKOHHU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,840,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005893,DTCC00438244,822476,21696
CHEMBL220247,P23975,,UWHKVOABKKOHHU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,4500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006120,DTCC00438244,822477,21696
CHEMBL2203551,P23975,,JUWUZLUBIRHYMM-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,EFFICACY,=,95.9,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,880443,DTCT0023180,11471915,DTCC01298943,621402,51811
CHEMBL2203551,P23975,,JUWUZLUBIRHYMM-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,203,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,880413,DTCT0023180,11471910,DTCC01298943,621402,51811
CHEMBL2203713,P23975,,BLZNLOLTHDUEOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22840695,INHIBITION,=,18,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins,,"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.",Eur. J. Med. Chem.,2012,55,,"Annedi SC, Maddaford SP, Ramnauth J, Renton P, Rybak T, Silverman S, Rakhit S, Mladenova G, Dove P, Andrews JS, Zhang D, Porreca F",,883010,DTCT0023180,11458186,DTCC00131535,738126,51915
CHEMBL2204341,P23975,RAC-SILA-VENLAFAXINE,KIXBFSFRCBHKLN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21413808,IC50,=,109,NM,,,,,,,,,,,,,,Inhibition of NET,,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,2011,54,8,,,879332,DTCT0023180,11458830,DTCC00045534,1417992,51826
CHEMBL2204341,P23975,RAC-SILA-VENLAFAXINE,KIXBFSFRCBHKLN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23061607,IC50,=,109,NM,,,,,,,,,,,,,,Inhibition of NET (unknown origin) assessed as noradrenaline reuptake,,Organosilicon molecules with medicinal applications.,J. Med. Chem.,2013,56,2,"Franz AK, Wilson SO",,934616,DTCT0023180,11751469,DTCC00045534,1418356,52878
CHEMBL2204342,P23975,(S)-SILA-VENLAFAXINE,KIXBFSFRCBHKLN-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21413808,IC50,=,4715,NM,,,,,,,,,,,,,,Inhibition of NET,,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,2011,54,8,,,879332,DTCT0023180,11458821,DTCC00045535,251903,51826
CHEMBL2204360,P23975,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21486038,INHIBITION,=,88,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880221,DTCT0023180,11459019,DTCC01299713,1748126,51828
CHEMBL2205811,P23975,,ZKOQRCXMSDAJIR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,=,3638,NM,,,,,,,,,,,,,,Binding affinity to NET,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472831,DTCC01301027,1267730,51935
CHEMBL2205812,P23975,,TWMXGXSGGIIQDM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to NET,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472810,DTCC01301028,556858,51935
CHEMBL2205813,P23975,,FOTUXOOYRRRHFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884047,DTCT0023180,11474476,DTCC01301029,1688236,51935
CHEMBL2205814,P23975,,KULMFBVVFDTVNX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472787,DTCC01301030,1623988,51935
CHEMBL2205815,P23975,,MYZBXDLMEOAPIJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472771,DTCC01301031,1876967,51935
CHEMBL2205816,P23975,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472747,DTCC01301032,880294,51935
CHEMBL2205816,P23975,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12598260,DTCC01301032,881049,55935
CHEMBL2205817,P23975,,GFQHCUYWLHSGJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472736,DTCC01301033,912942,51935
CHEMBL2205818,P23975,,VTLZIWJSKWWYHL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472721,DTCC01301034,1106585,51935
CHEMBL2205819,P23975,,GOYQRMVWIWPDFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11477199,DTCC01301035,1170086,51935
CHEMBL2205820,P23975,,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11422202,DTCC01301036,1559073,51935
CHEMBL2205820,P23975,,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12600275,DTCC01301036,1559919,55935
CHEMBL2205821,P23975,,DHQYUPWRESNGBC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11427112,DTCC01301037,362894,51935
CHEMBL2205822,P23975,,CUIQKJJPRAKRJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11461299,DTCC01301038,1844780,51935
CHEMBL2205823,P23975,,WWXCWTRLUXMAHX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884047,DTCT0023180,11475944,DTCC01301039,1780156,51935
CHEMBL2205824,P23975,,LIKZWSUAMNZHAE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11474238,DTCC01301040,1688238,51935
CHEMBL2205825,P23975,,GYKFQDQFKGGVKD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11474225,DTCC01301041,750568,51935
CHEMBL2205826,P23975,,TVDFWGUKMIRJAD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11474207,DTCC01301042,750569,51935
CHEMBL2205827,P23975,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to NET,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11473007,DTCC01301043,1812524,51935
CHEMBL2205827,P23975,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12600307,DTCC01301043,1813367,55935
CHEMBL2205828,P23975,,QUMVESOWCHBEEV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11473002,DTCC01301044,1234798,51935
CHEMBL2205829,P23975,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472979,DTCC01301045,330310,51935
CHEMBL2205829,P23975,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12600273,DTCC01301045,331095,55935
CHEMBL2205830,P23975,,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472962,DTCC01301046,1494712,51935
CHEMBL2205830,P23975,,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12600274,DTCC01301046,1495531,55935
CHEMBL2205831,P23975,,RRBNCHNWWUXYEM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884047,DTCT0023180,11475839,DTCC01301047,556859,51935
CHEMBL2205831,P23975,,RRBNCHNWWUXYEM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601137,DTCC01301047,557648,55935
CHEMBL2205832,P23975,,ZUHLFYHHSNMSRE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884047,DTCT0023180,11475806,DTCC01301048,589038,51935
CHEMBL2205833,P23975,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884047,DTCT0023180,11475767,DTCC01301049,2039955,51935
CHEMBL2205833,P23975,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601138,DTCC01301049,2040747,55935
CHEMBL2205834,P23975,,QFMGHZDEZHDVJJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472906,DTCC01301050,167654,51935
CHEMBL2205835,P23975,,FPHVMMXTLGSYHV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472877,DTCC01301051,1623989,51935
CHEMBL2205835,P23975,,FPHVMMXTLGSYHV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12600277,DTCC01301051,1624817,55935
CHEMBL2205836,P23975,,PSBBAGWMKGXQRW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,=,9905,NM,,,,,,,,,,,,,,Binding affinity to NET,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11472851,DTCC01301052,1041425,51935
CHEMBL2206397,P23975,RO-4992479,NIRASHDWADNQJU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22795332,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human NE transporter at 10 uM by CEREP assay,,Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.,Bioorg. Med. Chem. Lett.,2012,22,16,"Galley G, Stalder H, Goergler A, Hoener MC, Norcross RD",,881984,DTCT0023180,11478572,DTCC00045622,835169,51910
CHEMBL2206507,P23975,,ZXQHLFVRUPRIEJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,5,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461603,DTCC01301700,102997,52000
CHEMBL2206508,P23975,,TWJQHLGFNXDIDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,5.8,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461602,DTCC01301701,29540,52000
CHEMBL2206509,P23975,,APTVKHQLUJFYAC-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,7.1,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461601,DTCC01301702,29635,52000
CHEMBL2206510,P23975,,NNPFARQTHIIRJL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,47,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461600,DTCC01301703,297670,52000
CHEMBL2206511,P23975,,QREUWDKINMWLMS-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,35,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461599,DTCC01301704,135390,52000
CHEMBL2206512,P23975,,SUYOCKAQLJWIGF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,100,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461632,DTCC01301705,102998,52000
CHEMBL2206513,P23975,,OBCHZURPAABPDI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,136,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461631,DTCC01301706,492501,52000
CHEMBL2206514,P23975,,AUOGWJKRNSZLMZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,137,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461630,DTCC01301707,1267735,52000
CHEMBL2206515,P23975,,NNVATDBGKYTMIL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,238,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461629,DTCC01301708,1430108,52000
CHEMBL2206516,P23975,,HEKXQZYFIMYCKA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,35,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461628,DTCC01301709,1202338,52000
CHEMBL2206517,P23975,,PPWGBAKMSRMGKP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,54,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461627,DTCC01301710,621431,52000
CHEMBL2206518,P23975,,DBOZEPCLJKANCL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,31.8,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461626,DTCC01301711,1688245,52000
CHEMBL2206519,P23975,,PUZGOXIAHPOFIX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,115,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461625,DTCC01301712,1844794,52000
CHEMBL2206520,P23975,,ZBINDVNASLJSJF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,116,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461623,DTCC01301713,1397976,52000
CHEMBL2206521,P23975,,QNWBLRHWGDFQHE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,1020,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461622,DTCC01301714,102999,52000
CHEMBL2206522,P23975,,PUACBDCIAIMRLD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,806,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461621,DTCC01301715,1719588,52000
CHEMBL2206523,P23975,,UIVAIANIXTWVHO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,28,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461618,DTCC01301716,264503,52000
CHEMBL2206523,P23975,,UIVAIANIXTWVHO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,630,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461617,DTCC01301716,264504,52000
CHEMBL2206524,P23975,,SPUPMMOBNUTZEB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,12.3,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461616,DTCC01301717,19698,52000
CHEMBL2206525,P23975,,FZJAPDJONFNIEV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,7.2,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461615,DTCC01301718,1876971,52000
CHEMBL2206526,P23975,,LZYIBOJIMRPXNJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,4.4,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461614,DTCC01301719,459290,52000
CHEMBL2206527,P23975,,OBNBMYWZKYYXNS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,13.5,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461613,DTCC01301720,70688,52000
CHEMBL2206528,P23975,,RUBLHLUAVCRNAN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,37,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461612,DTCC01301721,2007357,52000
CHEMBL2206529,P23975,,DQNPRNKGUDQMJY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,19,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461611,DTCC01301722,1559082,52000
CHEMBL2206530,P23975,,LULUPYXXDWTNNO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,29,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461610,DTCC01301723,621432,52000
CHEMBL2206531,P23975,,KNAQCUBNCHCAPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461609,DTCC01301724,1073918,52000
CHEMBL2206532,P23975,,KYUYTLMYZDCTDV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,7.3,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461608,DTCC01301725,847856,52000
CHEMBL2206533,P23975,,HYXFPJJRAOYSTI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,16.5,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461607,DTCC01301726,1559083,52000
CHEMBL2206534,P23975,,WBMAKFNAAWXWBA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461606,DTCC01301727,232075,52000
CHEMBL2206535,P23975,,LJEZBJASWTZZEM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,15,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461605,DTCC01301728,621433,52000
CHEMBL2206536,P23975,,WUPUWAHXLJUMFK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,14,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461604,DTCC01301729,685974,52000
CHEMBL220713,P23975,,VCYYAUWOLSKMPO-CUNXSJBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,317,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010354,DTCC00439799,1275232,21742
CHEMBL2207376,P23975,,MJYQMQCVUXOIFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912,INHIBITION,=,13.5,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892,DTCT0023180,11493421,DTCC01302559,750581,52134
CHEMBL2207382,P23975,,MBFLODNVCSXSKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912,INHIBITION,=,6.78,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892,DTCT0023180,11493420,DTCC01302565,1041441,52134
CHEMBL2207386,P23975,,AGKMPGSBLMAGAX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912,INHIBITION,=,10.83,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892,DTCT0023180,11493423,DTCC01302569,718295,52134
CHEMBL2207388,P23975,,CULSPSVPJXBZMJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912,INHIBITION,=,10.16,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892,DTCT0023180,11493422,DTCC01302571,814971,52134
CHEMBL220765,P23975,,MOOPIJCZPWGNKW-FIPFOOKPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,524,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010353,DTCC00439800,1405569,21742
CHEMBL220766,P23975,,FVWTYUWMRRCCPG-CPJSRVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,388,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010349,DTCC00439816,1820231,21742
CHEMBL220801,P23975,,AEEJHYWVYVJIRH-OFVILXPXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,1820,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010361,DTCC00439868,855386,21742
CHEMBL220819,P23975,,UCYBGEFJKJSJQI-HOFKKMOUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,3449,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010363,DTCC00439862,467183,21742
CHEMBL221067,P23975,,SHAKAEUQTANHLB-NVQXNPDNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,4168,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010364,DTCC00439861,1663588,21742
CHEMBL221753,P23975,BENZETHONIUM CHLORIDE,UREZNYTWGJKWBI-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,907,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7259734,DTCC00440345,120969,46191
CHEMBL221753,P23975,BENZETHONIUM CHLORIDE,UREZNYTWGJKWBI-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,900,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7259735,DTCC00440345,120969,46191
CHEMBL22183,P23975,,UABIXNSHHIMZEP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,320.4,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822317,DTCC00155377,1295730,19630
CHEMBL22183,P23975,,UABIXNSHHIMZEP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,61,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809410,DTCC00155377,1307496,19300
CHEMBL22183,P23975,,UABIXNSHHIMZEP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901119,DTCC00155377,1295916,20463
CHEMBL22183,P23975,,UABIXNSHHIMZEP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18793858,KI,=,325,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,2008,16,19,"Mavel S, Vercouillie J, Garreau L, Raguza T, Ravna AW, Chalon S, Guilloteau D, Emond P",,492712,DTCT0023180,2458490,DTCC00155377,1297312,32562
CHEMBL221886,P23975,SISOMICIN,URWAJWIAIPFPJE-YFMIWBNJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7484352,DTCC00443300,703986,46191
CHEMBL221886,P23975,SISOMICIN,URWAJWIAIPFPJE-YFMIWBNJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7484353,DTCC00443300,703986,46191
CHEMBL221903,P23975,,AZOHUEDNMOIDOC-NVQXNPDNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,1230,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010362,DTCC00439867,2079320,21742
CHEMBL221993,P23975,,MMKZDDDDODERSJ-JAAVRUMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,3850,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043049,DTCC00445276,1982248,22167
CHEMBL221993,P23975,,MMKZDDDDODERSJ-JAAVRUMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,1930,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043050,DTCC00445276,1982248,22167
CHEMBL2220427,P23975,ERYTHROMYCIN ESTOLATE,TYQXKHPOXXXCTP-CSLYCKPJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7336921,DTCC01305390,639579,46191
CHEMBL2220427,P23975,ERYTHROMYCIN ESTOLATE,TYQXKHPOXXXCTP-CSLYCKPJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7336922,DTCC01305390,639579,46191
CHEMBL2220442,P23975,FLUVASTATIN,FJLGEFLZQAZZCD-VAWYXSNFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7307894,DTCC01305406,1059330,46191
CHEMBL2220442,P23975,FLUVASTATIN,FJLGEFLZQAZZCD-VAWYXSNFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7309920,DTCC01305406,1059330,46191
CHEMBL222705,P23975,,QUSLQENMLDRCTO-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,1200,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043074,DTCC00445218,337940,22167
CHEMBL222705,P23975,,QUSLQENMLDRCTO-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,741,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043075,DTCC00445218,337940,22167
CHEMBL222787,P23975,,LQDARHFLRKPAMM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17367122,INHIBITION,=,80,%,,cell_based,,,,,,,,,,,CHO,Displacement of radiolabeled protriptyline from human recombinant NET expressed in CHO cells at 10 uM,,Designing active template molecules by combining computational de novo design and human chemist's expertise.,J. Med. Chem.,2007,50,8,"Lameijer EW, Tromp RA, Spanjersberg RF, Brussee J, Ijzerman AP",,429319,DTCT0023180,2035642,DTCC00443726,131277,22123
CHEMBL222863,P23975,OUABAIN,LPMXVESGRSUGHW-HBYQJFLCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7375855,DTCC00444362,1059335,46191
CHEMBL222863,P23975,OUABAIN,LPMXVESGRSUGHW-HBYQJFLCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7375856,DTCC00444362,1059335,46191
CHEMBL223058,P23975,,MPEVJCKYRIDFRP-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17123820,KI,=,8.29,NM,,,,,,,,,,,,,,Binding affinity at NET,,Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.,Bioorg. Med. Chem.,2007,15,2,"Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C",,432854,DTCT0023180,2059436,DTCC00447390,228144,22425
CHEMBL223166,P23975,,MZGJHBJKODTIQM-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17123820,KI,=,7.93,NM,,,,,,,,,,,,,,Binding affinity at NET,,Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.,Bioorg. Med. Chem.,2007,15,2,"Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C",,432854,DTCT0023180,2059437,DTCC00447407,1069964,22425
CHEMBL223166,P23975,,MZGJHBJKODTIQM-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17983754,KI,=,0.95,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,2008,16,2,"Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,466322,DTCT0023180,2290051,DTCC00447407,1086913,25467
CHEMBL223166,P23975,,MZGJHBJKODTIQM-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19067522,KI,=,0.95,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,2009,52,1,"Zeng F, Mun J, Jarkas N, Stehouwer JS, Voll RJ, Tamagnan GD, Howell L, Votaw JR, Kilts CD, Nemeroff CB, Goodman MM",,560274,DTCT0023180,2450471,DTCC00447407,1070820,31766
CHEMBL224062,P23975,,ZCJYSKHDYKCJTO-MOUZIVPDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,282,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050409,DTCC00445540,326266,22251
CHEMBL224062,P23975,,ZCJYSKHDYKCJTO-MOUZIVPDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,191,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050410,DTCC00445540,326266,22251
CHEMBL224771,P23975,,YJWQTICONBXOHT-KOQKOIQBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,480,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050420,DTCC00445673,1393914,22251
CHEMBL224771,P23975,,YJWQTICONBXOHT-KOQKOIQBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,280,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050421,DTCC00445673,1393914,22251
CHEMBL224819,P23975,,HNVGNUVAMRLMSG-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,32.4,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043070,DTCC00445232,1787762,22167
CHEMBL224819,P23975,,HNVGNUVAMRLMSG-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,16.2,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043071,DTCC00445232,1787762,22167
CHEMBL225235,P23975,,RYRHNOGQFYLMHQ-KOQKOIQBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,132,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050403,DTCC00445551,1872944,22251
CHEMBL225235,P23975,,RYRHNOGQFYLMHQ-KOQKOIQBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,61,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050404,DTCC00445551,1872944,22251
CHEMBL2252949,P23975,(-)-CAMPHOR,DSSYKIVIOFKYAU-OIBJUYFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418534,DTCC01315138,510302,46191
CHEMBL2252949,P23975,(-)-CAMPHOR,DSSYKIVIOFKYAU-OIBJUYFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7418535,DTCC01315138,510302,46191
CHEMBL22587,P23975,ITRACONAZOLE,VHVPQPYKVGDNFY-ZPGVKDDISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7411841,DTCC01738573,51481,46191
CHEMBL22587,P23975,ITRACONAZOLE,VHVPQPYKVGDNFY-ZPGVKDDISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7411842,DTCC01738573,51481,46191
CHEMBL226335,P23975,RUTIN,IKGXIBQEEMLURG-NVPNHPEKSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14750355,DTCC00448737,2109891,69275
CHEMBL226933,P23975,,LAVPLSGMUSPWHO-BQUSRXHISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,1810,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115146,DTCC00452934,1663767,23035
CHEMBL226933,P23975,,LAVPLSGMUSPWHO-BQUSRXHISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,3630,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115092,DTCC00452934,1663767,23035
CHEMBL226984,P23975,,UYCWPYLNAMMOLO-NQAVQENRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,2040,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115147,DTCC00452920,1820408,23035
CHEMBL226984,P23975,,UYCWPYLNAMMOLO-NQAVQENRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,990,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115093,DTCC00452920,1820408,23035
CHEMBL227179,P23975,RTI-219,WEUZYHQNGQDGAB-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,750,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115053,DTCC00002836,919631,23035
CHEMBL227179,P23975,RTI-219,WEUZYHQNGQDGAB-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,1840,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115050,DTCC00002836,919631,23035
CHEMBL227180,P23975,,RUZFACWXYQTPTF-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,912,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115160,DTCC00452904,984417,23035
CHEMBL227180,P23975,,RUZFACWXYQTPTF-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,2700,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115106,DTCC00452904,984417,23035
CHEMBL227231,P23975,,DRLOWUSIOOIRRD-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,2300,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115158,DTCC00452906,1725425,23035
CHEMBL227231,P23975,,DRLOWUSIOOIRRD-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,2530,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115104,DTCC00452906,1725425,23035
CHEMBL227232,P23975,,YTNASRCFNXLDGR-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,582,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115157,DTCC00452907,272474,23035
CHEMBL227232,P23975,,YTNASRCFNXLDGR-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,2270,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115103,DTCC00452907,272474,23035
CHEMBL227233,P23975,,PQQIGLGAWBKHRP-NQAVQENRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,620,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115155,DTCC00452909,1016679,23035
CHEMBL227233,P23975,,PQQIGLGAWBKHRP-NQAVQENRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,1270,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115101,DTCC00452909,1016679,23035
CHEMBL227934,P23975,STRYCHNINE,QMGVPVSNSZLJIA-FVWCLLPLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486731,DTCC00448002,1092350,46191
CHEMBL227934,P23975,STRYCHNINE,QMGVPVSNSZLJIA-FVWCLLPLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486732,DTCC00448002,1092350,46191
CHEMBL229381,P23975,,CACJYDSRIOGEJW-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,1170,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115151,DTCC00452915,952065,23035
CHEMBL229381,P23975,,CACJYDSRIOGEJW-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,2870,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115097,DTCC00452915,952065,23035
CHEMBL229383,P23975,NYSTATIN,VQOXZBDYSJBXMA-VHFLTRTASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7375759,DTCC00451716,51495,46191
CHEMBL229383,P23975,NYSTATIN,VQOXZBDYSJBXMA-VHFLTRTASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7375760,DTCC00451716,51495,46191
CHEMBL229429,P23975,,WTLBLIGPXACYET-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17571866,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxitine from NET,,Synthesis and simple 18F-labeling of 3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with positron emission tomography.,J. Med. Chem.,2007,50,14,"Siméon FG, Brown AK, Zoghbi SS, Patterson VM, Innis RB, Pike VW",,439699,DTCT0023180,2110799,DTCC00452403,403579,22982
CHEMBL229436,P23975,,JERGWFJDGWCPDJ-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,1550,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115148,DTCC00452919,110602,23035
CHEMBL229436,P23975,,JERGWFJDGWCPDJ-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,1970,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115094,DTCC00452919,110602,23035
CHEMBL229699,P23975,,IWJUZLMNKAYNPQ-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,4870,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115152,DTCC00452914,1114280,23035
CHEMBL229699,P23975,,IWJUZLMNKAYNPQ-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,1630,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115098,DTCC00452914,1114280,23035
CHEMBL23,P23975,DILTIAZEM,HSUGRBWQSSZJOP-RTWAWAEBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7359758,DTCC00133282,866019,46191
CHEMBL23,P23975,DILTIAZEM,HSUGRBWQSSZJOP-RTWAWAEBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7359759,DTCC00133282,866019,46191
CHEMBL230000,P23975,,RXBAZUHMGOEBGO-CLFYSBASSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17705359,KI,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Binding affinity to human NET expressed in HEK293 cells,,Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.,J. Med. Chem.,2007,50,19,"Plisson C, Stehouwer JS, Voll RJ, Howell L, Votaw JR, Owens MJ, Goodman MM",,445752,DTCT0023180,2125119,DTCC00457694,163956,23541
CHEMBL23034,P23975,,KPKLDBBNSFWOFA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15456270,KI,=,699,NM,,cell_based,,,,,,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,2004,47,21,"Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP",,303519,DTCT0023180,1792716,DTCC00155518,616789,19119
CHEMBL23034,P23975,,KPKLDBBNSFWOFA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,1352,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822200,DTCC00155518,616856,19630
CHEMBL23034,P23975,,KPKLDBBNSFWOFA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,699,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809654,DTCC00155518,628600,19300
CHEMBL230951,P23975,L-HOMOCYSTEATE,VBOQYPQEPHKASR-VKHMYHEASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730850,DTCC00002972,2104237,69159
CHEMBL2311152,P23975,[3H]NOREPINEPHRINE,SFLSHLFXELFNJZ-CMIMLBRMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17428804,KM,=,690,NM,,cell_based,,,,,,,,,,,,Binding affinity to human wild type NET expressed in african green monkey COS1 cells,,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,2007,282,24,"Paczkowski FA, Sharpe IA, Dutertre S, Lewis RJ",,505498,DTCT0023180,2401682,DTCC01335025,339144,29252
CHEMBL2311152,P23975,[3H]NOREPINEPHRINE,SFLSHLFXELFNJZ-CMIMLBRMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17428804,VMAX,=,1.78,PMOL/MIN,,cell_based,,,,,,,,,,,,Activity at human wild type NET expressed in african green monkey COS1 cells assessed per mg protein,,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,2007,282,24,"Paczkowski FA, Sharpe IA, Dutertre S, Lewis RJ",,505497,DTCT0023180,2401694,DTCC01335025,339144,29252
CHEMBL2313297,P23975,,CUWBKAWUQFYRQI-RMKNXTFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23281824,INHIBITION,=,57,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins by scintillation counting analysis,,Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitors.,J. Med. Chem.,2013,56,3,"Rivara S, Piersanti G, Bartoccini F, Diamantini G, Pala D, Riccioni T, Stasi MA, Cabri W, Borsini F, Mor M, Tarzia G, Minetti P",,935770,DTCT0023180,11761070,DTCC01336743,1962396,53344
CHEMBL231684,P23975,,OJEXZTOASHOTIX-WOJBJXKFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,51000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2150083,DTCC00461143,1280192,23432
CHEMBL231809,P23975,,OLBSGDZXLHSPOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443462,DTCT0023180,2159611,DTCC00463291,855880,23363
CHEMBL231858,P23975,,BGHABJXKIQKRJZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,339000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149693,DTCC00460890,1857121,23432
CHEMBL231858,P23975,,BGHABJXKIQKRJZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,871000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150027,DTCC00460890,1857121,23432
CHEMBL232068,P23975,,BLAXQDSTBRMZPC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,10000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150026,DTCC00460892,83042,23432
CHEMBL232068,P23975,,BLAXQDSTBRMZPC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,81000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149692,DTCC00460892,83042,23432
CHEMBL232069,P23975,,DMFIBBAULMICJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,215000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149691,DTCC00460893,1889399,23432
CHEMBL232069,P23975,,DMFIBBAULMICJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150050,DTCC00460893,1889399,23432
CHEMBL232070,P23975,,ARUHQVGRDPJNBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,1100000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149690,DTCC00460895,147843,23432
CHEMBL232070,P23975,,ARUHQVGRDPJNBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150049,DTCC00460895,147843,23432
CHEMBL232104,P23975,,BRIVIXLMMUIBJY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17606674,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of NET at 10 uM,Not Active,"Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.",Antimicrob. Agents Chemother.,2007,51,10,"Van Voorhis WC, Rivas KL, Bendale P, Nallan L, Hornéy C, Barrett LK, Bauer KD, Smart BP, Ankala S, Hucke O, Verlinde CL, Chakrabarti D, Strickland C, Yokoyama K, Buckner FS, Hamilton AD, Williams DK, Lombardo LJ, Floyd D, Gelb MH",,498996,DTCT0023180,2717333,DTCC00461356,1166865,34114
CHEMBL2321990,P23975,,XXTLAOZBJDRYIU-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,49,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783929,DTCC01340345,1688614,53459
CHEMBL2321991,P23975,,NFEQUCGNNCYRCD-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3.3,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783928,DTCC01340346,492867,53459
CHEMBL2321992,P23975,,NFEQUCGNNCYRCD-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,250,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783927,DTCC01340347,363293,53459
CHEMBL2321993,P23975,,QLSUBNPMUSWHLS-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783926,DTCC01340348,232510,53459
CHEMBL2321994,P23975,,QLSUBNPMUSWHLS-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,430,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783925,DTCC01340349,1974958,53459
CHEMBL2321995,P23975,,NTSBDQLGAZMMFC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,57,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783950,DTCC01340350,1624397,53459
CHEMBL2321996,P23975,,NTSBDQLGAZMMFC-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,12,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783949,DTCC01340351,1139347,53459
CHEMBL2321997,P23975,,NTSBDQLGAZMMFC-LLVKDONJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,54,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783948,DTCC01340352,20748,53459
CHEMBL2321998,P23975,,PMLBVCPRUZMORG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,66,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783947,DTCC01340353,103407,53459
CHEMBL2321999,P23975,,PMLBVCPRUZMORG-JTQLQIEISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,17,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783946,DTCC01340354,654201,53459
CHEMBL2322000,P23975,,PMLBVCPRUZMORG-SNVBAGLBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,24,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783945,DTCC01340355,782995,53459
CHEMBL2322001,P23975,,APQGMQHBIOJWDO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,25,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783944,DTCC01340356,1430458,53459
CHEMBL2322002,P23975,,YSGVIJFMBOEZJZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,83,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783943,DTCC01340357,459712,53459
CHEMBL232299,P23975,,FDYWMYJFNNYCEI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,3900,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150022,DTCC00460921,1507214,23432
CHEMBL232299,P23975,,FDYWMYJFNNYCEI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,13000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149679,DTCC00460921,1507214,23432
CHEMBL232498,P23975,,PLVZUCHZVZCSGX-GORDUTHDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,255000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149677,DTCC00460923,1728483,23432
CHEMBL232498,P23975,,PLVZUCHZVZCSGX-GORDUTHDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150041,DTCC00460923,1728483,23432
CHEMBL2326501,P23975,,KRCLPAGVJVBLJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23237837,INHIBITION,=,52,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human recombinant NE transporter expressed in CHO cells at 1 uM,,Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties.,Bioorg. Med. Chem. Lett.,2013,23,2,"Butini S, Gemma S, Brindisi M, Maramai S, Minetti P, Celona D, Napolitano R, Borsini F, Cabri W, Fezza F, Merlini L, Dallavalle S, Campiani G, Maccarrone M",,939645,DTCT0023180,11784448,DTCC01344807,1353507,53501
CHEMBL232663,P23975,,FPDIGUTXTUXSEH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,62000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2150059,DTCC00461151,408405,23432
CHEMBL232663,P23975,,FPDIGUTXTUXSEH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150062,DTCC00461151,408405,23432
CHEMBL2326684,P23975,,MMBDWDAKDCKUAX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,130,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783942,DTCC01344992,330731,53459
CHEMBL2326685,P23975,,KRNOLRHDBBTXOP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,170,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783941,DTCC01344993,1139390,53459
CHEMBL2326686,P23975,,PTKQUPHPZRJQRH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,130,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783940,DTCC01344994,459752,53459
CHEMBL2326687,P23975,,IGHNBPCIIFLLHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,250,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783939,DTCC01344995,589459,53459
CHEMBL2326688,P23975,,NWTJKIVXQLVNCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,430,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783938,DTCC01344996,1812972,53459
CHEMBL2326689,P23975,,LBMMBEDCUJAMIZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,120,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783937,DTCC01344997,1748544,53459
CHEMBL2326690,P23975,,IHFKHNCURWJDHC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,46,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783936,DTCC01344998,525145,53459
CHEMBL2326691,P23975,,NYADKXRJISYHGA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,74,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783935,DTCC01344999,1300639,53459
CHEMBL2326692,P23975,,CWYBNSVSYKQGJB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,130,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783934,DTCC01345000,1942012,53459
CHEMBL2326693,P23975,,ODFLDWCDMOARBM-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,12,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783933,DTCC01345001,848265,53459
CHEMBL2326694,P23975,,RZPGXWQFZWSYES-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,15,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783931,DTCC01345002,1170519,53459
CHEMBL2326695,P23975,,XXTLAOZBJDRYIU-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5.1,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783930,DTCC01345003,330732,53459
CHEMBL232671,P23975,,WLWFROPHDLATTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,285000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150034,DTCC00460874,434848,23432
CHEMBL232671,P23975,,WLWFROPHDLATTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,470000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149704,DTCC00460874,434848,23432
CHEMBL232672,P23975,,NRWFUCFNIMDFPX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,550000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149702,DTCC00460876,1378090,23432
CHEMBL232672,P23975,,NRWFUCFNIMDFPX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,1390000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150032,DTCC00460876,1378090,23432
CHEMBL232674,P23975,,SADMOVBJKBFJNN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,247000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150030,DTCC00460882,1825075,23432
CHEMBL232674,P23975,,SADMOVBJKBFJNN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,1318000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149697,DTCC00460882,1825075,23432
CHEMBL232675,P23975,,BWUZPMKOTOLHJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,111000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149696,DTCC00460884,310118,23432
CHEMBL232675,P23975,,BWUZPMKOTOLHJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150051,DTCC00460884,310118,23432
CHEMBL232866,P23975,,HTZRCXHILRRXTC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,2884000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149700,DTCC00460878,43161,23432
CHEMBL232866,P23975,,HTZRCXHILRRXTC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150053,DTCC00460878,43161,23432
CHEMBL232867,P23975,,LGPCFMYKDFHTOT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,240000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149698,DTCC00460880,43160,23432
CHEMBL232867,P23975,,LGPCFMYKDFHTOT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,646000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150031,DTCC00460880,43160,23432
CHEMBL232870,P23975,,FYXXKYRAPMHRTN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,314000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150028,DTCC00460888,83041,23432
CHEMBL232870,P23975,,FYXXKYRAPMHRTN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,993000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149694,DTCC00460888,83041,23432
CHEMBL232879,P23975,,LQZNMKWOFOJVOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,121000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149684,DTCC00460907,1151460,23432
CHEMBL232879,P23975,,LQZNMKWOFOJVOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150044,DTCC00460907,1151460,23432
CHEMBL233088,P23975,,JCGZOWXIYHYCOD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,4720,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150024,DTCC00460911,1021360,23432
CHEMBL233088,P23975,,JCGZOWXIYHYCOD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,15000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149683,DTCC00460911,1021360,23432
CHEMBL233530,P23975,METHYL 2-PHENYLCYCLOHEXANECARBOXYLATE,IMAGBMSOGGYLDK-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,1360000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2150086,DTCC00003077,1603893,23432
CHEMBL233532,P23975,,OBKUWTMFPMVPNX-RTBURBONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,658000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2150089,DTCC00461137,277386,23432
CHEMBL2336610,P23975,,YCPGWXQYWPBVKD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23168018,KI,=,11800,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine uptake at human NET expressed in COS7 cells after 5 mins by beta-counting,,A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.,Bioorg. Med. Chem. Lett.,2013,23,1,"Zhang P, Jørgensen TN, Loland CJ, Newman AH",,943964,DTCT0023180,11814468,DTCC01350030,428617,53759
CHEMBL2336611,P23975,,WYURUVQXJTWRLS-NUSMLGSUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23168018,KI,=,194,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine uptake at human NET expressed in COS7 cells after 5 mins by beta-counting,,A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.,Bioorg. Med. Chem. Lett.,2013,23,1,"Zhang P, Jørgensen TN, Loland CJ, Newman AH",,943964,DTCT0023180,11814470,DTCC01350031,2040428,53759
CHEMBL2337586,P23975,,WDFMVSDPRALOJK-YJBOKZPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.398,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800436,DTCC01350973,2040443,53876
CHEMBL2337587,P23975,,WDFMVSDPRALOJK-CRAIPNDOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800435,DTCC01350974,589519,53876
CHEMBL2337588,P23975,,WDFMVSDPRALOJK-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800434,DTCC01350975,2072286,53876
CHEMBL2337589,P23975,,WDFMVSDPRALOJK-QAPCUYQASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800433,DTCC01350976,1909700,53876
CHEMBL2337590,P23975,,YHCLEHAMAKETBI-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,7.94,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800432,DTCC01350977,1656719,53876
CHEMBL2337591,P23975,,YHCLEHAMAKETBI-SJLPKXTDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800431,DTCC01350978,977047,53876
CHEMBL2337592,P23975,,KBLODNDMWLXBEK-YOEHRIQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,3.98,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800430,DTCC01350979,1720075,53876
CHEMBL2337593,P23975,,KBLODNDMWLXBEK-RHSMWYFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800429,DTCC01350980,1074451,53876
CHEMBL2337594,P23975,,UUSPTDRDECONSP-YOEHRIQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800428,DTCC00131998,1202811,53876
CHEMBL2337595,P23975,,UUSPTDRDECONSP-RHSMWYFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.501,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800427,DTCC00131999,1495225,53876
CHEMBL2337596,P23975,,FDZMWAFQMOJQFO-YOEHRIQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,31.62,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800426,DTCC01350981,1202812,53876
CHEMBL2337597,P23975,,FDZMWAFQMOJQFO-RHSMWYFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800425,DTCC01350982,265044,53876
CHEMBL2337598,P23975,,NCBYCBRHLYXVNZ-RHSMWYFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,3.98,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800424,DTCC01350983,880745,53876
CHEMBL2337599,P23975,,YVEIFDFSCWTJRT-SJLPKXTDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,50.12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800423,DTCC01350984,1942080,53876
CHEMBL2337600,P23975,,LVUBCLOONUNZAC-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800422,DTCC01350985,557347,53876
CHEMBL2337601,P23975,,RRGCJEHCXSKPFY-RHSMWYFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.501,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800421,DTCC01350986,1909701,53876
CHEMBL2337602,P23975,,MCHVXQNUHBOZIA-GUYCJALGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,1.58,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800420,DTCC01350987,1107122,53876
CHEMBL2337603,P23975,,MCHVXQNUHBOZIA-CXAGYDPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800419,DTCC01350988,1170584,53876
CHEMBL2337604,P23975,,DRRQCYGCMNHHQK-GUYCJALGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800418,DTCC01350989,1688709,53876
CHEMBL2337605,P23975,,URVPSAOJVKMKND-BBRMVZONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.398,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800417,DTCC01350990,1462675,53876
CHEMBL2337606,P23975,,URVPSAOJVKMKND-CZUORRHYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800416,DTCC01350991,783109,53876
CHEMBL2337607,P23975,,MJNJOFYBUSUCSO-GUYCJALGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800415,DTCC01350992,1202813,53876
CHEMBL2337608,P23975,,MJNJOFYBUSUCSO-CXAGYDPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800413,DTCC01350993,298188,53876
CHEMBL2338031,P23975,,KXRRNOJECCYJIA-GUYCJALGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,7.94,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800412,DTCC01351410,1527538,53876
CHEMBL2338032,P23975,,RSAGNBIVUSOUTP-BBRMVZONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800411,DTCC01351411,2072290,53876
CHEMBL2338033,P23975,,UAGADFQXODVTNQ-CXAGYDPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,3.98,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800410,DTCC01351412,199868,53876
CHEMBL2338034,P23975,,QFQJPPPPEDIVLD-GUYCJALGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800409,DTCC01351413,168141,53876
CHEMBL2338035,P23975,,GFBHUZKPXOPMMX-GUYCJALGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800408,DTCC01351414,135838,53876
CHEMBL2338036,P23975,,GIKANUDLIOICAL-KSSFIOAISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.501,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800407,DTCC01351415,20997,53876
CHEMBL2338037,P23975,,GIKANUDLIOICAL-RDTXWAMCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,31.62,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800406,DTCC01351416,654301,53876
CHEMBL2338038,P23975,,BMBZYVSLEAFRRW-KSSFIOAISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800405,DTCC01351417,944917,53876
CHEMBL2338039,P23975,,ZBOZPXXCXYETEE-YJBOKZPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,3.98,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800404,DTCC01351418,1170589,53876
CHEMBL2338040,P23975,,OIMUKKZXUMOQAB-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,50.12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800403,DTCC01351419,1398497,53876
CHEMBL2338041,P23975,,OIMUKKZXUMOQAB-SJKOYZFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800402,DTCC01351420,1139462,53876
CHEMBL2338042,P23975,,HIKRIVCRSDESKA-LRDDRELGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.501,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800401,DTCC01351421,913500,53876
CHEMBL2338043,P23975,,HIKRIVCRSDESKA-MLGOLLRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,1.26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800400,DTCC01351422,428631,53876
CHEMBL2338044,P23975,,DHKBDZKBBAEQNU-LRDDRELGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.631,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800399,DTCC01351423,654302,53876
CHEMBL2338045,P23975,,IJNSXDVGJQEXPC-ZBEGNZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800398,DTCC01351424,1139463,53876
CHEMBL2338046,P23975,,IJNSXDVGJQEXPC-BDJLRTHQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,1,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800397,DTCC01351425,654303,53876
CHEMBL2338047,P23975,,IRFOFLZPBFIIGA-LRDDRELGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,1,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800396,DTCC01351426,1041952,53876
CHEMBL2338048,P23975,,DPINDTNFGDXWLU-LRDDRELGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.316,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800395,DTCC01351427,718766,53876
CHEMBL2338049,P23975,,DPINDTNFGDXWLU-MLGOLLRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.501,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800394,DTCC01351428,1139464,53876
CHEMBL2338050,P23975,,DPINDTNFGDXWLU-BLLLJJGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,3.98,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800393,DTCC01351429,557351,53876
CHEMBL2338051,P23975,,DPINDTNFGDXWLU-WBMJQRKESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,3.98,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800392,DTCC01351430,1430565,53876
CHEMBL2338052,P23975,,QLILSXLCYHMHMR-ZBEGNZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800391,DTCC01351431,913501,53876
CHEMBL2338053,P23975,,QLILSXLCYHMHMR-BDJLRTHQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,1.58,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800390,DTCC01351432,1009458,53876
CHEMBL2338054,P23975,,DNTVXLSMTRVFMZ-MBSDFSHPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800389,DTCC01351433,913502,53876
CHEMBL2338055,P23975,,QQMFCCASOIUAMW-KKSFZXQISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,2.51,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800388,DTCC01351434,1107123,53876
CHEMBL234127,P23975,,KRQBCJRFWIYJDK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,2500000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149688,DTCC00460899,1921432,23432
CHEMBL234127,P23975,,KRQBCJRFWIYJDK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150047,DTCC00460899,1921432,23432
CHEMBL234128,P23975,,IXOXSNBFVBNEKC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,2110000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149687,DTCC00460901,1021359,23432
CHEMBL234128,P23975,,IXOXSNBFVBNEKC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150046,DTCC00460901,1021359,23432
CHEMBL234379,P23975,,CJOTYXSOAIOWPI-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,94000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2150082,DTCC00461146,730684,23432
CHEMBL234705,P23975,,RSNYUBDIPFPZKJ-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,IC50,=,37,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]Nisoxetine from human NET expressed in HEK293 cells,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443465,DTCT0023180,2160341,DTCC00463281,1114496,23363
CHEMBL234706,P23975,,RSNYUBDIPFPZKJ-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,IC50,=,390,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]Nisoxetine from human NET expressed in HEK293 cells,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443465,DTCT0023180,2160340,DTCC00463283,564651,23363
CHEMBL234706,P23975,,RSNYUBDIPFPZKJ-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560923,IC50,=,390,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]nisoxetine from human NET expressed in HEK293 cells,,Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,15,"Denhart DJ, Deskus JA, Ditta JL, Gao Q, Dalton King H, Kozlowski ES, Meng Z, LaPaglia MA, Mattson GK, Molski TF, Taber MT, Lodge NJ, Mattson RJ, Macor JE",,578029,DTCT0023180,2898664,DTCC00463283,565694,34817
CHEMBL234706,P23975,,RSNYUBDIPFPZKJ-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20034793,IC50,=,390,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,2010,20,3,"Marcin LR, Mattson RJ, Gao Q, Wu D, Molski TF, Mattson GK, Lodge NJ",,610435,DTCT0023180,3195439,DTCC00463283,566338,37394
CHEMBL234926,P23975,ALLYL ALCOHOL,XXROGKLTLUQVRX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7284322,DTCC00463304,1992799,46191
CHEMBL234926,P23975,ALLYL ALCOHOL,XXROGKLTLUQVRX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7285671,DTCC00463304,1992799,46191
CHEMBL234927,P23975,,UBQCLKWUZCABQJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,INHIBITION,=,35,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443462,DTCT0023180,2159939,DTCC00463285,952298,23363
CHEMBL234928,P23975,,GFNMZMSNUJYADM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443462,DTCT0023180,2159921,DTCC00463288,1755927,23363
CHEMBL2349310,P23975,,ZMQSLMZOWVGBSM-GXTWGEPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23516963,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter (unknown origin),Active,"Substituted 7-amino-5-thio-thiazolo[4,5-d]pyrimidines as potent and selective antagonists of the fractalkine receptor (CX3CR1).",J. Med. Chem.,2013,56,8,"Karlström S, Nordvall G, Sohn D, Hettman A, Turek D, Åhlin K, Kers A, Claesson M, Slivo C, Lo-Alfredsson Y, Petersson C, Bessidskaia G, Svensson PH, Rein T, Jerning E, Malmberg Å, Ahlgen C, Ray C, Vares L, Ivanov V, Johansson R",,953454,DTCT0023180,11863556,DTCC01354607,751072,54288
CHEMBL2349533,P23975,,PDUYPEOJRTWPFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23434029,INHIBITION,=,63,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM,,Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.,Bioorg. Med. Chem. Lett.,2013,23,7,"Chae E, Shin YJ, Ryu EJ, Ji MK, Ryune Cho N, Lee KH, Jeong HJ, Kim SJ, Choi Y, Seok Oh K, Park CE, Soo Yoon Y",,951522,DTCT0023180,11848267,DTCC01354831,1676752,54195
CHEMBL235569,P23975,,YUMUSCBAOZYAIX-BARDWOONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446069,KI,=,4.88,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,2007,17,11,"Zeng F, Stehouwer JS, Jarkas N, Voll RJ, Williams L, Camp VM, Votaw JR, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,444173,DTCT0023180,2167227,DTCC00464564,1328960,23431
CHEMBL236046,P23975,,DYUSEVKSEDICGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17616397,KI,=,290,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,17,"Letavic MA, Stocking EM, Barbier AJ, Bonaventure P, Boggs JD, Lord B, Miller KL, Wilson SJ, Carruthers NI",,448655,DTCT0023180,2181918,DTCC00468026,472285,23789
CHEMBL2367892,P23975,TEICOPLANIN,DDTDNCYHLGRFBM-YZEKDTGTSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7476551,DTCC01364937,1734064,46191
CHEMBL2367892,P23975,TEICOPLANIN,DDTDNCYHLGRFBM-YZEKDTGTSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7476552,DTCC01364937,1734064,46191
CHEMBL2371923,P23975,,WOXOMROGQFUOGC-PYZAKKTJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16821765,IC50,=,25000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of rat NET-mediated norepinephrine uptake in CHO cells,,Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction.,J. Med. Chem.,2006,49,14,"Ding J, Shi J, Cui D, Xu L, Duan S, Guo L, Fei J",,376176,DTCT0023180,1948649,DTCC01368514,951793,21079
CHEMBL2371930,P23975,,FEENACCUUASIIK-OPQDNGBESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17064074,EC50,=,1380.38,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET in COS7 cells,,Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.,J. Med. Chem.,2006,49,22,"Lovelace ES, Armishaw CJ, Colgrave ML, Wahlstrom ME, Alewood PF, Daly NL, Craik DJ",,408655,DTCT0023180,1987725,DTCC01368519,1393810,21453
CHEMBL2371931,P23975,,MLQKNFBXQZTRNM-HEZRXYLWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17064074,EC50,=,1819.7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET in COS7 cells,,Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.,J. Med. Chem.,2006,49,22,"Lovelace ES, Armishaw CJ, Colgrave ML, Wahlstrom ME, Alewood PF, Daly NL, Craik DJ",,408655,DTCT0023180,1987848,DTCC01368520,433684,21453
CHEMBL237512,P23975,,FWJKAQILVAFVQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17616397,KI,=,250,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,17,"Letavic MA, Stocking EM, Barbier AJ, Bonaventure P, Boggs JD, Lord B, Miller KL, Wilson SJ, Carruthers NI",,448655,DTCT0023180,2181920,DTCC00468066,310187,23789
CHEMBL2380971,P23975,,DWEUBXIQNVYDHT-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,IC50,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,Not Determined,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959038,DTCT0023180,12430671,DTCC01374523,686561,54551
CHEMBL2380971,P23975,,DWEUBXIQNVYDHT-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,INHIBITION,=,68,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959039,DTCT0023180,12430677,DTCC01374523,686561,54551
CHEMBL2380972,P23975,,PUIPTRFLVUMEKQ-OCCSQVGLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,IC50,=,510,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959038,DTCT0023180,12430670,DTCC01374524,2007951,54551
CHEMBL2380972,P23975,,PUIPTRFLVUMEKQ-OCCSQVGLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,INHIBITION,=,78,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959039,DTCT0023180,12430676,DTCC01374524,2007951,54551
CHEMBL2380975,P23975,,PUIPTRFLVUMEKQ-JSGCOSHPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,IC50,=,3700,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959038,DTCT0023180,12430672,DTCC01374527,363496,54551
CHEMBL2380975,P23975,,PUIPTRFLVUMEKQ-JSGCOSHPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,INHIBITION,=,16,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959039,DTCT0023180,12430678,DTCC01374527,363496,54551
CHEMBL2380979,P23975,,DMOBQDGHIHODJN-QWHCGFSZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,IC50,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,Not Determined,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959038,DTCT0023180,12430674,DTCC01374531,1909789,54551
CHEMBL2380979,P23975,,DMOBQDGHIHODJN-QWHCGFSZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,INHIBITION,=,25,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959039,DTCT0023180,12430680,DTCC01374531,1909789,54551
CHEMBL2380980,P23975,,DWEUBXIQNVYDHT-ZFWWWQNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,IC50,=,8200,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959038,DTCT0023180,12430673,DTCC01374532,1074546,54551
CHEMBL2380980,P23975,,DWEUBXIQNVYDHT-ZFWWWQNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,INHIBITION,=,-1.7,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959039,DTCT0023180,12430679,DTCC01374532,1074546,54551
CHEMBL2380983,P23975,,ZALXONRNDYIIGY-AAEUAGOBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,IC50,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,Not Determined,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959038,DTCT0023180,12430675,DTCC01374535,298265,54551
CHEMBL2380983,P23975,,ZALXONRNDYIIGY-AAEUAGOBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23578689,INHIBITION,=,55,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,10,"Ditta JL, Denhart DJ, Deskus JA, Epperson JR, Meng Z, Gao Q, Mattson GK, Lapaglia MA, Taber MT, Molski TF, Lodge NJ, Mattson RJ, Macor JE",,959039,DTCT0023180,12430681,DTCC01374535,298265,54551
CHEMBL2385460,P23975,,XPLWBHWPOUEOSJ-GSZYCOFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,INHIBITION,<,70,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM relative to control,,,ACS Med. Chem. Lett.,2013,4,6,,,960921,DTCT0023180,12452544,DTCC01376362,1235427,54625
CHEMBL2385464,P23975,,WUMCAEVLFYSGKO-UTKFAANNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,INHIBITION,<,70,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM relative to control,,,ACS Med. Chem. Lett.,2013,4,6,,,960921,DTCT0023180,12452543,DTCC01376366,2072385,54625
CHEMBL2386162,P23975,,SNNRWIBSGBMYRF-ZFWWWQNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,6.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454712,DTCC01377069,525319,54354
CHEMBL2386162,P23975,,SNNRWIBSGBMYRF-ZFWWWQNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,INHIBITION,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET transfected in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake incubated 30 mins prior to substrate addition measured after 1 minute 50 secs,Active,,ACS Med. Chem. Lett.,2013,4,6,,,961642,DTCT0023180,12454701,DTCC01377069,525319,54354
CHEMBL2386163,P23975,,LTFSJEXVJFCDEL-SLHAJLBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454794,DTCC01377070,913583,54354
CHEMBL2386163,P23975,,LTFSJEXVJFCDEL-SLHAJLBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454793,DTCC01377070,913584,54354
CHEMBL2386164,P23975,,SNNRWIBSGBMYRF-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454792,DTCC01377071,1877629,54354
CHEMBL2386165,P23975,,SNNRWIBSGBMYRF-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,438,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454791,DTCC01377072,1559702,54354
CHEMBL2386166,P23975,,SNNRWIBSGBMYRF-UKRRQHHQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,177,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454790,DTCC01377073,880829,54354
CHEMBL2386917,P23975,,ICTBPKWPCGSFPZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23622982,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter by radioligand binding assay,Not Active,"Discovery of 2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators.",Bioorg. Med. Chem. Lett.,2013,23,11,"Guo C, Linton A, Jalaie M, Kephart S, Ornelas M, Pairish M, Greasley S, Richardson P, Maegley K, Hickey M, Li J, Wu X, Ji X, Xie Z",,963166,DTCT0023180,12457867,DTCC01377828,1736790,54684
CHEMBL238867,P23975,,PWAQSKSFOYUNMV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,7.5,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213026,DTCC00473143,553121,24154
CHEMBL238868,P23975,,XFIVQANHMYEPDG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,37,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213057,DTCC00473147,811220,24154
CHEMBL239079,P23975,,VGVAYDIHTPWEKS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,97,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213056,DTCC00473150,455480,24154
CHEMBL2391147,P23975,,ZTGRWYMPQCQTHD-ONGXEEELSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23582449,INHIBITION,=,-17,%,,,,,,,,,,,,,,Binding affinity to human nonepinephrine transporter at 10 uM by radioligand displacement assay relative to control,,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,2013,21,10,"Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M",,964345,DTCT0023180,12465368,DTCC01378839,220399,54817
CHEMBL2391541,P23975,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,42657.95,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465478,DTCC01379235,1386484,54821
CHEMBL2391541,P23975,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,12008,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465477,DTCC01379235,1386484,54821
CHEMBL2391541,P23975,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human recombinant norepinephrine transporter expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,964941,DTCT0023180,12464697,DTCC01379235,1386484,54821
CHEMBL2391541,P23975,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26739781,KI,<,10000,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016,26,3,"Cozzi NV, Daley PF.",,1550158,DTCT0023180,62501,DTCC01379235,1369782,65871
CHEMBL2392692,P23975,,PVTFEAGMCGMRRS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23664879,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 1 uM relative to control,,"Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.",Bioorg. Med. Chem. Lett.,2013,23,12,"Thalji RK, McAtee JJ, Belyanskaya S, Brandt M, Brown GD, Costell MH, Ding Y, Dodson JW, Eisennagel SH, Fries RE, Gross JW, Harpel MR, Holt DA, Israel DI, Jolivette LJ, Krosky D, Li H, Lu Q, Mandichak T, Roethke T, Schnackenberg CG, Schwartz B, Shewchuk LM, Xie W, Behm DJ, Douglas SA, Shaw AL, Marino JP",,965571,DTCT0023180,12464849,DTCC01380390,1353885,54882
CHEMBL239297,P23975,,ZGPGDMLZVXIWAH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,114,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213055,DTCC00473151,876538,24154
CHEMBL239301,P23975,,HFHWEFNEZUUCLY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,95,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213053,DTCC00473155,1970826,24154
CHEMBL239302,P23975,,QLIVPGJLVJVMJT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,>,1000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213052,DTCC00473157,488848,24154
CHEMBL2397268,P23975,,JAKRIQWSQWQJHM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23627311,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter (unknown origin) at 5 uM by psychoactive drug screening programme assay,,Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.,J. Med. Chem.,2013,56,13,"Santangelo Freel RM, Ogden KK, Strong KL, Khatri A, Chepiga KM, Jensen HS, Traynelis SF, Liotta DC",,968888,DTCT0023180,12483459,DTCC01381880,1353904,54936
CHEMBL24,P23975,ATENOLOL,METKIMKYRPQLGS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7262281,DTCC00133283,574620,46191
CHEMBL24,P23975,ATENOLOL,METKIMKYRPQLGS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7262282,DTCC00133283,574620,46191
CHEMBL2407319,P23975,,VPFSCTXNTBOTFE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,9.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520436,DTCC01385719,447430,55253
CHEMBL2407320,P23975,,YLCDOWWZEWUKRA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,8.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12521355,DTCC01385720,1865433,55253
CHEMBL2407321,P23975,,RPURJJSUIZKBOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,200,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520364,DTCC01385721,1515638,55253
CHEMBL2407322,P23975,,ITKQJLPIARUDPX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,18,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520420,DTCC01385722,771199,55253
CHEMBL2407323,P23975,,PSMAIUZEWLCYGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,12,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520430,DTCC01385723,1897814,55253
CHEMBL2407324,P23975,,OFVYRZBLIGHUKA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,120,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520374,DTCC01385724,2028535,55253
CHEMBL2407325,P23975,,YROYMUJBXFJCBF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,44,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520396,DTCC01385725,2060455,55253
CHEMBL2407326,P23975,,NSTTWNJKAWCIFK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,28,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520407,DTCC01385726,771200,55253
CHEMBL2407327,P23975,,PFPDWJWOZCMTIS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,22,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520416,DTCC01385727,2060456,55253
CHEMBL2407328,P23975,,AQLYDOOFZXWOAC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,36,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520402,DTCC01385728,285927,55253
CHEMBL2407329,P23975,,HJKCBQAEYYPLHW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,98,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520379,DTCC01385729,1547663,55253
CHEMBL2407330,P23975,,PXYULNPULNZYHU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,130,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520372,DTCC01385730,1062140,55253
CHEMBL2407331,P23975,,DBZNPAHUGJSVMH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,70,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520389,DTCC01385731,480904,55253
CHEMBL2407332,P23975,,PLAKLZGCXGCZCY-YDALLXLXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,15,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520423,DTCC01385732,1768653,55253
CHEMBL2407333,P23975,,PLAKLZGCXGCZCY-UTONKHPSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,21,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520417,DTCC01385733,1676895,55253
CHEMBL2407334,P23975,,YYWIEWLZZQPVRT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,25,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520411,DTCC01385734,739026,55253
CHEMBL2407335,P23975,,UMJOPAHCVSNVNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,110,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520377,DTCC01385735,2092555,55253
CHEMBL2407336,P23975,,PLAKLZGCXGCZCY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,14,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520426,DTCC01385736,965181,55253
CHEMBL2407337,P23975,,DEYDFIXCTXWVHT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23769168,IC50,=,28,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,2013,21,15,"Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J",,974162,DTCT0023180,12520408,DTCC01385737,56781,55253
CHEMBL241228,P23975,,WTZRMYOBIYKNQJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,33,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213046,DTCC00473165,1491096,24154
CHEMBL2414911,P23975,,KRSNVUPLMVRORR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23880542,KI,=,867,NM,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter by ligand displacement assay,,Neuroactive diol and acyloin metabolites from cone snail-associated bacteria.,Bioorg. Med. Chem. Lett.,2013,23,17,"Lin Z, Marett L, Hughen RW, Flores M, Forteza I, Ammon MA, Concepcion GP, Espino S, Olivera BM, Rosenberg G, Haygood MG, Light AR, Schmidt EW",,976616,DTCT0023180,12540440,DTCC01390108,1995698,55488
CHEMBL241646,P23975,,APMCQNBYSJNSHZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,56,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213050,DTCC00473159,164040,24154
CHEMBL241647,P23975,,ZXTNAQHXTXATFR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,7,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213049,DTCC00473160,1587653,24154
CHEMBL241648,P23975,,SZDGGXPDQJKRHQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,14,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213047,DTCC00473163,844082,24154
CHEMBL241694,P23975,ETHISTERONE,CHNXZKVNWQUJIB-CEGNMAFCSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337039,DTCC00474598,1674144,46191
CHEMBL241694,P23975,ETHISTERONE,CHNXZKVNWQUJIB-CEGNMAFCSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337040,DTCC00474598,1674144,46191
CHEMBL2419440,P23975,,DAAWESBJYLHFAS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23837744,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of norepinephrine transporter (unknown origin) at 10 uM,Active,"Atropisomeric 4-phenyl-4H-1,2,4-triazoles as selective glycine transporter 1 inhibitors.",J. Med. Chem.,2013,56,14,"Sugane T, Tobe T, Hamaguchi W, Shimada I, Maeno K, Miyata J, Suzuki T, Kimizuka T, Sakamoto S, Tsukamoto S",,980310,DTCT0023180,12560621,DTCC01392128,1418940,55697
CHEMBL242011,P23975,HINOKININ,DDWGQGZPYDSYEL-LSDHHAIUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24112084,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at human NET expressed in african green monkey COS7 cells assessed as norepinephrine release at 0.5 to 500 uM after 10 mins using [3H]-norepinephrine pretreated for 1 hr before compound addition followed by wash out by reversed transport efflux assay,Not Active,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,2013,76,10,"Timple JM, Magalhães LG, Souza Rezende KC, Pereira AC, Cunha WR, Andrade e Silva ML, Mortensen OV, Fontana AC",,984381,DTCT0023180,12599634,DTCC00456953,1203097,56016
CHEMBL242011,P23975,HINOKININ,DDWGQGZPYDSYEL-LSDHHAIUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24112084,IC50,=,8760,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK cells using [3H]-norepinephrine as substrate after 10 mins by scintillation counting,,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,2013,76,10,"Timple JM, Magalhães LG, Souza Rezende KC, Pereira AC, Cunha WR, Andrade e Silva ML, Mortensen OV, Fontana AC",,984396,DTCT0023180,12599654,DTCC00456953,1203097,56016
CHEMBL242011,P23975,HINOKININ,DDWGQGZPYDSYEL-LSDHHAIUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24112084,INHIBITION,,,,,cell_based,,,,,,,,,,,,Non-competitive inhibition of human NET expressed in MDCK cells using [3H]-norepinephrine as substrate,Active,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,2013,76,10,"Timple JM, Magalhães LG, Souza Rezende KC, Pereira AC, Cunha WR, Andrade e Silva ML, Mortensen OV, Fontana AC",,984387,DTCT0023180,12599643,DTCC00456953,1203097,56016
CHEMBL242273,P23975,SAFROLE,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481884,DTCC00455925,315669,46191
CHEMBL242273,P23975,SAFROLE,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481885,DTCC00455925,315669,46191
CHEMBL242338,P23975,,SIIICDNNMDMWCI-KBXIAJHMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,10,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150037,DTCC00460849,795031,23432
CHEMBL242338,P23975,,SIIICDNNMDMWCI-KBXIAJHMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,34,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149717,DTCC00460849,795031,23432
CHEMBL242920,P23975,,MXCAKGCIGZRYGJ-QWHCGFSZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,2300,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149711,DTCC00460864,1182357,23432
CHEMBL2429890,P23975,,VGYQUDBPYFLBLJ-PTCVETCVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,=,7352,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12601184,DTCC01398005,1268545,55935
CHEMBL2430676,P23975,,XWQSXOFSOWLMBI-DJIMGWMZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598022,DTCC01396632,1515747,55968
CHEMBL2430677,P23975,,NCPFSSICYASJEG-KBAYOESNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598021,DTCC01396633,188365,55968
CHEMBL2430678,P23975,,YGVBSRWLELWASD-KZNAEPCWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598019,DTCC01396634,1354057,55968
CHEMBL2430679,P23975,,YJTXADGPCUCDFY-KZNAEPCWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598020,DTCC01396635,252918,55968
CHEMBL2430680,P23975,,IJNVPBUKXATNNR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,2033,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598079,DTCC01396636,1929933,55968
CHEMBL2430680,P23975,,IJNVPBUKXATNNR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,83,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598094,DTCC01396636,1929933,55968
CHEMBL2430680,P23975,,IJNVPBUKXATNNR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,89.2,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598195,DTCC01396636,1929933,55968
CHEMBL2430681,P23975,,BKSQHIKAUPPMAY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,5176,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598080,DTCC01396637,1191056,55968
CHEMBL2430681,P23975,,BKSQHIKAUPPMAY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,56.6,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598196,DTCC01396637,1191056,55968
CHEMBL2430681,P23975,,BKSQHIKAUPPMAY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,75,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598095,DTCC01396637,1191056,55968
CHEMBL2430682,P23975,,MLLKPBZCMWKIND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,1662,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598081,DTCC01396638,1515748,55968
CHEMBL2430682,P23975,,MLLKPBZCMWKIND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,66.9,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598197,DTCC01396638,1515748,55968
CHEMBL2430682,P23975,,MLLKPBZCMWKIND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,87,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598096,DTCC01396638,1515748,55968
CHEMBL2430683,P23975,,MEPVQYBSRCKVHV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,7619,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598082,DTCC01396639,1191057,55968
CHEMBL2430683,P23975,,MEPVQYBSRCKVHV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,15,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598198,DTCC01396639,1191057,55968
CHEMBL2430683,P23975,,MEPVQYBSRCKVHV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,60,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598097,DTCC01396639,1191057,55968
CHEMBL2430684,P23975,,LUQRHZHXLQQJTM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,990.3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598083,DTCC01396640,868993,55968
CHEMBL2430684,P23975,,LUQRHZHXLQQJTM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,40.4,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598199,DTCC01396640,868993,55968
CHEMBL2430684,P23975,,LUQRHZHXLQQJTM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,90,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598098,DTCC01396640,868993,55968
CHEMBL2430685,P23975,,HTKNCQZCINRNGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,1900,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598085,DTCC01396641,1708698,55968
CHEMBL2430685,P23975,,HTKNCQZCINRNGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,56.9,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598200,DTCC01396641,1708698,55968
CHEMBL2430685,P23975,,HTKNCQZCINRNGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,92,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598099,DTCC01396641,1708698,55968
CHEMBL2430686,P23975,,KVVQAOOISUGMSL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,2745,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598086,DTCC01396642,416900,55968
CHEMBL2430686,P23975,,KVVQAOOISUGMSL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,44.5,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598180,DTCC01396642,416900,55968
CHEMBL2430686,P23975,,KVVQAOOISUGMSL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,78,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598100,DTCC01396642,416900,55968
CHEMBL2430687,P23975,,UUNYJDCLTZOEDK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,2521,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598087,DTCC01396643,416901,55968
CHEMBL2430687,P23975,,UUNYJDCLTZOEDK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,24.2,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598179,DTCC01396643,416901,55968
CHEMBL2430687,P23975,,UUNYJDCLTZOEDK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,90,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598101,DTCC01396643,416901,55968
CHEMBL2430688,P23975,,DARUNLRORREIKV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,509.5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598088,DTCC01396644,1321285,55968
CHEMBL2430688,P23975,,DARUNLRORREIKV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,91.6,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598178,DTCC01396644,1321285,55968
CHEMBL2430688,P23975,,DARUNLRORREIKV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,99,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598102,DTCC01396644,1321285,55968
CHEMBL2430689,P23975,,KECBOARJOOAZSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,3570,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598089,DTCC01396645,220579,55968
CHEMBL2430689,P23975,,KECBOARJOOAZSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,74,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598103,DTCC01396645,220579,55968
CHEMBL2430689,P23975,,KECBOARJOOAZSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,82.3,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598157,DTCC01396645,220579,55968
CHEMBL2430690,P23975,,YIXJHLSDNZJSDC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,41,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598104,DTCC01396646,220580,55968
CHEMBL2430690,P23975,,YIXJHLSDNZJSDC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,68.9,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598158,DTCC01396646,220580,55968
CHEMBL2430691,P23975,,GPFOQDAZAVIYMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,12.1,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598159,DTCC01396647,1833554,55968
CHEMBL2430691,P23975,,GPFOQDAZAVIYMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,33,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598105,DTCC01396647,1833554,55968
CHEMBL2430692,P23975,,XOMFYIZXAHTPCL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,384.2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598072,DTCC01396648,642627,55968
CHEMBL2430692,P23975,,XOMFYIZXAHTPCL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,90.5,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598160,DTCC01396648,642627,55968
CHEMBL2430692,P23975,,XOMFYIZXAHTPCL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,93,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598106,DTCC01396648,642627,55968
CHEMBL2430693,P23975,,HAUQQZNNDHTKIA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,3825,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598055,DTCC01396649,1833555,55968
CHEMBL2430693,P23975,,HAUQQZNNDHTKIA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,72,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598092,DTCC01396649,1833555,55968
CHEMBL2430693,P23975,,HAUQQZNNDHTKIA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,75.4,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598161,DTCC01396649,1833555,55968
CHEMBL2430694,P23975,,OZKUXEIZXWPRFX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,59,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598091,DTCC01396650,1256262,55968
CHEMBL2430694,P23975,,OZKUXEIZXWPRFX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,65.7,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598162,DTCC01396650,1256262,55968
CHEMBL2430695,P23975,,LTOCWIOHTZQZEL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,865.7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598056,DTCC01396651,1963074,55968
CHEMBL2430695,P23975,,LTOCWIOHTZQZEL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,87,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598090,DTCC01396651,1963074,55968
CHEMBL2430695,P23975,,LTOCWIOHTZQZEL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,91.6,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598164,DTCC01396651,1963074,55968
CHEMBL2430696,P23975,,UCFURURGGMKGCC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598073,DTCC01396652,123899,55968
CHEMBL2430696,P23975,,UCFURURGGMKGCC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,79.9,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598165,DTCC01396652,123899,55968
CHEMBL2430697,P23975,,UXGIXJLEBICYQD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,26,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598074,DTCC01396653,1158638,55968
CHEMBL2430697,P23975,,UXGIXJLEBICYQD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,64.8,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598166,DTCC01396653,1158638,55968
CHEMBL2430698,P23975,,AXKWQHHRWNPPGK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,5,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598075,DTCC01396654,416902,55968
CHEMBL2430698,P23975,,AXKWQHHRWNPPGK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,62.1,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598167,DTCC01396654,416902,55968
CHEMBL2430699,P23975,,YHCGXHXZKOJYFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,482.9,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598057,DTCC01396655,2092677,55968
CHEMBL2430699,P23975,,YHCGXHXZKOJYFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,11.7,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598168,DTCC01396655,2092677,55968
CHEMBL2430699,P23975,,YHCGXHXZKOJYFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,94,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598076,DTCC01396655,2092677,55968
CHEMBL2430700,P23975,,JFHFWAQIJRRGSM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,1187,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598058,DTCC01396656,1321286,55968
CHEMBL2430700,P23975,,JFHFWAQIJRRGSM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,49.6,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598169,DTCC01396656,1321286,55968
CHEMBL2430700,P23975,,JFHFWAQIJRRGSM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,91,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598077,DTCC01396656,1321286,55968
CHEMBL2430701,P23975,,QOTGNPSPQIIZKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,1376,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598059,DTCC01396657,1768775,55968
CHEMBL2430701,P23975,,QOTGNPSPQIIZKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,27.4,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598170,DTCC01396657,1768775,55968
CHEMBL2430701,P23975,,QOTGNPSPQIIZKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,89,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983925,DTCT0023180,12598078,DTCC01396657,1768775,55968
CHEMBL243141,P23975,,GKCCZGXUGNBNGL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,2500,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149709,DTCC00460866,504906,23432
CHEMBL2431797,P23975,(-)-O-METHYLCUBEBIN,UUUXPUGZNDRYSV-ZQIYAJFXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24112084,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK cells using [3H]-norepinephrine as substrate at 200 uM after 10 mins by scintillation counting,Not Active,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,2013,76,10,"Timple JM, Magalhães LG, Souza Rezende KC, Pereira AC, Cunha WR, Andrade e Silva ML, Mortensen OV, Fontana AC",,984385,DTCT0023180,12599638,DTCC01397761,557647,56016
CHEMBL2432038,P23975,,OKCSFONJDXUZOU-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601129,DTCC01398006,913793,55935
CHEMBL2432039,P23975,,CHZUEGVOEFMIJH-ZKRSMWHSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601128,DTCC01398007,1845582,55935
CHEMBL243204,P23975,,WMVXAQQBRYETCJ-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,35200,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149714,DTCC00460856,1214657,23432
CHEMBL2432040,P23975,,MPBJQDFYALBXED-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601156,DTCC01398008,1139742,55935
CHEMBL2432041,P23975,,MSTPNDDVMWUDFF-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601155,DTCC01398009,71453,55935
CHEMBL2432042,P23975,,LNTMHZZRTAQEJQ-CPVTZQMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601154,DTCC01398010,589816,55935
CHEMBL2432043,P23975,,LKFSLMWAVKMONG-KPCGFGSOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601153,DTCC01398011,2040745,55935
CHEMBL2432044,P23975,,IDXFKHDXIHNWAI-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601152,DTCC01398012,2040746,55935
CHEMBL2432045,P23975,,ZWCQZHOWEDKJBN-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601136,DTCC01398013,1657028,55935
CHEMBL2432046,P23975,,KNBHNNRMMAKKFI-SEDVZXITSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601135,DTCC01398014,1009784,55935
CHEMBL2432047,P23975,,CNPQMMDLXZBMLB-KPCGFGSOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601134,DTCC01398015,1268546,55935
CHEMBL2432048,P23975,,KBAKPEFQDPCCTP-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601133,DTCC01398016,1495532,55935
CHEMBL2432049,P23975,,DUZKXKAAUHDBQA-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601132,DTCC01398017,298486,55935
CHEMBL2432050,P23975,,SJWCMFMHVZULSJ-DKSPCFMDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601131,DTCC01398018,881050,55935
CHEMBL2432051,P23975,,CPLYGLAQLNAQOI-SEDVZXITSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601130,DTCC01398019,71454,55935
CHEMBL2432052,P23975,,SGFPDDMJMPKKTB-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601151,DTCC01398020,783458,55935
CHEMBL2432053,P23975,,DEOOAAFCKARVDM-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601150,DTCC01398021,751332,55935
CHEMBL2432054,P23975,,QQUOSDRKLSIRED-DKSPCFMDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,=,8533,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12601183,DTCC01398022,945256,55935
CHEMBL2432055,P23975,,VNGQWOKKSKAESQ-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601149,DTCC01398023,2040748,55935
CHEMBL2432056,P23975,,JHFKLSFCMAHSDK-LLOIJXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601147,DTCC01398024,103846,55935
CHEMBL2432057,P23975,,QHQJBDOHEUWLBB-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601146,DTCC01398025,71455,55935
CHEMBL2432058,P23975,,MJOVYQVAQIHDSE-DKSPCFMDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601145,DTCC01398026,2008169,55935
CHEMBL2432059,P23975,,YLVXPEMITKSDOS-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601143,DTCC01398027,2008170,55935
CHEMBL2432060,P23975,,CKFQOWSPJPMWEK-IINHSQADSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601142,DTCC01398028,1235634,55935
CHEMBL2432061,P23975,,ZFZXJOHWFSRUAO-LLOIJXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601141,DTCC01398029,1720366,55935
CHEMBL2432062,P23975,,SSQDVMAIIMMISV-SEDVZXITSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601140,DTCC01398030,1780918,55935
CHEMBL2432063,P23975,,BMHWWKPJPARTBN-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446,DTCT0023180,12601139,DTCC01398031,331096,55935
CHEMBL243712,P23975,AMISULPRIDE,NTJOBXMMWNYJFB-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19337725,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728306,DTCC00458164,2103595,69290
CHEMBL2440659,P23975,,AXVLPJHYYFHCHK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24074843,INHIBITION,>,35,%,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from human recombinant NET expressed in MDCK cells at 10 uM relative to control,,Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.,Bioorg. Med. Chem. Lett.,2013,23,21,"Felts AS, Rodriguez AL, Morrison RD, Venable DF, Manka JT, Bates BS, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA",,990301,DTCT0023180,12632816,DTCC01401025,1592232,56261
CHEMBL2442940,P23975,,INPPXFAIFVJMMD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24050790,INHIBITION,,,,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter at 10 uM by radioligand binding assay,Not Active,"Identification of a novel benzoxazolone derivative as a selective, orally active 18 kDa translocator protein (TSPO) ligand.",J. Med. Chem.,2013,56,20,"Fukaya T, Ishiyama T, Baba S, Masumoto S",,991142,DTCT0023180,12640920,DTCC01403311,103900,56238
CHEMBL24441,P23975,BETAHISTINE,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7272669,DTCC00159008,606968,46191
CHEMBL24441,P23975,BETAHISTINE,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7272670,DTCC00159008,606968,46191
CHEMBL245061,P23975,,ZKDZVMXERDGTGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,11000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149706,DTCC00460870,1214658,23432
CHEMBL245061,P23975,,ZKDZVMXERDGTGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,28000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150036,DTCC00460870,1214658,23432
CHEMBL245061,P23975,,ZKDZVMXERDGTGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,11000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249776,DTCC00460870,1214851,24671
CHEMBL245416,P23975,L-MIMOSINE,WZNJWVWKTVETCG-YFKPBYRVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7422811,DTCC00474857,2025639,46191
CHEMBL245416,P23975,L-MIMOSINE,WZNJWVWKTVETCG-YFKPBYRVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7422812,DTCC00474857,2025639,46191
CHEMBL245482,P23975,,CHDGVSNCSOCUHK-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224524,DTCC00479486,1507401,24303
CHEMBL245492,P23975,,VWGQRLFYWPDXNG-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,13,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224516,DTCC00479499,375537,24303
CHEMBL245687,P23975,,KAVHHDMCLXFYPS-NRFANRHFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224512,DTCC00479504,989305,24303
CHEMBL245687,P23975,,KAVHHDMCLXFYPS-NRFANRHFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,IC50,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490412,DTCT0023180,2765699,DTCC00479504,973624,30733
CHEMBL245880,P23975,,PIMIZGGCAMLEJJ-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224526,DTCC00479483,956950,24303
CHEMBL245880,P23975,,PIMIZGGCAMLEJJ-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,IC50,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490412,DTCT0023180,2765693,DTCC00479483,941586,30733
CHEMBL246388,P23975,,RFEHSKWKBMZDQP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19926484,KI,=,1245,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,2010,18,1,"Mavel S, Meheux N, Guilloteau D, Emond P",,607220,DTCT0023180,3223154,DTCC00478144,1407627,37264
CHEMBL246519,P23975,,RVDUVVPILREHEK-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,40,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224511,DTCC00479507,1247814,24303
CHEMBL246920,P23975,,MDQSOSLERPCADB-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224529,DTCC00479479,148018,24303
CHEMBL246955,P23975,,XYYGFCDTBHAUSN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17127059,KI,=,106,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells,,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,4,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453471,DTCT0023180,2219075,DTCC00477235,1361791,24220
CHEMBL247340,P23975,,NRMWWURWZRGVIQ-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,4,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224520,DTCC00479493,1410714,24303
CHEMBL247341,P23975,,MKNCFIMZZSMFIK-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224519,DTCC00479494,1636346,24303
CHEMBL247538,P23975,,IVMHSWRHRXAZNE-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224517,DTCC00479497,634171,24303
CHEMBL247733,P23975,,BGSBHLAICAANSC-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224522,DTCC00479488,83192,24303
CHEMBL247733,P23975,,BGSBHLAICAANSC-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306892,DTCC00479488,67207,25268
CHEMBL247733,P23975,,BGSBHLAICAANSC-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369762,DTCC00479488,78773,26388
CHEMBL247733,P23975,,BGSBHLAICAANSC-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766840,DTCC00479488,79271,30743
CHEMBL247933,P23975,,CAISPEIKDAWTHS-LOSJGSFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17583504,KI,=,460,NM,,,,,,,,,,,,,,Binding affinity to NET,,Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,15,"Keith JM, Gomez LA, Barbier AJ, Wilson SJ, Boggs JD, Lord B, Mazur C, Aluisio L, Lovenberg TW, Carruthers NI",,456613,DTCT0023180,2241104,DTCC00479073,569397,24544
CHEMBL248702,P23975,DEXFENFLURAMINE,DBGIVFWFUFKIQN-VIFPVBQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340111,DTCC00487049,1351109,46191
CHEMBL248702,P23975,DEXFENFLURAMINE,DBGIVFWFUFKIQN-VIFPVBQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340112,DTCC00487049,1351109,46191
CHEMBL248824,P23975,,DPGZNUSUOPLFNV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,>,100000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249821,DTCC00483199,1313135,24671
CHEMBL248825,P23975,,GBLKVAKAYJPCCZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,61000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249818,DTCC00483201,698594,24671
CHEMBL248932,P23975,,OUMLAORSIFDYJV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,IC50,=,710,NM,,,,,,,,,,,,,,Inhibition of NET,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457381,DTCT0023180,2247044,DTCC00484159,99349,24627
CHEMBL248932,P23975,,OUMLAORSIFDYJV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,INHIBITION,=,68,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457380,DTCT0023180,2247037,DTCC00484159,99349,24627
CHEMBL249134,P23975,,CUZLSPYEHKUVQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,IC50,=,560,NM,,,,,,,,,,,,,,Inhibition of NET,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457381,DTCT0023180,2247043,DTCC00484162,2003591,24627
CHEMBL249134,P23975,,CUZLSPYEHKUVQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,INHIBITION,=,69,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457380,DTCT0023180,2247036,DTCC00484162,2003591,24627
CHEMBL249161,P23975,,AQBBMDYZYWMBQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,IC50,,,,,,,,,,,,,,,,,Inhibition of NET,Not Determined,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457381,DTCT0023180,2247050,DTCC00484100,1263967,24627
CHEMBL249161,P23975,,AQBBMDYZYWMBQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,INHIBITION,=,13,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457380,DTCT0023180,2247042,DTCC00484100,1263967,24627
CHEMBL249213,P23975,,KZTLVKCVXWWSHF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,250000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249832,DTCC00483187,1571554,24671
CHEMBL249214,P23975,,XEKOGGCKFOLDIR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,9000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249826,DTCC00483193,1410778,24671
CHEMBL249215,P23975,,RLZDYYKLMOPCMU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,170000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249824,DTCC00483195,1987255,24671
CHEMBL249329,P23975,,QDLBXJOPGVUQLI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,IC50,=,39000,NM,,,,,,,,,,,,,,Inhibition of NET,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457381,DTCT0023180,2247046,DTCC00484147,293990,24627
CHEMBL249329,P23975,,QDLBXJOPGVUQLI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457380,DTCT0023180,2247039,DTCC00484147,293990,24627
CHEMBL24944,P23975,TRIBROMSALAN,KVSKGMLNBAPGKH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446288,DTCC00154630,1830693,46191
CHEMBL24944,P23975,TRIBROMSALAN,KVSKGMLNBAPGKH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446289,DTCC00154630,1830693,46191
CHEMBL249807,P23975,,PXCLIXMWUZNIDA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,410000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249836,DTCC00112187,2020165,24671
CHEMBL249854,P23975,,ZFRLEPMXXGKKBN-WPFOTENUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17418570,KI,=,7700,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter,,CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.,Bioorg. Med. Chem. Lett.,2007,17,11,"Pruitt JR, Batt DG, Wacker DA, Bostrom LL, Booker SK, McLaughlin E, Houghton GC, Varnes JG, Christ DD, Covington M, Das AM, Davies P, Graden D, Kariv I, Orlovsky Y, Stowell NC, Vaddi KG, Wadman EA, Welch PK, Yeleswaram S, Solomon KA, Newton RC, Decicco CP, Carter PH, Ko SS",,458982,DTCT0023180,2259414,DTCC00487163,827723,24816
CHEMBL249951,P23975,,HCOYSMZXQIWWOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,IC50,=,8700,NM,,,,,,,,,,,,,,Inhibition of NET,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457381,DTCT0023180,2247045,DTCC00484152,1716191,24627
CHEMBL249951,P23975,,HCOYSMZXQIWWOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,INHIBITION,=,18,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457380,DTCT0023180,2247038,DTCC00484152,1716191,24627
CHEMBL25,P23975,ASPIRIN,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7275000,DTCC00133284,51447,46191
CHEMBL25,P23975,ASPIRIN,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7275001,DTCC00133284,51447,46191
CHEMBL250000,P23975,,OXDQCMPUWXORTN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,300000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249837,DTCC00112185,1280433,24671
CHEMBL250008,P23975,,SZBJSPPPDLPVBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,210000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249835,DTCC00483175,1636393,24671
CHEMBL250450,P23975,ISOQUERCETIN,OVSQVDMCBVZWGM-QSOFNFLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14753423,DTCC00486067,2109951,69275
CHEMBL250689,P23975,,ASRDPULQBHFPGU-WFIHMLKPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17418570,KI,=,950,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter,,CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.,Bioorg. Med. Chem. Lett.,2007,17,11,"Pruitt JR, Batt DG, Wacker DA, Bostrom LL, Booker SK, McLaughlin E, Houghton GC, Varnes JG, Christ DD, Covington M, Das AM, Davies P, Graden D, Kariv I, Orlovsky Y, Stowell NC, Vaddi KG, Wadman EA, Welch PK, Yeleswaram S, Solomon KA, Newton RC, Decicco CP, Carter PH, Ko SS",,458982,DTCT0023180,2259530,DTCC00487112,1857360,24816
CHEMBL251254,P23975,HYPEROSIDE,OVSQVDMCBVZWGM-DTGCRPNFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14748619,DTCC00487046,2109632,69275
CHEMBL251576,P23975,,LJOGQAFQXBMQQW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of NET,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457381,DTCT0023180,2247020,DTCC00484088,909251,24627
CHEMBL251576,P23975,,LJOGQAFQXBMQQW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,INHIBITION,=,-4.9,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457380,DTCT0023180,2247019,DTCC00484088,909251,24627
CHEMBL251694,P23975,(R)-VENLAFAXINE,PNVNVHUZROJLTJ-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21413808,IC50,=,61,NM,,,,,,,,,,,,,,Inhibition of NET,,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,2011,54,8,,,879332,DTCT0023180,11458836,DTCC00003875,673693,51826
CHEMBL252556,P23975,IDEBENONE,JGPMMRGNQUBGND-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7330000,DTCC00485000,185554,46191
CHEMBL252556,P23975,IDEBENONE,JGPMMRGNQUBGND-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7330001,DTCC00485000,185554,46191
CHEMBL252557,P23975,GLYCOLIC ACID,AEMRFAOFKBGASW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308285,DTCC00485664,962448,46191
CHEMBL252557,P23975,GLYCOLIC ACID,AEMRFAOFKBGASW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308286,DTCC00485664,962448,46191
CHEMBL252719,P23975,(S)-MIANSERIN,UEQUQVLFIPOEMF-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,71,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731052,DTCC00003851,2104291,68566
CHEMBL252720,P23975,(S)-VENLAFAXINE,PNVNVHUZROJLTJ-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21413808,IC50,=,754,NM,,,,,,,,,,,,,,Inhibition of NET,,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,2011,54,8,,,879332,DTCT0023180,11458833,DTCC00487033,90552,51826
CHEMBL252720,P23975,(S)-VENLAFAXINE,PNVNVHUZROJLTJ-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23061607,IC50,=,149,NM,,,,,,,,,,,,,,Inhibition of NET (unknown origin) assessed as noradrenaline reuptake,,Organosilicon molecules with medicinal applications.,J. Med. Chem.,2013,56,2,"Franz AK, Wilson SO",,934616,DTCT0023180,11751470,DTCC00487033,90895,52878
CHEMBL252923,P23975,"1R,2S-MILNACIPRAN",GJJFMKBJSRMPLA-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14573386,KI,=,200,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14742525,DTCC00486849,2108076,69056
CHEMBL252923,P23975,"1R,2S-MILNACIPRAN",GJJFMKBJSRMPLA-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,22,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14742524,DTCC00486849,2108075,69177
CHEMBL252923,P23975,"1R,2S-MILNACIPRAN",GJJFMKBJSRMPLA-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,68,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14742523,DTCC00486849,2108075,69177
CHEMBL252923,P23975,"1R,2S-MILNACIPRAN",GJJFMKBJSRMPLA-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,5500,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372803,DTCC00486849,455698,25565
CHEMBL252923,P23975,"1R,2S-MILNACIPRAN",GJJFMKBJSRMPLA-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,5500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374249,DTCC00486849,472565,25551
CHEMBL252923,P23975,"1R,2S-MILNACIPRAN",GJJFMKBJSRMPLA-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,41,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454707,DTCC00486849,459925,54354
CHEMBL252923,P23975,"1R,2S-MILNACIPRAN",GJJFMKBJSRMPLA-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,85,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454786,DTCC00486849,459925,54354
CHEMBL253182,P23975,,AQWGYBOWCFEBRM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18085744,KI,=,618,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET t expressed in HEK293 cells,,"Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.",J. Med. Chem.,2008,51,2,"Jarkas N, Voll RJ, Williams L, Votaw JR, Owens M, Goodman MM",,460402,DTCT0023180,2268671,DTCC00485234,1037875,24992
CHEMBL253184,P23975,,SZIXMPCDFZGATL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18085744,KI,=,725,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET t expressed in HEK293 cells,,"Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.",J. Med. Chem.,2008,51,2,"Jarkas N, Voll RJ, Williams L, Votaw JR, Owens M, Goodman MM",,460402,DTCT0023180,2268682,DTCC00485237,1491242,24992
CHEMBL253376,P23975,BROMHEXINE,OJGDCBLYJGHCIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264516,DTCC00112211,444635,46191
CHEMBL253376,P23975,BROMHEXINE,OJGDCBLYJGHCIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264517,DTCC00112211,444635,46191
CHEMBL253387,P23975,,ZUJSUIUCXPKMMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18085744,KI,=,467,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET t expressed in HEK293 cells,,"Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.",J. Med. Chem.,2008,51,2,"Jarkas N, Voll RJ, Williams L, Votaw JR, Owens M, Goodman MM",,460402,DTCT0023180,2268681,DTCC00112264,1555554,24992
CHEMBL253597,P23975,,DHZBNHMEIOBPAE-JVVVGQRLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18067245,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to NET receptor at 10 uM,,Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.,J. Med. Chem.,2008,51,1,"Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW",,460133,DTCT0023180,2267479,DTCC00485513,1458632,24978
CHEMBL254219,P23975,DIGITOXIN,WDJUZGPOPHTGOT-XUDUSOBPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7344600,DTCC00112296,994591,46191
CHEMBL254219,P23975,DIGITOXIN,WDJUZGPOPHTGOT-XUDUSOBPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7344601,DTCC00112296,994591,46191
CHEMBL255112,P23975,,XXWKAPSDJYNICL-SVBPBHIXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18243691,INHIBITION,=,61,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,2008,18,4,"Erickson SD, Banner B, Berthel S, Conde-Knape K, Falcioni F, Hakimi I, Hennessy B, Kester RF, Kim K, Ma C, McComas W, Mennona F, Mischke S, Orzechowski L, Qian Y, Salari H, Tengi J, Thakkar K, Taub R, Tilley JW, Wang H",,464128,DTCT0023180,2307689,DTCC00501539,1744737,25297
CHEMBL255196,P23975,,PEFNNJLMNBFNNG-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,4495,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307482,DTCC00501467,472522,25295
CHEMBL255246,P23975,,QSSYRFOLGZMPLN-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,20,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374319,DTCC00490896,1378471,25551
CHEMBL255303,P23975,,PDGMXEUBNYMTST-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372800,DTCC00492341,811456,25565
CHEMBL255448,P23975,,XTOFIVJPRPHPAF-WCQYABFASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,1100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374329,DTCC00490969,472566,25551
CHEMBL255449,P23975,,PUKHAHUSCTVYAW-SWLSCSKDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,8.7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374330,DTCC00490971,310519,25551
CHEMBL255450,P23975,,OMTGXKFSSPIPRK-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,2.8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374230,DTCC00490972,1214978,25551
CHEMBL255663,P23975,,POGCTVQQHWBYLG-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,2.7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374231,DTCC00112580,1700759,25551
CHEMBL255768,P23975,,QEDLIMYVQKJVCR-MJGOQNOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307484,DTCC00501545,439440,25295
CHEMBL255839,P23975,,UVKUMJGXPDEXSQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303652,DTCC00500296,827855,25699
CHEMBL255957,P23975,,JHJNQSMDFYVXBO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,157,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306878,DTCC00501901,326719,25268
CHEMBL256019,P23975,,YLMUIVZGFNCEHD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303637,DTCC00500710,537388,25699
CHEMBL256020,P23975,,HFDKMRZLKAZCKK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,170,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303636,DTCC00500712,148242,25699
CHEMBL256021,P23975,,KGCAQBRBCVWBSF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,960,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303661,DTCC00500713,893011,25699
CHEMBL256039,P23975,,XAFDYZFDMXIOPG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,360,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303646,DTCC00500203,1280585,25699
CHEMBL256058,P23975,,BBLALPDUHCRAKZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,70,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306891,DTCC00501998,1199000,25268
CHEMBL256135,P23975,,XWGDWRZGNMYDDL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,85,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369746,DTCC00492149,500595,26388
CHEMBL256136,P23975,,OZGYIQFKTKLWDA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369745,DTCC00492150,1373739,26388
CHEMBL256137,P23975,,FCUSICKWCXJXBW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,51,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369749,DTCC00492152,856030,26388
CHEMBL256163,P23975,,ZQJYAEVPJBDRFS-GOEBONIOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,898,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307475,DTCC00501142,892954,25295
CHEMBL256168,P23975,,PBERLNCGGCSXEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306880,DTCC00501904,1555614,25268
CHEMBL256227,P23975,,BJSPCVGBAKIYFP-MJGOQNOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,3867,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307491,DTCC00500995,1539673,25295
CHEMBL256293,P23975,,TWSKMFBDRRENNV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322679,DTCC00492197,876838,19394
CHEMBL256293,P23975,,TWSKMFBDRRENNV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369752,DTCC00492197,888211,26388
CHEMBL256371,P23975,,ZQJYAEVPJBDRFS-ZBFHGGJFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307476,DTCC00501181,83331,25295
CHEMBL256397,P23975,,YNXFZOVYRWOMIR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,2800,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303639,DTCC00500754,795394,25699
CHEMBL256408,P23975,N-(2-OXAZOLEMETHYL)MILNACIPRAN,NCRFMJNGTNNKEE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303660,DTCC00004437,472587,25699
CHEMBL256447,P23975,,WDLBUKLHPSKQTF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,3700,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303638,DTCC00500755,1889790,25699
CHEMBL256511,P23975,,IGNDYXSKELQDJB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,246,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369751,DTCC00492198,920090,26388
CHEMBL256557,P23975,,IMHXBNROFRDAND-HNAYVOBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372769,DTCC00492335,585523,25565
CHEMBL256646,P23975,,MMSNYIQZTXLKBV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303640,DTCC00500758,634370,25699
CHEMBL256667,P23975,,QSCRGZVJRUUPPV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,8.4,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303632,DTCC00500540,1539740,25699
CHEMBL256816,P23975,,LDPRCWPXDFHEJU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,42,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306882,DTCC00501947,294104,25268
CHEMBL256817,P23975,,BRMWMWORGPTOCB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,46,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306885,DTCC00501948,9102,25268
CHEMBL256818,P23975,,GLZVSWBABDDJJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,78,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306883,DTCC00501950,1394326,25268
CHEMBL256819,P23975,,FCZCOULCVQEFCA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,21,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306886,DTCC00501952,844281,25268
CHEMBL256841,P23975,,LHEVFGSJGDXFCO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303630,DTCC00500456,1410930,25699
CHEMBL256902,P23975,,GWOOARVSRFHYAH-MJGOQNOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,3861,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307479,DTCC00501331,1987338,25295
CHEMBL256970,P23975,,CTPBZYGSXVZQMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369748,DTCC00492148,1308597,26388
CHEMBL257047,P23975,,NOZPULFYDFZTCM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303654,DTCC00500460,1636538,25699
CHEMBL257048,P23975,"N,N-DIMETHYL MILNACIPRAN",NMRSWXVEITZBIQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303653,DTCC00500461,1280584,25699
CHEMBL257083,P23975,,ZQJYAEVPJBDRFS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,3873,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307478,DTCC00501290,827801,25295
CHEMBL257130,P23975,,JUESHDJIQYYBKK-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,150,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374238,DTCC00491052,1345974,25551
CHEMBL25719,P23975,GERANIOL,GLZPCOQZEFWAFX-JXMROGBWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312452,DTCC00159285,898289,46191
CHEMBL25719,P23975,GERANIOL,GLZPCOQZEFWAFX-JXMROGBWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312453,DTCC00159285,898289,46191
CHEMBL257221,P23975,,HASNZFFRDSPBMJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,3300,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296160,DTCC00501678,1555604,25227
CHEMBL257264,P23975,,CWHLGCRIEMGRGS-WBVHZDCISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,5948,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307480,DTCC00501382,1728810,25295
CHEMBL257265,P23975,,CUCYIEARHKRHHK-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307481,DTCC00501427,1987337,25295
CHEMBL257280,P23975,,DDPFMTCKLODLQM-GKBBYZSKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18243691,INHIBITION,=,12,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,2008,18,4,"Erickson SD, Banner B, Berthel S, Conde-Knape K, Falcioni F, Hakimi I, Hennessy B, Kester RF, Kim K, Ma C, McComas W, Mennona F, Mischke S, Orzechowski L, Qian Y, Salari H, Tengi J, Thakkar K, Taub R, Tilley JW, Wang H",,464128,DTCT0023180,2307683,DTCC00501417,1809032,25297
CHEMBL257335,P23975,,VQHFZGHDNLRMRZ-SUMWQHHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,8.1,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372772,DTCC00492380,1426753,25565
CHEMBL257336,P23975,,SHSUQLQDTJDCTQ-IFXJQAMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372774,DTCC00492382,714748,25565
CHEMBL257338,P23975,,GSMNVIUCCXHOLS-GUYCJALGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,65,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374239,DTCC00491055,601690,25551
CHEMBL257348,P23975,,RGPDAGIHVSVOQP-BDBMTWCYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,37,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374320,DTCC00490900,569548,25551
CHEMBL257388,P23975,,XCUFOYFDVQBJRW-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,8.2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374325,DTCC00490925,180295,25551
CHEMBL257389,P23975,,WDJLGAAWPRVZRR-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,3.9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374323,DTCC00490927,795372,25551
CHEMBL257390,P23975,,QRBKUYBUQLQJEH-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,64,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374328,DTCC00490929,989516,25551
CHEMBL257423,P23975,,WYCWVUGQDBCHEF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,256,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306888,DTCC00501994,844280,25268
CHEMBL257423,P23975,,WYCWVUGQDBCHEF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,180,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654488,DTCC00501994,844714,30519
CHEMBL257424,P23975,,BSYKAWMTFFQDNB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,82,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306889,DTCC00501996,455652,25268
CHEMBL257424,P23975,,BSYKAWMTFFQDNB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,50,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654487,DTCC00501996,456079,30519
CHEMBL257481,P23975,,FUFMKPBBSWMURG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,78,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306874,DTCC00501867,2003692,25268
CHEMBL257549,P23975,,RTMQOOCMZQWPBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372805,DTCC00492384,1905857,25565
CHEMBL257550,P23975,,ZAKNFBUXJCNYEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372804,DTCC00492385,1684967,25565
CHEMBL257551,P23975,,FOMBUMQDBKFBLB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372806,DTCC00492387,585521,25565
CHEMBL257592,P23975,,YEIRDCHLYKWPAP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,86,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369755,DTCC00492236,597126,26388
CHEMBL257593,P23975,,AQIDZODGJIWGLO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,47,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369759,DTCC00492237,1341227,26388
CHEMBL257602,P23975,,NYOJDMQJBPXCHG-GXTWGEPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,5.6,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374233,DTCC00491008,1728844,25551
CHEMBL257603,P23975,,IQIONMXYTYNILR-WCQYABFASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374232,DTCC00491009,375722,25551
CHEMBL257704,P23975,EPLIVANSERIN,VAIOZOCLKVMIMN-PRJWTAEASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15999145,KI,=,739.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755032,DTCC00498890,2104430,69464
CHEMBL257738,P23975,,ANDYBNKRXGVQGP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,140,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296159,DTCC00501641,1491280,25227
CHEMBL257808,P23975,,QIEUXXFCMLEYMI-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,170,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374236,DTCC00491011,1151826,25551
CHEMBL257809,P23975,,ISKVOQJXBREYEF-ZANVPECISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,29,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374245,DTCC00491095,957144,25551
CHEMBL257810,P23975,,LLAFUUNOXYVHHL-ZANVPECISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,40,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374244,DTCC00491096,2052453,25551
CHEMBL257905,P23975,,UETBCRHGQLBFHE-JWQCQUIFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18243691,INHIBITION,=,24,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,2008,18,4,"Erickson SD, Banner B, Berthel S, Conde-Knape K, Falcioni F, Hakimi I, Hennessy B, Kester RF, Kim K, Ma C, McComas W, Mennona F, Mischke S, Orzechowski L, Qian Y, Salari H, Tengi J, Thakkar K, Taub R, Tilley JW, Wang H",,464128,DTCT0023180,2307685,DTCC00501419,682395,25297
CHEMBL257906,P23975,,NNGIOOYYOUWXAP-PISWEHOVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18243691,INHIBITION,=,77,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,2008,18,4,"Erickson SD, Banner B, Berthel S, Conde-Knape K, Falcioni F, Hakimi I, Hennessy B, Kester RF, Kim K, Ma C, McComas W, Mennona F, Mischke S, Orzechowski L, Qian Y, Salari H, Tengi J, Thakkar K, Taub R, Tilley JW, Wang H",,464128,DTCT0023180,2307684,DTCC00501420,1166518,25297
CHEMBL257909,P23975,,LUJLISGGFLGFKZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,112,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296158,DTCC00501642,1555605,25227
CHEMBL257940,P23975,,WZHXVKWOVBWNIB-RHDGDCLCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18160282,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 10 uM,,Discovery of novel orally active ureido NPY Y5 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,3,"Li G, Stamford AW, Huang Y, Cheng KC, Cook J, Farley C, Gao J, Ghibaudi L, Greenlee WJ, Guzzi M, van Heek M, Hwa JJ, Kelly J, Mullins D, Parker EM, Wainhaus S, Zhang X",,468038,DTCT0023180,2301305,DTCC00499075,424837,25590
CHEMBL257964,P23975,,LRXREOMAEUNNPU-GWCFXTLKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,76,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374246,DTCC00491136,1345973,25551
CHEMBL257991,P23975,SRT-1720,IASPBORHOMBZMY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19199480,IC50,=,2470,NM,,,,,,,,,,,,,,Inhibition of norepinephrine transporter,,"Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.",J. Med. Chem.,2009,52,5,"Vu CB, Bemis JE, Disch JS, Ng PY, Nunes JJ, Milne JC, Carney DP, Lynch AV, Smith JJ, Lavu S, Lambert PD, Gagne DJ, Jirousek MR, Schenk S, Olefsky JM, Perni RB",,495766,DTCT0023180,2599089,DTCC00004050,1756240,32146
CHEMBL258013,P23975,,DRYNWXRVJSBMFJ-CPFSXVBKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,270,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374242,DTCC00491092,1889770,25551
CHEMBL258060,P23975,,NTOHKBIOUPYUFZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,25,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306863,DTCC00501742,260795,25268
CHEMBL258062,P23975,,RFJRYJRDVNGNCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,33,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306869,DTCC00501822,1199001,25268
CHEMBL258063,P23975,,GGDZOYZQDNYTKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306872,DTCC00501823,1523500,25268
CHEMBL258140,P23975,,IXAZZNONZSLTKY-QUCCMNQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,6688,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307490,DTCC00500945,1247958,25295
CHEMBL258180,P23975,,KHDOKCLXCQAKEX-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372797,DTCC00492295,1587899,25565
CHEMBL258260,P23975,,LZBZURMZSQMQEB-KPGYKUMBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18243691,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,2008,18,4,"Erickson SD, Banner B, Berthel S, Conde-Knape K, Falcioni F, Hakimi I, Hennessy B, Kester RF, Kim K, Ma C, McComas W, Mennona F, Mischke S, Orzechowski L, Qian Y, Salari H, Tengi J, Thakkar K, Taub R, Tilley JW, Wang H",,464128,DTCT0023180,2307688,DTCC00501537,876738,25297
CHEMBL258271,P23975,,HEBFKAQNVHADTH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,84,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306871,DTCC00501824,650457,25268
CHEMBL258291,P23975,,JZCIRLJPOBBVMR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,159,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322663,DTCC00112910,1394450,19394
CHEMBL258292,P23975,,IKZQDEYILGZICZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,438,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322664,DTCC00497933,294225,19394
CHEMBL258336,P23975,,HRKLUXSFAYPUIK-CVEARBPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,1518,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307472,DTCC00501090,244725,25295
CHEMBL258336,P23975,,HRKLUXSFAYPUIK-CVEARBPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,3789,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307483,DTCC00501090,244724,25295
CHEMBL258338,P23975,,HRKLUXSFAYPUIK-JKSUJKDBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,1565,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307471,DTCC00501092,83332,25295
CHEMBL258449,P23975,,BDGQOYDELXXRKV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,282,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369760,DTCC00492279,240107,26388
CHEMBL258450,P23975,,YKZNMHWYVVPEPW-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372799,DTCC00492337,1037977,25565
CHEMBL258451,P23975,,IWUJCJJESBVFNA-HNAYVOBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372770,DTCC00492339,1394381,25565
CHEMBL258713,P23975,,XKQXMBVWEDMNAK-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367401,DTCC00493438,439563,26231
CHEMBL258930,P23975,,JTCQOAITNDJYSA-IEBWSBKVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,350,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367404,DTCC00493439,277807,26231
CHEMBL259136,P23975,,MPTXQMSURVDICU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,159,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369741,DTCC00492861,1567117,26388
CHEMBL259209,P23975,MILNACIPRAN,GJJFMKBJSRMPLA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,77,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303625,DTCC00492474,1700779,25699
CHEMBL259209,P23975,MILNACIPRAN,GJJFMKBJSRMPLA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,77,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372765,DTCC00492474,1684966,25565
CHEMBL259209,P23975,MILNACIPRAN,GJJFMKBJSRMPLA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,77,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2600047,DTCC00492474,1696998,32649
CHEMBL259209,P23975,MILNACIPRAN,GJJFMKBJSRMPLA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013,23,5,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623,DTCT0023180,11800439,DTCC00492474,1688708,53876
CHEMBL259694,P23975,,KQAWRUCRTMUOJJ-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372787,DTCC00492722,1426752,25565
CHEMBL259765,P23975,,XSZZVXRYXJUWCA-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,610,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367412,DTCC00492934,1280652,26231
CHEMBL26,P23975,SULPIRIDE,BGRJTUBHPOOWDU-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7474182,DTCC00133325,413978,46191
CHEMBL26,P23975,SULPIRIDE,BGRJTUBHPOOWDU-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7474183,DTCC00133325,413978,46191
CHEMBL260036,P23975,,JTDKALUSBWIJPG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,25,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369740,DTCC00492862,207709,26388
CHEMBL260037,P23975,,YMESBXUQEPAMAY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,394,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369739,DTCC00492863,1917228,26388
CHEMBL260038,P23975,,ZEFZLXPQUSMAFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,257,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369743,DTCC00492865,532708,26388
CHEMBL260039,P23975,,JRNAGNLSMXSNPN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369742,DTCC00492866,1599638,26388
CHEMBL260131,P23975,,HZHJKYFUXCEIEP-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,5.9,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372775,DTCC00492426,1716322,25565
CHEMBL260258,P23975,,XSZZVXRYXJUWCA-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,6,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367413,DTCC00492968,2052532,26231
CHEMBL260259,P23975,,PVISFTMIHRDVDS-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367415,DTCC00492970,277806,26231
CHEMBL260335,P23975,,UZYRBFYXTKDZOC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,6400,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372808,DTCC00492427,131811,25565
CHEMBL260336,P23975,,NGJYHUYANNRTCI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372809,DTCC00492429,1620510,25565
CHEMBL260439,P23975,,GNGXSMDBVKAQSC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303642,DTCC00492471,698736,25699
CHEMBL260439,P23975,,GNGXSMDBVKAQSC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372812,DTCC00492471,682433,25565
CHEMBL260440,P23975,,GAARSROYUMPZLY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303634,DTCC00492472,1345998,25699
CHEMBL260440,P23975,,GAARSROYUMPZLY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372811,DTCC00492472,1329288,25565
CHEMBL260823,P23975,,ZHYJMAJSBAQRIU-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,830,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367410,DTCC00493515,1700841,26231
CHEMBL260863,P23975,,OLIZEOZRLLYHDY-HNAYVOBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372785,DTCC00492671,553377,25565
CHEMBL260988,P23975,,PRTQZTFEHWCKDF-BLLLJJGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372789,DTCC00492726,1873568,25565
CHEMBL261076,P23975,,PVISFTMIHRDVDS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,36,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367417,DTCC00493044,1636616,26231
CHEMBL261076,P23975,,PVISFTMIHRDVDS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,320,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367416,DTCC00493044,1636617,26231
CHEMBL261465,P23975,,XBLJZKGUMJUESI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,366,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322678,DTCC00497679,359434,19394
CHEMBL262357,P23975,,LAMKUIMKGNOGQJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,921,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322676,DTCC00497677,1905925,19394
CHEMBL26260,P23975,BETA-NAPHTHOFLAVONE,OUGIDAPQYNCXRA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269866,DTCC00163498,1641845,46191
CHEMBL26260,P23975,BETA-NAPHTHOFLAVONE,OUGIDAPQYNCXRA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269867,DTCC00163498,1641845,46191
CHEMBL262777,P23975,VANCOMYCIN,MYPYJXKWCTUITO-LYRMYLQWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446647,DTCC00189637,51514,46191
CHEMBL262777,P23975,VANCOMYCIN,MYPYJXKWCTUITO-LYRMYLQWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446648,DTCC00189637,51514,46191
CHEMBL26320,P23975,GBR-12935,RAQPOZGWANIDQT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871666,IC50,=,1261,NM,,,,,,,,,,,,,,Compound was tested for its ability to inhibit the uptake of Norepinephrine in Norepinephrine transporter system,,Design and synthesis of a biotinylated dopamine transporter ligand for the purification and labeling of dopaminergic neurons.,Bioorg. Med. Chem. Lett.,1998,8,3,"Zimmermann K, Hengerer B",,143137,DTCT0023180,1220006,DTCC01739281,486373,2969
CHEMBL26320,P23975,GBR-12935,RAQPOZGWANIDQT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,165,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,818802,DTCC01739281,486034,15898
CHEMBL26320,P23975,GBR-12935,RAQPOZGWANIDQT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,630,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,818799,DTCC01739281,486034,15898
CHEMBL263373,P23975,,FUHOKNRCOVAKDB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,275,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367422,DTCC00493162,244842,26231
CHEMBL263373,P23975,,FUHOKNRCOVAKDB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,1490,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367421,DTCC00493162,244843,26231
CHEMBL263920,P23975,,NUGRPPXOWJFLKG-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367394,DTCC00493349,601763,26231
CHEMBL264158,P23975,,LHOSACAWSLTLQJ-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367398,DTCC00493392,1248088,26231
CHEMBL264159,P23975,,SGXWOKUJCWMPJE-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367397,DTCC00493393,924913,26231
CHEMBL264160,P23975,,ZCLPMZOFUORDSQ-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367399,DTCC00493395,408849,26231
CHEMBL264173,P23975,,QQHREAWMTUYOBO-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,180,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367393,DTCC00493350,2084703,26231
CHEMBL264174,P23975,,QMMAMXVYCMLPGH-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,84,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367395,DTCC00493352,666618,26231
CHEMBL264374,P23975,BEZAFIBRATE,IIBYAHWJQTYFKB-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7261516,DTCC00179544,249938,46191
CHEMBL264374,P23975,BEZAFIBRATE,IIBYAHWJQTYFKB-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7261517,DTCC00179544,249938,46191
CHEMBL264418,P23975,,IJMPFBJUROFOGZ-NVXWUHKLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,130,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367406,DTCC00493475,537441,26231
CHEMBL264430,P23975,,FYRQVFPRGMKFAC-LAUBAEHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372780,DTCC00492611,424829,25565
CHEMBL264678,P23975,,PAYGGRIFYBKVNJ-SUMWQHHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,6.3,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372779,DTCC00492608,2068319,25565
CHEMBL264680,P23975,,IJMPFBJUROFOGZ-RDJZCZTQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367407,DTCC00112638,601762,26231
CHEMBL265951,P23975,,YYYWQSQFBVNAPA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,296,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322675,DTCC00497648,1937931,19394
CHEMBL267044,P23975,LEVOSULPIRIDE,BGRJTUBHPOOWDU-NSHDSACASA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431641,DTCC00136073,1734057,46191
CHEMBL267044,P23975,LEVOSULPIRIDE,BGRJTUBHPOOWDU-NSHDSACASA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431642,DTCC00136073,1734057,46191
CHEMBL267345,P23975,AMPHOTERICIN B,APKFDSVGJQXUKY-INPOYWNPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287632,DTCC00139627,51445,46191
CHEMBL267345,P23975,AMPHOTERICIN B,APKFDSVGJQXUKY-INPOYWNPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7287633,DTCC00139627,51445,46191
CHEMBL267615,P23975,,ZEYRDXUWJDGTLD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10715164,KI,>,10000,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards human NET(norepinephrine) transporter,,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,2000,43,5,"Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK",,140883,DTCT0023180,884518,DTCC00133863,905249,16105
CHEMBL267648,P23975,PEFLOXACIN,FHFYDNQZQSQIAI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386895,DTCC00141792,735393,46191
CHEMBL267648,P23975,PEFLOXACIN,FHFYDNQZQSQIAI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386896,DTCC00141792,735393,46191
CHEMBL267744,P23975,TICRYNAFEN,AGHANLSBXUWXTB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7474791,DTCC00134562,1544902,46191
CHEMBL267744,P23975,TICRYNAFEN,AGHANLSBXUWXTB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7474792,DTCC00134562,1544902,46191
CHEMBL267894,P23975,AMOBARBITAL,VIROVYVQCGLCII-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7302425,DTCC00134214,1092340,46191
CHEMBL267894,P23975,AMOBARBITAL,VIROVYVQCGLCII-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7302426,DTCC00134214,1092340,46191
CHEMBL268291,P23975,DIMETHYLFORMAMIDE,ZMXDDKWLCZADIW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415886,DTCC00136577,1765977,46191
CHEMBL268291,P23975,DIMETHYLFORMAMIDE,ZMXDDKWLCZADIW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415887,DTCC00136577,1765977,46191
CHEMBL269538,P23975,HARMINE,BXNJHAXVSOCGBA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643338,KI,=,3260,NM,,,,,,,,,,,,,,Binding affinity towards NET,,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,2003,13,24,"Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA",,142610,DTCT0023180,1119517,DTCC00132472,627749,6037
CHEMBL269732,P23975,TACROLIMUS,QJJXYPPXXYFBGM-LFZNUXCKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456826,DTCC00132983,1765982,46191
CHEMBL269732,P23975,TACROLIMUS,QJJXYPPXXYFBGM-LFZNUXCKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456827,DTCC00132983,1765982,46191
CHEMBL269798,P23975,,WLIAMZZYIMPMEA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303649,DTCC00500249,83397,25699
CHEMBL269799,P23975,,LRQFAGSCSIOKKB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303648,DTCC00500250,601706,25699
CHEMBL269939,P23975,,MFKHVNDQMBWBBI-PISWEHOVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18243691,INHIBITION,=,69,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,2008,18,4,"Erickson SD, Banner B, Berthel S, Conde-Knape K, Falcioni F, Hakimi I, Hennessy B, Kester RF, Kim K, Ma C, McComas W, Mennona F, Mischke S, Orzechowski L, Qian Y, Salari H, Tengi J, Thakkar K, Taub R, Tilley JW, Wang H",,464128,DTCT0023180,2307686,DTCC00501497,1937818,25297
CHEMBL27,P23975,PROPRANOLOL,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7400781,DTCC00133355,51503,46191
CHEMBL27,P23975,PROPRANOLOL,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7400782,DTCC00133355,51503,46191
CHEMBL270099,P23975,,FBYDVYUKCVAEAU-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17983754,KI,=,1.35,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,2008,16,2,"Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,466322,DTCT0023180,2290052,DTCC00503868,1760631,25467
CHEMBL270151,P23975,,KBHALIJUSMYPCR-AFWDCEBSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18243691,INHIBITION,=,64,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,2008,18,4,"Erickson SD, Banner B, Berthel S, Conde-Knape K, Falcioni F, Hakimi I, Hennessy B, Kester RF, Kim K, Ma C, McComas W, Mennona F, Mischke S, Orzechowski L, Qian Y, Salari H, Tengi J, Thakkar K, Taub R, Tilley JW, Wang H",,464128,DTCT0023180,2307687,DTCC00501499,2003697,25297
CHEMBL270165,P23975,,BRKDRAMGEIRGGU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,3700,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296168,DTCC00502248,228561,25227
CHEMBL270240,P23975,,SKEKTDQXWYTVGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303655,DTCC00500504,1119464,25699
CHEMBL270299,P23975,BAY-11-7085,VHKZGNPOHPFPER-ONNFQVAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7268240,DTCC00504714,1220273,46191
CHEMBL270299,P23975,BAY-11-7085,VHKZGNPOHPFPER-ONNFQVAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7268241,DTCC00504714,1220273,46191
CHEMBL270366,P23975,,JPMSOQZFFUMLIX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,951,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322672,DTCC00498045,131878,19394
CHEMBL270569,P23975,,SZXFAVGUAGOGII-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,2600,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303657,DTCC00500545,1442650,25699
CHEMBL270570,P23975,,ZEDCZVINJCBZGE-MJGOQNOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307485,DTCC00500858,827800,25295
CHEMBL270595,P23975,,OXEFHEYEQUISKC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818156,DTCT0023180,10479349,DTCC00502273,1928089,48255
CHEMBL270607,P23975,,NWKCIVHGGAEYQL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,2000,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296161,DTCC00502336,1809017,25227
CHEMBL270625,P23975,,HZRDBNNJLUYHJA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,530,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296152,DTCC00502297,747004,25227
CHEMBL270642,P23975,,IHHOPZQJPZTOOA-ZBFHGGJFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,525,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307488,DTCC00500901,1793053,25295
CHEMBL270786,P23975,,UMFDUXSRXIHGAG-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,6248,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307486,DTCC00500861,1345925,25295
CHEMBL270791,P23975,,CRLQFKMWDMUITC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322661,DTCC00497869,1716395,19394
CHEMBL272002,P23975,,VANVVYOTKNTIED-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17983754,KI,=,1.32,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,2008,16,2,"Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,466322,DTCT0023180,2290056,DTCC00503889,1760630,25467
CHEMBL272003,P23975,,ZWMWTNKSRCRPSI-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17983754,KI,=,2.06,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,2008,16,2,"Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,466322,DTCT0023180,2290050,DTCC00503891,310507,25467
CHEMBL272063,P23975,,IXBHAYXQNHDHST-WBVHZDCISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,3776,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307487,DTCC00500863,1668819,25295
CHEMBL272074,P23975,,RBGQVIWIAYEYFG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303658,DTCC00500631,343176,25699
CHEMBL272285,P23975,,PZVMCTLCQFNWSD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,130,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303635,DTCC00500632,1700780,25699
CHEMBL272286,P23975,,PGQYZXSMJFWTHI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303659,DTCC00500634,1728859,25699
CHEMBL272493,P23975,,PCZHCTVLCPQAAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,17,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306865,DTCC00501789,682393,25268
CHEMBL272530,P23975,,PNHQUTMNPCBPOX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,8000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303645,DTCC00500154,827856,25699
CHEMBL272531,P23975,,VPKOLELPULBVMY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,6100,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303664,DTCC00500155,795393,25699
CHEMBL272533,P23975,O-METHYL TRAMADOL,VWXSFQRIRPPNDO-WBVHZDCISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,161,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307493,DTCC00004446,698677,25295
CHEMBL272699,P23975,,QUZXTJYADOYRDB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,420,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296157,DTCC00502085,1716263,25227
CHEMBL272744,P23975,,BHAREOZDRRGSHA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,860,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303666,DTCC00500159,634369,25699
CHEMBL272790,P23975,,CBSPAZYMJJLPIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,570,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303650,DTCC00500252,763233,25699
CHEMBL272986,P23975,,QPWPMQLSJRESDN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303663,DTCC00500805,439499,25699
CHEMBL273157,P23975,,YIRWGCANORBOOM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,470,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296167,DTCC00502202,1198989,25227
CHEMBL273208,P23975,,AIBJZSMLYKTKIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322662,DTCC00497900,1652842,19394
CHEMBL273208,P23975,,AIBJZSMLYKTKIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912677,DTCC00497900,1653799,35247
CHEMBL273348,P23975,TOSUFLOXACIN,WUWFMDMBOJLQIV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459728,DTCC00145035,2025645,46191
CHEMBL273348,P23975,TOSUFLOXACIN,WUWFMDMBOJLQIV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459729,DTCC00145035,2025645,46191
CHEMBL273575,P23975,NOMIFENSINE,XXPANQJNYNUNES-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,15.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732591,DTCC00145687,2104703,68566
CHEMBL273575,P23975,NOMIFENSINE,XXPANQJNYNUNES-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845,KI,=,29,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732590,DTCC00145687,2104704,68736
CHEMBL273575,P23975,NOMIFENSINE,XXPANQJNYNUNES-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,23,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461633,DTCC00145687,589047,52000
CHEMBL273575,P23975,NOMIFENSINE,XXPANQJNYNUNES-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,630.96,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465485,DTCC00145687,609706,54821
CHEMBL273575,P23975,NOMIFENSINE,XXPANQJNYNUNES-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,83,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465484,DTCC00145687,609706,54821
CHEMBL273575,P23975,NOMIFENSINE,XXPANQJNYNUNES-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783953,DTCC00145687,589417,53459
CHEMBL274119,P23975,RACEMETHIONINE,FFEARJCKVFRZRR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733405,DTCC00135493,2104905,69159
CHEMBL274525,P23975,ABT-418,ILLGYRJAYAAAEW-QMMMGPOBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,7518514,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14740807,DTCC00137246,2107062,69433
CHEMBL275212,P23975,,ABXUYGWOEIXKBD-KTKRTIGZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,450,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144970,DTCT0023180,959073,DTCC00144047,1663924,17996
CHEMBL275742,P23975,DEXPROPRANOLOL,AQHHHDLHHXJYJD-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7383882,DTCC00140656,1674148,46191
CHEMBL275742,P23975,DEXPROPRANOLOL,AQHHHDLHHXJYJD-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7383883,DTCC00140656,1674148,46191
CHEMBL27577,P23975,SALICYLAMIDE,SKZKKFZAGNVIMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455850,DTCC00161342,185557,46191
CHEMBL27577,P23975,SALICYLAMIDE,SKZKKFZAGNVIMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455851,DTCC00161342,185557,46191
CHEMBL276832,P23975,HYDRALAZINE,RPTUSVTUFVMDQK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325554,DTCC00139551,1416032,46191
CHEMBL276832,P23975,HYDRALAZINE,RPTUSVTUFVMDQK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325555,DTCC00139551,1416032,46191
CHEMBL277100,P23975,TEMAFLOXACIN,QKDHBVNJCZBTMR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482916,DTCC00145004,1124457,46191
CHEMBL277100,P23975,TEMAFLOXACIN,QKDHBVNJCZBTMR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482917,DTCC00145004,1124457,46191
CHEMBL277474,P23975,ANTIPYRINE,VEQOALNAAJBPNY-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7260743,DTCC00154395,509231,46191
CHEMBL277474,P23975,ANTIPYRINE,VEQOALNAAJBPNY-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7260744,DTCC00154395,509231,46191
CHEMBL27769,P23975,STANOLONE,NVKAWKQGWWIWPM-ABEVXSGRSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460672,DTCC00161007,1318447,46191
CHEMBL27769,P23975,STANOLONE,NVKAWKQGWWIWPM-ABEVXSGRSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460673,DTCC00161007,1318447,46191
CHEMBL278165,P23975,,CHLYWPGOYPDIPF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9986702,KI,=,35,NM,,cell_based,,,,,,,,,,,,In vitro binding affinity against monoamine transporter NET (norepinephrine transporter) in LLC-PK1 cell membranes.,,"A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.",J. Med. Chem.,1999,42,3,"Oya S, Kung MP, Acton PD, Mu M, Hou C, Kung HF",,142940,DTCT0023180,1683015,DTCC00155109,1208038,15555
CHEMBL278172,P23975,BENZOCAINE,BLFLLBZGZJTVJG-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267148,DTCC00146075,88623,46191
CHEMBL278172,P23975,BENZOCAINE,BLFLLBZGZJTVJG-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267149,DTCC00146075,88623,46191
CHEMBL279157,P23975,,KWGRBVOPPLSCSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,43.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14737806,DTCC00145885,2106426,69025
CHEMBL279157,P23975,,KWGRBVOPPLSCSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,218,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14737808,DTCC00145885,2106426,69025
CHEMBL279157,P23975,,KWGRBVOPPLSCSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,4092,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14737807,DTCC00145885,2106426,69025
CHEMBL27979,P23975,"A-349,821",CFUHKRLMDNFZED-SFTDATJTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12657274,KI,=,9772.37,NM,,,,,,,,,,,,,,Binding affinity towards human UPTK-NE transporter,,Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2003,13,7,"Faghih R, Dwight W, Pan JB, Fox GB, Krueger KM, Esbenshade TA, McVey JM, Marsh K, Bennani YL, Hancock AA",,142618,DTCT0023180,970135,DTCC00160807,711123,6248
CHEMBL28079,P23975,ZAPRINAST,REZGGXNDEMKIQB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444232,DTCC00165545,1862720,46191
CHEMBL28079,P23975,ZAPRINAST,REZGGXNDEMKIQB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444233,DTCC00165545,1862720,46191
CHEMBL280998,P23975,CATECHOL,YCIMNLLNPGFGHC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340776,DTCC00161195,541717,46191
CHEMBL280998,P23975,CATECHOL,YCIMNLLNPGFGHC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340777,DTCC00161195,541717,46191
CHEMBL281594,P23975,VANOXERINE,NAUWTFJOPJWYOT-UHFFFAOYSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213078,IC50,=,79,NM,,,,,,,,,,,,,,Compound was tested for the inhibition of norepinephrine (NE) reuptake,,Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,2002,45,19,"Prisinzano T, Greiner E, Johnson EM, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,142775,DTCT0023180,908645,DTCC00152898,1112898,16938
CHEMBL281594,P23975,VANOXERINE,NAUWTFJOPJWYOT-UHFFFAOYSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213078,RATIO,=,18,,,,,,,,,,,,,,,Ratio of IC50 value against Norepinephrine transporter (NE) to that of Dopamine transporter (DA),,Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,2002,45,19,"Prisinzano T, Greiner E, Johnson EM, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,142782,DTCT0023180,908648,DTCC00152898,1112898,16938
CHEMBL282468,P23975,CHOLINE CHLORIDE,SGMZJAMFUVOLNK-UHFFFAOYSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7364743,DTCC00159655,120971,46191
CHEMBL282468,P23975,CHOLINE CHLORIDE,SGMZJAMFUVOLNK-UHFFFAOYSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7364744,DTCC00159655,120971,46191
CHEMBL282575,P23975,ESTRADIOL BENZOATE,UYIFTLBWAOGQBI-BZDYCCQFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,17229,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267224,DTCC00165062,1674141,46191
CHEMBL282575,P23975,ESTRADIOL BENZOATE,UYIFTLBWAOGQBI-BZDYCCQFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,17087,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267225,DTCC00165062,1674141,46191
CHEMBL283196,P23975,ALPHA-NAPHTHOFLAVONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295184,DTCC00163499,671784,46191
CHEMBL283196,P23975,ALPHA-NAPHTHOFLAVONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295185,DTCC00163499,671784,46191
CHEMBL283416,P23975,,MWJUXAHARLFJAN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,INHIBITION,=,27,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443462,DTCT0023180,2159942,DTCC00161408,1631616,23363
CHEMBL283899,P23975,,HNOKHIURIJOQKM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,INHIBITION,=,15,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443462,DTCT0023180,2159916,DTCC00161496,467496,23363
CHEMBL284994,P23975,"(1R,4S)-TRANS-SERTRALINE",VGKDLMBJGBXTGI-YVEFUNNKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,817,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731513,DTCC01739603,2104233,68466
CHEMBL284994,P23975,"(1R,4S)-TRANS-SERTRALINE",VGKDLMBJGBXTGI-YVEFUNNKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,1716,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731516,DTCC01739603,2104233,68466
CHEMBL284994,P23975,"(1R,4S)-TRANS-SERTRALINE",VGKDLMBJGBXTGI-YVEFUNNKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,420,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731515,DTCC01739603,2104425,68566
CHEMBL284994,P23975,"(1R,4S)-TRANS-SERTRALINE",VGKDLMBJGBXTGI-YVEFUNNKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,714,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731514,DTCC01739603,2104236,68918
CHEMBL284994,P23975,"(1R,4S)-TRANS-SERTRALINE",VGKDLMBJGBXTGI-YVEFUNNKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,925,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731512,DTCC01739603,2104236,68918
CHEMBL286398,P23975,PROPYLENE GLYCOL,DNIAPMSPPWPWGF-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7405144,DTCC00167384,1798417,46191
CHEMBL286398,P23975,PROPYLENE GLYCOL,DNIAPMSPPWPWGF-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7405145,DTCC00167384,1798417,46191
CHEMBL288826,P23975,,DKXNWXXUHISEHY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.19,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531879,DTCC00176910,333720,63581
CHEMBL289469,P23975,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7329705,DTCC00177095,249942,46191
CHEMBL289469,P23975,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7329706,DTCC00177095,249942,46191
CHEMBL29,P23975,BENZYLPENICILLIN,JGSARLDLIJGVTE-MBNYWOFBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7374071,DTCC00133537,51497,46191
CHEMBL29,P23975,BENZYLPENICILLIN,JGSARLDLIJGVTE-MBNYWOFBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7374072,DTCC00133537,51497,46191
CHEMBL290106,P23975,BITHIONOL,JFIOVJDNOJYLKP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1235,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7272796,DTCC00104360,153440,46191
CHEMBL290106,P23975,BITHIONOL,JFIOVJDNOJYLKP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1225,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7272797,DTCC00104360,153440,46191
CHEMBL290634,P23975,(SS)-METHYL-PHENIDATE,DUGOZIWVEXMGBE-STQMWFEESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845,KI,=,339,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736810,DTCC01739731,2106091,68736
CHEMBL290916,P23975,EDARAVONE,QELUYTUMUWHWMC-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7313232,DTCC00181825,443476,46191
CHEMBL290916,P23975,EDARAVONE,QELUYTUMUWHWMC-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7313233,DTCC00181825,443476,46191
CHEMBL291338,P23975,"3,3',4',5-TETRACHLOROSALICYLANILIDE",SJQBHPJLLIJASD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7291904,DTCC00204573,1447875,46191
CHEMBL291338,P23975,"3,3',4',5-TETRACHLOROSALICYLANILIDE",SJQBHPJLLIJASD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7291905,DTCC00204573,1447875,46191
CHEMBL29292,P23975,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448399,DTCC00165773,120979,46191
CHEMBL29292,P23975,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448400,DTCC00165773,120979,46191
CHEMBL293492,P23975,CINNAMALDEHYDE,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7360548,DTCC00198978,1124447,46191
CHEMBL293492,P23975,CINNAMALDEHYDE,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7360549,DTCC00198978,1124447,46191
CHEMBL293583,P23975,,OZUHPVAODZNQKI-XGAFWQRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18644726,KI,=,96.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,2008,18,16,"Funke U, Fischer S, Hiller A, Scheunemann M, Deuther-Conrad W, Brust P, Steinbach J",,509626,DTCT0023180,2774192,DTCC00202048,111461,30803
CHEMBL294105,P23975,,XTYJQBUILMRWGE-GZAGPRJLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10821718,KI,=,68,NM,,cell_based,,,,,,,,,,,,Compound was evaluated for inhibition of [3H]NE uptake in HEK-hNET cells expressing Human norepinephrine transporter,,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,2000,43,10,"Hoepping A, Johnson KM, George C, Flippen-Anderson J, Kozikowski AP",,142794,DTCT0023180,1202477,DTCC00214567,1773582,15725
CHEMBL294105,P23975,,XTYJQBUILMRWGE-GZAGPRJLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10821718,KI,=,1040,NM,,cell_based,,,,,,,,,,,,Compound was evaluated for binding affinity using [125I]RTI-55 as a radioligand in HEK-hNET cells expressing human norepinephrine transporter,,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,2000,43,10,"Hoepping A, Johnson KM, George C, Flippen-Anderson J, Kozikowski AP",,142793,DTCT0023180,1202476,DTCC00214567,1773582,15725
CHEMBL294199,P23975,CAPSAICIN,YKPUWZUDDOIDPM-SOFGYWHQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7274719,DTCC00207211,736256,46191
CHEMBL294199,P23975,CAPSAICIN,YKPUWZUDDOIDPM-SOFGYWHQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7274720,DTCC00207211,736256,46191
CHEMBL294481,P23975,,OZUHPVAODZNQKI-RVWIWJKTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18644726,KI,=,1020,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,2008,18,16,"Funke U, Fischer S, Hiller A, Scheunemann M, Deuther-Conrad W, Brust P, Steinbach J",,509626,DTCT0023180,2774091,DTCC00202081,79262,30803
CHEMBL294733,P23975,,GDTWDHOANPFJQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15080991,KI,=,1360,NM,,cell_based,,,,,,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,2004,14,9,"Bois F, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB, Tamagnan G",,142934,DTCT0023180,1301648,DTCC00217707,1785233,6830
CHEMBL295234,P23975,,CWOYLIJQLSNRRN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643338,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity towards NET,,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,2003,13,24,"Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA",,142610,DTCT0023180,1104946,DTCC00188761,2046015,6037
CHEMBL295416,P23975,PIRINIXIC ACID,SZRPDCCEHVWOJX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376622,DTCC00183846,671791,46191
CHEMBL295416,P23975,PIRINIXIC ACID,SZRPDCCEHVWOJX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376623,DTCC00183846,671791,46191
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10411589,KI,=,4.21,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14743865,DTCC00186557,2108538,69057
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12620070,RATIO,=,0.05,,,,,,,,,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),,Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,2003,46,6,"Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB",,144999,DTCT0023180,556863,DTCC00186557,628342,17720
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15456270,KI,=,1.6,NM,,cell_based,,,,,,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,2004,47,21,"Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP",,303519,DTCT0023180,1791259,DTCC00186557,616786,19119
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,83.7,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556620,DTCC00186557,618361,28813
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,15,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649862,DTCC00186557,629736,31203
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,15,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445669,DTCC00186557,618620,30880
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,6,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686037,DTCC00186557,630140,31294
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,6,NM,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake at NET,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603447,DTCT0023180,3155574,DTCC00186557,2095542,36729
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19860431,LOGEC50,=,-8.99,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in COS7 cells assessed as inhibition of [3H]norepinephrine uptake,,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,2009,52,22,"Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, Lewis RJ",,620287,DTCT0023180,3263108,DTCC00186557,631166,37806
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,8.3,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038963,DTCC00186557,637528,42566
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21310612,IC50,=,7.94,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2011,21,5,"Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA",,726960,DTCT0023180,5148742,DTCC00186557,619999,43660
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21739935,IC50,=,7.94,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,2011,54,15,"Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA",,761203,DTCT0023180,6041799,DTCC00186557,620385,45500
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,IC50,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863447,DTCT0023180,11410187,DTCC00186557,641511,51438
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,78,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410241,DTCC00186557,641511,51438
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598173,DTCC00186557,642628,55968
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,20,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880515,DTCC00186557,623215,60843
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,78,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876493,DTCC00186557,623215,60843
CHEMBL295467,P23975,NISOXETINE,ITJNARMNRKSWTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,92,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885101,DTCC00186557,623215,60843
CHEMBL295698,P23975,KETOCONAZOLE,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,24203,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427013,DTCC00191118,51483,46191
CHEMBL295698,P23975,KETOCONAZOLE,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,24003,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427014,DTCC00191118,51483,46191
CHEMBL296419,P23975,ASTEMIZOLE,GXDALQBWZGODGZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1375,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277935,DTCC00186013,413968,46191
CHEMBL296419,P23975,ASTEMIZOLE,GXDALQBWZGODGZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1364,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277936,DTCC00186013,413968,46191
CHEMBL296602,P23975,INDATRALINE,SVFXPTLYMIXFRX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,1.58,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065305,DTCC00197918,620409,45533
CHEMBL29835,P23975,BESIPIRDINE,OTPPJICEBWOCKD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,430,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,963785,DTCC00165050,2078331,13807
CHEMBL299052,P23975,,VHGCDTVCOLNTBX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,2.03,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731327,DTCC00202425,2104389,68566
CHEMBL299052,P23975,,VHGCDTVCOLNTBX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845,KI,=,5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731326,DTCC00202425,2104388,68736
CHEMBL299233,P23975,TALOPRAM,LJBBMCNHIUJBDU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,66.1,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556617,DTCC00198172,1621053,28813
CHEMBL3,P23975,NICOTINE,SNICXCGAKADSCV-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394755,DTCC00132283,51492,46191
CHEMBL3,P23975,NICOTINE,SNICXCGAKADSCV-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394756,DTCC00132283,51492,46191
CHEMBL30,P23975,CIMETIDINE,AQIXAKUUQRKLND-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7356230,DTCC00133542,282997,46191
CHEMBL30,P23975,CIMETIDINE,AQIXAKUUQRKLND-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7356231,DTCC00133542,282997,46191
CHEMBL30008,P23975,FLUNARIZINE,SMANXXCATUTDDT-QPJJXVBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1339,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322556,DTCC00164139,542576,46191
CHEMBL30008,P23975,FLUNARIZINE,SMANXXCATUTDDT-QPJJXVBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1328,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322557,DTCC00164139,542576,46191
CHEMBL302795,P23975,TENOXICAM,LZNWYQJJBLGYLT-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456890,DTCC00224436,1641854,46191
CHEMBL302795,P23975,TENOXICAM,LZNWYQJJBLGYLT-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456891,DTCC00224436,1641854,46191
CHEMBL303232,P23975,,OECDZVROWVHNGS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15080991,KI,>,20000,NM,,cell_based,,,,,,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,2004,14,9,"Bois F, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB, Tamagnan G",,142934,DTCT0023180,1306549,DTCC00217945,1722825,6830
CHEMBL303266,P23975,,ZQNWAFLIAPMFBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,IC50,=,266,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,145001,DTCT0023180,1027021,DTCC00220612,981877,5618
CHEMBL303266,P23975,,ZQNWAFLIAPMFBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,KI,=,2970,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142613,DTCT0023180,1027018,DTCC00220612,981877,5618
CHEMBL303266,P23975,,ZQNWAFLIAPMFBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,RATIO,=,0.09,,,,,,,,,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142615,DTCT0023180,1027024,DTCC00220612,981877,5618
CHEMBL30327,P23975,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN",HGUFODBRKLSHSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7303055,DTCC00168237,833154,46191
CHEMBL30327,P23975,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN",HGUFODBRKLSHSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7303056,DTCC00168237,833154,46191
CHEMBL303494,P23975,,ITEKLFIKJBIAEP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15080991,KI,=,3024,NM,,cell_based,,,,,,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,2004,14,9,"Bois F, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB, Tamagnan G",,142934,DTCT0023180,1292011,DTCC00218343,1079048,6830
CHEMBL3039597,P23975,GENTAMICIN,NPEFREDMMVQEPL-RWPARATISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305890,DTCC01405528,51474,46191
CHEMBL3039597,P23975,GENTAMICIN,NPEFREDMMVQEPL-RWPARATISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305891,DTCC01405528,51474,46191
CHEMBL304656,P23975,,RQTWPNKOATVIPT-CFXFOKGESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10821718,KI,=,640,NM,,cell_based,,,,,,,,,,,,Compound was evaluated for inhibition of [3H]NE uptake in HEK-hNET cells expressing Human norepinephrine transporter,,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,2000,43,10,"Hoepping A, Johnson KM, George C, Flippen-Anderson J, Kozikowski AP",,142794,DTCT0023180,1184748,DTCC00105489,518204,15725
CHEMBL304656,P23975,,RQTWPNKOATVIPT-CFXFOKGESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10821718,KI,=,3770,NM,,cell_based,,,,,,,,,,,,Compound was evaluated for binding affinity using [125I]RTI-55 as a radioligand in HEK-hNET cells expressing human norepinephrine transporter,,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,2000,43,10,"Hoepping A, Johnson KM, George C, Flippen-Anderson J, Kozikowski AP",,142793,DTCT0023180,1184747,DTCC00105489,518204,15725
CHEMBL305660,P23975,EBASTINE,MJJALKDDGIKVBE-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,460.3,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7306708,DTCC00223547,1704690,46191
CHEMBL305660,P23975,EBASTINE,MJJALKDDGIKVBE-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,456.4,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7306709,DTCC00223547,1704690,46191
CHEMBL306043,P23975,GOLD SODIUM THIOMALATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321108,DTCC00225368,1188067,46191
CHEMBL306043,P23975,GOLD SODIUM THIOMALATE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321109,DTCC00225368,1188067,46191
CHEMBL306208,P23975,,ZEOHVQFWFVMPGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,IC50,=,8.2,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,145001,DTCT0023180,1045635,DTCC00220161,1693262,5618
CHEMBL306208,P23975,,ZEOHVQFWFVMPGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,KI,=,37,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142613,DTCT0023180,1045632,DTCC00220161,1693262,5618
CHEMBL306208,P23975,,ZEOHVQFWFVMPGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,RATIO,=,0.22,,,,,,,,,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142615,DTCT0023180,1045638,DTCC00220161,1693262,5618
CHEMBL306700,P23975,VILOXAZINE,YWPHCCPCQOJSGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,155,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14744055,DTCC00226370,2108595,68566
CHEMBL306700,P23975,VILOXAZINE,YWPHCCPCQOJSGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,155,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,606869,DTCC00226370,1080357,3008
CHEMBL30713,P23975,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,3715.35,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465480,DTCC01739501,1995571,54821
CHEMBL30713,P23975,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,642,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465479,DTCC01739501,1995571,54821
CHEMBL30713,P23975,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human recombinant norepinephrine transporter expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,964941,DTCT0023180,12464698,DTCC01739501,1995571,54821
CHEMBL307145,P23975,PYROGALLOL,WQGWDDDVZFFDIG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7396588,DTCC00231461,1220280,46191
CHEMBL307145,P23975,PYROGALLOL,WQGWDDDVZFFDIG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7396589,DTCC00231461,1220280,46191
CHEMBL307314,P23975,,HNCXDNKKOJCVCN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,IC50,=,487,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,145001,DTCT0023180,1018258,DTCC00220158,108020,5618
CHEMBL307314,P23975,,HNCXDNKKOJCVCN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,KI,=,830,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142613,DTCT0023180,1018102,DTCC00220158,108020,5618
CHEMBL307314,P23975,,HNCXDNKKOJCVCN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,RATIO,=,5.6,,,,,,,,,,,,,,,Selectivity ratio determined of Ki human Norepinephrine transporter to Ki human Serotonin transporter,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142617,DTCT0023180,356202,DTCC00220158,108020,5618
CHEMBL307314,P23975,,HNCXDNKKOJCVCN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,RATIO,=,10.99,,,,,,,,,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142615,DTCT0023180,1018207,DTCC00220158,108020,5618
CHEMBL307956,P23975,,LKSUTFUZSGZMOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15081025,KI,=,10000,NM,,,,,,,,,,,,,,Binding affinity towards Norepinephrine transporter using [3H]nisoxitine as radioligand,,"Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).",Bioorg. Med. Chem. Lett.,2004,14,9,"Peddi S, Roth BL, Glennon RA, Westkaemper RB",,143139,DTCT0023180,844189,DTCC00229182,3613,6858
CHEMBL3084641,P23975,,QVLWORPSNMYKIE-QYESKELBSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,INHIBITION,=,38,%,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143138,DTCT0023180,1021625,DTCC01407617,194387,14474
CHEMBL3084803,P23975,ASTROMICIN,BIDUPMYXGFNAEJ-APGVDKLISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7259340,DTCC01407776,768473,46191
CHEMBL3084803,P23975,ASTROMICIN,BIDUPMYXGFNAEJ-APGVDKLISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7259341,DTCC01407776,768473,46191
CHEMBL3084927,P23975,,HBOJXELDXYNVMR-YNVWKDRESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,KI,=,577,NM,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143140,DTCT0023180,1051586,DTCC01407899,615936,14474
CHEMBL3085018,P23975,,XJLOQWKHCAZUQM-LGKQTMLJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,8250,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874063,DTCC01407990,1242289,20058
CHEMBL3085019,P23975,,QVIXLSYROOSFHA-OWZKRDHZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,152000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874062,DTCC01407992,1209413,20058
CHEMBL3085023,P23975,,DEBMLCCWWGKBJP-WKCHPHFGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,3550,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874064,DTCC01407996,403109,20058
CHEMBL3085024,P23975,,VCZAQTQIUKEOCH-ACDBMABISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,7580,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874073,DTCC01407997,531802,20058
CHEMBL3085025,P23975,,NIYGPRSVPKAIKA-CWNQJQRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,3170,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874072,DTCC01407998,1372822,20058
CHEMBL3085027,P23975,,HKWYFLNOIRZTIH-BWTSREIZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,997,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874069,DTCC01408000,77892,20058
CHEMBL3085028,P23975,,YLOMMHJWKYDOFW-KOUNCHBCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,5580,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874068,DTCC01408001,951619,20058
CHEMBL3085029,P23975,,YGVRYGYKGFIQTL-NUNAXRQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,2920,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874067,DTCC01408002,919118,20058
CHEMBL3085030,P23975,,OIYSCQVQNFKYTO-PKQPGRETSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,1630,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874066,DTCC01408003,822206,20058
CHEMBL3085031,P23975,,WMXMBHFOTXTZMK-LGKQTMLJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,2470,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874065,DTCC01408004,206786,20058
CHEMBL3085032,P23975,,OJNGNVWCSYYTTM-MUJYYYPQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,259,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874071,DTCC01408005,1146169,20058
CHEMBL3085033,P23975,,JSMMTOCSBNIMIR-AERCQKQUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,8410,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874070,DTCC01408006,1405275,20058
CHEMBL3092631,P23975,,KNECEHLDOUTFJU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24269480,INHIBITION,>,50,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin),,Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds.,Bioorg. Med. Chem. Lett.,2013,23,24,"Ruel R, L'Heureux A, Thibeault C, Lapointe P, Martel A, Qiao JX, Hua J, Price LA, Wu Q, Chang M, Zheng J, Huang CS, Wexler RR, Rehfuss R, Lam PY",,1277485,DTCT0023180,12957392,DTCC01412231,1527966,56687
CHEMBL3094311,P23975,,NHUZHVAPAIJQRS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903,INHIBITION,=,64.7,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082,DTCT0023180,12962132,DTCC01413925,1127501,56656
CHEMBL3094312,P23975,,KKYAPAJUTFYVRD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903,INHIBITION,=,29.3,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082,DTCT0023180,12962090,DTCC01413926,351566,56656
CHEMBL3094313,P23975,,XVKBXJCHXRLYAQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903,INHIBITION,=,58.5,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082,DTCT0023180,12962048,DTCC01413927,933254,56656
CHEMBL3094314,P23975,,NLGKYLSBSOGION-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903,INHIBITION,=,60.1,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082,DTCT0023180,12962006,DTCC01413928,901389,56656
CHEMBL3094316,P23975,,RSZFCDGHJLBYEB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903,INHIBITION,=,63.6,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082,DTCT0023180,12963234,DTCC01413930,1708845,56656
CHEMBL3094317,P23975,,VCEAPZBMHGKMHI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903,INHIBITION,=,61.3,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082,DTCT0023180,12962301,DTCC01413931,1256448,56656
CHEMBL3094318,P23975,,CYPDLWIUOMSUJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903,INHIBITION,=,76.1,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082,DTCT0023180,12962259,DTCC01413932,1737126,56656
CHEMBL3094319,P23975,,YYONFKYBFNEIKC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903,INHIBITION,=,59.9,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082,DTCT0023180,12962217,DTCC01413933,965453,56656
CHEMBL3094320,P23975,,UZVSKGBBGCJIRV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903,INHIBITION,=,83.9,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082,DTCT0023180,12962174,DTCC01413934,1644990,56656
CHEMBL3099899,P23975,,VDWKDBPHAPPUBO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24215892,INHIBITION,=,-17,%,,,,,,,,,,,,,,Inhibition of human NET at 10 uM relative to control,,"Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs).",Bioorg. Med. Chem. Lett.,2013,23,24,"Mercer SP, Roecker AJ, Garson S, Reiss DR, Meacham Harrell C, Murphy KL, Bruno JG, Bednar RA, Lemaire W, Cui D, Cabalu TD, Tang C, Prueksaritanont T, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ",,1282795,DTCT0023180,12972941,DTCC01415896,1737150,56711
CHEMBL31,P23975,GATIFLOXACIN,XUBOMFCQGDBHNK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318621,DTCC00133611,185553,46191
CHEMBL31,P23975,GATIFLOXACIN,XUBOMFCQGDBHNK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318622,DTCC00133611,185553,46191
CHEMBL3104091,P23975,,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696,DTCT0023180,12984212,DTCC01417357,351604,56928
CHEMBL3104092,P23975,,RQBRUGMHSQYCNU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159,KI,=,1348.96,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696,DTCT0023180,12984171,DTCC01417358,1030177,56928
CHEMBL3104092,P23975,,RQBRUGMHSQYCNU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159,KI,=,1349,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696,DTCT0023180,12984089,DTCC01417358,1030177,56928
CHEMBL3104093,P23975,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159,KI,=,1949.84,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696,DTCT0023180,12984130,DTCC01417359,577788,56928
CHEMBL3104093,P23975,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159,KI,=,1955,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696,DTCT0023180,12984072,DTCC01417359,577788,56928
CHEMBL3105242,P23975,,ZASUYZQUSFFDOQ-AACQVBLVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24262882,KI,=,785,NM,,,,,,,,,,,,,,Displacement of [3H]Imipramin from human NET after 2 hrs by liquid scintillation counting analysis,,"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,2013,21,24,"Rami-Mark C, Bornatowicz B, Fink C, Otter P, Ungersboeck J, Vraka C, Haeusler D, Nics L, Spreitzer H, Hacker M, Mitterhauser M, Wadsak W",,1285656,DTCT0023180,12992725,DTCC01418487,1528029,56861
CHEMBL3105243,P23975,,CJJUYQAVCJRKRK-KOSPPIAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24262882,KI,=,153,NM,,,,,,,,,,,,,,Displacement of [3H]Imipramin from human NET after 2 hrs by liquid scintillation counting analysis,,"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,2013,21,24,"Rami-Mark C, Bornatowicz B, Fink C, Otter P, Ungersboeck J, Vraka C, Haeusler D, Nics L, Spreitzer H, Hacker M, Mitterhauser M, Wadsak W",,1285656,DTCT0023180,12992723,DTCC01418488,1813556,56861
CHEMBL310555,P23975,OXYQUINOLINE,MCJGNVYPOGVAJF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7382426,DTCC00239255,1092347,46191
CHEMBL310555,P23975,OXYQUINOLINE,MCJGNVYPOGVAJF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7382427,DTCC00239255,1092347,46191
CHEMBL310604,P23975,HOMOCYSTEINE,FFFHZYDWPBMWHY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14743991,DTCC00239847,2108578,69159
CHEMBL311347,P23975,,SIIICDNNMDMWCI-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12620070,KI,=,1.4,NM,,cell_based,,,,,,,,,,,,In vitro competitive binding versus [3H]- nisoxatine in murine kidney cells transfected with cDNA for human norepinephrine transporter (NET),,Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,2003,46,6,"Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB",,144972,DTCT0023180,546134,DTCC00241823,206430,17720
CHEMBL311347,P23975,,SIIICDNNMDMWCI-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12620070,RATIO,=,1.4,,,,,,,,,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),,Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,2003,46,6,"Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB",,144999,DTCT0023180,546136,DTCC00241823,206430,17720
CHEMBL311347,P23975,,SIIICDNNMDMWCI-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,36,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144971,DTCT0023180,965516,DTCC00241823,207413,17996
CHEMBL311347,P23975,,SIIICDNNMDMWCI-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15080991,KI,=,11.2,NM,,cell_based,,,,,,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,2004,14,9,"Bois F, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB, Tamagnan G",,142934,DTCT0023180,1315863,DTCC00241823,204606,6830
CHEMBL311347,P23975,,SIIICDNNMDMWCI-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,36,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043080,DTCC00241823,207117,22167
CHEMBL311347,P23975,,SIIICDNNMDMWCI-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,22,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043081,DTCC00241823,207117,22167
CHEMBL311350,P23975,PIROMIDIC ACID,RCIMBBZXSXFZBV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380954,DTCC00230394,1862718,46191
CHEMBL311350,P23975,PIROMIDIC ACID,RCIMBBZXSXFZBV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380955,DTCC00230394,1862718,46191
CHEMBL3113642,P23975,,LUDBNRIKUAJOOY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24393810,INHIBITION,=,1,%,,,,,,,,,,,,,,Displacement of [3H]-nisoxetin from human norepinephrine transporter at 1 uM relative to control,,A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.,Eur. J. Med. Chem.,2014,73,,"Mattsson C, Svensson P, Sonesson C",,1290596,DTCT0023180,13028294,DTCC01421724,997806,57189
CHEMBL3113644,P23975,,ORDPXOCNLOPGLX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24393810,INHIBITION,=,-2,%,,,,,,,,,,,,,,Displacement of [3H]-nisoxetin from human norepinephrine transporter at 1 uM relative to control,,A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.,Eur. J. Med. Chem.,2014,73,,"Mattsson C, Svensson P, Sonesson C",,1290596,DTCT0023180,13028293,DTCC01421726,739402,57189
CHEMBL311469,P23975,2-ACETYLAMINOFLUORENE,CZIHNRWJTSTCEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,8595,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7297383,DTCC00242606,2025633,46191
CHEMBL311469,P23975,2-ACETYLAMINOFLUORENE,CZIHNRWJTSTCEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,8524,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7297384,DTCC00242606,2025633,46191
CHEMBL3115074,P23975,,FMJSLPJYTAKVLJ-CQVJSGDESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26091726,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of human NE transporter at 10 uM relative to control,,Discovery and characterization of a potent and selective EP4 receptor antagonist.,Bioorg. Med. Chem. Lett.,2015,25,16,"Schiffler MA, Chandrasekhar S, Fisher MJ, Harvey A, Kuklish SL, Wang XS, Warshawsky AM, York JS, Yu XP",,1508946,DTCT0023180,14498807,DTCC01423122,1336428,63221
CHEMBL311617,P23975,,FMGYKKMPNATWHP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10411589,KI,=,507,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739929,DTCC00225067,2107248,69057
CHEMBL31184,P23975,BENZO[DEF]CHRYSENE,FMMWHPNWAFZXNH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7261322,DTCC00168186,866017,46191
CHEMBL31184,P23975,BENZO[DEF]CHRYSENE,FMMWHPNWAFZXNH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7261323,DTCC00168186,866017,46191
CHEMBL312037,P23975,,MMKZDDDDODERSJ-GXRBRPDZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,60,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043078,DTCC00241877,435627,22167
CHEMBL312037,P23975,,MMKZDDDDODERSJ-GXRBRPDZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,36,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043079,DTCC00241877,435627,22167
CHEMBL312037,P23975,,MMKZDDDDODERSJ-GXRBRPDZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,60,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050429,DTCC00241877,424306,22251
CHEMBL312037,P23975,,MMKZDDDDODERSJ-GXRBRPDZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,3850,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050427,DTCC00241877,424307,22251
CHEMBL312037,P23975,,MMKZDDDDODERSJ-GXRBRPDZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,36,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050430,DTCC00241877,424306,22251
CHEMBL312037,P23975,,MMKZDDDDODERSJ-GXRBRPDZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,1930,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050428,DTCC00241877,424307,22251
CHEMBL3124968,P23975,,BNSBTAITEDOQSS-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24410637,ACTIVITY,>,10,%,,,,,,,,,,,,,,Activity at NET (unknown origin) at 10 uM relative to control,,Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.,J. Med. Chem.,2014,57,3,"Brown DG, Bernstein PR, Griffin A, Wesolowski S, Labrecque D, Tremblay MC, Sylvester M, Mauger R, Edwards PD, Throner SR, Folmer JJ, Cacciola J, Scott C, Lazor LA, Pourashraf M, Santhakumar V, Potts WM, Sydserff S, Giguère P, Lévesque C, Dasser M, Groblewski T",,1296739,DTCT0023180,13064664,DTCC01429351,1930286,57454
CHEMBL3127675,P23975,,CRWYIZWOHXWIGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24410637,ACTIVITY,>,10,%,,,,,,,,,,,,,,Activity at NET (unknown origin) at 10 uM relative to control,,Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.,J. Med. Chem.,2014,57,3,"Brown DG, Bernstein PR, Griffin A, Wesolowski S, Labrecque D, Tremblay MC, Sylvester M, Mauger R, Edwards PD, Throner SR, Folmer JJ, Cacciola J, Scott C, Lazor LA, Pourashraf M, Santhakumar V, Potts WM, Sydserff S, Giguère P, Lévesque C, Dasser M, Groblewski T",,1296739,DTCT0023180,13064663,DTCC01429354,1930287,57454
CHEMBL313041,P23975,,MRBFFQVXMIGKST-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560772,DTCT0023180,2467269,DTCC00244893,164652,31698
CHEMBL313041,P23975,,MRBFFQVXMIGKST-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560769,DTCT0023180,2467245,DTCC00244893,164652,31698
CHEMBL313041,P23975,,MRBFFQVXMIGKST-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533,DTCT0023180,2809677,DTCC00244893,164514,32805
CHEMBL313041,P23975,,MRBFFQVXMIGKST-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530,DTCT0023180,2809650,DTCC00244893,164514,32805
CHEMBL313493,P23975,METHANESULFONIC ACID METHYL ESTER,MBABOKRGFJTBAE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415232,DTCC00245877,671790,46191
CHEMBL313493,P23975,METHANESULFONIC ACID METHYL ESTER,MBABOKRGFJTBAE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415233,DTCC00245877,671790,46191
CHEMBL313833,P23975,TRANYLCYPROMINE,AELCINSCMGFISI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,5900,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14747258,DTCC00240593,2109379,68566
CHEMBL316561,P23975,PROGLUMIDE,DGMKFQYCZXERLX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376982,DTCC00259031,1383781,46191
CHEMBL316561,P23975,PROGLUMIDE,DGMKFQYCZXERLX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376983,DTCC00259031,1383781,46191
CHEMBL316862,P23975,,OVSAXOVRTVDPOU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,205,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657194,DTCC00265257,941238,30478
CHEMBL316862,P23975,,OVSAXOVRTVDPOU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,125,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657165,DTCC00265257,941238,30478
CHEMBL317757,P23975,DIFLUOROBENZTROPINE,MHNSOBBJZCWUGS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,KI,>,8500,NM,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143140,DTCT0023180,1046546,DTCC00265655,1360143,14474
CHEMBL317757,P23975,DIFLUOROBENZTROPINE,MHNSOBBJZCWUGS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,844,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874061,DTCC00265655,1372823,20058
CHEMBL3186763,P23975,,DCAMTBFFNOHDAW-DYTRJAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25244572,INHIBITION,=,91.1,%,,,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET at 10 uM,,"Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.",J. Med. Chem.,2014,57,20,"Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE",,1439060,DTCT0023180,14011993,DTCC01442275,2029987,59962
CHEMBL319244,P23975,CAFFEIC ACID PHENETHYL ESTER,SWUARLUWKZWEBQ-VQHVLOKHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3787,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7260472,DTCC00274084,88625,46191
CHEMBL319244,P23975,CAFFEIC ACID PHENETHYL ESTER,SWUARLUWKZWEBQ-VQHVLOKHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3756,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7260473,DTCC00274084,88625,46191
CHEMBL321067,P23975,,VMBSZAVHWRUISI-KRCSLNALSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10698458,IC50,=,11,NM,,cell_based,,,,,,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,2000,10,3,"Tamiz AP, Smith MP, Kozikowski AP",,142803,DTCT0023180,1150455,DTCC00270704,1132855,4077
CHEMBL3215298,P23975,ABAMECTIN,IBSREHMXUMOFBB-JFUDTMANSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7285429,DTCC01462720,2025634,46191
CHEMBL3215298,P23975,ABAMECTIN,IBSREHMXUMOFBB-JFUDTMANSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7285430,DTCC01462720,2025634,46191
CHEMBL3215892,P23975,,MTATYSOUXXNXHF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912,INHIBITION,=,6.28,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892,DTCT0023180,11493419,DTCC01463309,1041440,52134
CHEMBL3218985,P23975,,MUQXFOQLDSJMCX-YADHBBJMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,INHIBITION,=,50,%,,,,,,,,,,,,,,Binding affinity to NE transporter (unknown origin) at 10 uM by displacement assay relative to control,,,MedChemComm,2011,2,7,,,1329201,DTCT0023180,13581701,DTCC01465893,1689327,39232
CHEMBL322067,P23975,,JOQQHMGSIKNGAF-HLFYOVGASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,=,22,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142776,DTCT0023180,1586476,DTCC00284567,368765,5814
CHEMBL322067,P23975,,JOQQHMGSIKNGAF-HLFYOVGASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,44,NM,,,,,,,,,,,,,,Compound was tested for its ability to displace [3H]citalopram from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142779,DTCT0023180,1586473,DTCC00284567,368765,5814
CHEMBL322348,P23975,,RPEDEMBGNMELBV-YHZLUUAOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,,,,,,,,,,,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Not Determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142777,DTCT0023180,1591678,DTCC00284025,368766,5814
CHEMBL322348,P23975,,RPEDEMBGNMELBV-YHZLUUAOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,120,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1591675,DTCC00284025,368766,5814
CHEMBL323447,P23975,,OGDCBGGLUZRVAG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,=,297,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142776,DTCT0023180,1587647,DTCC00284093,401606,5814
CHEMBL323447,P23975,,OGDCBGGLUZRVAG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,183,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1587644,DTCC00284093,401606,5814
CHEMBL32363,P23975,,ZPUCINDJVBIVPJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15121762,KI,=,2420,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14738056,DTCC00170558,2106501,69662
CHEMBL323678,P23975,,GDIDBVDYSJUGMI-NGKMOHNRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,,,,,,,,,,,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Not Determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142777,DTCT0023180,1582743,DTCC00284606,1564827,5814
CHEMBL323678,P23975,,GDIDBVDYSJUGMI-NGKMOHNRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,68,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1582740,DTCC00284606,1564827,5814
CHEMBL324269,P23975,,DTPZQRWLIAELHU-YHZLUUAOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,,,,,,,,,,,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Not Determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142777,DTCT0023180,1565712,DTCC00284677,1564828,5814
CHEMBL324269,P23975,,DTPZQRWLIAELHU-YHZLUUAOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,385,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1565710,DTCC00284677,1564828,5814
CHEMBL324631,P23975,PIPERIDINE BASED ANALOGUE OF COCAINE (STRUCTURAL MIX),,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10576690,KI,=,392.6,NM,,,,,,,,,,,,,,Norepinephrine transporter activity was determined by inhibition of monoamine [3H]-NE reuptake,,Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine.,Bioorg. Med. Chem. Lett.,1999,9,22,"Hoepping A, Babich J, Zubieta JA, Johnson KM, Machill S, Kozikowski AP",,143135,DTCT0023180,1292338,DTCC00280649,680145,3457
CHEMBL324631,P23975,PIPERIDINE BASED ANALOGUE OF COCAINE (STRUCTURAL MIX),,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10576690,KI,=,2030,NM,,,,,,,,,,,,,,Norepinephrine transporter activity was determined by inhibition of monoamine [3H]-NE reuptake,,Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine.,Bioorg. Med. Chem. Lett.,1999,9,22,"Hoepping A, Babich J, Zubieta JA, Johnson KM, Machill S, Kozikowski AP",,143135,DTCT0023180,1291038,DTCC00280649,680144,3457
CHEMBL324967,P23975,,MBVKPOXXMWDHKB-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,=,18400,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter; Average of two experiments,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142808,DTCT0023180,1088878,DTCC00292354,1618364,6492
CHEMBL325372,P23975,METHYLPARABEN,LXCFILQKKLGQFO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7430384,DTCC00280408,315667,46191
CHEMBL325372,P23975,METHYLPARABEN,LXCFILQKKLGQFO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7430385,DTCC00280408,315667,46191
CHEMBL325669,P23975,,JIMSUICOCSIKLE-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,=,235500,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter; Average of two experiments,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142808,DTCT0023180,1062453,DTCC00292328,1068188,6492
CHEMBL3262896,P23975,,OFHXXBRBGWUOHR-NYYWCZLTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24678947,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) at 10 uM,Not Active,Identification and characterization of small molecule modulators of the Epstein-Barr virus-induced gene 2 (EBI2) receptor.,J. Med. Chem.,2014,57,8,"Gessier F, Preuss I, Yin H, Rosenkilde MM, Laurent S, Endres R, Chen YA, Marsilje TH, Seuwen K, Nguyen DG, Sailer AW",,1351324,DTCT0023180,13682491,DTCC01488347,772128,58652
CHEMBL326466,P23975,,NWCPOGFPLUASJD-QUDVFMAMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,=,25,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142776,DTCT0023180,1598086,DTCC00284092,1175857,5814
CHEMBL326466,P23975,,NWCPOGFPLUASJD-QUDVFMAMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,152,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1598083,DTCC00284092,1175857,5814
CHEMBL326466,P23975,,NWCPOGFPLUASJD-QUDVFMAMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16220969,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition constant against norepinephrine transporter,,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,2005,48,21,"Morphy R, Rankovic Z",,321161,DTCT0023180,1862024,DTCC00284092,1165711,19940
CHEMBL326713,P23975,,GGNUKUMOMWBKFX-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,=,554000,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142807,DTCT0023180,1076645,DTCC00292144,1196860,6492
CHEMBL326713,P23975,,GGNUKUMOMWBKFX-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,=,695000,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142807,DTCT0023180,1078974,DTCC00292144,1196861,6492
CHEMBL32749,P23975,FERULIC ACID,KSEBMYQBYZTDHS-HWKANZROSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7309620,DTCC00171237,1544898,46191
CHEMBL32749,P23975,FERULIC ACID,KSEBMYQBYZTDHS-HWKANZROSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7309621,DTCC00171237,1544898,46191
CHEMBL3287653,P23975,,IWWHJVANFFIWSJ-GNFJTHHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24944746,INHIBITION,,,,,cell_based,,,,,,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Not Active,Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,2014,5,6,"Kumar V, Rahbek-Clemmensen T, Billesbølle CB, Jorgensen TN, Gether U, Newman AH",,1365902,DTCT0023180,13778964,DTCC01498626,752012,59573
CHEMBL3287654,P23975,,HDOQLXMDBHVEMJ-SMWREMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24944746,INHIBITION,,,,,cell_based,,,,,,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Not Active,Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,2014,5,6,"Kumar V, Rahbek-Clemmensen T, Billesbølle CB, Jorgensen TN, Gether U, Newman AH",,1365902,DTCT0023180,13778965,DTCC01498627,655244,59573
CHEMBL3287655,P23975,,OQGUIOWSTCLFME-GNFJTHHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24944746,INHIBITION,,,,,cell_based,,,,,,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Not Active,Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,2014,5,6,"Kumar V, Rahbek-Clemmensen T, Billesbølle CB, Jorgensen TN, Gether U, Newman AH",,1365902,DTCT0023180,13778966,DTCC01498628,364407,59573
CHEMBL3287656,P23975,,NEVFWHLXCFNVPG-DTSDQNDWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24944746,INHIBITION,,,,,cell_based,,,,,,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Not Active,Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,2014,5,6,"Kumar V, Rahbek-Clemmensen T, Billesbølle CB, Jorgensen TN, Gether U, Newman AH",,1365902,DTCT0023180,13778967,DTCC01498629,2073236,59573
CHEMBL3287723,P23975,,AOYJKNKRKBOUAP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24735492,INHIBITION,=,-4.8,%,,,,,,,,,,,,,,Binding affinity to human NET at 10 uM by radioligand displacement assay,,Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence.,J. Med. Chem.,2014,57,10,"Dhanya RP, Sheffler DJ, Dahl R, Davis M, Lee PS, Yang L, Nickols HH, Cho HP, Smith LH, D'Souza MS, Conn PJ, Der-Avakian A, Markou A, Cosford ND",,1361699,DTCT0023180,13779806,DTCC01498697,200946,59335
CHEMBL3289656,P23975,,PQVQCEDGSJVHMK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24800940,KI,=,2754.23,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by PDSP assay,,Identification of a new selective dopamine D4 receptor ligand.,Bioorg. Med. Chem.,2014,22,12,"Sampson D, Zhu XY, Eyunni SV, Etukala JR, Ofori E, Bricker B, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1365256,DTCT0023180,13768379,DTCC01500650,643587,59363
CHEMBL3289656,P23975,,PQVQCEDGSJVHMK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24800940,KI,=,2773,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by PDSP assay,,Identification of a new selective dopamine D4 receptor ligand.,Bioorg. Med. Chem.,2014,22,12,"Sampson D, Zhu XY, Eyunni SV, Etukala JR, Ofori E, Bricker B, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1365256,DTCT0023180,13768378,DTCC01500650,643587,59363
CHEMBL3290152,P23975,,UBNJOSSBOHRSMZ-SOFGYWHQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24918261,INHIBITION,>,50,%,,,,,,,,,,,,,,Displacement of antagonist radioligand from human NET at 10 uM,,Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo.,J. Med. Chem.,2014,57,12,"Fancelli D, Abate A, Amici R, Bernardi P, Ballarini M, Cappa A, Carenzi G, Colombo A, Contursi C, Di Lisa F, Dondio G, Gagliardi S, Milanesi E, Minucci S, Pain G, Pelicci PG, Saccani A, Storto M, Thaler F, Varasi M, Villa M, Plyte S",,1361557,DTCT0023180,13771765,DTCC01501151,429606,59534
CHEMBL3291022,P23975,,WKRFGCNWUFZBLO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24814532,DRUG UPTAKE,,,,,cell_based,,,,,,,,,,,,Cellular uptake in human SK-N-SH cells assessed as noradrenaline transporter-mediated uptake at 1 x 10'-4 M after 15 mins by [3H]-noradrenaline uptake assay,Active,Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.,Bioorg. Med. Chem. Lett.,2014,24,12,"Hampel T, Bruns M, Bayer M, Handgretinger R, Bruchelt G, Brückner R",,1362494,DTCT0023180,13756322,DTCC01502029,189337,59387
CHEMBL3291023,P23975,,RHOHKPLNPSKULL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24814532,DRUG UPTAKE,,,,,cell_based,,,,,,,,,,,,Cellular uptake in human SK-N-SH cells assessed as noradrenaline transporter-mediated uptake at 1 x 10'-4 M after 15 mins by [3H]-noradrenaline uptake assay,Active,Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.,Bioorg. Med. Chem. Lett.,2014,24,12,"Hampel T, Bruns M, Bayer M, Handgretinger R, Bruchelt G, Brückner R",,1362494,DTCT0023180,13756323,DTCC01502030,643601,59387
CHEMBL33,P23975,LEVOFLOXACIN,GSDSWSVVBLHKDQ-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427354,DTCC00133684,51486,46191
CHEMBL33,P23975,LEVOFLOXACIN,GSDSWSVVBLHKDQ-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427355,DTCC00133684,51486,46191
CHEMBL3309701,P23975,,JFZWFXQVYNCLJA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,33.5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880520,DTCC01509956,494265,60843
CHEMBL3309701,P23975,,JFZWFXQVYNCLJA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,90,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876496,DTCC01509956,494265,60843
CHEMBL3309701,P23975,,JFZWFXQVYNCLJA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885104,DTCC01509956,494265,60843
CHEMBL3309701,P23975,,JFZWFXQVYNCLJA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880737,DTCC01509956,494265,60843
CHEMBL3309701,P23975,,JFZWFXQVYNCLJA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454667,DTCT0023180,13880609,DTCC01509956,494265,60843
CHEMBL3309701,P23975,,JFZWFXQVYNCLJA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454668,DTCT0023180,13880548,DTCC01509956,494265,60843
CHEMBL3309702,P23975,,KYHMFLOOKCBLDX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,37.2,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880521,DTCC01509957,1749856,60843
CHEMBL3309702,P23975,,KYHMFLOOKCBLDX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,86,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876497,DTCC01509957,1749856,60843
CHEMBL3309702,P23975,,KYHMFLOOKCBLDX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885105,DTCC01509957,1749856,60843
CHEMBL3309702,P23975,,KYHMFLOOKCBLDX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880738,DTCC01509957,1749856,60843
CHEMBL3309702,P23975,,KYHMFLOOKCBLDX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454667,DTCT0023180,13880610,DTCC01509957,1749856,60843
CHEMBL3309702,P23975,,KYHMFLOOKCBLDX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454668,DTCT0023180,13880603,DTCC01509957,1749856,60843
CHEMBL3309703,P23975,,YMKIEQRAGKLOPM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,50,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876498,DTCC01509958,24085,60843
CHEMBL3309703,P23975,,YMKIEQRAGKLOPM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885106,DTCC01509958,24085,60843
CHEMBL3309703,P23975,,YMKIEQRAGKLOPM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880739,DTCC01509958,24085,60843
CHEMBL3309704,P23975,,IGFZSDUARCFCFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,39,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876499,DTCC01509959,461221,60843
CHEMBL3309704,P23975,,IGFZSDUARCFCFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885107,DTCC01509959,461221,60843
CHEMBL3309704,P23975,,IGFZSDUARCFCFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880740,DTCC01509959,461221,60843
CHEMBL3309705,P23975,,ZEMHRXZHHOGKCW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,70,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876500,DTCC01509960,1236695,60843
CHEMBL3309705,P23975,,ZEMHRXZHHOGKCW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885108,DTCC01509960,1236695,60843
CHEMBL3309705,P23975,,ZEMHRXZHHOGKCW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880741,DTCC01509960,1236695,60843
CHEMBL3309706,P23975,,SVQJWGJWTNGCQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,50,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876501,DTCC01509961,526535,60843
CHEMBL3309706,P23975,,SVQJWGJWTNGCQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885109,DTCC01509961,526535,60843
CHEMBL3309706,P23975,,SVQJWGJWTNGCQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880742,DTCC01509961,526535,60843
CHEMBL3310035,P23975,,RQPAEAIGXOANQF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET (unknown origin) expressed in HEK cells at 10 uM after 90 mins by microbeta counting analysis,Not Active,,J. Nat. Prod.,2014,77,5,,,1451619,DTCT0023180,13892113,DTCC01510285,655458,57486
CHEMBL3310477,P23975,,RPBPOTIIGUEQSZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,56,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876502,DTCC01510728,169438,60843
CHEMBL3310477,P23975,,RPBPOTIIGUEQSZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885110,DTCC01510728,169438,60843
CHEMBL3310477,P23975,,RPBPOTIIGUEQSZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880743,DTCC01510728,169438,60843
CHEMBL3310478,P23975,,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,33.7,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880522,DTCC01510729,623235,60843
CHEMBL3310478,P23975,,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876503,DTCC01510729,623235,60843
CHEMBL3310478,P23975,,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885111,DTCC01510729,623235,60843
CHEMBL3310478,P23975,,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880744,DTCC01510729,623235,60843
CHEMBL3310478,P23975,,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454667,DTCT0023180,13880611,DTCC01510729,623235,60843
CHEMBL3310478,P23975,,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454668,DTCT0023180,13880604,DTCC01510729,623235,60843
CHEMBL3310479,P23975,,CGKMHQPZZRFYHQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,13,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876504,DTCC01510730,1464018,60843
CHEMBL3310479,P23975,,CGKMHQPZZRFYHQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,99,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885112,DTCC01510730,1464018,60843
CHEMBL3310479,P23975,,CGKMHQPZZRFYHQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880745,DTCC01510730,1464018,60843
CHEMBL3310480,P23975,,UBQLLVMEOGBWCI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,32,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880455,DTCC01510731,687823,60843
CHEMBL3310480,P23975,,UBQLLVMEOGBWCI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885113,DTCC01510731,687823,60843
CHEMBL3310480,P23975,,UBQLLVMEOGBWCI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880746,DTCC01510731,687823,60843
CHEMBL3310481,P23975,,DOQJYOJZNNPBRY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880456,DTCC01510732,526536,60843
CHEMBL3310481,P23975,,DOQJYOJZNNPBRY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,97,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885114,DTCC01510732,526536,60843
CHEMBL3310481,P23975,,DOQJYOJZNNPBRY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880747,DTCC01510732,526536,60843
CHEMBL3310482,P23975,,LWGULHIUMBMSRR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,10.6,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880618,DTCC01510733,1204072,60843
CHEMBL3310482,P23975,,LWGULHIUMBMSRR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880457,DTCC01510733,1204072,60843
CHEMBL3310482,P23975,,LWGULHIUMBMSRR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885115,DTCC01510733,1204072,60843
CHEMBL3310482,P23975,,LWGULHIUMBMSRR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880748,DTCC01510733,1204072,60843
CHEMBL3310483,P23975,,YFFZLXAPKOKACC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880523,DTCC01510734,72459,60843
CHEMBL3310483,P23975,,YFFZLXAPKOKACC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880458,DTCC01510734,72459,60843
CHEMBL3310483,P23975,,YFFZLXAPKOKACC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885116,DTCC01510734,72459,60843
CHEMBL3310483,P23975,,YFFZLXAPKOKACC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880749,DTCC01510734,72459,60843
CHEMBL3310483,P23975,,YFFZLXAPKOKACC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454667,DTCT0023180,13880612,DTCC01510734,72459,60843
CHEMBL3310483,P23975,,YFFZLXAPKOKACC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454668,DTCT0023180,13880605,DTCC01510734,72459,60843
CHEMBL3310484,P23975,,GVIKXRIOBFGDFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,15.9,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880524,DTCC01510735,1943368,60843
CHEMBL3310484,P23975,,GVIKXRIOBFGDFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880459,DTCC01510735,1943368,60843
CHEMBL3310484,P23975,,GVIKXRIOBFGDFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885117,DTCC01510735,1943368,60843
CHEMBL3310484,P23975,,GVIKXRIOBFGDFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880750,DTCC01510735,1943368,60843
CHEMBL3310484,P23975,,GVIKXRIOBFGDFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454667,DTCT0023180,13880613,DTCC01510735,1943368,60843
CHEMBL3310484,P23975,,GVIKXRIOBFGDFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454668,DTCT0023180,13880606,DTCC01510735,1943368,60843
CHEMBL3310485,P23975,,JAJZURBQJLCEQE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,14.6,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880525,DTCC01510736,687824,60843
CHEMBL3310485,P23975,,JAJZURBQJLCEQE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880460,DTCC01510736,687824,60843
CHEMBL3310485,P23975,,JAJZURBQJLCEQE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885118,DTCC01510736,687824,60843
CHEMBL3310485,P23975,,JAJZURBQJLCEQE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880751,DTCC01510736,687824,60843
CHEMBL3310485,P23975,,JAJZURBQJLCEQE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454667,DTCT0023180,13880614,DTCC01510736,687824,60843
CHEMBL3310485,P23975,,JAJZURBQJLCEQE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454668,DTCT0023180,13880607,DTCC01510736,687824,60843
CHEMBL3310486,P23975,,GVURCJXFYIMVMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,32.5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880526,DTCC01510737,1431834,60843
CHEMBL3310486,P23975,,GVURCJXFYIMVMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880461,DTCC01510737,1431834,60843
CHEMBL3310486,P23975,,GVURCJXFYIMVMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885119,DTCC01510737,1431834,60843
CHEMBL3310486,P23975,,GVURCJXFYIMVMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880752,DTCC01510737,1431834,60843
CHEMBL3310486,P23975,,GVURCJXFYIMVMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454667,DTCT0023180,13880615,DTCC01510737,1431834,60843
CHEMBL3310486,P23975,,GVURCJXFYIMVMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,RATIO IC50,>,7,,,cell_based,,,,,,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454668,DTCT0023180,13880608,DTCC01510737,1431834,60843
CHEMBL3310487,P23975,,FQRVPUNOHDAYPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,30.8,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880687,DTCC01510738,461222,60843
CHEMBL3310487,P23975,,FQRVPUNOHDAYPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880462,DTCC01510738,461222,60843
CHEMBL3310487,P23975,,FQRVPUNOHDAYPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885120,DTCC01510738,461222,60843
CHEMBL3310487,P23975,,FQRVPUNOHDAYPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880753,DTCC01510738,461222,60843
CHEMBL3310488,P23975,,AVYVBCVILBXGLV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,68.6,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880688,DTCC01510739,1269575,60843
CHEMBL3310488,P23975,,AVYVBCVILBXGLV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,87,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880463,DTCC01510739,1269575,60843
CHEMBL3310488,P23975,,AVYVBCVILBXGLV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885121,DTCC01510739,1269575,60843
CHEMBL3310488,P23975,,AVYVBCVILBXGLV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880754,DTCC01510739,1269575,60843
CHEMBL3310489,P23975,,PMFYWAOJTSDFLF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,14.7,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880689,DTCC01510740,1846520,60843
CHEMBL3310489,P23975,,PMFYWAOJTSDFLF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880464,DTCC01510740,1846520,60843
CHEMBL3310489,P23975,,PMFYWAOJTSDFLF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885122,DTCC01510740,1846520,60843
CHEMBL3310489,P23975,,PMFYWAOJTSDFLF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880755,DTCC01510740,1846520,60843
CHEMBL3310490,P23975,,NFVMXEOTEJTNLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,33.1,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880690,DTCC01510741,849649,60843
CHEMBL3310490,P23975,,NFVMXEOTEJTNLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880465,DTCC01510741,849649,60843
CHEMBL3310490,P23975,,NFVMXEOTEJTNLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885123,DTCC01510741,849649,60843
CHEMBL3310490,P23975,,NFVMXEOTEJTNLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880756,DTCC01510741,849649,60843
CHEMBL3310491,P23975,,INAKZKQNNCSLRZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,37,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880466,DTCC01510742,397540,60843
CHEMBL3310491,P23975,,INAKZKQNNCSLRZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885124,DTCC01510742,397540,60843
CHEMBL3310491,P23975,,INAKZKQNNCSLRZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880757,DTCC01510742,397540,60843
CHEMBL3310492,P23975,,QDXMLWBTDCCUTJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,22,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880467,DTCC01510743,687825,60843
CHEMBL3310493,P23975,,WALNRLHGEDDGRH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880468,DTCC01510744,1943369,60843
CHEMBL3310494,P23975,,IBFDSAQZQXGCJT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,30,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880469,DTCC01510745,1302034,60843
CHEMBL3310495,P23975,,WTHYQJZGHQZHTL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,37,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880470,DTCC01510746,1171793,60843
CHEMBL3310496,P23975,,BSZJUUFTQGBZQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,23,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880471,DTCC01510747,1140747,60843
CHEMBL3310497,P23975,,GFGPKOBHHRPKSF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,74,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880637,DTCC01510748,461223,60843
CHEMBL3310497,P23975,,GFGPKOBHHRPKSF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885125,DTCC01510748,461223,60843
CHEMBL3310497,P23975,,GFGPKOBHHRPKSF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880758,DTCC01510748,461223,60843
CHEMBL3310498,P23975,,XZQIYFJCZFNASH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,79,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880638,DTCC01510749,1528909,60843
CHEMBL3310498,P23975,,XZQIYFJCZFNASH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885126,DTCC01510749,1528909,60843
CHEMBL3310498,P23975,,XZQIYFJCZFNASH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880759,DTCC01510749,1528909,60843
CHEMBL3310621,P23975,,CEILENYWVBYUHW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,52,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880639,DTCC01510867,201358,60843
CHEMBL3310621,P23975,,CEILENYWVBYUHW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885127,DTCC01510867,201358,60843
CHEMBL3310621,P23975,,CEILENYWVBYUHW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880760,DTCC01510867,201358,60843
CHEMBL3310622,P23975,,TZJCUYLPPDCFHU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,25,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880640,DTCC01510868,1010804,60843
CHEMBL3310622,P23975,,TZJCUYLPPDCFHU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,96,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885128,DTCC01510868,1010804,60843
CHEMBL3310622,P23975,,TZJCUYLPPDCFHU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880761,DTCC01510868,1010804,60843
CHEMBL3310623,P23975,,GUVSOKCRWWGAEF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,23,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880641,DTCC01510869,233886,60843
CHEMBL3310623,P23975,,GUVSOKCRWWGAEF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885129,DTCC01510869,233886,60843
CHEMBL3310623,P23975,,GUVSOKCRWWGAEF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880762,DTCC01510869,233886,60843
CHEMBL3310624,P23975,,PVENMTZFPWNCAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,67,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880642,DTCC01510870,1528910,60843
CHEMBL3310624,P23975,,PVENMTZFPWNCAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885130,DTCC01510870,1528910,60843
CHEMBL3310624,P23975,,PVENMTZFPWNCAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,100,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880763,DTCC01510870,1528910,60843
CHEMBL3310625,P23975,,IWAFLTUMYXUBBH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,21,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880643,DTCC01510871,558645,60843
CHEMBL3310626,P23975,,LHDXSWGNSMXQLB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,68,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880644,DTCC01510872,169439,60843
CHEMBL3310627,P23975,,JZLLVPLMTCNSLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,13,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880645,DTCC01510873,429909,60843
CHEMBL3310628,P23975,,HQCGHDLCHPAWBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,37,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880646,DTCC01510874,137120,60843
CHEMBL3310629,P23975,,WDKXWEBKYOHYSC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,8,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880647,DTCC01510875,1976405,60843
CHEMBL3310630,P23975,,NRVOSXXQMRKXOI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,56,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880648,DTCC01510876,526537,60843
CHEMBL3310631,P23975,,GIXNXFPSTUDIAY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,18,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880649,DTCC01510877,429910,60843
CHEMBL3310632,P23975,,AYEJAYBDNXGSOD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880650,DTCC01510878,1749874,60843
CHEMBL3310633,P23975,,FJRHKFCLJYAKFM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880651,DTCC01510879,1943370,60843
CHEMBL3310634,P23975,,XCSFWQOZLCRJAK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,6,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880652,DTCC01510880,332074,60843
CHEMBL3310635,P23975,,KHACQPYREOXZTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,7,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880653,DTCC01510881,1399779,60843
CHEMBL3310636,P23975,,BTQKCUGOWJLBQO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880654,DTCC01510882,946236,60843
CHEMBL3310637,P23975,,PCSGUMGUIACOPL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,18,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880655,DTCC01510883,104872,60843
CHEMBL3310638,P23975,,VKOHWMDCIHAUTC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,43,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880656,DTCC01510884,882008,60843
CHEMBL3310639,P23975,,DCSFZFQYIIRZFM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,91,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880657,DTCC01510885,104873,60843
CHEMBL3310640,P23975,,UJWNMDBIDDUPKQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,83,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880658,DTCC01510886,397542,60843
CHEMBL3310641,P23975,,IRQADABOPVURIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,65,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13880659,DTCC01510887,946237,60843
CHEMBL3311308,P23975,,FQUAFMNPXPXOJE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24881566,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human NET by BacMam bind SPA/summary (Abse5) assay,,Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).,Bioorg. Med. Chem. Lett.,2014,24,14,"Sparks SM, Chen G, Collins JL, Danger D, Dock ST, Jayawickreme C, Jenkinson S, Laudeman C, Leesnitzer MA, Liang X, Maloney P, McCoy DC, Moncol D, Rash V, Rimele T, Vulimiri P, Way JM, Ross S",,1455322,DTCT0023180,13918410,DTCC01511540,558563,60691
CHEMBL3317694,P23975,,GJZAPYUNMABLBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,13,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911329,DTCC01513430,169304,60940
CHEMBL3317695,P23975,,MTYNQRLUWCXWLL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,260,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911328,DTCC01513431,1367209,60940
CHEMBL3317696,P23975,,OTPNPTZDWITNTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,2000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911327,DTCC01513432,1625751,60940
CHEMBL3317697,P23975,,RLSDCBVRAGSYCJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,660,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911325,DTCC01513433,1846391,60940
CHEMBL3317698,P23975,,LUYDHJNQCRADNJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,1700,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911324,DTCC01513434,1203925,60940
CHEMBL3317699,P23975,,IYQPFLICRCNMTK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,3200,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911323,DTCC01513435,494152,60940
CHEMBL3317700,P23975,,UGMVHZUXVSBGFN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,8,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911322,DTCC01513436,719934,60940
CHEMBL3317701,P23975,,UMZZJUZWLRKJTC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,7.7,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911321,DTCC01513437,590632,60940
CHEMBL3317702,P23975,,XJTZQDVYMGLFOP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,14,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911320,DTCC01513438,2009037,60940
CHEMBL3317703,P23975,,MASFTFKGBFXWJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,9.2,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911319,DTCC01513439,1203926,60940
CHEMBL3317704,P23975,,XJTZQDVYMGLFOP-YDALLXLXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,3.8,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911344,DTCC01513440,655484,60940
CHEMBL3317705,P23975,,XJTZQDVYMGLFOP-UTONKHPSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,570,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911345,DTCC01513441,1367210,60940
CHEMBL331799,P23975,,PORDAYLSLHLTRQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,=,45,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142776,DTCT0023180,1570668,DTCC00284605,1468120,5814
CHEMBL331799,P23975,,PORDAYLSLHLTRQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,266,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1570665,DTCC00284605,1468120,5814
CHEMBL332097,P23975,,DRRXQCXSBONKPD-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,=,97100,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter; Average of two experiments,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142808,DTCT0023180,1091406,DTCC00292136,1068190,6492
CHEMBL332098,P23975,,LEIFDHLVPBJTIV-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,=,4720,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter; Average of two experiments,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142808,DTCT0023180,1081460,DTCC00292137,1424632,6492
CHEMBL3321789,P23975,,AWIYLVWAILOVMX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422,KI,=,1791,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255,DTCT0023180,13943044,DTCC01515423,221778,61087
CHEMBL3321790,P23975,,MPWWGTFDWDZHRM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422,KI,=,1409,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255,DTCT0023180,13943045,DTCC01515424,675886,61087
CHEMBL3321791,P23975,,QOECKZUXJGSVMP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422,KI,=,510,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255,DTCT0023180,13943046,DTCC01515425,1866695,61087
CHEMBL3321792,P23975,,QHLAPIQLWATZKM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422,KI,=,462,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255,DTCT0023180,13943047,DTCC01515426,1996869,61087
CHEMBL3323088,P23975,,APTVKHQLUJFYAC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,KI,=,7.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904144,DTCC01516721,740288,61025
CHEMBL3323089,P23975,,YSXLAKJPPGTIOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,2.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904143,DTCC01516722,740289,61025
CHEMBL3323089,P23975,,YSXLAKJPPGTIOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314410,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,182112,DTCC01516722,709958,65123
CHEMBL3323089,P23975,,YSXLAKJPPGTIOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701391,DTCC01516722,709958,65123
CHEMBL3323089,P23975,,YSXLAKJPPGTIOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677511,DTCC01516722,709958,65123
CHEMBL3323089,P23975,,YSXLAKJPPGTIOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,19.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677541,DTCC01516722,709958,65123
CHEMBL3323090,P23975,,FKCXCDFQELSYLK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,5.2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904142,DTCC01516723,1738060,61025
CHEMBL3323090,P23975,,FKCXCDFQELSYLK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314411,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,166362,DTCC01516723,1711804,65123
CHEMBL3323090,P23975,,FKCXCDFQELSYLK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701392,DTCC01516723,1711804,65123
CHEMBL3323090,P23975,,FKCXCDFQELSYLK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,7.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677512,DTCC01516723,1711804,65123
CHEMBL3323090,P23975,,FKCXCDFQELSYLK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,254,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677542,DTCC01516723,1711804,65123
CHEMBL3323091,P23975,,HXJTYROTEDEIBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,<,1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904141,DTCC01516724,1257386,61025
CHEMBL3323091,P23975,,HXJTYROTEDEIBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,13.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677507,DTCC01516724,1226327,65123
CHEMBL3323091,P23975,,HXJTYROTEDEIBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,13.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677509,DTCC01516724,1226327,65123
CHEMBL3323091,P23975,,HXJTYROTEDEIBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,20,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314406,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,177293,DTCC01516724,1226327,65123
CHEMBL3323091,P23975,,HXJTYROTEDEIBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,20,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314408,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,181891,DTCC01516724,1226327,65123
CHEMBL3323091,P23975,,HXJTYROTEDEIBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,20,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701387,DTCC01516724,1226327,65123
CHEMBL3323091,P23975,,HXJTYROTEDEIBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,20,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701389,DTCC01516724,1226327,65123
CHEMBL3323091,P23975,,HXJTYROTEDEIBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,92.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677537,DTCC01516724,1226327,65123
CHEMBL3323091,P23975,,HXJTYROTEDEIBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,92.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677539,DTCC01516724,1226327,65123
CHEMBL3323092,P23975,,HGTGGWUXBQZEBH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,15,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904140,DTCC01516725,1678134,61025
CHEMBL3323093,P23975,,CZRBQWFOPMBTQM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,22,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904139,DTCC01516726,1516847,61025
CHEMBL3323094,P23975,,SCNQXZMXILXZRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,69,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904138,DTCC01516727,1996908,61025
CHEMBL3323094,P23975,,SCNQXZMXILXZRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314407,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,169010,DTCC01516727,1966221,65123
CHEMBL3323094,P23975,,SCNQXZMXILXZRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701388,DTCC01516727,1966221,65123
CHEMBL3323094,P23975,,SCNQXZMXILXZRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677508,DTCC01516727,1966221,65123
CHEMBL3323094,P23975,,SCNQXZMXILXZRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,19.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677538,DTCC01516727,1966221,65123
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904096,DTCC01516728,1866723,61025
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,350,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904136,DTCC01516728,1866724,61025
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314405,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,160348,DTCC01516728,1836697,65123
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314413,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,179210,DTCC01516728,1836697,65123
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677484,DTCC01516728,1836697,65123
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701386,DTCC01516728,1836697,65123
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677506,DTCC01516728,1836697,65123
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677514,DTCC01516728,1836697,65123
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677536,DTCC01516728,1836697,65123
CHEMBL3323095,P23975,,MHFUBIDIXOMIAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677544,DTCC01516728,1836697,65123
CHEMBL3323096,P23975,,WHFIZFJGGYNLFH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,10,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904135,DTCC01516729,1769888,61025
CHEMBL3323097,P23975,,OADBNBUTUOPDJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,130,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904134,DTCC01516730,287206,61025
CHEMBL3323097,P23975,,OADBNBUTUOPDJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,8.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677543,DTCC01516730,255974,65123
CHEMBL3323097,P23975,,OADBNBUTUOPDJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,11.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677535,DTCC01516730,255974,65123
CHEMBL3323097,P23975,,OADBNBUTUOPDJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,14.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677505,DTCC01516730,255974,65123
CHEMBL3323097,P23975,,OADBNBUTUOPDJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,28.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314412,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,176461,DTCC01516730,255974,65123
CHEMBL3323097,P23975,,OADBNBUTUOPDJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,28.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677483,DTCC01516730,255974,65123
CHEMBL3323097,P23975,,OADBNBUTUOPDJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,37.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314404,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,166734,DTCC01516730,255974,65123
CHEMBL3323097,P23975,,OADBNBUTUOPDJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,37.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701385,DTCC01516730,255974,65123
CHEMBL3323097,P23975,,OADBNBUTUOPDJD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,128,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677513,DTCC01516730,255974,65123
CHEMBL3323098,P23975,,LJLKXARFBFJHOY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,INHIBITION,=,58,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450418,DTCT0023180,13907689,DTCC01516731,319751,61025
CHEMBL3323099,P23975,,RLPCKFFTXOAFOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,52,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904133,DTCC01516732,1964206,61025
CHEMBL3323100,P23975,,CFUHORQJAJFNTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,7.8,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904095,DTCC01516733,1159723,61025
CHEMBL3323101,P23975,,AAHLCKVWZXFMPB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904132,DTCC01516734,1289872,61025
CHEMBL3323101,P23975,,AAHLCKVWZXFMPB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677515,DTCC01516734,1259393,65123
CHEMBL3323101,P23975,,AAHLCKVWZXFMPB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314414,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,177830,DTCC01516734,1259393,65123
CHEMBL3323101,P23975,,AAHLCKVWZXFMPB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677485,DTCC01516734,1259393,65123
CHEMBL3323101,P23975,,AAHLCKVWZXFMPB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,137,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677545,DTCC01516734,1259393,65123
CHEMBL3323102,P23975,,CUFCKDTWFRBJEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,8.8,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904090,DTCC01516735,1096451,61025
CHEMBL3323102,P23975,,CUFCKDTWFRBJEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,6.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314424,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,162599,DTCC01516735,1065423,65123
CHEMBL3323102,P23975,,CUFCKDTWFRBJEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,6.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677495,DTCC01516735,1065423,65123
CHEMBL3323102,P23975,,CUFCKDTWFRBJEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,13.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677555,DTCC01516735,1065423,65123
CHEMBL3323102,P23975,,CUFCKDTWFRBJEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,19.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677525,DTCC01516735,1065423,65123
CHEMBL3323103,P23975,,DWFQMVGSQLUODG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,INHIBITION,=,48,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450418,DTCT0023180,13907690,DTCC01516736,1420102,61025
CHEMBL3323104,P23975,,JRUNWUCFSINWFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,11,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904085,DTCC01516737,1678135,61025
CHEMBL3323104,P23975,,JRUNWUCFSINWFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,11.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314425,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,159194,DTCC01516737,1647906,65123
CHEMBL3323104,P23975,,JRUNWUCFSINWFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,11.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677496,DTCC01516737,1647906,65123
CHEMBL3323104,P23975,,JRUNWUCFSINWFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,29.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677526,DTCC01516737,1647906,65123
CHEMBL3323104,P23975,,JRUNWUCFSINWFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,180,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677556,DTCC01516737,1647906,65123
CHEMBL3323105,P23975,,DYQBWKPHLQJDJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,13,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904087,DTCC01516738,448634,61025
CHEMBL3323105,P23975,,DYQBWKPHLQJDJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,11.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314426,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,185153,DTCC01516738,419990,65123
CHEMBL3323105,P23975,,DYQBWKPHLQJDJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,11.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677497,DTCC01516738,419990,65123
CHEMBL3323105,P23975,,DYQBWKPHLQJDJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,22.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677557,DTCC01516738,419990,65123
CHEMBL3323105,P23975,,DYQBWKPHLQJDJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,300,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677527,DTCC01516738,419990,65123
CHEMBL3323106,P23975,,DUMPPDQZUJJGKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,6.8,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904086,DTCC01516739,1581085,61025
CHEMBL3323107,P23975,,AQEBNLPGUGBPPZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,19,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904088,DTCC01516740,2029786,61025
CHEMBL3323108,P23975,,XMNGPUYPQMMGIP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,22,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904089,DTCC01516741,1802435,61025
CHEMBL3323109,P23975,,WXJVSDNWZOTTOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,1000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904183,DTCC01516742,2029787,61025
CHEMBL3323110,P23975,,VSXRMFADTFRTBM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,INHIBITION,=,15,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450418,DTCT0023180,13907691,DTCC01516743,1289873,61025
CHEMBL3323172,P23975,,LPEVXVVSNBJGCU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,INHIBITION,=,32,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450418,DTCT0023180,13907692,DTCC01516805,1387772,61025
CHEMBL3323173,P23975,,KILGJUZHPOSPFN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,1.3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904131,DTCC01516806,1484432,61025
CHEMBL3323174,P23975,,DELHGKQNJWIBFE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904130,DTCC01516807,675932,61025
CHEMBL3323175,P23975,,ZDZGDSLKDOSHHZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,5.5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904129,DTCC01516808,1678136,61025
CHEMBL3323176,P23975,,RQGSUGDPXICJIV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,41,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904184,DTCC01516809,1451872,61025
CHEMBL3323177,P23975,,VBHKUWHGDVHSSQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,180,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904186,DTCC01516810,482198,61025
CHEMBL3323178,P23975,,REFDLFNZTJITBX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,2.9,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904128,DTCC01516811,1128405,61025
CHEMBL3323179,P23975,,BDLAKWIEWPJWSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,<,3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904127,DTCC01516812,1678137,61025
CHEMBL3323179,P23975,,BDLAKWIEWPJWSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,<,3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314422,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,173009,DTCC01516812,1647905,65123
CHEMBL3323179,P23975,,BDLAKWIEWPJWSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,<,3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677493,DTCC01516812,1647905,65123
CHEMBL3323179,P23975,,BDLAKWIEWPJWSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677553,DTCC01516812,1647905,65123
CHEMBL3323179,P23975,,BDLAKWIEWPJWSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677523,DTCC01516812,1647905,65123
CHEMBL3323180,P23975,,VGAJKWKQOHMKHS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,INHIBITION,=,99,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450418,DTCT0023180,13907693,DTCC01516813,2029788,61025
CHEMBL3323181,P23975,,QLQQUDCJVQOCBW-OAQYLSRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,8.3,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13904187,DTCC01516814,1802436,61025
CHEMBL3323182,P23975,,QLQQUDCJVQOCBW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,93,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13907675,DTCC01516815,1678138,61025
CHEMBL3323182,P23975,,QLQQUDCJVQOCBW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,7.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677552,DTCC01516815,1647904,65123
CHEMBL3323182,P23975,,QLQQUDCJVQOCBW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,7.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314421,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,170819,DTCC01516815,1647904,65123
CHEMBL3323182,P23975,,QLQQUDCJVQOCBW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,7.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677492,DTCC01516815,1647904,65123
CHEMBL3323182,P23975,,QLQQUDCJVQOCBW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,53.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677522,DTCC01516815,1647904,65123
CHEMBL3323183,P23975,,RAPYOTFVDQSFNZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,23,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904126,DTCC01516816,870105,61025
CHEMBL3323184,P23975,,ZRXUBWRDOKMUIN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,16,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,,ACS Med. Chem. Lett.,2014,5,7,,,1450415,DTCT0023180,13907676,DTCC01516817,2093719,61025
CHEMBL3323185,P23975,,ULLMROULDBOCOZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,110,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904125,DTCC01516818,643723,61025
CHEMBL3323186,P23975,,ZJEDITUWACTVKK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,INHIBITION,=,35,%,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450418,DTCT0023180,13907694,DTCC01516819,254043,61025
CHEMBL3323187,P23975,,AKCCORFIPGKYKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,IC50,=,9100,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13904094,DTCC01516820,772380,61025
CHEMBL3334503,P23975,,XWALEBCOFGKXBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,73.5,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968318,DTCC01521916,643758,59781
CHEMBL333465,P23975,LOBELANE,ISVBJSRQEBWKPB-SZPZYZBQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15121762,KI,=,1800,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741640,DTCC00300230,2107783,69662
CHEMBL3334769,P23975,,WWEXFJSAHWQFBA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,157.3,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968266,DTCC01521912,740332,59781
CHEMBL3334770,P23975,,PJXULSBRZWCAJP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,52.7,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968316,DTCC01521913,1645995,59781
CHEMBL3334771,P23975,,TWOMIKAXPRBJNB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,79.1,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968317,DTCC01521914,319788,59781
CHEMBL3334772,P23975,,MLGACOKYDQJTGD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,635.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968267,DTCC01521915,675964,59781
CHEMBL3334773,P23975,,AAXDLPLNFKHHPR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,425.7,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968268,DTCC01521917,1996942,59781
CHEMBL3334774,P23975,,ODTKQPAQIAKYDZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,74,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968319,DTCC01521918,1802473,59781
CHEMBL3334775,P23975,,QIIDHPUHHXZNJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,4.9,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968320,DTCC01521919,2061652,59781
CHEMBL3334776,P23975,,UPVLRNUPSLZGHM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,68.9,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968269,DTCC01521920,1451908,59781
CHEMBL3334777,P23975,,YVOMATWVFCSQME-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,35.3,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968321,DTCC01521921,1866762,59781
CHEMBL3334778,P23975,,XIYLELDHKGRFPU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,19,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968322,DTCC01521922,998791,59781
CHEMBL3334779,P23975,,PIBFRRUEZPEANJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,37.8,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968323,DTCC01521923,1063446,59781
CHEMBL3334780,P23975,,GPZZVYRXCADSAJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,5.3,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968324,DTCC01521924,1769928,59781
CHEMBL3334781,P23975,,CUPOAMXQXTXPSU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,50.6,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968325,DTCC01521925,1769929,59781
CHEMBL3334782,P23975,,UBTISEJLHYNQTI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,49.5,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968326,DTCC01521926,1996943,59781
CHEMBL3334783,P23975,,HFKOIMHFPUBUFE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,327.9,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968270,DTCC01521927,643759,59781
CHEMBL3334784,P23975,,ARIJCTMJQZWJNV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,68.9,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968327,DTCC01521928,902374,59781
CHEMBL3334785,P23975,,IMMKHFZNCWNBOD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,74.2,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968328,DTCC01521929,546628,59781
CHEMBL3334786,P23975,,ZKYDECUCAZOZDB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,87.6,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968329,DTCC01521930,2029837,59781
CHEMBL3334787,P23975,,GLFCAUWDGGEFFN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,83.2,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968330,DTCC01521931,1451909,59781
CHEMBL3334788,P23975,,UIOBXKSDWRXQBR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,77.4,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968331,DTCC01521932,1096483,59781
CHEMBL3334789,P23975,,KEQMEADCNMBAIF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,29.3,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968332,DTCC01521933,1678173,59781
CHEMBL3334790,P23975,,VQCUPTYEZOLTOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,40.4,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968333,DTCC01521934,189526,59781
CHEMBL3334791,P23975,,ZGHQVNYQNYKDCM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,52.5,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968334,DTCC01521935,2061653,59781
CHEMBL3334792,P23975,,ONLLHTKWUBCLOO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,19.4,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456972,DTCT0023180,13968335,DTCC01521936,902375,59781
CHEMBL3334793,P23975,,JQUXSYNGQWDWDG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,1456.3,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968271,DTCC01521937,966400,59781
CHEMBL3334794,P23975,,FFTJRFHZXXMTTK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,495,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968272,DTCC01521938,1738096,59781
CHEMBL3334795,P23975,,SWBSCJHQPHFHOQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,2541.5,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968273,DTCC01521939,837475,59781
CHEMBL3334796,P23975,,QHRPNPFRUGWUJT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,249.9,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968274,DTCC01521940,1322429,59781
CHEMBL3334797,P23975,,KEGBICCDHKITSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,477.5,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968275,DTCC01521941,1996944,59781
CHEMBL3334797,P23975,,KEGBICCDHKITSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,INHIBITION,=,96.7,%,,,,,,,,,,,,,,Displacement of [3H]Imipramin from human NET at 10 uM relative to control,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1458812,DTCT0023180,13968474,DTCC01521941,1996944,59781
CHEMBL3334798,P23975,,JDOZNEHOYKLUQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,633.5,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968276,DTCC01521942,1451910,59781
CHEMBL3334799,P23975,,SWFPZMNSOVHJBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,427.6,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968277,DTCC01521943,448665,59781
CHEMBL3334800,P23975,,RTJQGAYVHIKRGT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,205.7,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968278,DTCC01521944,1738097,59781
CHEMBL3334801,P23975,,NTSASDUHAQEZEA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,373.5,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968279,DTCC01521945,2029838,59781
CHEMBL3334802,P23975,,NYBUFVNFJIAWTL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,136.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968280,DTCC01521946,287247,59781
CHEMBL3335556,P23975,,CVKXGRRJHJHUFY-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25221667,ACTIVITY,=,68,%,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter (unknown origin) at 10 uM by radioligand binding assay,,,ACS Med. Chem. Lett.,2014,5,9,,,1439014,DTCT0023180,13997547,DTCC01522697,1593093,59913
CHEMBL333667,P23975,,ZOVQSSMFGDAFDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,399,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,956193,DTCC00298177,1694131,15367
CHEMBL333667,P23975,,ZOVQSSMFGDAFDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,604,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,956188,DTCC00298177,1694131,15367
CHEMBL334255,P23975,CETYLPYRIDINIUM BROMIDE,DVBJBNKEBPCGSY-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2653,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7371023,DTCC00294369,510299,46191
CHEMBL334255,P23975,CETYLPYRIDINIUM BROMIDE,DVBJBNKEBPCGSY-UHFFFAOYSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2631,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7371024,DTCC00294369,510299,46191
CHEMBL334577,P23975,,ADCPRYKGPAHETD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213054,KI,=,5.3,NM,,,,,,,,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Ahmad UF, Koletar J, Kelly L, Brand L, Kopajtic TA",,142614,DTCT0023180,857616,DTCC00313535,173685,16915
CHEMBL334923,P23975,,BOHGZALGHLQJNA-QINSGFPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11229746,AFFINITY,=,6,%,,,,,,,,,,,,,,Compound was tested for binding affinity against noradrenergic uptake,,First tricyclic oximino derivatives as 5-HT3 ligands.,Bioorg. Med. Chem. Lett.,2001,11,4,"Baglin I, Daveu C, Lancelot JC, Bureau R, Dauphin F, Pfeiffer B, Renard P, Delagrange P, Rault S",,144839,DTCT0023180,1635208,DTCC00326287,680704,4473
CHEMBL334929,P23975,,OIHBSJFKSKENBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,145003,DTCT0023180,1068815,DTCC00323029,563026,6048
CHEMBL3350037,P23975,,DEQANNDTNATYII-JDBXKHNRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7384428,DTCC01529235,510306,46191
CHEMBL3350037,P23975,,DEQANNDTNATYII-JDBXKHNRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7384429,DTCC01529235,510306,46191
CHEMBL3350391,P23975,,QVIXLSYROOSFHA-ACDBMABISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16213721,KI,=,1810,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,2005,15,24,"Grundt P, Kopajtic TA, Katz JL, Newman AH",,326609,DTCT0023180,1874026,DTCC01529585,174745,20058
CHEMBL335165,P23975,,WIQKRMGNDCWEGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142608,DTCT0023180,824604,DTCC00314201,1947882,5984
CHEMBL3353960,P23975,,AZXLOZLZVXIRFJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25017029,IC50,=,82,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2014,24,16,"Honda E, Ishichi Y, Kimura E, Yoshikawa M, Kanzaki N, Nakagawa H, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Terauchi J",,1456596,DTCT0023180,13911330,DTCC01531381,526406,60940
CHEMBL335423,P23975,,KXYMHOPZXNZJHG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,IC50,=,1452,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142799,DTCT0023180,852139,DTCC00314558,1723825,5984
CHEMBL335423,P23975,,KXYMHOPZXNZJHG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,KI,=,4500,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142608,DTCT0023180,852138,DTCC00314558,1723825,5984
CHEMBL3355573,P23975,,PIVJTBXDGKAQQI-BPUTZDHNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25155913,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 30 uM,,Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa.,Bioorg. Med. Chem.,2014,22,19,"Reck F, Ehmann DE, Dougherty TJ, Newman JV, Hopkins S, Stone G, Agrawal N, Ciaccio P, McNulty J, Barthlow H, O'Donnell J, Goteti K, Breen J, Comita-Prevoir J, Cornebise M, Cronin M, Eyermann CJ, Geng B, Carr GR, Pandarinathan L, Tang X, Cottone A, Zhao L, Bezdenejnih-Snyder N",,1454242,DTCT0023180,13949387,DTCC01533010,1399701,59769
CHEMBL3355575,P23975,,HXCSDXBLCTUKEB-BXWFABGCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25155913,INHIBITION,=,52,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 30 uM,,Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa.,Bioorg. Med. Chem.,2014,22,19,"Reck F, Ehmann DE, Dougherty TJ, Newman JV, Hopkins S, Stone G, Agrawal N, Ciaccio P, McNulty J, Barthlow H, O'Donnell J, Goteti K, Breen J, Comita-Prevoir J, Cornebise M, Cronin M, Eyermann CJ, Geng B, Carr GR, Pandarinathan L, Tang X, Cottone A, Zhao L, Bezdenejnih-Snyder N",,1454242,DTCT0023180,13949427,DTCC01533012,266346,59769
CHEMBL336100,P23975,,AAADQEFQWNJHOZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,818966,DTCC00313566,853995,16914
CHEMBL336100,P23975,,AAADQEFQWNJHOZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,0.9,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,818963,DTCC00313566,853995,16914
CHEMBL336613,P23975,,ZRGPKZSODCXXDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,6.9,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,856316,DTCC00313533,1629954,16914
CHEMBL336613,P23975,,ZRGPKZSODCXXDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,170,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,856313,DTCC00313533,1629954,16914
CHEMBL336920,P23975,(R)-DULOXETINE,ZEUITGRIYCTCEM-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,IC50,=,13.2,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602900,DTCT0023180,3162397,DTCC00323168,663619,36631
CHEMBL336920,P23975,(R)-DULOXETINE,ZEUITGRIYCTCEM-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,KI,=,61.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602897,DTCT0023180,3162373,DTCC00323168,663619,36631
CHEMBL336940,P23975,,JIVIBEFNFXNPFI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,4.7,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,829199,DTCC00314108,1883102,16914
CHEMBL336940,P23975,,JIVIBEFNFXNPFI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,6.8,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,829196,DTCC00314108,1883102,16914
CHEMBL337020,P23975,,KLRMDPMJYLBCKY-IJXZTRCJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213054,KI,=,690,NM,,,,,,,,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Ahmad UF, Koletar J, Kelly L, Brand L, Kopajtic TA",,142614,DTCT0023180,876961,DTCC00313946,1850957,16915
CHEMBL337791,P23975,,IEMZWXPJSYEEOM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,81,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1055762,DTCC00323078,1947991,6048
CHEMBL337798,P23975,,UKLJVQPVIADCAE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,67,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1071260,DTCC00322993,982968,6048
CHEMBL337822,P23975,,GOZODOHXYHQNFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1080667,DTCC00322746,1786394,6048
CHEMBL338115,P23975,6-METHOXY-HARMALAN,HMBHRMFLDKKSCT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643338,KI,>,4100,NM,,,,,,,,,,,,,,Binding affinity towards NET,,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,2003,13,24,"Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA",,142610,DTCT0023180,1099610,DTCC01742985,1306588,6037
CHEMBL338790,P23975,,SSMIFVHARFVINF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7303165,DTCC00302791,1512803,46191
CHEMBL338790,P23975,,SSMIFVHARFVINF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7303166,DTCC00302791,1512803,46191
CHEMBL340281,P23975,,AYESQVUVFADUMC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213054,KI,=,5.2,NM,,,,,,,,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Ahmad UF, Koletar J, Kelly L, Brand L, Kopajtic TA",,142614,DTCT0023180,867919,DTCC00313514,1112817,16915
CHEMBL340978,P23975,BENOXAPROFEN,MITFXPHMIHQXPI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7276799,DTCC00314414,510297,46191
CHEMBL340978,P23975,BENOXAPROFEN,MITFXPHMIHQXPI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7276800,DTCC00314414,510297,46191
CHEMBL34139,P23975,GENACONAZOLE,HFGZFHCWKKQGIS-NOZJJQNGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331467,DTCC00173585,1416030,46191
CHEMBL34139,P23975,GENACONAZOLE,HFGZFHCWKKQGIS-NOZJJQNGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7331468,DTCC00173585,1416030,46191
CHEMBL341898,P23975,"(R,S)-INDATRALINE",SVFXPTLYMIXFRX-XJKSGUPXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,15,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1169408,DTCC00334273,1936154,16052
CHEMBL341898,P23975,"(R,S)-INDATRALINE",SVFXPTLYMIXFRX-XJKSGUPXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,22,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1169407,DTCC00334273,1936154,16052
CHEMBL342055,P23975,,HUOXUHKHSINJFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12565962,KI,=,393,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),,Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,3,"Enyedy IJ, Sakamuri S, Zaman WA, Johnson KM, Wang S",,142780,DTCT0023180,659869,DTCC00336880,1229626,6092
CHEMBL34259,P23975,METHOTREXATE,FBOZXECLQNJBKD-ZDUSSCGKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7436500,DTCC00173293,1351113,46191
CHEMBL34259,P23975,METHOTREXATE,FBOZXECLQNJBKD-ZDUSSCGKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7436501,DTCC00173293,1351113,46191
CHEMBL342716,P23975,,FJIWMGGJQBHZKG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,42,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1075910,DTCC00323439,2078059,6048
CHEMBL343211,P23975,,UDCVQVNMMCKETF-NZQKXSOJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,1600,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1142528,DTCC00334017,1262498,16052
CHEMBL343211,P23975,,UDCVQVNMMCKETF-NZQKXSOJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,2800,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1142527,DTCC00334017,1262498,16052
CHEMBL343324,P23975,,ZLTWNSXILLAQPT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,145003,DTCT0023180,1078278,DTCC00323225,1306608,6048
CHEMBL343369,P23975,RHENIUM COMPLEX,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9804682,IC50,=,7.3,NM,,,,,,,,,,,,,,The compound was tested in vitro for binding affinity for the norepinephrine transporter (NET) using competitive binding assay.,,TROTEC-1: a new high-affinity ligand for labeling of the dopamine transporter.,J. Med. Chem.,1998,41,23,"Hoepping A, Reisgys M, Brust P, Seifert S, Spies H, Alberto R, Johannsen B",,142804,DTCT0023180,1509101,DTCC00322016,809580,14928
CHEMBL344110,P23975,,AXJNQTWCGWGLCZ-LPHOPBHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,650,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1137912,DTCC00334008,1294978,16052
CHEMBL344110,P23975,,AXJNQTWCGWGLCZ-LPHOPBHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,1800,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1137913,DTCC00334008,1294978,16052
CHEMBL344116,P23975,,NNNDXILSDZTFTR-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,400,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1166885,DTCC00334360,1774957,16052
CHEMBL344116,P23975,,NNNDXILSDZTFTR-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,640,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1166886,DTCC00334360,1774957,16052
CHEMBL34431,P23975,CILOSTAMIDE,UIAYVIIHMORPSJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347624,DTCC00173669,1894963,46191
CHEMBL34431,P23975,CILOSTAMIDE,UIAYVIIHMORPSJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7347625,DTCC00173669,1894963,46191
CHEMBL344513,P23975,,IAXQDXIYZZJWKO-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,150,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1136733,DTCC00333986,226911,16052
CHEMBL344513,P23975,,IAXQDXIYZZJWKO-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,310,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1136734,DTCC00333986,226911,16052
CHEMBL345251,P23975,,PWZMTBUSUJELNZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,944095,DTCC00345029,983197,13807
CHEMBL345439,P23975,,MYHWCLVILIUBBP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,4700,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,946762,DTCC00345046,271261,13807
CHEMBL345442,P23975,,JWHRWJZJTWFYRA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,750,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,970383,DTCC00345638,1015529,13807
CHEMBL345607,P23975,,VFLCTSVVOXXGMD-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,970395,DTCC00345623,1694711,13807
CHEMBL346021,P23975,,LUHJZDCSPPPIDT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,957275,DTCC00344824,1303418,13807
CHEMBL346142,P23975,,YSSNAKHTYQUUHB-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,936471,DTCC00345593,2078330,13807
CHEMBL346178,P23975,OSANETANT,DZOJBGLFWINFBF-UMSFTDKQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25738882,INHIBITION,>=,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from recombinant human norepinephrine transporter expressed in CHO cells at 1 uM after 120 mins by scintillation counting analysis relative to control,,Discovery and optimization of novel antagonists to the human neurokinin-3 receptor for the treatment of sex-hormone disorders (part I).,J. Med. Chem.,2015,58,7,"Hoveyda HR, Fraser GL, Roy MO, Dutheuil G, Batt F, El Bousmaqui M, Korac J, Lenoir F, Lapin A, Noël S, Blanc S",,1475794,DTCT0023180,14114164,DTCC00342636,1710181,62080
CHEMBL347199,P23975,,QHMFRKMGCLKZRZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,670,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,946754,DTCC00345654,789094,13807
CHEMBL347336,P23975,,HPHYXLXHERUQOH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,6200,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,968954,DTCC00345211,336881,13807
CHEMBL347666,P23975,,LCPXLRHRFOEFHQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,13000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,952002,DTCC00345207,109443,13807
CHEMBL347772,P23975,2-BENZHYDRYL-PYRIDINE,MMXYNKLYVRNTCK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12565962,KI,=,5530,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),,Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,3,"Enyedy IJ, Sakamuri S, Zaman WA, Johnson KM, Wang S",,142780,DTCT0023180,665786,DTCC01743628,1936182,6092
CHEMBL347914,P23975,,ZGKKKWMQYVOFGE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,2600,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,936462,DTCC00345229,174051,13807
CHEMBL347933,P23975,,YLXLGAOEMZMTCN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,12000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,966532,DTCC00345558,724809,13807
CHEMBL348034,P23975,,KUBLGYWISNGZNK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,680,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,937838,DTCC00345209,2014058,13807
CHEMBL348716,P23975,,HAJXHZRMFWRJQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,955999,DTCC00344952,1145479,13807
CHEMBL348865,P23975,,OLLIUPXULGNHBZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,949281,DTCC00345452,1819225,13807
CHEMBL35,P23975,FUROSEMIDE,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322735,DTCC00133917,51472,46191
CHEMBL35,P23975,FUROSEMIDE,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322736,DTCC00133917,51472,46191
CHEMBL350692,P23975,,JFXXREWKFGYUCE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,963822,DTCC00345089,1948265,13807
CHEMBL351760,P23975,,FOWTXXOWJKWIGY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,12800,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,950584,DTCC00344801,1436465,13807
CHEMBL3545252,P23975,DOCETAXEL HYDRATE,XCDIRYDKECHIPE-QHEQPUDQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362081,DTCC01631667,51465,46191
CHEMBL3545252,P23975,DOCETAXEL HYDRATE,XCDIRYDKECHIPE-QHEQPUDQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362082,DTCC01631667,51465,46191
CHEMBL3559671,P23975,POLYVINYL ALCOHOL,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393933,DTCC01642718,1155684,46191
CHEMBL3559671,P23975,POLYVINYL ALCOHOL,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393934,DTCC01642718,1155684,46191
CHEMBL356531,P23975,,RUFGGNDBOBTWQC-LPHOPBHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,2200,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1136756,DTCC00334148,1936155,16052
CHEMBL356531,P23975,,RUFGGNDBOBTWQC-LPHOPBHVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1136757,DTCC00334148,1936155,16052
CHEMBL356552,P23975,,FIGPOABEAKIBCL-YOEHRIQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,170,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1169419,DTCC00334386,777456,16052
CHEMBL356750,P23975,,UNCBFTIAWJTNTF-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,21,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1143578,DTCC00334118,745373,16052
CHEMBL356750,P23975,,UNCBFTIAWJTNTF-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,52,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1143577,DTCC00334118,745373,16052
CHEMBL356750,P23975,,UNCBFTIAWJTNTF-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,130,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1156529,DTCC00334118,745374,16052
CHEMBL356750,P23975,,UNCBFTIAWJTNTF-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,130,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1156530,DTCC00334118,745374,16052
CHEMBL356922,P23975,,LKXCLZURUSBJKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,9900,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,966522,DTCC00344954,1915669,13807
CHEMBL356981,P23975,,AXJNQTWCGWGLCZ-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,260,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1149639,DTCC00333991,1197378,16052
CHEMBL356981,P23975,,AXJNQTWCGWGLCZ-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,420,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1149640,DTCC00333991,1197378,16052
CHEMBL357312,P23975,,YBUFEUDZXKMCFS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12565962,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),,Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,3,"Enyedy IJ, Sakamuri S, Zaman WA, Johnson KM, Wang S",,142780,DTCT0023180,685854,DTCC00337222,1743153,6092
CHEMBL357322,P23975,4-BENZYLPYRIDINE,DBOLXXRVIFGDTI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12565962,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),,Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,3,"Enyedy IJ, Sakamuri S, Zaman WA, Johnson KM, Wang S",,142780,DTCT0023180,461201,DTCC01743625,1229625,6092
CHEMBL357553,P23975,,SDCIJOLMGUGDKZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,968947,DTCC00344849,1565549,13807
CHEMBL3577955,P23975,,PWDBREUBRYUEGC-BTJKTKAUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human NET at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496655,DTCT0023180,14434956,DTCC01646031,903869,62611
CHEMBL3577956,P23975,,ABJWJGMTLYSISP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human NET at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496655,DTCT0023180,14434957,DTCC01646032,386606,62611
CHEMBL3577957,P23975,,MRTJHEDYFUFHHQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human NET at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496655,DTCT0023180,14434958,DTCC01646033,1550378,62611
CHEMBL357995,P23975,BOPINDOLOL,UUOJIACWOAYWEZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7278697,DTCC00343658,510298,46191
CHEMBL357995,P23975,BOPINDOLOL,UUOJIACWOAYWEZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7278698,DTCC00343658,510298,46191
CHEMBL3586032,P23975,,UZJCBPUZLIMFRR-VJGNERBWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25981690,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of radioligand binding at human NET at 10 uM,,2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptor.,Bioorg. Med. Chem. Lett.,2015,25,13,"Takahashi B, Funami H, Iwaki T, Maruoka H, Nagahira A, Koyama M, Kamiide Y, Matsuo T, Muto T, Annoura H",,1500447,DTCT0023180,14451012,DTCC01649004,1225913,62878
CHEMBL358967,P23975,PARA-CHLOROAMPHETAMINE,WWPITPSIWMXDPE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19717215,IC50,=,207,NM,,,,,,,,,,,,,,Inhibition of human noradrenaline transporter,,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,2009,44,12,"Cloonan SM, Keating JJ, Butler SG, Knox AJ, Jørgensen AM, Peters GH, Rai D, Corrigan D, Lloyd DG, Williams DC, Meegan MJ",,622530,DTCT0023180,3256935,DTCC01743595,683894,37648
CHEMBL359025,P23975,,MSLSPRSRIMVUAY-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,75,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1172996,DTCC00334171,2066655,16052
CHEMBL359025,P23975,,MSLSPRSRIMVUAY-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,110,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1172995,DTCC00334171,2066655,16052
CHEMBL3593274,P23975,,KETAPAGKHJIKAN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,2.1,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473322,DTCC01651618,1421733,63002
CHEMBL3593275,P23975,,OPTPKUISFYHAGF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,17,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473321,DTCC01651619,1647491,63002
CHEMBL3593391,P23975,,OPTPKUISFYHAGF-YDALLXLXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,700,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473320,DTCC01651736,1900624,63002
CHEMBL3593392,P23975,,OPTPKUISFYHAGF-UTONKHPSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,5.6,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473319,DTCC01651737,1356773,63002
CHEMBL3593393,P23975,,WDNXRQXGZIPADY-PKKHVXKMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,8.5,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473318,DTCC01651738,450237,63002
CHEMBL3593394,P23975,,WDNXRQXGZIPADY-KATIXKQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,6,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473317,DTCC01651739,1421735,63002
CHEMBL3593395,P23975,,WDNXRQXGZIPADY-CSDGMEMJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473316,DTCC01651740,935788,63002
CHEMBL3593396,P23975,,WDNXRQXGZIPADY-WYUVZMMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,5.8,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473315,DTCC01651741,1486114,63002
CHEMBL3593397,P23975,,FDKMWPCRMXOEIV-NINOIYOQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,52,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473314,DTCC01651742,1804037,63002
CHEMBL3593398,P23975,,JJVNHIVTHFANPP-KATIXKQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,12,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473313,DTCC01651743,1130038,63002
CHEMBL3593399,P23975,,BXQHWNKKHXHIDQ-HTKOBJQYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,0.77,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473312,DTCC01651744,94324,63002
CHEMBL3593400,P23975,,ITALTGDRMWXEDY-UOUQJYNVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,0.33,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473311,DTCC01651745,450238,63002
CHEMBL3593401,P23975,,VZFSSAZWIAREQM-YLCXCWDSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,5.8,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473310,DTCC01651746,2063187,63002
CHEMBL3593402,P23975,,YYOKDTWKQIVDFK-XCBLFTOQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,2.3,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473309,DTCC01651747,548108,63002
CHEMBL3593402,P23975,,YYOKDTWKQIVDFK-XCBLFTOQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,2.3,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297958,DTCC01651747,549279,67412
CHEMBL3593403,P23975,,YQVZJLGBHWQCGT-UOUQJYNVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,13,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473308,DTCC01651748,806252,63002
CHEMBL3593404,P23975,,BYHRMOSVXQWMGN-SLHAJLBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,3.3,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473307,DTCC01651749,1486115,63002
CHEMBL3593405,P23975,,FMBFPKABXNIGRK-SLHAJLBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26051602,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,2015,23,15,"Fujimori I, Yukawa T, Kamei T, Nakada Y, Sakauchi N, Yamada M, Ohba Y, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Hamada T, Igari T, Okuda T, Yamamoto S, Tsukamoto T, Ishichi Y, Ueno H",,1505018,DTCT0023180,14473306,DTCC01651750,1421736,63002
CHEMBL360328,P23975,LORCASERIN,XTTZERNUQAFMOF-QMMMGPOBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19284718,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,2009,52,7,"Cho SJ, Jensen NH, Kurome T, Kadari S, Manzano ML, Malberg JE, Caldarone B, Roth BL, Kozikowski AP",,566868,DTCT0023180,2486838,DTCC00382003,436500,33028
CHEMBL3608450,P23975,,XYYAWEJOUNEPTR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26227772,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512567,DTCT0023180,14522442,DTCC01659060,2010933,63285
CHEMBL361259,P23975,,YVKDUIAAPBKHMJ-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9986702,KI,=,1.82,NM,,,,,,,,,,,,,,Compound was tested for inhibiting reuptake of [3H]- NE by norepinephrine transporter,,"A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.",J. Med. Chem.,1999,42,3,"Oya S, Kung MP, Acton PD, Mu M, Hou C, Kung HF",,143134,DTCT0023180,1698074,DTCC00392836,1915013,15555
CHEMBL361259,P23975,,YVKDUIAAPBKHMJ-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9986702,KI,=,11.3,NM,,cell_based,,,,,,,,,,,,In vitro binding affinity against monoamine transporter NET (norepinephrine transporter) in LLC-PK1 cell membranes.,,"A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.",J. Med. Chem.,1999,42,3,"Oya S, Kung MP, Acton PD, Mu M, Hou C, Kung HF",,142940,DTCT0023180,1698078,DTCC00392836,1915013,15555
CHEMBL361259,P23975,,YVKDUIAAPBKHMJ-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15456270,KI,=,11.3,NM,,cell_based,,,,,,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,2004,47,21,"Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP",,303519,DTCT0023180,1793405,DTCC00392836,1904841,19119
CHEMBL3612693,P23975,,QYOJMNDDVVEPFN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26372073,INHIBITION,,,,,,,,,,,,,,,,,Displacement of [3H]-nisoxetine from norepinephrine transporter (unknown origin) at 1 to 10 mM,Active,Reengineered tricyclic anti-cancer agents.,Bioorg. Med. Chem.,2015,23,19,"Kastrinsky DB, Sangodkar J, Zaware N, Izadmehr S, Dhawan NS, Narla G, Ohlmeyer M",,1515638,DTCT0023180,14527247,DTCC01661140,1369058,63615
CHEMBL3612825,P23975,,IBNJJBGOQUDBKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,267,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531901,DTCC01661274,657320,63581
CHEMBL3612825,P23975,,IBNJJBGOQUDBKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.12,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531847,DTCC01661274,657320,63581
CHEMBL3612826,P23975,,OXADJUSYVLITBP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,268,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531902,DTCC01661275,1978108,63581
CHEMBL3612826,P23975,,OXADJUSYVLITBP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.72,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531875,DTCC01661275,1978108,63581
CHEMBL3612827,P23975,,XEQQTZYAFZACLX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,621,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531903,DTCC01661276,1369061,63581
CHEMBL3612827,P23975,,XEQQTZYAFZACLX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.54,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531876,DTCC01661276,1369061,63581
CHEMBL3612828,P23975,,PWJHFYJVKXVMET-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,4750,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531904,DTCC01661277,2043357,63581
CHEMBL3612828,P23975,,PWJHFYJVKXVMET-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.8,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531877,DTCC01661277,2043357,63581
CHEMBL3612829,P23975,,MRCYIBGVKYPKAF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,153,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531905,DTCC01661278,657321,63581
CHEMBL3612829,P23975,,MRCYIBGVKYPKAF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.59,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531878,DTCC01661278,657321,63581
CHEMBL3612830,P23975,,WMWWIRQFIVCLLM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.37,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531880,DTCC01661279,980281,63581
CHEMBL3612831,P23975,,AEWLCYATCHHWMP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,0.62,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531881,DTCC01661280,980282,63581
CHEMBL3612832,P23975,,OMKGHFXHPUBOFJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.32,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531846,DTCC01661281,1691652,63581
CHEMBL3612833,P23975,,XFUBYPOXEIGKQC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,342,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531906,DTCC01661282,1594928,63581
CHEMBL3612833,P23975,,XFUBYPOXEIGKQC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.03,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531845,DTCC01661282,1594928,63581
CHEMBL3612834,P23975,,DNULEDAKWYIMHX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,885,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531907,DTCC01661283,1044994,63581
CHEMBL3612834,P23975,,DNULEDAKWYIMHX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,0.94,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531844,DTCC01661283,1044994,63581
CHEMBL3612835,P23975,,BJTGZJWWRAYVMS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,238,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531908,DTCC01661284,1044995,63581
CHEMBL3612835,P23975,,BJTGZJWWRAYVMS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531843,DTCC01661284,1044995,63581
CHEMBL3612836,P23975,,HDKHKSGEUQDNGB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531842,DTCC01661285,2075319,63581
CHEMBL3613147,P23975,,VPUIRNPMXUBXBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.49,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531882,DTCC01661599,721719,63581
CHEMBL3613148,P23975,,LOGKFOZAEYYIAV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.09,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531883,DTCC01661600,915174,63581
CHEMBL3613149,P23975,,QOGZMINVAKYXMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.92,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531884,DTCC01661601,528095,63581
CHEMBL3613150,P23975,,QXORAPZZHCKPIB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,472,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531909,DTCC01661602,1912662,63581
CHEMBL3613150,P23975,,QXORAPZZHCKPIB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.49,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531885,DTCC01661602,1912662,63581
CHEMBL3613151,P23975,,BAMKKHHTCLKCOQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.04,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531886,DTCC01661603,495989,63581
CHEMBL3613152,P23975,,KPTPOXGMWXQMFV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.54,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531887,DTCC01661604,657322,63581
CHEMBL3613153,P23975,,DHGQDGVOFHPDSG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,IC50,=,275,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514154,DTCT0023180,14531910,DTCC01661605,947877,63581
CHEMBL3613153,P23975,,DHGQDGVOFHPDSG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,0.53,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531871,DTCC01661605,947877,63581
CHEMBL3613154,P23975,,XBKFHSYCRYCLCK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,0.1,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531872,DTCC01661606,818443,63581
CHEMBL3613155,P23975,,KPCRSRJGGIXJEI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.27,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531873,DTCC01661607,1945130,63581
CHEMBL3613156,P23975,,JFNSLRXMKOYKGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,0.83,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514151,DTCT0023180,14531874,DTCC01661608,1912663,63581
CHEMBL3613157,P23975,,QHJHMCYAXBKCKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26337019,RATIO,=,1.97,,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,2015,23,19,"Paudel S, Cao Y, Guo S, An B, Kim KM, Cheon SH",,1514152,DTCT0023180,14531888,DTCC01661609,851360,63581
CHEMBL3613642,P23975,,KORKKQLDGMHNKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26235950,INHIBITION,=,4,%,,,,,,,,,,,,,,Binding affinity to human NE transporter assessed as inhibition of control specific binding at 10 uM,,Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.,Bioorg. Med. Chem. Lett.,2015,25,18,"Wei ZL, Nguyen MT, O'Mahony DJ, Acevedo A, Zipfel S, Zhang Q, Liu L, Dourado M, Chi C, Yip V, DeFalco J, Gustafson A, Emerling DE, Kelly MG, Kincaid J, Vincent F, Duncton MA",,1514574,DTCT0023180,14536045,DTCC01662099,495991,63547
CHEMBL361949,P23975,,UFBLPBWRPPLNJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853309,DTCC00383082,1905005,19894
CHEMBL3622346,P23975,,BIALXFMHWCNRAQ-OQIWPSSASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25801931,INHIBITION,=,8,%,,,,,,,,,,,,,,Inhibition of human NET at 10 uM relative to control,,Pseudosaccharin amines as potent and selective KV1.5 blockers.,Bioorg. Med. Chem. Lett.,2015,25,21,"Lloyd J, Finlay HJ, Kover A, Johnson J, Pi Z, Jiang J, Neels J, Cavallaro C, Wexler R, Conder ML, Shi H, Li D, Sun H, Chimalakonda A, Huang C, Salvati M, Levesque P",,1520945,DTCT0023180,14565608,DTCC01665769,1816197,63815
CHEMBL3622360,P23975,,QWHKGOUNYNQXJA-FEHRVWHQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25801931,INHIBITION,=,6,%,,,,,,,,,,,,,,Inhibition of human NET at 10 uM relative to control,,Pseudosaccharin amines as potent and selective KV1.5 blockers.,Bioorg. Med. Chem. Lett.,2015,25,21,"Lloyd J, Finlay HJ, Kover A, Johnson J, Pi Z, Jiang J, Neels J, Cavallaro C, Wexler R, Conder ML, Shi H, Li D, Sun H, Chimalakonda A, Huang C, Salvati M, Levesque P",,1520945,DTCT0023180,14566338,DTCC01665783,203016,63815
CHEMBL362783,P23975,,MVOUTMRHQVFORJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,483.55,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809651,DTCC00396504,110002,19300
CHEMBL3633757,P23975,,AJIMVLSQIMXLNV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26475518,INHIBITION,<,50,%,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from recombinant human NET at 10 uM after 1.5 hrs by Microbeta scintillation counting analysis relative to control,,Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT2A receptor.,Bioorg. Med. Chem. Lett.,2015,25,22,"Ponnala S, Kapadia N, Madapa S, Alberts IL, Harding WW",,1527265,DTCT0023180,14599733,DTCC01670761,1077577,64247
CHEMBL363396,P23975,,WTJNBQYUXJFISF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,505,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822335,DTCC00396204,1651788,19630
CHEMBL363396,P23975,,WTJNBQYUXJFISF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,219,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809548,DTCC00396204,1663125,19300
CHEMBL3634745,P23975,,OOOKPENMJKOYJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26421921,IC50,>,1200,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter (unknown origin),,"Design, Synthesis, and Pharmacological Evaluation of 5,6-Disubstituted Pyridin-2(1H)-one Derivatives as Phosphodiesterase 10A (PDE10A) Antagonists.",J. Med. Chem.,2015,58,20,"Lingam VS, Dahale DH, Rathi VE, Shingote YB, Thakur RR, Mindhe AS, Kummari S, Khairatkar-Joshi N, Bajpai M, Shah DM, Sapalya RS, Gullapalli S, Gupta PK, Gudi GS, Jadhav SB, Pattem R, Thomas A",,1525555,DTCT0023180,14591038,DTCC01671759,968112,64196
CHEMBL3639720,P23975,,CFCQNYUGCHNQOU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1049,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678547,DTCC01705780,2043649,65048
CHEMBL3640036,P23975,,KESMMXPCOOCEDA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,25,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317707,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,171156,DTCC01737395,980863,65140
CHEMBL3640036,P23975,,KESMMXPCOOCEDA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4728,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317695,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,179137,DTCC01737395,980863,65140
CHEMBL364050,P23975,,VCCPIFXWHLLCQB-KOLCDFICSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853328,DTCC00406336,1198197,19894
CHEMBL364713,P23975,NOSCAPINE,AKNNEGZIBPJZJG-MSOLQXFVSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7401564,DTCC00398932,898293,46191
CHEMBL364713,P23975,NOSCAPINE,AKNNEGZIBPJZJG-MSOLQXFVSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7401565,DTCC00398932,898293,46191
CHEMBL365055,P23975,,CYQHDGVGYUKXFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15380202,INHIBITION,=,67,%,,,,,,,,,,,,,,Inhibitory activity against Norepinephrine transporter at 10 uM,,4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists.,Bioorg. Med. Chem. Lett.,2004,14,20,"Receveur JM, Bjurling E, Ulven T, Little PB, Nørregaard PK, Högberg T",,307690,DTCT0023180,1775096,DTCC00389730,1328222,18270
CHEMBL365183,P23975,,XAYGSYISSLIYTN-YAAHMLIESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16220969,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition constant against norepinephrine transporter,,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,2005,48,21,"Morphy R, Rankovic Z",,321161,DTCT0023180,1862000,DTCC00408240,1905036,19940
CHEMBL365812,P23975,,XEZCTGHRWRPHGS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,3823,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822464,DTCC00399109,98521,19630
CHEMBL366170,P23975,,PEFLMXJNQRODSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,=,4440,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822449,DTCC00399187,1328341,19630
CHEMBL3663906,P23975,,IEHDEVXKWOALDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1400,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677530,DTCC01696421,159570,65123
CHEMBL3663906,P23975,,IEHDEVXKWOALDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,41400,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314399,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,159727,DTCC01696421,159570,65123
CHEMBL3663906,P23975,,IEHDEVXKWOALDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,41400,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701380,DTCC01696421,159570,65123
CHEMBL3663906,P23975,,IEHDEVXKWOALDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,128000,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677500,DTCC01696421,159570,65123
CHEMBL3663907,P23975,,HFAXMKVVLFVHBE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2450,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677531,DTCC01696422,872074,65123
CHEMBL3663907,P23975,,HFAXMKVVLFVHBE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3060,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314400,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,179640,DTCC01696422,872074,65123
CHEMBL3663907,P23975,,HFAXMKVVLFVHBE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3060,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701381,DTCC01696422,872074,65123
CHEMBL3663907,P23975,,HFAXMKVVLFVHBE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5990,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677501,DTCC01696422,872074,65123
CHEMBL3663908,P23975,,YTYBDRIOUDWUGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,488,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314401,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,180797,DTCC01696423,484229,65123
CHEMBL3663908,P23975,,YTYBDRIOUDWUGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,488,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701382,DTCC01696423,484229,65123
CHEMBL3663908,P23975,,YTYBDRIOUDWUGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2250,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677502,DTCC01696423,484229,65123
CHEMBL3663908,P23975,,YTYBDRIOUDWUGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3170,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677532,DTCC01696423,484229,65123
CHEMBL3663909,P23975,,NPFSYWQNMCUQFC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1640,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314402,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,158991,DTCC01696424,968302,65123
CHEMBL3663909,P23975,,NPFSYWQNMCUQFC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1640,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701383,DTCC01696424,968302,65123
CHEMBL3663909,P23975,,NPFSYWQNMCUQFC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5640,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677503,DTCC01696424,968302,65123
CHEMBL3663909,P23975,,NPFSYWQNMCUQFC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,7530,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677533,DTCC01696424,968302,65123
CHEMBL3663910,P23975,,XNBOTHGRHLGURP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,470,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677534,DTCC01696425,1680088,65123
CHEMBL3663910,P23975,,XNBOTHGRHLGURP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1375,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314403,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,160182,DTCC01696425,1680088,65123
CHEMBL3663910,P23975,,XNBOTHGRHLGURP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1375,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701384,DTCC01696425,1680088,65123
CHEMBL3663910,P23975,,XNBOTHGRHLGURP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2787,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677504,DTCC01696425,1680088,65123
CHEMBL3663911,P23975,,OXERSMRQMIRNOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,22,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314409,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,184384,DTCC01696426,1836698,65123
CHEMBL3663911,P23975,,OXERSMRQMIRNOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,22,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14701390,DTCC01696426,1836698,65123
CHEMBL3663911,P23975,,OXERSMRQMIRNOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,26.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677540,DTCC01696426,1836698,65123
CHEMBL3663911,P23975,,OXERSMRQMIRNOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,>,300,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677510,DTCC01696426,1836698,65123
CHEMBL3663912,P23975,,KIRDSTWSOYAHOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677546,DTCC01696427,936177,65123
CHEMBL3663912,P23975,,KIRDSTWSOYAHOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,8.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314415,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,170567,DTCC01696427,936177,65123
CHEMBL3663912,P23975,,KIRDSTWSOYAHOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,8.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677486,DTCC01696427,936177,65123
CHEMBL3663912,P23975,,KIRDSTWSOYAHOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,119,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677516,DTCC01696427,936177,65123
CHEMBL3663913,P23975,,HAQQTPCJCLWUMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,33,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677517,DTCC01696428,839458,65123
CHEMBL3663913,P23975,,HAQQTPCJCLWUMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,73,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314416,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,160518,DTCC01696428,839458,65123
CHEMBL3663913,P23975,,HAQQTPCJCLWUMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,73,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677487,DTCC01696428,839458,65123
CHEMBL3663913,P23975,,HAQQTPCJCLWUMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,93,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677547,DTCC01696428,839458,65123
CHEMBL3663914,P23975,,QMOZFCXYKWWVFV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677548,DTCC01696429,1647903,65123
CHEMBL3663914,P23975,,QMOZFCXYKWWVFV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,12.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314417,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,157341,DTCC01696429,1647903,65123
CHEMBL3663914,P23975,,QMOZFCXYKWWVFV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,12.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677488,DTCC01696429,1647903,65123
CHEMBL3663914,P23975,,QMOZFCXYKWWVFV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,35.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677518,DTCC01696429,1647903,65123
CHEMBL3663915,P23975,,JRMIJYKTHQCXEO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677549,DTCC01696430,1324330,65123
CHEMBL3663915,P23975,,JRMIJYKTHQCXEO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,24.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314418,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,164730,DTCC01696430,1324330,65123
CHEMBL3663915,P23975,,JRMIJYKTHQCXEO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,24.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677489,DTCC01696430,1324330,65123
CHEMBL3663915,P23975,,JRMIJYKTHQCXEO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,>,1000,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677519,DTCC01696430,1324330,65123
CHEMBL3663916,P23975,,TWKWOGUGCQDBEG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,12.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677550,DTCC01696431,1065422,65123
CHEMBL3663916,P23975,,TWKWOGUGCQDBEG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,58.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314419,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,183116,DTCC01696431,1065422,65123
CHEMBL3663916,P23975,,TWKWOGUGCQDBEG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,58.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677490,DTCC01696431,1065422,65123
CHEMBL3663916,P23975,,TWKWOGUGCQDBEG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,>,1000,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677520,DTCC01696431,1065422,65123
CHEMBL3663917,P23975,,FHVZRKFXAWGVLU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314420,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,169198,DTCC01696432,1194283,65123
CHEMBL3663917,P23975,,FHVZRKFXAWGVLU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677491,DTCC01696432,1194283,65123
CHEMBL3663917,P23975,,FHVZRKFXAWGVLU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677551,DTCC01696432,1194283,65123
CHEMBL3663917,P23975,,FHVZRKFXAWGVLU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,8.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677521,DTCC01696432,1194283,65123
CHEMBL3663918,P23975,,UBPCUEVRWJIHLS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314423,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,166456,DTCC01696433,645733,65123
CHEMBL3663918,P23975,,UBPCUEVRWJIHLS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677494,DTCC01696433,645733,65123
CHEMBL3663918,P23975,,UBPCUEVRWJIHLS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677554,DTCC01696433,645733,65123
CHEMBL3663918,P23975,,UBPCUEVRWJIHLS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,41.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677524,DTCC01696433,645733,65123
CHEMBL3663919,P23975,,ZUZFJRJMEROGCY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,12.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314427,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,175689,DTCC01696434,1647907,65123
CHEMBL3663919,P23975,,ZUZFJRJMEROGCY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,12.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677498,DTCC01696434,1647907,65123
CHEMBL3663919,P23975,,ZUZFJRJMEROGCY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,22.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677558,DTCC01696434,1647907,65123
CHEMBL3663919,P23975,,ZUZFJRJMEROGCY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,105,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677528,DTCC01696434,1647907,65123
CHEMBL3663920,P23975,,NUMHOXGZNHJTHF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,10.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677559,DTCC01696435,1932962,65123
CHEMBL3663920,P23975,,NUMHOXGZNHJTHF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,38.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",314428,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,183381,DTCC01696435,1932962,65123
CHEMBL3663920,P23975,,NUMHOXGZNHJTHF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,38.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677499,DTCC01696435,1932962,65123
CHEMBL3663920,P23975,,NUMHOXGZNHJTHF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,79.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.",,"Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528833,DTCT0023180,14677529,DTCC01696435,1932962,65123
CHEMBL366563,P23975,,LEVWYRKDKASIDU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14727081,DTCC00370225,2103226,69159
CHEMBL36715,P23975,PIRACETAM,GMZVRMREEHBGGF-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372361,DTCC00176308,1383779,46191
CHEMBL36715,P23975,PIRACETAM,GMZVRMREEHBGGF-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372362,DTCC00176308,1383779,46191
CHEMBL367169,P23975,,OLUONKODHNDKJM-HQRWHSCBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15012999,INHIBITION,=,23,%,,,,,,,,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,2004,14,4,"Shu M, Loebach JL, Parker KA, Mills SG, Chapman KT, Shen DM, Malkowitz L, Springer MS, Gould SL, DeMartino JA, Siciliano SJ, Salvo JD, Lyons K, Pivnichny JV, Kwei GY, Carella A, Carver G, Holmes K, Schleif WA, Danzeisen R, Hazuda D, Kessler J, Lineberger J, Miller MD, Emini EA",,142805,DTCT0023180,1458810,DTCC00374261,1328028,6665
CHEMBL3673127,P23975,,GWMUISILSXOPNB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,675.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678494,DTCC01705735,139119,65048
CHEMBL3673128,P23975,,LQAFCQOIRLFSLX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,384.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678495,DTCC01705736,106726,65048
CHEMBL3673129,P23975,,HZUHEVWACVPCEV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,443,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678497,DTCC01705737,1659868,65048
CHEMBL3673129,P23975,,HZUHEVWACVPCEV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,816.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678496,DTCC01705737,1659868,65048
CHEMBL3673130,P23975,,LXQRBRXJAMSDSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,70.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678498,DTCC01705738,786423,65048
CHEMBL3673131,P23975,,PVPLKGUBRLAGAF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,273.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678499,DTCC01705739,1173786,65048
CHEMBL3673132,P23975,,UBFYHGZTRDBAOO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,274.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678501,DTCC01705740,1077772,65048
CHEMBL3673132,P23975,,UBFYHGZTRDBAOO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1166,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678500,DTCC01705740,1077772,65048
CHEMBL3673133,P23975,,NQZVQAKLVZGMOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,102.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678503,DTCC01705741,27031,65048
CHEMBL3673133,P23975,,NQZVQAKLVZGMOR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,674.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678502,DTCC01705741,27031,65048
CHEMBL3673134,P23975,,APOHGRUBKIYISF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1209,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678504,DTCC01705742,171372,65048
CHEMBL3673135,P23975,,DZTZPWDKQRGFKW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,302.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678505,DTCC01705743,818718,65048
CHEMBL3673136,P23975,,YZTRIEWOXRNWOV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,73.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678507,DTCC01705744,754281,65048
CHEMBL3673136,P23975,,YZTRIEWOXRNWOV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,242.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678506,DTCC01705744,754281,65048
CHEMBL3673137,P23975,,DVONUWHZWNLFQL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,92.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678509,DTCC01705745,431882,65048
CHEMBL3673137,P23975,,DVONUWHZWNLFQL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,368.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678508,DTCC01705745,431882,65048
CHEMBL3673138,P23975,,CSAJSGHGBPMKBX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,881.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678510,DTCC01705746,203312,65048
CHEMBL3673139,P23975,,RPNWMLLBQPFWML-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,691,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678511,DTCC01705747,851656,65048
CHEMBL3673140,P23975,,FZFWHCGLHYASKK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,264.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678512,DTCC01705748,1433793,65048
CHEMBL3673141,P23975,,YJYMMJSBCVZBHP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,383.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678513,DTCC01705749,2011261,65048
CHEMBL3673142,P23975,,BENAFAMTKPICCC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2929,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678514,DTCC01705750,366745,65048
CHEMBL3673143,P23975,,UUEYKVGDKFNPHW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2305,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678515,DTCC01705751,106727,65048
CHEMBL3673144,P23975,,MNVQGSYZEJNUAT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,925.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678516,DTCC01705752,1271553,65048
CHEMBL3673145,P23975,,KWGNNADVFYRCOK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1020,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678517,DTCC01705753,1466039,65048
CHEMBL3673146,P23975,,UAJXVGMIEPUGSN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1545,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678518,DTCC01705754,1466040,65048
CHEMBL3673147,P23975,,BXKXPJPYACCXTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,805.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678519,DTCC01705755,1783919,65048
CHEMBL3673148,P23975,,OCDDZWTUNAXZEY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,175.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678520,DTCC01705756,2011262,65048
CHEMBL3673149,P23975,,FMMKJZJKDJFMKF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,5332,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678521,DTCC01705757,1945417,65048
CHEMBL3673150,P23975,,DWTFUODFLDHIAT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,392.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678522,DTCC01705758,1848513,65048
CHEMBL3673151,P23975,,AQSSBDDIMZJNQJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,432,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678523,DTCC01705759,1912945,65048
CHEMBL3673152,P23975,,LKORPZALGOFFBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,355.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678524,DTCC01705760,1238775,65048
CHEMBL3673153,P23975,,NVDYVZGABKJWFJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,5461,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678526,DTCC01705761,1401773,65048
CHEMBL3673154,P23975,,VQELKPWZCFCRFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,123.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678529,DTCC01705762,1206051,65048
CHEMBL3673155,P23975,,YJSPAIGIXYSMEQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,910.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678530,DTCC01705763,1751811,65048
CHEMBL3673156,P23975,,LGOLCLAISOMHIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,429.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678531,DTCC01705764,1401774,65048
CHEMBL3673157,P23975,,RTZINNBUTTZVCY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,54.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678532,DTCC01705765,1433794,65048
CHEMBL3673158,P23975,,LITXWCJWLOYNDV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,62.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678533,DTCC01705766,754282,65048
CHEMBL3673159,P23975,,USYVVKCTZJJTBD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,119,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678534,DTCC01705767,1530870,65048
CHEMBL3673160,P23975,,YSRPCSSZNWLITA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,451.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678535,DTCC01705768,1562744,65048
CHEMBL3673161,P23975,,FUDKVBNOVUMNRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,53.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678536,DTCC01705769,27032,65048
CHEMBL3673162,P23975,,XGJMFUFVUDLHTF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,147.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678537,DTCC01705770,74440,65048
CHEMBL3673163,P23975,,QEQQILAAIUZZEV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,79.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678538,DTCC01705771,1978397,65048
CHEMBL3673164,P23975,,LINSRJQQGQTFBQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,155.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678539,DTCC01705772,203313,65048
CHEMBL3673165,P23975,,WOGNFHHHGZELSI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,373,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678540,DTCC01705773,463248,65048
CHEMBL3673166,P23975,,YYPCUZDBNVUASA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,160.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678541,DTCC01705774,496278,65048
CHEMBL3673167,P23975,,SHTPCUCEADJDFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,35.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678542,DTCC01705775,1173787,65048
CHEMBL3673168,P23975,,NEPZBEGINWEWDI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,140.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678543,DTCC01705776,139120,65048
CHEMBL3673169,P23975,,OJMJJCYLOPIDKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,112.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678544,DTCC01705777,463249,65048
CHEMBL3673170,P23975,,PRHCBLDIFFVLSZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,133.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678545,DTCC01705778,496279,65048
CHEMBL3673171,P23975,,RWPUMYBDIXPXIA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,450.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678546,DTCC01705779,2011263,65048
CHEMBL3673172,P23975,,WOOPIGBZZPHOGG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,231.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678548,DTCC01705781,1466041,65048
CHEMBL3673173,P23975,,NJZNVVTVUJDMET-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,206.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678549,DTCC01705782,139121,65048
CHEMBL3673174,P23975,,PUYNZNIAZURARP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,344.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678550,DTCC01705783,431883,65048
CHEMBL3673175,P23975,,JVICAIHCMVKYNI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,540.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678551,DTCC01705784,1077773,65048
CHEMBL3673176,P23975,,UNUKMFOSTQWWQA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,175.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678553,DTCC01705785,431884,65048
CHEMBL3673176,P23975,,UNUKMFOSTQWWQA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,955.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678552,DTCC01705785,431884,65048
CHEMBL3673177,P23975,,XBECXOYAIBURBV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,78.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678554,DTCC01705786,1978398,65048
CHEMBL3673177,P23975,,XBECXOYAIBURBV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,798.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678555,DTCC01705786,1978398,65048
CHEMBL3673178,P23975,,YCAOLYRUUFDEGF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,438.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678525,DTCC01705787,1562745,65048
CHEMBL3673179,P23975,,RLLIIRDYLONSJW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,55.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678527,DTCC01705788,851657,65048
CHEMBL3673180,P23975,,PKEMWWJRFYCMFJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,8295,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",,"2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,2015,,,,,1528404,DTCT0023180,14678528,DTCC01705789,980601,65048
CHEMBL367461,P23975,,BRCFAGPWPWYSAX-QOCRQHEPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15012999,INHIBITION,=,13,%,,,,,,,,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,2004,14,4,"Shu M, Loebach JL, Parker KA, Mills SG, Chapman KT, Shen DM, Malkowitz L, Springer MS, Gould SL, DeMartino JA, Siciliano SJ, Salvo JD, Lyons K, Pivnichny JV, Kwei GY, Carella A, Carver G, Holmes K, Schleif WA, Danzeisen R, Hazuda D, Kessler J, Lineberger J, Miller MD, Emini EA",,142805,DTCT0023180,1459848,DTCC00371969,1936612,6665
CHEMBL3686863,P23975,,WOJKYHBOHSQZDW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27020304,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists.,Bioorg. Med. Chem. Lett.,2016,26,9,"Blanco MJ, Vetman T, Chandrasekhar S, Fisher MJ, Harvey A, Kuklish SL, Chambers M, Lin C, Mudra D, Oskins J, Wang XS, Yu XP, Warshawsky AM.",,1571697,DTCT0023180,229599,DTCC01719610,1045855,66780
CHEMBL36994,P23975,ANIRACETAM,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7271899,DTCC00176277,1447877,46191
CHEMBL36994,P23975,ANIRACETAM,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7271900,DTCC00176277,1447877,46191
CHEMBL369997,P23975,,HEFDYDISPNHKAM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,263,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895010,DTCC00415024,403174,20391
CHEMBL369997,P23975,,HEFDYDISPNHKAM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,370,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894978,DTCC00415024,403174,20391
CHEMBL370063,P23975,,KNTQYVICAJIRLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,146,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858074,DTCC00407290,649710,19679
CHEMBL370110,P23975,,HIBUHKNMTZCDMF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16219465,ACTIVITY,,,,,,,,,,,,,,,,,Inhibitory activity against NET upto 10 uM,Not Active,Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs.,Bioorg. Med. Chem. Lett.,2005,15,24,"Kling A, Lange UE, Mack H, Bakker MH, Drescher KU, Hornberger W, Hutchins CW, Möller A, Müller R, Schmidt M, Unger L, Wicke K, Schellhaas K, Steiner G",,326587,DTCT0023180,1875129,DTCC00410251,1724948,20052
CHEMBL370158,P23975,,WDYVPLUNLVBVMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,2020,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874494,DTCC00410556,843439,20064
CHEMBL3703725,P23975,,FBUHCPMYBAXIMM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,150.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302089,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,165659,DTCC01736357,334278,65026
CHEMBL3703725,P23975,,FBUHCPMYBAXIMM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,360.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302088,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,184202,DTCC01736357,334278,65026
CHEMBL3703726,P23975,,ILPGXQBGCYEMTR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,47.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302090,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,169013,DTCC01736358,1692189,65026
CHEMBL3703727,P23975,,YMSGTOASAZCQKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,63.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302091,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,160714,DTCC01736359,915743,65026
CHEMBL3703728,P23975,,LDGGSTOTUUPJPO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,132.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302092,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,168855,DTCC01736360,980847,65026
CHEMBL3703729,P23975,,MQRPDUHCJZKKNO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,549,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302093,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,178290,DTCC01736361,496499,65026
CHEMBL3703730,P23975,,AWYWUACFNBIOSL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,13,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302094,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,173528,DTCC01736362,884207,65026
CHEMBL3703731,P23975,,GMTDFEZUDHTSAN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,18.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302095,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,182716,DTCC01736363,2075887,65026
CHEMBL3703732,P23975,,RHVRAPZNMRRCCU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,97,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302096,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,158640,DTCC01736364,1304385,65026
CHEMBL3703733,P23975,,ZWAMWGRVKGXYIC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,86,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302097,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,162238,DTCC01736365,1142951,65026
CHEMBL3703734,P23975,,MFFCMNOKOQHLPH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,13,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302098,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,160258,DTCC01736366,2043884,65026
CHEMBL3703735,P23975,,PILUFBWYZBSMTQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,421.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302099,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,169602,DTCC01736367,334279,65026
CHEMBL3703736,P23975,,KILSXJAEWHCKLW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,131.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302100,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,164468,DTCC01736368,1434023,65026
CHEMBL3703737,P23975,,WOWZZXDFWZHBKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,282.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302101,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,177427,DTCC01736369,754500,65026
CHEMBL3703738,P23975,,DYQJFQKEXMXHKX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,194.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302102,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,161489,DTCC01736370,27281,65026
CHEMBL3703739,P23975,,ZDIVPUUGCMEOOI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,23.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302103,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,181899,DTCC01736371,2011505,65026
CHEMBL3703740,P23975,,NIXMEJRSHLSZKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,34.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302104,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,162812,DTCC01736372,980848,65026
CHEMBL3703741,P23975,,BEWPJYFILUTZHB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,214.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302105,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,170081,DTCC01736373,754501,65026
CHEMBL3703742,P23975,,SZGCLROZELTVOC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,9.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302106,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,166762,DTCC01736374,948413,65026
CHEMBL3703743,P23975,,NRTIHDQHAKWSTG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,26.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302107,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,182665,DTCC01736375,1304386,65026
CHEMBL3703744,P23975,,ZNELUNAFGGGGOF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,22.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302108,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,156965,DTCC01736376,1660097,65026
CHEMBL3703745,P23975,,HZPNLSFQNAKABD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1015,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302109,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,173193,DTCC01736377,27282,65026
CHEMBL3703746,P23975,,VXVOMCCQHIVMJK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,26,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302110,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,159166,DTCC01736378,2011506,65026
CHEMBL3703747,P23975,,WNADNMZKSSOJHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,70.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302111,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,178966,DTCC01736379,1369616,65026
CHEMBL3703748,P23975,,JDEHEODNVULATB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,51,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",302112,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,172597,DTCC01736380,657849,65026
CHEMBL3703749,P23975,,LGHFQLREBMQWRS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,174.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",198867,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,163714,DTCC01736381,27283,65026
CHEMBL3703750,P23975,,OLXVUIIXACCIHX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,63,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.",198870,"Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,2015,,,,,1535542,DTCT0023180,167127,DTCC01736382,1174050,65026
CHEMBL3704748,P23975,,XCAMEKYVLTTXGP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,10.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317702,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,160041,DTCC01737390,106954,65140
CHEMBL3704748,P23975,,XCAMEKYVLTTXGP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,38.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317690,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,161332,DTCC01737390,106954,65140
CHEMBL3704749,P23975,,GAWYDFHTJQSNCE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317703,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,163331,DTCC01737391,1752037,65140
CHEMBL3704749,P23975,,GAWYDFHTJQSNCE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2340,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317691,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,171853,DTCC01737391,1752037,65140
CHEMBL3704750,P23975,,SBTIZQKJKFHNPY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317704,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,184985,DTCC01737392,884219,65140
CHEMBL3704750,P23975,,SBTIZQKJKFHNPY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,13.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317692,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,167057,DTCC01737392,884219,65140
CHEMBL3704751,P23975,,BKVALIDOPGIDPZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317705,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,168601,DTCC01737393,1337004,65140
CHEMBL3704751,P23975,,BKVALIDOPGIDPZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1924,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317693,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,167124,DTCC01737393,1337004,65140
CHEMBL3704752,P23975,,ZJFMMMXNSXCMOB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,27.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317706,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,175383,DTCC01737394,657865,65140
CHEMBL3704752,P23975,,ZJFMMMXNSXCMOB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,77.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317694,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,175306,DTCC01737394,657865,65140
CHEMBL3704753,P23975,,OZLLUGNMXJLQIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,8.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317708,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,175879,DTCC01737396,657866,65140
CHEMBL3704753,P23975,,OZLLUGNMXJLQIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,50.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317696,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,183793,DTCC01737396,657866,65140
CHEMBL3704754,P23975,,OZLLUGNMXJLQIE-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317709,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,164684,DTCC01737397,884220,65140
CHEMBL3704754,P23975,,OZLLUGNMXJLQIE-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,30.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317697,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,179598,DTCC01737397,884220,65140
CHEMBL3704755,P23975,,OZLLUGNMXJLQIE-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,299.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317710,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,176402,DTCC01737398,528638,65140
CHEMBL3704755,P23975,,OZLLUGNMXJLQIE-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3415,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317698,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,158983,DTCC01737398,528638,65140
CHEMBL3704756,P23975,,ZEFQZGJPKZZHJW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5.49,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317711,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,181713,DTCC01737399,1369623,65140
CHEMBL3704756,P23975,,ZEFQZGJPKZZHJW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,>,10000,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317699,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,159207,DTCC01737399,1369623,65140
CHEMBL3704757,P23975,,ZEFQZGJPKZZHJW-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2.79,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317712,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,175864,DTCC01737400,432134,65140
CHEMBL3704757,P23975,,ZEFQZGJPKZZHJW-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,6515,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317700,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,161702,DTCC01737400,432134,65140
CHEMBL3704758,P23975,,ZEFQZGJPKZZHJW-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,328.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317713,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,158335,DTCC01737401,496507,65140
CHEMBL3704758,P23975,,ZEFQZGJPKZZHJW-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1086,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",317701,Methods of using cycloalkylmethylamine derivatives,,2015,,,,,1535093,DTCT0023180,161064,DTCC01737401,496507,65140
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,230,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,960119,DTCC00410065,1468289,15367
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,1770,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,960116,DTCC00410065,1468289,15367
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,230,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,825055,DTCC00410065,1455713,15898
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,1770,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,825052,DTCC00410065,1455713,15898
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10698458,IC50,=,186,NM,,cell_based,,,,,,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,2000,10,3,"Tamiz AP, Smith MP, Kozikowski AP",,142803,DTCT0023180,1152712,DTCC00410065,1456257,4077
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10821718,KI,=,264,NM,,cell_based,,,,,,,,,,,,Compound was evaluated for inhibition of [3H]NE uptake in HEK-hNET cells expressing Human norepinephrine transporter,,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,2000,43,10,"Hoepping A, Johnson KM, George C, Flippen-Anderson J, Kozikowski AP",,142794,DTCT0023180,1208984,DTCC00410065,1455669,15725
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10821718,KI,=,1740,NM,,cell_based,,,,,,,,,,,,Compound was evaluated for binding affinity using [125I]RTI-55 as a radioligand in HEK-hNET cells expressing human norepinephrine transporter,,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,2000,43,10,"Hoepping A, Johnson KM, George C, Flippen-Anderson J, Kozikowski AP",,142793,DTCT0023180,1208983,DTCC00410065,1455669,15725
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,190,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1136747,DTCC00410065,1457043,16052
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,2700,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1136746,DTCC00410065,1457043,16052
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,233,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,818954,DTCC00410065,1468444,16914
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,1940,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,818951,DTCC00410065,1468444,16914
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12565962,KI,=,108,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),,Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,3,"Enyedy IJ, Sakamuri S, Zaman WA, Johnson KM, Wang S",,142780,DTCT0023180,693338,DTCC00410065,1457089,6092
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,IC50,=,385,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,145001,DTCT0023180,1042095,DTCC00410065,1467417,5618
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,KI,=,830,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142613,DTCT0023180,1042092,DTCC00410065,1467417,5618
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,RATIO,=,0.46,,,,,,,,,,,,,,,Ratio of uptake inhibition to binding affinity to human Norepinephrine transporter (IC50/Ki),,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142616,DTCT0023180,1042098,DTCC00410065,1467417,5618
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,IC50,=,192,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142800,DTCT0023180,848531,DTCC00410065,1468460,5984
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,KI,=,645,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142608,DTCT0023180,848530,DTCC00410065,1468460,5984
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,3300,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043026,DTCC00410065,1469961,22167
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,1990,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043027,DTCC00410065,1469961,22167
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,=,462,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306535,DTCT0023180,1824121,DTCC00410065,1469462,19663
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,=,2990,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306359,DTCT0023180,1824122,DTCC00410065,1469462,19663
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,3300,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050383,DTCC00410065,1458275,22251
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,1990,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050384,DTCC00410065,1458275,22251
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,378,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895002,DTCC00410065,1454812,20391
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,2150,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894964,DTCC00410065,1454812,20391
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16821765,IC50,=,900,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of rat NET-mediated norepinephrine uptake in CHO cells,,Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction.,J. Med. Chem.,2006,49,14,"Ding J, Shi J, Cui D, Xu L, Duan S, Guo L, Fei J",,376176,DTCT0023180,1948832,DTCC00410065,1465345,21079
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,3300,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955109,DTCC00410065,1458097,20957
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,1990,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955106,DTCC00410065,1458097,20957
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,210,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005909,DTCC00410065,1469889,21696
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005900,DTCC00410065,1469889,21696
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,182,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150021,DTCC00410065,1474778,23432
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,887,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149672,DTCC00410065,1474778,23432
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138,IC50,=,1900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007,51,11,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923,DTCT0023180,2718431,DTCC00410065,1459018,34126
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,1990,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559251,DTCC00410065,1470930,28814
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,IC50,=,835,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560772,DTCT0023180,2467265,DTCC00410065,1459139,31698
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,KI,=,1115,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560769,DTCT0023180,2467241,DTCC00410065,1459139,31698
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,1281,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816201,DTCC00410065,1459574,32733
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,1116,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816091,DTCC00410065,1459574,32733
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,IC50,=,835,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533,DTCT0023180,2809681,DTCC00410065,1459001,32805
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,KI,=,1115,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530,DTCT0023180,2809654,DTCC00410065,1459001,32805
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,1990,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039242,DTCC00410065,1459801,35601
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,IC50,=,232,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602900,DTCT0023180,3162396,DTCC00410065,1459952,36631
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,KI,=,2377,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602897,DTCT0023180,3162372,DTCC00410065,1459952,36631
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,385,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083998,DTCC00410065,1471693,36341
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,830,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3083983,DTCC00410065,1471693,36341
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,6309.57,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465493,DTCC00410065,1483104,54821
CHEMBL370805,P23975,COCAINE,ZPUCINDJVBIVPJ-LJISPDSOSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,1257,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465492,DTCC00410065,1483104,54821
CHEMBL371300,P23975,,WBYHTZYHAFNBKW-ZETCQYMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16392816,INHIBITION,=,-11.2,%,,,,,,,,,,,,,,Inhibition of NET at 1 nM,,1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.,J. Med. Chem.,2006,49,1,"May JA, Dantanarayana AP, Zinke PW, McLaughlin MA, Sharif NA",,329394,DTCT0023180,1882083,DTCC00412210,1852068,20195
CHEMBL371300,P23975,,WBYHTZYHAFNBKW-ZETCQYMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16392816,INHIBITION,=,3.93,%,,,,,,,,,,,,,,Inhibition of NET at 100 nM,,1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.,J. Med. Chem.,2006,49,1,"May JA, Dantanarayana AP, Zinke PW, McLaughlin MA, Sharif NA",,329395,DTCT0023180,1882084,DTCC00412210,1852068,20195
CHEMBL371300,P23975,,WBYHTZYHAFNBKW-ZETCQYMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16392816,INHIBITION,=,42.59,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.,J. Med. Chem.,2006,49,1,"May JA, Dantanarayana AP, Zinke PW, McLaughlin MA, Sharif NA",,329396,DTCT0023180,1882085,DTCC00412210,1852068,20195
CHEMBL371300,P23975,,WBYHTZYHAFNBKW-ZETCQYMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16392816,KI,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.,J. Med. Chem.,2006,49,1,"May JA, Dantanarayana AP, Zinke PW, McLaughlin MA, Sharif NA",,329333,DTCT0023180,1882014,DTCC00412210,1852068,20195
CHEMBL37161,P23975,FENBENDAZOLE,HDDSHPAODJUKPD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7328739,DTCC00174892,2089748,46191
CHEMBL37161,P23975,FENBENDAZOLE,HDDSHPAODJUKPD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7328740,DTCC00174892,2089748,46191
CHEMBL371726,P23975,,ZOMRBJBMKLVVRD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,3956,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874492,DTCC00410564,1619682,20064
CHEMBL372312,P23975,,SWUVZKWCOBGPTH-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,11.3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895031,DTCC00415071,531861,20391
CHEMBL372312,P23975,,SWUVZKWCOBGPTH-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,109,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1895001,DTCC00415071,531861,20391
CHEMBL372318,P23975,,GTKJFGPZQFGMLW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,1430,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858099,DTCC00407304,778249,19679
CHEMBL372378,P23975,,YTXXRXPLJHCYAH-NUUPQPAYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16302792,KI,=,177,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,2005,48,24,"Cha JH, Zou MF, Adkins EM, Rasmussen SG, Loland CJ, Schoenenberger B, Gether U, Newman AH",,326506,DTCT0023180,1868413,DTCC00408931,1501917,20039
CHEMBL372435,P23975,,BCHCCPODJPHTTL-GKQVGWSZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15121762,KI,=,277,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14740574,DTCC00397891,2107442,69662
CHEMBL372795,P23975,STREPTOMYCIN,UCSJYZPVAKXKNQ-HZYVHMACSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473812,DTCC00411395,51509,46191
CHEMBL372795,P23975,STREPTOMYCIN,UCSJYZPVAKXKNQ-HZYVHMACSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473813,DTCC00411395,51509,46191
CHEMBL373211,P23975,,DEMWBYUAYXJYOC-VXGBXAGGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,321748,DTCT0023180,1853360,DTCC00406362,1775782,19894
CHEMBL373233,P23975,,BOPYYBXXVMRACX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,6,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858171,DTCC00407241,423935,19679
CHEMBL373385,P23975,,MMKZDDDDODERSJ-GRAKBVBRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,270,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043066,DTCC00445353,305306,22167
CHEMBL373385,P23975,,MMKZDDDDODERSJ-GRAKBVBRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,160,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043067,DTCC00445353,305306,22167
CHEMBL373508,P23975,,BAWNTPWIVXZYLH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17367122,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Displacement of radiolabeled protriptyline from human recombinant NET expressed in CHO cells at 10 uM,Not Active,Designing active template molecules by combining computational de novo design and human chemist's expertise.,J. Med. Chem.,2007,50,8,"Lameijer EW, Tromp RA, Spanjersberg RF, Brussee J, Ijzerman AP",,429319,DTCT0023180,2035690,DTCC00443721,1652260,22123
CHEMBL3735756,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,11,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human norepinephrine transporter stably expressed in HEK293 cells after 30 mins by neurotransmitter transporter uptake assay,,Identification of tris-(phenylalkyl)amines as new selective h5-HT2Breceptor antagonists,MedChemComm,2015,6,4,"Ponnala S, Kapadia N, Harding WW",,1538723,DTCT0023180,761,DTCC00063276,2011614,65324
CHEMBL373710,P23975,,XANSRGJYZPYJFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,210,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005987,DTCC00438246,1340584,21696
CHEMBL373710,P23975,,XANSRGJYZPYJFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,3000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006127,DTCC00438246,1340585,21696
CHEMBL373710,P23975,,XANSRGJYZPYJFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,830,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005977,DTCC00438246,1340584,21696
CHEMBL373710,P23975,,XANSRGJYZPYJFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,12000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006118,DTCC00438246,1340585,21696
CHEMBL373773,P23975,,SOCRIYWOGGANHT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,2900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005983,DTCC00438198,2079316,21696
CHEMBL373773,P23975,,SOCRIYWOGGANHT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,>,8800,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006177,DTCC00438198,2079315,21696
CHEMBL373773,P23975,,SOCRIYWOGGANHT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,2900,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005973,DTCC00438198,2079316,21696
CHEMBL373773,P23975,,SOCRIYWOGGANHT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,4000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006185,DTCC00438198,2079315,21696
CHEMBL3741992,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26460788,INHIBITION,<,30,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.,J. Med. Chem.,2015,58,21,"Lopez-Tapia F, Walker KA, Brotherton-Pleiss C, Caroon J, Nitzan D, Lowrie L, Gleason S, Zhao SH, Berger J, Cockayne D, Phippard D, Suttmann R, Fitch WL, Bourdet D, Rege P, Huang X, Broadbent S, Dvorak C, Zhu J, Wagner P, Padilla F, Loe B, Jahangir A, Alker A.",,1541674,DTCT0023180,20320,DTCC00065423,1804813,65488
CHEMBL374478,P23975,RIFAMPICIN,JQXXHWHPUNPDRT-WLSIYKJHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477336,DTCC00437710,51504,46191
CHEMBL374478,P23975,RIFAMPICIN,JQXXHWHPUNPDRT-WLSIYKJHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477337,DTCC00437710,51504,46191
CHEMBL374492,P23975,,MGKWXTIOHURCAH-LZDYDXGASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16821765,IC50,=,90000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of rat NET-mediated norepinephrine uptake in CHO cells,,Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction.,J. Med. Chem.,2006,49,14,"Ding J, Shi J, Cui D, Xu L, Duan S, Guo L, Fei J",,376176,DTCT0023180,1948757,DTCC00426967,142733,21079
CHEMBL374634,P23975,,CCEQAXVCJWOVQY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,27,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006059,DTCC00438236,1048977,21696
CHEMBL374634,P23975,,CCEQAXVCJWOVQY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,63,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006273,DTCC00438236,1048978,21696
CHEMBL374634,P23975,,CCEQAXVCJWOVQY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006050,DTCC00438236,1048977,21696
CHEMBL374634,P23975,,CCEQAXVCJWOVQY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,31,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006265,DTCC00438236,1048978,21696
CHEMBL374712,P23975,,ZEOHVQFWFVMPGM-FGDMXMHKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,559,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043052,DTCC00445275,2015114,22167
CHEMBL374712,P23975,,ZEOHVQFWFVMPGM-FGDMXMHKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,280,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043053,DTCC00445275,2015114,22167
CHEMBL374769,P23975,,DLVMQSXQUZPAKP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,520,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005986,DTCC00438170,2047236,21696
CHEMBL374769,P23975,,DLVMQSXQUZPAKP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,730,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006126,DTCC00438170,2047239,21696
CHEMBL374769,P23975,,DLVMQSXQUZPAKP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,1400,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005976,DTCC00438170,2047236,21696
CHEMBL374769,P23975,,DLVMQSXQUZPAKP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,>,5500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006117,DTCC00438170,2047239,21696
CHEMBL374967,P23975,,NSKKXDBWURWAOW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17367122,INHIBITION,=,77,%,,cell_based,,,,,,,,,,,CHO,Displacement of radiolabeled protriptyline from human recombinant NET expressed in CHO cells at 10 uM,,Designing active template molecules by combining computational de novo design and human chemist's expertise.,J. Med. Chem.,2007,50,8,"Lameijer EW, Tromp RA, Spanjersberg RF, Brussee J, Ijzerman AP",,429319,DTCT0023180,2035651,DTCC00443727,1715854,22123
CHEMBL375118,P23975,,ZHNMSSREJSABQA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,44,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005979,DTCC00438208,1114108,21696
CHEMBL375118,P23975,,ZHNMSSREJSABQA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,1000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006173,DTCC00438208,1114109,21696
CHEMBL375118,P23975,,ZHNMSSREJSABQA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,380,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005969,DTCC00438208,1114108,21696
CHEMBL375118,P23975,,ZHNMSSREJSABQA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,3300,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006181,DTCC00438208,1114109,21696
CHEMBL375131,P23975,,GYZLMHZBYPNULH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,38,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965612,DTCC00429729,1949212,21201
CHEMBL375131,P23975,,GYZLMHZBYPNULH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,77,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348383,DTCC00429729,1951693,39093
CHEMBL3752576,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26739781,KI,=,1000,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016,26,3,"Cozzi NV, Daley PF.",,1550158,DTCT0023180,61554,DTCC00070939,1531285,65871
CHEMBL3752900,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26739781,KI,=,630.96,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016,26,3,"Cozzi NV, Daley PF.",,1550158,DTCT0023180,62508,DTCC00070941,203699,65871
CHEMBL3753318,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26739781,KI,<,10000,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016,26,3,"Cozzi NV, Daley PF.",,1550158,DTCT0023180,61546,DTCC00070943,1174224,65871
CHEMBL3754085,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26764191,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human Noradrenaline transporter at 10 uM,,"Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.",Bioorg. Med. Chem. Lett.,2016,26,3,"Blanco MJ, Vetman T, Chandrasekhar S, Fisher MJ, Harvey A, Chambers M, Lin C, Mudra D, Oskins J, Wang XS, Yu XP, Warshawsky AM.",,1548180,DTCT0023180,53400,DTCC00071613,1045702,65899
CHEMBL3754166,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26739781,KI,=,1000,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016,26,3,"Cozzi NV, Daley PF.",,1550158,DTCT0023180,62504,DTCC00070942,852078,65871
CHEMBL3754496,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26739781,KI,=,1995.26,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016,26,3,"Cozzi NV, Daley PF.",,1550158,DTCT0023180,62511,DTCC00070940,981005,65871
CHEMBL375685,P23975,,PCXXVJSJWKSKBZ-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,1820,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115150,DTCC00452916,822692,23035
CHEMBL375685,P23975,,PCXXVJSJWKSKBZ-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,4240,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115096,DTCC00452916,822692,23035
CHEMBL375888,P23975,,ZEOHVQFWFVMPGM-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,5.14,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043072,DTCC00445231,78241,22167
CHEMBL375888,P23975,,ZEOHVQFWFVMPGM-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,3.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043073,DTCC00445231,78241,22167
CHEMBL375889,P23975,,SIIICDNNMDMWCI-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,52.4,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043068,DTCC00445233,661286,22167
CHEMBL375889,P23975,,SIIICDNNMDMWCI-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,32,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043069,DTCC00445233,661286,22167
CHEMBL376113,P23975,,FOMAEAAMXSBAJG-LANGDILFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,4000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115145,DTCC00452935,1916803,23035
CHEMBL376113,P23975,,FOMAEAAMXSBAJG-LANGDILFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,>,6100,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115091,DTCC00452935,1916803,23035
CHEMBL376180,P23975,AMINOPTERIN,TVZGACDUOSZQKY-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7284536,DTCC00445374,120968,46191
CHEMBL376180,P23975,AMINOPTERIN,TVZGACDUOSZQKY-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7284537,DTCC00445374,120968,46191
CHEMBL3763166,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26653033,INHIBITION,=,62,%,,,,,,,,,,,,,,Inhibition of Norepinephrine transporter (unknown origin) at 10 uM,,"Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.",J. Med. Chem.,2016,59,1,"Lin SY, Yeh TK, Kuo CC, Song JS, Cheng MF, Liao FY, Chao MW, Huang HL, Chen YL, Yang CY, Wu MH, Hsieh CL, Hsiao W, Peng YH, Wu JS, Lin LM, Sun M, Chao YS, Shih C, Wu SY, Pan SL, Hung MS, Ueng SH.",,1553781,DTCT0023180,91908,DTCC00075195,807224,66086
CHEMBL376737,P23975,,FTVCCHUPUJEUIW-FIPFOOKPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,381,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010356,DTCC00439793,1469899,21742
CHEMBL376852,P23975,,CJUVIUZOUUBMJB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,210,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005906,DTCC00438215,1884460,21696
CHEMBL376852,P23975,,CJUVIUZOUUBMJB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,1300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006132,DTCC00438215,1884461,21696
CHEMBL376852,P23975,,CJUVIUZOUUBMJB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,360,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005897,DTCC00438215,1884460,21696
CHEMBL376852,P23975,,CJUVIUZOUUBMJB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,>,9200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006123,DTCC00438215,1884461,21696
CHEMBL376899,P23975,,OMBOXYLBBHNWHL-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,541,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043076,DTCC00445217,1340652,22167
CHEMBL376899,P23975,,OMBOXYLBBHNWHL-SHWKFHJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,271,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043077,DTCC00445217,1340652,22167
CHEMBL376952,P23975,,BAYDYCDSOWCJTI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964042,DTCC00430004,2067652,21124
CHEMBL3769872,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26935940,IC50,=,33,NM,,,,,,,,,,,,,,Inhibition of recombinant human norepinephrine transporter assessed as reduction in [3H]-NA reuptake,,Emerging targets and new small molecule therapies in Parkinson's disease treatment.,Bioorg. Med. Chem.,2016,24,7,"Zhang H, Tong R, Bai L, Shi J, Ouyang L.",,1558447,DTCT0023180,105206,DTCC00078655,852148,66318
CHEMBL377057,P23975,,HYYSFPWXVUOONL-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,26,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927921,DTCC00422856,1307797,20707
CHEMBL3770651,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26935940,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of recombinant human norepinephrine transporter assessed as reduction in [3H]-NA reuptake,,Emerging targets and new small molecule therapies in Parkinson's disease treatment.,Bioorg. Med. Chem.,2016,24,7,"Zhang H, Tong R, Bai L, Shi J, Ouyang L.",,1558447,DTCT0023180,105205,DTCC00078654,2011745,66318
CHEMBL3770663,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26935940,IC50,=,33,NM,,,,,,,,,,,,,,Inhibition of recombinant human norepinephrine transporter assessed as reduction in [3H]-NA reuptake,,Emerging targets and new small molecule therapies in Parkinson's disease treatment.,Bioorg. Med. Chem.,2016,24,7,"Zhang H, Tong R, Bai L, Shi J, Ouyang L.",,1558447,DTCT0023180,105204,DTCC00078653,1628337,66318
CHEMBL3770836,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27072905,INHIBITION,>=,70,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.,Bioorg. Med. Chem. Lett.,2016,26,10,"Sturdivant JM, Royalty SM, Lin CW, Moore LA, Yingling JD, Laethem CL, Sherman B, Heintzelman GR, Kopczynski CC, deLong MA.",,1571390,DTCT0023180,229086,DTCC00079595,613671,66823
CHEMBL377189,P23975,,XEWUKTSZOJWBEW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,120,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964053,DTCC00429818,1652108,21124
CHEMBL37744,P23975,ZIMELDINE,OYPPVKRFBIWMSX-SXGWCWSVSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,9400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14734207,DTCC00176690,2105175,68566
CHEMBL3774423,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.26,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122155,DTCC00081128,1487106,66412
CHEMBL3774516,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.34,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122164,DTCC00081156,807288,66412
CHEMBL3774516,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,1170,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122189,DTCC00081156,807288,66412
CHEMBL3774556,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.46,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122161,DTCC00081153,1454544,66412
CHEMBL3774556,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,530,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122186,DTCC00081153,1454544,66412
CHEMBL3774732,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.36,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122158,DTCC00081134,1616391,66412
CHEMBL3774732,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,890,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122184,DTCC00081134,1616391,66412
CHEMBL3774764,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.23,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122166,DTCC00081158,1194904,66412
CHEMBL3774784,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26774927,ACTIVITY,=,7,%,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter at 10 uM by radioligand binding assay,,Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.,Eur. J. Med. Chem.,2016,109,,"Migliore M, Habrant D, Sasso O, Albani C, Bertozzi SM, Armirotti A, Piomelli D, Scarpelli R.",,1562868,DTCT0023180,114021,DTCC00080936,192014,66347
CHEMBL3774952,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.26,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122149,DTCC00081121,904960,66412
CHEMBL3774957,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.41,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122159,DTCC00081135,1837344,66412
CHEMBL3774957,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,380,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122185,DTCC00081135,1837344,66412
CHEMBL377498,P23975,,BQKRARPXRCZXGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894975,DTCC00415098,757708,20391
CHEMBL3775008,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.29,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122154,DTCC00081127,613617,66412
CHEMBL3775008,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122181,DTCC00081127,613617,66412
CHEMBL3775012,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.6,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122162,DTCC00081154,1712416,66412
CHEMBL3775012,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,610,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122187,DTCC00081154,1712416,66412
CHEMBL3775085,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.31,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122153,DTCC00081126,1260049,66412
CHEMBL3775085,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122180,DTCC00081126,1260049,66412
CHEMBL377510,P23975,,ROXOOMBIDGERBZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894977,DTCC00415094,1820026,20391
CHEMBL3775140,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.63,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122165,DTCC00081157,1901682,66412
CHEMBL3775140,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,560,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122190,DTCC00081157,1901682,66412
CHEMBL3775177,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.51,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122156,DTCC00081132,160182,66412
CHEMBL3775177,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122182,DTCC00081132,160182,66412
CHEMBL3775266,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,0.08,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 1 uM by liquid scintillation counting method relative to GBR-12909,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560529,DTCT0023180,122122,DTCC00081130,192018,66412
CHEMBL3775405,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.37,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122157,DTCC00081133,1292369,66412
CHEMBL3775405,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,1070,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122183,DTCC00081133,1292369,66412
CHEMBL3775429,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.18,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122152,DTCC00081125,1740609,66412
CHEMBL3775436,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26988801,INHIBITION,=,52.6,%,,,,,,,,,,,,,,Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016,24,8,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559739,DTCT0023180,118990,DTCC00081018,517082,66408
CHEMBL3775450,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,0.2,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 1 uM by liquid scintillation counting method relative to GBR-12909,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560529,DTCT0023180,122124,DTCC00081122,1260048,66412
CHEMBL377552,P23975,,QEKVURATSAPTGE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,INHIBITION,=,-23,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET at 1 uM,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355137,DTCT0023180,1928054,DTCC00422870,725623,20707
CHEMBL3775568,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.01,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122167,DTCC00081159,95337,66412
CHEMBL3775628,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,-0.05,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 1 uM by liquid scintillation counting method relative to GBR-12909,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560529,DTCT0023180,122121,DTCC00081131,1933604,66412
CHEMBL3775638,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.4,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122160,DTCC00081152,936805,66412
CHEMBL3775703,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.45,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122163,DTCC00081155,1740613,66412
CHEMBL3775703,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,IC50,=,760,NM,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560532,DTCT0023180,122188,DTCC00081155,1740613,66412
CHEMBL377574,P23975,,UTKRCKRKACMWMX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,9.6,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927975,DTCC00422496,142675,20707
CHEMBL3775769,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26988801,INHIBITION,=,34.5,%,,,,,,,,,,,,,,Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016,24,8,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559739,DTCT0023180,119876,DTCC00081020,774921,66408
CHEMBL3775835,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.29,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122150,DTCC00081123,1357776,66412
CHEMBL3775920,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,0.41,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 1 uM by liquid scintillation counting method relative to GBR-12909,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560529,DTCT0023180,122123,DTCC00081129,872682,66412
CHEMBL3775932,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122120,DTCC00081120,1033844,66412
CHEMBL3775944,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27041397,FC,=,1.16,,,,,,,,,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,2016,24,9,"Paudel S, Acharya S, Kim KM, Cheon SH.",,1560530,DTCT0023180,122151,DTCC00081124,1680703,66412
CHEMBL377678,P23975,,FVLVLFVHHIGOFZ-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,9.8,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927912,DTCC00422595,531931,20707
CHEMBL377714,P23975,,YGVNVXMPAVCLBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901159,DTCC00416353,391276,20463
CHEMBL377785,P23975,,BMNNHOAPHMYHIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16784855,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of (-)-[3H]NE uptake at NET,,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,2006,16,17,"Zeng F, Jarkas N, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,395412,DTCT0023180,1974061,DTCC00432208,1522927,21323
CHEMBL377785,P23975,,BMNNHOAPHMYHIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16784855,KI,=,17.28,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,2006,16,17,"Zeng F, Jarkas N, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,395400,DTCT0023180,1974021,DTCC00432208,1522927,21323
CHEMBL377882,P23975,,VILBBVHEBGZUJO-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,6,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927918,DTCC00422793,337730,20707
CHEMBL377900,P23975,,ZDQCOGINXTZCCG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,120,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964046,DTCC00429840,1744110,21124
CHEMBL378070,P23975,,BUKUIUSQEZHUTR-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,1060,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927991,DTCC00422846,564063,20707
CHEMBL378243,P23975,,LXDSBNMMECZLMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,990,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954958,DTCC00428125,552652,20957
CHEMBL378243,P23975,,LXDSBNMMECZLMT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,500,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954956,DTCC00428125,552652,20957
CHEMBL378319,P23975,,CCVMCNVDASICFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,75,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964048,DTCC00429902,1134657,21124
CHEMBL378377,P23975,,QPAFLDILQMKTGS-RBUKOAKNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,160.8,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917024,DTCC00419725,1037241,20590
CHEMBL378379,P23975,,JJMNVQSTRSYLOB-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,440,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906270,DTCC00417032,810641,20502
CHEMBL378418,P23975,,KVNXQYJMNFSXRE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,35,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965611,DTCC00429826,435486,21201
CHEMBL378447,P23975,,OOJWGIFGXZKDHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,38,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964056,DTCC00429842,1587234,21124
CHEMBL378483,P23975,,IOLBHHBTJKDZMF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,980,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954945,DTCC00428147,1165892,20957
CHEMBL378483,P23975,,IOLBHHBTJKDZMF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,490,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954943,DTCC00428147,1165892,20957
CHEMBL378498,P23975,,IUAVOMFUIPYCBG-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,6.1,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927914,DTCC00422426,1307798,20707
CHEMBL378536,P23975,,SFVKEKBNXMUWFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16784855,KI,=,4.84,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,2006,16,17,"Zeng F, Jarkas N, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,395400,DTCT0023180,1974026,DTCC00432236,1230654,21323
CHEMBL3785736,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26942860,ACTIVITY,>,77,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells assessed as remaining radioligand binding at 10 uM after 120 mins by scintillation counting method relative to control,,Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.,J. Med. Chem.,2016,59,6,"Schenkel LB, Olivieri PR, Boezio AA, Deak HL, Emkey R, Graceffa RF, Gunaydin H, Guzman-Perez A, Lee JH, Teffera Y, Wang W, Youngblood BD, Yu VL, Zhang M, Gavva NR, Lehto SG, Geuns-Meyer S.",,1569494,DTCT0023180,151594,DTCC00084444,322408,66630
CHEMBL37858,P23975,SARAFLOXACIN,XBHBWNFJWIASRO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477697,DTCC00180187,51508,46191
CHEMBL37858,P23975,SARAFLOXACIN,XBHBWNFJWIASRO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477698,DTCC00180187,51508,46191
CHEMBL3787247,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26988308,INHIBITION,=,65,%,,,,,,,,,,,,,,Inhibition of recombinant human norepinephrine transporter expressed in MDCK cells at 10 uM by radioligand binding assay,,"N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.",Bioorg. Med. Chem. Lett.,2016,26,8,"Felts AS, Rodriguez AL, Morrison RD, Venable DF, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA.",,1569854,DTCT0023180,142738,DTCC00085872,1849077,66674
CHEMBL378804,P23975,,UPTXQSAYNARODX-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,9600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906274,DTCC00417440,1102429,20502
CHEMBL378839,P23975,,ARSOFBZWWWOBKV-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,175,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927886,DTCC00422832,661070,20707
CHEMBL379021,P23975,,TVYLLZQTGLZFBW-OUONYHMNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16257206,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of reuptake of Norepinephrine,,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,2006,16,3,"Shao L, Abolin C, Hewitt MC, Koch P, Varney M",,333146,DTCT0023180,1892072,DTCC00414475,466937,20316
CHEMBL379181,P23975,,RDLXBTKNMZJTIX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954910,DTCC00428302,1619815,20957
CHEMBL379205,P23975,,APJFYUJBFNMVNI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,61,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965619,DTCC00429796,693416,21201
CHEMBL3792888,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27072905,INHIBITION,=,48,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.,Bioorg. Med. Chem. Lett.,2016,26,10,"Sturdivant JM, Royalty SM, Lin CW, Moore LA, Yingling JD, Laethem CL, Sherman B, Heintzelman GR, Kopczynski CC, deLong MA.",,1571390,DTCT0023180,229091,DTCC00087539,387737,66823
CHEMBL379333,P23975,,QLJHRHJFUIHEAT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,1400,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954977,DTCC00428124,617149,20957
CHEMBL379333,P23975,,QLJHRHJFUIHEAT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,710,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954974,DTCC00428124,617149,20957
CHEMBL3794389,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27072905,INHIBITION,=,96,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.,Bioorg. Med. Chem. Lett.,2016,26,10,"Sturdivant JM, Royalty SM, Lin CW, Moore LA, Yingling JD, Laethem CL, Sherman B, Heintzelman GR, Kopczynski CC, deLong MA.",,1571390,DTCT0023180,229080,DTCC00087556,1099035,66823
CHEMBL379446,P23975,,NAHZCGQMXZCULW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,531,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895021,DTCC00415331,435344,20391
CHEMBL379446,P23975,,NAHZCGQMXZCULW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,2690,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894991,DTCC00415331,435344,20391
CHEMBL379496,P23975,,IBJQKBDBQJHDOQ-KOXSSGOCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16821765,IC50,>,1000000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of rat NET-mediated norepinephrine uptake in CHO cells,,Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction.,J. Med. Chem.,2006,49,14,"Ding J, Shi J, Cui D, Xu L, Duan S, Guo L, Fei J",,376176,DTCT0023180,1948786,DTCC00427472,1534469,21079
CHEMBL379536,P23975,,AGCDRDCNYZHHKS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965607,DTCC00429793,1437399,21201
CHEMBL379679,P23975,,DSIUMNNVBQZCEG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,317,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895018,DTCC00415086,1501977,20391
CHEMBL379679,P23975,,DSIUMNNVBQZCEG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,4000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894988,DTCC00415086,1501977,20391
CHEMBL379699,P23975,,BPGTUWPLEUDMHZ-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,6,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927988,DTCC00422479,435399,20707
CHEMBL379755,P23975,,KZXIQLJNAIYPLZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,2320,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955003,DTCC00428084,1426090,20957
CHEMBL379755,P23975,,KZXIQLJNAIYPLZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,1160,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955002,DTCC00428084,1426090,20957
CHEMBL38,P23975,TRETINOIN,SHGAZHPCJJPHSC-YCNIQYBTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7451757,DTCC00134063,51513,46191
CHEMBL38,P23975,TRETINOIN,SHGAZHPCJJPHSC-YCNIQYBTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7451758,DTCC00134063,51513,46191
CHEMBL380056,P23975,,GFWKSCDPOYKBDG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,2130,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954921,DTCC00428273,617150,20957
CHEMBL380056,P23975,,GFWKSCDPOYKBDG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,1060,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1954920,DTCC00428273,617150,20957
CHEMBL380191,P23975,,GBWQTSFXTHVNTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,69,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1928000,DTCC00422477,1340438,20707
CHEMBL380383,P23975,,GAMXLCNZCZEZGS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16784855,KI,=,5.87,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,2006,16,17,"Zeng F, Jarkas N, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,395400,DTCT0023180,1974025,DTCC00110599,391414,21323
CHEMBL380406,P23975,,LMAWVKHKZVLUQO-JCOPYZAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,361,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902472,DTCC00416361,1372888,20396
CHEMBL380523,P23975,,TZMGQAAZTGUQJN-LIRRHRJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,270,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906269,DTCC00417099,195463,20502
CHEMBL380559,P23975,,RQBVJCCLVRZSFV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,ACTIVITY,=,39,%,,,,,,,,,,,,,,Percentage displacement of [3H]nisoxetine radioligand from norepinephrine transporter at concentration of 1000 nM,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,321703,DTCT0023180,1858136,DTCC00407328,1328422,19679
CHEMBL380559,P23975,,RQBVJCCLVRZSFV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,>,200,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858131,DTCC00407328,1328422,19679
CHEMBL380699,P23975,,SWUVZKWCOBGPTH-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1895000,DTCC00415078,1081315,20391
CHEMBL380758,P23975,,DACQOKGPDFDFGY-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,1250,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906275,DTCC00417432,1263385,20502
CHEMBL380890,P23975,,UIEMDECNRHYLAZ-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,3.2,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927919,DTCC00422779,757783,20707
CHEMBL381045,P23975,,WCMJUQVXFGLIRF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,3360,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874497,DTCC00410511,713895,20064
CHEMBL381046,P23975,,QBMUMECEHYHKPP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,6430,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874495,DTCC00410513,1102348,20064
CHEMBL381056,P23975,,PUKYDIKEMQFSPQ-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,150,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1928001,DTCC00422394,1566371,20707
CHEMBL381071,P23975,,MFCNYVIQGJNQQJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901157,DTCC00416370,1872760,20463
CHEMBL381079,P23975,,SAEFVYOQTPRNBW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,15.9,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927971,DTCC00422508,1598903,20707
CHEMBL381127,P23975,,HWYVHRCKBXGZLV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,235,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895020,DTCC00415500,1631064,20391
CHEMBL381127,P23975,,HWYVHRCKBXGZLV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,2600,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894990,DTCC00415500,1631064,20391
CHEMBL381256,P23975,,KGRXCESVCIYMSX-IMMIMJPRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,947,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902458,DTCC00416497,1469647,20396
CHEMBL381315,P23975,,TZMILLWOFHAFNQ-GTNSWQLSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,9100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906280,DTCC00417380,1619757,20502
CHEMBL381331,P23975,,MHJZXDDQSMFDMW-ZBEGNZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,Not Determined,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906282,DTCC00417372,1937079,20502
CHEMBL381373,P23975,,FMVNGPGSZIETQV-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,255,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1928007,DTCC00422772,1340436,20707
CHEMBL381754,P23975,,FHRNDZQBSORXCR-LIRRHRJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,540,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906290,DTCC00417125,1295920,20502
CHEMBL3817915,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297960,DTCC00098973,322572,67412
CHEMBL381792,P23975,,WBQILMOPSULAPL-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,60,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906266,DTCC00417107,1134541,20502
CHEMBL3818117,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,0.08,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297961,DTCC00098974,1422876,67412
CHEMBL3818345,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297966,DTCC00098979,1227176,67412
CHEMBL381842,P23975,,XQOCAAJLFFVLEP-ZXVJYWQYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,338,NM,,,,,,,,,,,,,,Inhibition of [3H]NE uptake,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335149,DTCT0023180,1902575,DTCC00416588,337656,20396
CHEMBL381842,P23975,,XQOCAAJLFFVLEP-ZXVJYWQYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,851,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902468,DTCC00416588,337656,20396
CHEMBL3818471,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,0.64,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297967,DTCC00098980,322573,67412
CHEMBL3818596,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297970,DTCC00099293,1869487,67412
CHEMBL3818901,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,0.21,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297968,DTCC00098981,1162493,67412
CHEMBL3818946,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297965,DTCC00098978,1999675,67412
CHEMBL3818953,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,0.13,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297959,DTCC00098972,1805164,67412
CHEMBL3819009,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297969,DTCC00099292,355295,67412
CHEMBL381914,P23975,,GRHZPOKPBBOJOD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901133,DTCC00416318,1295915,20463
CHEMBL3819201,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,0.079,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297962,DTCC00098975,1066279,67412
CHEMBL3819217,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297971,DTCC00099294,1357966,67412
CHEMBL3819243,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,0.065,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297963,DTCC00098976,2032644,67412
CHEMBL3819441,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,27325446,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,2016,24,16,"Yukawa T, Nakada Y, Sakauchi N, Kamei T, Yamada M, Ohba Y, Fujimori I, Ueno H, Takiguchi M, Kuno M, Kamo I, Nakagawa H, Fujioka Y, Igari T, Ishichi Y, Tsukamoto T.",,1586596,DTCT0023180,297964,DTCC00098977,1680875,67412
CHEMBL382001,P23975,,ZTKREAOJYPYCOX-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,190,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1928003,DTCC00422469,661069,20707
CHEMBL382034,P23975,,YKRZGFVSJMTZLF-LEWJYISDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,7.7,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917180,DTCC00420451,131026,20590
CHEMBL382034,P23975,,YKRZGFVSJMTZLF-LEWJYISDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,7.7,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917214,DTCC00420451,131026,20590
CHEMBL382241,P23975,,RBZDTFXHCQBMRR-OAUVRVJYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,1800,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906288,DTCC00417086,1775878,20502
CHEMBL382248,P23975,,FULUQLAFMOKDPE-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,8.3,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927913,DTCC00422513,110267,20707
CHEMBL3823832,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,INHIBITION,=,51,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins by scintillation counting analysis,,In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents,MedChemComm,2016,7,6,"Shao L, Campbell UC, Fang QK, Powell NA, Campbell JE, Jones PG, Hanania T, Alexandrov V, Morganstern I, Sabath E, Zhong HM, Large TH, Spear KL",,1586715,DTCT0023180,303639,DTCC00099681,1722211,67430
CHEMBL382554,P23975,,ZTLCDNXGGSLCCK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,33,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927908,DTCC00422754,984079,20707
CHEMBL382673,P23975,,HGBGXSPIBLZGHS-PXAZEXFGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906297,DTCC00417524,2067545,20502
CHEMBL382741,P23975,,WJNQZXPCJCLCNG-JOCHJYFZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821575,IC50,=,0.003,NM,,,,,,,,,,,,,,Inhibition of NET,,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,21,"Marquis RW, Lago AM, Callahan JF, Rahman A, Dong X, Stroup GB, Hoffman S, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Roethke T, Smith BR, Ward KW, Bhatnagar P",,591455,DTCT0023180,3056353,DTCC00109964,1524649,35717
CHEMBL382768,P23975,,AGRVUDWDZKZCAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894980,DTCC00415509,1372887,20391
CHEMBL382783,P23975,,XPPDUQXXSFOWGY-LNLSOMNWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,785,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902475,DTCC00416358,403178,20396
CHEMBL382810,P23975,,KUDFJDYXEMEWNB-OAUVRVJYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,2000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906264,DTCC00417363,972285,20502
CHEMBL382955,P23975,,VRVNOJASIHQHAC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,158000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874491,DTCC00410597,908541,20064
CHEMBL383071,P23975,,WOORERZMTSEMTL-BQAIUKQQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,40,NM,,,,,,,,,,,,,,Inhibition of [3H]NE uptake,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335149,DTCT0023180,1902573,DTCC00416456,855178,20396
CHEMBL383071,P23975,,WOORERZMTSEMTL-BQAIUKQQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,340,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902460,DTCC00416456,855178,20396
CHEMBL383081,P23975,,CKPPJIQWWSHKBB-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,1100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906286,DTCC00417331,7529,20502
CHEMBL383128,P23975,,PHROHJIYKYCBCW-UGSOOPFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,Not Determined,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906276,DTCC00417356,1004858,20502
CHEMBL383220,P23975,,NQBLHHIYFYAVRB-RBUKOAKNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,INHIBITION,=,19.8,%,,,,,,,,,,,,,,Binding affinity to NET at 100 nM,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344146,DTCT0023180,1917212,DTCC00419220,454958,20590
CHEMBL383347,P23975,,QZFLFWOTDWFGFO-MWLCHTKSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,KI,,,,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter; nt is not tested,Not Determined,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,320847,DTCT0023180,1853374,DTCC00406369,1970239,19894
CHEMBL383422,P23975,,HWLVSITUDAPLNE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16337793,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against NET,,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,2006,16,5,"Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dollé F, Besnard JC, Guilloteau D, Emond P",,338550,DTCT0023180,1901127,DTCC00416352,1715644,20463
CHEMBL383427,P23975,,ZSNSOTIXFBSXLU-LIRRHRJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,760,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906293,DTCC00417116,325986,20502
CHEMBL383464,P23975,,XBIRPUDVQBQYMW-JMAPEOGHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,736,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902470,DTCC00416621,1755232,20396
CHEMBL383611,P23975,,NEDZBDOBZLQEFI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,21,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927910,DTCC00422816,206907,20707
CHEMBL383682,P23975,,JNVMCWLQXGNYMA-LNLSOMNWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,330,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902463,DTCC00416234,1372891,20396
CHEMBL383706,P23975,,HGBGXSPIBLZGHS-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,770,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906261,DTCC00417447,1328530,20502
CHEMBL383706,P23975,,HGBGXSPIBLZGHS-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,770,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654546,DTCC00417447,1329661,30519
CHEMBL383734,P23975,,IWWHZPZRJFBBJV-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,86,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927916,DTCC00422419,1820104,20707
CHEMBL383745,P23975,,LBZCFIOVPDHQQT-JCOPYZAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,210,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902464,DTCC00416217,174817,20396
CHEMBL383873,P23975,,ZMKPUZMPYBNAFS-WQLSENKSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16784855,KI,=,12.53,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,2006,16,17,"Zeng F, Jarkas N, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,395400,DTCT0023180,1974023,DTCC00432348,358678,21323
CHEMBL383879,P23975,,ZZJGNQRWIXQQDJ-CUNXSJBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,1379,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010351,DTCC00439810,1081546,21742
CHEMBL384199,P23975,,ZSHFBVRJUAGORQ-FIPFOOKPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,497,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010357,DTCC00439789,272282,21742
CHEMBL384467,P23975,DEXAMETHASONE,UREBDLICKHMUKA-CXSFZGCWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7365839,DTCC00437785,639578,46191
CHEMBL384467,P23975,DEXAMETHASONE,UREBDLICKHMUKA-CXSFZGCWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7365840,DTCC00437785,639578,46191
CHEMBL384649,P23975,,SOCOFADTVIPCCY-CUNXSJBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,9261,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010350,DTCC00439815,78177,21742
CHEMBL384687,P23975,,OGFNNMZMCOBWPR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,48,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1963900,DTCC00429998,1304881,21124
CHEMBL385173,P23975,,HRJQWACHSNEZEE-DBUDALRPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17154506,KI,=,31.7,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,2006,49,23,"Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Owens MJ, Votaw JR, Goodman MM",,409351,DTCT0023180,1988936,DTCC00435244,822443,21461
CHEMBL385359,P23975,,QLPRIWAESOJKJS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,IC50,=,3040,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955055,DTCC00428479,1775962,20957
CHEMBL385359,P23975,,QLPRIWAESOJKJS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,=,1520,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955052,DTCC00428479,1775962,20957
CHEMBL385607,P23975,,BRTWZDQCGNRNRK-LVXARBLLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,5007,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010355,DTCC00439794,1405568,21742
CHEMBL386073,P23975,,NNOWQHZNUGOGEV-FIPFOOKPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,1480,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010360,DTCC00439873,532111,21742
CHEMBL386223,P23975,,JQQRBSOAFDAWGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965606,DTCC00110523,1340514,21201
CHEMBL386224,P23975,,CVFBVSUFNWOPLD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965617,DTCC00110525,984157,21201
CHEMBL386224,P23975,,CVFBVSUFNWOPLD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964038,DTCC00110525,972395,21124
CHEMBL386281,P23975,,OKJKIOJUDZFVDL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17234405,INHIBITION,=,45,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter receptor at 10uM,,"An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Iyengar RR, Lynch JK, Mulhern MM, Judd AS, Freeman JC, Gao J, Souers AJ, Zhao G, Wodka D, Doug Falls H, Brodjian S, Dayton BD, Reilly RM, Swanson S, Su Z, Martin RL, Leitza ST, Houseman KA, Diaz G, Collins CA, Sham HL, Kym PR",,421688,DTCT0023180,1995226,DTCC00436123,142822,21561
CHEMBL386493,P23975,,VMQXOMTZSIHVEX-LVXARBLLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16931001,KI,=,1052,NM,,,,,,,,,,,,,,Inhibition of NET,,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,2006,16,21,"Watson PS, Jiang B, Harrison K, Asakawa N, Welch PK, Covington M, Stowell NC, Wadman EA, Davies P, Solomon KA, Newton RC, Trainor GL, Friedman SM, Decicco CP, Ko SS",,424087,DTCT0023180,2010352,DTCC00439805,1405570,21742
CHEMBL386630,P23975,TESTOSTERONE,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7480981,DTCC00437190,477923,46191
CHEMBL386630,P23975,TESTOSTERONE,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7480982,DTCC00437190,477923,46191
CHEMBL386978,P23975,,VSVUJKJXMNJRFE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16854064,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,2006,49,15,"Carroll FI, Blough BE, Huang X, Nie Z, Mascarella SW, Deschamps J, Navarro HA",,366277,DTCT0023180,1955036,DTCC00428037,1069739,20957
CHEMBL387117,P23975,,FRKGVKAPAMAQSO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006057,DTCC00438226,564221,21696
CHEMBL387117,P23975,,FRKGVKAPAMAQSO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006271,DTCC00438226,564222,21696
CHEMBL387117,P23975,,FRKGVKAPAMAQSO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,190,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006048,DTCC00438226,564221,21696
CHEMBL387117,P23975,,FRKGVKAPAMAQSO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,660,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006263,DTCC00438226,564222,21696
CHEMBL38737,P23975,THIOACETAMIDE,YUKQRDCYNOVPGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481104,DTCC00179105,88637,46191
CHEMBL38737,P23975,THIOACETAMIDE,YUKQRDCYNOVPGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7481105,DTCC00179105,88637,46191
CHEMBL387758,P23975,,PSPJUVHWZINCFD-KOQKOIQBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,6100,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050416,DTCC00445689,2036041,22251
CHEMBL387758,P23975,,PSPJUVHWZINCFD-KOQKOIQBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,3700,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050417,DTCC00445689,2036041,22251
CHEMBL388255,P23975,,WMVXAQQBRYETCJ-QWHCGFSZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,36300,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149713,DTCC00460860,1825074,23432
CHEMBL388257,P23975,,XYPXWICAIAFXBP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,268,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149710,DTCC00460865,1247670,23432
CHEMBL388590,P23975,BENZBROMARONE,WHQCHUCQKNIQEC-UHFFFAOYSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7279795,DTCC00445492,153438,46191
CHEMBL388590,P23975,BENZBROMARONE,WHQCHUCQKNIQEC-UHFFFAOYSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7279796,DTCC00445492,153438,46191
CHEMBL388605,P23975,,UBUINJQFQXKDNL-JHDZUBBNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,10000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050407,DTCC00111085,1263638,22251
CHEMBL388605,P23975,,UBUINJQFQXKDNL-JHDZUBBNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,6000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050408,DTCC00111085,1263638,22251
CHEMBL388612,P23975,,MQFVMWBVJNBDJG-CIBWYJFOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,6500,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115154,DTCC00452912,1437667,23035
CHEMBL388612,P23975,,MQFVMWBVJNBDJG-CIBWYJFOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,2300,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115100,DTCC00452912,1437667,23035
CHEMBL388759,P23975,,BEKJWERDBUYMAG-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,960,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115159,DTCC00452905,1049153,23035
CHEMBL388759,P23975,,BEKJWERDBUYMAG-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,3290,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115105,DTCC00452905,1049153,23035
CHEMBL388760,P23975,,WUFOGTRCLDMXRM-RYTRXMBJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,650,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115156,DTCC00452908,952064,23035
CHEMBL388760,P23975,,WUFOGTRCLDMXRM-RYTRXMBJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,2510,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115102,DTCC00452908,952064,23035
CHEMBL388825,P23975,,UBUINJQFQXKDNL-XKXWHVAQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,78000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050405,DTCC00111086,326267,22251
CHEMBL388825,P23975,,UBUINJQFQXKDNL-XKXWHVAQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,46000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050406,DTCC00111086,326267,22251
CHEMBL388832,P23975,,MRPLQNITIUKVEG-SMOZNVCYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,4210,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115153,DTCC00452913,1949532,23035
CHEMBL388832,P23975,,MRPLQNITIUKVEG-SMOZNVCYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,1910,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115099,DTCC00452913,1949532,23035
CHEMBL388850,P23975,,URXGPOFPBIBVGT-NBDWZHNGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,920,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050425,DTCC00445672,1744283,22251
CHEMBL388850,P23975,,URXGPOFPBIBVGT-NBDWZHNGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,550,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050426,DTCC00445672,1744283,22251
CHEMBL389621,P23975,HYDROCORTISONE,JYGXADMDTFJGBT-VWUMJDOOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304315,DTCC00445397,800578,46191
CHEMBL389621,P23975,HYDROCORTISONE,JYGXADMDTFJGBT-VWUMJDOOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304316,DTCC00445397,800578,46191
CHEMBL390432,P23975,,RSNYUBDIPFPZKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,IC50,=,57,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]Nisoxetine from human NET expressed in HEK293 cells,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443465,DTCT0023180,2160339,DTCC00463280,1664000,23363
CHEMBL390432,P23975,,RSNYUBDIPFPZKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,INHIBITION,=,90,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443462,DTCT0023180,2159941,DTCC00463280,1664000,23363
CHEMBL390743,P23975,,ZPAUAFZKIQYYOJ-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,690,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115161,DTCC00452903,1820407,23035
CHEMBL390743,P23975,,ZPAUAFZKIQYYOJ-HIUFNZKISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,1700,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115107,DTCC00452903,1820407,23035
CHEMBL391074,P23975,,YKCOYIKIANOWTN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17616397,KI,=,96,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,17,"Letavic MA, Stocking EM, Barbier AJ, Bonaventure P, Boggs JD, Lord B, Miller KL, Wilson SJ, Carruthers NI",,448655,DTCT0023180,2181921,DTCC00468047,730758,23789
CHEMBL391143,P23975,,OVZCYWBNBLGMMB-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,20,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224518,DTCC00479496,1889561,24303
CHEMBL391806,P23975,,KQOBDZDVQFUADH-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224527,DTCC00479482,244585,24303
CHEMBL391864,P23975,,QDZIBQWKRRRXAL-OSRDXIQISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446069,KI,=,1.78,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,2007,17,11,"Zeng F, Stehouwer JS, Jarkas N, Voll RJ, Williams L, Camp VM, Votaw JR, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,444173,DTCT0023180,2167223,DTCC00464560,293802,23431
CHEMBL391947,P23975,,KUYNMYBNRQCGCC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17616397,KI,=,240,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,17,"Letavic MA, Stocking EM, Barbier AJ, Bonaventure P, Boggs JD, Lord B, Miller KL, Wilson SJ, Carruthers NI",,448655,DTCT0023180,2181922,DTCC00468028,827552,23789
CHEMBL392016,P23975,,CHDGVSNCSOCUHK-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224525,DTCC00479485,1119260,24303
CHEMBL392394,P23975,GS-39783,GSGVDKOCBKBMGG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,224,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733378,DTCC00467555,2104901,69025
CHEMBL393625,P23975,,QEMMIBZQGYYMNU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,12,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213054,DTCC00473152,1198820,24154
CHEMBL393701,P23975,METHYL 2-(3-(TRIFLUOROMETHYL)PHENYL)CYCLOHEXANECARBOXYLATE,RFECIGQVKKOIMS-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,991000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2150085,DTCC00003078,212073,23432
CHEMBL394089,P23975,,NWZPRTYDJDHZJI-HZPDHXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,675000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2150088,DTCC00461138,310119,23432
CHEMBL394157,P23975,,KHYFCJWXLVZFLY-QXSJWSMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446069,KI,=,4.67,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,2007,17,11,"Zeng F, Stehouwer JS, Jarkas N, Voll RJ, Williams L, Camp VM, Votaw JR, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,444173,DTCT0023180,2167225,DTCC00464568,1652423,23431
CHEMBL394158,P23975,,TYFSSZYOVLRLQK-QXSJWSMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446069,KI,=,1.86,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,2007,17,11,"Zeng F, Stehouwer JS, Jarkas N, Voll RJ, Williams L, Camp VM, Votaw JR, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,444173,DTCT0023180,2167224,DTCC00464571,1652424,23431
CHEMBL394373,P23975,METHYL 2-(4-(TRIFLUOROMETHYL)PHENYL)CYCLOHEXANECARBOXYLATE,RILPYESNVZTTIN-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,439000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2150084,DTCC00003079,310120,23432
CHEMBL394585,P23975,,FPYUHFVUAJRFHA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,178000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150035,DTCC00460872,762875,23432
CHEMBL394585,P23975,,FPYUHFVUAJRFHA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,420000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149705,DTCC00460872,762875,23432
CHEMBL395110,P23975,MEPAZINE,CBHCDHNUZWWAPP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1877,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427912,DTCC00464417,477046,46191
CHEMBL395110,P23975,MEPAZINE,CBHCDHNUZWWAPP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1861,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427913,DTCC00464417,477046,46191
CHEMBL395368,P23975,,ZYALYWXELCWDBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17127059,KI,=,118,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells,,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,4,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453471,DTCT0023180,2219073,DTCC00477229,67033,24220
CHEMBL395408,P23975,,BGSBHLAICAANSC-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,144,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224523,DTCC00479487,408576,24303
CHEMBL395609,P23975,,DIMAAAZZSSXDEH-DFBJGRDBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17127059,KI,=,121,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells,,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,4,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453471,DTCT0023180,2219074,DTCC00477237,682203,24220
CHEMBL395649,P23975,,QXYYDFAFOMWDHD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,499000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150025,DTCC00460905,2084293,23432
CHEMBL395649,P23975,,QXYYDFAFOMWDHD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,675000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149685,DTCC00460905,2084293,23432
CHEMBL395910,P23975,,BQCMCDRDLYXGDO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,4900,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150029,DTCC00460886,634008,23432
CHEMBL395910,P23975,,BQCMCDRDLYXGDO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,14000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149695,DTCC00460886,634008,23432
CHEMBL395931,P23975,,MDQSOSLERPCADB-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,15,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224510,DTCC00479477,1378261,24303
CHEMBL395998,P23975,,RXBAZUHMGOEBGO-LIOZXAKYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053782,KI,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,2008,51,24,"Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Camp VM, Malveaux EJ, Votaw JR, Howell L, Owens MJ, Goodman MM",,561314,DTCT0023180,2799897,DTCC00457748,888337,31538
CHEMBL396082,P23975,,QGGSNXQBFWAFCC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,26000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150033,DTCC00460875,1410549,23432
CHEMBL396082,P23975,,QGGSNXQBFWAFCC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,39000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149703,DTCC00460875,1410549,23432
CHEMBL396083,P23975,,MKGVCSJCNPSLPB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,789000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149701,DTCC00460877,1021358,23432
CHEMBL396083,P23975,,MKGVCSJCNPSLPB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150054,DTCC00460877,1021358,23432
CHEMBL396318,P23975,,JINIYXOBIKXUET-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,85000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149681,DTCC00460915,1053832,23432
CHEMBL396318,P23975,,JINIYXOBIKXUET-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150043,DTCC00460915,1053832,23432
CHEMBL396402,P23975,,CFBLMCGUBGGURK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,11,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213051,DTCC00473158,1005357,24154
CHEMBL396537,P23975,,OQPMHMPOPMZPGV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,INHIBITION,=,81,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443462,DTCT0023180,2159940,DTCC00463284,2015477,23363
CHEMBL396540,P23975,,ITHSRMGXDMLBTP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17391962,INHIBITION,=,99,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,11,"Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, Gao Q, Ma B, Beno BR, Mattson GK, Molski TF, Krause RG, Taber MT, Lodge NJ, Mattson RJ",,443462,DTCT0023180,2159937,DTCC00463287,952308,23363
CHEMBL396754,P23975,,SDIRDYYWJCYZFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149708,DTCC00460868,147842,23432
CHEMBL397392,P23975,,WMWARSGGACJLII-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224515,DTCC00479500,1345774,24303
CHEMBL397490,P23975,,XRGOEISCAQSORF-GHMZBOCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,3910,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149716,DTCC00460850,179908,23432
CHEMBL397490,P23975,,XRGOEISCAQSORF-GHMZBOCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,41600,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149715,DTCC00460850,179909,23432
CHEMBL397520,P23975,,XWZLDADSUCQSKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,2540000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149689,DTCC00460898,924487,23432
CHEMBL397520,P23975,,XWZLDADSUCQSKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150048,DTCC00460898,924487,23432
CHEMBL397787,P23975,,LQAVUHFNJFDFLC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2134969,DTCC00460879,1053831,23432
CHEMBL397787,P23975,,LQAVUHFNJFDFLC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150052,DTCC00460879,1053831,23432
CHEMBL397889,P23975,,CLVQITJMWWKDJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18052090,KI,=,279,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,2007,50,26,"Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF",,452612,DTCT0023180,2213048,DTCC00473162,876539,24154
CHEMBL398009,P23975,,KLBBBQNCHMPXRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,20000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150023,DTCC00460913,1571322,23432
CHEMBL398009,P23975,,KLBBBQNCHMPXRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,84000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149682,DTCC00460913,1571322,23432
CHEMBL398370,P23975,,IBOZZWGMZPMXBO-RQJABVFESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446069,KI,=,1.98,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,2007,17,11,"Zeng F, Stehouwer JS, Jarkas N, Voll RJ, Williams L, Camp VM, Votaw JR, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,444173,DTCT0023180,2167226,DTCC00464566,1652422,23431
CHEMBL398440,P23975,CHLOROXYLENOL,OSDLLIBGSJNGJE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362359,DTCC00485552,1059329,46191
CHEMBL398440,P23975,CHLOROXYLENOL,OSDLLIBGSJNGJE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362360,DTCC00485552,1059329,46191
CHEMBL398559,P23975,,ZYTLNNQUXXHCCG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,8000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249833,DTCC00483186,1182604,24671
CHEMBL399147,P23975,,AEWPIBYOYSOWAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,IC50,=,68000,NM,,,,,,,,,,,,,,Inhibition of NET,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457381,DTCT0023180,2247048,DTCC00484128,164127,24627
CHEMBL399147,P23975,,AEWPIBYOYSOWAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,INHIBITION,=,2.3,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457380,DTCT0023180,2247041,DTCC00484128,164127,24627
CHEMBL399228,P23975,,BIXIBQFJRMFLKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,9200,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249831,DTCC00483188,1921672,24671
CHEMBL399429,P23975,,DSBUEYRGXKHYAZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,12000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249829,DTCC00483190,1760507,24671
CHEMBL399430,P23975,,ODQZUOPUJDCECI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,130000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249828,DTCC00483191,1571555,24671
CHEMBL399730,P23975,(R)-CITALOPRAM,WSEQXVZVJXJVFP-HXUWFJFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,6243,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14747056,DTCC00486767,2106798,68918
CHEMBL399730,P23975,(R)-CITALOPRAM,WSEQXVZVJXJVFP-HXUWFJFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14747057,DTCC00486767,2106798,68918
CHEMBL399831,P23975,(-)-CUBEBIN,DIYWRNLYKJKHAM-MDOVXXIYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24112084,IC50,>,200000,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK cells using [3H]-norepinephrine as substrate after 10 mins by scintillation counting,,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,2013,76,10,"Timple JM, Magalhães LG, Souza Rezende KC, Pereira AC, Cunha WR, Andrade e Silva ML, Mortensen OV, Fontana AC",,984396,DTCT0023180,12599655,DTCC00003249,1527836,56016
CHEMBL4,P23975,OFLOXACIN,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7388786,DTCC00132314,1641850,46191
CHEMBL4,P23975,OFLOXACIN,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7388787,DTCC00132314,1641850,46191
CHEMBL40,P23975,PHENOBARBITAL,DDBREPKUVSBGFI-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380741,DTCC00134072,51499,46191
CHEMBL40,P23975,PHENOBARBITAL,DDBREPKUVSBGFI-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380743,DTCC00134072,51499,46191
CHEMBL400964,P23975,(R)-NOMIFENSINE,XXPANQJNYNUNES-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,6450,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461619,DTCC00003870,1780167,52000
CHEMBL400964,P23975,(R)-NOMIFENSINE,XXPANQJNYNUNES-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1200,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783951,DTCC00003870,1780532,53459
CHEMBL401069,P23975,,IPCUDCIZXKOOCV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,26000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249827,DTCC00483192,1668720,24671
CHEMBL401070,P23975,,SEBXOWVFQDITBN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,5800,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249825,DTCC00483194,892848,24671
CHEMBL401071,P23975,,IIHVGQJVNJHAMA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,85000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249823,DTCC00483196,1442497,24671
CHEMBL401347,P23975,,UOTMBQUAJZORIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,IC50,=,19000,NM,,,,,,,,,,,,,,Inhibition of NET,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457381,DTCT0023180,2247047,DTCC00484140,940888,24627
CHEMBL401347,P23975,,UOTMBQUAJZORIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457380,DTCT0023180,2247040,DTCC00484140,940888,24627
CHEMBL401417,P23975,,BDOAHAJYARXKHW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,IC50,,,,,,,,,,,,,,,,,Inhibition of NET,Not Determined,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457381,DTCT0023180,2247028,DTCC00484164,1841408,24627
CHEMBL401417,P23975,,BDOAHAJYARXKHW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17766113,INHIBITION,=,82,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM,,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,2007,17,20,"Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE",,457380,DTCT0023180,2247035,DTCC00484164,1841408,24627
CHEMBL401550,P23975,,KRJLGYVCEZYCEV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,131,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322667,DTCC00497963,424902,19394
CHEMBL401596,P23975,,GBSPTFCPJIXLFF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,36,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369750,DTCC00492195,1631912,26388
CHEMBL401621,P23975,,XYNHEKMBRVZVQR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,8100,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303656,DTCC00500542,1539739,25699
CHEMBL401651,P23975,,VOSGCNSEIZQWJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,82,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322666,DTCC00497965,164337,19394
CHEMBL401676,P23975,,BJQGGALRPGCIFD-WCQYABFASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,49,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374247,DTCC00491135,343159,25551
CHEMBL401677,P23975,,LYVNVEXOLQKXSZ-SUMWQHHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,2.9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374248,DTCC00491138,1119455,25551
CHEMBL401683,P23975,,ZRHGDWMRFCDZHY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,470,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296156,DTCC00502086,747005,25227
CHEMBL401804,P23975,,ZJRXMULNBNPBBB-SDBXPKJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,560,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374243,DTCC00491091,1313270,25551
CHEMBL401819,P23975,,VGUGGBCMZNBMLT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,46,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306867,DTCC00501791,67208,25268
CHEMBL401867,P23975,,PIVRFBAMCBQCDZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,760,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296155,DTCC00502042,1905803,25227
CHEMBL401877,P23975,,VXYNDBOWMKXSIO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,62,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306876,DTCC00501866,1652713,25268
CHEMBL401878,P23975,,KGLPNVVDPAVWHX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306877,DTCC00113001,1037929,25268
CHEMBL401976,P23975,,TYJYIHODVVLAMM-FZMZJTMJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,1500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374241,DTCC00491093,924839,25551
CHEMBL402000,P23975,,HNYCNSONMUNSQM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369754,DTCC00492202,143474,26388
CHEMBL402027,P23975,,CMSMRUGCRICBLQ-WCQYABFASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,44,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374324,DTCC00490926,310520,25551
CHEMBL402057,P23975,,UOPYFDKQWMFBDI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306887,DTCC00501995,1716274,25268
CHEMBL402088,P23975,,WNRLDTKTSLUNNC-GXTWGEPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,1500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374240,DTCC00491054,439476,25551
CHEMBL402089,P23975,,FYGDANPUVIMKMO-SUMWQHHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374318,DTCC00490897,148219,25551
CHEMBL402090,P23975,,KLAPRIKTPASOCO-GXTWGEPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374322,DTCC00490898,1280565,25551
CHEMBL402116,P23975,,OSJBPKOZISTQCO-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,2250,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307477,DTCC00501143,1475102,25295
CHEMBL402116,P23975,,OSJBPKOZISTQCO-HIFRSBDPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307474,DTCC00501143,1475103,25295
CHEMBL402345,P23975,,YJNSSHGTSILZGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,32,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306873,DTCC00492281,1555615,25268
CHEMBL402345,P23975,,YJNSSHGTSILZGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,32,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369761,DTCC00492281,1567116,26388
CHEMBL402365,P23975,,OCYYUEJRVUGFGH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,6500,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303667,DTCC00500208,1182771,25699
CHEMBL402371,P23975,,NMHWBLJSIIETCI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,38,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369744,DTCC00492146,371124,26388
CHEMBL402441,P23975,,GRFLLIUZAGYUSO-HNAYVOBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372768,DTCC00492336,228606,25565
CHEMBL402644,P23975,,SBAQYPMYNRQKBF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,3200,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296164,DTCC00502644,326712,25227
CHEMBL402794,P23975,BIS(2-ETHYLHEXYL)PHTHALATE,BJQHLKABXJIVAM-BGYRXZFFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264430,DTCC00499603,153439,46191
CHEMBL402794,P23975,BIS(2-ETHYLHEXYL)PHTHALATE,BJQHLKABXJIVAM-BGYRXZFFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264431,DTCC00499603,153439,46191
CHEMBL402851,P23975,,ZPMMCRKQYUFTEM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,15,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306890,DTCC00501999,392034,25268
CHEMBL402924,P23975,,MUJXFBPLIVKRBF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,50000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249834,DTCC00483176,83250,24671
CHEMBL402999,P23975,,RLOLTHVCQCDNSF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303643,DTCC00500804,1857496,25699
CHEMBL403,P23975,SULBACTAM,FKENQMMABCRJMK-RITPCOANSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456476,DTCC00132361,671795,46191
CHEMBL403,P23975,SULBACTAM,FKENQMMABCRJMK-RITPCOANSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7456477,DTCC00132361,671795,46191
CHEMBL403071,P23975,,SXCVOEWVYRDQSX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306881,DTCC00501903,714691,25268
CHEMBL403078,P23975,,DLQIUZVQSULILG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,83,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369758,DTCC00492238,338498,26388
CHEMBL403080,P23975,,YQRYFSQPEXVGIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369756,DTCC00492239,1885105,26388
CHEMBL403090,P23975,,IDPUQOWVIAMLNB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306864,DTCC00501741,228565,25268
CHEMBL403148,P23975,,XQRFKDJVDZKQDO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,730,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296162,DTCC00502414,714686,25227
CHEMBL403251,P23975,,JEYCKWDBZTXTRQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,74,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322680,DTCC00492199,1329360,19394
CHEMBL403251,P23975,,JEYCKWDBZTXTRQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369753,DTCC00492199,1341228,26388
CHEMBL403363,P23975,,QMRGFFVBWTXOKS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,13,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322665,DTCC00497935,1166636,19394
CHEMBL403370,P23975,,OCFADYHICWCDMN-ZBEGNZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,2200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374237,DTCC00491051,212403,25551
CHEMBL403377,P23975,,DMKNBJGZUPGVEW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,5700,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296154,DTCC00113013,714687,25227
CHEMBL403388,P23975,,ZFUPFIUXGORYPF-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,1010,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307492,DTCC00500997,1442587,25295
CHEMBL403441,P23975,PF-526014,CVFBVSUFNWOPLD-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306832,DTCC00004069,1744730,25268
CHEMBL403441,P23975,PF-526014,CVFBVSUFNWOPLD-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18417343,IC50,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,2008,18,9,"Whitlock GA, Fish PV, Fray MJ, Stobie A, Wakenhut F",,479729,DTCT0023180,2369738,DTCC00004069,1756110,26388
CHEMBL403441,P23975,PF-526014,CVFBVSUFNWOPLD-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20471260,KI,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,2010,20,12,"Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA",,634878,DTCT0023180,3348374,DTCC00004069,1757759,39093
CHEMBL403469,P23975,,YZLURQAUJPJHIZ-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372796,DTCC00492296,489052,25565
CHEMBL403570,P23975,,ZGYZPKKUJVRLKR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,33000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249822,DTCC00483198,375583,24671
CHEMBL403571,P23975,,HTBZTZYEMXZZLC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,42000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249820,DTCC00483200,795243,24671
CHEMBL403616,P23975,,RBKMRYYKCJETLF-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,20,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374331,DTCC00112579,1182749,25551
CHEMBL403730,P23975,,UEXMLAHFKICZJK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18243691,INHIBITION,=,57,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,2008,18,4,"Erickson SD, Banner B, Berthel S, Conde-Knape K, Falcioni F, Hakimi I, Hennessy B, Kester RF, Kim K, Ma C, McComas W, Mennona F, Mischke S, Orzechowski L, Qian Y, Salari H, Tengi J, Thakkar K, Taub R, Tilley JW, Wang H",,464128,DTCT0023180,2307604,DTCC00500857,844285,25297
CHEMBL403759,P23975,,SFBSHUOIEODSEA-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374234,DTCC00491010,1151827,25551
CHEMBL403760,P23975,,ZUTOYMZNVAREQR-GXTWGEPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,3700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374235,DTCC00491013,505245,25551
CHEMBL403949,P23975,,OXXNPMVLHAHIKP-WMLDXEAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,160,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372798,DTCC00492338,876779,25565
CHEMBL403956,P23975,,LZPBAUCREIASQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,232,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322670,DTCC00498016,1005643,19394
CHEMBL404,P23975,TAZOBACTAM,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7467821,DTCC00132373,88636,46191
CHEMBL404,P23975,TAZOBACTAM,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7467822,DTCC00132373,88636,46191
CHEMBL404013,P23975,,ACZMLOPMXAUHFP-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,4.5,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372795,DTCC00492248,1937861,25565
CHEMBL404027,P23975,,QUKVPZYBMYBTQO-FUHWJXTLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,8.3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374321,DTCC00490899,180296,25551
CHEMBL404145,P23975,,RSWULBWZZJNURY-SWLSCSKDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,73,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372801,DTCC00492340,1426751,25565
CHEMBL404197,P23975,,XACDGGGJRPPGDU-QUCCMNQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,3776,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307489,DTCC00500943,1313224,25295
CHEMBL404247,P23975,,RAEJZLUTUUNZSA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,1300,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296163,DTCC00502548,1523496,25227
CHEMBL404258,P23975,,XIINYKRQARUYJK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,14,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306884,DTCC00501949,1231240,25268
CHEMBL404317,P23975,,IHBJHLUWGRKAPP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306866,DTCC00501788,2068274,25268
CHEMBL404345,P23975,,NUQCHJVIHOGEMV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,4900,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303644,DTCC00500151,1182772,25699
CHEMBL404364,P23975,,UJXZJZLGZRRPNH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,41,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303647,DTCC00500206,148240,25699
CHEMBL404474,P23975,,MHSMLXPGKSUMMH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,63,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303641,DTCC00500757,148241,25699
CHEMBL404475,P23975,,NXELRJXDBIVZKB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,8400,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303662,DTCC00500760,115693,25699
CHEMBL404520,P23975,CHLORTETRACYCLINE,CYDMQBQPVICBEU-XRNKAMNCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7338907,DTCC00502280,1027048,46191
CHEMBL404520,P23975,CHLORTETRACYCLINE,CYDMQBQPVICBEU-XRNKAMNCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7338908,DTCC00502280,1027048,46191
CHEMBL404729,P23975,,OYNDMWYYCBLSSM-HNAYVOBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,3.2,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372771,DTCC00492381,1070406,25565
CHEMBL404730,P23975,,XKGBYDWMVKBQIC-OXJNMPFZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372773,DTCC00492383,2036516,25565
CHEMBL404754,P23975,,APWBVHFSBGGAAZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,38,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306870,DTCC00501825,455653,25268
CHEMBL404811,P23975,DIGITONIN,UVYVLBIGDKGWPX-YCCXZQINSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340311,DTCC00199357,249941,46191
CHEMBL404811,P23975,DIGITONIN,UVYVLBIGDKGWPX-YCCXZQINSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340312,DTCC00199357,249941,46191
CHEMBL404885,P23975,,MQNROJMRVKETEZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,194,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322671,DTCC00498018,1809150,19394
CHEMBL404956,P23975,,CPNTXNSOEZESIH-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,860,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367408,DTCC00112637,569623,26231
CHEMBL405,P23975,AMPHETAMINE,KWTSXDURSIMDCE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,7.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14734274,DTCC00132646,2105197,69025
CHEMBL405017,P23975,,WFOBTVZPUZNUSA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,58,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322669,DTCC00497993,67337,19394
CHEMBL405349,P23975,,MYIGEQURFWGOFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,15,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367420,DTCC00493119,505329,26231
CHEMBL405349,P23975,,MYIGEQURFWGOFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,390,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367419,DTCC00493119,505330,26231
CHEMBL405462,P23975,,CQJCAOGPWRQORA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372810,DTCC00492432,1458732,25565
CHEMBL405613,P23975,,WYBWTBVGJJOVDM-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,5.2,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372777,DTCC00492555,1937863,25565
CHEMBL405728,P23975,,AFBGSNRISAOHKD-FUHWJXTLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,160,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372790,DTCC00492725,1103164,25565
CHEMBL40583,P23975,3-METHYLCHOLANTHRENE,PPQNQXQZIWHJRB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,29650,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7289362,DTCC00181233,1894962,46191
CHEMBL40583,P23975,3-METHYLCHOLANTHRENE,PPQNQXQZIWHJRB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,29405,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7289363,DTCC00181233,1894962,46191
CHEMBL406,P23975,INDAPAMIDE,NDDAHWYSQHTHNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7420231,DTCC00132717,1609547,46191
CHEMBL406,P23975,INDAPAMIDE,NDDAHWYSQHTHNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7420232,DTCC00132717,1609547,46191
CHEMBL406156,P23975,,JJVUOKFSHYKOJS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303628,DTCC00500418,2084657,25699
CHEMBL406789,P23975,,LXFLYTRXPWVMTB-SUMWQHHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,7.1,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372788,DTCC00492727,1070405,25565
CHEMBL407,P23975,FLUMAZENIL,OFBIFZUFASYYRE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318320,DTCC00132733,1609545,46191
CHEMBL407,P23975,FLUMAZENIL,OFBIFZUFASYYRE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318321,DTCC00132733,1609545,46191
CHEMBL407030,P23975,GAMMA-CYCLODEXTRIN,MIFVTYPADKEWAV-HGRQBIKSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7310063,DTCC00003162,88629,46191
CHEMBL407030,P23975,GAMMA-CYCLODEXTRIN,MIFVTYPADKEWAV-HGRQBIKSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7310064,DTCC00003162,88629,46191
CHEMBL407135,P23975,COLISTINE,YKQOSKADJPQZHB-YNWHQGOSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7350268,DTCC00494880,1705874,46191
CHEMBL407135,P23975,COLISTINE,YKQOSKADJPQZHB-YNWHQGOSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7350269,DTCC00494880,1705874,46191
CHEMBL40733,P23975,DESMETHYLSERTRALINE,SRPXSILJHWNFMK-ZBEGNZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,811,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14738533,DTCC00177141,2106672,68466
CHEMBL40733,P23975,DESMETHYLSERTRALINE,SRPXSILJHWNFMK-ZBEGNZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,2365,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14738535,DTCC00177141,2106672,68466
CHEMBL40733,P23975,DESMETHYLSERTRALINE,SRPXSILJHWNFMK-ZBEGNZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,390,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14738534,DTCC00177141,2106673,68566
CHEMBL407563,P23975,,OSJBPKOZISTQCO-DZGCQCFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18242987,IC50,=,8999,NM,,,,,,,,,,,,,,Inhibition of NET mediated norepinephrine uptake,,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,2008,18,5,"Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M",,464100,DTCT0023180,2307473,DTCC00501140,666502,25295
CHEMBL407732,P23975,,ZHYJMAJSBAQRIU-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367411,DTCC00493514,795450,26231
CHEMBL407803,P23975,,AHXRAUZDJFQCSL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,IC50,=,2258,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,145001,DTCT0023180,1017042,DTCC00220159,529709,5618
CHEMBL407803,P23975,,AHXRAUZDJFQCSL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,KI,=,2068,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142613,DTCT0023180,1017039,DTCC00220159,529709,5618
CHEMBL407803,P23975,,AHXRAUZDJFQCSL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,RATIO,=,1.09,,,,,,,,,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142615,DTCT0023180,1017045,DTCC00220159,529709,5618
CHEMBL407815,P23975,,BGXIKTHXOUZBOU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,429,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306879,DTCC00501900,1458687,25268
CHEMBL408,P23975,TROGLITAZONE,GXPHKUHSUJUWKP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448294,DTCC00132763,800583,46191
CHEMBL408,P23975,TROGLITAZONE,GXPHKUHSUJUWKP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7448295,DTCC00132763,800583,46191
CHEMBL408016,P23975,,QNPLPYOQHFFYGC-HNAYVOBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,7.1,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372776,DTCC00492468,844341,25565
CHEMBL408206,P23975,,NZBRXUBKIJFZOJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,82,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296165,DTCC00502679,1523495,25227
CHEMBL408230,P23975,,PPEMPAPSRLGSIO-RDJZCZTQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,17,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367403,DTCC00493440,1475208,26231
CHEMBL408329,P23975,,MTFGWQIUGWXBJK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,461,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322674,DTCC00497650,1231363,19394
CHEMBL408384,P23975,,OKJDGNKVEJTMBB-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,7.6,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372786,DTCC00492723,1199046,25565
CHEMBL408867,P23975,[11C]SA4503,UVSWWUWQVAQPJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,INHIBITION,>,90,%,,,,,,,,,,,,,,Binding affinity to NE transporter (unknown origin) at 10 uM by displacement assay relative to control,,,MedChemComm,2011,2,7,,,1329201,DTCT0023180,13581744,DTCC00503459,590145,39232
CHEMBL408868,P23975,,PVISFTMIHRDVDS-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,420,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367414,DTCC00492971,666617,26231
CHEMBL408940,P23975,,BJWRNMDFZRRXMB-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372794,DTCC00492876,553376,25565
CHEMBL409277,P23975,,OGUCJMOATTVEME-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,29,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367396,DTCC00493351,1921865,26231
CHEMBL409546,P23975,,FXNBCHXTTZIOEI-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,210,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367402,DTCC00493437,1410983,26231
CHEMBL409715,P23975,,MJXIPRPHBIFHJC-MGPUTAFESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,4.2,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372784,DTCC00492669,844340,25565
CHEMBL409877,P23975,,HBSKTTXZUZBHRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18060777,KI,=,4800,NM,,,,,,,,,,,,,,Binding affinity to human NET,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463179,DTCT0023180,2296166,DTCC00502835,909342,25227
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8496700,INHIBITION,>,50,%,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake site of norepinephrine transporter at 100 nM,,The role of receptor binding in drug discovery.,J. Nat. Prod.,1993,56,4,"Sweetnam PM, Caldwell L, Lancaster J, Bauer C, McMillan B, Kinnier WJ, Price CH",,486242,DTCT0023180,2642507,DTCC00134078,1600020,27415
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,777,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730113,DTCC00134078,2104059,68466
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,2186,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730119,DTCC00134078,2104059,68466
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,240,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730116,DTCC00134078,2104048,68566
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,240,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,582359,DTCC00134078,1597897,3008
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,574,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730115,DTCC00134078,2104043,68918
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,599,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730114,DTCC00134078,2104043,68918
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845,KI,=,1022,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730120,DTCC00134078,2104044,68736
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,KI,=,440,NM,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,320813,DTCT0023180,1853293,DTCC00134078,1587007,19894
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16220969,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition constant against norepinephrine transporter,,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,2005,48,21,"Morphy R, Rankovic Z",,320757,DTCT0023180,1844755,DTCC00134078,1586984,19940
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359,IC50,=,5200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006,16,16,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293,DTCT0023180,1965623,DTCC00134078,1598974,21201
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,5200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964061,DTCC00134078,1587235,21124
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,1,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556618,DTCC00134078,1588467,28813
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,2000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649861,DTCC00134078,1599701,31203
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,2000,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445668,DTCC00134078,1588704,30880
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,563,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686033,DTCC00134078,1600087,31294
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,IC50,=,1020,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560772,DTCT0023180,2467266,DTCC00134078,1588359,31698
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,KI,=,1560,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560769,DTCT0023180,2467242,DTCC00134078,1588359,31698
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,IC50,=,1020,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533,DTCT0023180,2809682,DTCC00134078,1588201,32805
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,KI,=,1560,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530,DTCT0023180,2809655,DTCC00134078,1588201,32805
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,563,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725270,DTCC00134078,1588425,34196
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,IC50,,,,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Not Determined,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118,DTCT0023180,3446705,DTCC00134078,1601490,40497
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,6309.57,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465491,DTCC00134078,1612408,54821
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,1394,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465490,DTCC00134078,1612408,54821
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,56,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598171,DTCC00134078,1612570,55968
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,4410,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880514,DTCC00134078,1593183,60843
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,5,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876492,DTCC00134078,1593183,60843
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,8,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885100,DTCC00134078,1593183,60843
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,56,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880734,DTCC00134078,1593183,60843
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1303,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322665,DTCC00134078,1609546,46191
CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1292,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322666,DTCC00134078,1609546,46191
CHEMBL410015,P23975,,DUNLKPYMIRLCRM-IFXJQAMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,9.4,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372781,DTCC00492610,392084,25565
CHEMBL410054,P23975,,XMOVWPQOTYUSTK-FXAWDEMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372792,DTCC00492774,1296707,25565
CHEMBL410055,P23975,,FCURKYXBYVWDLH-FXAWDEMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,80,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372791,DTCC00492775,1937862,25565
CHEMBL410062,P23975,,RHHBTYFKWRRJPP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372807,DTCC00492428,1264132,25565
CHEMBL410286,P23975,,OULZYJCJGXXRLZ-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,160,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367400,DTCC00493394,1087020,26231
CHEMBL410622,P23975,,WRXKFTMLELOBNB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303629,DTCC00500420,1054190,25699
CHEMBL411,P23975,DIETHYLSTILBESTROL,RGLYKWWBQGJZGM-ISLYRVAYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3670,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7361707,DTCC00132930,2057648,46191
CHEMBL411,P23975,DIETHYLSTILBESTROL,RGLYKWWBQGJZGM-ISLYRVAYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3640,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7361708,DTCC00132930,2057648,46191
CHEMBL411033,P23975,,JMLINUIVZHMJBT-GCZMORHFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372782,DTCC00492612,164271,25565
CHEMBL411262,P23975,,XWFSWRARAVLBFN-ICSRJNTNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17983754,KI,=,1.21,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,2008,16,2,"Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,466322,DTCT0023180,2290053,DTCC00503867,892982,25467
CHEMBL411263,P23975,,JTLPJEXKDFZLAY-HKUYNNGSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17983754,KI,=,1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,2008,16,2,"Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM",,466322,DTCT0023180,2290054,DTCC00503869,1636510,25467
CHEMBL411655,P23975,,RGXBRYANHNSPHQ-VBKZILBWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,5.8,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372783,DTCC00492667,164270,25565
CHEMBL411677,P23975,,ILKYNXUJXDGZRH-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372793,DTCC00492778,99517,25565
CHEMBL411693,P23975,,YBLHYQJAYABBGT-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,2900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906272,DTCC00417018,424045,20502
CHEMBL411921,P23975,,JTCQOAITNDJYSA-HKUYNNGSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367405,DTCC00493476,731112,26231
CHEMBL411941,P23975,CYCLORGDFV,YYQUWEHEBOMRPH-NYUBLWNDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16722631,KI,,,,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter by radioligand binding assay,Not Determined,"An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.",J. Med. Chem.,2006,49,11,"Becker OM, Dhanoa DS, Marantz Y, Chen D, Shacham S, Cheruku S, Heifetz A, Mohanty P, Fichman M, Sharadendu A, Nudelman R, Kauffman M, Noiman S",,357806,DTCT0023180,1761396,DTCC00497602,1275093,20825
CHEMBL412873,P23975,SPARTEINE,SLRCCWJSBJZJBV-TUVASFSCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7475872,DTCC00141609,1674150,46191
CHEMBL412873,P23975,SPARTEINE,SLRCCWJSBJZJBV-TUVASFSCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7475873,DTCC00141609,1674150,46191
CHEMBL413,P23975,SIROLIMUS,QFJCIRLUMZQUOT-HPLJOQBZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455491,DTCC00132982,477921,46191
CHEMBL413,P23975,SIROLIMUS,QFJCIRLUMZQUOT-HPLJOQBZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455492,DTCC00132982,477921,46191
CHEMBL413562,P23975,,DVAKZGWOGMMTDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15974579,KI,=,108,NM,,cell_based,,,,,,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,2005,48,13,"Jarkas N, McConathy J, Voll RJ, Goodman MM",,303772,DTCT0023180,1809545,DTCC00396203,918967,19300
CHEMBL413965,P23975,FELBINAC,QRZAKQDHEVVFRX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7320170,DTCC00106501,1285874,46191
CHEMBL413965,P23975,FELBINAC,QRZAKQDHEVVFRX-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7320171,DTCC00106501,1285874,46191
CHEMBL414804,P23975,OXALIPLATIN,ZROHGHOFXNOHSO-BNTLRKBRSA-L,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380171,DTCC00333435,736264,46191
CHEMBL414804,P23975,OXALIPLATIN,ZROHGHOFXNOHSO-BNTLRKBRSA-L,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7380172,DTCC00333435,736264,46191
CHEMBL415,P23975,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,38,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14757223,DTCC00133038,2111098,68566
CHEMBL415,P23975,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11454918,KI,=,53.7,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14757224,DTCC00133038,2111090,69315
CHEMBL415,P23975,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14573386,KI,=,38,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14757215,DTCC00133038,2111095,69056
CHEMBL415,P23975,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,64.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598061,DTCC00133038,220581,55968
CHEMBL415,P23975,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26372073,INHIBITION,=,5,%,,,,,,,,,,,,,,Displacement of [3H]-nisoxetine from norepinephrine transporter (unknown origin) at 0.1 mM relative to control,,Reengineered tricyclic anti-cancer agents.,Bioorg. Med. Chem.,2015,23,19,"Kastrinsky DB, Sangodkar J, Zaware N, Izadmehr S, Dhawan NS, Narla G, Ohlmeyer M",,1515633,DTCT0023180,14527993,DTCC00133038,202976,63615
CHEMBL415,P23975,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26372073,INHIBITION,=,76,%,,,,,,,,,,,,,,Displacement of [3H]-nisoxetine from norepinephrine transporter (unknown origin) at 1 mM relative to control,,Reengineered tricyclic anti-cancer agents.,Bioorg. Med. Chem.,2015,23,19,"Kastrinsky DB, Sangodkar J, Zaware N, Izadmehr S, Dhawan NS, Narla G, Ohlmeyer M",,1515634,DTCT0023180,14527994,DTCC00133038,202976,63615
CHEMBL415,P23975,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26372073,INHIBITION,=,100,%,,,,,,,,,,,,,,Displacement of [3H]-nisoxetine from norepinephrine transporter (unknown origin) at 10 mM relative to control,,Reengineered tricyclic anti-cancer agents.,Bioorg. Med. Chem.,2015,23,19,"Kastrinsky DB, Sangodkar J, Zaware N, Izadmehr S, Dhawan NS, Narla G, Ohlmeyer M",,1515635,DTCT0023180,14527995,DTCC00133038,202976,63615
CHEMBL415,P23975,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,71,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367341,DTCC00133038,217576,46191
CHEMBL415,P23975,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,70,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367342,DTCC00133038,217576,46191
CHEMBL415098,P23975,,NUAPUMDPHIFPBC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303633,DTCC00112968,83398,25699
CHEMBL415244,P23975,,CRAGVFOTRKKIFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,74,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1093107,DTCC00323077,724518,6048
CHEMBL415324,P23975,TRANILAST,NZHGWWWHIYHZNX-CSKARUKUSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446178,DTCC00281196,1674153,46191
CHEMBL415324,P23975,TRANILAST,NZHGWWWHIYHZNX-CSKARUKUSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7446179,DTCC00281196,1674153,46191
CHEMBL41543,P23975,,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7291805,DTCC00180007,866015,46191
CHEMBL41543,P23975,,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7291806,DTCC00180007,866015,46191
CHEMBL415690,P23975,BETADEX,WHGYBXFWUBPSRW-FOUAGVGXSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7261402,DTCC00463534,249937,46191
CHEMBL415690,P23975,BETADEX,WHGYBXFWUBPSRW-FOUAGVGXSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7261403,DTCC00463534,249937,46191
CHEMBL416,P23975,METHOXSALEN,QXKHYNVANLEOEG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406597,DTCC00133091,1765976,46191
CHEMBL416,P23975,METHOXSALEN,QXKHYNVANLEOEG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406598,DTCC00133091,1765976,46191
CHEMBL416409,P23975,,GGGXMDDQIHPMRC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213078,IC50,=,93,NM,,,,,,,,,,,,,,Compound was tested for the inhibition of norepinephrine (NE) reuptake,,Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,2002,45,19,"Prisinzano T, Greiner E, Johnson EM, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,142775,DTCT0023180,924816,DTCC00173267,270956,16938
CHEMBL416409,P23975,,GGGXMDDQIHPMRC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213078,RATIO,=,13,,,,,,,,,,,,,,,Ratio of IC50 value against Norepinephrine transporter (NE) to that of Dopamine transporter (DA),,Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,2002,45,19,"Prisinzano T, Greiner E, Johnson EM, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,142781,DTCT0023180,924819,DTCC00173267,270956,16938
CHEMBL417,P23975,EPIRUBICIN,AOJJSUZBOXZQNB-VTZDEGQISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7313353,DTCC00133135,671788,46191
CHEMBL417,P23975,EPIRUBICIN,AOJJSUZBOXZQNB-VTZDEGQISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7313354,DTCC00133135,671788,46191
CHEMBL417035,P23975,,FECMCOWJDSNXAS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,190,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,853843,DTCC00218127,1196033,15898
CHEMBL417035,P23975,,FECMCOWJDSNXAS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,190,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,853840,DTCC00218127,1196033,15898
CHEMBL417049,P23975,,SUFVPROIOBRYEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,818792,DTCC00218463,1100171,15898
CHEMBL417049,P23975,,SUFVPROIOBRYEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,29,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,818789,DTCC00218463,1100171,15898
CHEMBL417249,P23975,,WDOKGNOTOAMJEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,KI,=,5920,NM,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143140,DTCT0023180,1021621,DTCC00140584,1003770,14474
CHEMBL418971,P23975,BISPHENOL A,IISBACLAFKSPIT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,16620,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269998,DTCC00260853,88624,46191
CHEMBL418971,P23975,BISPHENOL A,IISBACLAFKSPIT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,16483,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269999,DTCC00260853,88624,46191
CHEMBL419385,P23975,,TXMJJPVQXBIOQV-YHZLUUAOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,,,,,,,,,,,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Not Determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142777,DTCT0023180,1577183,DTCC00284679,205332,5814
CHEMBL419385,P23975,,TXMJJPVQXBIOQV-YHZLUUAOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,50,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1577180,DTCC00284679,205332,5814
CHEMBL419728,P23975,,JGWXNVMXDBFNMX-KRCSLNALSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10698458,IC50,=,23,NM,,cell_based,,,,,,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,2000,10,3,"Tamiz AP, Smith MP, Kozikowski AP",,142803,DTCT0023180,1163976,DTCC00269695,1424400,4077
CHEMBL42,P23975,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1470,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7363107,DTCC00134115,51460,46191
CHEMBL42,P23975,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1458,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7363108,DTCC00134115,51460,46191
CHEMBL420,P23975,GUANABENZ,WDZVGELJXXEGPV-YIXHJXPBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312729,DTCC00133212,1416031,46191
CHEMBL420,P23975,GUANABENZ,WDZVGELJXXEGPV-YIXHJXPBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312730,DTCC00133212,1416031,46191
CHEMBL420142,P23975,,ZYSPQRLLQVFKDB-NTISSMGPSA-M,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15177457,KI,>,10000000,NM,,,,,,,,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,2004,14,13,"Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, Threlkeld PG, Wheeler WJ, Yi P, Zmijewski M",,142807,DTCT0023180,1069628,DTCC00292114,1164360,6492
CHEMBL420644,P23975,,HQVQWOHDTVRIMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,120,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657196,DTCC00265720,844516,30478
CHEMBL420644,P23975,,HQVQWOHDTVRIMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,249,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657167,DTCC00265720,844516,30478
CHEMBL420900,P23975,,DBQULVOZIKDPMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,IC50,=,192,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142802,DTCT0023180,946956,DTCC00298073,173522,15367
CHEMBL420900,P23975,,DBQULVOZIKDPMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10479296,KI,=,477,NM,,cell_based,,,,,,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,1999,42,18,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,142935,DTCT0023180,946951,DTCC00298073,173522,15367
CHEMBL421,P23975,SULFASALAZINE,NCEXYHBECQHGNR-QZQOTICOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7474078,DTCC00133232,2025643,46191
CHEMBL421,P23975,SULFASALAZINE,NCEXYHBECQHGNR-QZQOTICOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7474079,DTCC00133232,2025643,46191
CHEMBL421867,P23975,,CPELCYRAOXWACY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,230,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,829050,DTCC00219025,1838535,15898
CHEMBL421867,P23975,,CPELCYRAOXWACY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,120,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,829047,DTCC00219025,1838535,15898
CHEMBL422,P23975,TRIFLUOPERAZINE,ZEWQUBUPAILYHI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453631,DTCC00133320,962453,46191
CHEMBL422,P23975,TRIFLUOPERAZINE,ZEWQUBUPAILYHI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453632,DTCC00133320,962453,46191
CHEMBL422290,P23975,,WSLCFIYYDJNWLK-KAXARAQCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9804682,IC50,=,16.3,NM,,,,,,,,,,,,,,The compound was tested in vitro for binding affinity for the norepinephrine transporter (NET) using competitive binding assay.,,TROTEC-1: a new high-affinity ligand for labeling of the dopamine transporter.,J. Med. Chem.,1998,41,23,"Hoepping A, Reisgys M, Brust P, Seifert S, Spies H, Alberto R, Johannsen B",,142804,DTCT0023180,1492584,DTCC00322017,129935,14928
CHEMBL422931,P23975,,GZAMCYJCPQMIHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23477943,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of NET (unknown origin),,Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.,Bioorg. Med. Chem.,2013,21,8,"Wu YJ, He H, Bertekap R, Westphal R, Lelas S, Newton A, Wallace T, Taber M, Davis C, Macor JE, Bronson J",,951582,DTCT0023180,11855622,DTCC00156158,751057,54264
CHEMBL422931,P23975,,GZAMCYJCPQMIHJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23477943,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM,Active,Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.,Bioorg. Med. Chem.,2013,21,8,"Wu YJ, He H, Bertekap R, Westphal R, Lelas S, Newton A, Wallace T, Taber M, Davis C, Macor JE, Bronson J",,951588,DTCT0023180,11855517,DTCC00156158,751057,54264
CHEMBL423192,P23975,ANISOMYCIN,YKJYKKNCCRKFSL-RDBSUJKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277807,DTCC00329526,866016,46191
CHEMBL423192,P23975,ANISOMYCIN,YKJYKKNCCRKFSL-RDBSUJKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7277808,DTCC00329526,866016,46191
CHEMBL424,P23975,SALICYLIC ACID,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460179,DTCC00133347,51507,46191
CHEMBL424,P23975,SALICYLIC ACID,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460180,DTCC00133347,51507,46191
CHEMBL42442,P23975,OXFENDAZOLE,BEZZFPOZAYTVHN-UHFFFAOYSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393147,DTCC00184703,282999,46191
CHEMBL42442,P23975,OXFENDAZOLE,BEZZFPOZAYTVHN-UHFFFAOYSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393148,DTCC00184703,282999,46191
CHEMBL424496,P23975,,MSLSPRSRIMVUAY-YJBOKZPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,1500,NM,,,,,,,,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142785,DTCT0023180,1155215,DTCC00334384,5905,16052
CHEMBL424496,P23975,,MSLSPRSRIMVUAY-YJBOKZPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11150168,KI,=,3500,NM,,,,,,,,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,2000,43,26,"Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL",,142784,DTCT0023180,1155214,DTCC00334384,5905,16052
CHEMBL424660,P23975,,ZEUITGRIYCTCEM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14573386,KI,=,7.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14734762,DTCC00323076,2105372,69056
CHEMBL424660,P23975,,ZEUITGRIYCTCEM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643350,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,2003,13,24,"Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT",,142612,DTCT0023180,1078280,DTCC00323076,1883232,6048
CHEMBL424660,P23975,,ZEUITGRIYCTCEM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,1.17,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14734764,DTCC00323076,2105371,69177
CHEMBL424660,P23975,,ZEUITGRIYCTCEM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,20,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14734763,DTCC00323076,2105371,69177
CHEMBL424682,P23975,,WOORERZMTSEMTL-GNAFDRTKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,560,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902461,DTCC00416452,789854,20396
CHEMBL425010,P23975,,GZRLZFDDKKLOGM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15801845,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,2005,48,7,"Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M",,303505,DTCT0023180,1822458,DTCC00399264,1522608,19630
CHEMBL42553,P23975,,AMIHUYQKNJHXPT-XNSJETLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16302792,KI,=,5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,2005,48,24,"Cha JH, Zou MF, Adkins EM, Rasmussen SG, Loland CJ, Schoenenberger B, Gether U, Newman AH",,326506,DTCT0023180,1868409,DTCC00186978,1501916,20039
CHEMBL425589,P23975,,KPESCGPEZLRTMM-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,690,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1928004,DTCC00422333,272123,20707
CHEMBL425961,P23975,,HSPJWADLPHSZQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1964039,DTCC00430002,1970460,21124
CHEMBL426123,P23975,(-)-THALIDOMIDE,UEJJHQNACJXSKW-VIFPVBQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295644,DTCC00001569,1609540,46191
CHEMBL426123,P23975,(-)-THALIDOMIDE,UEJJHQNACJXSKW-VIFPVBQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295645,DTCC00001569,1609540,46191
CHEMBL426178,P23975,,DTGXSBMWMFLEGI-OEXSPLCWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,13000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050411,DTCC00445539,1715873,22251
CHEMBL426178,P23975,,DTGXSBMWMFLEGI-OEXSPLCWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,7800,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050444,DTCC00445539,1715873,22251
CHEMBL426304,P23975,,NYDUTEZMPZHSRY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,IC50,=,81,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334929,DTCT0023180,1895024,DTCC00415037,693271,20391
CHEMBL426304,P23975,,NYDUTEZMPZHSRY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16480278,KI,=,670,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,2006,49,4,"Meltzer PC, Butler D, Deschamps JR, Madras BK",,334928,DTCT0023180,1894995,DTCC00415037,693271,20391
CHEMBL426316,P23975,,YZGSHBDJMLWEBX-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,8.3,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927980,DTCC00422852,1209529,20707
CHEMBL426317,P23975,,PGGCRGAETLNAJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16458504,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to NET by radioligand binding assay,,"Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand.",Bioorg. Med. Chem. Lett.,2006,16,8,"Prabhakaran J, Parsey RV, Majo VJ, Hsiung SC, Milak MS, Tamir H, Simpson NR, Van Heertum RL, Mann JJ, Dileep Kumar JS",,346868,DTCT0023180,1918100,DTCC00419919,661040,20646
CHEMBL426659,P23975,,DCBHDYASYVFKAM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16202585,IC50,=,41500,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,2005,15,24,"Krunic A, Mariappan SV, Reith ME, Dunn WJ",,326654,DTCT0023180,1874498,DTCC00410608,2067474,20064
CHEMBL426743,P23975,LY-2152041,RKSAEPSMCMRCOK-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17123820,KI,=,10.8,NM,,,,,,,,,,,,,,Binding affinity at NET,,Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.,Bioorg. Med. Chem.,2007,15,2,"Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C",,432854,DTCT0023180,2059435,DTCC00002567,1715887,22425
CHEMBL42710,P23975,EUGENOL,RRAFCDWBNXTKKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7307335,DTCC00183810,1253322,46191
CHEMBL42710,P23975,EUGENOL,RRAFCDWBNXTKKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7307336,DTCC00183810,1253322,46191
CHEMBL427215,P23975,(R)-SILA-VENLAFAXINE,KIXBFSFRCBHKLN-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16513343,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of noradrenaline reuptake at human recombinant noradrenaline transporter,,(R)-sila-venlafaxine: a selective noradrenaline reuptake inhibitor for the treatment of emesis.,Bioorg. Med. Chem. Lett.,2006,16,9,"Showell GA, Barnes MJ, Daiss JO, Mills JS, Montana JG, Tacke R, Warneck JB",,351278,DTCT0023180,1922159,DTCC00001674,1405414,20729
CHEMBL427215,P23975,(R)-SILA-VENLAFAXINE,KIXBFSFRCBHKLN-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21413808,IC50,=,251,NM,,,,,,,,,,,,,,Inhibition of NET,,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,2011,54,8,,,879332,DTCT0023180,11458824,DTCC00001674,1417993,51826
CHEMBL427215,P23975,(R)-SILA-VENLAFAXINE,KIXBFSFRCBHKLN-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23061607,IC50,=,251,NM,,,,,,,,,,,,,,Inhibition of NET (unknown origin) assessed as noradrenaline reuptake,,Organosilicon molecules with medicinal applications.,J. Med. Chem.,2013,56,2,"Franz AK, Wilson SO",,934616,DTCT0023180,11751468,DTCC00001674,1418355,52878
CHEMBL427216,P23975,GLICLAZIDE,BOVGTQGAOIONJV-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7316728,DTCC00422269,800576,46191
CHEMBL427216,P23975,GLICLAZIDE,BOVGTQGAOIONJV-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7316729,DTCC00422269,800576,46191
CHEMBL427526,P23975,(R)-IBUPROPHEN,HEFNNWSXXWATRW-SNVBAGLBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468486,DTCC00396930,671793,46191
CHEMBL427526,P23975,(R)-IBUPROPHEN,HEFNNWSXXWATRW-SNVBAGLBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468487,DTCC00396930,671793,46191
CHEMBL427563,P23975,,CPNTXNSOEZESIH-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18387300,KI,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,2008,18,8,"Fish PV, Deur C, Gan X, Greene K, Hoople D, Mackenny M, Para KS, Reeves K, Ryckmans T, Stiff C, Stobie A, Wakenhut F, Whitlock GA",,477349,DTCT0023180,2367409,DTCC00493516,2052481,26231
CHEMBL427904,P23975,,HKERIGVYOINJIO-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,2.9,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372778,DTCC00492558,585522,25565
CHEMBL428,P23975,TROVAFLOXACIN,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441495,DTCC00133538,1577011,46191
CHEMBL428,P23975,TROVAFLOXACIN,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441496,DTCC00133538,1577011,46191
CHEMBL428408,P23975,,AQRRWNJTDQZWAN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17869101,KI,=,18000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,21,"Boye SV, Ortega-Caballero F, Sinning S, Wiborg O, Jensen HH, Bols M",,457757,DTCT0023180,2249830,DTCC00483189,1539568,24671
CHEMBL428647,P23975,PACLITAXEL,RCINICONZNJXQF-MZXODVADSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7391085,DTCC00138918,51496,46191
CHEMBL428647,P23975,PACLITAXEL,RCINICONZNJXQF-MZXODVADSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7391086,DTCC00138918,51496,46191
CHEMBL428706,P23975,,GZWPHROGQGOESZ-HJWRWDBZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,24,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line using [125I]RTI-55 as radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144968,DTCT0023180,944482,DTCC00144084,1949683,17996
CHEMBL428706,P23975,,GZWPHROGQGOESZ-HJWRWDBZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16451060,KI,=,15,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Evaluation of carbon-11-labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]nortropane as a potential radioligand for imaging the serotonin transporter by PET.,J. Med. Chem.,2006,49,3,"Plisson C, Jarkas N, McConathy J, Voll RJ, Votaw J, Williams L, Howell LL, Kilts CD, Goodman MM",,330474,DTCT0023180,1888171,DTCC00144084,1949042,20243
CHEMBL428880,P23975,CROMOLYN,IMZMKUWMOSJXDT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337519,DTCC00138605,671787,46191
CHEMBL428880,P23975,CROMOLYN,IMZMKUWMOSJXDT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337520,DTCC00138605,671787,46191
CHEMBL429,P23975,LABETALOL,SGUAFYQXFOLMHL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3354,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427097,DTCC00133676,120973,46191
CHEMBL429,P23975,LABETALOL,SGUAFYQXFOLMHL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3326,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427098,DTCC00133676,120973,46191
CHEMBL429023,P23975,ROTENONE,JUVIOZPCNVVQFO-HBGVWJBISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485996,DTCC00134556,1027058,46191
CHEMBL429023,P23975,ROTENONE,JUVIOZPCNVVQFO-HBGVWJBISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485997,DTCC00134556,1027058,46191
CHEMBL429759,P23975,,HGZVDXQCKWQIFI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,179,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322673,DTCC00498070,99575,19394
CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12761331,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730557,DTCC00186878,2104160,68767
CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19717215,IC50,=,405,NM,,,,,,,,,,,,,,Inhibition of human noradrenaline transporter,,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,2009,44,12,"Cloonan SM, Keating JJ, Butler SG, Knox AJ, Jørgensen AM, Peters GH, Rai D, Corrigan D, Lloyd DG, Williams DC, Meegan MJ",,622530,DTCT0023180,3256937,DTCC00186878,295616,37648
CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20466553,IC50,=,405,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines.",Bioorg. Med. Chem.,2010,18,11,"Cloonan SM, Keating JJ, Corrigan D, O'Brien JE, Kavanagh PV, Williams DC, Meegan MJ",,639476,DTCT0023180,3376847,DTCC00186878,307550,39293
CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,1995.26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465487,DTCC00186878,318410,54821
CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,398,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465486,DTCC00186878,318410,54821
CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26233799,EC50,=,1000,NM,,cell_based,,,,,,,,,,,,Binding affinity to human NET expressed in HEK293 cells assessed as induction of [3H]MPP+ release by liquid scintillation counting method,,"Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.",Bioorg. Med. Chem.,2015,23,17,"Del Bello F, Sakloth F, Partilla JS, Baumann MH, Glennon RA",,1511143,DTCT0023180,14500361,DTCC00186878,288908,63351
CHEMBL43064,P23975,CINNARIZINE,DERZBLKQOCDDDZ-JLHYYAGUSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2832,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7364860,DTCC01738588,930078,46191
CHEMBL43064,P23975,CINNARIZINE,DERZBLKQOCDDDZ-JLHYYAGUSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2808,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7364861,DTCC01738588,930078,46191
CHEMBL430840,P23975,,QDDIKUPXWGQLSU-SIUPQYRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10698458,IC50,=,620,NM,,cell_based,,,,,,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,2000,10,3,"Tamiz AP, Smith MP, Kozikowski AP",,142803,DTCT0023180,1150445,DTCC00269663,1456258,4077
CHEMBL432022,P23975,,HSALZIQGHGTBLM-RYTUYPIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,IC50,,,,,,,,,,,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Not Determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142777,DTCT0023180,1580046,DTCC00284680,917613,5814
CHEMBL432022,P23975,,HSALZIQGHGTBLM-RYTUYPIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12951108,KI,=,316,NM,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2003,13,19,"Axford L, Boot JR, Hotten TM, Keenan M, Martin FM, Milutinovic S, Moore NA, O'Neill MF, Pullar IA, Tupper DE, Van Belle KR, Vivien V",,142778,DTCT0023180,1580043,DTCC00284680,917613,5814
CHEMBL432394,P23975,,GAZPWELASOLBPG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10956218,KI,=,230,NM,,,,,,,,,,,,,,In vitro binding affinity on cloned Norepinephrine transporter,,"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.",J. Med. Chem.,2000,43,16,"Wilson AA, Ginovart N, Schmidt M, Meyer JH, Threlkeld PG, Houle S",,142937,DTCT0023180,574135,DTCC00275254,205260,15844
CHEMBL432727,P23975,,YDRFQAANTRDVRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,IC50,=,1846,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,145001,DTCT0023180,1015771,DTCC00220157,1629158,5618
CHEMBL432727,P23975,,YDRFQAANTRDVRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,KI,=,330,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142613,DTCT0023180,1015768,DTCC00220157,1629158,5618
CHEMBL432727,P23975,,YDRFQAANTRDVRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,RATIO,=,5.59,,,,,,,,,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142615,DTCT0023180,1015774,DTCC00220157,1629158,5618
CHEMBL432727,P23975,,YDRFQAANTRDVRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12798324,RATIO,=,8.3,,,,,,,,,,,,,,,Selectivity ratio determined of Ki human Norepinephrine transporter to Ki human Serotonin transporter,,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fandrick K, Feng X, Janowsky A, Johnson R, Cashman JR",,142617,DTCT0023180,1015777,DTCC00220157,1629158,5618
CHEMBL433257,P23975,HARRINGTONINE,HAVJATCHLFRDHY-KSZYUSJVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308467,DTCC00188822,1447883,46191
CHEMBL433257,P23975,HARRINGTONINE,HAVJATCHLFRDHY-KSZYUSJVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308468,DTCC00188822,1447883,46191
CHEMBL434,P23975,ISOPROTERENOL,JWZZKOKVBUJMES-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7437432,DTCC00133870,315665,46191
CHEMBL434,P23975,ISOPROTERENOL,JWZZKOKVBUJMES-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7437433,DTCC00133870,315665,46191
CHEMBL434063,P23975,GW1929,QTQMRBZOBKYXCG-MHZLTWQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,40308,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325503,DTCC01743578,994594,46191
CHEMBL434063,P23975,GW1929,QTQMRBZOBKYXCG-MHZLTWQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,39975,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325504,DTCC01743578,994594,46191
CHEMBL434959,P23975,,WBUKLOIGDUMVEL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,68000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149680,DTCC00460916,956816,23432
CHEMBL434959,P23975,,WBUKLOIGDUMVEL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150042,DTCC00460916,956816,23432
CHEMBL435,P23975,HYDROCHLOROTHIAZIDE,JZUFKLXOESDKRF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7334147,DTCC00133916,1285877,46191
CHEMBL435,P23975,HYDROCHLOROTHIAZIDE,JZUFKLXOESDKRF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7334148,DTCC00133916,1285877,46191
CHEMBL435034,P23975,,KUKSICQKSBGDSV-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,957284,DTCC00345569,1630299,13807
CHEMBL436132,P23975,,PZHJZKURLFYNOX-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,IC50,=,3240,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440431,DTCT0023180,2115149,DTCC00452917,1631478,23035
CHEMBL436132,P23975,,PZHJZKURLFYNOX-GNXKAVGDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17602602,KI,=,2210,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,2007,50,15,"Gong PK, Blough BE, Brieaddy LE, Huang X, Kuhar MJ, Navarro HA, Carroll FI",,440428,DTCT0023180,2115095,DTCC00452917,1631478,23035
CHEMBL436673,P23975,,GAWWNBHCOINKBY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,27,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322677,DTCC00497680,1135435,19394
CHEMBL437,P23975,SULFATHIAZOLE,JNMRHUJNCSQMMB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7478455,DTCC00133961,1027059,46191
CHEMBL437,P23975,SULFATHIAZOLE,JNMRHUJNCSQMMB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7478456,DTCC00133961,1027059,46191
CHEMBL437002,P23975,,LEVTWCPGXIVKEH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7292960,DTCC00473690,1734052,46191
CHEMBL437002,P23975,,LEVTWCPGXIVKEH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7292816,DTCC00473690,1734052,46191
CHEMBL438,P23975,SULFAMERAZINE,QPPBRPIAZZHUNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482622,DTCC00133994,1798418,46191
CHEMBL438,P23975,SULFAMERAZINE,QPPBRPIAZZHUNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482623,DTCC00133994,1798418,46191
CHEMBL438059,P23975,,UEYARIMIGYJNDI-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,3.3,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927995,DTCC00422709,33583,20707
CHEMBL438257,P23975,,GIENPXSUZALJHK-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,410,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906271,DTCC00417031,940256,20502
CHEMBL438321,P23975,,YZXXWGROTHDVOH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,2020000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2149686,DTCC00460903,375383,23432
CHEMBL438321,P23975,,YZXXWGROTHDVOH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,Not Determined,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444201,DTCT0023180,2150045,DTCC00460903,375383,23432
CHEMBL438450,P23975,,PHZZSZDDGUPIKS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16137883,KI,=,150,NM,,,,,,,,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2005,15,20,"Beadle CD, Boot J, Camp NP, Dezutter N, Findlay J, Hayhurst L, Masters JJ, Penariol R, Walter MW",,320846,DTCT0023180,1858156,DTCC00407228,1004763,19679
CHEMBL438490,P23975,,GMAJNYRLILNPJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17412583,ACTIVITY,=,73,%,,,,,,,,,,,,,,Binding affinity at noradrenaline transporter at 1 uM,,Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity.,Bioorg. Med. Chem. Lett.,2007,17,11,"Stocking EM, Miller JM, Barbier AJ, Wilson SJ, Boggs JD, McAllister HM, Wu J, Lovenberg TW, Carruthers NI, Wolin RL",,455317,DTCT0023180,2231646,DTCC00469887,1005410,24411
CHEMBL438490,P23975,,GMAJNYRLILNPJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17412583,KI,=,201,NM,,,,,,,,,,,,,,Binding affinity at human noradrenaline transporter,,Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity.,Bioorg. Med. Chem. Lett.,2007,17,11,"Stocking EM, Miller JM, Barbier AJ, Wilson SJ, Boggs JD, McAllister HM, Wu J, Lovenberg TW, Carruthers NI, Wolin RL",,455318,DTCT0023180,2231647,DTCC00469887,1005410,24411
CHEMBL438627,P23975,,TVYLLZQTGLZFBW-ZEYWGEJISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16257206,IC50,=,3200,NM,,,,,,,,,,,,,,Inhibition of reuptake of Norepinephrine,,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,2006,16,3,"Shao L, Abolin C, Hewitt MC, Koch P, Varney M",,333146,DTCT0023180,1892074,DTCC00414452,499742,20316
CHEMBL43882,P23975,TRICHLOROETHANE,UBOXGVDOUJQMTN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7451886,DTCC00104711,1830694,46191
CHEMBL43882,P23975,TRICHLOROETHANE,UBOXGVDOUJQMTN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7451887,DTCC00104711,1830694,46191
CHEMBL438889,P23975,,YZHPFFVLNPTVQU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18240382,IC50,=,17,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,2008,18,2,"Whitlock GA, Blagg J, Fish PV",,463818,DTCT0023180,2306868,DTCC00501821,1329239,25268
CHEMBL439,P23975,SULFADIAZINE,SEEPANYCNGTZFQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469569,DTCC00133995,1734063,46191
CHEMBL439,P23975,SULFADIAZINE,SEEPANYCNGTZFQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469570,DTCC00133995,1734063,46191
CHEMBL439337,P23975,,FPQRVMRURWGBHW-LIRRHRJNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,650,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906294,DTCC00416927,1263386,20502
CHEMBL439423,P23975,,BIHDNMFWZMAKEI-WCQYABFASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,110,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374326,DTCC00490930,472567,25551
CHEMBL44,P23975,GENISTEIN,TZBJGXHYKVUXJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335754,DTCC00134437,2089749,46191
CHEMBL44,P23975,GENISTEIN,TZBJGXHYKVUXJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335755,DTCC00134437,2089749,46191
CHEMBL440230,P23975,,KQOBDZDVQFUADH-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224528,DTCC00479480,342958,24303
CHEMBL440272,P23975,,PMCPPYXVCCGLLE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9435902,KI,=,4790,NM,,,,,,,,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,1997,40,26,"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH",,143140,DTCT0023180,1024142,DTCC00140538,874906,14474
CHEMBL440554,P23975,,NYXHSNJGOQCTBS-MQMFKJKRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15012999,INHIBITION,=,42,%,,,,,,,,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,2004,14,4,"Shu M, Loebach JL, Parker KA, Mills SG, Chapman KT, Shen DM, Malkowitz L, Springer MS, Gould SL, DeMartino JA, Siciliano SJ, Salvo JD, Lyons K, Pivnichny JV, Kwei GY, Carella A, Carver G, Holmes K, Schleif WA, Danzeisen R, Hazuda D, Kessler J, Lineberger J, Miller MD, Emini EA",,142805,DTCT0023180,1451610,DTCC00372652,1554413,6665
CHEMBL440584,P23975,,NVIWIEFWADBWQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18313294,KI,=,255,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,6,"Fish PV, Ryckmans T, Stobie A, Wakenhut F",,473951,DTCT0023180,2322668,DTCC00497992,260929,19394
CHEMBL440878,P23975,,MRBFFQVXMIGKST-NWDGAFQWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,IC50,>,100000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602900,DTCT0023180,3162402,DTCC00243500,426041,36631
CHEMBL440878,P23975,,MRBFFQVXMIGKST-NWDGAFQWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602897,DTCT0023180,3162378,DTCC00243500,426041,36631
CHEMBL441075,P23975,PIPERIDINE BASED ANALOGUE OF COCAINE,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10576690,KI,=,231.1,NM,,,,,,,,,,,,,,Norepinephrine transporter activity was determined by inhibition of monoamine [3H]-NE reuptake,,Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine.,Bioorg. Med. Chem. Lett.,1999,9,22,"Hoepping A, Babich J, Zubieta JA, Johnson KM, Machill S, Kozikowski AP",,143135,DTCT0023180,1304406,DTCC00281164,1774345,3457
CHEMBL441358,P23975,,SECNEKAFHNWBBW-WLHGVMLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16497500,KI,=,1.8,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,2006,16,10,"Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmonds RG, Smith SM, Richards SJ, Timms GH, Whatton MA, Wolfe CN, Wood VA",,355136,DTCT0023180,1927986,DTCC00422487,1405425,20707
CHEMBL441687,P23975,GLYCYRRHIZIN,LPLVUJXQOOQHMX-QWBHMCJMSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312595,DTCC00424760,1992805,46191
CHEMBL441687,P23975,GLYCYRRHIZIN,LPLVUJXQOOQHMX-QWBHMCJMSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312596,DTCC00424760,1992805,46191
CHEMBL441864,P23975,,FZAYBHQQLZFDLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005981,DTCC00438200,78170,21696
CHEMBL441864,P23975,,FZAYBHQQLZFDLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,1700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2006175,DTCC00438200,78172,21696
CHEMBL441864,P23975,,FZAYBHQQLZFDLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,490,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005971,DTCC00438200,78170,21696
CHEMBL441864,P23975,,FZAYBHQQLZFDLP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,1500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2006183,DTCC00438200,78172,21696
CHEMBL442,P23975,ERGOTAMINE,XCGSFFUVFURLIX-VFGNJEKYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7330396,DTCC00134058,1027052,46191
CHEMBL442,P23975,ERGOTAMINE,XCGSFFUVFURLIX-VFGNJEKYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7330397,DTCC00134058,1027052,46191
CHEMBL442234,P23975,METHYL 2-(4-(TRIFLUOROMETHOXY)PHENYL)CYCLOHEXANECARBOXYLATE,YZQHGCDBPHKCKB-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17446076,KI,=,719000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,2007,15,12,"Petersen MD, Boye SV, Nielsen EH, Willumsen J, Sinning S, Wiborg O, Bols M",,444198,DTCT0023180,2150087,DTCC00003076,1954334,23432
CHEMBL442272,P23975,,NUAORYLXEWKQRZ-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17267217,IC50,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA from human NET expressed in HEK293 cells,,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Fish PV, Fray MJ, Stobie A, Wakenhut F, Whitlock GA",,454294,DTCT0023180,2224514,DTCC00479501,795192,24303
CHEMBL442843,P23975,,AZMKBJHIXZCVNL-BXKDBHETSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,>,10000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816217,DTCC00567195,877639,32733
CHEMBL442843,P23975,,AZMKBJHIXZCVNL-BXKDBHETSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,71990,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816108,DTCC00567195,877639,32733
CHEMBL442924,P23975,,WQZFFUKLKSSLDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,151,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602742,DTCC00564653,1471181,32656
CHEMBL443,P23975,SULFAMETHOXAZOLE,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460934,DTCC00134101,315670,46191
CHEMBL443,P23975,SULFAMETHOXAZOLE,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460935,DTCC00134101,315670,46191
CHEMBL443090,P23975,,KATOUFNMRLTTPE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,8400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620129,DTCC00570248,1136282,33285
CHEMBL443797,P23975,,QYIDZGIRYRGUNF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,180,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,823804,DTCC00219045,1968064,15898
CHEMBL443797,P23975,,QYIDZGIRYRGUNF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,42,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,823801,DTCC00219045,1968064,15898
CHEMBL443922,P23975,,RUEHEMMKOYGDGT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,290,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654486,DTCC00514072,2036891,30519
CHEMBL443952,P23975,,FHNHVNKWEHYJDJ-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,1000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447059,DTCC00561321,2004539,30886
CHEMBL443979,P23975,,WSZDFPKNUKEBNH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19445453,KI,>,6000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human NET expressed in HEK293 cells,,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,2009,52,11,"Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH",,523086,DTCT0023180,2826448,DTCC00536198,1756442,33656
CHEMBL443979,P23975,,WSZDFPKNUKEBNH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19445453,KI,>,6000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,2009,52,11,"Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH",,523089,DTCT0023180,2826457,DTCC00536198,1756442,33656
CHEMBL444412,P23975,KF-A2,RINBNPPEMJIWTC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007,51,11,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923,DTCT0023180,2718424,DTCC00005706,682771,34126
CHEMBL444540,P23975,,HGUDCSBIBQSBGQ-GNAFDRTKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16509591,KI,=,103,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,2006,49,5,"Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC",,335144,DTCT0023180,1902467,DTCC00416855,1372890,20396
CHEMBL444633,P23975,RIFABUTIN,ATEBXHFBFRCZMA-VXTBVIBXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472946,DTCC00465352,1092349,46191
CHEMBL444633,P23975,RIFABUTIN,ATEBXHFBFRCZMA-VXTBVIBXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472947,DTCC00465352,1092349,46191
CHEMBL444742,P23975,,SQKSQRKXCFBFLF-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,8,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445642,DTCC00561225,165011,30880
CHEMBL444742,P23975,,SQKSQRKXCFBFLF-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447048,DTCC00561225,165014,30886
CHEMBL444985,P23975,,ZINGRQZUIVEPKX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,4400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620113,DTCC00570244,586439,33285
CHEMBL445,P23975,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,1.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739644,DTCC00134116,2107124,68466
CHEMBL445,P23975,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,21,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739643,DTCC00134116,2107124,68466
CHEMBL445,P23975,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,4.37,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739642,DTCC00134116,2107119,68566
CHEMBL445,P23975,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10715164,KI,=,6.3,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards human NET (norepinephrine) transporter,,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,2000,43,5,"Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK",,140882,DTCT0023180,874366,DTCC00134116,1066381,16105
CHEMBL445,P23975,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,1.49,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739645,DTCC00134116,2107118,69177
CHEMBL445,P23975,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,8.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739641,DTCC00134116,2107118,69177
CHEMBL445,P23975,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3.21,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399285,DTCC00134116,1092345,46191
CHEMBL445,P23975,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3.18,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399286,DTCC00134116,1092345,46191
CHEMBL445082,P23975,,AROKURNCLIVVKP-RDTXWAMCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,26,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445665,DTCC00561214,1038731,30880
CHEMBL445082,P23975,,AROKURNCLIVVKP-RDTXWAMCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,40,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447070,DTCC00561214,1038736,30886
CHEMBL445185,P23975,,WNSBUBHOLORHPN-CVEARBPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,2000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649859,DTCC00509585,1049633,31203
CHEMBL445206,P23975,ISOEUGENOL,BJIOGJUNALELMI-ARJAWSKDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428920,DTCC00115215,1830686,46191
CHEMBL445206,P23975,ISOEUGENOL,BJIOGJUNALELMI-ARJAWSKDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428921,DTCC00115215,1830686,46191
CHEMBL445743,P23975,,NTKCCYPDVMIZQP-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,300,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725283,DTCC00537256,261341,34196
CHEMBL445747,P23975,,KNMQSIXWQIRNCP-NDXYWBNTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19284718,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,2009,52,7,"Cho SJ, Jensen NH, Kurome T, Kadari S, Manzano ML, Malberg JE, Caldarone B, Roth BL, Kozikowski AP",,566868,DTCT0023180,2486839,DTCC00534485,1696627,33028
CHEMBL445794,P23975,,IQZVBBALTJFFCB-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,2900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620031,DTCC00570022,197124,33285
CHEMBL445800,P23975,,QHIKEMVZWMXQMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,1499,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657187,DTCC00509466,617978,30478
CHEMBL445800,P23975,,QHIKEMVZWMXQMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,1034,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657157,DTCC00509466,617978,30478
CHEMBL445977,P23975,,CBSIZHJYORKATA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,100000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561512,DTCC00541555,1885520,28872
CHEMBL446,P23975,SULFAMETHAZINE,ASWVTGNCAZCNNR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486846,DTCC00134119,574627,46191
CHEMBL446,P23975,SULFAMETHAZINE,ASWVTGNCAZCNNR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486847,DTCC00134119,574627,46191
CHEMBL446084,P23975,(R)-NORFLUOXETINE,WIQRCHMSJFFONW-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,IC50,=,1995,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560772,DTCT0023180,2467268,DTCC00006521,10407,31698
CHEMBL446084,P23975,(R)-NORFLUOXETINE,WIQRCHMSJFFONW-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,KI,=,7490,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560769,DTCT0023180,2467244,DTCC00006521,10407,31698
CHEMBL44618,P23975,CHLOROFORM,HEDRZPFGACZZDS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7358057,DTCC00187868,1383774,46191
CHEMBL44618,P23975,CHLOROFORM,HEDRZPFGACZZDS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7358058,DTCC00187868,1383774,46191
CHEMBL446230,P23975,,PEOZAOHZZSCNEV-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,2600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620060,DTCC00570091,68162,33285
CHEMBL446260,P23975,,IFOBTLHRUXGTFC-RBUKOAKNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,>,10000,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793575,DTCC00514534,240220,31630
CHEMBL446281,P23975,,AILKVNMCCFEAQT-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,>,322,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766851,DTCC00543414,1632350,30743
CHEMBL446321,P23975,,OPZIFOOJYWJNSE-DLBZAZTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793568,DTCC00513583,1147225,31630
CHEMBL446481,P23975,,FDNFLRXXOIWCQA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,630,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654477,DTCC00526397,1620867,30519
CHEMBL44657,P23975,ETOPOSIDE,VJJPUSNTGOMMGY-MRVIYFEKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7332889,DTCC00188464,51468,46191
CHEMBL44657,P23975,ETOPOSIDE,VJJPUSNTGOMMGY-MRVIYFEKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7332890,DTCC00188464,51468,46191
CHEMBL446570,P23975,,WPKZZLMFEYGCJR-WBVHZDCISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,660,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649853,DTCC00113736,1982803,31203
CHEMBL446809,P23975,,IJZRPGINHKPXPE-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,6,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686044,DTCC00544973,533147,31294
CHEMBL447,P23975,SECOBARBITAL,KQPKPCNLIDLUMF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455969,DTCC00134177,1862719,46191
CHEMBL447,P23975,SECOBARBITAL,KQPKPCNLIDLUMF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455970,DTCC00134177,1862719,46191
CHEMBL447183,P23975,AR-C102222,GIZYIOOBBUHOBS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21398123,IC50,,,,,,,,,,,,,,,,,Inhibition of NET,Not Active,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,2011,21,8,"Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV",,740010,DTCT0023180,5908705,DTCC01742353,394357,44050
CHEMBL447598,P23975,,RFOPOIPYLVKPSZ-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,520,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649838,DTCC00509803,790749,31203
CHEMBL447750,P23975,,OOZOQFAQHUVOAM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,2322,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816206,DTCC00567114,1395246,32733
CHEMBL447750,P23975,,OOZOQFAQHUVOAM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,4543,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816096,DTCC00567114,1395246,32733
CHEMBL447825,P23975,,KHKLNHSDQIKVSU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,61,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816203,DTCC00567053,392975,32733
CHEMBL447825,P23975,,KHKLNHSDQIKVSU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,1106,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816093,DTCC00567053,392975,32733
CHEMBL44814,P23975,CARBON TETRACHLORIDE,VZGDMQKNWNREIO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7260599,DTCC00187852,1512806,46191
CHEMBL44814,P23975,CARBON TETRACHLORIDE,VZGDMQKNWNREIO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7260600,DTCC00187852,1512806,46191
CHEMBL448375,P23975,,WINONEAFBRSOAL-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,17,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445661,DTCC00561272,1232097,30880
CHEMBL448375,P23975,,WINONEAFBRSOAL-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447054,DTCC00561272,1232095,30886
CHEMBL448648,P23975,,KLWUNOLDNDXUMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,ACTIVITY,=,38,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487430,DTCT0023180,2657271,DTCC00113744,392264,30478
CHEMBL448648,P23975,,KLWUNOLDNDXUMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,INHIBITION,=,31,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487429,DTCT0023180,2657251,DTCC00113744,392264,30478
CHEMBL448689,P23975,,YBOXDTVMHIUYEG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,4900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654476,DTCC00526398,99874,30519
CHEMBL44884,P23975,ETHAMBUTOL,AEUTYOVWOVBAKS-UWVGGRQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7324173,DTCC00187691,381010,46191
CHEMBL44884,P23975,ETHAMBUTOL,AEUTYOVWOVBAKS-UWVGGRQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7324174,DTCC00187691,381010,46191
CHEMBL448897,P23975,,JZFGPXKITYCBJZ-CVEARBPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,550,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725292,DTCC00537402,1745252,34196
CHEMBL448900,P23975,,YYVFHUIYCOUOCD-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,62,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767518,DTCC00543413,1567572,30743
CHEMBL448912,P23975,,FZRYLYZNENTFJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,347,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816213,DTCC00567191,845202,32733
CHEMBL448912,P23975,,FZRYLYZNENTFJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816104,DTCC00567191,845202,32733
CHEMBL448953,P23975,,ZUFCXVFSSJFSOT-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,303,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657191,DTCC00510085,1070574,30478
CHEMBL448953,P23975,,ZUFCXVFSSJFSOT-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,339,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657162,DTCC00510085,1070574,30478
CHEMBL449015,P23975,,WNTGIUMXZUDPIG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,530,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654464,DTCC00526523,1971500,30519
CHEMBL449047,P23975,,AHRDEWSZTRJWJB-BTXUNPJVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,75,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559258,DTCC00541335,1178509,28814
CHEMBL449145,P23975,,UHXIHVPCQYVYLG-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,92,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767524,DTCC00543357,371545,30743
CHEMBL449235,P23975,,HYXUARRYTJMRKQ-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,118,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765592,DTCC00543847,1006121,30733
CHEMBL449277,P23975,,OIJZGDHTGREJNF-UHGJSFDGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18644726,KI,=,772,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,2008,18,16,"Funke U, Fischer S, Hiller A, Scheunemann M, Deuther-Conrad W, Brust P, Steinbach J",,509626,DTCT0023180,2774191,DTCC00543539,1632351,30803
CHEMBL45,P23975,MELATONIN,DRLFMBDRBRZALE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415011,DTCC00134723,50368,46191
CHEMBL45,P23975,MELATONIN,DRLFMBDRBRZALE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7415012,DTCC00134723,50368,46191
CHEMBL450184,P23975,,OORQAYQYEWAQJS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18793858,KI,>,1000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,2008,16,19,"Mavel S, Vercouillie J, Garreau L, Raguza T, Ravna AW, Chalon S, Guilloteau D, Emond P",,492712,DTCT0023180,2458485,DTCC00547525,1427354,32562
CHEMBL450435,P23975,,PXHGECKMKPJNDM-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,74,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765585,DTCC00543714,844943,30733
CHEMBL450623,P23975,,ZYQIUGBSDWKKMU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303651,DTCC00500294,2084656,25699
CHEMBL450710,P23975,,GPVPGABIUWQWLB-GXTWGEPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,18,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688229,DTCC00545296,877362,31354
CHEMBL450710,P23975,,GPVPGABIUWQWLB-GXTWGEPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,19,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688208,DTCC00545296,877369,31354
CHEMBL450769,P23975,,PJDWTDSVCNJUGD-OLZOCXBDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,1864,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816224,DTCC00567294,1232164,32733
CHEMBL450769,P23975,,PJDWTDSVCNJUGD-OLZOCXBDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,455,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816115,DTCC00567294,1232164,32733
CHEMBL450813,P23975,,RCMVHXAYSDWNBI-GFCCVEGCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,37,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766841,DTCC00543486,1147618,30743
CHEMBL450907,P23975,,KFFYQORCJDVDTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,1930,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816231,DTCC00114087,812351,32733
CHEMBL450907,P23975,,KFFYQORCJDVDTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,5133,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816232,DTCC00114087,812352,32733
CHEMBL450907,P23975,,KFFYQORCJDVDTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,10600,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816122,DTCC00114087,812351,32733
CHEMBL450907,P23975,,KFFYQORCJDVDTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,30430,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816123,DTCC00114087,812352,32733
CHEMBL450907,P23975,,KFFYQORCJDVDTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,IC50,=,1930,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533,DTCT0023180,2809676,DTCC00114087,811747,32805
CHEMBL450907,P23975,,KFFYQORCJDVDTB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,KI,=,10600,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530,DTCT0023180,2809649,DTCC00114087,811747,32805
CHEMBL450987,P23975,,UNRUJFXXAULDMY-NWDGAFQWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,3392,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816222,DTCC00567292,261732,32733
CHEMBL450987,P23975,,UNRUJFXXAULDMY-NWDGAFQWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,9085,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816113,DTCC00567292,261732,32733
CHEMBL451,P23975,CHLORDIAZEPOXIDE,ANTSCNMPPGJYLG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7349421,DTCC00134272,574622,46191
CHEMBL451,P23975,CHLORDIAZEPOXIDE,ANTSCNMPPGJYLG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7349422,DTCC00134272,574622,46191
CHEMBL451071,P23975,,GFNCCLBUKZBTIA-LOPIXSETSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,150,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559259,DTCC00541334,436590,28814
CHEMBL451105,P23975,,DIEUHEQWLCVFKO-DNVCBOLYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,700,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445666,DTCC00561213,197006,30880
CHEMBL451120,P23975,,WPGUQXCZGQYNLZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,7900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654475,DTCC00526399,1776992,30519
CHEMBL451165,P23975,,GYURBKTVOWBCTD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,50,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654474,DTCC00526400,811855,30519
CHEMBL451232,P23975,,MSSKZLHARRXFKT-VNUWRVCDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19284718,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,2009,52,7,"Cho SJ, Jensen NH, Kurome T, Kadari S, Manzano ML, Malberg JE, Caldarone B, Roth BL, Kozikowski AP",,566868,DTCT0023180,2486840,DTCC00533610,1664522,33028
CHEMBL451264,P23975,,SAGAKZDNFJIHDD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18793858,KI,>,2500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,2008,16,19,"Mavel S, Vercouillie J, Garreau L, Raguza T, Ravna AW, Chalon S, Guilloteau D, Emond P",,492712,DTCT0023180,2458482,DTCC00546808,1971736,32562
CHEMBL451460,P23975,,FXQBHPKGRGPIKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,1400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620093,DTCC00570171,1717159,33285
CHEMBL451500,P23975,,ILYANWOXFYOOPX-TUUXNKATSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,IC50,=,7441,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533,DTCT0023180,2809680,DTCC00114090,1588200,32805
CHEMBL451500,P23975,,ILYANWOXFYOOPX-TUUXNKATSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,KI,=,7441,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530,DTCT0023180,2809653,DTCC00114090,1588200,32805
CHEMBL451620,P23975,,IOEFEBQWPLLQHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793576,DTCC00514533,111146,31630
CHEMBL451652,P23975,,SUAFTJAVJHXARK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,92,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816205,DTCC00567113,812347,32733
CHEMBL451652,P23975,,SUAFTJAVJHXARK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,2013,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816095,DTCC00567113,812347,32733
CHEMBL451837,P23975,,GNCUMPKNBKWCMB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,>,10000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816216,DTCC00567194,1653629,32733
CHEMBL451837,P23975,,GNCUMPKNBKWCMB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816107,DTCC00567194,1653629,32733
CHEMBL452,P23975,CLONAZEPAM,DGBIGWXXNGSACT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7371699,DTCC00134302,574623,46191
CHEMBL452,P23975,CLONAZEPAM,DGBIGWXXNGSACT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7371700,DTCC00134302,574623,46191
CHEMBL452376,P23975,,OLYZEORLRJZNQC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,760,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654481,DTCC00526184,1070773,30519
CHEMBL452429,P23975,,DZEOBMAMUUMJNJ-SJCJKPOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,230,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447055,DTCC00561324,229419,30886
CHEMBL45245,P23975,PHENANTHRIDIN-6(5H)-ONE,RZFVLEJOHSLEFR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282477,DTCC01739960,2057642,46191
CHEMBL45245,P23975,PHENANTHRIDIN-6(5H)-ONE,RZFVLEJOHSLEFR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282478,DTCC01739960,2057642,46191
CHEMBL452861,P23975,(-)-PROPANOLOL ,AQHHHDLHHXJYJD-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468822,DTCC00515151,1253328,46191
CHEMBL452861,P23975,(-)-PROPANOLOL ,AQHHHDLHHXJYJD-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468823,DTCC00515151,1253328,46191
CHEMBL452928,P23975,,IBMMANZZPBFJNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,1541,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816211,DTCC00567119,11755,32733
CHEMBL452928,P23975,,IBMMANZZPBFJNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,634,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816102,DTCC00567119,11755,32733
CHEMBL453,P23975,SULFISOXAZOLE,NHUHCSRWZMLRLA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486986,DTCC00134318,477922,46191
CHEMBL453,P23975,SULFISOXAZOLE,NHUHCSRWZMLRLA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486987,DTCC00134318,477922,46191
CHEMBL453061,P23975,,WZVJYHZPOKMITP-WBVHZDCISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,630,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649839,DTCC00509802,2047907,31203
CHEMBL453062,P23975,,FDBFTQAPQQWDDD-CRAIPNDOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,190,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649841,DTCC00509800,436230,31203
CHEMBL453321,P23975,,WZVJYHZPOKMITP-NVXWUHKLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,950,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649837,DTCC00509804,1725937,31203
CHEMBL453493,P23975,"(3,4-DICHLOROPHENYL)(2-((DIMETHYLAMINO)METHYL)PHENYL)METHANONE",RYTIZBPXUHTIDS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,8600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654497,DTCC00006368,1362389,30519
CHEMBL453838,P23975,,VDFAJYFMKVKZLC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,47,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686039,DTCC00513567,952964,31294
CHEMBL453838,P23975,,VDFAJYFMKVKZLC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,47,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789620,DTCC00513567,941273,31613
CHEMBL453996,P23975,,MUOXAGUZMVATIC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,1800,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620105,DTCC00570174,1653671,33285
CHEMBL454507,P23975,,QXJNTMSGRQZRFO-PDZHLSQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,IC50,=,6553,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560772,DTCT0023180,2467271,DTCC00530921,1685339,31698
CHEMBL454507,P23975,,QXJNTMSGRQZRFO-PDZHLSQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,KI,=,4600,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560769,DTCT0023180,2467247,DTCC00530921,1685339,31698
CHEMBL454674,P23975,,VQXFWDGKPFYMCF-DLBZAZTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,11,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793569,DTCC00513582,338603,31630
CHEMBL454675,P23975,,QKJSLGBMXQASRH-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,17,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793566,DTCC00513585,111136,31630
CHEMBL454770,P23975,,JZKRUQHCKJXZSS-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793589,DTCC00513820,1502900,31630
CHEMBL454798,P23975,,MYUDLLKSAURVGJ-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,240,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725280,DTCC00537202,1653266,34196
CHEMBL455221,P23975,,XPMTXFPUXPYNCB-LSDHHAIUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,7124,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816233,DTCC00567387,747949,32733
CHEMBL455221,P23975,,XPMTXFPUXPYNCB-LSDHHAIUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,2222,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816124,DTCC00567387,747949,32733
CHEMBL455447,P23975,,OQRZMLVFIJAOKO-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,10,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445676,DTCC00514461,1653573,30880
CHEMBL455447,P23975,,OQRZMLVFIJAOKO-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,7,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793581,DTCC00514461,1664307,31630
CHEMBL455448,P23975,,YIEXSVBTWQZEGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793580,DTCC00514462,273034,31630
CHEMBL455937,P23975,,LRISBEQMFXITND-HEHWQVRWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,>,3000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780261,DTCC00562403,953144,31509
CHEMBL456,P23975,ETHACRYNIC ACID,AVOLMBLBETYQHX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7319916,DTCC00134433,1155679,46191
CHEMBL456,P23975,ETHACRYNIC ACID,AVOLMBLBETYQHX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7319917,DTCC00134433,1155679,46191
CHEMBL456017,P23975,,WFCMRRKVDOAHNR-MFKMUULPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,>,10000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816220,DTCC00567290,1038798,32733
CHEMBL456017,P23975,,WFCMRRKVDOAHNR-MFKMUULPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,48870,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816111,DTCC00567290,1038798,32733
CHEMBL456221,P23975,,UNRUJFXXAULDMY-VXGBXAGGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,7983,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816221,DTCC00567291,165076,32733
CHEMBL456221,P23975,,UNRUJFXXAULDMY-VXGBXAGGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,24120,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816112,DTCC00567291,165076,32733
CHEMBL456222,P23975,,PJDWTDSVCNJUGD-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,1774,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816223,DTCC00567293,229493,32733
CHEMBL456222,P23975,,PJDWTDSVCNJUGD-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,1782,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816114,DTCC00567293,229493,32733
CHEMBL456223,P23975,,CLSUYIGLXGEXLU-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,4746,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816226,DTCC00567296,941860,32733
CHEMBL456223,P23975,,CLSUYIGLXGEXLU-CHWSQXEVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,8520,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816117,DTCC00567296,941860,32733
CHEMBL456638,P23975,,HDLNQDARKJUPIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,210,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816208,DTCC00567116,910293,32733
CHEMBL456638,P23975,,HDLNQDARKJUPIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,1494,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816098,DTCC00567116,910293,32733
CHEMBL456639,P23975,,LKTJWDXCFJJUGY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,360,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816209,DTCC00567117,2037413,32733
CHEMBL456639,P23975,,LKTJWDXCFJJUGY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,2736,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816100,DTCC00567117,2037413,32733
CHEMBL456654,P23975,,ABAOWFCFAADMKA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,8,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602750,DTCC00564544,240800,32656
CHEMBL456807,P23975,PHENYLHYDRAZINE,HKOOXMFOFWEVGF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402324,DTCC00514646,413975,46191
CHEMBL456807,P23975,PHENYLHYDRAZINE,HKOOXMFOFWEVGF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402325,DTCC00514646,413975,46191
CHEMBL457,P23975,GEMFIBROZIL,HEMJJKBWTPKOJG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7327186,DTCC00134705,1285875,46191
CHEMBL457,P23975,GEMFIBROZIL,HEMJJKBWTPKOJG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7327187,DTCC00134705,1285875,46191
CHEMBL457299,P23975,ETHYLENE GLYCOL,LYCAIKOWRPUZTN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7311524,DTCC00525050,1383777,46191
CHEMBL457299,P23975,ETHYLENE GLYCOL,LYCAIKOWRPUZTN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7311525,DTCC00525050,1383777,46191
CHEMBL457415,P23975,,OXWLQFOLXMGQTM-CHKHYCHESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,180,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780257,DTCC00562399,468558,31509
CHEMBL457416,P23975,,TVDANBVAWXCYSJ-MKRRPMGHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,>,5000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780258,DTCC00562400,2080665,31509
CHEMBL457635,P23975,,JXMNHUDMPQBBLE-BAEQUSMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,1230,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780260,DTCC00562402,1210932,31509
CHEMBL457655,P23975,,JPRQFPVEGGQSSX-CLDCJMNLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,1460,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780264,DTCC00562727,144163,31509
CHEMBL457865,P23975,,LQPCABVKUZFZCC-GNQYJHKCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,21.8,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780251,DTCC00562723,1696971,31509
CHEMBL457866,P23975,,DILAIXDPRRLKOQ-DXWGQUKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,330,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780262,DTCC00562725,1341884,31509
CHEMBL457930,P23975,,OSAULANLOUKVQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602744,DTCC00564604,1726536,32656
CHEMBL457931,P23975,,CRTQNTKRJCYBET-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602743,DTCC00564605,501244,32656
CHEMBL457966,P23975,,XXFWDPHWYVNJQG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,2126,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816215,DTCC00567193,522114,32733
CHEMBL457966,P23975,,XXFWDPHWYVNJQG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,5947,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816106,DTCC00567193,522114,32733
CHEMBL457967,P23975,,AZMKBJHIXZCVNL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,>,10000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816218,DTCC00567196,2037414,32733
CHEMBL457967,P23975,,AZMKBJHIXZCVNL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,57020,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816109,DTCC00567196,2037414,32733
CHEMBL457968,P23975,,TUZLHPUVXHTPCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,374,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816214,DTCC00567192,618697,32733
CHEMBL457968,P23975,,TUZLHPUVXHTPCQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,882,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816105,DTCC00567192,618697,32733
CHEMBL458019,P23975,PARAQUAT DICHLORIDE,FIKAKWIAUPDISJ-UHFFFAOYSA-L,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373946,DTCC00549932,283000,46191
CHEMBL458019,P23975,PARAQUAT DICHLORIDE,FIKAKWIAUPDISJ-UHFFFAOYSA-L,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373947,DTCC00549932,283000,46191
CHEMBL458072,P23975,,UWVXBFZXNOPEDU-CHKHYCHESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,270,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780254,DTCC00562336,371750,31509
CHEMBL458080,P23975,,BTBAPWWSVZCOSR-DXWGQUKGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,2200,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780263,DTCC00562726,1243865,31509
CHEMBL458282,P23975,,GPDDTDCIQUPUIA-MKRRPMGHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,4100,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780256,DTCC00562338,339195,31509
CHEMBL458488,P23975,,KXLFAQOYCLVWOS-LJPFFJIGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,1690,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780253,DTCC00562335,1210929,31509
CHEMBL458639,P23975,,IAIACGGIZWXQIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,23,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816202,DTCC00567052,779941,32733
CHEMBL458639,P23975,,IAIACGGIZWXQIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,2767,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816092,DTCC00567052,779941,32733
CHEMBL459,P23975,METHYLDOPA,CJCSPKMFHVPWAR-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423826,DTCC00135281,185555,46191
CHEMBL459,P23975,METHYLDOPA,CJCSPKMFHVPWAR-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423827,DTCC00135281,185555,46191
CHEMBL459165,P23975,,VHOZFHYPZOTVKS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602753,DTCC00564542,1309326,32656
CHEMBL459165,P23975,,VHOZFHYPZOTVKS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602754,DTCC00564542,1309325,32656
CHEMBL459165,P23975,,VHOZFHYPZOTVKS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,78,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602752,DTCC00564542,1309327,32656
CHEMBL459176,P23975,,OSXVIZKTSFAUPG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602746,DTCC00564602,273636,32656
CHEMBL459332,P23975,,JVTAHMMQYMBPEN-IYIFBUTFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,2040,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780267,DTCC00562787,823788,31509
CHEMBL459333,P23975,,ZSXFOCIJQHAVQI-JRTRGBLZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,2600,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780268,DTCC00562788,1567777,31509
CHEMBL459367,P23975,,BWBCTVUBHWYIEP-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,2857,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816230,DTCC00567386,877643,32733
CHEMBL459367,P23975,,BWBCTVUBHWYIEP-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,20180,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816121,DTCC00567386,877643,32733
CHEMBL459390,P23975,,ZUIXQIJYPVGBQL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,Not Determined,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816235,DTCC00567541,1524366,32733
CHEMBL459390,P23975,,ZUIXQIJYPVGBQL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816126,DTCC00567541,1524366,32733
CHEMBL459391,P23975,,DSDLGRNFGNGRFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,Not Determined,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816236,DTCC00567542,522119,32733
CHEMBL459391,P23975,,DSDLGRNFGNGRFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816127,DTCC00567542,522119,32733
CHEMBL459644,P23975,,YAOMVDAPALQFPR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,INHIBITION,=,29,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487429,DTCT0023180,2657249,DTCC00510087,1426923,30478
CHEMBL459644,P23975,,YAOMVDAPALQFPR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,717,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657153,DTCC00510087,1426923,30478
CHEMBL459730,P23975,,OQIBXTHHXDTIBJ-OAQYLSRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18754613,INHIBITION,<,50,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human cloned NET,,"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.",J. Med. Chem.,2008,51,18,"Donohue SR, Pike VW, Finnema SJ, Truong P, Andersson J, Gulyás B, Halldin C",,512536,DTCT0023180,2562884,DTCC00529017,2036926,31906
CHEMBL459852,P23975,,KVRIVKGFVFCJEI-NTEVMMBTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,577,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657183,DTCC00510088,1264311,30478
CHEMBL459852,P23975,,KVRIVKGFVFCJEI-NTEVMMBTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,187,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657151,DTCC00510088,1264311,30478
CHEMBL46,P23975,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7401674,DTCC00134875,315668,46191
CHEMBL46,P23975,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7401675,DTCC00134875,315668,46191
CHEMBL460204,P23975,,KJRMGZKFHBXRRA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,8530,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816234,DTCC00567388,229494,32733
CHEMBL460204,P23975,,KJRMGZKFHBXRRA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,4064,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816125,DTCC00567388,229494,32733
CHEMBL460291,P23975,LACIDIPINE,GKQPCPXONLDCMU-CCEZHUSRSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,5735,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431376,DTCC00514659,736260,46191
CHEMBL460291,P23975,LACIDIPINE,GKQPCPXONLDCMU-CCEZHUSRSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,5687,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431377,DTCC00514659,736260,46191
CHEMBL460295,P23975,,WGJPAKIMPPHUPQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,2800,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793573,DTCC00514536,984964,31630
CHEMBL460406,P23975,,FOEJRTWJHDIANT-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,3101,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816228,DTCC00567384,1459578,32733
CHEMBL460406,P23975,,FOEJRTWJHDIANT-ZIAGYGMSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,12100,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816119,DTCC00567384,1459578,32733
CHEMBL460407,P23975,,BWBCTVUBHWYIEP-UONOGXRCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,2934,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816229,DTCC00567385,1588797,32733
CHEMBL460407,P23975,,BWBCTVUBHWYIEP-UONOGXRCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,8541,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816120,DTCC00567385,1588797,32733
CHEMBL460499,P23975,CARMOFUR,AOCCBINRVIKJHY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362163,DTCC00515303,51452,46191
CHEMBL460499,P23975,CARMOFUR,AOCCBINRVIKJHY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362164,DTCC00515303,51452,46191
CHEMBL461095,P23975,,ZUFCXVFSSJFSOT-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,46,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657192,DTCC00510084,2068508,30478
CHEMBL461095,P23975,,ZUFCXVFSSJFSOT-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,41,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657163,DTCC00510084,2068508,30478
CHEMBL461143,P23975,,BLWMSZSENYHERE-RBUKOAKNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793563,DTCC00513767,1725986,31630
CHEMBL461148,P23975,,DIIRBUSHKZQLRI-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,22,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789626,DTCC00113858,1296935,31613
CHEMBL461152,P23975,,CFRDDSRHIVKVRS-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,INHIBITION,=,51,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558179,DTCT0023180,2789679,DTCC00513755,876998,31613
CHEMBL461153,P23975,,ATQOTXBBRYXYCL-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,44,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789622,DTCC00513756,392312,31613
CHEMBL461241,P23975,,VAVYBCGVZAGHSF-ZNAMSDCWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,>,3000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780269,DTCC00562789,1788969,31509
CHEMBL461268,P23975,,NZCDMSTWUUULEH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,59,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816204,DTCC00567112,1588791,32733
CHEMBL461268,P23975,,NZCDMSTWUUULEH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816094,DTCC00567112,1588791,32733
CHEMBL461322,P23975,,LXKDYSGDYBBTJV-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,166,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789624,DTCC00113856,2036732,31613
CHEMBL461323,P23975,,VBPKFUYKYAIDNV-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,32,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789625,DTCC00113857,521482,31613
CHEMBL461330,P23975,,KNRWBQQXTOGVJT-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,463,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789621,DTCC00513754,553588,31613
CHEMBL461571,P23975,,DHUATBAZHILHIC-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18701276,IC50,=,2160,NM,,,,,,,,,,,,,,Displacement of radioligand from NET,,Highly functionalized 7-azaindoles as selective PPAR gamma modulators.,Bioorg. Med. Chem. Lett.,2008,18,17,"Debenham SD, Chan A, Lau FW, Liu W, Wood HB, Lemme K, Colwell L, Habulihaz B, Akiyama TE, Einstein M, Doebber TW, Sharma N, Wang CF, Wu M, Berger JP, Meinke PT",,512427,DTCT0023180,2579217,DTCC00512123,1725965,31847
CHEMBL461705,P23975,,NESUISGAACOCQG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,38,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657181,DTCC00510161,164440,30478
CHEMBL461705,P23975,,NESUISGAACOCQG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,18,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657149,DTCC00510161,164440,30478
CHEMBL461706,P23975,,NESUISGAACOCQG-RMRYJAPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,540,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657180,DTCC00510162,1329483,30478
CHEMBL461706,P23975,,NESUISGAACOCQG-RMRYJAPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,214,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657148,DTCC00510162,1329483,30478
CHEMBL461707,P23975,,NESUISGAACOCQG-ZEECNFPPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,25,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657179,DTCC00510163,617989,30478
CHEMBL461707,P23975,,NESUISGAACOCQG-ZEECNFPPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,17,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657147,DTCC00510163,617989,30478
CHEMBL461727,P23975,AMYGDALIN,XUCIJNAGGSZNQT-JHSLDZJXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301179,DTCC00113956,1674140,46191
CHEMBL461727,P23975,AMYGDALIN,XUCIJNAGGSZNQT-JHSLDZJXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301180,DTCC00113956,1674140,46191
CHEMBL462311,P23975,,FOEJRTWJHDIANT-UONOGXRCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,481,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816227,DTCC00567297,1588794,32733
CHEMBL462311,P23975,,FOEJRTWJHDIANT-UONOGXRCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,2440,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816118,DTCC00567297,1588794,32733
CHEMBL462384,P23975,,BZEJZLOEKMOQPW-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793565,DTCC00513643,888310,31630
CHEMBL462401,P23975,,YIEXSVBTWQZEGZ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,770,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793578,DTCC00514531,240219,31630
CHEMBL462402,P23975,,RWLJNOQFNVGFMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,10,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793577,DTCC00514532,758670,31630
CHEMBL462410,P23975,,CYHDCZGFQGQXJH-CLFYSBASSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053782,KI,=,67.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,2008,51,24,"Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Camp VM, Malveaux EJ, Votaw JR, Howell L, Owens MJ, Goodman MM",,561314,DTCT0023180,2799894,DTCC00515326,694206,31538
CHEMBL462431,P23975,,MBCIBUXZJAIISR-VURMDHGXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053782,KI,=,109.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,2008,51,24,"Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Camp VM, Malveaux EJ, Votaw JR, Howell L, Owens MJ, Goodman MM",,561314,DTCT0023180,2799892,DTCC00515265,1438199,31538
CHEMBL462547,P23975,URETHANE,JOYRKODLDBILNP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450257,DTCC00513785,1155688,46191
CHEMBL462547,P23975,URETHANE,JOYRKODLDBILNP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450258,DTCC00513785,1155688,46191
CHEMBL462585,P23975,,VKZWZSZGPDLBNV-FPLPWBNLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053782,KI,=,30.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,2008,51,24,"Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Camp VM, Malveaux EJ, Votaw JR, Howell L, Owens MJ, Goodman MM",,561314,DTCT0023180,2799895,DTCC00515327,1147252,31538
CHEMBL462805,P23975,POLYGALATENOSIDE B,PBKBHCJPMCMBCZ-GDLYOHBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16989524,IC50,=,6040,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane,,Antidepressant principles of the roots of Polygala tenuifolia.,J. Nat. Prod.,2006,69,9,"Cheng MC, Li CY, Ko HC, Ko FN, Lin YL, Wu TS",,526495,DTCT0023180,2737611,DTCC00506408,1599646,29650
CHEMBL463000,P23975,POLYGALATENOSIDE A,JDGKZYSACWLQKT-RBRZPYPVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16989524,IC50,=,30000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane,,Antidepressant principles of the roots of Polygala tenuifolia.,J. Nat. Prod.,2006,69,9,"Cheng MC, Li CY, Ko HC, Ko FN, Lin YL, Wu TS",,526495,DTCT0023180,2737609,DTCC00506407,1664210,29650
CHEMBL463387,P23975,,XBZYPUYXVGRGJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602741,DTCC00564654,2048527,32656
CHEMBL463388,P23975,,YOAPWCHKPSMTER-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,288,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602739,DTCC00564656,501246,32656
CHEMBL463389,P23975,,PNEAEOHMGHCGPC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,71,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602738,DTCC00117093,2048528,32656
CHEMBL463431,P23975,,BKWWNLJWEVOUOL-DLBZAZTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533,DTCT0023180,2809678,DTCC00114088,2068587,32805
CHEMBL463431,P23975,,BKWWNLJWEVOUOL-DLBZAZTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,KI,=,39119,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530,DTCT0023180,2809651,DTCC00114088,2068587,32805
CHEMBL463431,P23975,,BKWWNLJWEVOUOL-DLBZAZTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,IC50,>,100000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602900,DTCT0023180,3162403,DTCC00114088,2069598,36631
CHEMBL463431,P23975,,BKWWNLJWEVOUOL-DLBZAZTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,KI,=,39119,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602897,DTCT0023180,3162379,DTCC00114088,2069598,36631
CHEMBL463585,P23975,,FIIZGBLPZZYXCS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602737,DTCC00117094,1917912,32656
CHEMBL464099,P23975,N-METHYLLAUROTETANINE,ZFLRVRLYWHNAEC-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25695425,KI,>,950,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK cell membranes by radioligand binding assay,,Semisynthetic Studies on and Biological Evaluation of N-Methyllaurotetanine Analogues as Ligands for 5-HT Receptors.,J. Nat. Prod.,2015,78,4,"Madapa S, Harding WW",,1499799,DTCT0023180,14439266,DTCC00005857,624816,62678
CHEMBL464422,P23975,,FOEJRTWJHDIANT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,IC50,=,481,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533,DTCT0023180,2809675,DTCC00114086,1906099,32805
CHEMBL464422,P23975,,FOEJRTWJHDIANT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,KI,=,2440,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530,DTCT0023180,2809648,DTCC00114086,1906099,32805
CHEMBL465123,P23975,SEPROXETINE,WIQRCHMSJFFONW-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,3050,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14744098,DTCC00530866,2108226,68466
CHEMBL465123,P23975,SEPROXETINE,WIQRCHMSJFFONW-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,3947,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14744097,DTCC00530866,2108226,68466
CHEMBL465123,P23975,SEPROXETINE,WIQRCHMSJFFONW-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,1426,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14744099,DTCC00530866,2108608,68566
CHEMBL465123,P23975,SEPROXETINE,WIQRCHMSJFFONW-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,IC50,=,2806,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560772,DTCT0023180,2467267,DTCC00530866,585943,31698
CHEMBL465123,P23975,SEPROXETINE,WIQRCHMSJFFONW-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,KI,=,6186,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560769,DTCT0023180,2467243,DTCC00530866,585943,31698
CHEMBL465515,P23975,,AVSJNVNTDDYDEP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,10500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620125,DTCC00570247,1199896,33285
CHEMBL466006,P23975,,KYTHDBXSBSSRTI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19445453,KI,>,6000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human NET expressed in HEK293 cells,,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,2009,52,11,"Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH",,523086,DTCT0023180,2826447,DTCC00536280,404440,33656
CHEMBL466006,P23975,,KYTHDBXSBSSRTI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19445453,KI,>,6000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,2009,52,11,"Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH",,523089,DTCT0023180,2826456,DTCC00536280,404440,33656
CHEMBL466187,P23975,,MCNALKIPDZCJNZ-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19067522,KI,=,3.14,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,2009,52,1,"Zeng F, Mun J, Jarkas N, Stehouwer JS, Voll RJ, Tamagnan GD, Howell L, Votaw JR, Kilts CD, Nemeroff CB, Goodman MM",,560274,DTCT0023180,2450475,DTCC00529992,747479,31766
CHEMBL466293,P23975,,ZDXWQKDOOAYJBD-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,62,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725279,DTCC00537201,294627,34196
CHEMBL466500,P23975,,YDGFCJZXRYFURC-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,20,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725281,DTCC00537254,327282,34196
CHEMBL466501,P23975,,ZCUPCXFJNBQNMK-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,23,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725282,DTCC00537255,1745249,34196
CHEMBL466670,P23975,,IZYQNPOIOLPIRC-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,156,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725293,DTCC00537404,196714,34196
CHEMBL466963,P23975,,BSMJJWYXCCOYNP-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,31,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767528,DTCC00543285,1696743,30743
CHEMBL467,P23975,HYDROXYUREA,VSNHCAURESNICA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7317160,DTCC00136099,1155681,46191
CHEMBL467,P23975,HYDROXYUREA,VSNHCAURESNICA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7317161,DTCC00136099,1155681,46191
CHEMBL467094,P23975,NANTENINE,WSVWKHTVFGTTKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19963380,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET,,Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.,Bioorg. Med. Chem. Lett.,2010,20,2,"Legendre O, Pecic S, Chaudhary S, Zimmerman SM, Fantegrossi WE, Harding WW",,604293,DTCT0023180,3169950,DTCC00115128,663129,36881
CHEMBL467123,P23975,,BJBCUOODXPAOKN-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,34,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725290,DTCC00537330,618308,34196
CHEMBL467124,P23975,,OQXFVNHXQYQZBS-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,INHIBITION,=,32,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500245,DTCT0023180,2725295,DTCC00537332,1459203,34196
CHEMBL467323,P23975,,RZKZTKPGTZKVOQ-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,12,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725287,DTCC00537327,779558,34196
CHEMBL467323,P23975,,RZKZTKPGTZKVOQ-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,12,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217336,DTCC00537327,792110,37100
CHEMBL467324,P23975,,ITZFVZTXKPPHPP-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,110,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725289,DTCC00537329,1264623,34196
CHEMBL467335,P23975,,STZYVQIHBQCDSY-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,INHIBITION,=,32,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500245,DTCT0023180,2725296,DTCC00537401,1329780,34196
CHEMBL467432,P23975,,BTDIKAPSRZPGSC-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19067522,KI,=,1.02,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,2009,52,1,"Zeng F, Mun J, Jarkas N, Stehouwer JS, Voll RJ, Tamagnan GD, Howell L, Votaw JR, Kilts CD, Nemeroff CB, Goodman MM",,560274,DTCT0023180,2450476,DTCC00529991,10392,31766
CHEMBL467512,P23975,,KCFUXTYNOWCQBR-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,400,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725284,DTCC00537257,1556119,34196
CHEMBL467513,P23975,,WGKLCHBGQMKIIW-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,99,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725285,DTCC00537258,1716788,34196
CHEMBL467736,P23975,,SYDKDXKLTMXNAA-JXLXBRSFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19284718,KI,=,3404,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,2009,52,7,"Cho SJ, Jensen NH, Kurome T, Kadari S, Manzano ML, Malberg JE, Caldarone B, Roth BL, Kozikowski AP",,566868,DTCT0023180,2486833,DTCC00534420,1632240,33028
CHEMBL468,P23975,THALIDOMIDE,UEJJHQNACJXSKW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459243,DTCC00136280,348406,46191
CHEMBL468,P23975,THALIDOMIDE,UEJJHQNACJXSKW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459244,DTCC00136280,348406,46191
CHEMBL469,P23975,KETOROLAC,OZWKMVRBQXNZKK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435541,DTCC00136324,120972,46191
CHEMBL469,P23975,KETOROLAC,OZWKMVRBQXNZKK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435542,DTCC00136324,120972,46191
CHEMBL469068,P23975,,DINOQTNPFRDVRK-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,39,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767523,DTCC00543358,1470949,30743
CHEMBL469150,P23975,,VIHUCKRDYCSWQL-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,217,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725276,DTCC00537198,99978,34196
CHEMBL469150,P23975,,VIHUCKRDYCSWQL-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,217,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217334,DTCC00537198,112477,37100
CHEMBL469151,P23975,,CKTXYRYJADRLRV-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,61,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725277,DTCC00537199,618306,34196
CHEMBL469222,P23975,,ANVIRSRIYYSFBV-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,31,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767525,DTCC00543356,79272,30743
CHEMBL469233,P23975,,FXQFRAJLWAPPQJ-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,94,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767520,DTCC00543361,533130,30743
CHEMBL469458,P23975,,OSFVTFVGHYSFBU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,INHIBITION,=,34,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487429,DTCT0023180,2657248,DTCC00113692,1716493,30478
CHEMBL469458,P23975,,OSFVTFVGHYSFBU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,519,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657161,DTCC00113692,1716493,30478
CHEMBL469459,P23975,,JHIFTPLQHSGJLO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,600,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657190,DTCC00113693,67426,30478
CHEMBL469459,P23975,,JHIFTPLQHSGJLO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,514,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657160,DTCC00113693,67426,30478
CHEMBL469460,P23975,,ZASZYPPXOGNZRV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,870,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657189,DTCC00113694,811634,30478
CHEMBL469460,P23975,,ZASZYPPXOGNZRV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,745,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657159,DTCC00113694,811634,30478
CHEMBL469475,P23975,,PXVMYRXIGXGAFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,92,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657170,DTCC00509473,2036680,30478
CHEMBL469475,P23975,,PXVMYRXIGXGAFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,61,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657139,DTCC00509473,2036680,30478
CHEMBL469476,P23975,,XQNGYGNOPUIZQG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,284,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657173,DTCC00509470,1873744,30478
CHEMBL469476,P23975,,XQNGYGNOPUIZQG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,140,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657142,DTCC00509470,1873744,30478
CHEMBL469551,P23975,,PYEILVKGQDUINV-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620097,DTCC00570172,779969,33285
CHEMBL469552,P23975,,SHJHTXWKDLOBQS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,1900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620109,DTCC00570175,425659,33285
CHEMBL469605,P23975,,ZCVDRKAWDMMKKP-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,3000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620056,DTCC00570090,1330216,33285
CHEMBL469606,P23975,,ZCVDRKAWDMMKKP-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Not Determined,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620064,DTCC00570092,2037460,33285
CHEMBL469607,P23975,,MLXZSGRSLJXYNT-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,3000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620072,DTCC00570094,360263,33285
CHEMBL469666,P23975,,ZWZSMMPAZKEDJW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,INHIBITION,=,34,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487429,DTCT0023180,2657229,DTCC00113691,2003927,30478
CHEMBL469667,P23975,,DJVJRXDBDBMWFD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,147,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657177,DTCC00113696,1362201,30478
CHEMBL469667,P23975,,DJVJRXDBDBMWFD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,91,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657145,DTCC00113696,1362201,30478
CHEMBL469668,P23975,WAY-256805,DJVJRXDBDBMWFD-JPKZNVRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,82,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657174,DTCC00005224,1458894,30478
CHEMBL469668,P23975,WAY-256805,DJVJRXDBDBMWFD-JPKZNVRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,50,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657143,DTCC00005224,1458894,30478
CHEMBL469809,P23975,,IQZVBBALTJFFCB-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,1200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620036,DTCC00570023,1199890,33285
CHEMBL469810,P23975,,KZMOSMDAUNHNBH-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,6800,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620040,DTCC00570024,489897,33285
CHEMBL469811,P23975,,LMGLVWVNPWWAAK-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,10600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620044,DTCC00570025,1427631,33285
CHEMBL469812,P23975,,QBEXADKSFJNYHO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620048,DTCC00570026,489898,33285
CHEMBL469887,P23975,,CURALKDCIXHBQR-JTDONDQYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,454,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655381,DTCC00509451,1296885,30473
CHEMBL469888,P23975,,GRQJWLQCSDAJSU-MFYZWQBTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,455,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655380,DTCC00509452,1329474,30473
CHEMBL469889,P23975,,WVFLQQCCAZKCGK-LIAHKDQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,519,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655368,DTCC00509453,261050,30473
CHEMBL469912,P23975,PUROMYCIN,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7383669,DTCC00511258,477920,46191
CHEMBL469912,P23975,PUROMYCIN,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7383670,DTCC00511258,477920,46191
CHEMBL469946,P23975,,MGQRODBGBVCRHA-FZMZJTMJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,4.4,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2599963,DTCC00565990,1309342,32649
CHEMBL469947,P23975,,OZOIMHBDGJFSOJ-NHYWBVRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,17,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2600009,DTCC00565992,1374497,32649
CHEMBL47,P23975,VITAMIN E,GVJHHUAWPYXKBD-IEOSBIPESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298024,DTCC00135004,348395,46191
CHEMBL47,P23975,VITAMIN E,GVJHHUAWPYXKBD-IEOSBIPESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7298025,DTCC00135004,348395,46191
CHEMBL470078,P23975,,IWYMWKSOTYKSEE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,1452,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657188,DTCC00509465,553545,30478
CHEMBL470078,P23975,,IWYMWKSOTYKSEE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,1376,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657158,DTCC00509465,553545,30478
CHEMBL470079,P23975,,SYEDLPTWFRUJMC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,673,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657185,DTCC00509468,941233,30478
CHEMBL470079,P23975,,SYEDLPTWFRUJMC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,368,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657155,DTCC00509468,941233,30478
CHEMBL470080,P23975,,FCVFHVSYVLGVRV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,ACTIVITY,=,34,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487430,DTCT0023180,2657270,DTCC00509469,811637,30478
CHEMBL470080,P23975,,FCVFHVSYVLGVRV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,INHIBITION,=,19,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487429,DTCT0023180,2657252,DTCC00509469,811637,30478
CHEMBL470082,P23975,,JLLXWYHRIUISMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,94,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657169,DTCC00509474,1491475,30478
CHEMBL470082,P23975,,JLLXWYHRIUISMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,58,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657137,DTCC00509474,1491475,30478
CHEMBL470313,P23975,,XCYJTWMYHQVABH-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,1053,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789674,DTCC00513944,67478,31613
CHEMBL470481,P23975,,XQNGYGNOPUIZQG-RMRYJAPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,1290,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657172,DTCC00509471,1620663,30478
CHEMBL470481,P23975,,XQNGYGNOPUIZQG-RMRYJAPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,544,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657141,DTCC00509471,1620663,30478
CHEMBL470482,P23975,,XQNGYGNOPUIZQG-ZEECNFPPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,140,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657171,DTCC00509472,1458895,30478
CHEMBL470482,P23975,,XQNGYGNOPUIZQG-ZEECNFPPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,117,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657140,DTCC00509472,1458895,30478
CHEMBL470488,P23975,,OPHKAGKHRDCCTP-DPYJAVKESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655406,DTCC00509456,1103346,30473
CHEMBL470690,P23975,,IZMZEMAKFSYLMD-KHQMHLGISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,1030,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655382,DTCC00113722,1906008,30473
CHEMBL470903,P23975,,DECJIAJUQYVNQV-KHQMHLGISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,552,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655383,DTCC00509427,1199223,30473
CHEMBL471,P23975,SOTALOL,ZBMZVLHSJCTVON-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7467132,DTCC00136675,88634,46191
CHEMBL471,P23975,SOTALOL,ZBMZVLHSJCTVON-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7467133,DTCC00136675,88634,46191
CHEMBL471001,P23975,"1S,2R-MILNACIPRAN",GJJFMKBJSRMPLA-ZFWWWQNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,40,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2600028,DTCC00008993,1178795,32649
CHEMBL471002,P23975,,VXBRIAOTINONRK-FZMZJTMJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,15,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2600003,DTCC00565989,1885779,32649
CHEMBL471029,P23975,,UAUSBXOENIHVFX-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,80,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620084,DTCC00570169,618735,33285
CHEMBL471035,P23975,,IMESNXOOQNBNMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,827,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620117,DTCC00570245,2004653,33285
CHEMBL471036,P23975,LITOXETINE,MJJDYOLPMGIWND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,6500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620135,DTCC00570249,1842402,33285
CHEMBL471036,P23975,LITOXETINE,MJJDYOLPMGIWND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,1400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104745,DTCC00570249,1842667,36264
CHEMBL471211,P23975,,ASCGGWXVCATSKL-YOEHRIQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,21,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2600012,DTCC00566061,1664895,32649
CHEMBL471345,P23975,,IHFKYJNUXPYFQN-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,INHIBITION,=,27,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558179,DTCT0023180,2789677,DTCC00513866,132041,31613
CHEMBL471518,P23975,,OJWLQAQJTIVAQB-HXUWFJFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,311,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789629,DTCC00513868,132042,31613
CHEMBL471519,P23975,,LYBIOYSWEAGQEQ-HXUWFJFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,9,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789630,DTCC00513869,1458950,31613
CHEMBL471696,P23975,,GDSLVFLGCFUFPN-KHQMHLGISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655410,DTCC00509429,164430,30473
CHEMBL471855,P23975,,OZOVADGYFYTOAE-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,80,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620076,DTCC00570095,229522,33285
CHEMBL471898,P23975,,YVGUKIACEDKFHT-LIAHKDQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,349,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655370,DTCC00509431,489211,30473
CHEMBL471899,P23975,,PEUIEZIOUGCTOJ-RRIHMMEISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,788,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655369,DTCC00509432,1231469,30473
CHEMBL472,P23975,GLYBURIDE,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7333834,DTCC00136719,51475,46191
CHEMBL472,P23975,GLYBURIDE,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7333835,DTCC00136719,51475,46191
CHEMBL472253,P23975,,DBDIPFBJGDKNIO-FZMZJTMJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,19,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2600010,DTCC00566059,1147879,32649
CHEMBL47244,P23975,PICROTOXININ,PIMZUZSSNYHVCU-YKWPQBAZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7341719,DTCC00186559,217577,46191
CHEMBL47244,P23975,PICROTOXININ,PIMZUZSSNYHVCU-YKWPQBAZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7341720,DTCC00186559,217577,46191
CHEMBL472563,P23975,,DIIRBUSHKZQLRI-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,INHIBITION,=,21,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558179,DTCT0023180,2789676,DTCC00513943,844557,31613
CHEMBL473966,P23975,,NTTIJAHCUAQKMW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,IC50,=,20370,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533,DTCT0023180,2809683,DTCC00519032,164516,32805
CHEMBL473966,P23975,,NTTIJAHCUAQKMW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,KI,=,19332,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530,DTCT0023180,2809656,DTCC00519032,164516,32805
CHEMBL47482,P23975,,GEICAQNIOJFRQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18847250,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxitine from NET,,"Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.",J. Med. Chem.,2008,51,21,"Runyon SP, Mosier PD, Roth BL, Glennon RA, Westkaemper RB",,537768,DTCT0023180,2680801,DTCC00187386,554190,31436
CHEMBL474922,P23975,,YZSUSCODCJEDGG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,680,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654483,DTCC00526182,973420,30519
CHEMBL475527,P23975,,GBPYXOBRYGPNKY-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,121,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789632,DTCC00513940,1555873,31613
CHEMBL475528,P23975,,LXKDYSGDYBBTJV-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,INHIBITION,=,25,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558179,DTCT0023180,2789675,DTCC00513941,2068546,31613
CHEMBL475534,P23975,NITRENDIPINE,PVHUJELLJLJGLN-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399165,DTCC00514677,88633,46191
CHEMBL475534,P23975,NITRENDIPINE,PVHUJELLJLJGLN-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7399166,DTCC00514677,88633,46191
CHEMBL475936,P23975,,LQYWRHPJMNCEEY-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,14,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686041,DTCC00544911,1885553,31294
CHEMBL475937,P23975,,BTDNKAUJHUIUPT-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,7,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686043,DTCC00544913,1821298,31294
CHEMBL475945,P23975,,DWTJKIXZDHRVPT-FQEVSTJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,>,3000,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686049,DTCC00545043,1115149,31294
CHEMBL475965,P23975,,IFWGJAXMPXZADJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19146417,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,2009,52,3,"Wroblowski B, Wigglesworth MJ, Szekeres PG, Smith GD, Rahman SS, Nicholson NH, Muir AI, Hall A, Heer JP, Garland SL, Coates WJ",,516839,DTCT0023180,2696311,DTCC00550152,1567645,32399
CHEMBL476,P23975,DACARBAZINE,FDKXTQMXEQVLRF-ZHACJKMWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7359136,DTCC00136858,800573,46191
CHEMBL476,P23975,DACARBAZINE,FDKXTQMXEQVLRF-ZHACJKMWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7359137,DTCC00136858,800573,46191
CHEMBL476116,P23975,,USUPIRYFHGUVOR-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,6,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765588,DTCC00543416,877350,30733
CHEMBL476116,P23975,,USUPIRYFHGUVOR-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,14,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766848,DTCC00543416,888651,30743
CHEMBL476116,P23975,,USUPIRYFHGUVOR-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2910617,DTCC00543416,877802,35247
CHEMBL476144,P23975,,MDXPOQYVXORXBP-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,18,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688220,DTCC00544722,2068923,31354
CHEMBL476154,P23975,,ILKQBHSHNTVIIC-HXUWFJFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,53,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686048,DTCC00544977,1821300,31294
CHEMBL476312,P23975,,HUGQKIWTNMQGCP-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765572,DTCC00543717,1556214,30733
CHEMBL476313,P23975,,BYZZRTNQROTLCL-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765570,DTCC00543719,1809679,30733
CHEMBL476315,P23975,,AMBALGQRTVWPRL-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,748,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765563,DTCC00543721,683049,30733
CHEMBL476320,P23975,,UYSHSCPIMATHOZ-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,23,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765575,DTCC00543854,1938449,30733
CHEMBL476356,P23975,,NVJYGIYRPBUKCC-PMACEKPBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,2,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688204,DTCC00544786,425356,31354
CHEMBL476527,P23975,,FYDXJUSDGLWNFV-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,63,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765584,DTCC00543779,1685485,30733
CHEMBL476941,P23975,,RDLDWTPNWMTWKO-FQEVSTJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765587,DTCC00543712,715363,30733
CHEMBL476942,P23975,,XFORZXNXAQQOKS-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,70,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765586,DTCC00543713,327381,30733
CHEMBL476954,P23975,,RCMVHXAYSDWNBI-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,IC50,=,23,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490412,DTCT0023180,2765698,DTCC00543412,779652,30733
CHEMBL476954,P23975,,RCMVHXAYSDWNBI-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,23,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767519,DTCC00543412,791132,30743
CHEMBL476954,P23975,,RCMVHXAYSDWNBI-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19647430,KI,=,52,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,2009,19,17,"Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA",,620407,DTCT0023180,3265107,DTCC00543412,792215,37586
CHEMBL477148,P23975,,PMNGGGSGAMTCOG-FQEVSTJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,27,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765573,DTCC00543716,909986,30733
CHEMBL477374,P23975,,FFWMVMYKTQEBAE-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766846,DTCC00543481,2048313,30743
CHEMBL477571,P23975,,VXAFVYYBYDYSHN-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765568,DTCC00543785,1556215,30733
CHEMBL477572,P23975,,BUJVJHVEEOZSIE-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,86,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765566,DTCC00543787,1809680,30733
CHEMBL477573,P23975,,JBTZQUNHYUVAIK-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,96,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765565,DTCC00543788,683051,30733
CHEMBL477580,P23975,,VGSCEHIVOAIVKK-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,29,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766845,DTCC00543482,176000,30743
CHEMBL477584,P23975,,ZFAZBQUXCIBGID-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766844,DTCC00543483,1210708,30743
CHEMBL477586,P23975,,ZBFNMJAOUOICQA-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766842,DTCC00543485,985287,30743
CHEMBL477587,P23975,,OIJZGDHTGREJNF-JKIUYZKVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18644726,KI,=,102,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,2008,18,16,"Funke U, Fischer S, Hiller A, Scheunemann M, Deuther-Conrad W, Brust P, Steinbach J",,509626,DTCT0023180,2774190,DTCC00543540,1632352,30803
CHEMBL477782,P23975,,DNSFFPXOVPKGCT-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765590,DTCC00543849,1394945,30733
CHEMBL477783,P23975,,NLRQPOSSIBJNGG-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,14,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765579,DTCC00543850,327386,30733
CHEMBL478,P23975,CHLOROPHENYLPIPERAZINE,VHFVKMTVMIZMIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,1940,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731435,DTCC00136958,2104410,68466
CHEMBL478,P23975,CHLOROPHENYLPIPERAZINE,VHFVKMTVMIZMIK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,4360,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731434,DTCC00136958,2104410,68466
CHEMBL478032,P23975,,FYCRQILFHXYKKL-WCQYABFASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,19,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688228,DTCC00544792,651066,31354
CHEMBL478622,P23975,,HUGQKIWTNMQGCP-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,29,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765560,DTCC00543724,941585,30733
CHEMBL478623,P23975,,FRXKHOISTFCGOP-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,466,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765562,DTCC00543722,489569,30733
CHEMBL478661,P23975,,FMOPBZKBYNKBBB-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,114,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688223,DTCC00544725,779670,31354
CHEMBL478833,P23975,,JNLWAWMHYQYRKA-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,34,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765582,DTCC00543781,1491869,30733
CHEMBL478834,P23975,,DRWJMJVERMOJBX-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765580,DTCC00543783,456304,30733
CHEMBL478834,P23975,,DRWJMJVERMOJBX-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912678,DTCC00543783,456805,35247
CHEMBL478835,P23975,,OLINBEUJWKQKCV-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765569,DTCC00543784,715364,30733
CHEMBL478836,P23975,,DGKNIGATLZIOSX-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,271,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765559,DTCC00543846,877353,30733
CHEMBL478876,P23975,,NVJYGIYRPBUKCC-UXHICEINSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,35,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688205,DTCC00544787,1491884,31354
CHEMBL478877,P23975,,SRCJGUQGCJJPSA-PKOBYXMFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,27,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688224,DTCC00544788,100076,31354
CHEMBL478878,P23975,,AYXSHRRPHCTQPJ-PMACEKPBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,49,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688225,DTCC00544789,1716897,31354
CHEMBL479,P23975,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1551,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459371,DTCC00137035,185558,46191
CHEMBL479,P23975,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1538,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459372,DTCC00137035,185558,46191
CHEMBL479044,P23975,,UVCDBPBNDXOVKD-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,124,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765591,DTCC00543848,1938448,30733
CHEMBL479383,P23975,,IJHSPFFWIXGDBB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18588282,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488400,DTCT0023180,2775972,DTCC00525641,1756334,30579
CHEMBL479409,P23975,,BKZBLBKUEHCXOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654462,DTCC00526525,973422,30519
CHEMBL479410,P23975,,FCXKPNHKJPFYSO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654461,DTCC00526526,1523866,30519
CHEMBL479410,P23975,,FCXKPNHKJPFYSO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18782666,IC50,=,770,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,19,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, MacKenny M, Stobie A, Tang K, Morgan P, Jones B",,535647,DTCT0023180,2685003,DTCC00526526,1535622,31309
CHEMBL479411,P23975,,VUQUGOYPDVYZTL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,2000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654465,DTCC00526522,1166923,30519
CHEMBL479683,P23975,,OLLHYYCQHNBTQC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24582985,INHIBITION,=,34.6,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM by radioligand binding assay relative to control,,5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.,Bioorg. Med. Chem. Lett.,2014,24,6,"Williams DA, Zaidi SA, Zhang Y",,1296934,DTCT0023180,13068439,DTCC00537969,1127642,57600
CHEMBL479783,P23975,,CCLDYFDEDOTWJF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,70,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654463,DTCC00526524,1523865,30519
CHEMBL479999,P23975,,XKDQGWQMRLNJCO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,430,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654473,DTCC00526401,521614,30519
CHEMBL480,P23975,LANSOPRAZOLE,MJIHNNLFOKEZEW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414333,DTCC00137040,1027055,46191
CHEMBL480,P23975,LANSOPRAZOLE,MJIHNNLFOKEZEW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7414334,DTCC00137040,1027055,46191
CHEMBL480988,P23975,,BKWWNLJWEVOUOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560772,DTCT0023180,2467270,DTCC00530920,844758,31698
CHEMBL480988,P23975,,BKWWNLJWEVOUOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,KI,=,39119,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560769,DTCT0023180,2467246,DTCC00530920,844758,31698
CHEMBL481,P23975,IRINOTECAN,UWKQSNNFCGGAFS-XIFFEERXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7420355,DTCC00137047,381014,46191
CHEMBL481,P23975,IRINOTECAN,UWKQSNNFCGGAFS-XIFFEERXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7420356,DTCC00137047,381014,46191
CHEMBL481124,P23975,,HACMDNQQWHUHKC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,2700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654478,DTCC00526396,1166922,30519
CHEMBL481280,P23975,,BUZBVOKDNAZIIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18588282,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488400,DTCT0023180,2775946,DTCC00525642,1756335,30579
CHEMBL481306,P23975,,FFJCCOLDJHZNND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,130,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654472,DTCC00526464,1971496,30519
CHEMBL481353,P23975,,YZFBWQVFTDRJGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,6700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654484,DTCC00526181,618173,30519
CHEMBL481526,P23975,,DUKLUAWTTPYZNJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,1500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654482,DTCC00526183,1555991,30519
CHEMBL481527,P23975,,UNSWDCIYZPOJLJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654485,DTCC00526180,1005920,30519
CHEMBL481695,P23975,,MOEZDBSMUWWXGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,4200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654460,DTCC00526574,618177,30519
CHEMBL481696,P23975,,RMKQQVTXLRWNDV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,2900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654459,DTCC00526575,682838,30519
CHEMBL481697,P23975,,USDWPOAZUSPDGS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,5600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654457,DTCC00526577,164599,30519
CHEMBL481863,P23975,JNJ-10392980,ZIQGASWXUSSORV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18588282,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488400,DTCT0023180,2775894,DTCC00006309,207957,30579
CHEMBL481941,P23975,4-(2-((DIMETHYLAMINO)METHYL)PHENOXY)BENZONITRILE,RQDOQYXVLGVVBA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Not Determined,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654480,DTCC00006319,359709,30519
CHEMBL482292,P23975,,UEHLVCUNIAJBCM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,1050,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654471,DTCC00526465,1716672,30519
CHEMBL482293,P23975,,ZMMDUENTAOWDLQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,3000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654469,DTCC00526467,1362384,30519
CHEMBL482294,P23975,,BPTUECTWLFZRON-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654468,DTCC00526468,553744,30519
CHEMBL482295,P23975,,DKXQXLBXXKLLSH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,6400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654467,DTCC00526469,1745124,30519
CHEMBL482903,P23975,,DYJBCVKMYPRGRR-BJUDXGSMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18487050,KI,=,1680,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,2008,16,12,"Ben-Daniel R, Deuther-Conrad W, Scheunemann M, Steinbach J, Brust P, Mishani E",,556833,DTCT0023180,2552115,DTCC00559465,327564,28919
CHEMBL483316,P23975,,VTAMJLRZTZEHBO-BJUDXGSMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18487050,KI,=,6600,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,2008,16,12,"Ben-Daniel R, Deuther-Conrad W, Scheunemann M, Steinbach J, Brust P, Mishani E",,556833,DTCT0023180,2552141,DTCC00559506,747845,28919
CHEMBL483749,P23975,,QPUXUSUONDVIKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19338356,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to NET,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009,52,7,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497700,DTCT0023180,2728014,DTCC00569050,273669,34004
CHEMBL48449,P23975,CANTHARIDIN,DHZBEENLJMYSHQ-XCVPVQRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7271747,DTCC00189104,1544894,46191
CHEMBL48449,P23975,CANTHARIDIN,DHZBEENLJMYSHQ-XCVPVQRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7271748,DTCC00189104,1544894,46191
CHEMBL484952,P23975,,MTEFLXYKMHWTNG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19338356,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to NET,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009,52,7,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497700,DTCT0023180,2728015,DTCC00569111,759316,34004
CHEMBL485259,P23975,EUCALYPTOL,WEEGYLXZBRQIMU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337166,DTCC00539560,542575,46191
CHEMBL485259,P23975,EUCALYPTOL,WEEGYLXZBRQIMU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7337167,DTCC00539560,542575,46191
CHEMBL485549,P23975,NIFURSOL,XXUXXCZCUGIGPP-WLRTZDKTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373298,DTCC00563507,2057651,46191
CHEMBL485549,P23975,NIFURSOL,XXUXXCZCUGIGPP-WLRTZDKTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373299,DTCC00563507,2057651,46191
CHEMBL486041,P23975,,SAYSUZYFOLMWGB-FOYRJYEQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,454,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655378,DTCC00509632,553547,30473
CHEMBL486042,P23975,,IZIPWOZWZWBTMH-FOYRJYEQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,840,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655376,DTCC00509634,1458896,30473
CHEMBL486043,P23975,,VQMGCAXPAOTPQE-HOCLYGCPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,840,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649847,DTCC00509728,694146,31203
CHEMBL486044,P23975,,WPKZZLMFEYGCJR-RDJZCZTQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,72,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649846,DTCC00509729,823181,31203
CHEMBL486045,P23975,,FDBFTQAPQQWDDD-MAUKXSAKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649844,DTCC00509731,1725936,31203
CHEMBL486235,P23975,,KJKJGUOGZBYCCJ-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,3000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649850,DTCC00113739,1114758,31203
CHEMBL486236,P23975,,VQTWAJKQIHYINF-QUCCMNQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,2000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649849,DTCC00509726,1696352,31203
CHEMBL486237,P23975,,KMLPWAMYQIJTNH-QUCCMNQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,1100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649848,DTCC00509727,1341284,31203
CHEMBL486278,P23975,,PBDMWGSHTOZGOM-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19492813,IC50,=,600,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter,,Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,13,"Marquis RW, Lago AM, Callahan JF, Trout RE, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Yang Z, Roethke T, Smith BR, Ward KW, Lee J, Keenan RM, Bhatnagar P",,520036,DTCT0023180,2835764,DTCC00552670,1147715,33744
CHEMBL486278,P23975,,PBDMWGSHTOZGOM-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821575,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of NET,,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,21,"Marquis RW, Lago AM, Callahan JF, Rahman A, Dong X, Stroup GB, Hoffman S, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Roethke T, Smith BR, Ward KW, Bhatnagar P",,591455,DTCT0023180,3056370,DTCC00552670,1136508,35717
CHEMBL486537,P23975,,VVROCSNBKQTQEO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602756,DTCC00565426,339239,32656
CHEMBL486538,P23975,,DQMQNSKBKIYETN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,41,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602755,DTCC00565427,208407,32656
CHEMBL487355,P23975,5-(3-BENZYLPYRROLIDIN-3-YL)-1H-INDOLE (STRUCTURAL MIX),UZKWACFLBGIUSH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602759,DTCC00565424,2016363,32656
CHEMBL487355,P23975,5-(3-BENZYLPYRROLIDIN-3-YL)-1H-INDOLE (STRUCTURAL MIX),UZKWACFLBGIUSH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602760,DTCC00565424,2016362,32656
CHEMBL487355,P23975,5-(3-BENZYLPYRROLIDIN-3-YL)-1H-INDOLE (STRUCTURAL MIX),UZKWACFLBGIUSH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602758,DTCC00565424,2016364,32656
CHEMBL487355,P23975,5-(3-BENZYLPYRROLIDIN-3-YL)-1H-INDOLE (STRUCTURAL MIX),UZKWACFLBGIUSH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20691589,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,2010,20,18,"Lucas MC, Weikert RJ, Carter DS, Cai HY, Greenhouse R, Iyer PS, Lin CJ, Lee EK, Madera AM, Moore A, Ozboya K, Schoenfeld RC, Steiner S, Zhai Y, Lynch SM",,652283,DTCT0023180,3448176,DTCC00565424,2017598,40418
CHEMBL487690,P23975,,NNOXYEGAVKKWOL-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,1600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649855,DTCC00509652,661901,31203
CHEMBL487691,P23975,,DQMYTSCZLQLEID-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,6000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649854,DTCC00509653,629738,31203
CHEMBL487763,P23975,,HYXMIUGYZHSSJS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,89,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602709,DTCC00565350,1756759,32656
CHEMBL487869,P23975,,CAAOEKZYPZJLCR-QAPCUYQASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,3000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649851,DTCC00509655,1308657,31203
CHEMBL487873,P23975,,RZZJNEKORGOFAD-XDGABKOJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,770,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655374,DTCC00509703,424989,30473
CHEMBL487874,P23975,,ILZIENIHITYFQQ-AEPIDVSQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,347,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655373,DTCC00509704,2068507,30473
CHEMBL487875,P23975,,LQBFAZFBAPGPPM-PHGOYLPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,357,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655372,DTCC00509705,2036681,30473
CHEMBL487894,P23975,DIPYRONE SODIUM,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351195,DTCC00513255,1416028,46191
CHEMBL487894,P23975,DIPYRONE SODIUM,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351196,DTCC00513255,1416028,46191
CHEMBL488,P23975,AMINOGLUTETHIMIDE,ROBVIMPUHSLWNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7300901,DTCC00137354,477910,46191
CHEMBL488,P23975,AMINOGLUTETHIMIDE,ROBVIMPUHSLWNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7300902,DTCC00137354,477910,46191
CHEMBL488025,P23975,EXISULIND,MVGSNCBCUWPVDA-MFOYZWKCSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465497,DTCC00113831,1674151,46191
CHEMBL488025,P23975,EXISULIND,MVGSNCBCUWPVDA-MFOYZWKCSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465498,DTCC00113831,1674151,46191
CHEMBL488049,P23975,,NDHNYVIKBFYSGN-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,430,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649843,DTCC00509798,1696356,31203
CHEMBL488222,P23975,,UPUKKBZBVUXCSQ-CVEARBPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,4000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649856,DTCC00509583,1982802,31203
CHEMBL488422,P23975,,RBLJKXZFEKSSRK-AEPIDVSQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,1300,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655367,DTCC00509629,1005746,30473
CHEMBL488423,P23975,,VSZILPWZKJQRHV-LIAHKDQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,435,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655379,DTCC00509631,650687,30473
CHEMBL488424,P23975,,XVISEQWOYJEMBG-CABCVRRESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,4000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649857,DTCC00509651,175618,31203
CHEMBL488638,P23975,DOV-102677,BSMNRYCSBFHEMQ-GZMMTYOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18539031,IC50,=,103,NM,,,,,,,,,,,,,,Inhibition of norepinephrine uptake at human cloned NET,,Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,13,"Zhang M, Jovic F, Vickers T, Dyck B, Tamiya J, Grey J, Tran JA, Fleck BA, Pick R, Foster AC, Chen C",,491871,DTCT0023180,2666819,DTCC00005289,1620679,31169
CHEMBL488638,P23975,DOV-102677,BSMNRYCSBFHEMQ-GZMMTYOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,794.33,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213793,DTCC00005289,1633307,37197
CHEMBL488638,P23975,DOV-102677,BSMNRYCSBFHEMQ-GZMMTYOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,58.88,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395883,DTCC00005289,1633708,39684
CHEMBL489773,P23975,,QNAJOTQQZIEJJF-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,4,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688215,DTCC00545362,489587,31354
CHEMBL489774,P23975,,VSMRJAFWIRCVKM-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,16,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688216,DTCC00545363,1621102,31354
CHEMBL489775,P23975,,YHKBQPFPSDCUBA-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,21,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688217,DTCC00545364,164829,31354
CHEMBL489977,P23975,2-((3-FLUOROPHENOXY)(PHENYL)METHYL)MORPHOLINE,XVDZZRJNPDNTBI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,11,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688218,DTCC00007630,2037138,31354
CHEMBL49,P23975,BUSPIRONE,QWCRAEMEVRGPNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7263300,DTCC00135177,120970,46191
CHEMBL49,P23975,BUSPIRONE,QWCRAEMEVRGPNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7263301,DTCC00135177,120970,46191
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,85,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733043,DTCC00137638,2104821,68466
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,328,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733046,DTCC00137638,2104821,68466
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,40,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733045,DTCC00137638,2104813,68566
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,40,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,358919,DTCC00137638,1176440,3008
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,45,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733044,DTCC00137638,2104812,68918
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,156,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733047,DTCC00137638,2104812,68918
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005,KI,=,90,NM,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005,48,19,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,320813,DTCT0023180,1853303,DTCC00137638,1165697,19894
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,100,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686034,DTCC00137638,1178554,31294
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,86,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7378205,DTCC00137638,1188071,46191
CHEMBL490,P23975,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,86,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7378206,DTCC00137638,1188071,46191
CHEMBL49080,P23975,CLENBUTEROL,STJMRWALKKWQGH-UHFFFAOYSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7341507,DTCC00193265,1155678,46191
CHEMBL49080,P23975,CLENBUTEROL,STJMRWALKKWQGH-UHFFFAOYSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7341508,DTCC00193265,1155678,46191
CHEMBL491268,P23975,,RVVDMQMBQDIWKD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,1300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654500,DTCC00114747,779452,30519
CHEMBL491408,P23975,,GUEUKMXCMIUBEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18782666,IC50,>,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,19,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, MacKenny M, Stobie A, Tang K, Morgan P, Jones B",,535647,DTCT0023180,2685006,DTCC00545697,1788770,31309
CHEMBL491753,P23975,KF-A3,KHFAFXFRTUHQNO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007,51,11,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923,DTCT0023180,2718425,DTCC00005711,1135661,34126
CHEMBL491754,P23975,KF-A5,YCWGZWYJTIJTHX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138,IC50,=,9100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007,51,11,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923,DTCT0023180,2718427,DTCC00005713,909701,34126
CHEMBL491810,P23975,,RJOGBLCDKSENEL-WCQYABFASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,9,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688230,DTCC00545365,1874128,31354
CHEMBL491889,P23975,KF-A6,YHXSELHUXJAOLR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007,51,11,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923,DTCT0023180,2718428,DTCC00005714,521550,34126
CHEMBL492013,P23975,,ZVXWSRHRVJCNFV-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,66,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688232,DTCC00545367,1167155,31354
CHEMBL492014,P23975,,WBUMYVRFZVRYPV-PMACEKPBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,457,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688233,DTCC00545368,425363,31354
CHEMBL492214,P23975,,XTOPLFVJQKWOCT-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,17,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688207,DTCC00545295,521837,31354
CHEMBL492215,P23975,,GPVPGABIUWQWLB-JSGCOSHPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,6940,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688209,DTCC00545297,683063,31354
CHEMBL492438,P23975,,GEFDXUZHLNJUMR-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18800760,IC50,=,500,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter,,Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.,J. Med. Chem.,2008,51,18,"Tahirovic YA, Geballe M, Gruszecka-Kowalik E, Myers SJ, Lyuboslavsky P, Le P, French A, Irier H, Choi WB, Easterling K, Yuan H, Wilson LJ, Kotloski R, McNamara JO, Dingledine R, Liotta DC, Traynelis SF, Snyder JP",,539366,DTCT0023180,2568872,DTCC00527247,1756346,31959
CHEMBL492841,P23975,,GVAGNJNCGNKLIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,7300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654496,DTCC00527131,973431,30519
CHEMBL492842,P23975,,QBOITYXCKDGUNE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,1300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654495,DTCC00114750,1620873,30519
CHEMBL492916,P23975,,SYDKDXKLTMXNAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19284718,KI,=,2733,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,2009,52,7,"Cho SJ, Jensen NH, Kurome T, Kadari S, Manzano ML, Malberg JE, Caldarone B, Roth BL, Kozikowski AP",,566868,DTCT0023180,2486829,DTCC00534422,1983053,33028
CHEMBL493,P23975,BROMOCRIPTINE,OZVBMTJYIDMWIL-AYFBDAFISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7271546,DTCC00137993,1544893,46191
CHEMBL493,P23975,BROMOCRIPTINE,OZVBMTJYIDMWIL-AYFBDAFISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7272892,DTCC00137993,1544893,46191
CHEMBL493027,P23975,,JIIHYINDBVZYIB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,9200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654493,DTCC00527200,228989,30519
CHEMBL493040,P23975,,TYVFKNAUSZXXJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654456,DTCC00114746,1841896,30519
CHEMBL493056,P23975,,GJORZJNPTHLFPB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,6000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654494,DTCC00527199,715142,30519
CHEMBL493057,P23975,,TVYXGLWTICSLOM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,2000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654492,DTCC00527201,294516,30519
CHEMBL493058,P23975,,KKCKVAFKRSKQRE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Not Determined,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654491,DTCC00527202,1362390,30519
CHEMBL493130,P23975,,LPQAVKPTKBXDEY-GHXDPTCOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19284718,KI,=,6780,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,2009,52,7,"Cho SJ, Jensen NH, Kurome T, Kadari S, Manzano ML, Malberg JE, Caldarone B, Roth BL, Kozikowski AP",,566868,DTCT0023180,2486837,DTCC00534489,175881,33028
CHEMBL493263,P23975,,IRKCYPUGOBXCFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,50,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654490,DTCC00527203,392470,30519
CHEMBL493264,P23975,,DVFKWYNNNBWGRC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,640,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654489,DTCC00527204,10297,30519
CHEMBL493369,P23975,,WXNMBSMVRGWTNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,100000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561517,DTCC00540874,273342,28872
CHEMBL493384,P23975,,HFIXKYCVEYCJOY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,=,19687,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561455,DTCC00540873,1567545,28872
CHEMBL493476,P23975,,JKBJIWKBKAEYBB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,3100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654498,DTCC00527128,1135730,30519
CHEMBL493568,P23975,,MGEYXYRIODCARZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19445453,KI,>,6000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human NET expressed in HEK293 cells,,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,2009,52,11,"Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH",,523086,DTCT0023180,2826446,DTCC00535729,2016002,33656
CHEMBL493568,P23975,,MGEYXYRIODCARZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19445453,KI,>,6000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,2009,52,11,"Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH",,523089,DTCT0023180,2826455,DTCC00535729,2016002,33656
CHEMBL493667,P23975,,LLTVABOFFOVVKQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Not Determined,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654499,DTCC00527127,228988,30519
CHEMBL494624,P23975,,DNTKPSJIKIXCOA-BPNKVWISSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,49,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559260,DTCC00541278,1853381,28814
CHEMBL494626,P23975,,DNTKPSJIKIXCOA-VZXSFKIWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,3.5,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559262,DTCC00541276,662261,28814
CHEMBL494786,P23975,,LTKIILYBJZQLLW-PEVLCXCCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,556,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559264,DTCC00541274,952916,28814
CHEMBL494807,P23975,,MNZCWNRZRKZOCQ-PQEADEMYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,31,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559257,DTCC00541336,1726274,28814
CHEMBL494814,P23975,,WAIMVSIHYKGAQF-GAPKJMMISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,14,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559256,DTCC00541337,240533,28814
CHEMBL495210,P23975,,IODDIRNVZLCLED-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,36.1,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556604,DTCC00540694,1556185,28813
CHEMBL495464,P23975,,OHTMMULBWQHGBT-JRJWNBDDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,3.4,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559263,DTCC00541275,856460,28814
CHEMBL495778,P23975,PENICILLIC ACID,YCOFRPYSZKIPBQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7404176,DTCC00115404,866022,46191
CHEMBL495778,P23975,PENICILLIC ACID,YCOFRPYSZKIPBQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7404177,DTCC00115404,866022,46191
CHEMBL495894,P23975,,BEGCAIREKDZFRP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,4.9,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556607,DTCC00541561,1745310,28813
CHEMBL496,P23975,HEXACHLOROPHENE,ACGUYXCXAPNIKK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312785,DTCC00138998,1765973,46191
CHEMBL496,P23975,HEXACHLOROPHENE,ACGUYXCXAPNIKK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312786,DTCC00138998,1765973,46191
CHEMBL496284,P23975,,WINONEAFBRSOAL-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,140,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445654,DTCC00561219,1038732,30880
CHEMBL496285,P23975,,FTQUSRCNRLUCRK-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,240,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445646,DTCC00561221,1906632,30880
CHEMBL496297,P23975,,MYDTUCJNFHJOAN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,0.2,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556615,DTCC00541502,747619,28813
CHEMBL496298,P23975,,AJRXGUDPNCWOIG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,4.79,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556614,DTCC00541503,1006094,28813
CHEMBL496911,P23975,,ANKBUMUPFQMGBF-SLWGAWGTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,430,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559253,DTCC00541394,1017588,28814
CHEMBL496913,P23975,,FPXGGQHHZZOHQY-GAPKJMMISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,50,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559254,DTCC00541393,1309058,28814
CHEMBL496938,P23975,,BYTXKMDEYAZNON-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18793858,KI,>,1900,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,2008,16,19,"Mavel S, Vercouillie J, Garreau L, Raguza T, Ravna AW, Chalon S, Guilloteau D, Emond P",,492712,DTCT0023180,2458486,DTCC00547526,586156,32562
CHEMBL497140,P23975,,LTDVATHIGODXNC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18793858,KI,>,1200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,2008,16,19,"Mavel S, Vercouillie J, Garreau L, Raguza T, Ravna AW, Chalon S, Guilloteau D, Emond P",,492712,DTCT0023180,2458487,DTCC00547527,618432,32562
CHEMBL497337,P23975,,BIXIWGCNVRAWEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,0.68,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556611,DTCC00541558,779630,28813
CHEMBL497338,P23975,,YUFDTETVOKSVLR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,100000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561511,DTCC00541556,888633,28872
CHEMBL497339,P23975,,LJNOQGHESDETDR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,19.6,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556608,DTCC00541560,10824,28813
CHEMBL497340,P23975,,BQYHDNIHHQQZPU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561508,DTCC00541615,1115099,28872
CHEMBL497461,P23975,,AROKURNCLIVVKP-KDOFPFPSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,420,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447061,DTCC00561270,1427526,30886
CHEMBL497463,P23975,,CBIWVBLPTDWHKB-APWZRJJASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447071,DTCC00116933,1653576,30886
CHEMBL497479,P23975,,DZEOBMAMUUMJNJ-SJKOYZFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,36,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445667,DTCC00561212,1167364,30880
CHEMBL497479,P23975,,DZEOBMAMUUMJNJ-SJKOYZFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447056,DTCC00561212,1167367,30886
CHEMBL497492,P23975,,AKOJURNFNIUCOV-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,45,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445645,DTCC00561222,1167365,30880
CHEMBL497493,P23975,,AKOJURNFNIUCOV-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,14,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445644,DTCC00561223,779876,30880
CHEMBL497512,P23975,,ULFUJAQEYUFVSH-HOTGVXAUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445636,DTCC00561312,1588706,30880
CHEMBL497512,P23975,,ULFUJAQEYUFVSH-HOTGVXAUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,4,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447046,DTCC00561312,1588708,30886
CHEMBL497549,P23975,,ZHLYFJIHCTWRCA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561507,DTCC00541616,823524,28872
CHEMBL497550,P23975,,VWPPLGQILGHEGL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561506,DTCC00541617,1341668,28872
CHEMBL497664,P23975,,UDDSGRJSILNSQD-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,4500,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445673,DTCC00561293,1006332,30880
CHEMBL497665,P23975,,OQRZMLVFIJAOKO-CRAIPNDOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,35,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445671,DTCC00561295,294950,30880
CHEMBL497666,P23975,MDL-28618,BDCMARKCSKLIKU-SUMWQHHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,880,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445674,DTCC00008731,229418,30880
CHEMBL497679,P23975,,PQCPVVBGHDVKFV-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,9,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445641,DTCC00561307,1971931,30880
CHEMBL497680,P23975,,BDDVUVHPEHJEPJ-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,13,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445640,DTCC00561308,1588705,30880
CHEMBL497845,P23975,,TUPKUZCHBMCYHC-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,11,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445639,DTCC00561309,1745513,30880
CHEMBL497846,P23975,,FTTNLGGOMYVLOP-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,7,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445638,DTCC00561310,456516,30880
CHEMBL497846,P23975,,FTTNLGGOMYVLOP-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,4,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447047,DTCC00561310,456519,30886
CHEMBL498,P23975,CHLORPROPAMIDE,RKWGIWYCVPQPMF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7369020,DTCC00139298,1253319,46191
CHEMBL498,P23975,CHLORPROPAMIDE,RKWGIWYCVPQPMF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7369021,DTCC00139298,1253319,46191
CHEMBL498120,P23975,,JMYADEOPJFRDDM-RTBURBONSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,27,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447050,DTCC00561275,1038735,30886
CHEMBL498141,P23975,,DKMITNDZRUDDGX-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447051,DTCC00561274,1232096,30886
CHEMBL498142,P23975,,AROKURNCLIVVKP-KSSFIOAISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,370,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447069,DTCC00116934,1906634,30886
CHEMBL498367,P23975,,PWVMDDIYWPUTLR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18793858,KI,>,1000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,2008,16,19,"Mavel S, Vercouillie J, Garreau L, Raguza T, Ravna AW, Chalon S, Guilloteau D, Emond P",,492712,DTCT0023180,2458484,DTCC00547524,1716883,32562
CHEMBL498481,P23975,,VVQIWKYSMSGPNS-KXBFYZLASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,690,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447057,DTCC00561323,1842305,30886
CHEMBL498482,P23975,,JMYADEOPJFRDDM-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,39,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447049,DTCC00561325,456518,30886
CHEMBL498495,P23975,,AROKURNCLIVVKP-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,200,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445657,DTCC00561216,68049,30880
CHEMBL498495,P23975,,AROKURNCLIVVKP-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447062,DTCC00561216,68054,30886
CHEMBL498509,P23975,,RQRGTZIPGLRQOJ-CXAGYDPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,46,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445664,DTCC00561297,877577,30880
CHEMBL498509,P23975,,RQRGTZIPGLRQOJ-CXAGYDPISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,35,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447066,DTCC00561297,877578,30886
CHEMBL498510,P23975,,RHFJKUASNIKDKP-SJKOYZFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,145,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445663,DTCC00561298,1330106,30880
CHEMBL498563,P23975,,DCABXDIJRCWHAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,0.3,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556613,DTCC00541504,1394917,28813
CHEMBL498564,P23975,,QTWYMQIZRRTWFB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,100000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561515,DTCC00541552,338954,28872
CHEMBL498565,P23975,,ZCFQGAKEQPCWDE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,100000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561513,DTCC00541554,1696728,28872
CHEMBL498566,P23975,,RYMGUUFPMNAKMP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,100000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561516,DTCC00541551,371524,28872
CHEMBL498680,P23975,,OWDDBNVCYYHRPW-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,140,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445659,DTCC00561300,941801,30880
CHEMBL498686,P23975,,CBIWVBLPTDWHKB-VQIMIIECSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,180,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445652,DTCC00561302,2004537,30880
CHEMBL498687,P23975,,OBPAJKUDOWNRDR-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,15,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445649,DTCC00561304,1777447,30880
CHEMBL498774,P23975,,GYJUQRIRWMPONQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,=,58100,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561510,DTCC00541613,1050004,28872
CHEMBL498775,P23975,,LCYYZQNDLDWZLI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561509,DTCC00541614,306280,28872
CHEMBL498847,P23975,SECNIDAZOLE,KPQZUUQMTUIKBP-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486227,DTCC00550707,1765980,46191
CHEMBL498847,P23975,SECNIDAZOLE,KPQZUUQMTUIKBP-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486228,DTCC00550707,1765980,46191
CHEMBL498904,P23975,,VQGISMYTICCORC-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793587,DTCC00513818,597224,31630
CHEMBL499,P23975,TIMOLOL,BLJRIMJGRPQVNF-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7479152,DTCC00139310,1894976,46191
CHEMBL499,P23975,TIMOLOL,BLJRIMJGRPQVNF-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7479153,DTCC00139310,1894976,46191
CHEMBL499461,P23975,,QXJNTMSGRQZRFO-DQZOQLMQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,IC50,=,6811,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560772,DTCT0023180,2467272,DTCC00530922,1329715,31698
CHEMBL499461,P23975,,QXJNTMSGRQZRFO-DQZOQLMQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888,KI,=,6567,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,1,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560769,DTCT0023180,2467248,DTCC00530922,1329715,31698
CHEMBL499576,P23975,,AEAWXYVKJBWNDY-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,7,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688219,DTCC00544721,1394955,31354
CHEMBL499815,P23975,ATRACTYLOSIDE,IUCNQFHEWLYECJ-CXCSZTQTSA-L,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267969,DTCC00539373,1765970,46191
CHEMBL499815,P23975,ATRACTYLOSIDE,IUCNQFHEWLYECJ-CXCSZTQTSA-L,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267970,DTCC00539373,1765970,46191
CHEMBL50,P23975,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14729957,DTCC00135230,2104025,69275
CHEMBL500,P23975,PINDOLOL,JZQKKSLKJUAGIC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385197,DTCC00139321,736265,46191
CHEMBL500,P23975,PINDOLOL,JZQKKSLKJUAGIC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385198,DTCC00139321,736265,46191
CHEMBL500629,P23975,,JMOZPPPEEGAIOO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654470,DTCC00526466,1362383,30519
CHEMBL501919,P23975,,ZXJNEUYTPXBETE-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,86,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765567,DTCC00543786,67818,30733
CHEMBL502129,P23975,,WXULFWHQRUUESN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,510,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654458,DTCC00526576,909769,30519
CHEMBL502379,P23975,,OOXPOUDWMPWCQG-RBUKOAKNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,1.5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793567,DTCC00513584,532803,31630
CHEMBL502620,P23975,ACLARUBICIN,USZYSDMBJDPRIF-SVEJIMAYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282593,DTCC00522599,1383771,46191
CHEMBL502620,P23975,ACLARUBICIN,USZYSDMBJDPRIF-SVEJIMAYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7282594,DTCC00522599,1383771,46191
CHEMBL502707,P23975,,OXYQNDFARIFPMG-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,89,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765576,DTCC00543853,1231874,30733
CHEMBL502896,P23975,CETRAXATE HYDROCHLORIDE,USROQQUKEBHOFF-SKKCDYJJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366586,DTCC00521861,477913,46191
CHEMBL502896,P23975,CETRAXATE HYDROCHLORIDE,USROQQUKEBHOFF-SKKCDYJJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366587,DTCC00521861,477913,46191
CHEMBL503,P23975,LOVASTATIN,PCZOHLXUXFIOCF-BXMDZJJMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,8753,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7412508,DTCC00140133,1480347,46191
CHEMBL503,P23975,LOVASTATIN,PCZOHLXUXFIOCF-BXMDZJJMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,8680,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7412509,DTCC00140133,1480347,46191
CHEMBL503234,P23975,,MXNHEKIHSVXJPG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Not Determined,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620121,DTCC00570246,11836,33285
CHEMBL503378,P23975,,XROTXTXRLBZJNT-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,49,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765578,DTCC00543851,1842099,30733
CHEMBL503461,P23975,,MLQKNFBXQZTRNM-AMVDFXKXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17428804,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE uptake at human wild type NET expressed in african green monkey COS1 cells after 48 hrs,Active,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,2007,282,24,"Paczkowski FA, Sharpe IA, Dutertre S, Lewis RJ",,505500,DTCT0023180,2401625,DTCC00557361,1050189,29252
CHEMBL503609,P23975,,RFZOKJQQTZLOBO-BJUDXGSMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18487050,KI,=,2770,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,2008,16,12,"Ben-Daniel R, Deuther-Conrad W, Scheunemann M, Steinbach J, Brust P, Mishani E",,556833,DTCT0023180,2552142,DTCC00559505,715521,28919
CHEMBL504,P23975,DIMETHYL SULFOXIDE,IAZDPXIOMUYVGZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7368454,DTCC00140586,1798409,46191
CHEMBL504,P23975,DIMETHYL SULFOXIDE,IAZDPXIOMUYVGZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7368455,DTCC00140586,1798409,46191
CHEMBL504028,P23975,,BVTKYAZPIRQNNS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,58,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816207,DTCC00567115,1167420,32733
CHEMBL504028,P23975,,BVTKYAZPIRQNNS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816097,DTCC00567115,1167420,32733
CHEMBL504033,P23975,,RNMJRHMRVJNPGK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,2.96,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556605,DTCC00540693,1297239,28813
CHEMBL504231,P23975,,IYTYICIRVUHWDC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,16,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602747,DTCC00564601,2048526,32656
CHEMBL504479,P23975,,KCCUCFUQSYGPBH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19492813,IC50,=,300,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter,,Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,13,"Marquis RW, Lago AM, Callahan JF, Trout RE, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Yang Z, Roethke T, Smith BR, Ward KW, Lee J, Keenan RM, Bhatnagar P",,520036,DTCT0023180,2835759,DTCC00552425,1341781,33744
CHEMBL504544,P23975,,HTJVDZSETPCPGD-HKUYNNGSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,28,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688226,DTCC00544790,1199624,31354
CHEMBL504606,P23975,,FHNHVNKWEHYJDJ-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,1300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447067,DTCC00561265,1938700,30886
CHEMBL504760,P23975,CAMPHOR,DSSYKIVIOFKYAU-XCBNKYQSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7350493,DTCC00113446,217578,46191
CHEMBL504760,P23975,CAMPHOR,DSSYKIVIOFKYAU-XCBNKYQSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7350494,DTCC00113446,217578,46191
CHEMBL504892,P23975,,RNEOSZBYBZJIGX-CVEARBPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,68,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725291,DTCC00537331,425274,34196
CHEMBL504971,P23975,,KWAYIPPRBHZSBU-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725275,DTCC00537197,618305,34196
CHEMBL505431,P23975,,JTGBYRRUQUQVJF-UFADHCMUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,IC50,=,957,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533,DTCT0023180,2809679,DTCC00114089,877056,32805
CHEMBL505431,P23975,,JTGBYRRUQUQVJF-UFADHCMUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502,KI,=,1748,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009,52,6,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530,DTCT0023180,2809652,DTCC00114089,877056,32805
CHEMBL505433,P23975,,FHNHVNKWEHYJDJ-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,18,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445662,DTCC00561299,1842304,30880
CHEMBL505433,P23975,,FHNHVNKWEHYJDJ-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447068,DTCC00561299,1842303,30886
CHEMBL505439,P23975,,KXCIACPDRWQKBQ-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,8000,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445655,DTCC00561218,1492087,30880
CHEMBL505592,P23975,,ROTDEDNYANYXDF-PMACEKPBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19067522,KI,=,3.68,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,2009,52,1,"Zeng F, Mun J, Jarkas N, Stehouwer JS, Voll RJ, Tamagnan GD, Howell L, Votaw JR, Kilts CD, Nemeroff CB, Goodman MM",,560274,DTCT0023180,2450474,DTCC00529993,132255,31766
CHEMBL50588,P23975,EMETINE,AUVVAXYIELKVAI-CKBKHPSWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7317469,DTCC00195239,216401,46191
CHEMBL50588,P23975,EMETINE,AUVVAXYIELKVAI-CKBKHPSWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7317470,DTCC00195239,216401,46191
CHEMBL505902,P23975,,XHOQDMBOUAKHDY-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,5000,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445675,DTCC00561292,2004536,30880
CHEMBL506,P23975,PRIMAQUINE,INDBQLZJXZLFIT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372623,DTCC00140892,1155686,46191
CHEMBL506,P23975,PRIMAQUINE,INDBQLZJXZLFIT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7372624,DTCC00140892,1155686,46191
CHEMBL506098,P23975,HYDROPEROXYCADIFORIN,DXFWUAWSMRONLI-RXGFHJPUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17618015,IC50,=,0.05,UG.ML-1,,,,,,,,,,,,,,Inhibition of noradrenaline transporter,,Bioactive peroxides as potential therapeutic agents.,Eur. J. Med. Chem.,2008,43,2,,,532093,DTCT0023180,2408063,DTCC00557981,554103,28636
CHEMBL506137,P23975,,BLPFKCJJWVVUNI-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793585,DTCC00513770,1438182,31630
CHEMBL506247,P23975,TANNIC ACID,LRBQNJMCXXYXIU-PPKXGCFTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465532,DTCC00524002,444643,46191
CHEMBL506247,P23975,TANNIC ACID,LRBQNJMCXXYXIU-PPKXGCFTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7465533,DTCC00524002,444643,46191
CHEMBL506397,P23975,,PYEILVKGQDUINV-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,772,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620101,DTCC00570173,779970,33285
CHEMBL506789,P23975,,MLXZSGRSLJXYNT-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,5400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620080,DTCC00570096,68163,33285
CHEMBL506874,P23975,,RLUHSIYRINOGAT-RTWAWAEBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,120,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725286,DTCC00537259,1809576,34196
CHEMBL507359,P23975,,YIEXSVBTWQZEGZ-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793579,DTCC00514463,273035,31630
CHEMBL507379,P23975,,CJCQYKYOUMGRPX-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,300,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793564,DTCC00513766,467952,31630
CHEMBL507422,P23975,,XDILVFHJKVYNDZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,=,1400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654479,DTCC00526395,1166921,30519
CHEMBL507723,P23975,,QEHHRDFKZARORR-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,25,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765589,DTCC00543711,1621085,30733
CHEMBL507806,P23975,,JOHKRZVJVWMMNT-LRDDRELGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,13,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2599999,DTCC00566058,1567804,32649
CHEMBL508102,P23975,CARBIMAZOLE,CFOYWRHIYXMDOT-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264977,DTCC00566137,1351108,46191
CHEMBL508102,P23975,CARBIMAZOLE,CFOYWRHIYXMDOT-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7264978,DTCC00566137,1351108,46191
CHEMBL508112,P23975,BENZOTHIAZYL DISULFIDE,AFZSMODLJJCVPP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7272607,DTCC00534219,606967,46191
CHEMBL508112,P23975,BENZOTHIAZYL DISULFIDE,AFZSMODLJJCVPP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7272608,DTCC00534219,606967,46191
CHEMBL508338,P23975,THIOMERSAL,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,931,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7476771,DTCC00113560,962452,46191
CHEMBL508338,P23975,THIOMERSAL,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,923,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7476772,DTCC00113560,962452,46191
CHEMBL50858,P23975,,VMITZEMDDZVHBZ-KCNJBTMXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12723940,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of Norepinephrine (NA) reuptake using cloned human Norepinephrine transporter was determined,,2002 Medicinal Chemistry Division Award address: monoamine transporters and opioid receptors. Targets for addiction therapy.,J. Med. Chem.,2003,46,10,,,144966,DTCT0023180,1103964,DTCC00196042,1552388,17278
CHEMBL508678,P23975,,LCUQDUYHYRSPMJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,>,10000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816212,DTCC00567190,489859,32733
CHEMBL508678,P23975,,LCUQDUYHYRSPMJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,8517,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816103,DTCC00567190,489859,32733
CHEMBL509,P23975,MECLOFENAMIC ACID,SBDNJUWAMKYJOX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427787,DTCC00140998,510304,46191
CHEMBL509,P23975,MECLOFENAMIC ACID,SBDNJUWAMKYJOX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427788,DTCC00140998,510304,46191
CHEMBL509007,P23975,,SQCPLVXIAQOQFF-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,>,3000,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686046,DTCC00544975,1050048,31294
CHEMBL509228,P23975,,KWAYIPPRBHZSBU-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,1100,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725294,DTCC00537405,1103636,34196
CHEMBL509373,P23975,,LXXOMHAIVSCBSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,75,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793572,DTCC00513580,790778,31630
CHEMBL509446,P23975,,LXXOMHAIVSCBSY-DLBZAZTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,77,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793571,DTCC00513581,1017258,31630
CHEMBL510139,P23975,CITRININ,CQIUKKVOEOPUDV-IYSWYEEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7360606,DTCC00525343,249940,46191
CHEMBL510139,P23975,CITRININ,CQIUKKVOEOPUDV-IYSWYEEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7360607,DTCC00525343,249940,46191
CHEMBL510352,P23975,,RQRGTZIPGLRQOJ-GUYCJALGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,3100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447065,DTCC00561267,100308,30886
CHEMBL510484,P23975,,ROTSFLNCGRVNJJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18782666,IC50,=,13,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,19,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, MacKenny M, Stobie A, Tang K, Morgan P, Jones B",,535647,DTCT0023180,2685005,DTCC00545618,597567,31309
CHEMBL510855,P23975,,ONSNNWXLUHKPDE-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,29,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725278,DTCC00537200,941511,34196
CHEMBL510915,P23975,,WQHNJPRNTDZGGW-RRPNLBNLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793570,DTCC00514460,1275944,31630
CHEMBL511,P23975,PYRILAMINE,YECBIJXISLIIDS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7392303,DTCC00141084,1830688,46191
CHEMBL511,P23975,PYRILAMINE,YECBIJXISLIIDS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7392304,DTCC00141084,1830688,46191
CHEMBL511163,P23975,,QLXIMJBRAWACSR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,3420,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816210,DTCC00567118,1395247,32733
CHEMBL511163,P23975,,QLXIMJBRAWACSR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816101,DTCC00567118,1395247,32733
CHEMBL511288,P23975,,ZLNPNQNLLKIKSH-FOYRJYEQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655407,DTCC00509455,1005745,30473
CHEMBL511347,P23975,WY-46824,KVRIVKGFVFCJEI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,58,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657184,DTCC00005280,1264310,30478
CHEMBL511347,P23975,WY-46824,KVRIVKGFVFCJEI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,46,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657152,DTCC00005280,1264310,30478
CHEMBL511466,P23975,,GLLHCTWOTAUGQC-ZSFQTYJUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,553,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655384,DTCC00509426,1296883,30473
CHEMBL511500,P23975,,CLSUYIGLXGEXLU-QWHCGFSZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,=,628,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816225,DTCC00567295,1167421,32733
CHEMBL511500,P23975,,CLSUYIGLXGEXLU-QWHCGFSZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,5993,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816116,DTCC00567295,1167421,32733
CHEMBL511525,P23975,,KVRIVKGFVFCJEI-JPKZNVRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,29,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657182,DTCC00510160,455881,30478
CHEMBL511525,P23975,,KVRIVKGFVFCJEI-JPKZNVRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,14,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657150,DTCC00510160,455881,30478
CHEMBL511603,P23975,,YSZKSMMSKUUKKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19445453,KI,>,6000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human NET expressed in HEK293 cells,,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,2009,52,11,"Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH",,523086,DTCT0023180,2826436,DTCC00536196,1503161,33656
CHEMBL511603,P23975,,YSZKSMMSKUUKKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19445453,KI,>,6000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,2009,52,11,"Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH",,523089,DTCT0023180,2826439,DTCC00536196,1503161,33656
CHEMBL511695,P23975,,KLRJYPAUNJPVOA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,INHIBITION,=,7,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487429,DTCT0023180,2657250,DTCC00510086,1070575,30478
CHEMBL511695,P23975,,KLRJYPAUNJPVOA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,1220,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657154,DTCC00510086,1070575,30478
CHEMBL511827,P23975,,NIAVVXCRSHJORD-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,6,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789631,DTCC00513870,1038205,31613
CHEMBL511959,P23975,,DJVJRXDBDBMWFD-NTEVMMBTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,3474,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657176,DTCC00113697,2068505,30478
CHEMBL511959,P23975,,DJVJRXDBDBMWFD-NTEVMMBTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,785,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657144,DTCC00113697,2068505,30478
CHEMBL512044,P23975,,BCZUZJIUZQQTDT-RBUKOAKNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793583,DTCC00513768,2047950,31630
CHEMBL512130,P23975,,WDAYPJKNBZKLPA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,1500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620089,DTCC00570170,1874446,33285
CHEMBL512189,P23975,,JUFVWXGWKDEQTH-RRIHMMEISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,466,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655371,DTCC00509430,359541,30473
CHEMBL512202,P23975,,WCTHXORWWZOJGX-HHZCPPTISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,1110,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780252,DTCC00562724,1567775,31509
CHEMBL512435,P23975,,VMHPHANZAYAVEB-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,73,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725288,DTCC00537328,844835,34196
CHEMBL512472,P23975,,ABWNRPAQIBGXIY-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,25,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767522,DTCC00543359,2016105,30743
CHEMBL512551,P23975,,JIQNPRNQHOWEMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,19,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602745,DTCC00564603,1503474,32656
CHEMBL512665,P23975,,BGQYUSCFJWWBHR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,40000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620052,DTCC00570027,1167468,33285
CHEMBL512677,P23975,,LYBIOYSWEAGQEQ-FQEVSTJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,215,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789673,DTCC00513945,1264363,31613
CHEMBL512685,P23975,,OAUPYPVBPTVZBM-CQMVAQQKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655409,DTCC00509450,9695,30473
CHEMBL512736,P23975,,WFCMRRKVDOAHNR-ZWNOBZJWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,IC50,>,10000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541290,DTCT0023180,2816219,DTCC00567197,1104000,32733
CHEMBL512736,P23975,,WFCMRRKVDOAHNR-ZWNOBZJWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19201198,KI,=,27500,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,2009,17,5,"Voelker T, Xia H, Fandrick K, Johnson R, Janowsky A, Cashman JR",,541288,DTCT0023180,2816110,DTCC00567197,1104000,32733
CHEMBL512795,P23975,,MOQOVFQXRKZPCT-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,INHIBITION,=,31,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500245,DTCT0023180,2725297,DTCC00537403,132329,34196
CHEMBL512851,P23975,,XCOOHOIRZJLJRQ-WFASDCNBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,2.3,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2599940,DTCC00565991,1885780,32649
CHEMBL512878,P23975,,DQRDMGPCIADVBP-ZSFQTYJUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655411,DTCC00509428,1199224,30473
CHEMBL512967,P23975,,KSQKTWNQJCTCMA-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,60,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767529,DTCC00543284,111465,30743
CHEMBL513,P23975,CARMUSTINE,DLGOEMSEDOSKAD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366497,DTCC00141242,1383773,46191
CHEMBL513,P23975,CARMUSTINE,DLGOEMSEDOSKAD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366498,DTCC00141242,1383773,46191
CHEMBL513090,P23975,,MDTSUTPVPDPVGP-CHKHYCHESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,160,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780255,DTCC00562337,1243858,31509
CHEMBL513139,P23975,,YRBVTLBLPHIXQP-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767526,DTCC00543287,920590,30743
CHEMBL513204,P23975,,WZTBYHQYXSTVTK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,240,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657186,DTCC00509467,1038149,30478
CHEMBL513204,P23975,,WZTBYHQYXSTVTK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,364,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657156,DTCC00509467,1038149,30478
CHEMBL513206,P23975,,IIVGYQYUSCHDRA-LIAHKDQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655408,DTCC00509454,617976,30473
CHEMBL513248,P23975,,DDNDQTODRFYZEU-WFASDCNBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,6,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2599976,DTCC00566060,37340,32649
CHEMBL513258,P23975,,RBNFIIOAQFISLC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,7,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602749,DTCC00564545,1210962,32656
CHEMBL513313,P23975,,RUCURZAOXQKURR-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,70,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767527,DTCC00543286,597539,30743
CHEMBL513360,P23975,,PXZVEYWSVBEKRN-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,64,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2767521,DTCC00543360,1470950,30743
CHEMBL513367,P23975,,HLQQIEZMTRFYMO-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174,IC50,=,5600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828,DTCT0023180,2620068,DTCC00570093,1395291,33285
CHEMBL513577,P23975,,XBSXEAMPHZZPKZ-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,201,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789628,DTCC00513867,489263,31613
CHEMBL513618,P23975,,FHGGWRRIFBYBAE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,700,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793574,DTCC00514535,1917331,31630
CHEMBL513884,P23975,,DFLDZWQBWUBYFS-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766849,DTCC00543415,111466,30743
CHEMBL513912,P23975,,SQCPLVXIAQOQFF-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,7,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686045,DTCC00544974,1535619,31294
CHEMBL514,P23975,LOMUSTINE,GQYIWUVLTXOXAJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427459,DTCC00141290,1765975,46191
CHEMBL514,P23975,LOMUSTINE,GQYIWUVLTXOXAJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427460,DTCC00141290,1765975,46191
CHEMBL514193,P23975,,VBPKFUYKYAIDNV-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,627,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789672,DTCC00513942,1685170,31613
CHEMBL514200,P23975,,BDOFPOSOPQRCSW-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,175,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686040,DTCC00544910,1696760,31294
CHEMBL514208,P23975,,XGCHOCPXNPEOLZ-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,7,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688222,DTCC00544724,392698,31354
CHEMBL514232,P23975,,WSUKOKAEFHVCAH-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765564,DTCC00543789,327382,30733
CHEMBL514354,P23975,,VLIFAHMVTGLJCP-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,19,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686042,DTCC00544912,791146,31294
CHEMBL514424,P23975,,QRNLLMHKIXCFGM-IYIFBUTFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,1850,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780265,DTCC00562728,1788967,31509
CHEMBL514447,P23975,,DUCJOVLKXCHFKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,60,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602751,DTCC00564543,888892,32656
CHEMBL514515,P23975,,ILKQBHSHNTVIIC-FQEVSTJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,>,3000,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686050,DTCC00545044,1438546,31294
CHEMBL514560,P23975,,DRWJMJVERMOJBX-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765561,DTCC00543723,2037114,30733
CHEMBL514759,P23975,,NPBACWUTGOBPGG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602748,DTCC00117092,985571,32656
CHEMBL514937,P23975,,RPJFGKOZZHLXFS-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793588,DTCC00513819,856127,31630
CHEMBL515,P23975,CHLORAMBUCIL,JCKYGMPEJWAADB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340870,DTCC00141382,477914,46191
CHEMBL515,P23975,CHLORAMBUCIL,JCKYGMPEJWAADB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7340871,DTCC00141382,477914,46191
CHEMBL515613,P23975,,FUONWQQDHNHFGH-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,1360,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688221,DTCC00544723,1777221,31354
CHEMBL515614,P23975,,DWTJKIXZDHRVPT-HXUWFJFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,26,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686047,DTCC00544976,1210727,31294
CHEMBL515914,P23975,AZARIBINE,QQOBRRFOVWGIMD-OJAKKHQRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7279512,DTCC00514747,477912,46191
CHEMBL515914,P23975,AZARIBINE,QQOBRRFOVWGIMD-OJAKKHQRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7279513,DTCC00514747,477912,46191
CHEMBL515936,P23975,,JTFGLXWULCGHRY-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765571,DTCC00543718,1524074,30733
CHEMBL515988,P23975,,CACJRDOFRVCXPK-WIOPOQQRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,2010,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780259,DTCC00562401,1853614,31509
CHEMBL516,P23975,CYPROHEPTADINE,JJCFRYNCJDLXIK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15081025,KI,=,290,NM,,,,,,,,,,,,,,Binding affinity towards Norepinephrine transporter using [3H]nisoxitine as radioligand,,"Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).",Bioorg. Med. Chem. Lett.,2004,14,9,"Peddi S, Roth BL, Glennon RA, Westkaemper RB",,143139,DTCT0023180,837193,DTCC00141384,808516,6858
CHEMBL516,P23975,CYPROHEPTADINE,JJCFRYNCJDLXIK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,564,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367729,DTCC00141384,833160,46191
CHEMBL516,P23975,CYPROHEPTADINE,JJCFRYNCJDLXIK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,559,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367730,DTCC00141384,833160,46191
CHEMBL516094,P23975,,CPFZMZOYHKWMOT-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,53,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765574,DTCC00543855,715365,30733
CHEMBL516507,P23975,,KIAUBZBIKKPZNR-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,7,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793586,DTCC00513771,1049676,31630
CHEMBL516730,P23975,,FFJNDOUWRPDJJX-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,46,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765577,DTCC00543852,1809682,30733
CHEMBL516825,P23975,,MBCIBUXZJAIISR-SOFGYWHQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053782,KI,=,1180,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,2008,51,24,"Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Camp VM, Malveaux EJ, Votaw JR, Howell L, Owens MJ, Goodman MM",,561314,DTCT0023180,2799896,DTCC00515328,629802,31538
CHEMBL516933,P23975,,CTNIUTSUTZHULD-JRTRGBLZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,2710,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780266,DTCC00562786,1147835,31509
CHEMBL516965,P23975,,XCYJTWMYHQVABH-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789627,DTCC00113859,618025,31613
CHEMBL51697,P23975,(S)-NOMIFENSINE,XXPANQJNYNUNES-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23084899,KI,=,21.5,NM,,,,,,,,,,,,,,Inhibition of human NET,,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,23,"Pechulis AD, Beck JP, Curry MA, Wolf MA, Harms AE, Xi N, Opalka C, Sweet MP, Yang Z, Vellekoop AS, Klos AM, Crocker PJ, Hassler C, Laws M, Kitchen DB, Smith MA, Olson RE, Liu S, Molino BF",,885013,DTCT0023180,11461620,DTCC01740208,847855,52000
CHEMBL51697,P23975,(S)-NOMIFENSINE,XXPANQJNYNUNES-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,,ACS Med. Chem. Lett.,2013,4,1,,,939924,DTCT0023180,11783952,DTCC01740208,848229,53459
CHEMBL517118,P23975,,ZOJBCUHWLQNKOW-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,INHIBITION,=,27,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558179,DTCT0023180,2789678,DTCC00513757,973280,31613
CHEMBL517305,P23975,,GVFNSRVEVUSCRN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,5,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602740,DTCC00564655,1374476,32656
CHEMBL517423,P23975,,LTGCAGJRXIORIR-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793584,DTCC00513769,1885195,31630
CHEMBL517424,P23975,,ANZMQHLROXAIJU-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,19,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789623,DTCC00113855,618024,31613
CHEMBL517712,P23975,ATROPINE,RKUNBYITZUJHSG-SPUOUPEWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7270629,DTCC00507754,1577004,46191
CHEMBL517712,P23975,ATROPINE,RKUNBYITZUJHSG-SPUOUPEWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7270630,DTCC00507754,1577004,46191
CHEMBL517963,P23975,,PMWLMRLBVALWMX-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,114,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766847,DTCC00543417,1917656,30743
CHEMBL517978,P23975,,JTVKAFWSBOMWKU-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765581,DTCC00543782,1362600,30733
CHEMBL518195,P23975,,YYJIBHFMUZUGND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,575,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657178,DTCC00510164,424995,30478
CHEMBL518195,P23975,,YYJIBHFMUZUGND-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,417,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657146,DTCC00510164,424995,30478
CHEMBL518276,P23975,,NFXSKGKGQACNCS-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18621528,KI,=,65,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490418,DTCT0023180,2765583,DTCC00543780,1685486,30733
CHEMBL518580,P23975,,YRGCYAJUEHMWAR-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18625557,IC50,=,98,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,15,"Wakenhut F, Fish PV, Fray MJ, Gurrell I, Mills JE, Stobie A, Whitlock GA",,513532,DTCT0023180,2766843,DTCC00543484,240568,30743
CHEMBL518748,P23975,,QIVITPMRYRPJPE-HOCLYGCPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,6,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688227,DTCC00544791,392699,31354
CHEMBL519240,P23975,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18983139,ACTIVITY,=,88.6,%,,,,,,,,,,,,,,Binding affinity to human NET at 10 uM relative to control,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494421,DTCT0023180,2604340,DTCC00008943,1621329,32034
CHEMBL519240,P23975,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18983139,INHIBITION,=,11,%,,,,,,,,,,,,,,Inhibition of human NET at 10 uM,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494203,DTCT0023180,2604260,DTCC00008943,1621329,32034
CHEMBL519819,P23975,,BZXPKSLKLWOLEJ-BJUDXGSMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18487050,KI,=,1810,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,2008,16,12,"Ben-Daniel R, Deuther-Conrad W, Scheunemann M, Steinbach J, Brust P, Mishani E",,556833,DTCT0023180,2552139,DTCC00559508,747846,28919
CHEMBL519910,P23975,,DNHPSSPWARRIMM-FOYRJYEQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,1100,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655375,DTCC00509702,973236,30473
CHEMBL520035,P23975,,IRDYKJUJFKVPBO-LIAHKDQHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,677,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655377,DTCC00509633,1199231,30473
CHEMBL520201,P23975,,NBLMTDPDGYITGF-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,150,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649845,DTCC00509730,35465,31203
CHEMBL520301,P23975,,HKMJCOCCPVLYPB-BJUDXGSMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18487050,KI,=,2880,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,2008,16,12,"Ben-Daniel R, Deuther-Conrad W, Scheunemann M, Steinbach J, Brust P, Mishani E",,556833,DTCT0023180,2552143,DTCC00559466,554129,28919
CHEMBL520349,P23975,,OHOQFGDSEWQDAX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19338356,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to NET,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009,52,7,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497700,DTCT0023180,2728016,DTCC00569166,1178835,34004
CHEMBL520735,P23975,,DTIHRSKIBFPMSD-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,800,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649858,DTCC00509650,1696351,31203
CHEMBL520736,P23975,,FDBFTQAPQQWDDD-QAPCUYQASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649842,DTCC00509799,1017216,31203
CHEMBL520760,P23975,,GRQBTYJVQQSMFR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18571404,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Not Determined,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,14,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,487517,DTCT0023180,2654466,DTCC00526521,228982,30519
CHEMBL520869,P23975,,CGANQTTYLGBMNA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,5,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602757,DTCC00565425,597794,32656
CHEMBL520970,P23975,,IGIFNSQJPOGUFY-BJUDXGSMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18487050,KI,=,712,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,2008,16,12,"Ben-Daniel R, Deuther-Conrad W, Scheunemann M, Steinbach J, Brust P, Mishani E",,556833,DTCT0023180,2552140,DTCC00559507,1330075,28919
CHEMBL521,P23975,IBUPROFEN,HEFNNWSXXWATRW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321397,DTCC00141944,833161,46191
CHEMBL521,P23975,IBUPROFEN,HEFNNWSXXWATRW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321398,DTCC00141944,833161,46191
CHEMBL521179,P23975,SR-3677,OQWZIAVXCYIZNN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18834107,INHIBITION,=,16,%,,,,,,,,,,,,,,Inhibition of human NET at 3 uM,,Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.,J. Med. Chem.,2008,51,21,"Feng Y, Yin Y, Weiser A, Griffin E, Cameron MD, Lin L, Ruiz C, Schürer SC, Inoue T, Rao PV, Schröter T, Lograsso P",,538235,DTCT0023180,2672805,DTCC00564119,1535842,31402
CHEMBL521392,P23975,,NBLMTDPDGYITGF-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,150,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649852,DTCC00113737,1535221,31203
CHEMBL521589,P23975,BAMBUTEROL,ANZXOIAKUNOVQU-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7265456,DTCC00514881,1318439,46191
CHEMBL521589,P23975,BAMBUTEROL,ANZXOIAKUNOVQU-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7265457,DTCC00514881,1318439,46191
CHEMBL522065,P23975,,OBPAJKUDOWNRDR-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,36,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445648,DTCC00561305,2069149,30880
CHEMBL522097,P23975,,COCNIWDSGPEBCT-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,2,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688213,DTCC00545361,261458,31354
CHEMBL522296,P23975,,AKCWJIPYUJCKIS-HOTGVXAUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,7,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688212,DTCC00545360,1329886,31354
CHEMBL522482,P23975,,XTOPLFVJQKWOCT-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,3,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688206,DTCC00545294,456322,31354
CHEMBL522483,P23975,,UKCDLIWPLWMDCP-GJZGRUSLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,20,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688210,DTCC00545298,910001,31354
CHEMBL522699,P23975,,XFRJSOUJVWXXAT-GAPKJMMISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,230,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559255,DTCC00541338,1983087,28814
CHEMBL522707,P23975,,JMKKUONSGMKXDD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,12.6,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556603,DTCC00540695,1621042,28813
CHEMBL522721,P23975,,URMSDCFJUVHWMC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,43.8,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556606,DTCC00541562,877329,28813
CHEMBL523146,P23975,,JOQTYFCRRMFQJX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18782666,IC50,>,10,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,,Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.,Bioorg. Med. Chem. Lett.,2008,18,19,"Middleton DS, Andrews M, Glossop P, Gymer G, Hepworth D, Jessiman A, Johnson PS, MacKenny M, Stobie A, Tang K, Morgan P, Jones B",,535647,DTCT0023180,2685004,DTCC00545549,952971,31309
CHEMBL523416,P23975,,CMINFVGCVRRRQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,2.72,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556612,DTCC00541557,1653320,28813
CHEMBL523475,P23975,,MVYOBBWPCHPRSG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19492813,IC50,=,1000,NM,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter,,Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,13,"Marquis RW, Lago AM, Callahan JF, Trout RE, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Yang Z, Roethke T, Smith BR, Ward KW, Lee J, Keenan RM, Bhatnagar P",,520036,DTCT0023180,2835769,DTCC00552426,953047,33744
CHEMBL523489,P23975,,WDSNWUWPKXWDIQ-WMZOPIPTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,13,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688231,DTCC00545366,1971722,31354
CHEMBL523574,P23975,,PXFCLZUOFIJVNC-KBXCAEBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,430,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445656,DTCC00561217,1777446,30880
CHEMBL523636,P23975,,UKCDLIWPLWMDCP-LSDHHAIUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18805691,ACTIVITY,=,2570,NM,,,,,,,,,,,,,,Binding affinity at NET,,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,20,"Xu W, Gray DL, Glase SA, Barta NS",,536123,DTCT0023180,2688211,DTCC00545299,327397,31354
CHEMBL523652,P23975,KF-A4,QHSXELZOXIQJEU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007,51,11,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923,DTCT0023180,2718426,DTCC00005712,1906125,34126
CHEMBL523916,P23975,,UXQWVKZZHZNXRM-SLWGAWGTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,2560,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559252,DTCC00541395,1178510,28814
CHEMBL524153,P23975,,RNPCOHCWKNMBRI-QHCPKHFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18799310,ACTIVITY,=,1790,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, a selective alpha2C adrenergic receptor antagonist.",Bioorg. Med. Chem. Lett.,2008,18,20,"Patel SD, Habeski WM, Min H, Zhang J, Roof R, Snyder B, Bora G, Campbell B, Li C, Hidayetoglu D, Johnson DS, Chaudhry A, Charlton ME, Kablaoui NM",,535933,DTCT0023180,2685297,DTCC00545284,1600091,31332
CHEMBL524188,P23975,,OHTMMULBWQHGBT-AAPAXJHYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18434164,KI,=,55,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,2008,16,10,"Jin C, Navarro HA, Carroll FI",,556594,DTCT0023180,2559261,DTCC00541277,306276,28814
CHEMBL524271,P23975,,VPTOWUWJWIVXIJ-LAUBAEHRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445672,DTCC00561294,1556452,30880
CHEMBL524313,P23975,,CGROONDICFFSDT-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447045,DTCC00561326,1938701,30886
CHEMBL52440,P23975,DEXTROMETHORPHAN,MKXZASYAUGDDCJ-NJAFHUGGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7352966,DTCC00195499,315664,46191
CHEMBL52440,P23975,DEXTROMETHORPHAN,MKXZASYAUGDDCJ-NJAFHUGGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7352967,DTCC00195499,315664,46191
CHEMBL524624,P23975,,VBCNPTPFVJBMLY-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,480,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445647,DTCC00561306,1809888,30880
CHEMBL524798,P23975,,BHTUHPLMWNGSLY-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,95,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445660,DTCC00561268,683281,30880
CHEMBL524798,P23975,,BHTUHPLMWNGSLY-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447064,DTCC00561268,683280,30886
CHEMBL525238,P23975,,VVQIWKYSMSGPNS-DNVCBOLYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447058,DTCC00561322,618624,30886
CHEMBL525249,P23975,,FDBFTQAPQQWDDD-YJBOKZPZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,160,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649840,DTCC00509801,984924,31203
CHEMBL525371,P23975,,UWKDYASULVDCRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18793858,KI,>,5200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,2008,16,19,"Mavel S, Vercouillie J, Garreau L, Raguza T, Ravna AW, Chalon S, Guilloteau D, Emond P",,492712,DTCT0023180,2458483,DTCC00547523,747678,32562
CHEMBL525375,P23975,,CBIWVBLPTDWHKB-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,40,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445658,DTCC00561215,683276,30880
CHEMBL525375,P23975,,CBIWVBLPTDWHKB-QFBILLFUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447072,DTCC00561215,683283,30886
CHEMBL525532,P23975,,BHTUHPLMWNGSLY-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,1000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447063,DTCC00561269,1492088,30886
CHEMBL525559,P23975,,MNHPKYUTSKOFJZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,8.43,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556610,DTCC00541443,100035,28813
CHEMBL525714,P23975,,CGVBIXZVEMXIQU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,1.7,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556609,DTCC00541559,100038,28813
CHEMBL525717,P23975,,WINONEAFBRSOAL-IAGOWNOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,370,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447053,DTCC00561273,1653574,30886
CHEMBL525952,P23975,,SPQWIGAZLYFACO-SREVYHEPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053782,KI,=,101.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,2008,51,24,"Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Camp VM, Malveaux EJ, Votaw JR, Howell L, Owens MJ, Goodman MM",,561314,DTCT0023180,2799893,DTCC00515266,1438200,31538
CHEMBL526,P23975,PROPOFOL,OLBCVFGFOZPWHH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,9393,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7396476,DTCC00142061,51502,46191
CHEMBL526,P23975,PROPOFOL,OLBCVFGFOZPWHH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,9316,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7396477,DTCC00142061,51502,46191
CHEMBL526270,P23975,,DKMITNDZRUDDGX-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,6,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445643,DTCC00561224,1395176,30880
CHEMBL526270,P23975,,DKMITNDZRUDDGX-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447052,DTCC00561224,1395178,30886
CHEMBL526306,P23975,,VPTOWUWJWIVXIJ-DYESRHJHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,400,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445670,DTCC00561296,715545,30880
CHEMBL526669,P23975,,FHNHVNKWEHYJDJ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,100,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445653,DTCC00561301,489803,30880
CHEMBL526669,P23975,,FHNHVNKWEHYJDJ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447060,DTCC00561301,489804,30886
CHEMBL526670,P23975,,PATATAHKRVWCHN-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,75,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445650,DTCC00561303,812282,30880
CHEMBL526825,P23975,,BKCSCHQRSOSNPN-HKUYNNGSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,8,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445637,DTCC00561311,456517,30880
CHEMBL526849,P23975,,ISXTVMLLUKKPCR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18461921,KI,>,100000,NM,,,,,,,,,,,,,,Binding affinity at NET,,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,2008,51,11,"Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A",,555733,DTCT0023180,2561514,DTCC00541553,920558,28872
CHEMBL527,P23975,PIROXICAM,QYSPLQLAKJAUJT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385301,DTCC00142164,866023,46191
CHEMBL527,P23975,PIROXICAM,QYSPLQLAKJAUJT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385302,DTCC00142164,866023,46191
CHEMBL528995,P23975,DOV-216303,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18539031,IC50,=,20.3,NM,,,,,,,,,,,,,,Inhibition of norepinephrine uptake at human cloned NET,,Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,13,"Zhang M, Jovic F, Vickers T, Dyck B, Tamiya J, Grey J, Tran JA, Fleck BA, Pick R, Foster AC, Chen C",,491871,DTCT0023180,2666813,DTCC00005288,779298,31169
CHEMBL528995,P23975,DOV-216303,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954985,KI,=,63,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493416,DTCT0023180,2602761,DTCC00005288,791349,32656
CHEMBL528995,P23975,DOV-216303,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,IC50,=,72.4,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118,DTCT0023180,3446711,DTCC00005288,792537,40497
CHEMBL528995,P23975,DOV-216303,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,20,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038962,DTCC00005288,798440,42566
CHEMBL528995,P23975,DOV-216303,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,23,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038961,DTCC00005288,798439,42566
CHEMBL528995,P23975,DOV-216303,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,143,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880519,DTCC00005288,784475,60843
CHEMBL529,P23975,AZITHROMYCIN,MQTOSJVFKKJCRP-BICOPXKESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7270759,DTCC00142593,1512804,46191
CHEMBL529,P23975,AZITHROMYCIN,MQTOSJVFKKJCRP-BICOPXKESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7270760,DTCC00142593,1512804,46191
CHEMBL529437,P23975,COCAINE HYDROCHLORIDE,PIQVDUKEQYOJNR-VZXSFKIWSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18556210,KI,=,1990,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,2008,16,14,"Jin C, Navarro HA, Page K, Carroll FI",,492351,DTCT0023180,2655341,DTCC00509630,1199230,30473
CHEMBL529437,P23975,COCAINE HYDROCHLORIDE,PIQVDUKEQYOJNR-VZXSFKIWSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19053748,KI,=,1990,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,2008,51,24,"Jin C, Navarro HA, Carroll FI",,560916,DTCT0023180,2780250,DTCC00509630,1210941,31509
CHEMBL529437,P23975,COCAINE HYDROCHLORIDE,PIQVDUKEQYOJNR-VZXSFKIWSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20597489,KI,,,,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET,Not Determined,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,2010,53,15,"Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM",,646995,DTCT0023180,3432100,DTCC00509630,1200637,40077
CHEMBL530334,P23975,,AFPFOKAYUJMERG-CABCVRRESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,5000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649860,DTCC00509584,758635,31203
CHEMBL531,P23975,PERGOLIDE,YEHCICAEULNIGD-MZMPZRCHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7384973,DTCC00142656,1318444,46191
CHEMBL531,P23975,PERGOLIDE,YEHCICAEULNIGD-MZMPZRCHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7384974,DTCC00142656,1318444,46191
CHEMBL532,P23975,ERYTHROMYCIN,ULGZDMOVFRHVEP-RWJQBGPGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7332645,DTCC00142668,51467,46191
CHEMBL532,P23975,ERYTHROMYCIN,ULGZDMOVFRHVEP-RWJQBGPGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7332646,DTCC00142668,51467,46191
CHEMBL534,P23975,KETOTIFEN,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7439792,DTCC00142999,217580,46191
CHEMBL534,P23975,KETOTIFEN,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7439793,DTCC00142999,217580,46191
CHEMBL534479,P23975,,ZNSNAOXTBUHNKX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,=,480,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306535,DTCT0023180,1824115,DTCC00578120,1307534,19663
CHEMBL534479,P23975,,ZNSNAOXTBUHNKX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15828826,IC50,>,7200,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,2005,48,8,"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE, Middaugh LD",,306359,DTCT0023180,1824116,DTCC00578120,1307534,19663
CHEMBL53463,P23975,DOXORUBICIN,AOJJSUZBOXZQNB-TZSSRYMLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7323716,DTCC00196573,51466,46191
CHEMBL53463,P23975,DOXORUBICIN,AOJJSUZBOXZQNB-TZSSRYMLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7323717,DTCC00196573,51466,46191
CHEMBL534723,P23975,,YIQFFQJVNKNCNB-FSRHSHDFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1963985,DTCC00122850,1393762,21124
CHEMBL534942,P23975,,IBUZSMCHAASZTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1963983,DTCC00578396,746390,21124
CHEMBL534942,P23975,,IBUZSMCHAASZTO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,50,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1963982,DTCC00578396,746389,21124
CHEMBL537196,P23975,,KVIXRWQLEHRFLW-DPSPSOFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,56,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917186,DTCC00578296,1393692,20590
CHEMBL538053,P23975,,NTMVOPDZLWZAQO-APTPAJQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,1800,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,459009,DTCC00580957,660129,3008
CHEMBL538876,P23975,,YYCOWMQMXNLRHZ-DXWKFQSLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22300887,KI,>,500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET receptor expressed in HEK293 cells,,QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).,Bioorg. Med. Chem.,2012,20,4,"Mavel S, Mincheva Z, Méheux N, Carcenac Y, Guilloteau D, Abarbri M, Emond P",,801861,DTCT0023180,7620649,DTCC00583675,781926,47277
CHEMBL538876,P23975,,YYCOWMQMXNLRHZ-DXWKFQSLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24262882,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin),,"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,2013,21,24,"Rami-Mark C, Bornatowicz B, Fink C, Otter P, Ungersboeck J, Vraka C, Haeusler D, Nics L, Spreitzer H, Hacker M, Mitterhauser M, Wadsak W",,1285652,DTCT0023180,12992717,DTCC00583675,783642,56861
CHEMBL539050,P23975,,KCLIFHPTVWHVGF-GUTACTQSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,44,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,595100,DTCC00580897,1694522,3008
CHEMBL539054,P23975,,BPTVMTODGGFNIG-KUGOCAJQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,22500,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,604568,DTCC00580973,271090,3008
CHEMBL539564,P23975,,GRNINAGHVYRWAO-HLRBRJAUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,21,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,606862,DTCC00580909,530941,3008
CHEMBL539716,P23975,,IWVPGLLZAJONSB-UXHICEINSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,42.5,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901939,DTCC00591590,1438946,35305
CHEMBL539716,P23975,,IWVPGLLZAJONSB-UXHICEINSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,90,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583226,DTCT0023180,2901967,DTCC00591590,1438946,35305
CHEMBL54,P23975,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422,KI,=,5500,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255,DTCT0023180,13943039,DTCC00135385,59464,61087
CHEMBL54,P23975,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1836,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7334065,DTCC00135385,51476,46191
CHEMBL54,P23975,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1820,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7334066,DTCC00135385,51476,46191
CHEMBL540107,P23975,,YIQFFQJVNKNCNB-FYZYNONXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363,IC50,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,16,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063,DTCT0023180,1963984,DTCC00581656,1458136,21124
CHEMBL540333,P23975,,BISDZXSPECCJOM-MOGJOVFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,1540,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,583543,DTCC00580919,1883336,3008
CHEMBL540445,P23975,PARTHENOLIDE,KTEXNACQROZXEV-SLXBATTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7382544,DTCC00556195,574624,46191
CHEMBL540445,P23975,PARTHENOLIDE,KTEXNACQROZXEV-SLXBATTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7382545,DTCC00556195,574624,46191
CHEMBL540978,P23975,,VKEVCZGXCJOVET-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876616,DTCC00589199,597898,34589
CHEMBL541,P23975,BENZOIC ACID,WPYMKLBDIGXBTP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269803,DTCC00143343,833157,46191
CHEMBL541,P23975,BENZOIC ACID,WPYMKLBDIGXBTP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269804,DTCC00143343,833157,46191
CHEMBL541196,P23975,,VLCYASXBDSCXJI-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912690,DTCC00586712,2004798,35247
CHEMBL541226,P23975,,AMLGZPQHVSFYSD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,16,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876641,DTCC00589242,920980,34589
CHEMBL54126,P23975,NEOSTIGMINE BROMIDE,LULNWZDBKTWDGK-UHFFFAOYSA-M,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373170,DTCC00197200,1027056,46191
CHEMBL54126,P23975,NEOSTIGMINE BROMIDE,LULNWZDBKTWDGK-UHFFFAOYSA-M,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373171,DTCC00197200,1027056,46191
CHEMBL542501,P23975,,UEKLEFLNJKLESJ-LMRHVHIWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,3430,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,603499,DTCC00576871,1786519,3008
CHEMBL542746,P23975,,JGYZGTZUFGVWMT-YYLIZZNMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,12500,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,610207,DTCC00576876,1754303,3008
CHEMBL542933,P23975,GBR-12909,VAHMWGICKYTGSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24315194,KI,=,48.5,NM,,,,,,,,,,,,,,Inhibition of NET (unknown origin),,"Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model.",Bioorg. Med. Chem.,2014,22,1,"Sharma H, Santra S, Debnath J, Antonio T, Reith M, Dutta A",,1282842,DTCT0023180,12975783,DTCC00022273,351586,56781
CHEMBL543876,P23975,GBR-12909,MIBSKSYCRFWIRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,IC50,=,1460,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863447,DTCT0023180,11410186,DTCC00022271,835062,51438
CHEMBL543876,P23975,GBR-12909,MIBSKSYCRFWIRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22938049,INHIBITION,=,-5.9,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,2012,55,18,"Han Y, Han M, Shin D, Song C, Hahn HG",,863450,DTCT0023180,11410240,DTCC00022271,835062,51438
CHEMBL543876,P23975,GBR-12909,MIBSKSYCRFWIRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,INHIBITION,=,85,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930,DTCT0023180,12598172,DTCC00022271,836198,55968
CHEMBL543876,P23975,GBR-12909,MIBSKSYCRFWIRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,1460,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880516,DTCC00022271,816743,60843
CHEMBL543876,P23975,GBR-12909,MIBSKSYCRFWIRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,-6,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876494,DTCC00022271,816743,60843
CHEMBL543876,P23975,GBR-12909,MIBSKSYCRFWIRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,20,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885102,DTCC00022271,816743,60843
CHEMBL543876,P23975,GBR-12909,MIBSKSYCRFWIRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,85,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880735,DTCC00022271,816743,60843
CHEMBL543925,P23975,,SFESMQNHNIKYIQ-CJRXIRLBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,29.9,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,602176,DTCC00576894,1565392,3008
CHEMBL544370,P23975,,YEPHLOVPJHBBRN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,0.62,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,817674,DTCC00576440,1565153,16914
CHEMBL544370,P23975,,YEPHLOVPJHBBRN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,8.8,NM,,,,,,,,,,,,,,Ability to displace [125I]- RTI-55 binding at the Norepinephrine transporter site on HEK cells expressing cDNA for the human transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,142607,DTCT0023180,817671,DTCC00576440,1565153,16914
CHEMBL54440,P23975,MEVASTATIN,AJLFOPYRIVGYMJ-INTXDZFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7434751,DTCC00201440,51490,46191
CHEMBL54440,P23975,MEVASTATIN,AJLFOPYRIVGYMJ-INTXDZFKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7434752,DTCC00201440,51490,46191
CHEMBL544633,P23975,,PBPZAEYGFWGLBT-VKLKMBQZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,35800,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,592756,DTCC00576965,1241387,3008
CHEMBL54465,P23975,,LOEPSYRVNXADMM-TYKWCNGQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18644726,KI,=,1430,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,2008,18,16,"Funke U, Fischer S, Hiller A, Scheunemann M, Deuther-Conrad W, Brust P, Steinbach J",,509626,DTCT0023180,2774165,DTCC00202121,436608,30803
CHEMBL545,P23975,ALCOHOL,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7328493,DTCC00143522,1416029,46191
CHEMBL545,P23975,ALCOHOL,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7328494,DTCC00143522,1416029,46191
CHEMBL545557,P23975,,JTDIXQXYTWHVIP-IDVLALEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,55,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,614888,DTCC00122817,1565391,3008
CHEMBL547,P23975,ISOTRETINOIN,SHGAZHPCJJPHSC-XFYACQKRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407530,DTCC00143769,930080,46191
CHEMBL547,P23975,ISOTRETINOIN,SHGAZHPCJJPHSC-XFYACQKRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407531,DTCC00143769,930080,46191
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,7865,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732365,DTCC00144121,2104667,68466
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732373,DTCC00144121,2104667,68466
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,4070,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732372,DTCC00144121,2104657,68566
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11454918,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732374,DTCC00144121,2104466,69315
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,5029,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732369,DTCC00144121,2104459,68918
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,6190,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732368,DTCC00144121,2104459,68918
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,6514,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732367,DTCC00144121,2104459,68918
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,7841,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732366,DTCC00144121,2104459,68918
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,4870,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732371,DTCC00144121,2104658,69177
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,8690,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732364,DTCC00144121,2104658,69177
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892,KI,=,6190,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004,47,5,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144969,DTCT0023180,936948,DTCC00144121,435920,17996
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609,INHIBITION,=,0.24,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008,51,10,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281,DTCT0023180,2556602,DTCC00144121,425329,28813
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23168018,KI,>,1000000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine uptake at human NET expressed in COS7 cells after 5 mins by beta-counting,,A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.,Bioorg. Med. Chem. Lett.,2013,23,1,"Zhang P, Jørgensen TN, Loland CJ, Newman AH",,943964,DTCT0023180,11814469,DTCC00144121,428618,53759
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2196,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351962,DTCC00144121,444637,46191
CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2178,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351963,DTCC00144121,444637,46191
CHEMBL54943,P23975,CYSTEINE,XUJNEKJLAYXESH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732636,DTCC00201307,2103464,69159
CHEMBL549509,P23975,,BBNHSIZBHGYEBG-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,37,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912691,DTCC00591440,2037585,35247
CHEMBL549510,P23975,,RQCXDPJNIVTCJD-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912692,DTCC00591441,1972130,35247
CHEMBL549584,P23975,,WQAXZHUMPQMMEW-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912689,DTCC00588313,68298,35247
CHEMBL549761,P23975,,XXHZUORXKGMGAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,13,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876602,DTCC00587574,273752,34589
CHEMBL549825,P23975,,RILKVQPDTVTHBN-FWJOYPJLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876632,DTCC00589235,1244024,34589
CHEMBL549825,P23975,,RILKVQPDTVTHBN-FWJOYPJLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,35,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876633,DTCC00589235,1244025,34589
CHEMBL549965,P23975,,MVRJFCQZNCIBPF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,23,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876607,DTCC00587585,2080825,34589
CHEMBL55,P23975,PENTAMIDINE,XDRYMKDFEDOLFX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2214,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7378341,DTCC00135468,51498,46191
CHEMBL55,P23975,PENTAMIDINE,XDRYMKDFEDOLFX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2196,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7378342,DTCC00135468,51498,46191
CHEMBL550289,P23975,,NQBQXWBCVCHJSE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,91,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876601,DTCC00590666,37609,34589
CHEMBL550401,P23975,,HGAHRPAUWSBEBM-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,32,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912703,DTCC00588332,295204,35247
CHEMBL550402,P23975,,FGTRDYXFZBKEJR-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912704,DTCC00588333,618889,35247
CHEMBL550469,P23975,,VITWCGUBRNYQIV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,6.31,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916803,DTCC00589987,1006578,34271
CHEMBL550696,P23975,,RYZMJJMMTKGIGG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,23,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876608,DTCC00590675,1665002,34589
CHEMBL550779,P23975,,MGXQLLRKRSAUPY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876626,DTCC00587610,1211091,34589
CHEMBL550870,P23975,,DVAFTUPEVMCRKD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,3.98,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916799,DTCC00589994,68300,34271
CHEMBL550932,P23975,,RIMYGAIUGCFOTN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,199.53,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916818,DTCC00591470,393171,34271
CHEMBL551135,P23975,,NRIPPOKFEABEPU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916814,DTCC00591484,586597,34271
CHEMBL551443,P23975,,AQWUGZUSQXSOTJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,404,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876609,DTCC00589189,37618,34589
CHEMBL551471,P23975,,MJXRIUSTMWJDCG-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,22,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912682,DTCC00589929,229665,35247
CHEMBL551473,P23975,,DONMCIZYEUHXSH-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,7.8,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901934,DTCC00590009,759458,35305
CHEMBL551474,P23975,,XWEOTQVRTMMRCV-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,4.1,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583226,DTCT0023180,2901987,DTCC00590011,339444,35305
CHEMBL551474,P23975,,XWEOTQVRTMMRCV-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,6.9,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901931,DTCC00590011,339444,35305
CHEMBL551556,P23975,,ABLMTRUAAOJKSC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,106,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876603,DTCC00592253,565685,34589
CHEMBL551573,P23975,,KWWVMVUZZJMGRZ-ZVDHGWRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876637,DTCC00592301,1918012,34589
CHEMBL551573,P23975,,KWWVMVUZZJMGRZ-ZVDHGWRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,44,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876636,DTCC00592301,1918011,34589
CHEMBL551646,P23975,,RMVVWYWHBYZSBH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876618,DTCC00589200,1789112,34589
CHEMBL551818,P23975,,LHPQIFURGZJMMZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,251.19,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916804,DTCC00588374,2069375,34271
CHEMBL551935,P23975,,HKMZTVMDWMICAE-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,72,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912680,DTCC00591423,1006569,35247
CHEMBL551991,P23975,BMS-269223,BQUXAJWDRCSKFN-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19541481,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,Not Active,Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,15,"Shi Y, Zhang J, Shi M, O'Connor SP, Bisaha SN, Li C, Sitkoff D, Pudzianowski AT, Chong S, Klei HE, Kish K, Yanchunas J, Liu EC, Hartl KS, Seiler SM, Steinbacher TE, Schumacher WA, Atwal KS, Stein PD",,577383,DTCT0023180,2895515,DTCC00022716,1906835,35088
CHEMBL552046,P23975,,PHRPRBMCXLFXOY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,23,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876621,DTCC00589209,2048660,34589
CHEMBL552167,P23975,,RXJIAQGHWRMBEZ-KGLIPLIRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560923,IC50,=,7900,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]nisoxetine from human NET expressed in HEK293 cells,,Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,15,"Denhart DJ, Deskus JA, Ditta JL, Gao Q, Dalton King H, Kozlowski ES, Meng Z, LaPaglia MA, Mattson GK, Molski TF, Taber MT, Lodge NJ, Mattson RJ, Macor JE",,578029,DTCT0023180,2898665,DTCC00592460,1083011,34817
CHEMBL552167,P23975,,RXJIAQGHWRMBEZ-KGLIPLIRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20034793,IC50,=,7900,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,2010,20,3,"Marcin LR, Mattson RJ, Gao Q, Wu D, Molski TF, Mattson GK, Lodge NJ",,610435,DTCT0023180,3195440,DTCC00592460,1083652,37394
CHEMBL552338,P23975,PF-3409409,SWADTMSKMJUFBO-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912684,DTCC00022877,261934,35247
CHEMBL552341,P23975,,JEUQNCNSWGGZRH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,79.43,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916800,DTCC00591507,1653807,34271
CHEMBL552938,P23975,,MZIGEEZFAITPCB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,25.12,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916811,DTCC00593090,1906868,34271
CHEMBL553025,P23975,VINORELBINE BASE,GBABOYUKABKIAF-IELIFDKJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444917,DTCC00587683,1027061,46191
CHEMBL553025,P23975,VINORELBINE BASE,GBABOYUKABKIAF-IELIFDKJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444918,DTCC00587683,1027061,46191
CHEMBL553224,P23975,,UOLFASMVWNZYMB-GIDGLZBFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19791802,KI,=,1.19,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,2009,52,19,"White JD, Juniku R, Huang K, Yang J, Wong DT",,582829,DTCT0023180,2903514,DTCC00590014,1265211,35322
CHEMBL553224,P23975,,UOLFASMVWNZYMB-GIDGLZBFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19791802,KI,=,4.16,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,2009,52,19,"White JD, Juniku R, Huang K, Yang J, Wong DT",,582829,DTCT0023180,2903513,DTCC00590014,1265210,35322
CHEMBL553395,P23975,,ABYFXYVIEFXQPH-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912694,DTCC00585231,295200,35247
CHEMBL554336,P23975,,SKAPWNQXRANDFK-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,61,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912705,DTCC00583759,425798,35247
CHEMBL554800,P23975,,ZCSHCEYGULDLOB-SCGPDRHWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,3.2,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917185,DTCC00581658,424054,20590
CHEMBL55505,P23975,,LOEPSYRVNXADMM-XUTJKUGGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18644726,KI,=,184,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,2008,18,16,"Funke U, Fischer S, Hiller A, Scheunemann M, Deuther-Conrad W, Brust P, Steinbach J",,509626,DTCT0023180,2774194,DTCC00202137,630119,30803
CHEMBL555121,P23975,,UYHGUPUXXZHREH-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,172,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912695,DTCC00588320,942035,35247
CHEMBL555146,P23975,,VGSYEFOBFMUWGO-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22313227,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant NET,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012,55,5,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818831,DTCT0023180,10474292,DTCC00380469,1106159,48153
CHEMBL555280,P23975,,HBOXPGCKZVUQOF-ZVWHLABXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,47900,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,582366,DTCC00580941,660128,3008
CHEMBL555565,P23975,,YKTFTKYTVUHUCP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,794.33,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916809,DTCC00589975,1232347,34271
CHEMBL556025,P23975,,WSDLKTZBSNTKJA-QJHJCNPRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,2250,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,605715,DTCC00576853,2013908,3008
CHEMBL556093,P23975,,LLXDSNCKQBRHMZ-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,10,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912687,DTCC00123238,974087,35247
CHEMBL556167,P23975,,KQHYJWANORXMTF-GRTNUQQKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16413778,KI,=,156,NM,,,,,,,,,,,,,,Binding affinity to NET,,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,2006,16,7,"Cases-Thomas MJ, Masters JJ, Walter MW, Campbell G, Haughton L, Gallagher PT, Dobson DR, Mancuso V, Bonnier B, Giard T, Defrance T, Vanmarsenille M, Ledgard A, White C, Ouwerkerk-Mahadevan S, Brunelle FJ, Dezutter NA, Herbots CA, Lienard JY, Findlay J, Hayhurst L, Boot J, Thompson LK, Hemrick-Luecke S",,344145,DTCT0023180,1917187,DTCC00578982,778380,20590
CHEMBL556268,P23975,,OWUWJHDPUJMAGB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,48,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876624,DTCC00593895,1017940,34589
CHEMBL556299,P23975,,DASUUHWEMHDMII-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916819,DTCC00594708,554379,34271
CHEMBL556539,P23975,,WXQUVTDLXMNHNT-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912686,DTCC00593031,68297,35247
CHEMBL556714,P23975,,RNLDMCBNMHSZQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,199.53,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916812,DTCC00594719,1427768,34271
CHEMBL556888,P23975,,IEAAUYDUGMCSHI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876627,DTCC00593908,1789113,34589
CHEMBL557119,P23975,,WOINXFXWLFAPBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,12.59,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916806,DTCC00594732,1492318,34271
CHEMBL557528,P23975,,ZOPKRUALFVBFRZ-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,39.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901935,DTCC00594824,176451,35305
CHEMBL557555,P23975,CIPROFIBRATE,KPSRODZRAIWAKH-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7369254,DTCC00590844,1447879,46191
CHEMBL557555,P23975,CIPROFIBRATE,KPSRODZRAIWAKH-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7369255,DTCC00590844,1447879,46191
CHEMBL557660,P23975,,FLOGKESFYXJKPK-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912693,DTCC00593047,1330355,35247
CHEMBL557868,P23975,,HNVLFSMNTLSQDR-RTWAWAEBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,91.9,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901990,DTCC00593127,533542,35305
CHEMBL558,P23975,MEXILETINE,VLPIATFUUWWMKC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7438990,DTCC00145505,1351114,46191
CHEMBL558,P23975,MEXILETINE,VLPIATFUUWWMKC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7438991,DTCC00145505,1351114,46191
CHEMBL558065,P23975,,UOLFASMVWNZYMB-WRRDZZDISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19791802,KI,=,153,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,2009,52,19,"White JD, Juniku R, Huang K, Yang J, Wong DT",,582829,DTCT0023180,2903511,DTCC00593129,1038957,35322
CHEMBL558329,P23975,,UOLFASMVWNZYMB-WSCVZUBPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19791802,KI,=,75.7,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,2009,52,19,"White JD, Juniku R, Huang K, Yang J, Wong DT",,582829,DTCT0023180,2903510,DTCC00594758,1653815,35322
CHEMBL558329,P23975,,UOLFASMVWNZYMB-WSCVZUBPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19791802,KI,=,330,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,2009,52,19,"White JD, Juniku R, Huang K, Yang J, Wong DT",,582829,DTCT0023180,2903512,DTCC00594758,1653809,35322
CHEMBL558525,P23975,,UOLFASMVWNZYMB-AEFICSSHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19791802,KI,=,27.8,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,2009,52,19,"White JD, Juniku R, Huang K, Yang J, Wong DT",,582829,DTCT0023180,2903515,DTCC00594759,327848,35322
CHEMBL558551,P23975,(R)-THALIDOMIDE,UEJJHQNACJXSKW-SECBINFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301282,DTCC00022784,1220271,46191
CHEMBL558551,P23975,(R)-THALIDOMIDE,UEJJHQNACJXSKW-SECBINFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7301283,DTCC00022784,1220271,46191
CHEMBL558651,P23975,,HPPVWRRONLIBLV-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912708,DTCC00593068,877809,35247
CHEMBL558853,P23975,,WQAXZHUMPQMMEW-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,38,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912713,DTCC00593075,1777714,35247
CHEMBL559081,P23975,,JAKBXJLCBFHUQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,14,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876613,DTCC00123509,208544,34589
CHEMBL559081,P23975,,JAKBXJLCBFHUQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,17,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876630,DTCC00123509,208545,34589
CHEMBL559081,P23975,,JAKBXJLCBFHUQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,220,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876631,DTCC00123509,208547,34589
CHEMBL559137,P23975,,VJAXFVGMNNFSQS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,1258.93,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916817,DTCC00583768,1071449,34271
CHEMBL559147,P23975,Y-27632,IYOZTVGMEWJPKR-IJLUTSLNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450498,DTCC00589732,1798420,46191
CHEMBL559147,P23975,Y-27632,IYOZTVGMEWJPKR-IJLUTSLNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450499,DTCC00589732,1798420,46191
CHEMBL559319,P23975,,LLXDSNCKQBRHMZ-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,825,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912712,DTCC00594704,715779,35247
CHEMBL559456,P23975,,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,6,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876628,DTCC00582984,339382,34589
CHEMBL559456,P23975,,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,7,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876612,DTCC00582984,339381,34589
CHEMBL559456,P23975,,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,128,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876629,DTCC00582984,339383,34589
CHEMBL559490,P23975,,PUQYZIQIINNNTQ-RTWAWAEBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,66.7,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901938,DTCC00583862,694991,35305
CHEMBL559610,P23975,,AJLUMLBNDXXSIW-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,11.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583226,DTCT0023180,2901974,DTCC00586879,371969,35305
CHEMBL559610,P23975,,AJLUMLBNDXXSIW-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,13.8,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901936,DTCC00586879,371969,35305
CHEMBL559654,P23975,,MNXBENJELVJIHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,84,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876617,DTCC00582995,1726662,34589
CHEMBL559802,P23975,,NQUQUDJZIDCEFJ-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912697,DTCC00586728,554376,35247
CHEMBL560049,P23975,,JPUDXOCAZQSFHB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,215,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876619,DTCC00583003,404891,34589
CHEMBL560050,P23975,,ICZPNJDXXLLJEO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876622,DTCC00583004,597900,34589
CHEMBL560535,P23975,,KSQOUNJPKDJKKL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,7.94,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916816,DTCC00585258,1777715,34271
CHEMBL560535,P23975,,KSQOUNJPKDJKKL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20570146,KI,=,7.94,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,2010,20,13,"Carter DS, Cai HY, Lee EK, Iyer PS, Lucas MC, Roetz R, Schoenfeld RC, Weikert RJ",,640165,DTCT0023180,3387695,DTCC00585258,1790071,39409
CHEMBL560536,P23975,,ISYQRUPHFNFRMZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,63.1,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916815,DTCC00585259,1071450,34271
CHEMBL560673,P23975,,CZVBECXOXXYCQD-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,60,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912696,DTCC00583739,197257,35247
CHEMBL560877,P23975,,CTVFQEBCIXRGTI-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,4.1,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583226,DTCT0023180,2901932,DTCC00583813,727269,35305
CHEMBL560877,P23975,,CTVFQEBCIXRGTI-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,10.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901985,DTCC00583813,727269,35305
CHEMBL560999,P23975,,DTBBOFHJHSCSAN-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,148,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912714,DTCC00586758,165276,35247
CHEMBL561,P23975,LOMEFLOXACIN,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423156,DTCC00145731,1480346,46191
CHEMBL561,P23975,LOMEFLOXACIN,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423157,DTCC00145731,1480346,46191
CHEMBL561140,P23975,,WFCCOUNTGTUDOI-SJORKVTESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,257,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901944,DTCC00585355,1342095,35305
CHEMBL561598,P23975,,KYMPTONVLFUIMS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,15.85,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916813,DTCC00586771,1556703,34271
CHEMBL561599,P23975,,CBKZFNTYOMFOLF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,1584.89,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916810,DTCC00586772,1906869,34271
CHEMBL561739,P23975,,OCXCCNYHGSRYEK-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,29,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912685,DTCC00585217,554372,35247
CHEMBL561878,P23975,,RVLRGNBXYBRGGM-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,13,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912707,DTCC00583760,100585,35247
CHEMBL562,P23975,GRISEOFULVIN,DDUHZTYCFQRHIY-RBHXEPJQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304136,DTCC00145751,800577,46191
CHEMBL562,P23975,GRISEOFULVIN,DDUHZTYCFQRHIY-RBHXEPJQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304137,DTCC00145751,800577,46191
CHEMBL562108,P23975,,FWQBSLOVNYWJFZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,>,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876625,DTCC00584514,662629,34589
CHEMBL562115,P23975,,UTLIGDFWNZZYCH-MANSERQUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22082561,IC50,=,22.48,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,,Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter.,Bioorg. Med. Chem. Lett.,2012,22,1,"Riss PJ, Hooker JM, Shea C, Xu Y, Carter P, Warner D, Ferrari V, Kim SW, Aigbirhio FI, Fowler JS, Roesch F",,879497,DTCT0023180,11464956,DTCC00584671,395646,51847
CHEMBL562115,P23975,,UTLIGDFWNZZYCH-MANSERQUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22082561,IC50,=,31.04,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]NE from human NET expressed in HEK293 cells,,Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter.,Bioorg. Med. Chem. Lett.,2012,22,1,"Riss PJ, Hooker JM, Shea C, Xu Y, Carter P, Warner D, Ferrari V, Kim SW, Aigbirhio FI, Fowler JS, Roesch F",,879498,DTCT0023180,11464957,DTCC00584671,395646,51847
CHEMBL562244,P23975,,ORQNDGDHUCGODU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876605,DTCC00123002,273753,34589
CHEMBL562444,P23975,,QHSQRSCEVZFFIU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,4850,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876610,DTCC00582982,597895,34589
CHEMBL562476,P23975,,ANOKEIWYHCYLAM-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,23,NM,,cell_based,,,,,,,,,,,MDCK,Displacement of [3H]Nisoxetine from human recombinant NET expressed in MDCK cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598118,DTCT0023180,3098181,DTCC00583855,469107,36091
CHEMBL562476,P23975,,ANOKEIWYHCYLAM-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,28,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097077,DTCC00583855,469107,36091
CHEMBL562476,P23975,,ANOKEIWYHCYLAM-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,137,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097076,DTCC00583855,469106,36091
CHEMBL562476,P23975,,ANOKEIWYHCYLAM-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,28,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045951,DTCC00583855,456871,35959
CHEMBL562476,P23975,,ANOKEIWYHCYLAM-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,28,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901945,DTCC00583855,468756,35305
CHEMBL562533,P23975,,HDXRSCIIKGHXQP-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912698,DTCC00585232,490060,35247
CHEMBL562569,P23975,,YFOORSARAMYVQM-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912688,DTCC00589937,683521,35247
CHEMBL562691,P23975,,PWCRFPCCCWITCB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,35,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876623,DTCC00583005,1050380,34589
CHEMBL562767,P23975,,IZHREGYJHUWQHR-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,56,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901940,DTCC00593192,1600516,35305
CHEMBL562802,P23975,,MQFMYYCALRUDSV-CQSZACIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,572,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912710,DTCC00594694,1395430,35247
CHEMBL562854,P23975,,ILOAMTJMRVQTSL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,42,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876615,DTCC00585963,1789111,34589
CHEMBL563,P23975,FLURBIPROFEN,SYTBZMRGLBWNTM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335471,DTCC00145756,1447882,46191
CHEMBL563,P23975,FLURBIPROFEN,SYTBZMRGLBWNTM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335472,DTCC00145756,1447882,46191
CHEMBL563030,P23975,,RILKVQPDTVTHBN-CWQZNGJJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,3,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876634,DTCC00585996,1178913,34589
CHEMBL563030,P23975,,RILKVQPDTVTHBN-CWQZNGJJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,13,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876635,DTCC00585996,1178914,34589
CHEMBL563060,P23975,,IQUFPTOFVDDVOF-UXHICEINSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,>,1000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901992,DTCC00590020,2016552,35305
CHEMBL563117,P23975,,IGKPIVYFTICMLH-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912706,DTCC00593067,295207,35247
CHEMBL56337,P23975,EPALRESTAT,CHNUOJQWGUIOLD-NFZZJPOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7334597,DTCC00204779,2025636,46191
CHEMBL56337,P23975,EPALRESTAT,CHNUOJQWGUIOLD-NFZZJPOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7334598,DTCC00204779,2025636,46191
CHEMBL563384,P23975,,SWADTMSKMJUFBO-CYBMUJFWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,1120,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912711,DTCC00588346,425800,35247
CHEMBL563404,P23975,,GNYXJFDSZWNBKT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,33,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876620,DTCC00589208,1600459,34589
CHEMBL563495,P23975,,KWWVMVUZZJMGRZ-CHPOKUKFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,14,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876638,DTCC00586003,339385,34589
CHEMBL563495,P23975,,KWWVMVUZZJMGRZ-CHPOKUKFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,43,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876639,DTCC00586003,339386,34589
CHEMBL563518,P23975,,GISYFCKSYSNKHX-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,10.8,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583226,DTCT0023180,2901962,DTCC00585356,1083077,35305
CHEMBL563518,P23975,,GISYFCKSYSNKHX-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,13.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901941,DTCC00585356,1083077,35305
CHEMBL56367,P23975,NIMESULIDE,HYWYRSMBCFDLJT-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7377565,DTCC00201992,736262,46191
CHEMBL56367,P23975,NIMESULIDE,HYWYRSMBCFDLJT-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7377566,DTCC00201992,736262,46191
CHEMBL563852,P23975,,PUMRLCALOZDUIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,45,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876604,DTCC00585943,79627,34589
CHEMBL563897,P23975,,VQHNOBXUTWSPMZ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,16.8,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583226,DTCT0023180,2901957,DTCC00591587,501419,35305
CHEMBL563897,P23975,,VQHNOBXUTWSPMZ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,17.5,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901943,DTCC00591587,501419,35305
CHEMBL563987,P23975,,XLDPRVVEMAUFLK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,24,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876614,DTCC00584505,889035,34589
CHEMBL564,P23975,PROMAZINE,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,13,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381311,DTCC00145816,413977,46191
CHEMBL564,P23975,PROMAZINE,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,13,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381312,DTCC00145816,413977,46191
CHEMBL564021,P23975,,VQXNEYZVHJNUFJ-ZDUSSCGKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,19,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912683,DTCC00586703,360425,35247
CHEMBL564059,P23975,,MQFMYYCALRUDSV-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912681,DTCC00589928,1232340,35247
CHEMBL564071,P23975,,YZKDZSSMZPGBAY-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,294,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912679,DTCC00588300,2037583,35247
CHEMBL564094,P23975,,YXBAJJFUPMTDTL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,12.59,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916805,DTCC00123530,1363083,34271
CHEMBL564100,P23975,,RFKSUPOWTRFCKG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,30,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876600,DTCC00593861,1309453,34589
CHEMBL564201,P23975,6-AZAURIDINE,WYXSYVWAUAUWLD-SHUUEZRQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7268097,DTCC00485142,768474,46191
CHEMBL564201,P23975,6-AZAURIDINE,WYXSYVWAUAUWLD-SHUUEZRQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7268098,DTCC00485142,768474,46191
CHEMBL564229,P23975,,RTKAHBPTWDBIEJ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,6.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583226,DTCT0023180,2901981,DTCC00590010,111862,35305
CHEMBL564229,P23975,,RTKAHBPTWDBIEJ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,7.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901933,DTCC00590010,111862,35305
CHEMBL564285,P23975,,FJFCTBPGJGVZBJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,1000,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916801,DTCC00586802,261942,34271
CHEMBL564288,P23975,,VLCJRBGIGILJAS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,50.12,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916808,DTCC00583785,1556704,34271
CHEMBL564445,P23975,,DBNIRDAYCJINLF-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,36.7,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901937,DTCC00586878,1697164,35305
CHEMBL564631,P23975,,UPHOWEAWENOKEG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175,IC50,=,5850,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205,DTCT0023180,2876611,DTCC00582983,920973,34589
CHEMBL564786,P23975,,QWDPOYBOJIBHAD-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,18.6,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901942,DTCC00583859,856918,35305
CHEMBL564934,P23975,,WXFURHRZZPXAMP-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,24,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912699,DTCC00594689,2037590,35247
CHEMBL564935,P23975,,OOCIRVSPZDCFHT-IBGZPJMESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912709,DTCC00594693,295197,35247
CHEMBL565,P23975,CLOFIBRATE,KNHUKKLJHYUCFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7354361,DTCC00145838,1641847,46191
CHEMBL565,P23975,CLOFIBRATE,KNHUKKLJHYUCFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7354362,DTCC00145838,1641847,46191
CHEMBL565309,P23975,,ANOKEIWYHCYLAM-ZWKOTPCHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,79,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097084,DTCC00606180,339751,36091
CHEMBL565332,P23975,,AIHZABOGLZWKHW-PMACEKPBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,38,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098175,DTCC00606194,176762,36091
CHEMBL565382,P23975,,OROOSQVGDDDAFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,2000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083952,DTCC00608687,953715,36341
CHEMBL565382,P23975,,OROOSQVGDDDAFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,4300,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105141,DTCC00608687,953715,36341
CHEMBL565386,P23975,,JBABGZDZOMSKLX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3104301,DTCC00608698,80090,36341
CHEMBL565386,P23975,,JBABGZDZOMSKLX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105072,DTCC00608698,80090,36341
CHEMBL565386,P23975,,JBABGZDZOMSKLX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207574,DTCC00608698,80228,37173
CHEMBL565396,P23975,,GIDJZDYNVHMFAH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,6500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105121,DTCC00608716,2049099,36341
CHEMBL565396,P23975,,GIDJZDYNVHMFAH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,7140,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105060,DTCC00608716,2049099,36341
CHEMBL565396,P23975,,GIDJZDYNVHMFAH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,5600,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207510,DTCC00608716,2049250,37173
CHEMBL565397,P23975,,WHPARCHZPIKXEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105029,DTCC00608717,1309893,36341
CHEMBL565397,P23975,,WHPARCHZPIKXEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105080,DTCC00608717,1309893,36341
CHEMBL565593,P23975,,HHZNTCLXZVSLGW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,4890,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105133,DTCC00608688,759847,36341
CHEMBL565593,P23975,,HHZNTCLXZVSLGW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,2580,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3083938,DTCC00608688,759847,36341
CHEMBL565594,P23975,,WEKVVEUCXILQOT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,360,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083999,DTCC00608689,1211527,36341
CHEMBL565594,P23975,,WEKVVEUCXILQOT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,2300,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3083942,DTCC00608689,1211527,36341
CHEMBL565638,P23975,,KPOGSLKDEJXGPM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,>,40000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104747,DTCC00608297,2037746,36264
CHEMBL565639,P23975,,ZQHFQDYTXXQENI-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,7500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104749,DTCC00608299,12690,36264
CHEMBL56564,P23975,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453745,DTCC00204705,736266,46191
CHEMBL56564,P23975,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453746,DTCC00204705,736266,46191
CHEMBL565844,P23975,,ABPSWEJOHYDZDP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083979,DTCC00608644,1148421,36341
CHEMBL565844,P23975,,ABPSWEJOHYDZDP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,5100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105132,DTCC00608644,1148421,36341
CHEMBL565844,P23975,,ABPSWEJOHYDZDP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,2040,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207495,DTCC00608644,1148553,37173
CHEMBL565845,P23975,,PFEJBPNFLAFPKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,1623,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083957,DTCC00608645,241342,36341
CHEMBL565845,P23975,,PFEJBPNFLAFPKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,4600,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105137,DTCC00608645,241342,36341
CHEMBL565845,P23975,,PFEJBPNFLAFPKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,7250,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207516,DTCC00608645,241484,37173
CHEMBL566000,P23975,,IELBAACIVCODPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105050,DTCC00608744,1244504,36341
CHEMBL566000,P23975,,IELBAACIVCODPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105108,DTCC00608744,1244504,36341
CHEMBL566000,P23975,,IELBAACIVCODPI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,2070,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207496,DTCC00608744,1244672,37173
CHEMBL566001,P23975,,QYLKSFXBRALDIS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105049,DTCC00608745,1083453,36341
CHEMBL566001,P23975,,QYLKSFXBRALDIS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105107,DTCC00608745,1083453,36341
CHEMBL566001,P23975,,QYLKSFXBRALDIS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,2540,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207504,DTCC00608745,1083602,37173
CHEMBL566050,P23975,,VBQDZZHUUPHQGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,43,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3084016,DTCC00608646,1918410,36341
CHEMBL566050,P23975,,VBQDZZHUUPHQGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,520,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3083988,DTCC00608646,1918410,36341
CHEMBL566050,P23975,,VBQDZZHUUPHQGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,180,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3206748,DTCC00608646,1918567,37173
CHEMBL566090,P23975,,BTTZJAYHAIJMSO-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,16,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045929,DTCC00598284,261989,35959
CHEMBL566173,P23975,,KSVISHYLWAYQCI-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,1200,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097079,DTCC00606197,1504019,36091
CHEMBL566193,P23975,,UAAZALAKZAQQRJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105017,DTCC00608726,566154,36341
CHEMBL566193,P23975,,UAAZALAKZAQQRJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105063,DTCC00608726,566154,36341
CHEMBL566207,P23975,,BMWDQBTXNBGORC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,4100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105145,DTCC00608746,1439295,36341
CHEMBL566207,P23975,,BMWDQBTXNBGORC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,6840,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105120,DTCC00608746,1439295,36341
CHEMBL566207,P23975,,BMWDQBTXNBGORC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,2350,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207501,DTCC00608746,1439439,37173
CHEMBL566208,P23975,,JYBXLCIZWPNCMU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,135,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3084010,DTCC00608747,307111,36341
CHEMBL566208,P23975,,JYBXLCIZWPNCMU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,2240,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3083943,DTCC00608747,307111,36341
CHEMBL566208,P23975,,JYBXLCIZWPNCMU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,389,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3206751,DTCC00608747,307259,37173
CHEMBL566240,P23975,,JVIKPFIJPCEZJS-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,357,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104758,DTCC00608280,1136573,36264
CHEMBL566376,P23975,,LQXLMIBCEDZZFC-SFTDATJTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,34,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098169,DTCC00606119,1439263,36091
CHEMBL566418,P23975,,HKOVZQZDXNHYOJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,86,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105009,DTCC00608734,1854150,36341
CHEMBL566418,P23975,,HKOVZQZDXNHYOJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,1800,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105012,DTCC00608734,1854150,36341
CHEMBL566420,P23975,,LOWDJVQAZMFOLZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,4798,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105134,DTCC00608697,1211528,36341
CHEMBL566420,P23975,,LOWDJVQAZMFOLZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,4760,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105135,DTCC00608697,1211528,36341
CHEMBL566420,P23975,,LOWDJVQAZMFOLZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,2520,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207502,DTCC00608697,1211692,37173
CHEMBL566534,P23975,ARTEMETHER,SXYIRMFQILZOAM-HVNFFKDJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7266584,DTCC00600123,736254,46191
CHEMBL566534,P23975,ARTEMETHER,SXYIRMFQILZOAM-HVNFFKDJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7266585,DTCC00600123,736254,46191
CHEMBL566576,P23975,,MOEMPBAHOJKXBG-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,7000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104759,DTCC00608281,1717438,36264
CHEMBL566586,P23975,,JSKNQLMFNCOKRW-PMACEKPBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,13,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098174,DTCC00606193,857314,36091
CHEMBL566618,P23975,,RPHSTODYKZLNFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,221,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3084007,DTCC00608738,1244503,36341
CHEMBL566618,P23975,,RPHSTODYKZLNFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,5700,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105126,DTCC00608738,1244503,36341
CHEMBL566618,P23975,,RPHSTODYKZLNFU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207544,DTCC00608738,1244674,37173
CHEMBL566816,P23975,,ANOKEIWYHCYLAM-QZTJIDSGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,150,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097086,DTCC00606200,1789528,36091
CHEMBL566830,P23975,,UYZAXUWVJGHEFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,1260,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083964,DTCC00608679,566153,36341
CHEMBL566830,P23975,,UYZAXUWVJGHEFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,3090,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3083937,DTCC00608679,566153,36341
CHEMBL566830,P23975,,UYZAXUWVJGHEFL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,1520,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207489,DTCC00608679,566299,37173
CHEMBL566832,P23975,,YDGOUEKZXBLUDG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105052,DTCC00608737,598352,36341
CHEMBL566832,P23975,,YDGOUEKZXBLUDG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105110,DTCC00608737,598352,36341
CHEMBL566832,P23975,,YDGOUEKZXBLUDG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,6200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207512,DTCC00608737,598511,37173
CHEMBL566886,P23975,,PGTPXIBBHIHMQS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,969,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083975,DTCC00608658,1726957,36341
CHEMBL566886,P23975,,PGTPXIBBHIHMQS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,3195,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105152,DTCC00608658,1726957,36341
CHEMBL566886,P23975,,PGTPXIBBHIHMQS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,607,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207476,DTCC00608658,1727034,37173
CHEMBL566957,P23975,,SGVYOOIAHHLONY-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,117,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045942,DTCC00598348,1717340,35959
CHEMBL566958,P23975,,MYBQVBFITHURNS-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,60,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045935,DTCC00598349,68365,35959
CHEMBL567,P23975,PERPHENAZINE,RGCVKNLCSQQDEP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393565,DTCC00145901,1798415,46191
CHEMBL567,P23975,PERPHENAZINE,RGCVKNLCSQQDEP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393566,DTCC00145901,1798415,46191
CHEMBL567041,P23975,,LUIWHKVXZYFQLW-CJRXIRLBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,104,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097078,DTCC00606057,1148393,36091
CHEMBL567248,P23975,,YNZNOMFLFOSBEA-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,45,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098177,DTCC00606204,1789529,36091
CHEMBL567288,P23975,,INDDCTQFCFNYFA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,1300,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104764,DTCC00608142,974269,36264
CHEMBL567289,P23975,,GSCMKUDZZALNHS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,1200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104765,DTCC00608143,1395599,36264
CHEMBL567292,P23975,GSK554418A,VARGWBUXBMFVJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19743867,ACTIVITY,=,15,%,,,,,,,,,,,,,,Binding affinity to NET at 1 uM,,"Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain.",J. Med. Chem.,2009,52,19,"Giblin GM, Billinton A, Briggs M, Brown AJ, Chessell IP, Clayton NM, Eatherton AJ, Goldsmith P, Haslam C, Johnson MR, Mitchell WL, Naylor A, Perboni A, Slingsby BP, Wilson AW",,597161,DTCT0023180,3107361,DTCC00023379,791885,36268
CHEMBL567467,P23975,,IPBRKYZIBYMQNY-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,49,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3098194,DTCC00606263,630871,36091
CHEMBL567479,P23975,,VEOJUGKGLUEXTM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105085,DTCC00608700,1665466,36341
CHEMBL567479,P23975,,VEOJUGKGLUEXTM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,3800,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105150,DTCC00608700,1665466,36341
CHEMBL567480,P23975,,PJSOCXYIJJIWHO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105031,DTCC00608701,1244502,36341
CHEMBL567480,P23975,,PJSOCXYIJJIWHO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105082,DTCC00608701,1244502,36341
CHEMBL567481,P23975,,SYMAJWVHHBJSJV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105023,DTCC00608702,1439293,36341
CHEMBL567481,P23975,,SYMAJWVHHBJSJV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105069,DTCC00608702,1439293,36341
CHEMBL567481,P23975,,SYMAJWVHHBJSJV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207578,DTCC00608702,1439451,37173
CHEMBL567482,P23975,,FKPMMRLETAKLGP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105020,DTCC00608703,1886344,36341
CHEMBL567482,P23975,,FKPMMRLETAKLGP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105066,DTCC00608703,1886344,36341
CHEMBL567597,P23975,ARTEMISININ,BLUAFEHZUWYNDE-DKGJTOOQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269237,DTCC00601707,1960072,46191
CHEMBL567597,P23975,ARTEMISININ,BLUAFEHZUWYNDE-DKGJTOOQSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7269238,DTCC00601707,1960072,46191
CHEMBL567656,P23975,,WNNACCODSWYYDZ-VXKWHMMOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,5,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098168,DTCC00606105,1179315,36091
CHEMBL567712,P23975,,OSHSXYCWEWJREH-LJQANCHMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,677,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104751,DTCC00608160,1524716,36264
CHEMBL567725,P23975,,WDVSSBLBRVMZEM-LLVKDONJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,5700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104757,DTCC00608250,812671,36264
CHEMBL567932,P23975,,CEUJKSVEPJAVKD-SFHVURJKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,24,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104753,DTCC00608176,328007,36264
CHEMBL567933,P23975,,YHNAHEPHKZYDTN-SECBINFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Not Determined,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104754,DTCC00608177,1717436,36264
CHEMBL567943,P23975,,MOEMPBAHOJKXBG-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,370,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104762,DTCC00608129,1006735,36264
CHEMBL567944,P23975,,RQQIFQXOKVSJMS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,8900,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104763,DTCC00608130,1717433,36264
CHEMBL567945,P23975,,ALLVIFFNCLDETM-SECBINFHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Not Determined,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104755,DTCC00608193,1006736,36264
CHEMBL568095,P23975,,YQOJGBMYXRTDBS-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,11,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098178,DTCC00606238,307087,36091
CHEMBL568096,P23975,,FKDKUDMUXGCBLI-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,118,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097083,DTCC00606239,80065,36091
CHEMBL568140,P23975,,MXUDEADPGZWZCH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,2100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083949,DTCC00608634,1886342,36341
CHEMBL568140,P23975,,MXUDEADPGZWZCH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,5400,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105131,DTCC00608634,1886342,36341
CHEMBL568140,P23975,,MXUDEADPGZWZCH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,1670,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207491,DTCC00608634,1886517,37173
CHEMBL568350,P23975,,HZPZVEJWTPAYPU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,2500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104761,DTCC00608300,1589131,36264
CHEMBL568372,P23975,,IMHRUEORWKDPGA-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,6000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104750,DTCC00123870,1167818,36264
CHEMBL569,P23975,PROCAINE,MFDFERRIHVXMIY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394201,DTCC00145963,930084,46191
CHEMBL569,P23975,PROCAINE,MFDFERRIHVXMIY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394202,DTCC00145963,930084,46191
CHEMBL569014,P23975,,NEVVQGBYHRTAEI-ZEQRLZLVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,41,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098172,DTCC00606008,695316,36091
CHEMBL569025,P23975,,DXTDNUFZTNALDJ-SFTDATJTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,18,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098170,DTCC00606154,469108,36091
CHEMBL569048,P23975,,CIJDFRPQIGEUOQ-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,230,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3098193,DTCC00606283,1018353,36091
CHEMBL569270,P23975,,UTPGRZGMQVAYAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24147864,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human NET by PDSP assay,,Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1).,J. Med. Chem.,2013,56,22,"Xu R, Zanotti-Fregonara P, Zoghbi SS, Gladding RL, Woock AE, Innis RB, Pike VW",,1274768,DTCT0023180,12941169,DTCC00606473,1333771,56413
CHEMBL569364,P23975,,PJZPOQITFNSOGK-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,92,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912702,DTCC00591452,1265202,35247
CHEMBL569465,P23975,,PREYWAJYVTVVPE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,472,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083991,DTCC00608683,501779,36341
CHEMBL569465,P23975,,PREYWAJYVTVVPE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,1171,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3083967,DTCC00608683,501779,36341
CHEMBL569465,P23975,,PREYWAJYVTVVPE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,370,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3206750,DTCC00608683,501935,37173
CHEMBL569699,P23975,,JQNSRSIGKZYQAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,8700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105118,DTCC00608709,80091,36341
CHEMBL569699,P23975,,JQNSRSIGKZYQAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,5700,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105127,DTCC00608709,80091,36341
CHEMBL569700,P23975,,YKOZIWZLLJVPPD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,2150,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083947,DTCC00608725,695342,36341
CHEMBL569700,P23975,,YKOZIWZLLJVPPD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,4000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105148,DTCC00608725,695342,36341
CHEMBL57,P23975,NEVIRAPINE,NQDJXKOVJZTUJA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381791,DTCC00135799,51491,46191
CHEMBL57,P23975,NEVIRAPINE,NQDJXKOVJZTUJA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381792,DTCC00135799,51491,46191
CHEMBL570317,P23975,,YKDPKVFUKKJFFE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916802,DTCC00588382,165279,34271
CHEMBL570593,P23975,,BKMZXLKUUMOTKA-XMMPIXPASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821575,IC50,=,5.4,NM,,,,,,,,,,,,,,Inhibition of NET,,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,21,"Marquis RW, Lago AM, Callahan JF, Rahman A, Dong X, Stroup GB, Hoffman S, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Roethke T, Smith BR, Ward KW, Bhatnagar P",,591455,DTCT0023180,3056381,DTCC00600916,651564,35717
CHEMBL570781,P23975,,GLMKIAAMEYVAIS-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,43,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912700,DTCC00589949,1459766,35247
CHEMBL570856,P23975,,ANOKEIWYHCYLAM-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,415,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097085,DTCC00606056,1789527,36091
CHEMBL570867,P23975,BMS-344577,YLSKCQOVDOZHTQ-VWLOTQADSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19896847,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human NE transporter at 10 uM,Not Active,Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577.,Bioorg. Med. Chem. Lett.,2009,19,24,"Shi Y, Li C, O'Connor SP, Zhang J, Shi M, Bisaha SN, Wang Y, Sitkoff D, Pudzianowski AT, Huang C, Klei HE, Kish K, Yanchunas J, Liu EC, Hartl KS, Seiler SM, Steinbacher TE, Schumacher WA, Atwal KS, Stein PD",,595587,DTCT0023180,3085710,DTCC00023387,1874752,36406
CHEMBL571,P23975,KETOPROFEN,DKYWVDODHFEZIM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431289,DTCC00145969,2025638,46191
CHEMBL571,P23975,KETOPROFEN,DKYWVDODHFEZIM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431290,DTCC00145969,2025638,46191
CHEMBL571443,P23975,,OUQIHZQQYQPARR-HNNXBMFYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19616432,KI,=,31,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009,19,16,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581595,DTCT0023180,2912701,DTCC00588331,295203,35247
CHEMBL571536,P23975,,XQHYQPRYOHIDGH-SNVBAGLBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,17400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104756,DTCC00608212,1589130,36264
CHEMBL571893,P23975,,YXAAWHCXAGWLQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19592243,KI,=,39.81,NM,,,,,,,,,,,,,,Inhibition of NET,,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2009,19,16,"Lucas MC, Carter DS, Cai HY, Lee EK, Schoenfeld RC, Steiner S, Villa M, Weikert RJ, Iyer PS",,582671,DTCT0023180,2916807,DTCC00589986,554381,34271
CHEMBL572,P23975,NITROFURANTOIN,NXFQHRVNIOXGAQ-YCRREMRBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7403533,DTCC00145970,1927018,46191
CHEMBL572,P23975,NITROFURANTOIN,NXFQHRVNIOXGAQ-YCRREMRBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7403534,DTCC00145970,1927018,46191
CHEMBL572142,P23975,,CLDXUDCHEILGJZ-GOTSBHOMSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,24,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098171,DTCC00606155,1439264,36091
CHEMBL572163,P23975,,PPLVDBKGJPKXLH-HSZRJFAPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821575,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of NET,,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,2009,52,21,"Marquis RW, Lago AM, Callahan JF, Rahman A, Dong X, Stroup GB, Hoffman S, Gowen M, DelMar EG, Van Wagenen BC, Logan S, Shimizu S, Fox J, Nemeth EF, Roethke T, Smith BR, Ward KW, Bhatnagar P",,591455,DTCT0023180,3056908,DTCC00600898,1297828,35717
CHEMBL572350,P23975,,XUWDFILRONYSDW-PMACEKPBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,1100,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097080,DTCC00606219,1083435,36091
CHEMBL572917,P23975,,VWWGPYFAWGEBAY-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,60,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045924,DTCC00598325,1717339,35959
CHEMBL572927,P23975,,HEBFYRLCWBRALV-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,21,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045931,DTCC00598261,618962,35959
CHEMBL572951,P23975,,TUHQZGVWJDBKNN-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,21,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045922,DTCC00598336,456872,35959
CHEMBL573,P23975,NIACIN,PVNIIMVLHYAWGP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386143,DTCC00146015,381015,46191
CHEMBL573,P23975,NIACIN,PVNIIMVLHYAWGP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386144,DTCC00146015,381015,46191
CHEMBL573361,P23975,,AOCFDQDGDIOFRW-CCRGXQTGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,1200,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039239,DTCC00595679,1621567,35601
CHEMBL573531,P23975,,QJRQNVRAJVCSDH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,162,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069533,DTCC00598865,197321,35768
CHEMBL573532,P23975,,VAXHGPCUAFNAQS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,554,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069562,DTCC00598868,1200077,35768
CHEMBL573667,P23975,,VDFAJYFMKVKZLC-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,34,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045921,DTCC00598337,1524620,35959
CHEMBL573766,P23975,,LGSKMJOUAMVJKK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,1940,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069597,DTCC00599014,1167693,35768
CHEMBL573769,P23975,4-(2-(BENZYLOXY)PHENYL)PIPERIDINE,XJJHPGZYVOFINN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,76,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069511,DTCC00023165,1524629,35768
CHEMBL573831,P23975,,LHOOAMLZVNHXAN-IOXAMRCBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039236,DTCC00595665,1621566,35601
CHEMBL573844,P23975,,UVNCBAMPWZRVGM-CPWXKJDLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,1900,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039228,DTCC00595689,715828,35601
CHEMBL573897,P23975,,CDVPUDLPRZVZHB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,34,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069496,DTCC00598854,974148,35768
CHEMBL573898,P23975,,BBYFZRZFESDGLZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,170,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069537,DTCC00598866,1653872,35768
CHEMBL573971,P23975,,ROZQUSZIXUCKCC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,20,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069485,DTCC00598890,1330416,35768
CHEMBL573972,P23975,,VWVYZCFGGWGOMP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,1710,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069590,DTCC00598891,456878,35768
CHEMBL573973,P23975,,ZTEDPRVVBLHAKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,1720,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069591,DTCC00598892,1071521,35768
CHEMBL574004,P23975,,IMXJQWVQVSZOKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,EC50,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589388,DTCT0023180,3069493,DTCC00598936,651529,35768
CHEMBL574004,P23975,,IMXJQWVQVSZOKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069482,DTCC00598936,651529,35768
CHEMBL574008,P23975,,DBVKCFHUKVYYIQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069459,DTCC00598875,845463,35768
CHEMBL574020,P23975,,OMORUWMYPOOINH-YNYQRCFRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,690,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039230,DTCC00595693,1874613,35601
CHEMBL574081,P23975,,GNESBMMZVPTREH-UHDQLFAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,1110,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039241,DTCC00595691,229707,35601
CHEMBL574126,P23975,,LCJMOOYZLAZDBK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069466,DTCC00598933,1556758,35768
CHEMBL574127,P23975,,WLIGTTARDYGFBV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,183,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069488,DTCC00598947,1459827,35768
CHEMBL574231,P23975,,WPYMMOOTBZOFOZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,97,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069519,DTCC00599022,1104252,35768
CHEMBL574317,P23975,,YBLWMYFOFQPXMI-UEXOWVPHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,515,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039231,DTCC00595648,132953,35601
CHEMBL574347,P23975,,MUPPOMFFBLBAKT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,115,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069523,DTCC00599004,1717346,35768
CHEMBL574348,P23975,4-(2-(PHENOXYMETHYL)PHENYL)PIPERIDINE,SYLMRMITUMFBTA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,1710,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069589,DTCC00023164,1653876,35768
CHEMBL574427,P23975,,QCGAHDLRCVBZHH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069457,DTCC00598855,1395487,35768
CHEMBL574428,P23975,,PTVWULKTBHSTNS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,170,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069536,DTCC00598920,393235,35768
CHEMBL574543,P23975,,HAPMRZPBVFBVGL-UHDQLFAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039232,DTCC00595649,974130,35601
CHEMBL574544,P23975,,YDNOASAJYGOBQG-CPWXKJDLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,21,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039233,DTCC00595650,683556,35601
CHEMBL574546,P23975,,RHZULZDFMYQLIX-UHDQLFAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,118,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039234,DTCC00595653,295230,35601
CHEMBL574629,P23975,,NSKFLKQWPVFAAE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069467,DTCC00598889,910546,35768
CHEMBL574920,P23975,,PHMNKJGYIDQICY-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,14,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045940,DTCC00598251,68364,35959
CHEMBL574921,P23975,,VLLHQEDHCOUXKK-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,15,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045932,DTCC00598253,1524619,35959
CHEMBL575077,P23975,4-(2-PHENOXYPHENYL)PIPERIDINE,YWIYMDPWBAXEKQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,416,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069554,DTCC00023162,1297798,35768
CHEMBL575131,P23975,,AKRRCLREANRVLZ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,84,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045945,DTCC00598316,1745827,35959
CHEMBL575132,P23975,,XQGCYOUBZLLPMY-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,7,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045926,DTCC00598317,425853,35959
CHEMBL575133,P23975,,SKJWCGCNEAHUQZ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,52,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045925,DTCC00598318,132976,35959
CHEMBL575199,P23975,,GBDCEJWZYYZILX-CCRGXQTGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,960,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039235,DTCC00595660,1777750,35601
CHEMBL575206,P23975,,SSYVIQKCLJMLJB-IOXAMRCBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039238,DTCC00595677,1777751,35601
CHEMBL575289,P23975,,OIRUCIGVEPJTON-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,192,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069541,DTCC00598994,845465,35768
CHEMBL575290,P23975,,QHHWSRAVBLCPAI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,EC50,=,49,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589388,DTCT0023180,3069503,DTCC00598995,456879,35768
CHEMBL575290,P23975,,QHHWSRAVBLCPAI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,13,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069477,DTCC00598995,456879,35768
CHEMBL575535,P23975,,UIJBKUNWEPERDV-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,16,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045949,DTCC00598291,197315,35959
CHEMBL575546,P23975,,QLJOCRJOIIVENA-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,20,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045927,DTCC00598301,877868,35959
CHEMBL575648,P23975,,XIHXZWUTKBABCV-IOXAMRCBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,>,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039240,DTCC00595685,1717320,35601
CHEMBL575699,P23975,,YQANZQCQGNYBAC-MOSHPQCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,650,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069564,DTCC00598946,1232406,35768
CHEMBL575700,P23975,,IGKKFJKUWPDJDR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,104,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069522,DTCC00598948,1842572,35768
CHEMBL575714,P23975,,KETAEAPLSWORIE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,80,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069514,DTCC00598988,165349,35768
CHEMBL575753,P23975,,CXPIEWAMVILDLK-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,92,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045934,DTCC00598368,68367,35959
CHEMBL575854,P23975,,BYRGPNIGCQCEQB-INXRADFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,1170,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039226,DTCC00595687,1745802,35601
CHEMBL575899,P23975,,XMQIWPUGABPALG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,526,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069561,DTCC00598909,425859,35768
CHEMBL575930,P23975,,WEBWNOZIRPUGTR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069473,DTCC00598864,295260,35768
CHEMBL576036,P23975,,RCMGBZYHSPTETA-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,224,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104767,DTCC00608178,1777875,36264
CHEMBL576063,P23975,,CCGVLNAUEKVICK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105056,DTCC00608715,437393,36341
CHEMBL576063,P23975,,CCGVLNAUEKVICK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105114,DTCC00608715,437393,36341
CHEMBL576063,P23975,,CCGVLNAUEKVICK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,6500,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207514,DTCC00608715,437541,37173
CHEMBL576145,P23975,,SPBUAQRRWQFNRI-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045938,DTCC00598272,425852,35959
CHEMBL576170,P23975,,WLILWEIYLCPPKG-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,11,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045946,DTCC00598315,1395486,35959
CHEMBL576542,P23975,,FFMLDCYSPNMTJA-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,91,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045920,DTCC00598338,780171,35959
CHEMBL576622,P23975,,WSLDIWPVDFGUNH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,400,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083996,DTCC00608686,1211526,36341
CHEMBL576622,P23975,,WSLDIWPVDFGUNH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,3190,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105153,DTCC00608686,1211526,36341
CHEMBL576758,P23975,,JHNQGHUWSOJCOC-UXHICEINSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,10,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045937,DTCC00598311,1745826,35959
CHEMBL576821,P23975,,LNIDNIKEDAQTOW-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,735,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104760,DTCC00608282,1874750,36264
CHEMBL577138,P23975,,CNZYWYSSMUKCGY-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,54,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045939,DTCC00598260,586656,35959
CHEMBL577272,P23975,,CMGOBJCRHLBLJP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Not Determined,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104746,DTCC00608279,1136572,36264
CHEMBL577283,P23975,,CEUJKSVEPJAVKD-GOSISDBHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,1200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104752,DTCC00608161,586743,36264
CHEMBL577497,P23975,,DWBBFNBXAKCWFH-QGZVFWFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,=,726,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104766,DTCC00608144,1810303,36264
CHEMBL577501,P23975,,CXFKXPAAWKFBPJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105042,DTCC00608656,533879,36341
CHEMBL577501,P23975,,CXFKXPAAWKFBPJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105099,DTCC00608656,533879,36341
CHEMBL577504,P23975,,SNORKSVJXFFHHB-ROUUACIJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,321,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097082,DTCC00606237,1050813,36091
CHEMBL577565,P23975,,NREAZRDUCYUONQ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,124,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045923,DTCC00598326,845458,35959
CHEMBL577597,P23975,,DQPHXSWTVKEOEO-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,22,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045928,DTCC00598292,261990,35959
CHEMBL577598,P23975,,OSJVAFCFAQCABQ-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,92,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045947,DTCC00598300,1395485,35959
CHEMBL577612,P23975,,KDLATVNCFJVLBE-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,527,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045948,DTCC00598299,100639,35959
CHEMBL577825,P23975,,UUZFTXGGHPBIFW-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,49,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045943,DTCC00598335,1006644,35959
CHEMBL577988,P23975,,DHLSZOUSVZEAKZ-IRXDYDNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,32,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098179,DTCC00123821,2081229,36091
CHEMBL578,P23975,ENALAPRIL,GBXSMTUPTTWBMN-XIRDDKMYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321701,DTCC00146157,49658,46191
CHEMBL578,P23975,ENALAPRIL,GBXSMTUPTTWBMN-XIRDDKMYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321702,DTCC00146157,49658,46191
CHEMBL578219,P23975,,KVHCMVHVGGEFGG-CCRGXQTGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,2000,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039237,DTCC00595666,1717319,35601
CHEMBL578346,P23975,,AZTPZTRJVCAAMX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740658,IC50,>,40000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,2009,19,20,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,596935,DTCT0023180,3104748,DTCC00608298,683682,36264
CHEMBL578419,P23975,,NNQDGWJXUJCRBF-MENKECLHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,121,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039229,DTCC00595690,780143,35601
CHEMBL578610,P23975,,JRPWUGPYWRJACU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105044,DTCC00608633,857344,36341
CHEMBL578610,P23975,,JRPWUGPYWRJACU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105102,DTCC00608633,857344,36341
CHEMBL578610,P23975,,JRPWUGPYWRJACU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,6480,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207513,DTCC00608633,857505,37173
CHEMBL578611,P23975,,ZKFFJBXJJFDBJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105039,DTCC00608657,1665465,36341
CHEMBL578611,P23975,,ZKFFJBXJJFDBJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105096,DTCC00608657,1665465,36341
CHEMBL578611,P23975,,ZKFFJBXJJFDBJM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,14000,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207523,DTCC00608657,1665605,37173
CHEMBL578612,P23975,,BJLKZFUZNNATGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Not Determined,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105026,DTCC00608678,372340,36341
CHEMBL578612,P23975,,BJLKZFUZNNATGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105077,DTCC00608678,372340,36341
CHEMBL578612,P23975,,BJLKZFUZNNATGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,1570,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207490,DTCC00608678,372482,37173
CHEMBL578815,P23975,,TZRAZPTWNAPWGU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,4603,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3105136,DTCC00608696,80089,36341
CHEMBL578815,P23975,,TZRAZPTWNAPWGU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,4476,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105139,DTCC00608696,80089,36341
CHEMBL578841,P23975,,MPFXFPLOFFDVSF-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,232,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045944,DTCC00123637,1556754,35959
CHEMBL579056,P23975,,NGSZLOCYHZRIMB-UHDQLFAASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,220,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039225,DTCC00595684,1653845,35601
CHEMBL579244,P23975,,YLXJJHBNSKFHOT-AEFFLSMTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,21,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045933,DTCC00598252,12460,35959
CHEMBL579254,P23975,,ICUSSYNHQDIHBC-CCRGXQTGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19523837,KI,=,129,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,2009,17,14,"Jin C, Navarro HA, Ivy Carroll F",,587779,DTCT0023180,3039227,DTCC00595688,1167657,35601
CHEMBL58,P23975,MITOXANTRONE,KKZJGLLVHKMTCM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,4989.8,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7439013,DTCC00103487,1092344,46191
CHEMBL58,P23975,MITOXANTRONE,KKZJGLLVHKMTCM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4948.5,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7439014,DTCC00103487,1092344,46191
CHEMBL580,P23975,LORAZEPAM,DIWRORZWFLOCLC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7440221,DTCC00146251,1285879,46191
CHEMBL580,P23975,LORAZEPAM,DIWRORZWFLOCLC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7440222,DTCC00146251,1285879,46191
CHEMBL580143,P23975,,VIWKHXNVEIOPSC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,718,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207480,DTCC00615348,727797,37173
CHEMBL582894,P23975,,FQEQHKRYLKAFDD-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,111,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045941,DTCC00598250,1589016,35959
CHEMBL582928,P23975,,PPQUPQGZDGZYJI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,EC50,=,83,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589388,DTCT0023180,3069517,DTCC00598908,877873,35768
CHEMBL582928,P23975,,PPQUPQGZDGZYJI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,168,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069535,DTCC00598908,877873,35768
CHEMBL583,P23975,GREPAFLOXACIN,AIJTTZAVMXIJGM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7333967,DTCC00146380,542577,46191
CHEMBL583,P23975,GREPAFLOXACIN,AIJTTZAVMXIJGM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7333968,DTCC00146380,542577,46191
CHEMBL583113,P23975,,DGZJTKQIMNNTQO-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,304,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045950,DTCC00598290,651528,35959
CHEMBL583332,P23975,,QPPDVPUFQFPJKK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069463,DTCC00598867,1810186,35768
CHEMBL583411,P23975,,OCYLDAPFNOMBGQ-MJGOQNOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,18,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045930,DTCC00598283,1167686,35959
CHEMBL583676,P23975,,HOYMQTQKCIHRHI-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,25,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098176,DTCC00606198,759819,36091
CHEMBL583750,P23975,,ONPYWJJNTLFDAR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069472,DTCC00598863,910545,35768
CHEMBL583751,P23975,,WWIFVPBPYYVHTD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,EC50,=,358,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589388,DTCT0023180,3069550,DTCC00598934,910548,35768
CHEMBL583751,P23975,,WWIFVPBPYYVHTD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,1370,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069586,DTCC00598934,910548,35768
CHEMBL583752,P23975,,WLJMFBUPVRQPDQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,EC50,=,21,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589388,DTCT0023180,3069489,DTCC00598935,1810184,35768
CHEMBL583752,P23975,,WLJMFBUPVRQPDQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069476,DTCC00598935,1810184,35768
CHEMBL584,P23975,NELFINAVIR,QAGYKUNXZHXKMR-HKWSIXNMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,8852,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398925,DTCC01738575,1798414,46191
CHEMBL584,P23975,NELFINAVIR,QAGYKUNXZHXKMR-HKWSIXNMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,8779,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398926,DTCC01738575,1798414,46191
CHEMBL584042,P23975,,UEDLLBHXEVXPDP-ZEQRLZLVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,INHIBITION,=,26,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598132,DTCT0023180,3098173,DTCC00606179,1309871,36091
CHEMBL584152,P23975,,SQRPNDYXHFVWJL-MSOLQXFVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,64,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3045936,DTCC00598324,812568,35959
CHEMBL584173,P23975,,BXXRQIARNFYYBC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19854053,KI,=,21,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,2009,19,23,"Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A",,589383,DTCT0023180,3069487,DTCC00598919,1717345,35768
CHEMBL585,P23975,TRIAMTERENE,FNYLWPVRPXGIIP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444444,DTCC00146599,1674154,46191
CHEMBL585,P23975,TRIAMTERENE,FNYLWPVRPXGIIP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444445,DTCC00146599,1674154,46191
CHEMBL585708,P23975,,OGJYXTXOUOYPDQ-OALUTQOASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,42,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3097081,DTCC00606226,1083438,36091
CHEMBL588119,P23975,SULOCTIDIL,BFCDFTHTSVTWOG-YLJYHZDGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1400.4,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469842,DTCC00123899,2057654,46191
CHEMBL588119,P23975,SULOCTIDIL,BFCDFTHTSVTWOG-YLJYHZDGSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1388.8,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469843,DTCC00123899,2057654,46191
CHEMBL589086,P23975,,ICYDUOWTRYFBOY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19926484,KI,=,8854,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,2010,18,1,"Mavel S, Meheux N, Guilloteau D, Emond P",,607220,DTCT0023180,3223157,DTCC00616923,953877,37264
CHEMBL589177,P23975,,KARYRXNBSOIGJH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19926484,KI,>,500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,2010,18,1,"Mavel S, Meheux N, Guilloteau D, Emond P",,607220,DTCT0023180,3223163,DTCC00616960,1697671,37264
CHEMBL589178,P23975,,DOYLLHOWPJQFPA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19926484,KI,=,632,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,2010,18,1,"Mavel S, Meheux N, Guilloteau D, Emond P",,607220,DTCT0023180,3223166,DTCC00616961,534078,37264
CHEMBL589179,P23975,,ASGNFMOFCHAUOT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19926484,KI,=,406,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,2010,18,1,"Mavel S, Meheux N, Guilloteau D, Emond P",,607220,DTCT0023180,3223170,DTCC00616962,1918588,37264
CHEMBL589250,P23975,,ZMRXSORFBXMBCB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,8200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207518,DTCC00615292,663177,37173
CHEMBL589494,P23975,,VMEDIUSDIYRUSA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,577,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3206757,DTCC00615347,241486,37173
CHEMBL59,P23975,DOPAMINE,VYFYYTLLBUKUHU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10411589,KI,=,323,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731853,DTCC00136007,2104530,69057
CHEMBL59,P23975,DOPAMINE,VYFYYTLLBUKUHU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,IC50,=,6.63,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142799,DTCT0023180,847021,DTCC00136007,1662172,5984
CHEMBL59,P23975,DOPAMINE,VYFYYTLLBUKUHU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14592523,KI,>,28000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,2003,13,22,"Meltzer PC, McPhee M, Madras BK",,142608,DTCT0023180,847020,DTCC00136007,1662172,5984
CHEMBL590472,P23975,,IDZYJTXHWNKKBY-VIKVFOODSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,2.51,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213739,DTCC00615577,1789721,37197
CHEMBL590615,P23975,,CWYDYWFZPBTTIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19954972,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to NET,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010,20,1,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603566,DTCT0023180,3164455,DTCC00609878,176896,36082
CHEMBL591514,P23975,,AXVMBCUCHZMEOH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19926484,KI,=,667,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,2010,18,1,"Mavel S, Meheux N, Guilloteau D, Emond P",,607220,DTCT0023180,3223160,DTCC00616924,1211713,37264
CHEMBL591928,P23975,,YZJOPQCWTRXOHP-URBRKQAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,1.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611008,DTCT0023180,3217330,DTCC00621451,1757527,37100
CHEMBL591928,P23975,,YZJOPQCWTRXOHP-URBRKQAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,2.7,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217257,DTCC00621451,1757527,37100
CHEMBL592167,P23975,,GNEJBSYNDIMJCO-WKXZFPGYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,3.7,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217242,DTCC00622355,663263,37100
CHEMBL592374,P23975,AMITIFADINE,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18539031,IC50,=,22.8,NM,,,,,,,,,,,,,,Inhibition of norepinephrine uptake at human cloned NET,,Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,13,"Zhang M, Jovic F, Vickers T, Dyck B, Tamiya J, Grey J, Tran JA, Fleck BA, Pick R, Foster AC, Chen C",,491871,DTCT0023180,2666816,DTCC00615072,617997,31169
CHEMBL592374,P23975,AMITIFADINE,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,63.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213794,DTCC00615072,631057,37197
CHEMBL592374,P23975,AMITIFADINE,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,147.91,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395880,DTCC00615072,631431,39684
CHEMBL592374,P23975,AMITIFADINE,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761,IC50,=,71.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969,DTCT0023180,13968265,DTCC00615072,643757,59781
CHEMBL592375,P23975,,ZGPLGLWQWPXKAN-YGOYTEALSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,181.97,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213791,DTCC00615073,1116144,37197
CHEMBL592696,P23975,,GKNLPWOESJYQTF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19926484,KI,=,1203,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,2010,18,1,"Mavel S, Meheux N, Guilloteau D, Emond P",,607220,DTCT0023180,3223148,DTCC00616921,760027,37264
CHEMBL592697,P23975,,BWXOLUJTEOFJOY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19926484,KI,=,503,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,2010,18,1,"Mavel S, Meheux N, Guilloteau D, Emond P",,607220,DTCT0023180,3223151,DTCC00616922,1822244,37264
CHEMBL592854,P23975,,VLLKJTHFWNJPCE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,8700,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207519,DTCC00615245,1244675,37173
CHEMBL593527,P23975,,XJPCNUDKTWEBSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,353,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155481,DTCC00611226,1375146,36729
CHEMBL593527,P23975,,XJPCNUDKTWEBSY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,306,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155480,DTCC00611226,1375146,36729
CHEMBL593614,P23975,,MCPOSCCUUUPTRR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,221,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155518,DTCC00611292,631014,36729
CHEMBL593614,P23975,,MCPOSCCUUUPTRR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,208,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155516,DTCC00611292,631014,36729
CHEMBL593821,P23975,,FWMIXTKPPHIFDD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,29,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155530,DTCC00611317,857464,36729
CHEMBL593821,P23975,,FWMIXTKPPHIFDD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,21,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155529,DTCC00611317,857464,36729
CHEMBL594068,P23975,,NQKROFWTWKENTC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,INHIBITION,=,43,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603452,DTCT0023180,3155541,DTCC00611337,1886464,36729
CHEMBL594171,P23975,,HKILKCVBPMXBMC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,INHIBITION,<,10,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603452,DTCT0023180,3155543,DTCC00612479,1665576,36729
CHEMBL594388,P23975,,UWXLPDJHYFZQEG-ZEUZZLKZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,5000,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160682,DTCC00612197,457047,36533
CHEMBL594519,P23975,,YHPHFVMVXIQRCD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,12,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155534,DTCC00611330,1757413,36729
CHEMBL594519,P23975,,YHPHFVMVXIQRCD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,13,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155533,DTCC00611330,1757413,36729
CHEMBL594585,P23975,R-NORDULOXETINE,ZMXLKLOJDLMZFC-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,IC50,=,188,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602900,DTCT0023180,3162398,DTCC00613173,197468,36631
CHEMBL594585,P23975,R-NORDULOXETINE,ZMXLKLOJDLMZFC-MRXNPFEDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,KI,=,953,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602897,DTCT0023180,3162374,DTCC00613173,197468,36631
CHEMBL595,P23975,PIOGLITAZONE,HYAFETHFCAUJAY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389543,DTCC00148462,1318445,46191
CHEMBL595,P23975,PIOGLITAZONE,HYAFETHFCAUJAY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389544,DTCC00148462,1318445,46191
CHEMBL595063,P23975,(S)-NORDULOXETINE,ZMXLKLOJDLMZFC-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,IC50,=,445,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602900,DTCT0023180,3162399,DTCC00613182,262180,36631
CHEMBL595063,P23975,(S)-NORDULOXETINE,ZMXLKLOJDLMZFC-INIZCTEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,KI,=,2402,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602897,DTCT0023180,3162375,DTCC00613182,262180,36631
CHEMBL595133,P23975,,AVHPWUACYYPSMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,146,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155485,DTCC00611236,1050934,36729
CHEMBL595133,P23975,,AVHPWUACYYPSMI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,78,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155484,DTCC00611236,1050934,36729
CHEMBL595190,P23975,,DEQWDXVSVPRQSI-PAASSLRSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,20,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160624,DTCC00612220,780358,36533
CHEMBL595252,P23975,,WLLDZAMGIXUOIX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,47,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155513,DTCC00611284,1789677,36729
CHEMBL595252,P23975,,WLLDZAMGIXUOIX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,27,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155512,DTCC00611284,1789677,36729
CHEMBL595449,P23975,,ILPANLYEJQKXKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19646882,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of NET,,Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.,Bioorg. Med. Chem.,2009,17,17,"Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S, Wannemacher KM, Howells RD, Welsh WJ",,601720,DTCT0023180,3163186,DTCC00612138,1136637,36541
CHEMBL595457,P23975,,BNWDHFFDZARHMY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,51,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155493,DTCC00611247,921542,36729
CHEMBL595457,P23975,,BNWDHFFDZARHMY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,25,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155492,DTCC00611247,921542,36729
CHEMBL595539,P23975,,RZXLCNVGLULZII-FLNOXTKTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,4900,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160681,DTCC00612188,2005053,36533
CHEMBL595540,P23975,,MXPYLJDZHAVWJM-DKOHEDPJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,440,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160653,DTCC00612189,554638,36533
CHEMBL595638,P23975,,LLOHGZFZQFVZTC-JLZXWRJPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,120,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160640,DTCC00612204,1492513,36533
CHEMBL595674,P23975,,OWRBWLIVQNSHAQ-DDZGMJBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,1700,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160671,DTCC00612195,878029,36533
CHEMBL595677,P23975,,XDCKKLJZZNMBOS-CHPDAQJUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,26,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160629,DTCC00612187,878028,36533
CHEMBL595751,P23975,,VZAQFIJMTJXBKF-VGYQQOEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,1500,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160670,DTCC00612196,262174,36533
CHEMBL595766,P23975,,MVCBKJMODFGYDE-LOKCHCMISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,2200,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160674,DTCC00612194,197462,36533
CHEMBL595767,P23975,,ZFJXYVKPCIOHJP-DDZGMJBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,620,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160656,DTCC00612201,910706,36533
CHEMBL596001,P23975,,AFKZQXYPUGXQNH-SESHTJHWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,8.5,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160617,DTCC00612219,586841,36533
CHEMBL596148,P23975,,AHCAMFIUFHMBFK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,80,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155501,DTCC00611264,534014,36729
CHEMBL596148,P23975,,AHCAMFIUFHMBFK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,45,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155500,DTCC00611264,534014,36729
CHEMBL596175,P23975,,QOGSMHDQGODXBS-BEJSXWRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,IC50,=,2097,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602900,DTCT0023180,3162400,DTCC00613183,68545,36631
CHEMBL596175,P23975,,QOGSMHDQGODXBS-BEJSXWRTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,KI,=,3236,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602897,DTCT0023180,3162376,DTCC00613183,68545,36631
CHEMBL596185,P23975,,QOGSMHDQGODXBS-HHMOXRITSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,IC50,=,2190,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602900,DTCT0023180,3162401,DTCC00613184,1745994,36631
CHEMBL596185,P23975,,QOGSMHDQGODXBS-HHMOXRITSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19740668,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009,17,19,"Cashman JR, Ghirmai S",,602897,DTCT0023180,3162377,DTCC00613184,1745994,36631
CHEMBL596714,P23975,,BLKKGRNFYMEBJN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,330,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191171,DTCC00618330,748417,37378
CHEMBL596715,P23975,,ZWJLIFWNALUYLT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,140,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191172,DTCC00618331,1939275,37378
CHEMBL596775,P23975,,AMOKJMKEFDPTPN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207552,DTCC00615293,1665606,37173
CHEMBL596784,P23975,,YMQUDJCSTPMZTF-IOASZLSFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,158.49,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213766,DTCC00615309,1789712,37197
CHEMBL596795,P23975,,JWSCWFWSMYRJBE-PSOPSSQASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,19.95,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213748,DTCC00615505,1504217,37197
CHEMBL596796,P23975,,CXJYZDWEGFRWPU-PSOPSSQASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,10,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213747,DTCC00615506,112411,37197
CHEMBL596805,P23975,,KXLJVOFBGQNGTJ-VIKVFOODSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1.58,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213734,DTCC00615640,2081414,37197
CHEMBL596806,P23975,,FSLROBKNJCTZIC-PYZFKAKLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,3.98,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213733,DTCC00615641,1083609,37197
CHEMBL596809,P23975,,RMFDASBXQBLDIL-OUJBWJOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1.74,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213787,DTCC00615133,1918563,37197
CHEMBL596809,P23975,,RMFDASBXQBLDIL-OUJBWJOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,3.16,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213789,DTCC00615133,1918562,37197
CHEMBL596809,P23975,,RMFDASBXQBLDIL-OUJBWJOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,4.57,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in LLCPK cells by liquid scintillation counting,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613745,DTCT0023180,3213664,DTCC00615133,1918563,37197
CHEMBL596987,P23975,,ONSLZFSSJGOMSK-GRDNDAEWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213764,DTCC00615310,1789714,37197
CHEMBL596987,P23975,,ONSLZFSSJGOMSK-GRDNDAEWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213765,DTCC00615310,1789713,37197
CHEMBL596989,P23975,,ONSLZFSSJGOMSK-CPUCHLNUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,12.59,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213763,DTCC00615367,792036,37197
CHEMBL597,P23975,PHENTOLAMINE,MRBDMNSDAVCSSF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393695,DTCC00148793,1641852,46191
CHEMBL597,P23975,PHENTOLAMINE,MRBDMNSDAVCSSF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393696,DTCC00148793,1641852,46191
CHEMBL597000,P23975,,PYIBCEOJEPANCH-MKBNYLNASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]noradrenalin reuptake at human NET expressed in LLCPK cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613762,DTCT0023180,3213870,DTCC00615507,209162,37197
CHEMBL597000,P23975,,PYIBCEOJEPANCH-MKBNYLNASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.126,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213745,DTCC00615507,209162,37197
CHEMBL597000,P23975,,PYIBCEOJEPANCH-MKBNYLNASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.316,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213746,DTCC00615507,209161,37197
CHEMBL597134,P23975,,FLHCVNZEHIWJGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,EC50,=,9,NM,,,,,,,,,,,,,,Agonist activity at NET,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609753,DTCT0023180,3191228,DTCC00618456,910767,37378
CHEMBL597134,P23975,,FLHCVNZEHIWJGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,33,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191180,DTCC00618456,910767,37378
CHEMBL597134,P23975,,FLHCVNZEHIWJGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,33,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048970,DTCC00618456,911441,42462
CHEMBL597135,P23975,,RNYJGXWCOXRLAG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,181,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191181,DTCC00618457,1460075,37378
CHEMBL597190,P23975,,VTIJRYTVJGTTAJ-BREBYQMCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1.58,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213772,DTCC00615252,598518,37197
CHEMBL597530,P23975,,OTTUCFBNHXCUBH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,536,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191167,DTCC00618327,457097,37378
CHEMBL597531,P23975,,GZJLFOYGSNAXDK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,292,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191169,DTCC00618329,780406,37378
CHEMBL597608,P23975,,BWQFRVKQDHYVEW-HUBLWGQQSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,3.98,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213749,DTCC00615504,112410,37197
CHEMBL597967,P23975,,KKLRTSAUACDUNQ-GTKSSXFLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,14,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217243,DTCC00622356,1984206,37100
CHEMBL597968,P23975,,DPNWJTQXCYFUOT-VOMIJIAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,2.3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217245,DTCC00622358,1277319,37100
CHEMBL598026,P23975,,DDDMGCMKOCLAAT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207532,DTCC00615187,1536544,37173
CHEMBL598168,P23975,,FNQZKQRJZBPGQR-URBRKQAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,7.6,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217246,DTCC00622359,1116240,37100
CHEMBL598202,P23975,,VTIJRYTVJGTTAJ-OUJBWJOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,3.98,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213774,DTCC00615251,1407601,37197
CHEMBL598202,P23975,,VTIJRYTVJGTTAJ-OUJBWJOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,346.74,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213773,DTCC00615251,1407602,37197
CHEMBL598215,P23975,,VNJFIBFHISUZRV-ZACQAIPSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213754,DTCC00615448,1342620,37197
CHEMBL598216,P23975,,ZVZFXZCYKJIUGR-KWBADKCTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,7.94,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213753,DTCC00615449,1633311,37197
CHEMBL598228,P23975,,NRTIMMZNHIFNOB-IJOPVONJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213737,DTCC00615637,1504223,37197
CHEMBL598346,P23975,,ZSIHFDAUAFSTIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,EC50,=,28,NM,,,,,,,,,,,,,,Agonist activity at NET,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609753,DTCT0023180,3191227,DTCC00618258,522624,37378
CHEMBL598346,P23975,,ZSIHFDAUAFSTIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,32,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191165,DTCC00618258,522624,37378
CHEMBL598346,P23975,,ZSIHFDAUAFSTIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,EC50,=,28,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human cloned NET expressed in HEK293 cells by FLIPR assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698920,DTCT0023180,5049805,DTCC00618258,523264,42462
CHEMBL598346,P23975,,ZSIHFDAUAFSTIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21185183,KI,=,32,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,2011,21,2,"Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T",,698905,DTCT0023180,5048969,DTCC00618258,523264,42462
CHEMBL598560,P23975,,HMSJPIAQQVBQMP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,247,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191178,DTCC00618383,1298010,37378
CHEMBL598561,P23975,,ATVZOYVGUWYSKX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,276,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191179,DTCC00618384,1874872,37378
CHEMBL598562,P23975,,AMNKPXBJLVWEJK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,413,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191176,DTCC00618381,1104473,37378
CHEMBL598614,P23975,,QZVQFWATMTZJGK-URBRKQAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,1.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611008,DTCT0023180,3217331,DTCC00621452,889718,37100
CHEMBL598614,P23975,,QZVQFWATMTZJGK-URBRKQAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,5.5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217258,DTCC00621452,889718,37100
CHEMBL598644,P23975,,MYVJXQAAFVJXRY-VIKVFOODSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,7.94,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213740,DTCC00615576,1148561,37197
CHEMBL598767,P23975,,GKIYCLAZFANGKD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,143,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191177,DTCC00618382,1939276,37378
CHEMBL598825,P23975,,GXWUVPPXUBCALT-JMSVASOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213779,DTCC00615201,1018515,37197
CHEMBL599,P23975,MELOXICAM,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7419353,DTCC00149080,638767,46191
CHEMBL599,P23975,MELOXICAM,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7419354,DTCC00149080,638767,46191
CHEMBL599028,P23975,,UDGISDAHRCDXMV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,135,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3206746,DTCC00615294,307260,37173
CHEMBL599230,P23975,,DNVMLFGJFSQQDE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,1180,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207487,DTCC00615295,112409,37173
CHEMBL599233,P23975,,LTLFRBMKBHQUTH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,4100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207508,DTCC00615349,405486,37173
CHEMBL599240,P23975,,SXVNDMHECZDJQS-RLFYNMQTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,39.81,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213761,DTCC00615369,824602,37197
CHEMBL599241,P23975,,UJQCJTWDIZLQBH-OUJBWJOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1.58,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213758,DTCC00615371,1854298,37197
CHEMBL599241,P23975,,UJQCJTWDIZLQBH-OUJBWJOFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,5.01,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213759,DTCC00615371,1854297,37197
CHEMBL599242,P23975,,UJQCJTWDIZLQBH-BREBYQMCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,316.23,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213757,DTCC00615372,1342618,37197
CHEMBL599371,P23975,,QNOVJSGRCXZVAL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,921,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191175,DTCC00618380,197534,37378
CHEMBL599376,P23975,,PYPVCBLWSWFYNN-MOSHPQCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20020710,ACTIVITY,=,14,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM by displacement assay,,Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.,J. Med. Chem.,2010,53,2,"Fritch PC, McNaughton-Smith G, Amato GS, Burns JF, Eargle CW, Roeloffs R, Harrison W, Jones L, Wickenden AD",,612975,DTCT0023180,3200815,DTCC00617832,307299,37339
CHEMBL599592,P23975,,MNKYSXOLQYNYNU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,27,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191182,DTCC00618458,1939277,37378
CHEMBL599593,P23975,,LVSZWRFDLAUNPF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,747,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191183,DTCC00618459,360720,37378
CHEMBL599608,P23975,,JLWSMMAHZFKYJR-URBRKQAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,9.7,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217237,DTCC00622281,1407689,37100
CHEMBL599609,P23975,,GNEJBSYNDIMJCO-MAOIFBLLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,6.2,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217240,DTCC00622284,1439534,37100
CHEMBL599638,P23975,,RMFDASBXQBLDIL-BREBYQMCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,223.87,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213786,DTCC00615135,1789709,37197
CHEMBL599639,P23975,,ORUPHFRKUPILCN-HEHGZKQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1.95,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213785,DTCC00615136,1244668,37197
CHEMBL599639,P23975,,ORUPHFRKUPILCN-HEHGZKQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,15.85,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213784,DTCC00615136,1244669,37197
CHEMBL599760,P23975,RO-85,WLMBSKSEPQCRJV-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20045645,ACTIVITY,>,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human recombinant NET expressed in CHO cells at 10 uM after 120 mins by scintillation counting,,"Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.",Bioorg. Med. Chem. Lett.,2010,20,3,"Brotherton-Pleiss CE, Dillon MP, Ford AP, Gever JR, Carter DS, Gleason SK, Lin CJ, Moore AG, Thompson AW, Villa M, Zhai Y",,612708,DTCT0023180,3188590,DTCC00030157,1918622,37451
CHEMBL599798,P23975,,SHDFZRRKZIILLR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,663,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191184,DTCC00618460,1136698,37378
CHEMBL599813,P23975,,GNEJBSYNDIMJCO-BGUVMLPUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,8.5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217241,DTCC00622285,1018586,37100
CHEMBL599845,P23975,,GXWUVPPXUBCALT-SLEUVZQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213781,DTCC00615200,727791,37197
CHEMBL599845,P23975,,GXWUVPPXUBCALT-SLEUVZQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,31.62,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213780,DTCC00615200,727792,37197
CHEMBL599846,P23975,,ZZWUEOYQVWAKCJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,2530,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207503,DTCC00615244,598517,37173
CHEMBL59986,P23975,A-85380,XKFMBGWHHBCWCD-QMMMGPOBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8887981,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732161,DTCC01740603,2104613,69282
CHEMBL6,P23975,INDOMETHACIN,CGIGDMFJXJATDK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428793,DTCC00132340,51479,46191
CHEMBL6,P23975,INDOMETHACIN,CGIGDMFJXJATDK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428794,DTCC00132340,51479,46191
CHEMBL600053,P23975,,BKYSPAJPVPEZOE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19954972,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010,20,1,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603565,DTCT0023180,3164454,DTCC00609877,405425,36082
CHEMBL600220,P23975,,WBTKYJAWLLWAMV-VOMIJIAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,5.7,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217253,DTCC00621374,372574,37100
CHEMBL600325,P23975,PROSCILLARIDIN,MYEJFUXQJGHEQK-ALRJYLEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7379320,DTCC00486948,1705878,46191
CHEMBL600325,P23975,PROSCILLARIDIN,MYEJFUXQJGHEQK-ALRJYLEOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7379321,DTCC00486948,1705878,46191
CHEMBL600424,P23975,,NKULKNQOSDDCTA-VOMIJIAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,4.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611008,DTCT0023180,3217329,DTCC00621375,80302,37100
CHEMBL600424,P23975,,NKULKNQOSDDCTA-VOMIJIAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,6.5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217254,DTCC00621375,80302,37100
CHEMBL600645,P23975,,VXAKZDFZAIJNGP-MJVIPROJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213857,DTCC00615446,307261,37197
CHEMBL600674,P23975,,LJCOZBDBGBEZNJ-ZFNKBKEPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,170,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217248,DTCC00621285,469354,37100
CHEMBL600854,P23975,,GRMXPWKSNKSJGL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,25,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191173,DTCC00618332,1006849,37378
CHEMBL601879,P23975,,WWIVDDWMWBWRJK-KGQXAQPSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,15,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217247,DTCC00621284,112475,37100
CHEMBL601880,P23975,,LVFOKOCPQCOYER-VOMIJIAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,2.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611008,DTCT0023180,3217328,DTCC00621286,1918636,37100
CHEMBL601880,P23975,,LVFOKOCPQCOYER-VOMIJIAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,6.3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217249,DTCC00621286,1918636,37100
CHEMBL602235,P23975,,JNLXUEPMJIMNHM-SLEUVZQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.398,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213771,DTCC00615253,824597,37197
CHEMBL602235,P23975,,JNLXUEPMJIMNHM-SLEUVZQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,199.53,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213770,DTCC00615253,824598,37197
CHEMBL602305,P23975,,ONWOFJCPRAZRKC-BOPFTXTBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20020710,ACTIVITY,=,43,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM by displacement assay,,Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.,J. Med. Chem.,2010,53,2,"Fritch PC, McNaughton-Smith G, Amato GS, Burns JF, Eargle CW, Roeloffs R, Harrison W, Jones L, Wickenden AD",,612975,DTCT0023180,3200817,DTCC00617956,663212,37339
CHEMBL602323,P23975,,WZYMYZUFIBBREW-OKCYCAHKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,7.94,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213736,DTCC00615638,1789722,37197
CHEMBL602550,P23975,,HMQMRPICUDGPQP-NSLUPJTDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,39,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217252,DTCC00621373,857575,37100
CHEMBL602850,P23975,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19954972,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of NET at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010,20,1,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603565,DTCT0023180,3164453,DTCC00609826,1309981,36082
CHEMBL602850,P23975,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11474342,DTCC00609826,1300183,51935
CHEMBL602850,P23975,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12600276,DTCC00609826,1301031,55935
CHEMBL603,P23975,ZAFIRLUKAST,YEEZWCHGZNKEEK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441044,DTCC00150003,1830696,46191
CHEMBL603,P23975,ZAFIRLUKAST,YEEZWCHGZNKEEK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441045,DTCC00150003,1830696,46191
CHEMBL603109,P23975,,IQUWBNFDLZZVRR-VOMIJIAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,19,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217255,DTCC00621376,1504283,37100
CHEMBL603417,P23975,,BOQKMDDOTKOYRK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,116,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155522,DTCC00611293,598454,36729
CHEMBL603417,P23975,,BOQKMDDOTKOYRK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,125,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155521,DTCC00611293,598454,36729
CHEMBL603430,P23975,,XTGQHXCVZRGUAO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,49,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155505,DTCC00611265,1148522,36729
CHEMBL603430,P23975,,XTGQHXCVZRGUAO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,28,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155504,DTCC00611265,1148522,36729
CHEMBL603480,P23975,,PYIBCEOJEPANCH-XHBSWPGZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,79.43,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213744,DTCC00615575,112413,37197
CHEMBL603495,P23975,,IYXFYMMSRUEOGZ-BHDTVMLSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,150,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217250,DTCC00621287,372571,37100
CHEMBL603540,P23975,,RMFDASBXQBLDIL-OPQQBVKSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1288.25,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213788,DTCC00615134,986256,37197
CHEMBL603620,P23975,,DGQVZUDAKWRJPY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207529,DTCC00615186,889648,37173
CHEMBL603855,P23975,,BTVODQSCRZBWKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,INHIBITION,=,48,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603452,DTCT0023180,3155546,DTCC00612454,339866,36729
CHEMBL603920,P23975,,HQJTZVWELLEYIW-VOMIJIAVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,17,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217256,DTCC00621377,1310107,37100
CHEMBL604685,P23975,,IZXAGSUHTCPYKG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,707,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155538,DTCC00611331,1439398,36729
CHEMBL604685,P23975,,IZXAGSUHTCPYKG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,1030,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155537,DTCC00611331,1439398,36729
CHEMBL605089,P23975,,JBNMIXNIEIEPSS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,1092,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155526,DTCC00611316,2017074,36729
CHEMBL605089,P23975,,JBNMIXNIEIEPSS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,1130,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155525,DTCC00611316,2017074,36729
CHEMBL605119,P23975,,SUHBXDPETHQPJC-RLFYNMQTSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213762,DTCC00615368,1407606,37197
CHEMBL605209,P23975,,JNLXUEPMJIMNHM-JMSVASOKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.251,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213769,DTCC00615306,1375181,37197
CHEMBL605213,P23975,,YYHJBTRUWUYGMM-MAOIFBLLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,72,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217239,DTCC00622283,38771,37100
CHEMBL605309,P23975,,HTHJJCBRKUSTFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,460,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155497,DTCC00611248,953819,36729
CHEMBL605309,P23975,,HTHJJCBRKUSTFT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,428,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155496,DTCC00611248,953819,36729
CHEMBL605501,P23975,,CFVHNYYHCCJXDK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,2850,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207506,DTCC00615243,1310030,37173
CHEMBL605502,P23975,,UVFXBMLDXDSRJM-SLEUVZQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,15.85,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213775,DTCC00615250,307256,37197
CHEMBL605990,P23975,,VKFRVICFXISTJZ-BHDTVMLSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,21,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217251,DTCC00621288,2049315,37100
CHEMBL606120,P23975,,ZGPLGLWQWPXKAN-HOTUBEGUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,28.84,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213790,DTCC00615074,1918559,37197
CHEMBL606144,P23975,,GRBCPJNRLNFZRM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,128,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155509,DTCC00611283,1083563,36729
CHEMBL606144,P23975,,GRBCPJNRLNFZRM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,73,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155508,DTCC00611283,1083563,36729
CHEMBL606150,P23975,,CQNQTEGBNDNNMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,302,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155489,DTCC00611237,1179437,36729
CHEMBL606150,P23975,,CQNQTEGBNDNNMO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,487,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155488,DTCC00611237,1179437,36729
CHEMBL606174,P23975,,XCXKFSMMFREDTK-SRJVRDNSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,23,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217244,DTCC00622357,889735,37100
CHEMBL606809,P23975,,ACGWDXHPVXMSNJ-KOQKOIQBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,380,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160651,DTCC00612221,974322,36533
CHEMBL607546,P23975,,GRBWDTDDMWUOBH-DDZGMJBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,3300,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160679,DTCC00612200,1071694,36533
CHEMBL607547,P23975,,XHEKSGUJENDBTI-SCCDFBDJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,1300,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160667,DTCC00612202,554639,36533
CHEMBL607548,P23975,,RLTILGBQVNXKRQ-DDZGMJBXSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,1200,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160666,DTCC00612203,1777940,36533
CHEMBL607871,P23975,,ORUPHFRKUPILCN-WOSRLPQWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,125.89,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213782,DTCC00615199,1439447,37197
CHEMBL608,P23975,PROBUCOL,FYPMFJGVHOHGLL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385576,DTCC00150969,962450,46191
CHEMBL608,P23975,PROBUCOL,FYPMFJGVHOHGLL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7385577,DTCC00150969,962450,46191
CHEMBL608148,P23975,,LKVOLTSPLLAMPJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,2440,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191166,DTCC00618259,165548,37378
CHEMBL608151,P23975,,IBZJKEOJOGAMGJ-COPLHBTASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]noradrenalin reuptake at human NET expressed in LLCPK cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613762,DTCT0023180,3213868,DTCC00615202,437543,37197
CHEMBL608151,P23975,,IBZJKEOJOGAMGJ-COPLHBTASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213777,DTCC00615202,437543,37197
CHEMBL608151,P23975,,IBZJKEOJOGAMGJ-COPLHBTASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1.58,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213778,DTCC00615202,437542,37197
CHEMBL608151,P23975,,IBZJKEOJOGAMGJ-COPLHBTASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20527970,KI,=,0.501,NM,,cell_based,,,,,,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,2010,53,13,"Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R",,642208,DTCT0023180,3395886,DTCC00615202,437941,39684
CHEMBL608151,P23975,,IBZJKEOJOGAMGJ-COPLHBTASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21550808,KI,=,0.501,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,2011,19,11,"Micheli F, Cavanni P, Bettati M, Bonanomi G, Di Fabio R, Fazzolari E, Marchioro C, Roscic M, Tarsi L, Visentini F, Zonzini L, Worby A",,763088,DTCT0023180,6065307,DTCC00615202,427236,45533
CHEMBL608380,P23975,,RSVUNKKDIROCQS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,IC50,=,960,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603450,DTCT0023180,3155477,DTCC00611225,176906,36729
CHEMBL608380,P23975,,RSVUNKKDIROCQS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,792,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603449,DTCT0023180,3155476,DTCC00611225,176906,36729
CHEMBL608430,P23975,,YMQUDJCSTPMZTF-HEHGZKQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1.26,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213768,DTCC00615307,144892,37197
CHEMBL608560,P23975,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19954972,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of NET at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010,20,1,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603565,DTCT0023180,3164343,DTCC00609825,1789660,36082
CHEMBL608560,P23975,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098,DTCT0023180,11474370,DTCC00609825,1780158,51935
CHEMBL608560,P23975,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449,DTCT0023180,12600278,DTCC00609825,1780917,55935
CHEMBL608703,P23975,,ZEOHVQFWFVMPGM-JYVUQVBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,39,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160632,DTCC00612185,328069,36533
CHEMBL608704,P23975,,GSKKFMDTLUPADS-PHBSMUBBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,5400,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160683,DTCC00612190,68537,36533
CHEMBL608708,P23975,,GKZNLBBTTXPNLH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,INHIBITION,=,12,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603452,DTCT0023180,3155545,DTCC00612455,598476,36729
CHEMBL60889,P23975,MOSAPRIDE,YPELFRMCRYSPKZ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7424325,DTCC00208987,217581,46191
CHEMBL60889,P23975,MOSAPRIDE,YPELFRMCRYSPKZ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7424326,DTCC00208987,217581,46191
CHEMBL609023,P23975,,NGRIUVQYFBDXMT-JYAVWHMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,7.94,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213735,DTCC00615639,1633313,37197
CHEMBL609624,P23975,,ZBHICRAJUNKGFK-QNGOZBTKSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20020710,ACTIVITY,=,34,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM by displacement assay,,Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.,J. Med. Chem.,2010,53,2,"Fritch PC, McNaughton-Smith G, Amato GS, Burns JF, Eargle CW, Roeloffs R, Harrison W, Jones L, Wickenden AD",,612975,DTCT0023180,3200816,DTCC00617833,1789752,37339
CHEMBL609883,P23975,,OGJYXTXOUOYPDQ-MOPGFXCFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake at NET,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603447,DTCT0023180,3155571,DTCC00612517,1018495,36729
CHEMBL609904,P23975,,OLCRHPXGKWMFIP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,74,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191168,DTCC00618328,1972436,37378
CHEMBL609908,P23975,,PQVFTFGHDAAJKQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20034793,IC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,2010,20,3,"Marcin LR, Mattson RJ, Gao Q, Wu D, Molski TF, Mattson GK, Lodge NJ",,610435,DTCT0023180,3195436,DTCC00618604,1536587,37394
CHEMBL61,P23975,PODOFILOX,YJGVMLPVUAXIQN-XVVDYKMHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389648,DTCC00136120,51501,46191
CHEMBL61,P23975,PODOFILOX,YJGVMLPVUAXIQN-XVVDYKMHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389649,DTCC00136120,51501,46191
CHEMBL61006,P23975,PHENYLPROPANOLAMINE,DLNKOYKMWOXYQA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,15,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741061,DTCC00209067,2107611,69025
CHEMBL61006,P23975,PHENYLPROPANOLAMINE,DLNKOYKMWOXYQA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,30.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741060,DTCC00209067,2107611,69025
CHEMBL61006,P23975,PHENYLPROPANOLAMINE,DLNKOYKMWOXYQA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,42.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741059,DTCC00209067,2107611,69025
CHEMBL61006,P23975,PHENYLPROPANOLAMINE,DLNKOYKMWOXYQA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,137,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14741062,DTCC00209067,2107611,69025
CHEMBL610220,P23975,,RXLIIMKHNRHPBV-IWIIMEHWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,25.12,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213738,DTCC00615578,437547,37197
CHEMBL610514,P23975,,STELSYDZPWCAMN-URBRKQAFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,4.6,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217238,DTCC00622282,1083695,37100
CHEMBL610766,P23975,,SIIICDNNMDMWCI-JYVUQVBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,19,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160623,DTCC00612186,1524807,36533
CHEMBL610795,P23975,,ORUPHFRKUPILCN-IOASZLSFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213783,DTCC00615137,1757463,37197
CHEMBL610897,P23975,,ZEOHVQFWFVMPGM-LMRVLLHPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,37,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043084,DTCC00625486,403450,22167
CHEMBL610897,P23975,,ZEOHVQFWFVMPGM-LMRVLLHPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,22,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043085,DTCC00625486,403450,22167
CHEMBL611,P23975,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459177,DTCC00103842,2025644,46191
CHEMBL611,P23975,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459178,DTCC00103842,2025644,46191
CHEMBL611063,P23975,,AVDNQARKBDHXAZ-UBNPUMAJSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,0.501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213767,DTCC00615308,727794,37197
CHEMBL611367,P23975,,JTZODQOWHKXAGE-HALDLXJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,3.98,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213732,DTCC00615642,2017120,37197
CHEMBL611379,P23975,,VNJFIBFHISUZRV-YESZJQIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213856,DTCC00615447,1697654,37197
CHEMBL611379,P23975,,VNJFIBFHISUZRV-YESZJQIVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,316.23,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213755,DTCC00615447,1697655,37197
CHEMBL611617,P23975,,WNOWEUDDCASDAD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,INHIBITION,<,10,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603452,DTCT0023180,3155544,DTCC00612456,1633278,36729
CHEMBL611677,P23975,,YTQLIVFAWSALJC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20031410,KI,=,1810,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,2010,20,3,"Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K",,609533,DTCT0023180,3191174,DTCC00618379,845707,37378
CHEMBL611959,P23975,,SIPPOOBBYQOQKQ-UYLXQDHASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,810,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160663,DTCC00612191,360670,36533
CHEMBL611960,P23975,,JAUMZHMWXNWFKB-PYNNCUBPSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,180,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160643,DTCC00612192,1654056,36533
CHEMBL611961,P23975,,VXFJRJWYWCHNJF-SESHTJHWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,100,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160639,DTCC00612193,1492512,36533
CHEMBL611962,P23975,,OWLDNNYJJFSQJU-LOKCHCMISA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,1900,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160672,DTCC00612198,1589191,36533
CHEMBL611963,P23975,,ZERAVOYPKCPVKA-VQTBRTBSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19560930,KI,=,2700,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,2009,17,14,"Nielsen S, Pedersen CM, Hansen SG, Petersen MD, Sinning S, Wiborg O, Jensen HH, Bols M",,601511,DTCT0023180,3160677,DTCC00612199,942232,36533
CHEMBL611970,P23975,,KBCFUZMHKDDBCJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,INHIBITION,<,10,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603452,DTCT0023180,3155542,DTCC00612485,38573,36729
CHEMBL611990,P23975,,DFPSUOZWGQDKPI-COPLHBTASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20170186,KI,=,31.62,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613740,DTCT0023180,3213760,DTCC00615370,1665609,37197
CHEMBL612,P23975,DEXTROAMPHETAMINE,KWTSXDURSIMDCE-QMMMGPOBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22037049,EC50,=,7.1,NM,,tissue,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET cloned in rat brain synaptosome by scintillation counting,,Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class.,Bioorg. Med. Chem.,2011,19,23,"Lewin AH, Miller GM, Gilmour B",,792745,DTCT0023180,7563970,DTCC00151426,736350,46681
CHEMBL612,P23975,DEXTROAMPHETAMINE,KWTSXDURSIMDCE-QMMMGPOBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,630.96,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465495,DTCC00151426,738955,54821
CHEMBL612,P23975,DEXTROAMPHETAMINE,KWTSXDURSIMDCE-QMMMGPOBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,101,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465494,DTCC00151426,738955,54821
CHEMBL612232,P23975,,AUIYTQCQFPAFCD-MLVZRXLZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10821718,KI,=,208,NM,,cell_based,,,,,,,,,,,,Compound was evaluated for inhibition of [3H]NE uptake in HEK-hNET cells expressing Human norepinephrine transporter,,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,2000,43,10,"Hoepping A, Johnson KM, George C, Flippen-Anderson J, Kozikowski AP",,142794,DTCT0023180,1179569,DTCC00105490,808384,15725
CHEMBL612232,P23975,,AUIYTQCQFPAFCD-MLVZRXLZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10821718,KI,=,5440,NM,,cell_based,,,,,,,,,,,,Compound was evaluated for binding affinity using [125I]RTI-55 as a radioligand in HEK-hNET cells expressing human norepinephrine transporter,,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,2000,43,10,"Hoepping A, Johnson KM, George C, Flippen-Anderson J, Kozikowski AP",,142793,DTCT0023180,1179568,DTCC00105490,808384,15725
CHEMBL614,P23975,PYRAZINAMIDE,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7388032,DTCC00151678,898296,46191
CHEMBL614,P23975,PYRAZINAMIDE,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7388033,DTCC00151678,898296,46191
CHEMBL621,P23975,TRAZODONE,PHLBKPHSAVXXEF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739289,DTCC00154041,2106986,68466
CHEMBL621,P23975,TRAZODONE,PHLBKPHSAVXXEF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,8500,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14739288,DTCC00154041,2106985,68566
CHEMBL621,P23975,TRAZODONE,PHLBKPHSAVXXEF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7449911,DTCC00154041,51512,46191
CHEMBL621,P23975,TRAZODONE,PHLBKPHSAVXXEF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7449912,DTCC00154041,51512,46191
CHEMBL62193,P23975,SULFADIMETHOXINE,ZZORFUFYDOWNEF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473930,DTCC00208934,703987,46191
CHEMBL62193,P23975,SULFADIMETHOXINE,ZZORFUFYDOWNEF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7473931,DTCC00208934,703987,46191
CHEMBL622,P23975,ETODOLAC,NNYBQONXHNTVIJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7328603,DTCC00154070,153443,46191
CHEMBL622,P23975,ETODOLAC,NNYBQONXHNTVIJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7328604,DTCC00154070,153443,46191
CHEMBL623,P23975,NEFAZODONE,VRBKIVRKKCLPHA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,618,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736941,DTCC00154100,2106140,68466
CHEMBL623,P23975,NEFAZODONE,VRBKIVRKKCLPHA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,713,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736940,DTCC00154100,2106140,68466
CHEMBL623,P23975,NEFAZODONE,VRBKIVRKKCLPHA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,360,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736942,DTCC00154100,2106137,68566
CHEMBL623,P23975,NEFAZODONE,VRBKIVRKKCLPHA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,360,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,584734,DTCC00154100,498829,3008
CHEMBL625,P23975,THIABENDAZOLE,WJCNZQLZVWNLKY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468023,DTCC00154204,217588,46191
CHEMBL625,P23975,THIABENDAZOLE,WJCNZQLZVWNLKY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7468024,DTCC00154204,217588,46191
CHEMBL6273,P23975,FLEROXACIN,XBJBPGROQZJDOJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7326701,DTCC00132376,1220277,46191
CHEMBL6273,P23975,FLEROXACIN,XBJBPGROQZJDOJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7326702,DTCC00132376,1220277,46191
CHEMBL628,P23975,PENTOXIFYLLINE,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7382670,DTCC00154570,1641851,46191
CHEMBL628,P23975,PENTOXIFYLLINE,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7382671,DTCC00154570,1641851,46191
CHEMBL629,P23975,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,19,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14727519,DTCC00154602,2103265,68466
CHEMBL629,P23975,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,102,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14727521,DTCC00154602,2103265,68466
CHEMBL629,P23975,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,35,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14727518,DTCC00154602,2103259,68566
CHEMBL629,P23975,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,13.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14727520,DTCC00154602,2103258,69177
CHEMBL629,P23975,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,63,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14727517,DTCC00154602,2103258,69177
CHEMBL629,P23975,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,2041.74,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465497,DTCC00154602,480843,54821
CHEMBL629,P23975,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,333,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465496,DTCC00154602,480843,54821
CHEMBL629,P23975,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,23,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7296783,DTCC00154602,477911,46191
CHEMBL629,P23975,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,22,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7296784,DTCC00154602,477911,46191
CHEMBL631,P23975,PROPAFENONE,JWHAUXFOSRPERK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3016,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7387919,DTCC00154637,1927020,46191
CHEMBL631,P23975,PROPAFENONE,JWHAUXFOSRPERK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2991,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7387920,DTCC00154637,1927020,46191
CHEMBL6310,P23975,,SCIRNASYBOGBOO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14643338,KI,,10000,NM,,,,,,,,,,,,,,Binding affinity towards NET; No data,Not Determined,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,2003,13,24,"Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA",,142611,DTCT0023180,1112879,DTCC00132496,2078044,6037
CHEMBL632,P23975,BETAMETHASONE,UREBDLICKHMUKA-DVTGEIKXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7275643,DTCC00154673,1188064,46191
CHEMBL632,P23975,BETAMETHASONE,UREBDLICKHMUKA-DVTGEIKXSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7275644,DTCC00154673,1188064,46191
CHEMBL633,P23975,AMIODARONE,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2271,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7291372,DTCC00154700,768472,46191
CHEMBL633,P23975,AMIODARONE,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2252,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7291373,DTCC00154700,768472,46191
CHEMBL63323,P23975,NIFLUMIC ACID,JZFPYUNJRRFVQU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7403414,DTCC00211494,639583,46191
CHEMBL63323,P23975,NIFLUMIC ACID,JZFPYUNJRRFVQU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7403415,DTCC00211494,639583,46191
CHEMBL63354,P23975,AMENTOFLAVONE,YUSWMAULDXZHPY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14753800,DTCC00216407,2103540,69275
CHEMBL635,P23975,PREDNISONE,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394060,DTCC00154731,381016,46191
CHEMBL635,P23975,PREDNISONE,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394061,DTCC00154731,381016,46191
CHEMBL63560,P23975,(R)-BICALUTAMIDE,LKJPYSCBVHEWIU-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281974,DTCC00216573,833153,46191
CHEMBL63560,P23975,(R)-BICALUTAMIDE,LKJPYSCBVHEWIU-KRWDZBQOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7281975,DTCC00216573,833153,46191
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,1644,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728889,DTCC00154763,2103718,68466
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,2269,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728887,DTCC00154763,2103718,68466
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,1060,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728891,DTCC00154763,2103709,68566
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,1060,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,593938,DTCC00154763,1501009,3008
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11454918,KI,=,6310,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728884,DTCC00154763,2103674,69315
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11750180,KI,=,2480,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728886,DTCC00154763,2103673,69314
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14573386,KI,=,2483,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728885,DTCC00154763,2103710,69056
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,1420,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728890,DTCC00154763,2103711,69177
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476,KI,=,1920,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728888,DTCC00154763,2103711,69177
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,535,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657132,DTCC00154763,1491481,30478
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,385,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657131,DTCC00154763,1491481,30478
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,535,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324044,DTCC00154763,1504449,38843
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153,IC50,=,581,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118,DTCT0023180,3446708,DTCC00154763,1504705,40497
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21413808,IC50,=,149,NM,,,,,,,,,,,,,,Inhibition of NET,,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,2011,54,8,,,879332,DTCT0023180,11458842,DTCC00154763,1514770,51826
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,7943.28,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465482,DTCC00154763,1515560,54821
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,1623,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465481,DTCC00154763,1515560,54821
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,IC50,=,5722,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467,DTCT0023180,13880517,DTCC00154763,1496536,60843
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,9,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672,DTCT0023180,13876495,DTCC00154763,1496536,60843
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,37,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479,DTCT0023180,13885103,DTCC00154763,1496536,60843
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340,INHIBITION,=,81,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014,24,15,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483,DTCT0023180,13880736,DTCC00154763,1496536,60843
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,680,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454710,DTCC00154763,1495317,54354
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2708,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450391,DTCC00154763,1512820,46191
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2685,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7450392,DTCC00154763,1512820,46191
CHEMBL637,P23975,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,>,553,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,,ACS Med. Chem. Lett.,2013,4,6,,,961681,DTCT0023180,12454788,DTCC00154763,1495317,54354
CHEMBL63703,P23975,,PSNHNKLTGOOICN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,87,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,835360,DTCC00219053,452553,15898
CHEMBL63703,P23975,,PSNHNKLTGOOICN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,180,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,835357,DTCC00219053,452553,15898
CHEMBL64,P23975,ISONIAZID,QRXWMOHMRWLFEY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7433195,DTCC00136222,51480,46191
CHEMBL64,P23975,ISONIAZID,QRXWMOHMRWLFEY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7433196,DTCC00136222,51480,46191
CHEMBL640,P23975,PROCAINAMIDE,REQCZEXYDRLIBE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389914,DTCC00154806,1577009,46191
CHEMBL640,P23975,PROCAINAMIDE,REQCZEXYDRLIBE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389915,DTCC00154806,1577009,46191
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,2.03,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,590455,DTCC00154807,2013909,3008
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18207394,IC50,=,5.1,NM,,,,,,,,,,,,,,Inhibition of human NET,,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,4,"Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M",,469334,DTCT0023180,2303669,DTCC00154807,2020318,25699
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,5.1,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372813,DTCC00154807,2003744,25565
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369,IC50,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008,18,14,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609,DTCT0023180,2649834,DTCC00154807,2015719,31203
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054,DTCT0023180,2445635,DTCC00154807,2004535,30880
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364,IC50,=,5,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008,18,16,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091,DTCT0023180,2447039,DTCC00154807,2004538,30886
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,3,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686036,DTCC00154807,2016121,31294
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789619,DTCC00154807,2003967,31613
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954038,IC50,=,5.1,NM,,cell_based,,,,,,,,,,,HEK293,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter",,"Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,2008,51,22,"Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C",,493240,DTCT0023180,2599972,DTCC00154807,2016368,32649
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18954981,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,2008,18,23,"Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,558433,DTCT0023180,2793582,DTCC00154807,2015763,31630
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725272,DTCC00154807,2004232,34196
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,3.1,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901946,DTCC00154807,2016557,35305
CHEMBL641,P23975,ATOMOXETINE,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20153188,IC50,=,3,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,2010,20,5,"Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P",,617684,DTCT0023180,3224258,DTCC00154807,2005195,38126
CHEMBL642,P23975,ACEBUTOLOL,GOEMGAFJFRBGGG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290781,DTCC00154812,1798405,46191
CHEMBL642,P23975,ACEBUTOLOL,GOEMGAFJFRBGGG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7290782,DTCC00154812,1798405,46191
CHEMBL643,P23975,PROMETHAZINE,PWWVAXIEGOYWEE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,4238,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7383594,DTCC00154825,1188074,46191
CHEMBL643,P23975,PROMETHAZINE,PWWVAXIEGOYWEE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4203,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7383595,DTCC00154825,1188074,46191
CHEMBL6437,P23975,MIANSERIN,UEQUQVLFIPOEMF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,163,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7409115,DTCC00132673,1383778,46191
CHEMBL6437,P23975,MIANSERIN,UEQUQVLFIPOEMF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,161,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7409116,DTCC00132673,1383778,46191
CHEMBL644,P23975,TRIMIPRAMINE,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,2450,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14746486,DTCC00154839,2109191,68566
CHEMBL6466,P23975,COUMARIN,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367609,DTCC00133265,833159,46191
CHEMBL6466,P23975,COUMARIN,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7367610,DTCC00133265,833159,46191
CHEMBL6467,P23975,4-METHYLTHIOAMPHETAMINE,OLEWMKVPSUCNLG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19717215,EC50,=,34673.69,NM,,cell_based,,,,,,,,,,,HEK293,Induction of human NET-dependent cytotoxicity in NET expressing HEK293 cells after 48 hrs by neutral red assay,,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,2009,44,12,"Cloonan SM, Keating JJ, Butler SG, Knox AJ, Jørgensen AM, Peters GH, Rai D, Corrigan D, Lloyd DG, Williams DC, Meegan MJ",,622536,DTCT0023180,3256948,DTCC00132550,1363495,37648
CHEMBL6467,P23975,4-METHYLTHIOAMPHETAMINE,OLEWMKVPSUCNLG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19717215,IC50,=,2375,NM,,,,,,,,,,,,,,Inhibition of human noradrenaline transporter,,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,2009,44,12,"Cloonan SM, Keating JJ, Butler SG, Knox AJ, Jørgensen AM, Peters GH, Rai D, Corrigan D, Lloyd DG, Williams DC, Meegan MJ",,622530,DTCT0023180,3256936,DTCC00132550,1363495,37648
CHEMBL648,P23975,CYCLIZINE,UVKZSORBKUEBAZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7350406,DTCC00154967,381007,46191
CHEMBL648,P23975,CYCLIZINE,UVKZSORBKUEBAZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7350407,DTCC00154967,381007,46191
CHEMBL64894,P23975,GENTIAN VIOLET,ZXJXZNDDNMQXFV-UHFFFAOYSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7310186,DTCC00212699,703981,46191
CHEMBL64894,P23975,GENTIAN VIOLET,ZXJXZNDDNMQXFV-UHFFFAOYSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7310187,DTCC00212699,703981,46191
CHEMBL649,P23975,NADOLOL,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428744,DTCC00154988,2057650,46191
CHEMBL649,P23975,NADOLOL,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7428745,DTCC00154988,2057650,46191
CHEMBL65,P23975,CAMPTOTHECIN,VSJKWCGYPAHWDS-FQEVSTJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7266311,DTCC00136347,51451,46191
CHEMBL65,P23975,CAMPTOTHECIN,VSJKWCGYPAHWDS-FQEVSTJZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7266312,DTCC00136347,51451,46191
CHEMBL650,P23975,METHYLPREDNISOLONE,VHRSUDSXCMQTMA-PJHHCJLFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7434639,DTCC00154993,1447885,46191
CHEMBL650,P23975,METHYLPREDNISOLONE,VHRSUDSXCMQTMA-PJHHCJLFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7434640,DTCC00154993,1447885,46191
CHEMBL653,P23975,NIZATIDINE,SGXXNSQHWDMGGP-IZZDOVSWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373419,DTCC00155018,866021,46191
CHEMBL653,P23975,NIZATIDINE,SGXXNSQHWDMGGP-IZZDOVSWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373420,DTCC00155018,866021,46191
CHEMBL654,P23975,MIRTAZAPINE,RONZAEMNMFQXRA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,2900,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14738875,DTCC00155023,2106815,68566
CHEMBL654,P23975,MIRTAZAPINE,RONZAEMNMFQXRA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,4600,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14747115,DTCC00155023,2106815,68566
CHEMBL654,P23975,MIRTAZAPINE,RONZAEMNMFQXRA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14738876,DTCC00155023,2106815,68566
CHEMBL657,P23975,DIPHENHYDRAMINE,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3542,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7338328,DTCC00155038,1285873,46191
CHEMBL657,P23975,DIPHENHYDRAMINE,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3513,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7338329,DTCC00155038,1285873,46191
CHEMBL659,P23975,GALANTAMINE,ASUTZQLVASHGKV-JDFRZJQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335611,DTCC00155049,994592,46191
CHEMBL659,P23975,GALANTAMINE,ASUTZQLVASHGKV-JDFRZJQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335612,DTCC00155049,994592,46191
CHEMBL660,P23975,AMANTADINE,DKNWSYNQZKUICI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7284411,DTCC00155056,1285872,46191
CHEMBL660,P23975,AMANTADINE,DKNWSYNQZKUICI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7284412,DTCC00155056,1285872,46191
CHEMBL66068,P23975,,GPTFOAJWBIXTMY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15080991,KI,=,118,NM,,cell_based,,,,,,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,2004,14,9,"Bois F, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB, Tamagnan G",,142934,DTCT0023180,1294225,DTCC00217944,2012603,6830
CHEMBL661,P23975,ALPRAZOLAM,VREFGVBLTWBCJP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7300779,DTCC00155057,994588,46191
CHEMBL661,P23975,ALPRAZOLAM,VREFGVBLTWBCJP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7300780,DTCC00155057,994588,46191
CHEMBL66112,P23975,,WPCCYICQOQQNOQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,200,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,830609,DTCC00218868,711744,15898
CHEMBL66112,P23975,,WPCCYICQOQQNOQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,150,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,830606,DTCC00218868,711744,15898
CHEMBL666,P23975,FOSCARNET,ZJAOAACCNHFJAH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7312205,DTCC00155151,1765971,46191
CHEMBL666,P23975,FOSCARNET,ZJAOAACCNHFJAH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7314227,DTCC00155151,1765971,46191
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,1.41,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14742574,DTCC00155419,2108094,68566
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18588282,IC50,=,7.1,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488304,DTCT0023180,2775822,DTCC00155419,240379,30579
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18983139,IC50,=,9.1,NM,,,,,,,,,,,,,,Displacement of radiolabeled protriptyline from human NET,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494499,DTCT0023180,2584055,DTCC00155419,230548,32034
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18983139,KI,=,6.8,NM,,,,,,,,,,,,,,Displacement of radiolabeled protriptyline from human NET,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494499,DTCT0023180,2584081,DTCC00155419,230548,32034
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20875743,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of human aorepinephrine transporter,,"Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships.",Bioorg. Med. Chem.,2010,18,21,"Hayashi S, Nakata E, Morita A, Mizuno K, Yamamura K, Kato A, Ohashi K",,714771,DTCT0023180,5075479,DTCC00155419,230636,43117
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20945906,KD,=,1.4,NM,,,,,,,,,,,,,,Inhibition of human NET,,Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain.,J. Med. Chem.,2010,53,21,"Altenbach RJ, Black LA, Strakhova MI, Manelli AM, Carr TL, Marsh KC, Wetter JM, Wensink EJ, Hsieh GC, Honore P, Garrison TR, Brioni JD, Cowart MD",,685427,DTCT0023180,3584356,DTCC00155419,242113,41905
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21726069,KI,=,2.3,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NE transporter,,"Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.",J. Med. Chem.,2011,54,15,"Dolusic E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R",,761951,DTCT0023180,6053719,DTCC00155419,248956,45491
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,IC50,=,1.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484609,DTCC00155419,251078,48312
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22420844,KI,=,2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820352,DTCT0023180,10484651,DTCC00155419,251078,48312
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23466604,IC50,=,2.1,NM,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter by radioligand displacement assay,,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,2013,63,,"Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F",,966023,DTCT0023180,12471214,DTCC00155419,252750,54801
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23466604,KI,=,1.6,NM,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter by radioligand displacement assay,,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,2013,63,,"Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F",,966023,DTCT0023180,12471141,DTCC00155419,252750,54801
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23582449,IC50,=,2.5,NM,,,,,,,,,,,,,,Binding affinity to human nonepinephrine transporter by radioligand displacement assay,,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,2013,21,10,"Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M",,964156,DTCT0023180,12465298,DTCC00155419,252735,54817
CHEMBL668,P23975,PROTRIPTYLINE,BWPIARFWQZKAIA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26988801,IC50,=,2.8,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016,24,8,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559990,DTCT0023180,117186,DTCC00155419,224352,66408
CHEMBL67024,P23975,,AKCNZFOHJFSRSN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,170,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,822596,DTCC00219046,1934844,15898
CHEMBL67024,P23975,,AKCNZFOHJFSRSN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,79,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,822593,DTCC00219046,1934844,15898
CHEMBL67078,P23975,,FDTFUBJUWHYSGU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,48,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,852603,DTCC00219047,1261211,15898
CHEMBL67078,P23975,,FDTFUBJUWHYSGU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,41,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,852600,DTCC00219047,1261211,15898
CHEMBL672,P23975,FENOFIBRATE,YMTINGFKWWXKFG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,21408,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7333026,DTCC01738591,1220276,46191
CHEMBL672,P23975,FENOFIBRATE,YMTINGFKWWXKFG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,21231,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7333027,DTCC01738591,1220276,46191
CHEMBL67203,P23975,,IQRFNUMAKGJEQR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,97,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,841343,DTCC00218429,1552641,15898
CHEMBL67203,P23975,,IQRFNUMAKGJEQR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,23,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,841340,DTCC00218429,1552641,15898
CHEMBL6731,P23975,TENAMFETAMINE,NGBBVGZWCFBOGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19717215,IC50,=,266,NM,,,,,,,,,,,,,,Inhibition of human noradrenaline transporter,,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,2009,44,12,"Cloonan SM, Keating JJ, Butler SG, Knox AJ, Jørgensen AM, Peters GH, Rai D, Corrigan D, Lloyd DG, Williams DC, Meegan MJ",,622530,DTCT0023180,3256938,DTCC00132691,2069747,37648
CHEMBL6731,P23975,TENAMFETAMINE,NGBBVGZWCFBOGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20466553,IC50,=,266,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines.",Bioorg. Med. Chem.,2010,18,11,"Cloonan SM, Keating JJ, Corrigan D, O'Brien JE, Kavanagh PV, Williams DC, Meegan MJ",,639476,DTCT0023180,3376850,DTCC00132691,2081710,39293
CHEMBL6731,P23975,TENAMFETAMINE,NGBBVGZWCFBOGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,IC50,=,3162.28,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465489,DTCC00132691,2092484,54821
CHEMBL6731,P23975,TENAMFETAMINE,NGBBVGZWCFBOGO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445,KI,=,704,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140,DTCT0023180,12465488,DTCC00132691,2092484,54821
CHEMBL67387,P23975,,XUBVUMLIQBPHGD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15080991,KI,=,1039,NM,,cell_based,,,,,,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,2004,14,9,"Bois F, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB, Tamagnan G",,142934,DTCT0023180,1310205,DTCC00218763,1240096,6830
CHEMBL679,P23975,EPINEPHRINE,UCTWMZQNUQWSLP-VIFPVBQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7309049,DTCC00156188,1512808,46191
CHEMBL679,P23975,EPINEPHRINE,UCTWMZQNUQWSLP-VIFPVBQESA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7309050,DTCC00156188,1512808,46191
CHEMBL683,P23975,CLOFIBRIC ACID,TXCGAZHTZHNUAI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7358687,DTCC00156551,1894964,46191
CHEMBL683,P23975,CLOFIBRIC ACID,TXCGAZHTZHNUAI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7358688,DTCC00156551,1894964,46191
CHEMBL685,P23975,MEBENDAZOLE,OPXLLQIJSORQAM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423495,DTCC00156769,800580,46191
CHEMBL685,P23975,MEBENDAZOLE,OPXLLQIJSORQAM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423496,DTCC00156769,800580,46191
CHEMBL686,P23975,MEFENAMIC ACID,HYYBABOKPJLUIN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406397,DTCC00157071,1416034,46191
CHEMBL686,P23975,MEFENAMIC ACID,HYYBABOKPJLUIN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406398,DTCC00157071,1416034,46191
CHEMBL689,P23975,MANNITOL,FBPFZTCFMRRESA-KVTDHHQDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7436212,DTCC00157212,1960078,46191
CHEMBL689,P23975,MANNITOL,FBPFZTCFMRRESA-KVTDHHQDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7436213,DTCC00157212,1960078,46191
CHEMBL691,P23975,ETHINYL ESTRADIOL,BFPYWIDHMRZLRN-SLHNCBLASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,959,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7332777,DTCC00158050,2089747,46191
CHEMBL691,P23975,ETHINYL ESTRADIOL,BFPYWIDHMRZLRN-SLHNCBLASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,951,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7332778,DTCC00158050,2089747,46191
CHEMBL69380,P23975,,XVRWPBKYLFMIHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,IC50,=,350,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140880,DTCT0023180,853853,DTCC00218839,291085,15898
CHEMBL69380,P23975,,XVRWPBKYLFMIHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10649976,KI,=,110,NM,,,,,,,,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,2000,43,2,"Choi SW, Elmaleh DR, Hanson RN, Fischman AJ",,140881,DTCT0023180,853850,DTCC00218839,291085,15898
CHEMBL695,P23975,TRIMETHADIONE,IRYJRGCIQBGHIV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444566,DTCC00158510,1830695,46191
CHEMBL695,P23975,TRIMETHADIONE,IRYJRGCIQBGHIV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444567,DTCC00158510,1830695,46191
CHEMBL696,P23975,ETHOSUXIMIDE,HAPOVYFOVVWLRS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7307204,DTCC00158516,88627,46191
CHEMBL696,P23975,ETHOSUXIMIDE,HAPOVYFOVVWLRS-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7307205,DTCC00158516,88627,46191
CHEMBL6966,P23975,VERAPAMIL,SGTNSNPWRIOYBX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7452246,DTCC00133226,51515,46191
CHEMBL6966,P23975,VERAPAMIL,SGTNSNPWRIOYBX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7452247,DTCC00133226,51515,46191
CHEMBL698,P23975,TETRACAINE,GKCBAIGFKIBETG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485219,DTCC00158693,866024,46191
CHEMBL698,P23975,TETRACAINE,GKCBAIGFKIBETG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485220,DTCC00158693,866024,46191
CHEMBL7002,P23975,CIGLITAZONE,YZFWTZACSRHJQD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2220,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7343353,DTCC00133474,413970,46191
CHEMBL7002,P23975,CIGLITAZONE,YZFWTZACSRHJQD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2201,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7343354,DTCC00133474,413970,46191
CHEMBL701,P23975,BACLOFEN,KPYSYYIEGFHWSV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7259602,DTCC00159319,1318438,46191
CHEMBL701,P23975,BACLOFEN,KPYSYYIEGFHWSV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7259603,DTCC00159319,1318438,46191
CHEMBL702,P23975,PIPERACILLIN,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398092,DTCC00159449,962449,46191
CHEMBL702,P23975,PIPERACILLIN,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7398093,DTCC00159449,962449,46191
CHEMBL70586,P23975,SPIRADOLINE,NYKCGQQJNVPOLU-ONTIZHBOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7484494,DTCC00226650,1318446,46191
CHEMBL70586,P23975,SPIRADOLINE,NYKCGQQJNVPOLU-ONTIZHBOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7484495,DTCC00226650,1318446,46191
CHEMBL707,P23975,DOXAZOSIN,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7342824,DTCC00159683,1992804,46191
CHEMBL707,P23975,DOXAZOSIN,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7342825,DTCC00159683,1992804,46191
CHEMBL70927,P23975,DEFERIPRONE,TZXKOCQBRNJULO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7348584,DTCC00224426,348396,46191
CHEMBL70927,P23975,DEFERIPRONE,TZXKOCQBRNJULO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7348585,DTCC00224426,348396,46191
CHEMBL71,P23975,CHLORPROMAZINE,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,19,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366683,DTCC00137262,51456,46191
CHEMBL71,P23975,CHLORPROMAZINE,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,19,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7366684,DTCC00137262,51456,46191
CHEMBL710,P23975,FINASTERIDE,DBEPLOCGEIEOCV-WSBQPABSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318179,DTCC00159940,348402,46191
CHEMBL710,P23975,FINASTERIDE,DBEPLOCGEIEOCV-WSBQPABSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7318180,DTCC00159940,348402,46191
CHEMBL711,P23975,PHENINDIONE,NFBAXHOPROOJAW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376411,DTCC00159969,185556,46191
CHEMBL711,P23975,PHENINDIONE,NFBAXHOPROOJAW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376412,DTCC00159969,185556,46191
CHEMBL712,P23975,ANISINDIONE,XRCFXMGQEVUZFC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7274872,DTCC00160027,574619,46191
CHEMBL712,P23975,ANISINDIONE,XRCFXMGQEVUZFC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7274873,DTCC00160027,574619,46191
CHEMBL714,P23975,ALBUTEROL,NDAUXUAQIAJITI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486112,DTCC00160256,962451,46191
CHEMBL714,P23975,ALBUTEROL,NDAUXUAQIAJITI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7486113,DTCC00160256,962451,46191
CHEMBL7143,P23975,,ACEHBQPPDDGCGZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10715164,KI,=,6380,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards human NET (norepinephrine) transporter,,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,2000,43,5,"Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK",,140882,DTCT0023180,866409,DTCC00133805,485122,16105
CHEMBL715,P23975,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393050,DTCC00160346,1512814,46191
CHEMBL715,P23975,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7393051,DTCC00160346,1512814,46191
CHEMBL716,P23975,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7400900,DTCC00160380,1734062,46191
CHEMBL716,P23975,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7400901,DTCC00160380,1734062,46191
CHEMBL717,P23975,MEDROXYPROGESTERONE ACETATE,PSGAAPLEWMOORI-PEINSRQWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7432078,DTCC00160710,1188069,46191
CHEMBL717,P23975,MEDROXYPROGESTERONE ACETATE,PSGAAPLEWMOORI-PEINSRQWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7436311,DTCC00160710,1188070,46191
CHEMBL717,P23975,MEDROXYPROGESTERONE ACETATE,PSGAAPLEWMOORI-PEINSRQWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7432079,DTCC00160710,1188069,46191
CHEMBL717,P23975,MEDROXYPROGESTERONE ACETATE,PSGAAPLEWMOORI-PEINSRQWSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7436312,DTCC00160710,1188070,46191
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8496700,ACTIVITY,=,87,%,,,,,,,,,,,,,,Displacement of [3H]DMI from norepinephrine transporter assessed as specific binding relative to total binding,,The role of receptor binding in drug discovery.,J. Nat. Prod.,1993,56,4,"Sweetnam PM, Caldwell L, Lancaster J, Bauer C, McMillan B, Kinnier WJ, Price CH",,486225,DTCT0023180,2642478,DTCC00137288,1115064,27415
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8496700,KI,=,580,NM,,,,,,,,,,,,,,Displacement of [3H]DMI from norepinephrine transporter,,The role of receptor binding in drug discovery.,J. Nat. Prod.,1993,56,4,"Sweetnam PM, Caldwell L, Lancaster J, Bauer C, McMillan B, Kinnier WJ, Price CH",,486188,DTCT0023180,2642477,DTCC00137288,1115064,27415
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,0.63,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715277,DTCC00137288,2099998,68466
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,3.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715246,DTCC00137288,2099998,68466
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,0.83,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715278,DTCC00137288,2099983,68566
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10411589,KI,=,8.54,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715219,DTCC00137288,2099987,69057
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845,KI,=,3.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715228,DTCC00137288,2099985,68736
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14573386,KI,=,3.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715224,DTCC00137288,2099984,69056
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16675639,KI,=,2.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715270,DTCC00137288,2100016,69000
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16675639,KI,=,3.9,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715222,DTCC00137288,2100016,69000
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16675639,KI,=,4.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715221,DTCC00137288,2100016,69000
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16989524,IC50,=,0.93,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane,,Antidepressant principles of the roots of Polygala tenuifolia.,J. Nat. Prod.,2006,69,9,"Cheng MC, Li CY, Ko HC, Ko FN, Lin YL, Wu TS",,526495,DTCT0023180,2737610,DTCC00137288,1114709,29650
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17123820,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity at NET,,Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.,Bioorg. Med. Chem.,2007,15,2,"Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C",,432854,DTCT0023180,2059434,DTCC00137288,1102696,22425
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17428804,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE uptake at human wild type NET expressed in african green monkey COS1 cells after 48 hrs,Active,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,2007,282,24,"Paczkowski FA, Sharpe IA, Dutertre S, Lewis RJ",,505500,DTCT0023180,2401654,DTCC00137288,1115315,29252
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138,IC50,=,4.2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007,51,11,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923,DTCT0023180,2718429,DTCC00137288,1103470,34126
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657231,DTCC00137288,1103354,30478
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,2.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657289,DTCC00137288,1103354,30478
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916,IC50,=,3.9,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,18,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516,DTCT0023180,2686097,DTCC00137288,1115150,31294
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,23,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178,DTCT0023180,2789686,DTCC00137288,1103398,31613
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244,DTCT0023180,2725363,DTCC00137288,1103637,34196
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009,19,17,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114,DTCT0023180,3098197,DTCC00137288,1115976,36091
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526,DTCT0023180,3046006,DTCC00137288,1111217,35959
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225,DTCT0023180,2901994,DTCC00137288,1115594,35305
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525,KI,=,2.1,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009,52,18,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583226,DTCT0023180,2901995,DTCC00137288,1115594,35305
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19791802,KI,=,5.11,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,2009,52,19,"White JD, Juniku R, Huang K, Yang J, Wong DT",,582829,DTCT0023180,2903522,DTCC00137288,1104182,35322
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247,KI,=,0.6,NM,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake at NET,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009,17,22,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603447,DTCT0023180,3155572,DTCC00137288,1116118,36729
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,3.3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611008,DTCT0023180,3217339,DTCC00137288,1116226,37100
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010,53,5,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007,DTCT0023180,3217338,DTCC00137288,1116226,37100
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,9,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360,DTCT0023180,3324054,DTCC00137288,1116418,38843
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,KI,=,2.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327,DTCT0023180,3342618,DTCC00137288,1099249,39069
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211,KI,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010,53,11,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326,DTCT0023180,3342617,DTCC00137288,1099249,39069
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20945906,KD,=,0.83,NM,,,,,,,,,,,,,,Inhibition of human NET,,Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain.,J. Med. Chem.,2010,53,21,"Altenbach RJ, Black LA, Strakhova MI, Manelli AM, Carr TL, Marsh KC, Wetter JM, Wensink EJ, Hsieh GC, Honore P, Garrison TR, Brioni JD, Cowart MD",,685427,DTCT0023180,3584355,DTCC00137288,1116771,41905
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841,DTCT0023180,6093895,DTCC00137288,1123629,45987
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421,KI,=,2.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011,54,19,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842,DTCT0023180,6093882,DTCC00137288,1123629,45987
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23403082,IC50,=,0.93,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013,23,6,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965300,DTCT0023180,12469488,DTCC00137288,1127139,54795
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23403082,INHIBITION,=,49,%,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells at 10 uM after 3 hrs relative to control,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013,23,6,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965628,DTCT0023180,12469556,DTCC00137288,1127139,54795
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23403082,KI,=,0.92,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013,23,6,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965300,DTCT0023180,12469422,DTCC00137288,1127139,54795
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181,IC50,=,1.5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,20,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926,DTCT0023180,12598060,DTCC00137288,1127328,55968
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159,KI,=,1.1,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696,DTCT0023180,12984039,DTCC00137288,1127527,56928
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159,KI,=,1.15,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696,DTCT0023180,12984005,DTCC00137288,1127527,56928
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7352886,DTCC00137288,1124448,46191
CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7352887,DTCC00137288,1124448,46191
CHEMBL720,P23975,BENZYL ALCOHOL,WVDDGKGOMKODPV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7278488,DTCC00161432,1641844,46191
CHEMBL720,P23975,BENZYL ALCOHOL,WVDDGKGOMKODPV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7278489,DTCC00161432,1641844,46191
CHEMBL723,P23975,CARVEDILOL,OGHNVEJMJSYVRP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,538,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370914,DTCC00162415,993764,46191
CHEMBL723,P23975,CARVEDILOL,OGHNVEJMJSYVRP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,533,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370915,DTCC00162415,993764,46191
CHEMBL726,P23975,FLUPHENAZINE,PLDUPXSUYLZYBN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1962,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7326934,DTCC00162562,1734056,46191
CHEMBL726,P23975,FLUPHENAZINE,PLDUPXSUYLZYBN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1946,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7326935,DTCC00162562,1734056,46191
CHEMBL727,P23975,THIOGUANINE,WYWHKKSPHMUBEB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455065,DTCC00162578,120978,46191
CHEMBL727,P23975,THIOGUANINE,WYWHKKSPHMUBEB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455066,DTCC00162578,120978,46191
CHEMBL728,P23975,PROCHLORPERAZINE,WIKYUJGCLQQFNW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,400,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402828,DTCC00162902,1512815,46191
CHEMBL728,P23975,PROCHLORPERAZINE,WIKYUJGCLQQFNW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,396,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402829,DTCC00162902,1512815,46191
CHEMBL7318,P23975,,VSGPGYWZVPDDSK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10715164,KI,>,10000,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards human NET(norepinephrine) transporter,,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,2000,43,5,"Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK",,140883,DTCT0023180,858863,DTCC00133862,581587,16105
CHEMBL741,P23975,LAMOTRIGINE,PYZRQGJRPPTADH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410003,DTCC00164108,1512811,46191
CHEMBL741,P23975,LAMOTRIGINE,PYZRQGJRPPTADH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7410004,DTCC00164108,1512811,46191
CHEMBL742,P23975,KETAMINE,YQEZLKZALYSWHR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7422736,DTCC00164207,1862716,46191
CHEMBL742,P23975,KETAMINE,YQEZLKZALYSWHR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7422737,DTCC00164207,1862716,46191
CHEMBL744,P23975,RILUZOLE,FTALBRSUTCGOEG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1733,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485885,DTCC00164269,348405,46191
CHEMBL744,P23975,RILUZOLE,FTALBRSUTCGOEG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1718,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7485886,DTCC00164269,348405,46191
CHEMBL748,P23975,PRALIDOXIME CHLORIDE,HIGSLXSBYYMVKI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402563,DTCC00164888,1798416,46191
CHEMBL748,P23975,PRALIDOXIME CHLORIDE,HIGSLXSBYYMVKI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7402564,DTCC00164888,1798416,46191
CHEMBL75435,P23975,DEXKETOPROFEN,DKYWVDODHFEZIM-NSHDSACASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7348666,DTCC00229147,1447880,46191
CHEMBL75435,P23975,DEXKETOPROFEN,DKYWVDODHFEZIM-NSHDSACASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7348667,DTCC00229147,1447880,46191
CHEMBL7568,P23975,QUINACRINE,GPKJTRJOBQGKQK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2896,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7403210,DTCC00134204,2089751,46191
CHEMBL7568,P23975,QUINACRINE,GPKJTRJOBQGKQK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2872,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7403211,DTCC00134204,2089751,46191
CHEMBL757,P23975,NANDROLONE,NPAGDVCDWIYMMC-IZPLOLCNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386029,DTCC00166843,930082,46191
CHEMBL757,P23975,NANDROLONE,NPAGDVCDWIYMMC-IZPLOLCNSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7386030,DTCC00166843,930082,46191
CHEMBL75880,P23975,PERHEXILINE,CYXKNKQEMFBLER-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3294.2,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389303,DTCC00230384,1124453,46191
CHEMBL75880,P23975,PERHEXILINE,CYXKNKQEMFBLER-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3267,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389304,DTCC00230384,1124453,46191
CHEMBL762,P23975,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373823,DTCC00167236,2025641,46191
CHEMBL762,P23975,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7373824,DTCC00167236,2025641,46191
CHEMBL765,P23975,GUANETHIDINE,ACGDKVXYNVEAGU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7316994,DTCC00167701,2089750,46191
CHEMBL765,P23975,GUANETHIDINE,ACGDKVXYNVEAGU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7316995,DTCC00167701,2089750,46191
CHEMBL768,P23975,ESMOLOL,AQNDDEOPVVGCPG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7307093,DTCC00167907,1253321,46191
CHEMBL768,P23975,ESMOLOL,AQNDDEOPVVGCPG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7307094,DTCC00167907,1253321,46191
CHEMBL76904,P23975,TYRPHOSTIN 23,VTJXFTPMFYAJJU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444684,DTCC00233094,1765983,46191
CHEMBL76904,P23975,TYRPHOSTIN 23,VTJXFTPMFYAJJU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7444685,DTCC00233094,1765983,46191
CHEMBL772,P23975,RESERPINE,QEVHRUUCFGRFIF-MDEJGZGSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459813,DTCC00168399,1992810,46191
CHEMBL772,P23975,RESERPINE,QEVHRUUCFGRFIF-MDEJGZGSSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459814,DTCC00168399,1992810,46191
CHEMBL773,P23975,GLYCINE,DHMQDGOQFOQNFH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304002,DTCC00168448,1544900,46191
CHEMBL773,P23975,GLYCINE,DHMQDGOQFOQNFH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7304003,DTCC00168448,1544900,46191
CHEMBL77675,P23975,"N,N'-DIPHENYL-GUANIDINE",OWRCNXZUPFZXOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1152,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7289264,DTCC01741294,1155675,46191
CHEMBL77675,P23975,"N,N'-DIPHENYL-GUANIDINE",OWRCNXZUPFZXOS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1143,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7289265,DTCC01741294,1155675,46191
CHEMBL781,P23975,MAZINDOL,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,0.46,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14714121,DTCC00170363,2099511,68466
CHEMBL781,P23975,MAZINDOL,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,1.93,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14714125,DTCC00170363,2099511,68466
CHEMBL781,P23975,MAZINDOL,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,IC50,=,4.9,NM,,cell_based,,,,,,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145000,DTCT0023180,820001,DTCC00170363,1306485,16914
CHEMBL781,P23975,MAZINDOL,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213053,KI,=,18,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA",,145004,DTCT0023180,819998,DTCC00170363,1306485,16914
CHEMBL781,P23975,MAZINDOL,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12213054,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,2002,45,19,"Houlihan WJ, Ahmad UF, Koletar J, Kelly L, Brand L, Kopajtic TA",,142614,DTCT0023180,857603,DTCC00170363,1306492,16915
CHEMBL783,P23975,NATEGLINIDE,OELFLUMRDSZNSF-BRWVUGGUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394639,DTCC00170640,1512813,46191
CHEMBL783,P23975,NATEGLINIDE,OELFLUMRDSZNSF-BRWVUGGUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7394640,DTCC00170640,1512813,46191
CHEMBL787,P23975,MONTELUKAST,UCHDWCPVSPXUMX-TZIWLTJVSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2689,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7420070,DTCC00171266,1798413,46191
CHEMBL787,P23975,MONTELUKAST,UCHDWCPVSPXUMX-TZIWLTJVSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2667,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7420071,DTCC00171266,1798413,46191
CHEMBL788,P23975,IDOXURIDINE,XQFRJNBWHJMXHO-RRKCRQDMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7334275,DTCC00171444,510301,46191
CHEMBL788,P23975,IDOXURIDINE,XQFRJNBWHJMXHO-RRKCRQDMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7334276,DTCC00171444,510301,46191
CHEMBL79,P23975,LIDOCAINE,NNJVILVZKWQKPM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435885,DTCC00137707,1609550,46191
CHEMBL79,P23975,LIDOCAINE,NNJVILVZKWQKPM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435886,DTCC00137707,1609550,46191
CHEMBL796,P23975,METHYLPHENIDATE,DUGOZIWVEXMGBE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,IC50,=,61,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423472,DTCT0023180,2005852,DTCC00173208,1663581,21696
CHEMBL796,P23975,METHYLPHENIDATE,DUGOZIWVEXMGBE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17228864,KI,=,660,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,2007,50,2,"Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A",,423471,DTCT0023180,2005849,DTCC00173208,1663581,21696
CHEMBL796,P23975,METHYLPHENIDATE,DUGOZIWVEXMGBE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25050161,KI,=,340,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,,ACS Med. Chem. Lett.,2014,5,7,,,1450412,DTCT0023180,13907729,DTCC00173208,1678133,61025
CHEMBL799,P23975,CILOSTAZOL,RRGUKTPIGVIEKM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351892,DTCC00173670,2057647,46191
CHEMBL799,P23975,CILOSTAZOL,RRGUKTPIGVIEKM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7351893,DTCC00173670,2057647,46191
CHEMBL8,P23975,CIPROFLOXACIN,MYSWGUAQZAJSOK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7339139,DTCC00103423,51457,46191
CHEMBL8,P23975,CIPROFLOXACIN,MYSWGUAQZAJSOK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7339140,DTCC00103423,51457,46191
CHEMBL80,P23975,NALOXONE,UZHSEJADLWPNLE-GRGSLBFTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7413833,DTCC00137855,1155683,46191
CHEMBL80,P23975,NALOXONE,UZHSEJADLWPNLE-GRGSLBFTSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7413834,DTCC00137855,1155683,46191
CHEMBL802,P23975,MINOXIDIL,ZFMITUMMTDLWHR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7426227,DTCC00174151,1641849,46191
CHEMBL802,P23975,MINOXIDIL,ZFMITUMMTDLWHR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7426228,DTCC00174151,1641849,46191
CHEMBL803,P23975,CYTARABINE,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7346219,DTCC00174264,51462,46191
CHEMBL803,P23975,CYTARABINE,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7346220,DTCC00174264,51462,46191
CHEMBL806,P23975,FLUTAMIDE,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305617,DTCC00175006,1253324,46191
CHEMBL806,P23975,FLUTAMIDE,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7305618,DTCC00175006,1253324,46191
CHEMBL808,P23975,ECONAZOLE,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2435,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308962,DTCC00175675,1764791,46191
CHEMBL808,P23975,ECONAZOLE,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2415,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308963,DTCC00175675,1764791,46191
CHEMBL809,P23975,SERTRALINE,VGKDLMBJGBXTGI-SJCJKPOMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604,KD,=,420,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998,8,5,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806,DTCT0023180,358946,DTCC00176302,1404415,3008
CHEMBL809,P23975,SERTRALINE,VGKDLMBJGBXTGI-SJCJKPOMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16314097,IC50,=,825,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,2006,16,5,"Middleton DS, Andrews M, Glossop P, Gymer G, Jessiman A, Johnson PS, Mackenny M, Pitcher MJ, Rooker T, Stobie A, Tang K, Morgan P",,339940,DTCT0023180,1906153,DTCC00176302,1393676,20502
CHEMBL809,P23975,SERTRALINE,VGKDLMBJGBXTGI-SJCJKPOMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21093273,IC50,=,825,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,2011,19,1,"Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA",,699305,DTCT0023180,5038931,DTCC00176302,1413946,42566
CHEMBL809,P23975,SERTRALINE,VGKDLMBJGBXTGI-SJCJKPOMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,984.8,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469061,DTCC00176302,1414866,46191
CHEMBL809,P23975,SERTRALINE,VGKDLMBJGBXTGI-SJCJKPOMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,976.6,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469062,DTCC00176302,1414866,46191
CHEMBL81,P23975,RALOXIFENE,GZUITABIAKMVPG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,282,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477228,DTCC01738582,1960080,46191
CHEMBL81,P23975,RALOXIFENE,GZUITABIAKMVPG-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,280,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7477229,DTCC01738582,1960080,46191
CHEMBL814,P23975,FLUVOXAMINE,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,2950,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14712827,DTCC00177242,2098840,68466
CHEMBL814,P23975,FLUVOXAMINE,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,4743,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14712829,DTCC00177242,2098840,68466
CHEMBL814,P23975,FLUVOXAMINE,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,1300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14712833,DTCC00177242,2098842,68566
CHEMBL814,P23975,FLUVOXAMINE,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,1119,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14712821,DTCC00177242,2098836,68918
CHEMBL814,P23975,FLUVOXAMINE,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544,KI,=,1427,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14712826,DTCC00177242,2098836,68918
CHEMBL817,P23975,TOLAZAMIDE,OUDSBRTVNLOZBN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7466185,DTCC00178466,1285883,46191
CHEMBL817,P23975,TOLAZAMIDE,OUDSBRTVNLOZBN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7466186,DTCC00178466,1285883,46191
CHEMBL818,P23975,IOBENGUANE,PDWUPXJEEYOOTR-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24814532,DRUG UPTAKE,,,,,cell_based,,,,,,,,,,,,Cellular uptake in human SK-N-SH cells assessed as noradrenaline transporter-mediated uptake at 1 x 10'-4 M after 15 mins by [3H]-noradrenaline uptake assay,Active,Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.,Bioorg. Med. Chem. Lett.,2014,24,12,"Hampel T, Bruns M, Bayer M, Handgretinger R, Bruchelt G, Brückner R",,1362494,DTCT0023180,13756321,DTCC00178685,287055,59387
CHEMBL81977,P23975,3-AMINOBENZAMIDE,GSCPDZHWVNUUFI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7286700,DTCC00237769,1798404,46191
CHEMBL81977,P23975,3-AMINOBENZAMIDE,GSCPDZHWVNUUFI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7286701,DTCC00237769,1798404,46191
CHEMBL820,P23975,BUSULFAN,COVZYZSDYWQREU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24814532,DRUG UPTAKE,,,,,cell_based,,,,,,,,,,,,Cellular uptake in human SK-N-SH cells assessed as noradrenaline transporter-mediated uptake at 1 x 10'-4 M after 15 mins by [3H]-noradrenaline uptake assay,Not Active,Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.,Bioorg. Med. Chem. Lett.,2014,24,12,"Hampel T, Bruns M, Bayer M, Handgretinger R, Bruchelt G, Brückner R",,1362494,DTCT0023180,13756324,DTCC00178870,902224,59387
CHEMBL820,P23975,BUSULFAN,COVZYZSDYWQREU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7266210,DTCC00178870,898285,46191
CHEMBL820,P23975,BUSULFAN,COVZYZSDYWQREU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7266211,DTCC00178870,898285,46191
CHEMBL822,P23975,TERBINAFINE,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,4129.5,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7463597,DTCC00179021,833164,46191
CHEMBL822,P23975,TERBINAFINE,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4095.4,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7463598,DTCC00179021,833164,46191
CHEMBL826,P23975,ENOXACIN,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325995,DTCC00179302,1219085,46191
CHEMBL826,P23975,ENOXACIN,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7325996,DTCC00179302,1219085,46191
CHEMBL828,P23975,PHENOTHIAZINE,WJFKNYWRSNBZNX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,461,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389433,DTCC00179549,1734060,46191
CHEMBL828,P23975,PHENOTHIAZINE,WJFKNYWRSNBZNX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,457,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7389434,DTCC00179549,1734060,46191
CHEMBL83,P23975,TAMOXIFEN,NKANXQFJJICGDU-QPLCGJKRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1472,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7461163,DTCC00137911,51510,46191
CHEMBL83,P23975,TAMOXIFEN,NKANXQFJJICGDU-QPLCGJKRSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1459,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7461164,DTCC00137911,51510,46191
CHEMBL832,P23975,SULFINPYRAZONE,MBGGBVCUIVRRBF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482762,DTCC00181706,1124456,46191
CHEMBL832,P23975,SULFINPYRAZONE,MBGGBVCUIVRRBF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482763,DTCC00181706,1124456,46191
CHEMBL833,P23975,TICLOPIDINE,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472472,DTCC00181784,1285882,46191
CHEMBL833,P23975,TICLOPIDINE,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7472473,DTCC00181784,1285882,46191
CHEMBL83668,P23975,TOLNAFTATE,FUSNMLFNXJSCDI-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7474916,DTCC00242570,1124458,46191
CHEMBL83668,P23975,TOLNAFTATE,FUSNMLFNXJSCDI-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7474917,DTCC00242570,1124458,46191
CHEMBL83729,P23975,WIN-35066-2,OMBOXYLBBHNWHL-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,IC50,=,920,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043088,DTCC01741416,110475,22167
CHEMBL83729,P23975,WIN-35066-2,OMBOXYLBBHNWHL-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15566309,KI,=,550,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,2004,47,25,"Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL",,429832,DTCT0023180,2043089,DTCC01741416,110475,22167
CHEMBL83729,P23975,WIN-35066-2,OMBOXYLBBHNWHL-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,IC50,=,920,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050431,DTCC01741416,98988,22251
CHEMBL83729,P23975,WIN-35066-2,OMBOXYLBBHNWHL-VOFREWHGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16279803,KI,=,550,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET,,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,2005,48,23,"Kotturi SV, Jiang S, Chang AC, Abraham P, Navarro HA, Kuhar MJ, Carroll FI",,431029,DTCT0023180,2050432,DTCC01741416,98988,22251
CHEMBL838,P23975,BENAZEPRIL,XPCFTKFZXHTYIP-PMACEKPBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7273843,DTCC00182957,574621,46191
CHEMBL838,P23975,BENAZEPRIL,XPCFTKFZXHTYIP-PMACEKPBSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7273844,DTCC00182957,574621,46191
CHEMBL84,P23975,TOPOTECAN,UCFGDBYHRUNTLO-QHCPKHFHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7483563,DTCC00138393,315672,46191
CHEMBL84,P23975,TOPOTECAN,UCFGDBYHRUNTLO-QHCPKHFHSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7483564,DTCC00138393,315672,46191
CHEMBL841,P23975,LOPERAMIDE,RDOIQAHITMMDAJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431749,DTCC00183381,1092343,46191
CHEMBL841,P23975,LOPERAMIDE,RDOIQAHITMMDAJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7431750,DTCC00183381,1092343,46191
CHEMBL84158,P23975,TIAPRIDE,JTVPZMFULRWINT-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7463750,DTCC00241707,1734065,46191
CHEMBL84158,P23975,TIAPRIDE,JTVPZMFULRWINT-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7463751,DTCC00241707,1734065,46191
CHEMBL844,P23975,BRIMONIDINE,XYLJNLCSTIOKRM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7258667,DTCC00183812,2057645,46191
CHEMBL844,P23975,BRIMONIDINE,XYLJNLCSTIOKRM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7258668,DTCC00183812,2057645,46191
CHEMBL85,P23975,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464362,DTCC00138594,1383782,46191
CHEMBL85,P23975,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7464363,DTCC00138594,1383782,46191
CHEMBL850,P23975,SPARFLOXACIN,DZZWHBIBMUVIIW-DTORHVGOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7471499,DTCC00185794,1124454,46191
CHEMBL850,P23975,SPARFLOXACIN,DZZWHBIBMUVIIW-DTORHVGOSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7471500,DTCC00185794,1124454,46191
CHEMBL852,P23975,MELPHALAN,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423616,DTCC00185853,249079,46191
CHEMBL852,P23975,MELPHALAN,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7423617,DTCC00185853,249079,46191
CHEMBL856,P23975,PRIMIDONE,DQMZLTXERSFNPB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376886,DTCC00186106,1674147,46191
CHEMBL856,P23975,PRIMIDONE,DQMZLTXERSFNPB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376887,DTCC00186106,1674147,46191
CHEMBL85728,P23975,"4,4'-METHYLENEDIANILINE",YBRVSVVVWCFQMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7293363,DTCC00242937,1318436,46191
CHEMBL85728,P23975,"4,4'-METHYLENEDIANILINE",YBRVSVVVWCFQMG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7293364,DTCC00242937,1318436,46191
CHEMBL85882,P23975,,LVTUDYZTQRSARZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18847250,KI,=,4490,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxitine from NET,,"Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.",J. Med. Chem.,2008,51,21,"Runyon SP, Mosier PD, Roth BL, Glennon RA, Westkaemper RB",,537768,DTCT0023180,2680805,DTCC00246537,1906651,31436
CHEMBL86,P23975,METOCLOPRAMIDE,TTWJBBZEZQICBI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7408982,DTCC00138614,51488,46191
CHEMBL86,P23975,METOCLOPRAMIDE,TTWJBBZEZQICBI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7408983,DTCC00138614,51488,46191
CHEMBL862,P23975,GUANFACINE,INJOMKTZOLKMBF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321226,DTCC00186365,1351111,46191
CHEMBL862,P23975,GUANFACINE,INJOMKTZOLKMBF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7321227,DTCC00186365,1351111,46191
CHEMBL86304,P23975,MOCLOBEMIDE,YHXISWVBGDMDLQ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407118,DTCC00246764,833162,46191
CHEMBL86304,P23975,MOCLOBEMIDE,YHXISWVBGDMDLQ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7407119,DTCC00246764,833162,46191
CHEMBL865,P23975,VALDECOXIB,LNPDTQAFDNKSHK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2927,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453858,DTCC00187234,866025,46191
CHEMBL865,P23975,VALDECOXIB,LNPDTQAFDNKSHK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2903,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7453859,DTCC00187234,866025,46191
CHEMBL866,P23975,MYCOPHENOLIC ACID,HPNSFSBZBAHARI-RUDMXATFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7437120,DTCC00188298,120975,46191
CHEMBL866,P23975,MYCOPHENOLIC ACID,HPNSFSBZBAHARI-RUDMXATFSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7437121,DTCC00188298,120975,46191
CHEMBL86754,P23975,IODOQUINOL,UXZFQZANDVDGMM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7437301,DTCC00246886,1220278,46191
CHEMBL86754,P23975,IODOQUINOL,UXZFQZANDVDGMM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7437302,DTCC00246886,1220278,46191
CHEMBL86760,P23975,,WJPJNUGOFZCYAX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18847250,KI,=,845,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxitine from NET,,"Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.",J. Med. Chem.,2008,51,21,"Runyon SP, Mosier PD, Roth BL, Glennon RA, Westkaemper RB",,537768,DTCT0023180,2680809,DTCC00246563,1524324,31436
CHEMBL870,P23975,ALENDRONIC ACID,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7299153,DTCC00190086,800568,46191
CHEMBL870,P23975,ALENDRONIC ACID,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7299154,DTCC00190086,800568,46191
CHEMBL871,P23975,ETIDRONIC ACID,DBVJJBKOTRCVKF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7324284,DTCC00190087,542574,46191
CHEMBL871,P23975,ETIDRONIC ACID,DBVJJBKOTRCVKF-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7324285,DTCC00190087,542574,46191
CHEMBL87285,P23975,ANDROSTERONE,QGXBDMJGAMFCBF-HLUDHZFRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7286295,DTCC00245174,930075,46191
CHEMBL87285,P23975,ANDROSTERONE,QGXBDMJGAMFCBF-HLUDHZFRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7286296,DTCC00245174,930075,46191
CHEMBL877,P23975,TRANEXAMIC ACID,GYDJEQRTZSCIOI-LJGSYFOKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7457563,DTCC00192310,1544904,46191
CHEMBL877,P23975,TRANEXAMIC ACID,GYDJEQRTZSCIOI-LJGSYFOKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7457564,DTCC00192310,1544904,46191
CHEMBL87708,P23975,LOFEPRAMINE,SAPNXPWPAUFAJU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,5.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14710958,DTCC00246941,2098308,68566
CHEMBL878,P23975,METOLAZONE,AQCHWTWZEMGIFD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7413276,DTCC00192311,1253327,46191
CHEMBL878,P23975,METOLAZONE,AQCHWTWZEMGIFD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7413277,DTCC00192311,1253327,46191
CHEMBL88,P23975,CYCLOPHOSPHAMIDE,CMSMOCZEIVJLDB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7359034,DTCC00139205,994590,46191
CHEMBL88,P23975,CYCLOPHOSPHAMIDE,CMSMOCZEIVJLDB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7359035,DTCC00139205,994590,46191
CHEMBL880,P23975,FAMCICLOVIR,GGXKWVWZWMLJEH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7311655,DTCC00192933,444642,46191
CHEMBL880,P23975,FAMCICLOVIR,GGXKWVWZWMLJEH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7311656,DTCC00192933,444642,46191
CHEMBL888,P23975,GEMCITABINE,SDUQYLNIPVEERB-QPPQHZFASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322879,DTCC00194280,51473,46191
CHEMBL888,P23975,GEMCITABINE,SDUQYLNIPVEERB-QPPQHZFASA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7322880,DTCC00194280,51473,46191
CHEMBL891,P23975,CLOXACILLIN,LQOLIRLGBULYKD-JKIFEVAISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7358813,DTCC00194952,2089744,46191
CHEMBL891,P23975,CLOXACILLIN,LQOLIRLGBULYKD-JKIFEVAISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7358814,DTCC00194952,2089744,46191
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14710656,DTCC00195238,2098244,68566
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14710658,DTCC00195238,2098246,68736
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12723940,IC50,=,1450,NM,,,,,,,,,,,,,,Inhibition of Norepinephrine (NA) reuptake using cloned human transporter was determined,,2002 Medicinal Chemistry Division Award address: monoamine transporters and opioid receptors. Targets for addiction therapy.,J. Med. Chem.,2003,46,10,,,144967,DTCT0023180,1130412,DTCC00195238,775837,17278
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,IC50,=,443,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595700,DTCT0023180,3083994,DTCC00195238,791889,36341
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19821577,KI,=,6970,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,2009,52,21,"Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ",,595697,DTCT0023180,3105119,DTCC00195238,791889,36341
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20158204,IC50,=,1850,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,2010,53,5,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,610770,DTCT0023180,3207493,DTCC00195238,792033,37173
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20509659,IC50,=,1850,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,2010,53,12,"Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI",,641577,DTCT0023180,3392345,DTCC00195238,780721,39669
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21058665,IC50,=,1850,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,2010,53,23,"Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI",,760469,DTCT0023180,6049260,DTCC00195238,781530,45377
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7260374,DTCC00195238,800571,46191
CHEMBL894,P23975,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7260375,DTCC00195238,800571,46191
CHEMBL895,P23975,NALBUPHINE,NETZHAKZCGBWSS-CEDHKZHLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7437257,DTCC00195307,413972,46191
CHEMBL895,P23975,NALBUPHINE,NETZHAKZCGBWSS-CEDHKZHLSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7437258,DTCC00195307,413972,46191
CHEMBL897,P23975,PROBENECID,DBABZHXKTCFAPX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381220,DTCC00195516,1188073,46191
CHEMBL897,P23975,PROBENECID,DBABZHXKTCFAPX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381221,DTCC00195516,1188073,46191
CHEMBL898,P23975,DIFLUNISAL,HUPFGZXOMWLGNK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370438,DTCC00195664,477917,46191
CHEMBL898,P23975,DIFLUNISAL,HUPFGZXOMWLGNK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7370439,DTCC00195664,477917,46191
CHEMBL9,P23975,NORFLOXACIN,OGJPXUAPXNRGGI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7390696,DTCC00132409,51494,46191
CHEMBL9,P23975,NORFLOXACIN,OGJPXUAPXNRGGI-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7390697,DTCC00132409,51494,46191
CHEMBL900,P23975,ORPHENADRINE,QVYRGXJJSLMXQH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2666,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406014,DTCC00195771,217582,46191
CHEMBL900,P23975,ORPHENADRINE,QVYRGXJJSLMXQH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2643,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406015,DTCC00195771,217582,46191
CHEMBL902,P23975,FAMOTIDINE,XUFQPHANEAPEMJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7315934,DTCC00196201,1155680,46191
CHEMBL902,P23975,FAMOTIDINE,XUFQPHANEAPEMJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7315935,DTCC00196201,1155680,46191
CHEMBL90555,P23975,VINCRISTINE,OGWKCGZFUXNPDA-XQKSVPLYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441731,DTCC00249955,51516,46191
CHEMBL90555,P23975,VINCRISTINE,OGWKCGZFUXNPDA-XQKSVPLYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7441732,DTCC00249955,51516,46191
CHEMBL91,P23975,MICONAZOLE,BYBLEWFAAKGYCD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2939,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7413398,DTCC00139665,1317286,46191
CHEMBL91,P23975,MICONAZOLE,BYBLEWFAAKGYCD-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2915,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7413399,DTCC00139665,1317286,46191
CHEMBL914,P23975,FEXOFENADINE,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7313929,DTCC00198847,413971,46191
CHEMBL914,P23975,FEXOFENADINE,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7313930,DTCC00198847,413971,46191
CHEMBL917,P23975,FLOXURIDINE,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7296101,DTCC00199915,1609542,46191
CHEMBL917,P23975,FLOXURIDINE,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7296102,DTCC00199915,1609542,46191
CHEMBL918,P23975,PHENACEMIDE,XPFRXWCVYUEORT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7397871,DTCC00199924,1577008,46191
CHEMBL918,P23975,PHENACEMIDE,XPFRXWCVYUEORT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7397872,DTCC00199924,1577008,46191
CHEMBL923,P23975,RISEDRONIC ACID,IIDJRNMFWXDHID-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459950,DTCC00200598,1927022,46191
CHEMBL923,P23975,RISEDRONIC ACID,IIDJRNMFWXDHID-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7459951,DTCC00200598,1927022,46191
CHEMBL92401,P23975,IPRONIAZID,NYMGNSNKLVNMIA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14709333,DTCC00256735,2097964,68566
CHEMBL92401,P23975,IPRONIAZID,NYMGNSNKLVNMIA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7411708,DTCC00256735,1992806,46191
CHEMBL92401,P23975,IPRONIAZID,NYMGNSNKLVNMIA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7411709,DTCC00256735,1992806,46191
CHEMBL926,P23975,DOBUTAMINE,JRWZLRBJNMZMFE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,383,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7359810,DTCC00105095,1383776,46191
CHEMBL926,P23975,DOBUTAMINE,JRWZLRBJNMZMFE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,380,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7359811,DTCC00105095,1383776,46191
CHEMBL93,P23975,ZILEUTON,MWLSOWXNZPKENC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7447823,DTCC00139913,51518,46191
CHEMBL93,P23975,ZILEUTON,MWLSOWXNZPKENC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7447824,DTCC00139913,51518,46191
CHEMBL932,P23975,DIPYRIDAMOLE,IZEKFCXSFNUWAM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7346908,DTCC00202383,444640,46191
CHEMBL932,P23975,DIPYRIDAMOLE,IZEKFCXSFNUWAM-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7346909,DTCC00202383,444640,46191
CHEMBL934,P23975,METYRAPONE,FJLBFSROUSIWMA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7426197,DTCC00202598,1992807,46191
CHEMBL934,P23975,METYRAPONE,FJLBFSROUSIWMA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7426198,DTCC00202598,1992807,46191
CHEMBL936,P23975,DIPHENIDOL,OGAKLTJNUQRZJU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7342637,DTCC00202761,1416027,46191
CHEMBL936,P23975,DIPHENIDOL,OGAKLTJNUQRZJU-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7342638,DTCC00202761,1416027,46191
CHEMBL93645,P23975,ACECLOFENAC,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7293479,DTCC00256586,1285871,46191
CHEMBL93645,P23975,ACECLOFENAC,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7293480,DTCC00256586,1285871,46191
CHEMBL94,P23975,PHYSOSTIGMINE,PIJVFDBKTWXHHD-HIFRSBDPSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376523,DTCC00139956,1862717,46191
CHEMBL94,P23975,PHYSOSTIGMINE,PIJVFDBKTWXHHD-HIFRSBDPSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7376524,DTCC00139956,1862717,46191
CHEMBL940,P23975,GABAPENTIN,UGJMXCAKCUNAIE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7327042,DTCC00204291,2025637,46191
CHEMBL940,P23975,GABAPENTIN,UGJMXCAKCUNAIE-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7327043,DTCC00204291,2025637,46191
CHEMBL941,P23975,IMATINIB,KTUFNOKKBVMGRW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7310879,DTCC01738580,51477,46191
CHEMBL941,P23975,IMATINIB,KTUFNOKKBVMGRW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7310880,DTCC01738580,51477,46191
CHEMBL9419,P23975,METACETAMOL,QLNWXBAGRTUKKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7283758,DTCC00136686,477909,46191
CHEMBL9419,P23975,METACETAMOL,QLNWXBAGRTUKKI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7283759,DTCC00136686,477909,46191
CHEMBL942,P23975,BISACODYL,KHOITXIGCFIULA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267351,DTCC00204742,736255,46191
CHEMBL942,P23975,BISACODYL,KHOITXIGCFIULA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7267352,DTCC00204742,736255,46191
CHEMBL945,P23975,AMILORIDE,XSDQTOBWRPYKKA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295301,DTCC00205274,2057644,46191
CHEMBL945,P23975,AMILORIDE,XSDQTOBWRPYKKA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7295302,DTCC00205274,2057644,46191
CHEMBL94739,P23975,FEMOXETINE,OJSFTALXCYKKFQ-YLJYHZDGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821,KI,=,760,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14708784,DTCC00259432,2097830,68566
CHEMBL95,P23975,TACRINE,YLJREFDVOIBQDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8558529,IC50,=,11000,NM,,,,,,,,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,1996,39,2,"Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC",,193312,DTCT0023180,948042,DTCC00140002,271262,13807
CHEMBL95,P23975,TACRINE,YLJREFDVOIBQDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,517,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7487075,DTCC00140002,283001,46191
CHEMBL95,P23975,TACRINE,YLJREFDVOIBQDA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,513,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7487076,DTCC00140002,283001,46191
CHEMBL9514,P23975,NOCODAZOLE,KYRVNWMVYQXFEU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7377689,DTCC00136712,2025640,46191
CHEMBL9514,P23975,NOCODAZOLE,KYRVNWMVYQXFEU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7377690,DTCC00136712,2025640,46191
CHEMBL954,P23975,ENCLOMIPHENE,GKIRPKYJQBWNGO-OCEACIFDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,862,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362987,DTCC00208231,1383775,46191
CHEMBL954,P23975,ENCLOMIPHENE,GKIRPKYJQBWNGO-OCEACIFDSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,855,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7362988,DTCC00208231,1383775,46191
CHEMBL95764,P23975,GLYPHOSATE,XDDAORKBJWWYJS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7316871,DTCC00263189,1894968,46191
CHEMBL95764,P23975,GLYPHOSATE,XDDAORKBJWWYJS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7316872,DTCC00263189,1894968,46191
CHEMBL959,P23975,RIMANTADINE,UBCHPRBFMUDMNC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455623,DTCC00208870,574626,46191
CHEMBL959,P23975,RIMANTADINE,UBCHPRBFMUDMNC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7455624,DTCC00208870,574626,46191
CHEMBL960,P23975,LEFLUNOMIDE,VHOGYURTWQBHIL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,4630,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427221,DTCC00208904,249943,46191
CHEMBL960,P23975,LEFLUNOMIDE,VHOGYURTWQBHIL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,4591,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7427222,DTCC00208904,249943,46191
CHEMBL964,P23975,DISULFIRAM,AUZONCFQVSMFAP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,70370,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7355507,DTCC00209451,1318441,46191
CHEMBL964,P23975,DISULFIRAM,AUZONCFQVSMFAP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,69812,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7355508,DTCC00209451,1318441,46191
CHEMBL972,P23975,SELEGILINE,MEZLKOACVSPNER-GFCCVEGCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460296,DTCC00210689,51433,46191
CHEMBL972,P23975,SELEGILINE,MEZLKOACVSPNER-GFCCVEGCSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7460297,DTCC00210689,51433,46191
CHEMBL975,P23975,MESNA,XOGTZOOQQBDUSI-UHFFFAOYSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406512,DTCC00211154,1960079,46191
CHEMBL975,P23975,MESNA,XOGTZOOQQBDUSI-UHFFFAOYSA-M,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7406513,DTCC00211154,1960079,46191
CHEMBL976,P23975,PRAZIQUANTEL,FSVJFNAIGNNGKK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381096,DTCC00213280,1383780,46191
CHEMBL976,P23975,PRAZIQUANTEL,FSVJFNAIGNNGKK-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7381097,DTCC00213280,1383780,46191
CHEMBL980,P23975,GUAIFENESIN,HSRJKNPTNIJEKV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308419,DTCC00214269,994593,46191
CHEMBL980,P23975,GUAIFENESIN,HSRJKNPTNIJEKV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7308420,DTCC00214269,994593,46191
CHEMBL983,P23975,SUCCINYLCHOLINE CHLORIDE,YOEWQQVKRJEPAE-UHFFFAOYSA-L,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482855,DTCC00215702,1674152,46191
CHEMBL983,P23975,SUCCINYLCHOLINE CHLORIDE,YOEWQQVKRJEPAE-UHFFFAOYSA-L,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7482856,DTCC00215702,1674152,46191
CHEMBL98350,P23975,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7421151,DTCC00262208,1960077,46191
CHEMBL98350,P23975,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7421152,DTCC00262208,1960077,46191
CHEMBL989,P23975,FLUOCINOLONE ACETONIDE,FEBLZLNTKCEFIT-VSXGLTOVSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335410,DTCC00218597,1351110,46191
CHEMBL989,P23975,FLUOCINOLONE ACETONIDE,FEBLZLNTKCEFIT-VSXGLTOVSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7335411,DTCC00218597,1351110,46191
CHEMBL990,P23975,BUTENAFINE,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,3909.9,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7271653,DTCC00218762,1862713,46191
CHEMBL990,P23975,BUTENAFINE,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,3877.5,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7271654,DTCC00218762,1862713,46191
CHEMBL991,P23975,STAVUDINE,XNKLLVCARDGLGL-JGVFFNPUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469450,DTCC00220129,1927023,46191
CHEMBL991,P23975,STAVUDINE,XNKLLVCARDGLGL-JGVFFNPUSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7469451,DTCC00220129,1927023,46191
CHEMBL99653,P23975,,YUTGLCAFRPAGFA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,IC50,=,32,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422,DTCT0023180,2657193,DTCC00265874,1652971,30478
CHEMBL99653,P23975,,YUTGLCAFRPAGFA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608,KI,=,21,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008,51,13,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421,DTCT0023180,2657164,DTCC00265874,1652971,30478
CHEMBL998,P23975,LORATADINE,JCCNYMKQOSZNPW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435973,DTCC00223343,1253325,46191
CHEMBL998,P23975,LORATADINE,JCCNYMKQOSZNPW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705,DTCT0023180,7435974,DTCC00223343,1253325,46191
CHEMBL99946,P23975,LEVOMILNACIPRAN,GJJFMKBJSRMPLA-DZGCQCFKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18445525,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of human NET,,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,11,"Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C",,467619,DTCT0023180,2372802,DTCC00268088,876778,25565
CHEMBL99946,P23975,LEVOMILNACIPRAN,GJJFMKBJSRMPLA-DZGCQCFKSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18468895,IC50,=,40,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,11,"Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C",,467790,DTCT0023180,2374226,DTCC00268088,892995,25551
,P23975,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10755640,KI,=,240,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14744922,DTCC01744004,2108863,69751
,P23975,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11082457,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14749172,DTCC01744004,2109583,69438
,P23975,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14746984,DTCC01744004,2109188,69275
,P23975,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14749654,DTCC01744004,2109188,69275
,P23975,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14751413,DTCC01744004,2110075,69159
,P23975,D-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-GSVOUGTGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755099,DTCC01745877,2104421,69159
,P23975,D-HOMOCYSTEINE SULFINIC ACID,PDNJLMZEGXHSCU-GSVOUGTGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14753013,DTCC01746621,2110340,69159
,P23975,D-HOMOCYSTEINE THIOLACTONE,KIWQWJKWBHZMDT-GSVOUGTGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14751359,DTCC01746491,2110074,69159
,P23975,DL-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755142,DTCC01745876,2104415,69159
,P23975,DL-METHAMPHETAMINE,MYWUZJCMWCOHBA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,12.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14756700,DTCC01746551,2110212,69025
,P23975,EED226,DYIRSNMPIZZNBK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,28135235,IC50,=,30000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14724690,DTCC01744057,2096701,67941
,P23975,EPHEDRONE,LPLLVINFLBSFRP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954796,KI,=,13.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14751721,DTCC01746523,2110128,69025
,P23975,HYDROXYNEFAZODONE,PPJRQXMDFSRWFH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,664,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14753148,DTCC01745959,2107663,68466
,P23975,HYDROXYNEFAZODONE,PPJRQXMDFSRWFH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,1053,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14753147,DTCC01745959,2107663,68466
,P23975,MDL 100907,HXTGXYRHXAGCFP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15999145,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14750504,DTCC01745097,2109914,69464
,P23975,S33005,UBIQMAFTTDZGEX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11454918,KI,=,1510,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730033,DTCC01745831,2104047,69315
,P23975,TH588,PNMYJIOQIAEYQL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24695224,% INHIBITION,=,99,,inhibition,,functional,,,,10000,NM,,,,,,,,,,,,,GAD H ET AL,,,DTCT0023180,14819121,DTCC01743988,2096467,67732
,P23975,TRIAZOLEDIONE,BTNXVMLCKOPOEP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14747991,DTCC01746184,2109527,68466